{"meta":{"query_hash":"ee89edce7903","filters":{"venue":"Clinical Pharmacology & Therapeutics"},"cohort_total":490,"direct_labels_cover":3,"predictions_cover":490,"exported":490,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ee89edce7903","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Pharmacology+%26+Therapeutics"},"results":[{"id":"W1486887573","doi":"10.1016/s0009-9236(03)90393-6b","title":"Perspective of canadian pediatricians on barriers to drug investigation in children in Canada","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Perspective (graphical); Medicine; Drug; Family medicine; Pharmacology; Computer science","score_opus":0.07613562687481412,"score_gpt":0.4110212150575115,"score_spread":0.33488558818269737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486887573","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19234115,0.010819965,0.0005773406,0.75049967,0.001244931,0.000095853124,0.0008069192,0.000054455177,0.043559738],"genre_scores_gemma":[0.8044702,0.014184183,0.0019501642,0.16597001,0.00087531545,0.00007203668,0.0002491691,0.0000675582,0.0121614095],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99183464,0.0011827165,0.00048706142,0.0003544573,0.0023004073,0.0038407624],"domain_scores_gemma":[0.9474842,0.008774403,0.005028768,0.0002418438,0.016179973,0.022290926],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004238978,0.0002963343,0.00050585467,0.0015831748,0.010489547,0.0042225095,0.0017649326,0.0051924437,0.011566422],"category_scores_gemma":[0.0182991,0.0005750495,0.0006423952,0.0030553567,0.0037513606,0.0012047666,0.001979406,0.006084237,0.0003100478],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041258824,0.0002404312,0.46636334,0.0010823067,0.00020346126,0.013472725,0.0479601,0.0014094997,0.0021581647,0.026978439,0.34191057,0.09780832],"study_design_scores_gemma":[0.00012478222,0.0002482057,0.48287195,0.0024154221,0.000258433,0.0037602405,0.1478005,0.0010667404,0.00095994776,0.0025295117,0.35768205,0.00028229467],"about_ca_topic_score_codex":0.9824964,"about_ca_topic_score_gemma":0.99256694,"teacher_disagreement_score":0.99576104,"about_ca_system_score_codex":0.07452735,"about_ca_system_score_gemma":0.2137075,"threshold_uncertainty_score":0.5407363},"labels":[],"label_agreement":null},{"id":"W1586266234","doi":"10.1002/cpt.176","title":"Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; Indiana Clinical and Translational Sciences Institute; National Institute of Environmental Health Sciences; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Transporter; Ontogeny; Drug; Pharmacology; Medicine; Computational biology; Chemistry; Biology; Biochemistry; Internal medicine; Gene","score_opus":0.19333240478759608,"score_gpt":0.47056720107202,"score_spread":0.27723479628442393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1586266234","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008203246,0.9980909,0.00011930064,0.00094313937,0.00021267457,0.000017213608,0.00012102274,0.0000047611793,0.0004088384],"genre_scores_gemma":[0.00039232874,0.99868447,0.000265805,0.00029607033,0.00007850927,0.000018410748,0.00009653951,0.0000013659641,0.00016646333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993753,0.00012627624,0.00022696429,0.00008501751,0.00015036788,0.000036204976],"domain_scores_gemma":[0.99723,0.0014755548,0.00045063073,0.000055763747,0.00070441887,0.0000835745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022057309,0.00084795634,0.0019483318,0.005021064,0.0002627842,0.0009738698,0.0012466499,0.0012557793,0.0048115538],"category_scores_gemma":[0.004373117,0.0004798419,0.0020103985,0.004028684,0.0004728641,0.0017028992,0.00081899075,0.0014149863,0.0013311565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015999415,0.000044489312,0.0007896576,0.12836856,0.0004641117,0.00032939855,0.00017440744,0.00032360878,0.0006411162,0.00425819,0.04933719,0.81510925],"study_design_scores_gemma":[0.00004739737,0.0000956131,0.0038841777,0.119884685,0.0017095567,0.0016844429,0.00017613887,0.00011645999,0.0004224693,0.0029931203,0.86894083,0.000045173783],"about_ca_topic_score_codex":0.0047503235,"about_ca_topic_score_gemma":0.007622386,"teacher_disagreement_score":0.005021064,"about_ca_system_score_codex":0.0012102235,"about_ca_system_score_gemma":0.005054808,"threshold_uncertainty_score":0.016096234},"labels":[],"label_agreement":null},{"id":"W1598794013","doi":"10.1002/cpt.167","title":"Children: Are We Doing Enough?","year":2015,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pediatric research; Medicine; Population; Psychology; Environmental health; Pediatrics","score_opus":0.293640376953571,"score_gpt":0.5088611963876836,"score_spread":0.2152208194341126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1598794013","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039015283,0.0023468966,0.000058182464,0.99411976,0.0019089872,0.0000027203555,0.000013452945,0.000007541461,0.001152298],"genre_scores_gemma":[0.005333254,0.004950746,0.0002635198,0.9788275,0.009174556,0.000011423494,0.000016011163,0.000010531647,0.0014125517],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938949,0.0026753119,0.0007228735,0.0006153091,0.0015182707,0.00057340675],"domain_scores_gemma":[0.98458856,0.008834509,0.0012788352,0.00040617873,0.0022805498,0.002611349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005686276,0.0005642268,0.001436365,0.0006653053,0.0035290262,0.0033907162,0.0013600859,0.028783452,0.0074085314],"category_scores_gemma":[0.03579194,0.00046258108,0.00089592376,0.0006696175,0.004430485,0.008169286,0.0018311118,0.041103348,0.0045030927],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008198056,0.00007311528,0.0063619846,0.00030106303,0.000053742533,0.0067456984,0.0011025411,0.00008973474,0.00033566283,0.009121104,0.9182002,0.057533104],"study_design_scores_gemma":[0.00013518422,0.00019994867,0.0053687072,0.0025848288,0.0000727334,0.024928516,0.0041662054,0.0003096254,0.00030458218,0.02969328,0.9321225,0.00011378127],"about_ca_topic_score_codex":0.007900285,"about_ca_topic_score_gemma":0.013624109,"teacher_disagreement_score":0.028783452,"about_ca_system_score_codex":0.0049245246,"about_ca_system_score_gemma":0.0047926055,"threshold_uncertainty_score":0.035730064},"labels":[],"label_agreement":null},{"id":"W1859537116","doi":"10.1002/cpt.158","title":"Risks of congenital malformations in offspring exposed to valproic acid <i>in utero</i>: A systematic review and cumulative meta‐analysis","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"In utero; Offspring; Valproic Acid; Meta-analysis; Medicine; Congenital malformations; Pregnancy; Obstetrics; Physiology; Internal medicine; Epilepsy; Biology; Fetus; Genetics; Psychiatry","score_opus":0.58865317533237,"score_gpt":0.578545360180645,"score_spread":0.010107815151725097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1859537116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003534688,0.9953512,0.0002950779,0.00011528779,0.00005489333,0.00004379062,0.0004214258,0.000006984823,0.00017671197],"genre_scores_gemma":[0.095558465,0.9016243,0.001171759,0.0003785205,0.00012299718,0.00016143147,0.0007397373,0.000012049397,0.00023070947],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970373,0.001210052,0.0008431597,0.00044771034,0.000354985,0.00010672792],"domain_scores_gemma":[0.99064964,0.007132979,0.0012037774,0.00026733868,0.0006475148,0.00009876694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005382022,0.0014526746,0.006224041,0.0041251434,0.00036081186,0.0014234044,0.0009821025,0.0010431345,0.0022484192],"category_scores_gemma":[0.013501998,0.0007916205,0.017132418,0.004994679,0.0002909653,0.00070628914,0.000950307,0.001041127,0.00019459982],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017001386,0.000034973033,0.019750252,0.3516003,0.57076323,0.00037768553,0.00012003428,0.0007790303,0.00052331906,0.0003590997,0.0017253768,0.052266534],"study_design_scores_gemma":[0.00022761103,0.00018620846,0.014301949,0.025912343,0.9515653,0.00037861097,0.000062373154,0.00022500906,0.00026041362,0.00040376428,0.00644774,0.000028625931],"about_ca_topic_score_codex":0.0048140795,"about_ca_topic_score_gemma":0.011656207,"teacher_disagreement_score":0.006224041,"about_ca_system_score_codex":0.0010114136,"about_ca_system_score_gemma":0.001751046,"threshold_uncertainty_score":0.028463185},"labels":[],"label_agreement":null},{"id":"W1886211687","doi":"10.1002/cpt.284","title":"Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Omalizumab; Asthma; Immunology; Medicine; Monoclonal antibody; Immunoglobulin E; Cytokine; Mepolizumab; Antibody; Allergy; Eosinophil","score_opus":0.4073594702037661,"score_gpt":0.5071271919195822,"score_spread":0.0997677217158161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886211687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019972885,0.99805176,0.00017602659,0.00019403186,0.00022266131,0.000011946462,0.000018535417,0.000010099795,0.001115212],"genre_scores_gemma":[0.0010642066,0.99727386,0.00028608454,0.00029622164,0.00015666097,0.000015126411,0.00004278574,0.000001986793,0.0008631223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997514,0.000044930148,0.000026775137,0.00003540255,0.000103553175,0.000037856415],"domain_scores_gemma":[0.99981576,0.00007624075,0.000028610086,0.0000070154033,0.00005076918,0.000021642209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007335928,0.0009597464,0.0013853116,0.0025307164,0.00026803833,0.0010215952,0.0010532396,0.0012350337,0.004233762],"category_scores_gemma":[0.0006118279,0.00036403074,0.000698431,0.0017367615,0.0004996341,0.0012785199,0.00086232467,0.0027651505,0.0025033036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012280414,0.000199148,0.00015245679,0.013024623,0.00013542378,0.0002730337,0.00007282909,0.0004666148,0.0041620126,0.0077336016,0.026421241,0.94723636],"study_design_scores_gemma":[0.00004678676,0.00013245211,0.00039377259,0.0016350606,0.00008710329,0.0008656023,0.000027362483,0.00009711654,0.0007402487,0.0019593923,0.99400085,0.000014296521],"about_ca_topic_score_codex":0.00073004403,"about_ca_topic_score_gemma":0.0015768628,"teacher_disagreement_score":0.004233762,"about_ca_system_score_codex":0.00062237045,"about_ca_system_score_gemma":0.00069067214,"threshold_uncertainty_score":0.014163315},"labels":[],"label_agreement":null},{"id":"W1919247819","doi":"10.1016/j.clpt.2005.12.124","title":"OV-A-3Genetic determinants of the hepatic expression of the phase II conjugating UGT1A3 enzyme","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Enzyme; Chemistry; Phase (matter); Biochemistry; Pharmacology; Medicine; Organic chemistry","score_opus":0.16431138991915625,"score_gpt":0.5032590767554878,"score_spread":0.3389476868363315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919247819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997247,0.00034860254,0.0011264951,0.000044483666,0.000015657452,0.00001662709,0.00054817204,0.00002383352,0.00062909606],"genre_scores_gemma":[0.9965204,0.00014216671,0.0008953633,0.000027871429,0.000012187674,0.00002212027,0.0011504018,0.000024973499,0.0012044604],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998534,0.00002608621,0.000013279793,0.000046288747,0.000022416374,0.00003862203],"domain_scores_gemma":[0.9998307,0.000039780527,0.000054954533,0.000026717724,0.0000143798225,0.0000333905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001369517,0.00020354998,0.00015956267,0.00028534923,0.00012806752,0.00022424739,0.000108816785,0.00017153652,0.0048486665],"category_scores_gemma":[0.0002307037,0.00009369558,0.000248339,0.00019521794,0.00019831955,0.000081444115,0.00013290056,0.00035979014,0.00079355325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010078453,0.000107655746,0.0069981623,0.000020977253,0.000017380275,0.00013798641,0.000030576317,0.00004208613,0.9877862,0.00015991263,0.00008547801,0.0036057562],"study_design_scores_gemma":[0.00030787598,0.0028093823,0.28958488,0.00002397337,0.00019348472,0.0042240215,0.00017052428,0.0018825935,0.68817544,0.0006423042,0.011964398,0.000021154932],"about_ca_topic_score_codex":0.0006678995,"about_ca_topic_score_gemma":0.00044389116,"teacher_disagreement_score":0.0048486665,"about_ca_system_score_codex":0.00016437829,"about_ca_system_score_gemma":0.00013360118,"threshold_uncertainty_score":0.01622039},"labels":[],"label_agreement":null},{"id":"W1921586980","doi":"10.1002/cpt.203","title":"Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Transparency (behavior); Risk analysis (engineering); Business; Risk assessment; Regulatory science; Drug development; Process management; Medicine; Drug; Pharmacology; Computer science; Computer security","score_opus":0.6491720548327571,"score_gpt":0.6195767082772885,"score_spread":0.029595346555468582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921586980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001195594,0.8096004,0.09995937,0.05809664,0.0024637678,0.0005774698,0.000651941,0.00028902778,0.027165828],"genre_scores_gemma":[0.048206564,0.70502305,0.21799654,0.019335397,0.003713961,0.0018399658,0.00097243907,0.00017351363,0.002738533],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.954952,0.02424444,0.004729512,0.0019275809,0.013209239,0.00093715725],"domain_scores_gemma":[0.81958145,0.14512487,0.01135024,0.0067283963,0.015890097,0.0013249516],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10276395,0.0033243613,0.0061079483,0.009624248,0.0015897176,0.013153164,0.00748137,0.008376496,0.007554999],"category_scores_gemma":[0.111903064,0.0015272747,0.005138587,0.0077671045,0.009761293,0.012345364,0.0072701974,0.0150632085,0.0018764784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056109257,0.000096926095,0.0003291867,0.017292937,0.00035197317,0.00009756954,0.0005391687,0.004482837,0.00026114075,0.73339295,0.016162407,0.22693676],"study_design_scores_gemma":[0.00008893431,0.00008325685,0.0008153677,0.05657321,0.0006332914,0.00026566786,0.00052032014,0.003725244,0.0004142443,0.60260224,0.3341316,0.00014660103],"about_ca_topic_score_codex":0.0063460856,"about_ca_topic_score_gemma":0.007166075,"teacher_disagreement_score":0.89723605,"about_ca_system_score_codex":0.0091374675,"about_ca_system_score_gemma":0.02506459,"threshold_uncertainty_score":0.5434742},"labels":[],"label_agreement":null},{"id":"W1950615881","doi":"10.1002/cpt.201","title":"Schizophrenia and the influence of male gender","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Schizophrenia (object-oriented programming); Psychiatry; Psychology; Medicine; Clinical psychology","score_opus":0.25729247375135267,"score_gpt":0.48338880913043497,"score_spread":0.2260963353790823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1950615881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828021,0.0044349246,0.0001036204,0.0020524345,0.00009276186,0.000007780481,0.00026462012,0.000007483571,0.01023427],"genre_scores_gemma":[0.99801123,0.0008784127,0.000038296857,0.00011288086,0.000025263913,0.0000014796575,0.000036176116,0.000004682857,0.0008915567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996214,0.00014276261,0.000014457741,0.000042111376,0.00009961979,0.000079723126],"domain_scores_gemma":[0.99863356,0.00045217894,0.00044046855,0.00007306869,0.00007883177,0.00032188787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054463255,0.00017870496,0.0003046833,0.000522355,0.0006968676,0.0010857608,0.00020060151,0.0002948039,0.0072600483],"category_scores_gemma":[0.003581633,0.00013356525,0.00027566205,0.00040617486,0.0005557993,0.00036403368,0.000534091,0.00041167694,0.0004267445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011172703,0.00013236387,0.9566228,0.000033073396,0.00012688525,0.0010625654,0.0017534879,0.00008624811,0.0009866464,0.002112847,0.0014070013,0.03455883],"study_design_scores_gemma":[0.000012055677,0.00015510275,0.99356127,0.000051596173,0.000046784855,0.0009148907,0.0017547458,0.00014209496,0.00013809577,0.0009593117,0.0022534982,0.0000105211575],"about_ca_topic_score_codex":0.009247563,"about_ca_topic_score_gemma":0.012694988,"teacher_disagreement_score":0.009247563,"about_ca_system_score_codex":0.0005218469,"about_ca_system_score_gemma":0.0007589712,"threshold_uncertainty_score":0.024287283},"labels":[],"label_agreement":null},{"id":"W1954522611","doi":"10.1016/j.clpt.2003.11.009","title":"Probing opioid effects in major depression hydromorphone (HM) challenge","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Placebo; Opioid; Major depressive disorder; Depression (economics); Medicine; Internal medicine; Hamd; Psychology; Hydromorphone; Anesthesia; Mood; Psychiatry; Significant difference; Receptor","score_opus":0.06385215346772229,"score_gpt":0.4052982068413665,"score_spread":0.34144605337364425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1954522611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900925,0.00046470287,0.00014482459,0.00002409302,0.000016233767,0.000094971125,0.00010283646,0.0000084805615,0.00013455951],"genre_scores_gemma":[0.99816185,0.0004312626,0.00040116004,0.000067941524,0.000024838366,0.00014123815,0.00014952062,0.0000016251329,0.0006205824],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998853,0.000039022645,0.000010060809,0.000017066259,0.000028015407,0.000020514872],"domain_scores_gemma":[0.99981576,0.000043407625,0.000056879067,0.000015050167,0.000013720515,0.000055200264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028949685,0.00027277495,0.0006903388,0.000080631624,0.00011376806,0.00011665018,0.00016365295,0.00034550935,0.0012540903],"category_scores_gemma":[0.00034106037,0.00015241229,0.0001704219,0.0000795932,0.00017142422,0.00010927262,0.00011658924,0.0005104525,0.00013731103],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10223702,0.006808055,0.011297458,0.0005920528,0.00023080925,0.0002754964,0.00017195658,0.00060582365,0.8295588,0.000065998305,0.0004229686,0.047733653],"study_design_scores_gemma":[0.0152931465,0.55355716,0.27187115,0.000043152446,0.00028204834,0.0009116648,0.0001693681,0.0022624263,0.15273677,0.00011433786,0.0027161534,0.00004266687],"about_ca_topic_score_codex":0.0004029052,"about_ca_topic_score_gemma":0.0012204971,"teacher_disagreement_score":0.0012540903,"about_ca_system_score_codex":0.00013452054,"about_ca_system_score_gemma":0.00015803232,"threshold_uncertainty_score":0.0041953325},"labels":[],"label_agreement":null},{"id":"W1964333742","doi":"10.1038/clpt.2012.154","title":"Epigenetic Chemical Probes","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Structural Genomics Consortium","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Epigenetics; Histone; DNA methylation; Gene expression; Computational biology; Methylation; Regulation of gene expression; Biology; DNA; Gene; Genetics","score_opus":0.19702409534672538,"score_gpt":0.4766277423614126,"score_spread":0.2796036470146872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964333742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002770469,0.70990777,0.036486343,0.003930553,0.006131809,0.0002965122,0.0009793917,0.00093313237,0.23856395],"genre_scores_gemma":[0.037408594,0.6724284,0.023338526,0.0054703862,0.0018304776,0.000567369,0.00183989,0.00015362677,0.25696272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996468,0.000047441772,0.0000151511,0.00008850949,0.00016176175,0.000040366114],"domain_scores_gemma":[0.99982065,0.000051264426,0.000024849456,0.000025802532,0.000054096836,0.00002346226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055534916,0.0011551556,0.0007178054,0.0011506168,0.0005974797,0.0009991027,0.0014934827,0.0019245113,0.038495515],"category_scores_gemma":[0.0005355441,0.000498433,0.00048996176,0.00074432784,0.00084607216,0.0013751686,0.0014372009,0.0028112864,0.023316193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011452699,0.00016386299,0.00022355441,0.0049602184,0.00006810415,0.00066810014,0.00012456984,0.00067187607,0.10815647,0.058215953,0.110089146,0.7165435],"study_design_scores_gemma":[0.000013811286,0.000046122394,0.0001358833,0.00021172136,0.000013197574,0.0005924772,0.000019575318,0.00009620849,0.014705342,0.0028782464,0.9812748,0.000012701343],"about_ca_topic_score_codex":0.0005339933,"about_ca_topic_score_gemma":0.0011438935,"teacher_disagreement_score":0.038495515,"about_ca_system_score_codex":0.000848939,"about_ca_system_score_gemma":0.000644647,"threshold_uncertainty_score":0.1287803},"labels":[],"label_agreement":null},{"id":"W1964612294","doi":"10.1016/j.clpt.2003.11.094","title":"Fluvoxamine (LUVOX™) use in pregnancy","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Fluvoxamine; Medicine; Pregnancy; Depression (economics); Obstetrics; Clinical pharmacology; Serotonin reuptake inhibitor; Birth weight; Prospective cohort study; Fluoxetine; Pediatrics; Internal medicine; Antidepressant; Serotonin; Pharmacology","score_opus":0.16347744935869693,"score_gpt":0.45778079357164003,"score_spread":0.29430334421294313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964612294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942668,0.004418805,0.00007871599,0.000077136676,0.0000084576595,0.00001783023,0.00022045035,0.0000029148773,0.00090900535],"genre_scores_gemma":[0.9983632,0.0012395318,0.00007509566,0.000038343333,0.000010153037,0.0000110768015,0.000096076845,5.134757e-7,0.00016607367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955064,0.00017134125,0.000050690218,0.00008615834,0.00009178323,0.000049501297],"domain_scores_gemma":[0.99910164,0.0003345452,0.00040295403,0.000029505287,0.000042140728,0.000089219335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004188516,0.000111619345,0.00022669663,0.00037027575,0.00020345976,0.00023496931,0.00013968695,0.0002947623,0.000933276],"category_scores_gemma":[0.0016774063,0.0001017331,0.00016592594,0.00042980234,0.00012433522,0.00012798794,0.00013791029,0.0002003043,0.000095610005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089033827,0.000109323926,0.9776529,0.00010367435,0.00009116159,0.000536392,0.00015327542,0.000049604503,0.0012174088,0.00004566087,0.00009785491,0.01905244],"study_design_scores_gemma":[0.000026811605,0.0015724407,0.9937337,0.00004615269,0.0000765904,0.0031871197,0.00007660953,0.00009811629,0.0003732663,0.000041099505,0.0007632568,0.0000047509984],"about_ca_topic_score_codex":0.0019994285,"about_ca_topic_score_gemma":0.0015977382,"teacher_disagreement_score":0.0019994285,"about_ca_system_score_codex":0.00027378977,"about_ca_system_score_gemma":0.00021370489,"threshold_uncertainty_score":0.00397557},"labels":[],"label_agreement":null},{"id":"W1965717563","doi":"10.1002/cpt.59","title":"From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux; Canadian Agency for Drugs and Technologies in Health; Health Canada","funders":"European Federation of Pharmaceutical Industries and Associations","keywords":"Risk analysis (engineering); Sustainability; Business; Drug development; Life span; Adaptive strategies; New product development; Medicine; Drug; Marketing; Gerontology; Pharmacology","score_opus":0.696669527203476,"score_gpt":0.5022952081605061,"score_spread":0.19437431904296987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965717563","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055634115,0.011253139,0.51519525,0.26700372,0.0018465479,0.0009568985,0.00036320672,0.00063889736,0.14710829],"genre_scores_gemma":[0.87951046,0.0043615117,0.07607004,0.027145492,0.0016809625,0.00080667384,0.000097038595,0.00017347785,0.010154289],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98679906,0.008778818,0.00041918218,0.0012262976,0.0017427705,0.0010339014],"domain_scores_gemma":[0.9734402,0.015533861,0.0028912176,0.0025284544,0.0014233196,0.0041830256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02105971,0.0007670069,0.0006700698,0.0014550326,0.0013232266,0.006310981,0.0020583107,0.0051660277,0.016149115],"category_scores_gemma":[0.04929308,0.00043948521,0.0014537895,0.0007984156,0.007620467,0.01657066,0.008633748,0.0067794346,0.0015562855],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031877906,0.00037271605,0.0030086085,0.00046115636,0.00016345085,0.00025799518,0.00072981435,0.010070069,0.0011115845,0.83691716,0.008350499,0.1382382],"study_design_scores_gemma":[0.00013563223,0.00040410447,0.0010177018,0.0003071214,0.000034770048,0.00024316143,0.00023559923,0.0065227803,0.00061093736,0.95742804,0.033002954,0.000057201934],"about_ca_topic_score_codex":0.00078291824,"about_ca_topic_score_gemma":0.00081279984,"teacher_disagreement_score":0.02105971,"about_ca_system_score_codex":0.0040992443,"about_ca_system_score_gemma":0.006568216,"threshold_uncertainty_score":0.11137569},"labels":[],"label_agreement":null},{"id":"W1966308229","doi":"10.1038/clpt.2013.42","title":"System, Crowd, and Communal Innovation: Can the Monks Solve the Elephant?","year":2013,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Evolutionary Game Theory and Cooperation","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Construct (python library); Computer science; Data science; Complex system; Artificial intelligence","score_opus":0.0659278245362619,"score_gpt":0.42742740838631677,"score_spread":0.3614995838500549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966308229","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009259451,0.03851316,0.0004537623,0.13572626,0.8241971,0.000013184345,0.000035746674,0.000052966265,0.00091526896],"genre_scores_gemma":[0.0010867381,0.025558272,0.00021731589,0.037058983,0.9322739,0.000023162129,0.000018311013,0.000026627178,0.0037366191],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977113,0.00063452945,0.00027088623,0.0003226972,0.0008763901,0.00018405363],"domain_scores_gemma":[0.9810637,0.013774155,0.0005628683,0.00035922517,0.0026568775,0.001583071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006626068,0.0034595467,0.0036479118,0.001946719,0.0031052968,0.008274661,0.005348005,0.019448606,0.0041513955],"category_scores_gemma":[0.017490095,0.0009125403,0.0020871765,0.0012038689,0.007180067,0.00811738,0.0020156654,0.029601555,0.0032783072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003330049,0.000015530964,0.000038467486,0.0003723548,0.000032669137,0.00013474266,0.000056631292,0.000069688445,0.0000459637,0.0030148493,0.987288,0.008897777],"study_design_scores_gemma":[0.000059623355,0.000039498558,0.00031557752,0.00082923623,0.00008247742,0.00033910622,0.00021456927,0.00051538314,0.000103357466,0.014126341,0.9833382,0.00003669605],"about_ca_topic_score_codex":0.002433502,"about_ca_topic_score_gemma":0.0056872093,"teacher_disagreement_score":0.019448606,"about_ca_system_score_codex":0.00287036,"about_ca_system_score_gemma":0.0028599561,"threshold_uncertainty_score":0.035042405},"labels":[],"label_agreement":null},{"id":"W1967478796","doi":"10.1038/clpt.2014.92","title":"Genetic Markers of Cisplatin-Induced Hearing Loss in Children","year":2014,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Clinical pharmacology; Cisplatin; Hearing loss; Medicine; Audiology; Psychology; Pharmacology; Internal medicine; Chemotherapy","score_opus":0.1521319106897729,"score_gpt":0.41366531784897154,"score_spread":0.26153340715919865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967478796","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005427128,0.003124017,0.00023810256,0.9745393,0.012403458,0.000014189138,0.00011910267,0.00004908138,0.0040857275],"genre_scores_gemma":[0.0777258,0.0067161405,0.0010590177,0.8465909,0.0585864,0.00006835994,0.00010542795,0.00006820522,0.009079704],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9981019,0.0007172296,0.00023510338,0.00025272294,0.0005013554,0.00019173158],"domain_scores_gemma":[0.9928243,0.004818444,0.00049236056,0.00019225501,0.0011426655,0.0005298661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022888025,0.00047580808,0.0008323217,0.00093105924,0.0018727748,0.0011052749,0.0012909957,0.014681219,0.002086841],"category_scores_gemma":[0.020054188,0.0004335918,0.0005163623,0.0005425148,0.0013864613,0.0013196649,0.0008018169,0.009975712,0.0015352205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016681173,0.000071500166,0.017631922,0.00009877483,0.00004709819,0.026141457,0.00048095113,0.00019057131,0.00087231974,0.0032093741,0.9253129,0.025776394],"study_design_scores_gemma":[0.00042844375,0.00051811745,0.039107602,0.002081269,0.0003200883,0.13439067,0.0022876903,0.0027641775,0.004043013,0.02309814,0.79063904,0.00032180757],"about_ca_topic_score_codex":0.005899908,"about_ca_topic_score_gemma":0.008441208,"teacher_disagreement_score":0.014681219,"about_ca_system_score_codex":0.0021638277,"about_ca_system_score_gemma":0.0015434207,"threshold_uncertainty_score":0.015699744},"labels":[],"label_agreement":null},{"id":"W1967851981","doi":"10.1016/j.clpt.2004.12.068","title":"Effects of infant formula, cow milk and human milk on drug metabolizing enzymes","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pregnane X receptor; Aryl hydrocarbon receptor; Infant formula; CYP3A4; Chemistry; Pharmacology; Breast milk; Receptor; Endocrinology; Internal medicine; Cytochrome P450; Biology; Enzyme; Medicine; Nuclear receptor; Biochemistry; Transcription factor; Gene","score_opus":0.056908851156162996,"score_gpt":0.427783864006138,"score_spread":0.370875012849975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967851981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247026,0.006269291,0.00027528915,0.000112174734,0.00003496999,0.00001653467,0.00024503598,0.000020922838,0.0005554257],"genre_scores_gemma":[0.99499017,0.0025209582,0.000745314,0.00010773068,0.000018611128,0.000022873704,0.0003768229,0.00000663944,0.0012107912],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985766,0.000047793124,0.00001105749,0.000020147088,0.00003416696,0.000029093155],"domain_scores_gemma":[0.9998839,0.000033217457,0.000031461237,0.0000072341313,0.000019737494,0.000024396597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017110333,0.00024026044,0.00023680045,0.00018053596,0.00009784697,0.00023019989,0.00009735639,0.0001591254,0.0011605655],"category_scores_gemma":[0.00034371985,0.00006533417,0.00021320119,0.00016840866,0.00011249039,0.00012332917,0.00022870066,0.0002051645,0.000107326836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012373243,0.0005597279,0.009031849,0.00047960604,0.00015063061,0.00051688624,0.00016015717,0.000117084586,0.93817425,0.00013663714,0.00047098048,0.03782898],"study_design_scores_gemma":[0.00021623094,0.009917109,0.07681067,0.0000721118,0.00035982116,0.0007089858,0.00030970018,0.00068779674,0.8991337,0.00009571591,0.011667398,0.000020873038],"about_ca_topic_score_codex":0.0008010815,"about_ca_topic_score_gemma":0.0008731343,"teacher_disagreement_score":0.0011605655,"about_ca_system_score_codex":0.00015512106,"about_ca_system_score_gemma":0.00017938955,"threshold_uncertainty_score":0.0038824677},"labels":[],"label_agreement":null},{"id":"W1970738061","doi":"10.1038/sj.clpt.6100359","title":"The Morally Uncomfortable Global Drug Gap","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Essential medicines; Population; Human rights; Consumption (sociology); Quality (philosophy); Economic growth; Medicine; Business; Development economics; Public relations; Law and economics; Political science; Law; Health care; Economics; Sociology; Environmental health; Social science","score_opus":0.17917928466033714,"score_gpt":0.4357705111054546,"score_spread":0.25659122644511745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970738061","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044249357,0.022993809,0.00278443,0.84740776,0.0027469876,0.000018511228,0.000116397154,0.00004192564,0.1194653],"genre_scores_gemma":[0.37781912,0.045546453,0.006615878,0.50819784,0.009864457,0.0001562813,0.00023355402,0.00025512686,0.05131129],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99458486,0.0031677452,0.00012961046,0.00043382056,0.001198274,0.00048563452],"domain_scores_gemma":[0.99245536,0.0048636226,0.00052630715,0.00047853406,0.00073066226,0.0009453948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077100615,0.00057477766,0.000734562,0.000859077,0.003240881,0.0066224877,0.0010421884,0.009361791,0.018695956],"category_scores_gemma":[0.013638349,0.00019392412,0.00042013422,0.0010570161,0.013186127,0.011214351,0.0063775033,0.011600205,0.0024789716],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001904331,0.000026682897,0.00021281019,0.00009049239,0.0000063855387,0.00013326456,0.0005085209,0.00024775282,0.000051152925,0.8920388,0.085610114,0.02105503],"study_design_scores_gemma":[0.000012106472,0.000016867183,0.0002580736,0.00034156442,0.0000031180036,0.00030117924,0.0007713991,0.00028660774,0.00007880969,0.6345965,0.36332345,0.000010355996],"about_ca_topic_score_codex":0.0017570199,"about_ca_topic_score_gemma":0.0016862497,"teacher_disagreement_score":0.018695956,"about_ca_system_score_codex":0.0044640764,"about_ca_system_score_gemma":0.0056141266,"threshold_uncertainty_score":0.06254417},"labels":[],"label_agreement":null},{"id":"W1971306812","doi":"10.1038/clpt.2011.249","title":"Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Omeprazole; Efavirenz; CYP2C19; CYP3A; Pharmacology; Pharmacokinetics; Chemistry; CYP3A4; CYP2B6; Oral administration; Drug interaction; Metabolism; Medicine; Cytochrome P450; Biochemistry; Immunology","score_opus":0.09949900459842544,"score_gpt":0.4534612111092563,"score_spread":0.3539622065108309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971306812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986405,0.0005813532,0.00034034264,0.00002088269,0.000010531596,0.000037296144,0.00006627182,0.00001843174,0.0002843733],"genre_scores_gemma":[0.9989768,0.00013392195,0.00030438966,0.00005672905,0.000020841688,0.00004397709,0.0001457742,0.0000057074863,0.00031191699],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99923575,0.00029541447,0.000042939428,0.000173841,0.00018011335,0.00007201172],"domain_scores_gemma":[0.9995409,0.00010926294,0.00013215031,0.00007880218,0.000051116436,0.00008772761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078261574,0.00048526638,0.0007107472,0.00027882203,0.00032200548,0.00028389148,0.00013961997,0.00049113843,0.00075659394],"category_scores_gemma":[0.0013384784,0.00031490417,0.0003374445,0.00021072649,0.00037390593,0.00018802121,0.00022946339,0.00057189865,0.00027872156],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041980855,0.0035667478,0.2792168,0.00019194782,0.0005076434,0.0020865179,0.0007390758,0.0003846544,0.6151262,0.000097641445,0.00067151425,0.055430412],"study_design_scores_gemma":[0.00063887524,0.060408164,0.86045337,0.000011961502,0.0002904528,0.0036207833,0.00017070818,0.0010690391,0.07174404,0.000113884715,0.0014531557,0.00002560934],"about_ca_topic_score_codex":0.00077367714,"about_ca_topic_score_gemma":0.00088365277,"teacher_disagreement_score":0.00078261574,"about_ca_system_score_codex":0.00022179396,"about_ca_system_score_gemma":0.0001593571,"threshold_uncertainty_score":0.004138887},"labels":[],"label_agreement":null},{"id":"W1971946342","doi":"10.1038/clpt.2013.103","title":"Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institute of Mental Health; National Institutes of Health; National Heart, Lung, and Blood Institute; U.S. Department of Veterans Affairs; National Institute for Health and Care Research; St. Jude Children's Research Hospital","keywords":"Pharmacogenetics; Dosing; Carbamazepine; Medicine; Genotype; Pharmacology; Human leukocyte antigen; Immunology; Biology; Genetics; Epilepsy; Psychiatry; Gene; Antigen","score_opus":0.30556172178049124,"score_gpt":0.5670369111085714,"score_spread":0.2614751893280801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971946342","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012029265,0.032234073,0.16993418,0.3196545,0.0071576224,0.022582907,0.014078015,0.008863161,0.41346624],"genre_scores_gemma":[0.08250936,0.0362495,0.5132668,0.19950141,0.006787687,0.04546149,0.030703438,0.0023548598,0.08316546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95777935,0.022028029,0.008375901,0.0009374356,0.009623916,0.0012553652],"domain_scores_gemma":[0.92774487,0.024354665,0.0071570603,0.0041895444,0.0335568,0.002997061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028588606,0.001001385,0.001740466,0.0033173,0.0015102294,0.0029527645,0.0051116385,0.008064321,0.014810343],"category_scores_gemma":[0.07638578,0.0007571212,0.0026521322,0.0035154584,0.0008881937,0.0016544226,0.002330172,0.0072781583,0.010976487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031378283,0.0008564605,0.0038885863,0.00079710205,0.000081910905,0.00073680386,0.00038107313,0.0015696865,0.00096948614,0.0066325404,0.6746469,0.30912566],"study_design_scores_gemma":[0.00081390614,0.00041798645,0.013668309,0.0049663945,0.00018259205,0.001989174,0.0003465241,0.0031772829,0.0021852634,0.010716103,0.9614157,0.00012057886],"about_ca_topic_score_codex":0.013783012,"about_ca_topic_score_gemma":0.01462946,"teacher_disagreement_score":0.028588606,"about_ca_system_score_codex":0.0029719283,"about_ca_system_score_gemma":0.012099211,"threshold_uncertainty_score":0.15119284},"labels":[],"label_agreement":null},{"id":"W1971983191","doi":"10.1038/clpt.2013.219","title":"Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity","year":2013,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Columbia university; Medicine; Research centre; University hospital; Library science; Family medicine; Media studies; Sociology","score_opus":0.13018917291056392,"score_gpt":0.39944532819208234,"score_spread":0.2692561552815184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971983191","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18422617,0.011221195,0.0034538207,0.770626,0.008020753,0.000065191314,0.00037876607,0.0001894916,0.021818621],"genre_scores_gemma":[0.85577697,0.0049445597,0.0018449696,0.10219433,0.02621175,0.00003759879,0.00008982895,0.000045358163,0.008854609],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99965966,0.000108293665,0.000044601413,0.00007234113,0.000071122595,0.000043945245],"domain_scores_gemma":[0.99836046,0.0011422898,0.0001340538,0.00008217599,0.00016385064,0.00011722313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048783782,0.00031697255,0.0006213958,0.0003004078,0.0005734598,0.0005994176,0.00046815778,0.0057541467,0.0024180848],"category_scores_gemma":[0.004714208,0.000117747964,0.0003857667,0.00025584685,0.0009917681,0.0006173827,0.00036412966,0.0027100309,0.00054344407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033338058,0.00038189493,0.11562617,0.00040255694,0.00036186478,0.44130728,0.0007144521,0.0024913535,0.02295987,0.015174239,0.23270535,0.1645412],"study_design_scores_gemma":[0.0014037438,0.0014780662,0.12826581,0.0005579273,0.0008211362,0.5029408,0.0012140409,0.018794583,0.017700508,0.07763126,0.24893893,0.00025320132],"about_ca_topic_score_codex":0.0016981493,"about_ca_topic_score_gemma":0.0019206639,"teacher_disagreement_score":0.0057541467,"about_ca_system_score_codex":0.00074388576,"about_ca_system_score_gemma":0.0004410183,"threshold_uncertainty_score":0.008089244},"labels":[],"label_agreement":null},{"id":"W1975055422","doi":"10.1016/j.clpt.2003.08.003","title":"Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cotinine; Nicotine; Medicine; Nicotine patch; Breast milk; Smoking cessation; Physiology; Breast feeding; Animal science; Anesthesia; Obstetrics; Internal medicine; Pediatrics; Chemistry; Biology","score_opus":0.14969422178743427,"score_gpt":0.42517178511759673,"score_spread":0.2754775633301625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975055422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997906,0.0000787119,0.00003393017,0.0000052527394,6.847111e-7,0.0000028436948,0.0000063619154,0.0000010175482,0.00008053947],"genre_scores_gemma":[0.99934584,0.00012238344,0.00023068738,0.00002197615,0.0000026796874,0.00000778365,0.000033686658,0.0000013000529,0.00023375393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997472,0.00007435528,0.000012142982,0.000039920393,0.00009306553,0.000033312397],"domain_scores_gemma":[0.999445,0.00021169025,0.00019787102,0.000031819876,0.000060040824,0.000053462867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003912982,0.00017386812,0.00022532072,0.00014344385,0.00014227317,0.00023692897,0.0001786695,0.00026226806,0.0006292285],"category_scores_gemma":[0.0018388823,0.0001621509,0.00011851847,0.00008995212,0.00018338581,0.00015556334,0.00014452379,0.00020994295,0.00011821495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038838761,0.0005240318,0.8468165,0.000068798356,0.00008193907,0.00068177574,0.00086006883,0.000077812045,0.11311068,0.000021022151,0.0000645092,0.03380896],"study_design_scores_gemma":[0.000023450271,0.004055416,0.9698665,0.0000124757435,0.00004746301,0.0012338436,0.00038339334,0.00038876,0.023638085,0.000014052629,0.00033260448,0.000003977582],"about_ca_topic_score_codex":0.0015983781,"about_ca_topic_score_gemma":0.0015445526,"teacher_disagreement_score":0.0015983781,"about_ca_system_score_codex":0.00026150775,"about_ca_system_score_gemma":0.00019399883,"threshold_uncertainty_score":0.0031781197},"labels":[],"label_agreement":null},{"id":"W1975412693","doi":"10.1016/s0009-9236(03)90518-2","title":"Effect of St. John's Wort on The Pharmacokinetics and Pharmacodynamics of Quazepam","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Clinical pharmacology; Pharmacology; Medicine","score_opus":0.05637052923680435,"score_gpt":0.3832040229372828,"score_spread":0.32683349370047843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975412693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976367,0.0007269906,0.00012207418,0.00017170524,0.00013668805,0.000038501505,0.00010051772,0.000027616896,0.0010392057],"genre_scores_gemma":[0.99708945,0.00064862595,0.00020793575,0.00008258115,0.00017116925,0.000018452565,0.0001126821,0.000014659624,0.0016546035],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99962974,0.00016459852,0.000030437475,0.00004136627,0.000049963055,0.00008399825],"domain_scores_gemma":[0.9984059,0.00082359323,0.00020079013,0.000098023265,0.00007658393,0.00039517094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051736686,0.00051027734,0.0008494221,0.00019505084,0.00027668788,0.00036168797,0.00036561178,0.00068009534,0.0067902566],"category_scores_gemma":[0.0028697064,0.00039881733,0.00047910467,0.00019092401,0.0011806239,0.000692988,0.00022925454,0.0011638402,0.000843356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70423496,0.009517444,0.0028681832,0.0008580789,0.00046593198,0.00066813704,0.00086662057,0.0007995814,0.19578733,0.0005989736,0.001818679,0.08151612],"study_design_scores_gemma":[0.041076202,0.65953475,0.07135051,0.00009610349,0.0009394156,0.0017044183,0.0005995738,0.0060261516,0.21302001,0.00042516875,0.00509064,0.00013704624],"about_ca_topic_score_codex":0.002223861,"about_ca_topic_score_gemma":0.003832811,"teacher_disagreement_score":0.0067902566,"about_ca_system_score_codex":0.00037913257,"about_ca_system_score_gemma":0.0008278649,"threshold_uncertainty_score":0.022715628},"labels":[],"label_agreement":null},{"id":"W1976694517","doi":"10.1038/clpt.2011.174","title":"Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research; Novartis Pharma; Pfizer; Johns Hopkins University; National Institute on Drug Abuse; AstraZeneca; National Institutes of Health","keywords":"Letrozole; CYP2A6; Medicine; Breast cancer; Exemestane; Pharmacogenomics; Pharmacogenetics; Internal medicine; Body mass index; Pharmacology; Oncology; Aromatase inhibitor; Endocrinology; Aromatase; Genotype; Cancer; Biology; Genetics; Metabolism","score_opus":0.02334594151501695,"score_gpt":0.3057416044835733,"score_spread":0.28239566296855634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976694517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911493,0.0005020342,0.00007059654,0.000025033218,0.0000036494653,0.0000068200366,0.0000852618,0.000004732507,0.00018688079],"genre_scores_gemma":[0.99932396,0.00017037339,0.00010955346,0.00002772493,0.000011272259,0.000008941163,0.00013175145,0.0000017609538,0.00021451327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977344,0.00009236334,0.00001760321,0.00003692549,0.000057776633,0.000021886288],"domain_scores_gemma":[0.9993765,0.0002360076,0.00024493536,0.000053796284,0.000026429923,0.00006230553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004528383,0.00017031372,0.0003911986,0.00031309036,0.00014499684,0.00029529535,0.00010840385,0.0004083258,0.0009504742],"category_scores_gemma":[0.002056108,0.00023862111,0.00020063843,0.00038389864,0.00016418028,0.00019513252,0.000141674,0.00034024537,0.0001813216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022419404,0.0002975295,0.9318998,0.000054996337,0.00044335384,0.0004163708,0.00015235775,0.00025138387,0.024487453,0.000036820085,0.00022519787,0.019315293],"study_design_scores_gemma":[0.0003739649,0.0019055846,0.9943908,0.00000358682,0.00016611969,0.0007652079,0.000036028112,0.00030457065,0.0016187106,0.00006662291,0.00036341048,0.0000054347543],"about_ca_topic_score_codex":0.0003910362,"about_ca_topic_score_gemma":0.0006675934,"teacher_disagreement_score":0.0009504742,"about_ca_system_score_codex":0.000104930696,"about_ca_system_score_gemma":0.00008405766,"threshold_uncertainty_score":0.0031796694},"labels":[],"label_agreement":null},{"id":"W1976804024","doi":"10.1038/clpt.2011.47","title":"Effects of Valproic Acid on Organic Acid Metabolism in Children: A Metabolic Profiling Study","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Valproic Acid; Carbamazepine; Metabolomics; Metabolism; Pharmacology; Organic acid; Medicine; Physiology; Internal medicine; Chemistry; Bioinformatics; Biology; Biochemistry; Epilepsy; Psychiatry","score_opus":0.08653330729861784,"score_gpt":0.4028912042756027,"score_spread":0.31635789697698485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976804024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995189,0.00021042851,0.000031403535,0.000013670682,0.00000159383,0.0000044605395,0.00011664892,0.000001561106,0.000101400576],"genre_scores_gemma":[0.99897337,0.0004458567,0.00015551617,0.000028407378,0.0000045533498,0.000009089385,0.0002735674,0.00000238813,0.000107252185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997106,0.00006511266,0.000029376104,0.00005324837,0.00008088107,0.000060742692],"domain_scores_gemma":[0.9995146,0.00006914143,0.00022732413,0.000021855973,0.00006311269,0.00010389559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023177701,0.0003930171,0.00054893346,0.00061866094,0.00035787773,0.00040247373,0.000113306094,0.0002914248,0.00049501285],"category_scores_gemma":[0.0009045424,0.00023227165,0.00044841217,0.0007394063,0.00027691247,0.00023036743,0.00027757036,0.00041027713,0.00017704857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077562034,0.00012221863,0.9876702,0.000045486162,0.00008711586,0.00073103793,0.00030472464,0.000053914304,0.0049761874,0.000018076089,0.00009458088,0.005120882],"study_design_scores_gemma":[0.00001206586,0.00075297046,0.9961469,0.0000069382827,0.000049233233,0.0015723872,0.00022856345,0.00003835111,0.0008648349,0.00000860126,0.0003152305,0.0000038289],"about_ca_topic_score_codex":0.0047295606,"about_ca_topic_score_gemma":0.005875381,"teacher_disagreement_score":0.0047295606,"about_ca_system_score_codex":0.00041004407,"about_ca_system_score_gemma":0.00038606138,"threshold_uncertainty_score":0.009404063},"labels":[],"label_agreement":null},{"id":"W1977589606","doi":"10.1002/cpt.10","title":"Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Riociguat; Nitric oxide; Cyclic guanosine monophosphate; Pulmonary hypertension; Medicine; Heme; Pharmacology; Soluble guanylyl cyclase; Vasodilation; cGMP-dependent protein kinase; Internal medicine; Cardiology; Chronic thromboembolic pulmonary hypertension; Chemistry; Guanylate cyclase; Biochemistry; Enzyme","score_opus":0.17882094088378364,"score_gpt":0.44878583287023316,"score_spread":0.2699648919864495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977589606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015749714,0.9982823,0.00010963105,0.00037500024,0.0001805054,0.0000049038854,0.000017177646,0.0000068345944,0.00086608186],"genre_scores_gemma":[0.0010637346,0.997357,0.00023005049,0.0002953293,0.00014889115,0.0000074198983,0.000044027838,0.0000015388724,0.0008520783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988437,0.000018447518,0.000015990792,0.000020421994,0.000046425466,0.000014394205],"domain_scores_gemma":[0.99986744,0.000051235056,0.000021696915,0.0000043851237,0.000039744216,0.000015525395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034358207,0.00061916583,0.001078032,0.0017329026,0.0002714179,0.0007299877,0.0005772133,0.0009980971,0.0046173017],"category_scores_gemma":[0.00030870072,0.00020061262,0.00053227216,0.0015687548,0.00036838293,0.0011376429,0.0005326604,0.0021071997,0.0018705612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086566804,0.00010213076,0.00017396506,0.0151083935,0.00009230354,0.00027930652,0.00007852331,0.00024019522,0.0034305905,0.0042189695,0.0299351,0.946254],"study_design_scores_gemma":[0.00003299705,0.00010773581,0.0007938159,0.0025039716,0.00012472665,0.001414381,0.00006198819,0.00010307249,0.00051330455,0.001957833,0.99237084,0.000015381273],"about_ca_topic_score_codex":0.00078444765,"about_ca_topic_score_gemma":0.0020904844,"teacher_disagreement_score":0.0046173017,"about_ca_system_score_codex":0.00043447476,"about_ca_system_score_gemma":0.0008269164,"threshold_uncertainty_score":0.0154464245},"labels":[],"label_agreement":null},{"id":"W1977830912","doi":"10.1067/mcp.2001.116977","title":"Simple approach to predict the maximal effect elicited by a drug when plasma concentrations are not available or are dissociated from the effect, as illustrated with chondroitin sulfate data","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chondroitin sulfate; Simple (philosophy); Drug; Plasma concentration; Pharmacology; Chemistry; Medicine; Biochemistry; Glycosaminoglycan; Philosophy","score_opus":0.2298775033815515,"score_gpt":0.47333417534679884,"score_spread":0.24345667196524734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977830912","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015163832,0.23655999,0.71161205,0.0019471075,0.0017286408,0.00086809386,0.0032700573,0.0025158615,0.026334438],"genre_scores_gemma":[0.14274956,0.28468686,0.53668624,0.0021026456,0.00092630734,0.0021543442,0.0036992377,0.00026664638,0.02672813],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990563,0.00017637508,0.00011366419,0.00019549714,0.0004249855,0.000033306394],"domain_scores_gemma":[0.9988236,0.00055011467,0.00016115158,0.000084396044,0.0003514943,0.000029289697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023397917,0.0024949731,0.0029630682,0.0020604597,0.00032019263,0.0012084254,0.0018574763,0.0016195308,0.0036071267],"category_scores_gemma":[0.0031294029,0.0007144197,0.0012468101,0.001082622,0.00073145493,0.0014910955,0.0005147323,0.0024938555,0.007322085],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040054778,0.00028675218,0.0024469555,0.010327584,0.0005239351,0.00026981608,0.00010979646,0.011788467,0.19559601,0.012768551,0.015890814,0.7495908],"study_design_scores_gemma":[0.0002585189,0.0041183615,0.015438989,0.0017281212,0.0016345918,0.0053592217,0.00028628643,0.07244446,0.45652416,0.045749962,0.39589247,0.0005648818],"about_ca_topic_score_codex":0.0013022765,"about_ca_topic_score_gemma":0.0024539148,"teacher_disagreement_score":0.0036071267,"about_ca_system_score_codex":0.0007972342,"about_ca_system_score_gemma":0.0011159903,"threshold_uncertainty_score":0.012374163},"labels":[],"label_agreement":null},{"id":"W1978174606","doi":"10.1016/s0009-9236(03)90387-0","title":"Pregnancy outcome in women receiving atypical antipsychotic drugs: A prospective, multicentre, controlled study","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Clinical pharmacology; Medicine; Antipsychotic; Pregnancy; Prospective cohort study; Atypical antipsychotic; Outcome (game theory); Pharmacology; Internal medicine; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.09371956116930731,"score_gpt":0.46689346688756395,"score_spread":0.37317390571825665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978174606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851006,0.0009101265,0.000075020806,0.0000381636,0.000011849182,0.000076214135,0.00014775734,0.0000022188472,0.00022840756],"genre_scores_gemma":[0.9981502,0.00090497895,0.00018201575,0.00012249386,0.00003173816,0.00012409248,0.00027984413,0.0000032501082,0.0002013346],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99837166,0.00087868376,0.00015301873,0.00023279895,0.00018604512,0.00017784015],"domain_scores_gemma":[0.9958334,0.0017321093,0.0013544784,0.00035018497,0.00019315687,0.0005365707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021647627,0.0008560463,0.0013933411,0.0009190868,0.0011898386,0.0008247163,0.00060373644,0.0014510695,0.0015182804],"category_scores_gemma":[0.0067532687,0.0010729408,0.00096362625,0.0018780885,0.0013879112,0.0009978318,0.00071455556,0.0012630768,0.00030968795],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027112007,0.0019081023,0.96200275,0.00019503743,0.0006700264,0.00085369643,0.0007774254,0.000088303066,0.0009888206,0.00006738109,0.00018234008,0.005154127],"study_design_scores_gemma":[0.0036918249,0.023738768,0.9678382,0.000062916224,0.0008981715,0.0016982045,0.0008780832,0.00025030703,0.0003027693,0.00012819252,0.000456886,0.00005567757],"about_ca_topic_score_codex":0.003718948,"about_ca_topic_score_gemma":0.0029781007,"teacher_disagreement_score":0.003718948,"about_ca_system_score_codex":0.00069798157,"about_ca_system_score_gemma":0.00083072635,"threshold_uncertainty_score":0.011448503},"labels":[],"label_agreement":null},{"id":"W1978813423","doi":"10.1016/j.clpt.2003.11.146","title":"Pharmacokinetics and tissue distribution of a new mesalamine rectal gel in ulcerative colitis patients","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Pharmacokinetics; Cmin; Cmax; Suppository; Ulcerative colitis; Medicine; Urine; Rectal administration; Pharmacology; Volume of distribution; Adverse effect; Enema; Gastroenterology; Internal medicine","score_opus":0.04348085409112832,"score_gpt":0.3898331272675848,"score_spread":0.34635227317645645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978813423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986841,0.0008305058,0.00017584591,0.000022323447,0.0000034682412,0.000013381025,0.00006886153,0.0000142541785,0.00018721109],"genre_scores_gemma":[0.9986299,0.00028308743,0.0005240013,0.000048991435,0.000010429735,0.00001799838,0.00012395537,0.0000029968849,0.00035851807],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983466,0.00006591269,0.000011656337,0.000033756372,0.000036063655,0.000017798557],"domain_scores_gemma":[0.99982786,0.00004429293,0.00006530483,0.000009115257,0.000013198348,0.000040162828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027493315,0.00017281856,0.00031127693,0.00013643567,0.00008049894,0.00025612485,0.000058403824,0.0002208825,0.0006667894],"category_scores_gemma":[0.0004910783,0.000113448914,0.0001937938,0.000107290616,0.000116184485,0.00019080388,0.00010072293,0.00031337465,0.00018062894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.078150116,0.0020161623,0.26118085,0.0004274358,0.00046336584,0.0013391641,0.0005865319,0.0018875429,0.48702645,0.00009388914,0.00085803744,0.16597043],"study_design_scores_gemma":[0.0013071221,0.12140047,0.8221772,0.000030916613,0.00038515427,0.0039893338,0.00026721862,0.0040349583,0.042636417,0.00004399957,0.0036901552,0.0000371102],"about_ca_topic_score_codex":0.00028375996,"about_ca_topic_score_gemma":0.00026445056,"teacher_disagreement_score":0.0006667894,"about_ca_system_score_codex":0.00014397484,"about_ca_system_score_gemma":0.00008765683,"threshold_uncertainty_score":0.0022306442},"labels":[],"label_agreement":null},{"id":"W1979098773","doi":"10.1016/j.clpt.2004.11.010","title":"Effect of NONMEM minimization status and number of replicates on bootstrap parameter distributions for population pharmacokinetic models: A case study","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"NONMEM; Covariate; Statistics; Nonparametric statistics; Population; Mathematics; Confidence interval; Pharmacokinetics; Coverage probability; Medicine; Econometrics; Pharmacology","score_opus":0.5229012801892853,"score_gpt":0.6348841190895517,"score_spread":0.11198283890026639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979098773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6220333,0.001619319,0.36846685,0.0020953845,0.00012977941,0.00071694545,0.00037245278,0.00065222004,0.003913755],"genre_scores_gemma":[0.8359574,0.00023693213,0.16201569,0.0002538137,0.000047048656,0.00060418906,0.00021477175,0.00021536222,0.000454832],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.8453579,0.13734531,0.004610501,0.003679749,0.008236288,0.0007702456],"domain_scores_gemma":[0.352726,0.6033455,0.010947415,0.021896344,0.010062271,0.001022432],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16058077,0.0011895683,0.0017404361,0.0008742686,0.0013861702,0.00146897,0.0014658455,0.0023265965,0.0018647583],"category_scores_gemma":[0.41363236,0.0006051623,0.0018471297,0.0009977929,0.0020627652,0.0023021838,0.0020208182,0.002376372,0.00040916845],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036860947,0.0030349195,0.13920273,0.0022853152,0.0025612642,0.0035710572,0.005210277,0.23953848,0.028064972,0.028983137,0.007693794,0.50299317],"study_design_scores_gemma":[0.0018327618,0.01484327,0.052999903,0.00057663315,0.0012471953,0.0035660355,0.0013930238,0.8095832,0.059907492,0.043598242,0.00998284,0.00046942756],"about_ca_topic_score_codex":0.0008975288,"about_ca_topic_score_gemma":0.0010477423,"teacher_disagreement_score":0.83941925,"about_ca_system_score_codex":0.00082513405,"about_ca_system_score_gemma":0.0010809308,"threshold_uncertainty_score":0.84924245},"labels":[],"label_agreement":null},{"id":"W1979383226","doi":"10.1038/clpt.2008.229","title":"The Critical Role of Clinical Pharmacology in Geriatric Psychopharmacology","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Psychopharmacology; Clinical pharmacology; Pharmacology; Medicine","score_opus":0.2131802617487013,"score_gpt":0.5840275869813631,"score_spread":0.37084732523266184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979383226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009754029,0.9925565,0.0005163388,0.0045797206,0.00053264765,0.00000877963,0.00000613276,0.000016989448,0.0016854062],"genre_scores_gemma":[0.0019596876,0.99105597,0.0013749195,0.0031393506,0.0018367891,0.000018325554,0.000010517121,0.000005797425,0.0005985844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643373,0.00174462,0.0003518975,0.00026798385,0.001093874,0.00010794894],"domain_scores_gemma":[0.9871952,0.008819415,0.0008329113,0.00047976762,0.0021243258,0.0005484147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007968929,0.0013183515,0.0033806122,0.0029409914,0.0006542681,0.0038865232,0.0018064084,0.004958896,0.004649528],"category_scores_gemma":[0.0078095607,0.0006492894,0.00081099645,0.0035523945,0.003611108,0.0058633536,0.002097575,0.008212466,0.0031331226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007631373,0.00011347347,0.0003577096,0.0093385205,0.00008763008,0.00033175142,0.00026275776,0.0003357023,0.00053910026,0.01788799,0.036364835,0.9343043],"study_design_scores_gemma":[0.00007533832,0.00020790828,0.0019856265,0.010379471,0.00008963096,0.0029200576,0.00025156137,0.00025751666,0.00024213079,0.020571854,0.96296185,0.000057227313],"about_ca_topic_score_codex":0.0019598503,"about_ca_topic_score_gemma":0.0021258076,"teacher_disagreement_score":0.007968929,"about_ca_system_score_codex":0.0024097771,"about_ca_system_score_gemma":0.0055337553,"threshold_uncertainty_score":0.04214424},"labels":[],"label_agreement":null},{"id":"W1979585641","doi":"10.1038/clpt.2013.122","title":"Profiling Serum Bile Acid Glucuronides in Humans: Gender Divergences, Genetic Determinants, and Response to Fenofibrate","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Heart, Lung, and Blood Institute; Canadian Liver Foundation; Canadian Institutes of Health Research; Health Canada; Institut Universitaire de France; National Institutes of Health","keywords":"UGT2B7; Glucuronidation; Fenofibrate; Chenodeoxycholic acid; Glucuronosyltransferase; Chemistry; Internal medicine; Bile acid; Endocrinology; Pharmacology; Biochemistry; Enzyme; Biology; Microsome; Medicine","score_opus":0.07475749646715302,"score_gpt":0.3924157924352398,"score_spread":0.31765829596808676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979585641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991266,0.00032616878,0.00015852491,0.000016868396,0.0000030285853,0.0000036795454,0.00012784434,0.0000031214229,0.00023426676],"genre_scores_gemma":[0.99937326,0.00009627829,0.00013239238,0.00003205265,0.0000036914596,0.000004494844,0.00014196668,0.000003481896,0.0002124634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982303,0.000051134277,0.000013720812,0.00006006525,0.000026768908,0.000025257501],"domain_scores_gemma":[0.9998362,0.000031076175,0.00005424176,0.000023690684,0.000019228015,0.00003554623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020075784,0.00019050467,0.00031446855,0.00039426037,0.00018057055,0.00024492329,0.00007835005,0.0002096239,0.0009612321],"category_scores_gemma":[0.0005814828,0.000117345226,0.00014966192,0.00027975236,0.00018639027,0.00011042865,0.00013998603,0.00015643516,0.00015987839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046972833,0.000114060575,0.8956049,0.000039045222,0.00013736109,0.0005574035,0.0003081998,0.00009582584,0.08011322,0.00009767215,0.00015549605,0.018079614],"study_design_scores_gemma":[0.000017573133,0.0006429818,0.99261475,0.0000031304724,0.00003986604,0.0012397346,0.00013390608,0.00014590727,0.004710031,0.00007256419,0.00037416324,0.000005338918],"about_ca_topic_score_codex":0.0006740411,"about_ca_topic_score_gemma":0.0006396375,"teacher_disagreement_score":0.0009612321,"about_ca_system_score_codex":0.00012875187,"about_ca_system_score_gemma":0.00008176254,"threshold_uncertainty_score":0.0032156706},"labels":[],"label_agreement":null},{"id":"W1982471127","doi":"10.1016/s0009-9236(03)90668-0","title":"Population Pharmacokinetics of Meropenem in Febrile Neutropenics Using NPEM and Optimal Sampling Design","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Meropenem; Pharmacokinetics; Medicine; Population pharmacokinetics; Clinical pharmacology; Pharmacology; Sampling (signal processing); Population; Intensive care medicine; Antibiotics; Biology; Computer science; Microbiology; Environmental health; Antibiotic resistance","score_opus":0.23623169247991838,"score_gpt":0.4720359587662643,"score_spread":0.23580426628634593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982471127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6752859,0.00044893063,0.32149246,0.0002103835,0.00004199347,0.0014368152,0.00022682952,0.00025504298,0.00060160074],"genre_scores_gemma":[0.9145984,0.00025973553,0.08281664,0.00013866121,0.00003898945,0.001431825,0.0002747611,0.000039105744,0.00040191488],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.98539805,0.0127802165,0.00027007822,0.0007256983,0.0005844459,0.0002415062],"domain_scores_gemma":[0.98052555,0.015654465,0.0016133611,0.0011689338,0.000725565,0.00031215043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018317347,0.0009455636,0.0024828825,0.0006075601,0.0002574155,0.0011006949,0.0009475974,0.0009603145,0.0008749628],"category_scores_gemma":[0.034075525,0.0012125127,0.0010701836,0.0004653721,0.00096063013,0.0012363655,0.0011026142,0.0016245061,0.00012423235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09375062,0.0042240866,0.082399644,0.0007102327,0.002228452,0.00037192833,0.0012939216,0.56459886,0.010489084,0.00935119,0.0013702523,0.22921176],"study_design_scores_gemma":[0.0031237558,0.0183553,0.023018923,0.000049172264,0.0007348762,0.00029402858,0.0001185588,0.9391878,0.0053686304,0.008290374,0.0013485881,0.00010996794],"about_ca_topic_score_codex":0.0014643652,"about_ca_topic_score_gemma":0.00093249424,"teacher_disagreement_score":0.018317347,"about_ca_system_score_codex":0.0008819599,"about_ca_system_score_gemma":0.0018582499,"threshold_uncertainty_score":0.09687251},"labels":[],"label_agreement":null},{"id":"W1982900038","doi":"10.1016/s0009-9236(03)90392-4","title":"Artificial intelligence (AI) in prediction of beta‐lactam antibiotic toxicity","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Beta-lactam; Antibiotics; Lactam; Medicine; Chemistry; Microbiology; Biology; Stereochemistry","score_opus":0.24756681448672718,"score_gpt":0.5019714092959835,"score_spread":0.2544045948092563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982900038","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4363464,0.02202122,0.5058674,0.0059440695,0.000995133,0.00025920852,0.00047096587,0.0016204604,0.026475098],"genre_scores_gemma":[0.92880094,0.0030640634,0.065733954,0.0004627116,0.00028505424,0.00007114126,0.00014560118,0.00002057831,0.0014159002],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99917126,0.00045226063,0.000079969745,0.00008654926,0.00015831579,0.00005178097],"domain_scores_gemma":[0.9922925,0.006839159,0.00025191827,0.00011250302,0.0004060785,0.000097747485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028159302,0.0005690915,0.00057013636,0.0013445625,0.0003168067,0.0013416334,0.00058796536,0.0009712106,0.0009656197],"category_scores_gemma":[0.008690484,0.00018135169,0.0005399174,0.0010082297,0.00054306525,0.00088580913,0.00046713316,0.0011713152,0.0002461427],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009709435,0.00073649397,0.036742397,0.00041322966,0.0006346687,0.00031134867,0.00018572542,0.42612195,0.0032889459,0.010366871,0.005338863,0.5148886],"study_design_scores_gemma":[0.000028828916,0.00016048808,0.0032064943,0.000036807116,0.000073202624,0.000079668986,0.000043832842,0.9853254,0.0009865527,0.0092654675,0.0007803616,0.0000129095015],"about_ca_topic_score_codex":0.006369326,"about_ca_topic_score_gemma":0.003120449,"teacher_disagreement_score":0.006369326,"about_ca_system_score_codex":0.0005168353,"about_ca_system_score_gemma":0.0005849922,"threshold_uncertainty_score":0.0148922205},"labels":[],"label_agreement":null},{"id":"W1984346203","doi":"10.1038/clpt.2011.95","title":"Mycophenolate Mofetil Monitoring: Is There Evidence That It Can Improve Outcomes?","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacy; Library science; Family medicine; Internal medicine; Medical education; Computer science","score_opus":0.3805374254270274,"score_gpt":0.48477275951386484,"score_spread":0.10423533408683744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984346203","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12609838,0.7325461,0.0022773638,0.114218354,0.0057411343,0.00016152192,0.0012759055,0.00013730835,0.017543921],"genre_scores_gemma":[0.64264345,0.27862075,0.007054749,0.051357687,0.017591652,0.00019892931,0.0009764694,0.000047190275,0.0015091278],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99595416,0.001997495,0.0005661852,0.0004318893,0.00086033024,0.00019000239],"domain_scores_gemma":[0.9253832,0.058098778,0.010339084,0.0013097003,0.003360134,0.001509089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010361309,0.00095875113,0.005075289,0.0009385706,0.00056700566,0.0021356642,0.001026723,0.004281984,0.0058869035],"category_scores_gemma":[0.051589724,0.00036136483,0.0028645848,0.0024456484,0.001072858,0.0027158195,0.00057706423,0.0034890433,0.00078625244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025563627,0.0012411999,0.18858404,0.011820391,0.01242209,0.0004164283,0.00020865761,0.00071266125,0.00081729307,0.0021812685,0.019796114,0.7362362],"study_design_scores_gemma":[0.033500314,0.019523581,0.5910068,0.074420355,0.08008528,0.0032907627,0.0010631006,0.0040747076,0.004056696,0.019130275,0.16935195,0.0004961623],"about_ca_topic_score_codex":0.0013915548,"about_ca_topic_score_gemma":0.003271564,"teacher_disagreement_score":0.010361309,"about_ca_system_score_codex":0.00084612577,"about_ca_system_score_gemma":0.0017948613,"threshold_uncertainty_score":0.054796517},"labels":[],"label_agreement":null},{"id":"W1984939312","doi":"10.1038/clpt.2011.42","title":"Environmental and Genetic Factors Affecting Transport of Imatinib by OATP1A2","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; American Lebanese Syrian Associated Charities","keywords":"Imatinib; Pharmacology; Bioavailability; Rosuvastatin; Organic anion-transporting polypeptide; Transporter; Drug; Chemistry; Medicine; Internal medicine; Biochemistry; Gene","score_opus":0.08487687495840779,"score_gpt":0.3675479273089365,"score_spread":0.2826710523505287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984939312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835193,0.0003474252,0.00036463744,0.00010227231,0.000005511831,0.000008337704,0.00020471019,0.000007040199,0.0006081998],"genre_scores_gemma":[0.99923146,0.00014913811,0.00017501468,0.000021037433,0.0000062229715,0.000005927839,0.00011403159,0.000010615525,0.00028649118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994555,0.00023390625,0.000040240866,0.000119254415,0.000078309866,0.000072721145],"domain_scores_gemma":[0.99931836,0.00026321923,0.0002523538,0.00005319439,0.00003721679,0.00007575677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035532037,0.00021471448,0.00023604464,0.00037911755,0.00027704108,0.00034020437,0.0001300369,0.00022274551,0.0028946646],"category_scores_gemma":[0.0012545312,0.00015315381,0.00018236121,0.0004924905,0.00037980016,0.00016648522,0.00018590358,0.00026457137,0.00021715027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057961084,0.00053727,0.5104676,0.00012947439,0.00031137842,0.00502884,0.0005079963,0.00046294543,0.46028906,0.0010013105,0.0006868348,0.014781168],"study_design_scores_gemma":[0.000050968978,0.0006959412,0.9631457,0.000009804072,0.00014620868,0.00423035,0.0002458756,0.0005976079,0.02842453,0.00028955867,0.0021446294,0.000018930043],"about_ca_topic_score_codex":0.0021088186,"about_ca_topic_score_gemma":0.0017609441,"teacher_disagreement_score":0.0028946646,"about_ca_system_score_codex":0.00024373103,"about_ca_system_score_gemma":0.00024260982,"threshold_uncertainty_score":0.009683609},"labels":[],"label_agreement":null},{"id":"W1985860900","doi":"10.1016/s0009-9236(03)90451-6","title":"Understanding Why Physicians Modify or Ignore Prescribing Guidelines","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Clinical pharmacology; Medicine; Pharmacology; Intensive care medicine; Family medicine","score_opus":0.8390255197767043,"score_gpt":0.6068816241768574,"score_spread":0.23214389559984683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985860900","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0812053,0.0019358566,0.0057321633,0.8889829,0.0011789621,0.000088575594,0.00009788607,0.00015317326,0.020625232],"genre_scores_gemma":[0.7648759,0.0030569176,0.015355916,0.2124041,0.0013008252,0.00012967778,0.00012168852,0.00011283989,0.0026421717],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9667417,0.019482197,0.0022235932,0.0015901463,0.0076888436,0.0022734401],"domain_scores_gemma":[0.74510443,0.19695778,0.027199741,0.0041395617,0.020091167,0.0065073026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036364682,0.00042311588,0.00069738115,0.0013710401,0.0033048275,0.005648199,0.0017061658,0.013499191,0.0039575985],"category_scores_gemma":[0.2293865,0.0008577058,0.00091887714,0.0010135889,0.0050458713,0.007328913,0.0017729898,0.010342737,0.0008362668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045065008,0.0011062972,0.19417536,0.0011278987,0.00078239583,0.00469545,0.07244071,0.00198701,0.0013950447,0.056542262,0.36014402,0.30515286],"study_design_scores_gemma":[0.0010189642,0.0007746461,0.19171362,0.006046149,0.0016856097,0.0059843776,0.109192625,0.020809114,0.0038559437,0.31963366,0.3386699,0.00061546336],"about_ca_topic_score_codex":0.019402724,"about_ca_topic_score_gemma":0.036976967,"teacher_disagreement_score":0.036364682,"about_ca_system_score_codex":0.005885442,"about_ca_system_score_gemma":0.01883135,"threshold_uncertainty_score":0.19231719},"labels":[],"label_agreement":null},{"id":"W1986311009","doi":"10.1016/j.clpt.2004.12.026","title":"Effect of St. John's Wort administration on CYP2C8 mediated rosiglitazone metabolism","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosiglitazone; Pharmacokinetics; CYP2C8; Pharmacology; Medicine; Internal medicine; Metabolism; Receptor; CYP3A4; Cytochrome P450","score_opus":0.13527301971220893,"score_gpt":0.516411642202892,"score_spread":0.3811386224906831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986311009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999223,0.00039720265,0.00014136957,0.00001798979,0.0000101249825,0.000022424643,0.000037417576,0.00000539023,0.00014513214],"genre_scores_gemma":[0.9985972,0.0002972731,0.00055997923,0.00003432206,0.000025021747,0.000031900185,0.00006604542,0.0000045941024,0.00038365144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947196,0.00023682811,0.00004171726,0.0000934192,0.00009882007,0.000057348327],"domain_scores_gemma":[0.99931395,0.00019611344,0.0002800411,0.00006502138,0.00003590849,0.00010893726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062484,0.00038938588,0.0008353955,0.0002222103,0.00017465238,0.00030865308,0.00015702532,0.00028916032,0.0016423701],"category_scores_gemma":[0.000738189,0.0001993509,0.000515629,0.00016694893,0.00041067548,0.00013936087,0.00013572602,0.00039138045,0.00019211226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18517426,0.007432916,0.10702758,0.0006866444,0.001204416,0.00058876444,0.00021490027,0.0011263593,0.57546514,0.00016208323,0.0004005763,0.12051635],"study_design_scores_gemma":[0.0054667876,0.3077981,0.5146555,0.000043973057,0.0010786066,0.0015466528,0.00017253145,0.0031847265,0.16328552,0.00013649144,0.0025823952,0.000048809747],"about_ca_topic_score_codex":0.00044329197,"about_ca_topic_score_gemma":0.0008222156,"teacher_disagreement_score":0.0016423701,"about_ca_system_score_codex":0.00021984983,"about_ca_system_score_gemma":0.00029161794,"threshold_uncertainty_score":0.0054942966},"labels":[],"label_agreement":null},{"id":"W1987001131","doi":"10.1038/sj.clpt.6100432","title":"Looking at Research Through a Different Lens: The Canadian Institute of Gender and Health","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Gender and Health; Dalhousie University","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Sociocultural evolution; Psychological intervention; Psychology; Gender disparity; Gerontology; Gender studies; Medicine; Sociology; Psychiatry","score_opus":0.6929637212245021,"score_gpt":0.6100638401577978,"score_spread":0.08289988106670432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987001131","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088809355,0.21192333,0.003299468,0.7251863,0.015247667,0.000051414278,0.00025095223,0.00007956989,0.04307331],"genre_scores_gemma":[0.13271214,0.3040866,0.01848734,0.497974,0.01734227,0.00041109422,0.00045142072,0.00040777176,0.028127346],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9481881,0.023210527,0.001999241,0.0039131823,0.017024653,0.005664314],"domain_scores_gemma":[0.9547063,0.017645204,0.0019120928,0.0023952823,0.014652487,0.008688613],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.047115475,0.0022283292,0.003137452,0.014616061,0.0334968,0.03319637,0.0060508507,0.015170414,0.005560069],"category_scores_gemma":[0.035235394,0.0011870504,0.0014224844,0.02180144,0.119155034,0.016286725,0.011990104,0.03828142,0.0008706785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046765424,0.000028762528,0.0011692293,0.00048943394,0.000035136658,0.000152258,0.025325533,0.00013541449,0.00014742343,0.74265593,0.19987291,0.029941069],"study_design_scores_gemma":[0.000032862317,0.000022982591,0.0021109711,0.0025637809,0.000031345397,0.00016483062,0.019271087,0.00008958225,0.00009576984,0.117238924,0.85824054,0.00013730372],"about_ca_topic_score_codex":0.9133707,"about_ca_topic_score_gemma":0.93197083,"teacher_disagreement_score":0.95288455,"about_ca_system_score_codex":0.128573,"about_ca_system_score_gemma":0.30234244,"threshold_uncertainty_score":0.93286675},"labels":[],"label_agreement":null},{"id":"W1987328209","doi":"10.1016/s0009-9236(03)90557-1","title":"Repeated exposure to amethocaine: reports of adverse local skin reactions","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Clinical pharmacology; Tetracaine; Pharmacology; Medicine; Adverse effect; Dermatology; Anesthesia; Lidocaine","score_opus":0.08029169533552635,"score_gpt":0.437798565426057,"score_spread":0.3575068700905306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987328209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775178,0.0068564545,0.004215316,0.0008479058,0.00019189711,0.00017560298,0.00012555429,0.0002490548,0.009820485],"genre_scores_gemma":[0.99565035,0.0011794386,0.0007322518,0.0005658838,0.00020780241,0.00003563016,0.00008880707,0.000027535374,0.001512283],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9985933,0.00032209838,0.00022069352,0.00016331188,0.00056085456,0.0001397704],"domain_scores_gemma":[0.9950696,0.0019962597,0.0014192044,0.00065538933,0.0005122161,0.0003473521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072909606,0.0008862515,0.00088149233,0.00073609,0.00087964354,0.00061885256,0.0005373056,0.0027527865,0.0022611527],"category_scores_gemma":[0.0058782175,0.00047165362,0.0010697193,0.0005757707,0.0005633993,0.0005316997,0.0005870826,0.001969639,0.001436878],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037748942,0.0021610423,0.2173274,0.0007798292,0.00057365716,0.53383225,0.0044701295,0.00044742215,0.12524784,0.00038620253,0.0036729027,0.10732643],"study_design_scores_gemma":[0.00012318477,0.007035404,0.16477333,0.000072680894,0.00036850874,0.78969353,0.0008286684,0.0006108173,0.027743103,0.00017018818,0.008507004,0.00007353651],"about_ca_topic_score_codex":0.0011906379,"about_ca_topic_score_gemma":0.0013992272,"teacher_disagreement_score":0.0027527865,"about_ca_system_score_codex":0.000414004,"about_ca_system_score_gemma":0.00025697285,"threshold_uncertainty_score":0.007564366},"labels":[],"label_agreement":null},{"id":"W1987702273","doi":"10.1016/s0009-9236(03)90459-0","title":"Suboptimal Pharmacotherapy for Depression in Pregnancy","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pharmacotherapy; Depression (economics); Pregnancy; Medicine; MEDLINE; Psychiatry; Obstetrics; Biology","score_opus":0.13134345792429117,"score_gpt":0.48406170355967454,"score_spread":0.35271824563538334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987702273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6636391,0.2078119,0.002351,0.080204144,0.00066779746,0.00014443917,0.0011448172,0.00013581038,0.043900922],"genre_scores_gemma":[0.96822685,0.024884142,0.0017710503,0.0040118718,0.00023324639,0.000041571326,0.00017915509,0.000010250291,0.00064188597],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991357,0.00037372814,0.00020836624,0.00004669008,0.00014739124,0.00008831444],"domain_scores_gemma":[0.9976781,0.0009542984,0.00062594505,0.00012243289,0.0002998655,0.00031938846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001163095,0.00010112916,0.0006952563,0.00025596152,0.0003262998,0.0005566327,0.0001897214,0.0005199044,0.0024194366],"category_scores_gemma":[0.011256771,0.00010884231,0.00023814244,0.0006210032,0.00017469036,0.00034596885,0.00029480728,0.0011438935,0.00026566559],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033367085,0.0006947105,0.30650735,0.0018450198,0.000799174,0.0019505011,0.00047005998,0.001088736,0.003258842,0.004057805,0.018600274,0.65739083],"study_design_scores_gemma":[0.00075780816,0.002701497,0.9359232,0.0019042321,0.0008542022,0.007902272,0.00061891397,0.0022905616,0.0016210784,0.01048102,0.034904603,0.00004058652],"about_ca_topic_score_codex":0.0041615204,"about_ca_topic_score_gemma":0.011680139,"teacher_disagreement_score":0.0041615204,"about_ca_system_score_codex":0.0014019955,"about_ca_system_score_gemma":0.001747562,"threshold_uncertainty_score":0.010172188},"labels":[],"label_agreement":null},{"id":"W1987867942","doi":"10.1067/mcp.2000.107651","title":"Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Coalition for Research in Women's Health","funders":"National Institute on Drug Abuse","keywords":"Nicotine; CYP2A6; Pharmacology; Placebo; Bioavailability; Crossover study; Methoxsalen; Nicotine patch; Cmax; Oral administration; Medicine; Chemistry; Internal medicine; Metabolism; Cytochrome P450; CYP1A2; Psoriasis; Dermatology","score_opus":0.09260801774726429,"score_gpt":0.42110883067766636,"score_spread":0.32850081293040206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987867942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997898,0.00089136837,0.00066237175,0.000057443754,0.000016708558,0.00007033566,0.0000521191,0.000033982604,0.00031776095],"genre_scores_gemma":[0.99634224,0.0008853503,0.0018222547,0.000058236175,0.000038871352,0.00009396786,0.00013284732,0.000009679685,0.0006165275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978226,0.00007281599,0.000017778912,0.00004187257,0.0000566578,0.000028738059],"domain_scores_gemma":[0.9997211,0.0000809462,0.00011133075,0.000022823891,0.000018106119,0.000045714023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037155914,0.00031446197,0.00062547904,0.00012060409,0.00011088861,0.00019988402,0.00024613965,0.00028121434,0.0024085245],"category_scores_gemma":[0.0004224197,0.00020915494,0.0002494812,0.00009208649,0.00037847206,0.00020339749,0.0001431954,0.00060034235,0.00023053463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016633332,0.0029697674,0.004034385,0.00026644315,0.00014270586,0.000044115513,0.000038574348,0.00019936648,0.9501249,0.000063924526,0.00016296898,0.02531946],"study_design_scores_gemma":[0.009252226,0.217105,0.09913466,0.00006225095,0.000475727,0.0007152851,0.00008448763,0.002647172,0.66731924,0.00016085972,0.003018789,0.000024306923],"about_ca_topic_score_codex":0.00035067488,"about_ca_topic_score_gemma":0.0007589954,"teacher_disagreement_score":0.0024085245,"about_ca_system_score_codex":0.00014794254,"about_ca_system_score_gemma":0.00029494418,"threshold_uncertainty_score":0.008057356},"labels":[],"label_agreement":null},{"id":"W1988452792","doi":"10.1038/sj.clpt.6100100","title":"Prenatal Multivitamin Supplementation and Rates of Pediatric Cancers: A Meta-Analysis","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Multivitamin; Medicine; Odds ratio; Meta-analysis; Pregnancy; Pediatrics; MEDLINE; Confidence interval; Internal medicine; Obstetrics; Vitamin","score_opus":0.5383269603492036,"score_gpt":0.6126765721517698,"score_spread":0.07434961180256627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988452792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03189632,0.9651156,0.0010789814,0.00029248346,0.0002570136,0.00017299251,0.0007569017,0.000051718154,0.00037798518],"genre_scores_gemma":[0.5498742,0.4435788,0.0030625775,0.00070836424,0.00034941873,0.0006831873,0.001059761,0.00005416341,0.00062955625],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99330646,0.0036813268,0.0012983176,0.00090172386,0.0005484619,0.0002638087],"domain_scores_gemma":[0.98441815,0.011804953,0.0017914048,0.00068418286,0.0009922709,0.0003089868],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009543093,0.0025935476,0.011768595,0.0040089907,0.0005726148,0.002499514,0.0020005496,0.0022698434,0.0027106032],"category_scores_gemma":[0.022854524,0.0017158892,0.04278777,0.005340631,0.0004591969,0.0009704913,0.0011819589,0.0019085539,0.00026967216],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049849027,0.000033261713,0.0140304,0.0540551,0.9203214,0.00021822104,0.000052154937,0.0007523652,0.00025882432,0.000064646985,0.00038948495,0.0048391446],"study_design_scores_gemma":[0.0004978696,0.0002074068,0.007001693,0.002341722,0.9889002,0.00009326721,0.00002087969,0.0002913718,0.00010475221,0.00007871621,0.00044887714,0.0000131375355],"about_ca_topic_score_codex":0.009650895,"about_ca_topic_score_gemma":0.011530198,"teacher_disagreement_score":0.9882314,"about_ca_system_score_codex":0.0015575946,"about_ca_system_score_gemma":0.0017877283,"threshold_uncertainty_score":0.05046928},"labels":[],"label_agreement":null},{"id":"W1988649996","doi":"10.1038/clpt.2010.90","title":"Refilling and Switching of Antiepileptic Drugs and Seizure-Related Events","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging","keywords":"Medicine; Medical prescription; Odds ratio; Confidence interval; Epilepsy; Antiepileptic drug; Odds; Pediatrics; Emergency medicine; Anesthesia; Internal medicine; Psychiatry; Pharmacology","score_opus":0.07577093616275075,"score_gpt":0.3784942365549937,"score_spread":0.30272330039224293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988649996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976568,0.0007620669,0.00015554868,0.00013957862,0.000006025959,0.00002790742,0.0008505752,0.0000037049801,0.00039774022],"genre_scores_gemma":[0.99846894,0.00026498715,0.00017664279,0.000065285385,0.000013717095,0.000011893185,0.00080134586,0.0000018359868,0.00019528868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955629,0.001869553,0.00040893382,0.0007683027,0.00077797484,0.00061227684],"domain_scores_gemma":[0.9784734,0.0076344255,0.010812966,0.001061747,0.00092180696,0.0010956588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039437674,0.00029359473,0.00074516254,0.0018368564,0.00045785637,0.0012693494,0.0010631254,0.001084353,0.0018212005],"category_scores_gemma":[0.023264354,0.00044150138,0.0010460025,0.0023783194,0.0005715341,0.00079654664,0.0006064897,0.0013374755,0.00016101463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034142975,0.00008809405,0.9977836,0.000017658273,0.0001892774,0.000106936124,0.00004691866,0.00012140076,0.000034911372,0.00006805135,0.00006343065,0.0011384947],"study_design_scores_gemma":[0.000029354502,0.00010061701,0.99852496,0.000015520054,0.00007248111,0.00015954189,0.000078708574,0.00078329525,0.00003504022,0.000057269513,0.00013694787,0.000006329175],"about_ca_topic_score_codex":0.1746429,"about_ca_topic_score_gemma":0.13355953,"teacher_disagreement_score":0.1746429,"about_ca_system_score_codex":0.0024433148,"about_ca_system_score_gemma":0.0015843885,"threshold_uncertainty_score":0.3472528},"labels":[],"label_agreement":null},{"id":"W1989066750","doi":"10.1016/j.clpt.2004.11.109","title":"Child neurodevelopment following treatment for nausea and vomiting of pregnancy with diclectin: A prospective controlled study","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Vomiting; Nausea; Medicine; Hyperemesis gravidarum; Pregnancy; Prospective cohort study; Pediatrics; Adverse effect; In utero; Percentile; Antiemetic; Obstetrics; Fetus; Anesthesia; Internal medicine","score_opus":0.08374206248901647,"score_gpt":0.4421941945630332,"score_spread":0.3584521320740167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989066750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740845,0.0009630355,0.00009322579,0.000030577165,0.000024506868,0.0009131908,0.00031622447,0.0000057931684,0.000244994],"genre_scores_gemma":[0.99525875,0.0011579953,0.00039177106,0.00015885389,0.000074017786,0.0017477872,0.0008210453,0.0000043912273,0.00038539388],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99744284,0.0011424145,0.00025227372,0.0005397274,0.0003540054,0.0002687466],"domain_scores_gemma":[0.9962947,0.0011058764,0.0011143448,0.00046688368,0.00032327324,0.0006948405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030610934,0.0010673348,0.001508399,0.0007784601,0.0014160649,0.00080784794,0.0008743473,0.0012894179,0.0023514559],"category_scores_gemma":[0.004479719,0.0007208823,0.0016542303,0.0012316193,0.0016841528,0.00079162844,0.0006859266,0.0012367482,0.00035697644],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18438111,0.040052548,0.749813,0.0010079462,0.0031934069,0.0010114793,0.0010977525,0.00018559836,0.0020973675,0.00010383964,0.00072463724,0.016331319],"study_design_scores_gemma":[0.040955134,0.18435757,0.7691552,0.00009498359,0.001813021,0.00070172054,0.000635849,0.00026617688,0.0006190333,0.000084618674,0.001246358,0.00007032128],"about_ca_topic_score_codex":0.0079028485,"about_ca_topic_score_gemma":0.009430921,"teacher_disagreement_score":0.0079028485,"about_ca_system_score_codex":0.001062149,"about_ca_system_score_gemma":0.0016964814,"threshold_uncertainty_score":0.01618886},"labels":[],"label_agreement":null},{"id":"W1989512634","doi":"10.1038/sj.clpt.6100033","title":"Cytochrome P4502D6 (CYP2D6) Gene Locus Heterogeneity: Characterization of Gene Duplication Events","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Gene duplication; Gene; Locus (genetics); Genetics; Biology; CYP2D6; Allele; Polymerase chain reaction; Copy-number variation; Genotype; Genome","score_opus":0.20364432140957647,"score_gpt":0.5107263157474201,"score_spread":0.30708199433784367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989512634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990097,0.00017914645,0.0005506403,0.00001226663,6.845516e-7,0.000007034821,0.00008501478,0.000002638999,0.00015263571],"genre_scores_gemma":[0.99911827,0.00008225358,0.00055907475,0.0000075148114,0.0000024639496,0.0000054085367,0.00014374354,0.0000016021885,0.00007950363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981004,0.00004444294,0.000018037617,0.00006229251,0.000046268826,0.00001902374],"domain_scores_gemma":[0.999728,0.00008679062,0.00010230025,0.000019233526,0.000026387654,0.000037370424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023601607,0.00009791062,0.0001610587,0.00047107154,0.00008240949,0.00015027181,0.00009623328,0.00011993479,0.00057225575],"category_scores_gemma":[0.0005442055,0.000063843996,0.000105025596,0.00033930843,0.0001596817,0.00009519634,0.00013469627,0.00015153992,0.000113305236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053231296,0.000078359,0.45334202,0.000056520395,0.00007621451,0.0015694714,0.00024729155,0.00039828173,0.5178943,0.00028116326,0.000119114695,0.025405036],"study_design_scores_gemma":[0.000028553315,0.00031632552,0.94335884,0.0000071840723,0.00004167296,0.012573528,0.00013951461,0.0012264805,0.04079471,0.00021276256,0.0012884,0.000012025184],"about_ca_topic_score_codex":0.0004099026,"about_ca_topic_score_gemma":0.0004492097,"teacher_disagreement_score":0.00057225575,"about_ca_system_score_codex":0.00011722366,"about_ca_system_score_gemma":0.00008302419,"threshold_uncertainty_score":0.0019144416},"labels":[],"label_agreement":null},{"id":"W1989597392","doi":"10.1038/clpt.2011.112","title":"Chemotherapy and Cognitive Impairment: Treatment Options","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital","funders":"","keywords":"Etiology; Chemotherapy; Cognition; Medicine; Intensive care medicine; Psychological intervention; Cognitive impairment; MEDLINE; Psychiatry; Surgery","score_opus":0.23600879077622297,"score_gpt":0.510962765064955,"score_spread":0.27495397428873203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989597392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006472067,0.9992686,0.000030568615,0.00019071106,0.000032726668,0.000003203073,0.0000066470434,0.0000023824814,0.00040048762],"genre_scores_gemma":[0.0006020925,0.998946,0.000081231534,0.000119460376,0.000061656,0.0000060571183,0.00001276735,4.6251722e-7,0.00017032975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982625,0.00004566188,0.000032837586,0.000025233892,0.00005827669,0.000011654772],"domain_scores_gemma":[0.99969435,0.00016247852,0.00006701344,0.000009357424,0.000046622587,0.000020253925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060572,0.00082340883,0.0019143323,0.0018550678,0.00026237962,0.00086370006,0.000834539,0.0010196894,0.004425476],"category_scores_gemma":[0.0007855383,0.0001997413,0.0006280781,0.0018158416,0.00042213488,0.0009162032,0.000534752,0.0013758943,0.001030352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000838083,0.000101269376,0.00017529863,0.024496915,0.00012783044,0.00013836207,0.000043654305,0.00018595193,0.00044482737,0.001610406,0.012106593,0.9604851],"study_design_scores_gemma":[0.00013299927,0.00033114865,0.004255406,0.04397577,0.00075233827,0.0032351804,0.00024852462,0.00019171338,0.00068611675,0.005554788,0.940593,0.000043071817],"about_ca_topic_score_codex":0.0013797402,"about_ca_topic_score_gemma":0.0036235081,"teacher_disagreement_score":0.004425476,"about_ca_system_score_codex":0.0004940239,"about_ca_system_score_gemma":0.000896991,"threshold_uncertainty_score":0.014804661},"labels":[],"label_agreement":null},{"id":"W1989806059","doi":"10.1016/s0009-9236(03)90448-6","title":"The effect of Hemodialysis on the Export of Homocysteine by Erythrocytes","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacology; Hemodialysis; Homocysteine; Medicine; Chemistry; Internal medicine","score_opus":0.04634742188722327,"score_gpt":0.3779020907042069,"score_spread":0.3315546688169836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989806059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439347,0.002822953,0.00033182753,0.0003560105,0.00013228397,0.000029710309,0.0001616025,0.000028265384,0.0017437937],"genre_scores_gemma":[0.9956896,0.0011598485,0.0005271593,0.0002093103,0.00020964992,0.000017874929,0.00022254293,0.00002528517,0.0019387867],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995359,0.00020856186,0.00003495628,0.000044769153,0.00005049715,0.00012538336],"domain_scores_gemma":[0.9982768,0.0010640827,0.0001213149,0.00025258143,0.000087005,0.00019820561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071141846,0.00037255618,0.0011364368,0.00016062545,0.00037760622,0.0008333443,0.00059725164,0.0010697494,0.0044749817],"category_scores_gemma":[0.002051287,0.0003362412,0.0007453223,0.0002581036,0.0011320092,0.0011985593,0.00040284623,0.0016401167,0.00045920126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4950331,0.0022030482,0.004167801,0.00050390174,0.00039493167,0.0014385441,0.00065159507,0.00087042595,0.44597557,0.0013552998,0.0014522382,0.04595354],"study_design_scores_gemma":[0.00718123,0.04431438,0.07999614,0.00007567124,0.0006641967,0.0022538656,0.0005631591,0.0051015387,0.8517243,0.0009794282,0.0070434436,0.00010254588],"about_ca_topic_score_codex":0.001871898,"about_ca_topic_score_gemma":0.0016049929,"teacher_disagreement_score":0.0044749817,"about_ca_system_score_codex":0.0005334441,"about_ca_system_score_gemma":0.0008046719,"threshold_uncertainty_score":0.014970243},"labels":[],"label_agreement":null},{"id":"W1990359955","doi":"10.1038/clpt.2013.45","title":"ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport-Mediated PK and DDIs in Humans","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences","keywords":"Transporter; Pharmacology; Computational biology; Pharmacokinetics; Clinical pharmacology; In vivo; Drug; Computer science; Chemistry; Medicine; Biology; Biochemistry","score_opus":0.23383863383423395,"score_gpt":0.4729230737368746,"score_spread":0.23908443990264064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990359955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020302357,0.47823957,0.24023631,0.08457529,0.021196557,0.0038312704,0.02374684,0.0058184452,0.1403255],"genre_scores_gemma":[0.0117419055,0.5048872,0.33455667,0.028269265,0.0066603427,0.0077059697,0.02836193,0.002018658,0.075798064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99405587,0.0019862184,0.0010677096,0.0002644858,0.0023937353,0.000232008],"domain_scores_gemma":[0.98420066,0.004469739,0.00169662,0.0012783271,0.00790069,0.0004538949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012469913,0.0028773479,0.0031848866,0.005927621,0.00075989356,0.002421992,0.006407381,0.0061915494,0.017147232],"category_scores_gemma":[0.020082291,0.001340494,0.004388089,0.0047071283,0.0012823152,0.0027507767,0.0021127386,0.0067962315,0.023391018],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019662344,0.00024337723,0.0003828808,0.008469551,0.00013788757,0.00042631116,0.0001896685,0.0047443113,0.0031767043,0.023828497,0.47168618,0.48651809],"study_design_scores_gemma":[0.000058089623,0.000120347155,0.0007890622,0.0053464477,0.00017651128,0.00045910996,0.00006327913,0.0014309768,0.0022762613,0.00933486,0.9798855,0.00005945629],"about_ca_topic_score_codex":0.013939473,"about_ca_topic_score_gemma":0.008039483,"teacher_disagreement_score":0.017147232,"about_ca_system_score_codex":0.002798576,"about_ca_system_score_gemma":0.009069094,"threshold_uncertainty_score":0.06594801},"labels":[],"label_agreement":null},{"id":"W1990473701","doi":"10.1038/sj.clpt.6100345","title":"Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Pharmacodynamics; Antagonist; Tolerability; Medicine; Crossover study; Clinical pharmacology; Receptor antagonist; Chemistry; Placebo; Receptor; Adverse effect; Internal medicine","score_opus":0.039673737585190556,"score_gpt":0.3898679952633786,"score_spread":0.35019425767818807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990473701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497163,0.0027206508,0.0010271051,0.000094862,0.000025076406,0.00018518092,0.00026499192,0.000058728903,0.0006517278],"genre_scores_gemma":[0.9973562,0.0008716923,0.00079443125,0.00014325524,0.00008133594,0.00013780099,0.00027251002,0.000013753624,0.00032904383],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994191,0.00027721474,0.000044553486,0.000085130276,0.0001280978,0.000045954042],"domain_scores_gemma":[0.9991417,0.00025921542,0.00029470513,0.00007246186,0.00006024821,0.0001716613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007564822,0.00038942468,0.0011318593,0.0002633307,0.00024186936,0.0003938858,0.00026655156,0.0006768145,0.0012162223],"category_scores_gemma":[0.0019792616,0.00039508336,0.00051780895,0.00026816662,0.00049515185,0.0005195591,0.00012282112,0.0011944973,0.000353068],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41736194,0.012968872,0.0239136,0.00078058126,0.0018242609,0.0006382337,0.0002823197,0.0026193294,0.3270907,0.00033624147,0.0016304592,0.21055336],"study_design_scores_gemma":[0.066231064,0.63335985,0.19815072,0.000048115646,0.002417987,0.0034477103,0.00013910791,0.0053132083,0.08554567,0.0003814597,0.004852925,0.00011211381],"about_ca_topic_score_codex":0.00037607134,"about_ca_topic_score_gemma":0.00040542518,"teacher_disagreement_score":0.0012162223,"about_ca_system_score_codex":0.0004175346,"about_ca_system_score_gemma":0.0003468096,"threshold_uncertainty_score":0.0040687323},"labels":[],"label_agreement":null},{"id":"W1990927912","doi":"10.1038/clpt.2008.11","title":"Drug Addiction: A Critical Problem Calling for Novel Solutions","year":2008,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto","keywords":"Citation; Clinical pharmacology; Addiction; Computer science; Library science; Medicine; World Wide Web; Pharmacology; Psychiatry","score_opus":0.19523616979030597,"score_gpt":0.4622269179221973,"score_spread":0.2669907481318913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990927912","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003427488,0.012344154,0.00023225154,0.0694825,0.91702396,0.000009783844,0.000019577665,0.000045840236,0.0008075495],"genre_scores_gemma":[0.00032805215,0.005357752,0.0001672094,0.032232717,0.9583604,0.000013455186,0.000010023219,0.000018921291,0.0035115336],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955124,0.0011573286,0.0006401682,0.0006453814,0.0017406921,0.0003039648],"domain_scores_gemma":[0.97136027,0.014774046,0.0015855959,0.00093516667,0.008271279,0.003073667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008578921,0.004457687,0.0051339115,0.004041201,0.0036482255,0.0070464453,0.0043571144,0.038383123,0.00696186],"category_scores_gemma":[0.023980767,0.0017122452,0.003176141,0.0015295874,0.0049055777,0.007276839,0.0028854513,0.03870118,0.007915326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002627625,0.000011241423,0.000023631414,0.00023206441,0.000025759322,0.00023538173,0.000016562444,0.000021459553,0.000059656446,0.0005176045,0.99027574,0.008554663],"study_design_scores_gemma":[0.00008147634,0.00005022863,0.00026723064,0.000740032,0.00011212371,0.0010096068,0.000071179755,0.00021614987,0.000120740566,0.0029328463,0.99436116,0.000037305614],"about_ca_topic_score_codex":0.0013397946,"about_ca_topic_score_gemma":0.0045798034,"teacher_disagreement_score":0.038383123,"about_ca_system_score_codex":0.0029616698,"about_ca_system_score_gemma":0.0029070058,"threshold_uncertainty_score":0.04537022},"labels":[],"label_agreement":null},{"id":"W1992259971","doi":"10.1038/sj.clpt.6100434","title":"Combination of Phenotype Assessments and CYP2C9-VKORC1 Polymorphisms in the Determination of Warfarin Dose Requirements in Heavily Medicated Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep Saint-Jean-sur-Richelieu; Institut universitaire de cardiologie et de pneumologie de Québec; Montreal Heart Institute; Bausch Health (Canada); Centre Integre de Sante et de Services Sociaux de Laval; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; Warfarin; Vitamin K epoxide reductase; CYP2C9; Medicine; Internal medicine; Pharmacology; Genotype; Losartan; Biology; Genetics; Gene; Atrial fibrillation; Cytochrome P450; Renin–angiotensin system","score_opus":0.24618215903103102,"score_gpt":0.5471762856085234,"score_spread":0.30099412657749236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992259971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996996,0.00005775909,0.000096608885,0.00001532384,0.0000012821185,0.0000024043302,0.000040617713,0.000002830363,0.00008360037],"genre_scores_gemma":[0.99969923,0.00002187448,0.00016118998,0.000013616985,0.0000039652864,0.0000024347967,0.000068030924,0.0000014343658,0.000028334476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991818,0.00030506655,0.00010491895,0.00018710837,0.00015534744,0.000065705266],"domain_scores_gemma":[0.9983791,0.00068669824,0.0005104458,0.0001427622,0.00010215617,0.00017882074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059701945,0.00035765176,0.00062053825,0.0005038086,0.00023864227,0.0004972386,0.0002306703,0.00035793724,0.0003720385],"category_scores_gemma":[0.003084796,0.00024863752,0.00034716638,0.00061037677,0.00027307495,0.00025704884,0.00031805047,0.00044578494,0.00011835019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054951967,0.000039866285,0.9943157,0.0000053233416,0.00006911096,0.00017473029,0.000043401447,0.00023490096,0.0014433676,0.00001024388,0.000039115635,0.0030748032],"study_design_scores_gemma":[0.000024254965,0.00042856348,0.9962126,0.0000028875143,0.0000741211,0.0006382171,0.00005845739,0.0016992266,0.0007435806,0.000047109243,0.00006362602,0.000007363294],"about_ca_topic_score_codex":0.0013128676,"about_ca_topic_score_gemma":0.0024481602,"teacher_disagreement_score":0.0013128676,"about_ca_system_score_codex":0.00027546054,"about_ca_system_score_gemma":0.00021853192,"threshold_uncertainty_score":0.0031573772},"labels":[],"label_agreement":null},{"id":"W1992499756","doi":"10.1016/s0009-9236(03)90365-1","title":"Amiodarone for in‐hospital cardiac resuscitation: A cohort study with long‐term follow up and neurological outcomes","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac Arrest and Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Dalhousie University; Western University","funders":"","keywords":"Medicine; Amiodarone; Resuscitation; Cohort; Cohort study; Term (time); Emergency medicine; Internal medicine; Intensive care medicine; Cardiology; Pediatrics; Atrial fibrillation","score_opus":0.052545102555996585,"score_gpt":0.4073779371636639,"score_spread":0.3548328346076673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992499756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994167,0.00012864546,0.000046807814,0.00004987044,0.000014558248,0.000008525905,0.00015152968,0.0000017701577,0.00018156719],"genre_scores_gemma":[0.99923253,0.00011216311,0.000040452684,0.000051175917,0.000021154243,0.000014488244,0.00026680063,0.0000025495347,0.00025868454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926776,0.00022966885,0.00007169736,0.00015997989,0.00007898512,0.00019190923],"domain_scores_gemma":[0.997413,0.0005657716,0.0007266384,0.00039452614,0.0002367605,0.0006633853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012275225,0.0005397427,0.0007240391,0.00061583973,0.0011351662,0.0011019019,0.0005537009,0.0012958988,0.0020926949],"category_scores_gemma":[0.0040260847,0.0007620709,0.0012827623,0.0009983843,0.0005207912,0.0011623418,0.00057345175,0.0017028718,0.00046591245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026096564,0.00047510234,0.9939674,0.000009461468,0.00038737545,0.0004817879,0.0001954573,0.000041173676,0.00063648797,0.00001888253,0.00015352025,0.0010235352],"study_design_scores_gemma":[0.00016319475,0.0016985752,0.9961713,0.0000088799525,0.00027476245,0.0007239835,0.0003812419,0.00015731523,0.0001672274,0.000038762777,0.00019525914,0.00001963752],"about_ca_topic_score_codex":0.005503389,"about_ca_topic_score_gemma":0.0066251983,"teacher_disagreement_score":0.005503389,"about_ca_system_score_codex":0.00044165587,"about_ca_system_score_gemma":0.00069780526,"threshold_uncertainty_score":0.0109426975},"labels":[],"label_agreement":null},{"id":"W1992517458","doi":"10.1038/clpt.2010.175","title":"Breaking Barriers in the Genomics and Pharmacogenetics of Drug Addiction","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Center for Research Resources; National Institute of Mental Health; National Institute on Alcohol Abuse and Alcoholism; Economic and Social Research Council; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Addiction; Pharmacogenetics; Missing heritability problem; Genetic architecture; Precision medicine; Pharmacogenomics; Personalized medicine; Genomics; Clinical pharmacology; Genome-wide association study; Biobank; Medicine; Computational biology; Biology; Bioinformatics; Psychiatry; Pharmacology; Genome; Genetics; Genetic variants; Gene; Single-nucleotide polymorphism; Phenotype","score_opus":0.1614504724314493,"score_gpt":0.4681222746317638,"score_spread":0.30667180220031454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992517458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009963084,0.99489105,0.0006361265,0.0027242806,0.00026451296,0.0000037346726,0.0000061686665,0.000009376376,0.0013651567],"genre_scores_gemma":[0.0010519483,0.9954834,0.00096120744,0.0010101584,0.0007097161,0.0000076010615,0.000011569826,0.000003230913,0.00076129154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993747,0.0002427791,0.00006672028,0.00008494768,0.00019359676,0.000037315098],"domain_scores_gemma":[0.9982451,0.0012419142,0.000100235266,0.000082040904,0.0002345416,0.000096213094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033759046,0.0009205478,0.0017848272,0.0020904774,0.00038615783,0.0017518771,0.0014766967,0.0028877668,0.0025715933],"category_scores_gemma":[0.0024153017,0.0004496355,0.0005221096,0.0015438764,0.002482325,0.0038380455,0.0014682395,0.004592098,0.0018452028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006802228,0.000084385065,0.00035237166,0.0050754105,0.000094250994,0.00042437104,0.0001400524,0.0005019407,0.0014227161,0.038047105,0.03225332,0.921536],"study_design_scores_gemma":[0.000020381558,0.00006154239,0.0010289476,0.0028845915,0.000046133984,0.0014685602,0.00012540181,0.00018489495,0.00045254035,0.024878189,0.9688215,0.000027373704],"about_ca_topic_score_codex":0.0015798558,"about_ca_topic_score_gemma":0.0029441996,"teacher_disagreement_score":0.0033759046,"about_ca_system_score_codex":0.0012257216,"about_ca_system_score_gemma":0.0020257053,"threshold_uncertainty_score":0.017853677},"labels":[],"label_agreement":null},{"id":"W1993226580","doi":"10.1038/sj.clpt.6100274","title":"Professional Students' Perceptions of the Value, Role, and Impact of Science in Clinical Education","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Innovations in Medical Education","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clinical pharmacology; Perception; Value (mathematics); Medical education; Medicine; Psychology; Pharmacology; Mathematics education; Mathematics; Neuroscience","score_opus":0.05687965832188259,"score_gpt":0.5829835005610173,"score_spread":0.5261038422391348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993226580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97901195,0.0007493437,0.0013171197,0.005276841,0.00013596693,0.00005590671,0.000025778314,0.0000172943,0.013409744],"genre_scores_gemma":[0.9963735,0.0005597445,0.00034141462,0.0010272175,0.000046884576,0.00001967364,0.000022898603,0.000007776798,0.0016009023],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9892007,0.0035685808,0.0007544203,0.00041958448,0.004920928,0.0011357637],"domain_scores_gemma":[0.949493,0.021227114,0.007302557,0.0014395284,0.007843509,0.01269427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015756125,0.0002702294,0.00041949592,0.0018888975,0.0024629813,0.009347461,0.0005084106,0.0020620986,0.0042161206],"category_scores_gemma":[0.052937556,0.0003015861,0.00052921026,0.0007851787,0.0053904904,0.0028174692,0.0042055417,0.003955178,0.00052869675],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009291845,0.0018419552,0.5658595,0.00069250946,0.0002190646,0.0011496472,0.28931794,0.00085328985,0.007589944,0.015223199,0.009037266,0.10728652],"study_design_scores_gemma":[0.0002565655,0.0037333886,0.3906108,0.0011207014,0.00021504644,0.0034710777,0.48691553,0.0029476357,0.0037237522,0.023821937,0.082819335,0.000364244],"about_ca_topic_score_codex":0.001766886,"about_ca_topic_score_gemma":0.0022498565,"teacher_disagreement_score":0.015756125,"about_ca_system_score_codex":0.002302957,"about_ca_system_score_gemma":0.003856794,"threshold_uncertainty_score":0.08332735},"labels":[],"label_agreement":null},{"id":"W1994118391","doi":"10.1016/s0009-9236(03)90699-0","title":"Effects of amitriptyline, gabapentin, and carbamazepine on morphine‐induced respiratory depression in rabbits","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Amitriptyline; Gabapentin; Carbamazepine; Morphine; Depression (economics); Medicine; Pharmacology; Anesthesia; Respiratory system; Clinical pharmacology; Anticonvulsant; Drug; Epilepsy; Internal medicine; Psychiatry","score_opus":0.10543303560678406,"score_gpt":0.3957801989706196,"score_spread":0.29034716336383554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994118391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963182,0.0015917093,0.00041100022,0.0001711,0.00008578034,0.00005646941,0.0002468614,0.000044487824,0.0010744171],"genre_scores_gemma":[0.99529403,0.0018830167,0.0005371013,0.00008735421,0.00006921023,0.00005058085,0.0002942435,0.000018973806,0.0017655294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994444,0.00010002365,0.00006985688,0.00008750191,0.000114086135,0.00018403781],"domain_scores_gemma":[0.9991498,0.00022209105,0.00019047066,0.000107592125,0.000089395595,0.00024059156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047824986,0.00060972816,0.0011001141,0.0006039151,0.00042986032,0.00043338333,0.00068869634,0.0007335275,0.0010242775],"category_scores_gemma":[0.0012310939,0.00061180687,0.00093086,0.00045322347,0.0012913242,0.00072169653,0.0003577989,0.0016561411,0.00041874798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058399677,0.0017591815,0.002010593,0.0002484606,0.00020371455,0.00073446386,0.0005891815,0.000392942,0.91939384,0.00042100978,0.00043915515,0.015407904],"study_design_scores_gemma":[0.001424319,0.040311605,0.022772316,0.000034170615,0.0004346702,0.0005465813,0.00031744383,0.0025239196,0.92953086,0.00016877532,0.0018634057,0.00007192219],"about_ca_topic_score_codex":0.0033080224,"about_ca_topic_score_gemma":0.004076132,"teacher_disagreement_score":0.0033080224,"about_ca_system_score_codex":0.0005884778,"about_ca_system_score_gemma":0.00055907643,"threshold_uncertainty_score":0.0065775514},"labels":[],"label_agreement":null},{"id":"W1996874607","doi":"10.1016/s0009-9236(03)90534-0","title":"Duration of Grapefruit Juice Effect on Fexofenadine Interaction","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Grapefruit juice; Fexofenadine; Terfenadine; Duration (music); Pharmacology; Food science; Medicine; Chemistry; Pharmacokinetics; Physics","score_opus":0.18959654549128294,"score_gpt":0.522796970606952,"score_spread":0.33320042511566905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996874607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930315,0.0037673844,0.00021004977,0.0001811041,0.00013174007,0.00003902018,0.00043532,0.000041565963,0.002162182],"genre_scores_gemma":[0.99552923,0.0007860805,0.0001596596,0.000089206645,0.0001019743,0.000020035572,0.00038342923,0.000009704567,0.0029207494],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997279,0.000084329346,0.00001769265,0.00004928687,0.00005328572,0.00006756475],"domain_scores_gemma":[0.99864227,0.000787191,0.00013352466,0.000105915096,0.00007855598,0.00025250335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005626576,0.0003374971,0.001244071,0.0001564893,0.00032271238,0.00050342025,0.00019899369,0.0004911457,0.0086113205],"category_scores_gemma":[0.0021790764,0.00024609274,0.0005224755,0.00011191445,0.00038504563,0.0005477826,0.00027171645,0.0009616388,0.0005818609],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36398217,0.0019826589,0.019535055,0.00055617,0.000761605,0.0007754366,0.00053700706,0.00039905088,0.5312651,0.0005224101,0.0015471998,0.078136176],"study_design_scores_gemma":[0.004961466,0.13558976,0.5482675,0.00013861689,0.0012968215,0.0023881255,0.0005488072,0.0019389989,0.2910446,0.00044068703,0.013254947,0.00012972842],"about_ca_topic_score_codex":0.0013332963,"about_ca_topic_score_gemma":0.0021298006,"teacher_disagreement_score":0.0086113205,"about_ca_system_score_codex":0.0003064589,"about_ca_system_score_gemma":0.00042621212,"threshold_uncertainty_score":0.02880776},"labels":[],"label_agreement":null},{"id":"W1997060267","doi":"10.1016/s0009-9236(03)90578-9","title":"Interleukin (IL)‐6 downregulates expression of the pregnane X receptor (PXR) in mice","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pregnane X receptor; Pregnane; Receptor; Pharmacology; Chemistry; Internal medicine; Endocrinology; Biology; Medicine; Nuclear receptor; Stereochemistry; Biochemistry; Gene; Transcription factor","score_opus":0.08460571790958556,"score_gpt":0.4001334436873575,"score_spread":0.31552772577777194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997060267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826994,0.0024215886,0.006221853,0.0015765559,0.0003897779,0.0000843771,0.002091939,0.00074980914,0.0037647886],"genre_scores_gemma":[0.97295815,0.0024042241,0.0048636,0.0006109727,0.00021453235,0.0001686931,0.0019032749,0.00041987095,0.016456602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890614,0.00017973705,0.00011065467,0.0002373783,0.0002493499,0.0003168253],"domain_scores_gemma":[0.9989231,0.00014231936,0.0004485653,0.00012694244,0.000054729462,0.0003042555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005264886,0.0011495086,0.000806721,0.0017328754,0.00046130916,0.0012076389,0.00060654234,0.0011599455,0.0050857374],"category_scores_gemma":[0.00036443438,0.000911148,0.0009657356,0.0005369052,0.0015216164,0.00083313265,0.00045647795,0.004397448,0.0021420687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009523666,0.00023228333,0.00028170823,0.00003974248,0.000013228019,0.0002195388,0.00004574632,0.000095375806,0.9962203,0.0003595387,0.00017514698,0.0013651875],"study_design_scores_gemma":[0.00046014125,0.0015817297,0.0049263476,0.000028753919,0.000096166674,0.00084995455,0.00017126407,0.001236495,0.98671585,0.0004080998,0.0034981892,0.000026935486],"about_ca_topic_score_codex":0.00057866477,"about_ca_topic_score_gemma":0.0008963059,"teacher_disagreement_score":0.0050857374,"about_ca_system_score_codex":0.0006499754,"about_ca_system_score_gemma":0.00039964204,"threshold_uncertainty_score":0.01701349},"labels":[],"label_agreement":null},{"id":"W1997519635","doi":"10.1038/sj.clpt.6100096","title":"Molecular Imaging as a Tool for Personalized and Targeted Anticancer Therapy","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Library science; Citation; Psychology; Sociology; Computer science","score_opus":0.32858627950061575,"score_gpt":0.6135134024562962,"score_spread":0.2849271229556804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997519635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015533417,0.9933466,0.0014282473,0.0008079874,0.0005703941,0.000013188918,0.00002330298,0.00003426692,0.003620732],"genre_scores_gemma":[0.0014488222,0.9921193,0.0012925674,0.00082424434,0.00071170443,0.000022100761,0.000041363477,0.0000063775237,0.0035334707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997451,0.00004852576,0.00002183561,0.00004064029,0.00011976785,0.000024168805],"domain_scores_gemma":[0.9996458,0.00016973469,0.00004264479,0.000014915337,0.00009879579,0.000028030607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094630045,0.0015622266,0.0020004525,0.0027297826,0.00031254697,0.0015399152,0.0012936564,0.0021180091,0.0049819266],"category_scores_gemma":[0.00066864816,0.00050204183,0.0005142356,0.0023392309,0.0010867086,0.002073355,0.00084195816,0.0027749622,0.003963996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082627106,0.00014364964,0.0000936369,0.004847975,0.00006714685,0.00024191721,0.00003232871,0.0004728439,0.0060066544,0.007853775,0.051691562,0.92846584],"study_design_scores_gemma":[0.000035371013,0.000113100374,0.0003133317,0.0008949673,0.00008457491,0.0017301965,0.000025176272,0.00034957493,0.0025691825,0.002998859,0.99086165,0.00002401528],"about_ca_topic_score_codex":0.0010185417,"about_ca_topic_score_gemma":0.0018826455,"teacher_disagreement_score":0.0049819266,"about_ca_system_score_codex":0.0010696107,"about_ca_system_score_gemma":0.0010666406,"threshold_uncertainty_score":0.016666234},"labels":[],"label_agreement":null},{"id":"W1997897011","doi":"10.1038/clpt.2014.89","title":"Inflammation-Related Genetic Variations and Survival in Patients With Advanced Non–Small Cell Lung Cancer Receiving First-Line Chemotherapy","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; Harvard University","keywords":"Internal medicine; Oncology; Single-nucleotide polymorphism; Medicine; Hazard ratio; Lung cancer; Confidence interval; SNP; Gene; Biology; Genotype; Genetics","score_opus":0.015025441563181145,"score_gpt":0.3016473445819246,"score_spread":0.28662190301874346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997897011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99960226,0.00019136169,0.00004926315,0.000015755932,0.0000029931846,0.0000031158227,0.000071119866,0.0000015897501,0.00006255433],"genre_scores_gemma":[0.9996592,0.000049917042,0.00004715916,0.000015368736,0.0000058010714,0.0000038600006,0.0001532298,0.0000011148535,0.00006428771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996282,0.00013436502,0.000030468504,0.00010609713,0.000049098388,0.000051694697],"domain_scores_gemma":[0.99902153,0.0003577541,0.00031414878,0.000100896854,0.00007521143,0.00013035399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006116087,0.00028532013,0.00037631992,0.00033652424,0.0002820623,0.0003871763,0.00025822668,0.00048882817,0.000704261],"category_scores_gemma":[0.0018534412,0.00019574356,0.00040930053,0.0005741817,0.00026755373,0.0001722229,0.0002491097,0.0004573364,0.00013829983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006440026,0.000041306863,0.9965162,0.0000064426513,0.00009556823,0.000059921083,0.000030516443,0.000111522575,0.00092645624,0.000008720807,0.000047052068,0.0015122188],"study_design_scores_gemma":[0.00003281085,0.00021863816,0.99885595,0.0000032154435,0.00006700451,0.00013157287,0.0000306975,0.00034493994,0.0001838821,0.000029168077,0.0000989933,0.000003066609],"about_ca_topic_score_codex":0.0016115622,"about_ca_topic_score_gemma":0.002046685,"teacher_disagreement_score":0.0016115622,"about_ca_system_score_codex":0.00027804077,"about_ca_system_score_gemma":0.0002217134,"threshold_uncertainty_score":0.0032345057},"labels":[],"label_agreement":null},{"id":"W1998309751","doi":"10.1038/clpt.2008.58","title":"Optical Molecular Imaging: From Single Cell to Patient","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Molecular imaging; Drug discovery; Nanotechnology; Clinical pharmacology; Optical imaging; Computer science; Computational biology; Drug delivery; Drug development; Medical physics; Drug; Data science; Medicine; Bioinformatics; Pharmacology; Biology; Biotechnology; Materials science; Physics; In vivo","score_opus":0.048950665375147556,"score_gpt":0.4047380817440643,"score_spread":0.35578741636891675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998309751","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063789725,0.18476452,0.61892843,0.033659875,0.0028779686,0.00057295256,0.0060747024,0.012801665,0.07653024],"genre_scores_gemma":[0.4215158,0.13337322,0.37527004,0.02029503,0.003725325,0.0009289483,0.0033928321,0.0026135792,0.03888516],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994288,0.00010357357,0.000031758,0.00019077693,0.00020305562,0.000042011336],"domain_scores_gemma":[0.9990908,0.00027082962,0.00009180682,0.0002316195,0.00023798847,0.00007694309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013216333,0.000447026,0.0010656898,0.0010857462,0.00035821067,0.002733395,0.0011813061,0.0016965783,0.006121571],"category_scores_gemma":[0.0023738514,0.0005730311,0.00037192824,0.000834347,0.00096223364,0.0026511878,0.0017529407,0.002055342,0.0045090583],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055778126,0.00016412513,0.0063058655,0.0010548233,0.00011656354,0.00077159423,0.0004017124,0.0025032863,0.19178778,0.018242694,0.06505607,0.7130377],"study_design_scores_gemma":[0.00011176674,0.0008640895,0.013304068,0.0010702203,0.00035800913,0.016186437,0.0005907354,0.023338247,0.35938865,0.05108321,0.5334248,0.00027985568],"about_ca_topic_score_codex":0.00083233835,"about_ca_topic_score_gemma":0.00067313056,"teacher_disagreement_score":0.006121571,"about_ca_system_score_codex":0.0009222909,"about_ca_system_score_gemma":0.00057194143,"threshold_uncertainty_score":0.020478725},"labels":[],"label_agreement":null},{"id":"W1999064448","doi":"10.1016/s0009-9236(03)00200-5","title":"Folic acid food fortification is associated with a decline in neuroblastoma","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; Pediatric Oncology Group; SickKids Foundation; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Hepatoblastoma; Neuroblastoma; Confidence interval; Incidence (geometry); Rate ratio; Pediatrics; Gastroenterology; Internal medicine; Biology","score_opus":0.10127665997931388,"score_gpt":0.4183061422281397,"score_spread":0.3170294822488258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999064448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958507,0.0017064426,0.00010608843,0.0002665776,0.000010342647,0.00000886034,0.0005799487,0.000025458796,0.0014456082],"genre_scores_gemma":[0.9984145,0.0004427499,0.00009570619,0.000034043507,0.0000047551116,0.0000036439867,0.0003586442,0.0000047843605,0.0006411316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970645,0.00003765122,0.000025151687,0.00007182501,0.00010234126,0.000056518642],"domain_scores_gemma":[0.99656796,0.0003884727,0.0018844381,0.00020188515,0.0006152483,0.0003419401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004475743,0.0001401475,0.0002716553,0.0005038852,0.0004195755,0.0005719278,0.000390876,0.00047064,0.0017368012],"category_scores_gemma":[0.00373836,0.00016975857,0.00032881898,0.00091748347,0.00035326596,0.00020491093,0.00023415704,0.0006147783,0.00017934832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039054884,0.00004821303,0.9935021,0.000019305133,0.00004891426,0.00016656156,0.000121405494,0.000051378625,0.0012379421,0.000028368262,0.00019772469,0.0041875965],"study_design_scores_gemma":[0.000001710113,0.00003434372,0.99951625,0.00000291327,0.000013693023,0.00009983957,0.000027007336,0.000029888439,0.00007165816,0.000008997103,0.00019279041,8.1360497e-7],"about_ca_topic_score_codex":0.18597203,"about_ca_topic_score_gemma":0.11767714,"teacher_disagreement_score":0.18597203,"about_ca_system_score_codex":0.001769662,"about_ca_system_score_gemma":0.0018345822,"threshold_uncertainty_score":0.3697791},"labels":[],"label_agreement":null},{"id":"W1999481780","doi":"10.1038/clpt.2013.57","title":"Biomarkers for Smoking Cessation","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; National Cancer Institute; National Institute on Drug Abuse; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; Pfizer","keywords":"Drug development; Biomarker; Biomarker discovery; Identification (biology); Medicine; Disease; Drug discovery; Regulatory science; Pharmacodynamics; Smoking cessation; Computational biology; Personalized medicine; Bioinformatics; Drug; Pharmacology; Biology; Pathology; Pharmacokinetics; Proteomics","score_opus":0.3310320414159591,"score_gpt":0.541898029911326,"score_spread":0.21086598849536686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999481780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013752608,0.995767,0.0004944823,0.0010870916,0.0004626391,0.000010050032,0.000040417053,0.000013163497,0.0019875946],"genre_scores_gemma":[0.0018538326,0.9942399,0.0009529035,0.0006751532,0.00047353882,0.000021608774,0.00007253571,0.0000026852179,0.0017078526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997192,0.00006863933,0.000036961148,0.00004941215,0.00010850419,0.000017374681],"domain_scores_gemma":[0.99965453,0.00016510002,0.000049594575,0.000014346718,0.00009337329,0.000023006129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009241636,0.0009424561,0.0011636456,0.0022859373,0.0003069888,0.00089900265,0.00060891453,0.0014487463,0.0050924495],"category_scores_gemma":[0.0011141638,0.00021995338,0.00060406997,0.0012432714,0.0005671251,0.0010785188,0.00070333335,0.0023825646,0.0031048406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047738606,0.00008619969,0.00044659417,0.005505307,0.00009705602,0.0001613086,0.000053562737,0.0001623951,0.0019218966,0.009133083,0.028091796,0.954293],"study_design_scores_gemma":[0.000016260523,0.00010535789,0.0021933827,0.004469862,0.000116188385,0.0014958198,0.00006019289,0.00012986793,0.0009649627,0.007253265,0.98316634,0.000028520528],"about_ca_topic_score_codex":0.0011209544,"about_ca_topic_score_gemma":0.002186351,"teacher_disagreement_score":0.0050924495,"about_ca_system_score_codex":0.00060507056,"about_ca_system_score_gemma":0.0009957985,"threshold_uncertainty_score":0.017035902},"labels":[],"label_agreement":null},{"id":"W1999615559","doi":"10.1016/s0009-9236(03)90391-2","title":"Health‐related quality of life among children with adverse drug reactions","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Medicine; Drug reaction; Adverse effect; Quality (philosophy); Intensive care medicine; Environmental health; Pharmacology; Emergency medicine","score_opus":0.17470963778169132,"score_gpt":0.4918954244785921,"score_spread":0.3171857866969008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999615559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819916,0.0004610348,0.000023414139,0.0002315258,0.00001308064,0.000007116034,0.0003472157,0.0000023735672,0.00071507326],"genre_scores_gemma":[0.99899405,0.00035305784,0.000048724323,0.000067549605,0.000010894097,0.0000075327903,0.00035037764,0.0000013916651,0.00016645984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991517,0.00020867902,0.0001013932,0.000086578606,0.00021780313,0.00023383359],"domain_scores_gemma":[0.9967399,0.00054350303,0.0017713421,0.00007245692,0.0003189941,0.0005537446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070346514,0.0002412703,0.0006780864,0.0007191471,0.0005565022,0.0007446982,0.00027960225,0.0005560706,0.00202778],"category_scores_gemma":[0.0045305477,0.00028267477,0.0011618901,0.0011938204,0.00035210548,0.0006035029,0.0005871732,0.001409667,0.00022175338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004428244,0.0000634997,0.99754745,0.000013896704,0.000032853353,0.00017842387,0.00012855606,0.000020827889,0.00005065646,0.000016112375,0.00015533433,0.0017481123],"study_design_scores_gemma":[0.00000441682,0.00011895933,0.99875915,0.000010067339,0.000025373136,0.0005964903,0.00026562673,0.000034338034,0.000029614652,0.000012782528,0.00013986976,0.0000032614803],"about_ca_topic_score_codex":0.012894083,"about_ca_topic_score_gemma":0.013676241,"teacher_disagreement_score":0.012894083,"about_ca_system_score_codex":0.00070549094,"about_ca_system_score_gemma":0.0006054793,"threshold_uncertainty_score":0.025638103},"labels":[],"label_agreement":null},{"id":"W1999813571","doi":"10.1016/s0009-9236(03)90626-6","title":"Pain control in children with otitis media","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Otitis; Medicine; Clinical pharmacology; Pain control; Intensive care medicine; Audiology; Pharmacology; Anesthesia; Surgery","score_opus":0.0415964455890094,"score_gpt":0.3801473200717874,"score_spread":0.33855087448277804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999813571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97895217,0.013531657,0.00044189068,0.0009402125,0.000103844905,0.000036561996,0.00023206833,0.000024722976,0.005736909],"genre_scores_gemma":[0.99489486,0.0041065854,0.0003247285,0.000146701,0.00005844123,0.000024661138,0.00012404853,0.0000040237396,0.00031599813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995604,0.00009557365,0.000054438824,0.000034303306,0.00013398958,0.0001213602],"domain_scores_gemma":[0.99898034,0.00032792301,0.000372546,0.000021817514,0.000106167194,0.00019113377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003050216,0.0002627852,0.0005671216,0.00031174734,0.0003460462,0.00037915856,0.00018009736,0.00032073157,0.0015924391],"category_scores_gemma":[0.0029680608,0.00009367396,0.00028205826,0.00035862942,0.00033322666,0.00024972347,0.0002773426,0.000683909,0.0001452462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022796926,0.0007505551,0.8360254,0.00072649785,0.00015349752,0.009729657,0.0014596366,0.0003886479,0.0044770488,0.00039638928,0.0034329817,0.14017995],"study_design_scores_gemma":[0.00016297704,0.0020027775,0.9764605,0.00016451256,0.00010017111,0.015630273,0.0014501598,0.00027130777,0.0010768464,0.00011237918,0.0025552781,0.0000127957965],"about_ca_topic_score_codex":0.0049313335,"about_ca_topic_score_gemma":0.0061648535,"teacher_disagreement_score":0.0049313335,"about_ca_system_score_codex":0.0006006709,"about_ca_system_score_gemma":0.00074663525,"threshold_uncertainty_score":0.009805262},"labels":[],"label_agreement":null},{"id":"W2001716038","doi":"10.1016/s0009-9236(03)90533-9","title":"Population Pharmacokinetics of Omeprazole in Healthy Adults and in Children With Gastroesophageal Reflux Disease","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Omeprazole; Pharmacokinetics; Reflux; Medicine; Disease; Pharmacology; Population; Gastroenterology; GERD; Internal medicine; Environmental health","score_opus":0.033022999228771395,"score_gpt":0.39068193855790295,"score_spread":0.35765893932913156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001716038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986253,0.00058509066,0.00019185846,0.00004479069,0.0000066177377,0.000009528525,0.00020356763,0.000018158342,0.00031503054],"genre_scores_gemma":[0.9987484,0.00036388318,0.0001852199,0.000059037015,0.000021763559,0.000017721055,0.00041912668,0.000010229414,0.00017449885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939084,0.00017903201,0.000043202384,0.00015075662,0.00013835485,0.00009780271],"domain_scores_gemma":[0.9986817,0.00051534316,0.00031124993,0.000101212405,0.00012438255,0.00026606882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063278666,0.0003654104,0.0011786878,0.00035026993,0.00028001363,0.00057887245,0.00020072666,0.00070717547,0.0008787736],"category_scores_gemma":[0.0030603134,0.0004351261,0.0005153585,0.0004323971,0.00037447544,0.00084719434,0.00041334308,0.0011673921,0.00026985529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055119675,0.00034096534,0.97354907,0.00006764458,0.00044679755,0.00077477534,0.0006097007,0.00063640845,0.004280028,0.00012060319,0.00070055254,0.012961454],"study_design_scores_gemma":[0.00006203599,0.0017252325,0.995786,0.0000025102975,0.00008312195,0.001108964,0.00017990882,0.00046380758,0.00027046847,0.00003979686,0.00026851572,0.000009634138],"about_ca_topic_score_codex":0.002589708,"about_ca_topic_score_gemma":0.002673428,"teacher_disagreement_score":0.002589708,"about_ca_system_score_codex":0.0004894049,"about_ca_system_score_gemma":0.0003522683,"threshold_uncertainty_score":0.0051492453},"labels":[],"label_agreement":null},{"id":"W2002894959","doi":"10.1016/s0009-9236(03)00238-8","title":"Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine,","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Fexofenadine; Verapamil; Terfenadine; Bioavailability; Chemistry; Pharmacology; Jejunum; Pharmacokinetics; Intestinal permeability; Absorption (acoustics); Perfusion; First pass effect; Chromatography; Internal medicine; Medicine; Biochemistry; Calcium; Materials science","score_opus":0.07520230082439355,"score_gpt":0.3770851599621532,"score_spread":0.30188285913775964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002894959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90454465,0.071995236,0.01994587,0.00062383246,0.00008745351,0.00015893867,0.00027615041,0.00018450223,0.0021833933],"genre_scores_gemma":[0.98298925,0.007725719,0.006001627,0.00010281408,0.000060154394,0.000044882876,0.00014545741,0.000014768148,0.0029153223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996106,0.00007828184,0.00002772701,0.00015960328,0.000070514725,0.000053244108],"domain_scores_gemma":[0.9996605,0.00010852866,0.00011982351,0.00002530774,0.000046819187,0.000039019786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004937422,0.0007853763,0.0007750482,0.00041737745,0.00032970044,0.00081705215,0.00038441244,0.0008571089,0.0031769746],"category_scores_gemma":[0.0007220006,0.0004240636,0.0006109748,0.00022050017,0.00047857477,0.0013004215,0.0002995766,0.00070490426,0.00059287215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009687532,0.00037349475,0.026539225,0.0018833325,0.00037032887,0.0029673898,0.00038365336,0.0010127386,0.8603605,0.001290508,0.00050335407,0.09462791],"study_design_scores_gemma":[0.0012566383,0.0122590745,0.23045689,0.00025595806,0.0014309987,0.03580988,0.0006467355,0.014780742,0.68330103,0.002288492,0.017390294,0.00012322898],"about_ca_topic_score_codex":0.0010058547,"about_ca_topic_score_gemma":0.00087929657,"teacher_disagreement_score":0.0031769746,"about_ca_system_score_codex":0.0007920212,"about_ca_system_score_gemma":0.00041600663,"threshold_uncertainty_score":0.010628104},"labels":[],"label_agreement":null},{"id":"W2003017820","doi":"10.1067/mcp.2000.106464","title":"Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Metoprolol; Pharmacology; Diphenhydramine; Antihistamine; CYP2D6; Drug interaction; Debrisoquine; Medicine; Pharmacokinetics; Chemistry; In vivo; Histamine; Endocrinology; Internal medicine; Cytochrome P450; Biology; Metabolism","score_opus":0.15374140742723044,"score_gpt":0.46811064952311976,"score_spread":0.31436924209588935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003017820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996006,0.00019459148,0.00007380058,0.000008821732,0.000002886091,0.000006398293,0.00001832363,0.0000021282465,0.00009242729],"genre_scores_gemma":[0.9995757,0.000056665485,0.00010148848,0.000015723408,0.000007618898,0.000006271104,0.00003238808,9.294144e-7,0.00020317498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996904,0.00015522049,0.000016134534,0.00005299622,0.000043130596,0.00004215732],"domain_scores_gemma":[0.999691,0.00015254124,0.00006244591,0.000019892443,0.0000119686065,0.000062264306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035902383,0.00027321975,0.00044912015,0.00016125185,0.00021198943,0.00023214922,0.00009530052,0.0002778526,0.0012560771],"category_scores_gemma":[0.0006620034,0.0002278301,0.00025711305,0.0001325477,0.00025117505,0.00013358639,0.0001527475,0.000311638,0.00012287419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08337685,0.0028385944,0.7688841,0.00012976557,0.000490931,0.0016954629,0.00040532375,0.0003188983,0.10399809,0.000119726596,0.00018034455,0.037561852],"study_design_scores_gemma":[0.0009461266,0.028543126,0.9588052,0.0000029538762,0.00031755847,0.0010887882,0.00009367854,0.0006577897,0.009027865,0.000052343534,0.00045518222,0.000009397934],"about_ca_topic_score_codex":0.0006026734,"about_ca_topic_score_gemma":0.0009471844,"teacher_disagreement_score":0.0012560771,"about_ca_system_score_codex":0.00018997047,"about_ca_system_score_gemma":0.00012013121,"threshold_uncertainty_score":0.0042020082},"labels":[],"label_agreement":null},{"id":"W2003043566","doi":"10.1016/j.clpt.2004.08.025","title":"Population pharmacokinetics of CCI-779: Correlations to safety and pharmacogenomic responses in patients with advanced renal cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Sirolimus; Medicine; Pharmacokinetics; Population; Pharmacology; Adverse effect; Pharmacogenomics; Peripheral blood mononuclear cell; Internal medicine; Area under the curve; Hematocrit; Oncology; Biology; In vitro","score_opus":0.02514505152344249,"score_gpt":0.37672007863888796,"score_spread":0.35157502711544547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003043566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701154,0.0005664748,0.0020341114,0.000045281777,0.000001626297,0.000014970917,0.00012990984,0.000013931544,0.000182142],"genre_scores_gemma":[0.99910563,0.000091610265,0.00056051445,0.000019764493,0.0000054107895,0.000009400627,0.00016314686,0.0000023995674,0.000042113377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993017,0.00032647088,0.000032980064,0.00016318198,0.00013938591,0.000036347712],"domain_scores_gemma":[0.9979608,0.0010797882,0.00060433825,0.00015390363,0.000121074154,0.00008000125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016543091,0.00023171204,0.0005287641,0.00021770524,0.000097703196,0.0003832388,0.00017113301,0.00025054315,0.0006539558],"category_scores_gemma":[0.004083384,0.00012813984,0.00028406936,0.00026657878,0.00016900273,0.00024315053,0.00015178909,0.00033322317,0.000106038344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005810603,0.0003192657,0.9098445,0.00011052417,0.0009517349,0.000120849705,0.00013406893,0.022028841,0.015517899,0.00016050405,0.0002698707,0.044731393],"study_design_scores_gemma":[0.00042960985,0.0058905683,0.9247916,0.000013957136,0.00049388927,0.00079346664,0.0000898425,0.05556435,0.009831069,0.00051954744,0.0015452679,0.000036806996],"about_ca_topic_score_codex":0.00080991257,"about_ca_topic_score_gemma":0.00068090175,"teacher_disagreement_score":0.0016543091,"about_ca_system_score_codex":0.0004140107,"about_ca_system_score_gemma":0.00045367648,"threshold_uncertainty_score":0.008748949},"labels":[],"label_agreement":null},{"id":"W2003795943","doi":"10.1016/s0009-9236(03)90535-2","title":"Volume of Grapefruit Juice and Bioavailability of Fexofenadine","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Grapefruit juice; Fexofenadine; Bioavailability; Terfenadine; Volume (thermodynamics); Pharmacology; Chemistry; Medicine; Pharmacokinetics","score_opus":0.09259043979338591,"score_gpt":0.43360508676102094,"score_spread":0.34101464696763506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003795943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615496,0.0024172293,0.00025744108,0.00010292336,0.0000671859,0.000018181578,0.00016964177,0.000040125225,0.00077237666],"genre_scores_gemma":[0.99719065,0.0006083301,0.0002035425,0.000047546328,0.000060840062,0.0000068322006,0.00019159964,0.0000114100085,0.0016792675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99979967,0.00006864107,0.000013296315,0.00003796461,0.00004096842,0.000039440147],"domain_scores_gemma":[0.99927956,0.000335407,0.00010950713,0.00006635263,0.000049958366,0.00015929638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038824795,0.00030500532,0.0005165408,0.00019740136,0.00017861022,0.0005691135,0.00019943665,0.0005769628,0.0035989815],"category_scores_gemma":[0.0015650986,0.00030174022,0.00036714145,0.00010620188,0.00033242197,0.0007806653,0.0001918794,0.0007609483,0.00040910253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41162536,0.0028373199,0.026200248,0.00034741976,0.00091267494,0.0010119246,0.00055044494,0.0013628432,0.4746676,0.0006347179,0.0020795546,0.077769905],"study_design_scores_gemma":[0.0052215843,0.09520707,0.2986981,0.00009791753,0.0012735577,0.0025893187,0.00062628475,0.01073717,0.5767761,0.00069169333,0.007917359,0.00016377472],"about_ca_topic_score_codex":0.0019735,"about_ca_topic_score_gemma":0.001787131,"teacher_disagreement_score":0.0035989815,"about_ca_system_score_codex":0.0003851147,"about_ca_system_score_gemma":0.00028343577,"threshold_uncertainty_score":0.01203984},"labels":[],"label_agreement":null},{"id":"W2003955744","doi":"10.1038/clpt.2013.80","title":"Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; BC Children's Hospital; Université de Montréal; Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Columbia university; Library science; Medicine; Family medicine; Media studies; Sociology","score_opus":0.04276627127521036,"score_gpt":0.3529355795704113,"score_spread":0.3101693082952009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003955744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862933,0.00017544682,0.00051620614,0.000032059503,0.000008490314,0.000012067123,0.00044437282,0.000007883509,0.0001741283],"genre_scores_gemma":[0.99892515,0.00010758065,0.0003687344,0.000021881946,0.000006823171,0.0000148454,0.0004376834,0.000009716539,0.00010767919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986765,0.00033701016,0.00013572168,0.00042334007,0.00030326823,0.00012415933],"domain_scores_gemma":[0.9971781,0.0008693912,0.00089639093,0.0005324326,0.00033055976,0.00019311339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012877801,0.000631752,0.0006255565,0.00072417123,0.0005723624,0.00068764505,0.0005046399,0.0004522654,0.001380759],"category_scores_gemma":[0.006280747,0.00028412245,0.0010851165,0.0009681494,0.0004995243,0.00028907266,0.0006111579,0.0008369919,0.00028303775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031610372,0.000020818188,0.99149585,0.000018308181,0.00024607292,0.0008518087,0.00022444973,0.00027808643,0.0034471466,0.000054237484,0.00014619296,0.0029009494],"study_design_scores_gemma":[0.00003983552,0.00022869738,0.99249345,0.000016411419,0.00026081968,0.0030023383,0.00019850858,0.00051295274,0.0022997474,0.00006887498,0.00086633366,0.000011987194],"about_ca_topic_score_codex":0.0090263765,"about_ca_topic_score_gemma":0.0051723886,"teacher_disagreement_score":0.0090263765,"about_ca_system_score_codex":0.00050052354,"about_ca_system_score_gemma":0.0006900682,"threshold_uncertainty_score":0.017947674},"labels":[],"label_agreement":null},{"id":"W2004772633","doi":"10.1038/clpt.2009.201","title":"Sustained Neurobehavioral Effects of Exposure to SSRI Antidepressants During Development: Molecular to Clinical Evidence","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"National Institute of Mental Health","keywords":"Serotonergic; Clinical pharmacology; Serotonin reuptake inhibitor; Serotonin; Mood; Fluoxetine; Medicine; Serotonin Uptake Inhibitors; Psychiatry; Sertraline; Psychology; Prenatal exposure; Antidepressant; Pharmacology; Pregnancy; Internal medicine; Anxiety; Biology; Gestation","score_opus":0.09180549067901014,"score_gpt":0.4731599964903224,"score_spread":0.38135450581131225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004772633","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12271768,0.8454375,0.0010189454,0.015223875,0.00037927652,0.000110123736,0.00052443787,0.000045434015,0.014542657],"genre_scores_gemma":[0.30083445,0.6912152,0.0014998139,0.0036311203,0.0013397612,0.00008933002,0.00028717172,0.000009013927,0.0010941033],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995652,0.00011617205,0.00007908046,0.000082908584,0.000112347996,0.000044239547],"domain_scores_gemma":[0.99484444,0.003148149,0.0010975001,0.00018857468,0.0005160679,0.00020517451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012535845,0.00054338784,0.001095237,0.0006514917,0.00023354297,0.0010968221,0.0007985903,0.0016301444,0.0048221964],"category_scores_gemma":[0.0035988654,0.000285439,0.0003964871,0.0005193145,0.0013866415,0.00065396575,0.0004755328,0.0012421003,0.000660393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076081664,0.0017051257,0.05953451,0.01644002,0.0011785321,0.004667833,0.00034056974,0.00038777728,0.04896486,0.0054935534,0.00492005,0.84875894],"study_design_scores_gemma":[0.0023873437,0.041733593,0.6062978,0.021547796,0.0074559823,0.02551522,0.0020751364,0.0010169686,0.05915271,0.016928697,0.2157048,0.0001840059],"about_ca_topic_score_codex":0.0010596788,"about_ca_topic_score_gemma":0.0019002281,"teacher_disagreement_score":0.0048221964,"about_ca_system_score_codex":0.0006577038,"about_ca_system_score_gemma":0.0015330972,"threshold_uncertainty_score":0.016131818},"labels":[],"label_agreement":null},{"id":"W2005533850","doi":"10.1038/sj.clpt.6100506","title":"Novel Methods for the Detection of Drug and Alcohol Exposure During Pregnancy:Implications for Maternal and Child Health","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Pregnancy; Drug; Alcohol; Obstetrics; Medicine; Environmental health; Maternal health; Psychiatry; Health services; Chemistry; Biology","score_opus":0.1822372335718684,"score_gpt":0.521680560583615,"score_spread":0.3394433270117466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005533850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002112709,0.9963462,0.0014264942,0.0005805564,0.00020233514,0.000014745393,0.00004768072,0.000020457217,0.0011503159],"genre_scores_gemma":[0.0012711639,0.9948127,0.002578655,0.0002840646,0.0001800746,0.00003056048,0.00006463936,0.0000044039894,0.0007737846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987914,0.00029906342,0.00009631524,0.00025605632,0.00048203988,0.00007513159],"domain_scores_gemma":[0.9968929,0.0018912748,0.0003752464,0.00010223326,0.00062877225,0.00010949205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004489386,0.001670585,0.0034760742,0.00454919,0.00035913868,0.0014681359,0.002337224,0.002710781,0.004281379],"category_scores_gemma":[0.0032598998,0.00077389873,0.0010096596,0.0030582498,0.0016902519,0.0022301206,0.000950365,0.0031902744,0.0040479754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091941045,0.00014743395,0.0009722229,0.00799884,0.00010531396,0.00018496948,0.00006275093,0.00027019912,0.0054548467,0.002345607,0.009028187,0.9733377],"study_design_scores_gemma":[0.00008579248,0.00089670194,0.010463082,0.007925909,0.00054754625,0.0077582034,0.00041180625,0.00073591917,0.011383067,0.008323417,0.95127153,0.00019708413],"about_ca_topic_score_codex":0.0020679613,"about_ca_topic_score_gemma":0.0027878708,"teacher_disagreement_score":0.00454919,"about_ca_system_score_codex":0.0010420643,"about_ca_system_score_gemma":0.0014411192,"threshold_uncertainty_score":0.023742437},"labels":[],"label_agreement":null},{"id":"W2005818996","doi":"10.1038/clpt.2008.50","title":"Mice as Clinically Relevant Models for the Study of Cytochrome P450-dependent Metabolism","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Research Nova Scotia","keywords":"Drug metabolism; Cytochrome P450; Biology; Computational biology; Drug; Xenobiotic; Drug discovery; Function (biology); Gene; Metabolism; Drug development; Pharmacology; Bioinformatics; Genetics; Biochemistry; Enzyme","score_opus":0.46419484390673466,"score_gpt":0.5847167342678442,"score_spread":0.12052189036110955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005818996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010815802,0.99057734,0.0026125587,0.00040307804,0.0003283886,0.000039990657,0.00012338704,0.00006969607,0.004763902],"genre_scores_gemma":[0.0037142253,0.9891283,0.0035073357,0.00050301047,0.00017802388,0.00008214499,0.0002481295,0.000014821287,0.0026239299],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960715,0.00009938722,0.000039969385,0.00006360363,0.00016629805,0.000023579198],"domain_scores_gemma":[0.9996822,0.00014382522,0.00005811812,0.000020570882,0.00006595457,0.000029397239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010349937,0.000927838,0.0017355897,0.0014027028,0.00016902061,0.0008685088,0.0010740776,0.0011531174,0.0028682223],"category_scores_gemma":[0.0005029982,0.0002456251,0.00035275458,0.0010825146,0.00049854134,0.0009015052,0.00048701777,0.0019677829,0.0026662531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020621349,0.00027099557,0.00041147645,0.01114726,0.00010186446,0.0007463378,0.000084818355,0.0004519663,0.07478181,0.01398553,0.02932847,0.8684833],"study_design_scores_gemma":[0.00005597592,0.00035408212,0.0010481521,0.0013902822,0.0001472519,0.0030601376,0.000043028507,0.00013606554,0.012187047,0.0034172637,0.97813123,0.000029493242],"about_ca_topic_score_codex":0.00032117462,"about_ca_topic_score_gemma":0.00057786255,"teacher_disagreement_score":0.0028682223,"about_ca_system_score_codex":0.00041393476,"about_ca_system_score_gemma":0.00047752832,"threshold_uncertainty_score":0.009595215},"labels":[],"label_agreement":null},{"id":"W2006541492","doi":"10.1016/s0009-9236(03)90685-0","title":"Folic Acid Fortification and Rates of Neuroblastoma in Ontario","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Folic acid; Neuroblastoma; Fortification; Medicine; Environmental health; Internal medicine; Chemistry; Food science; Biology; Genetics","score_opus":0.16696521616172066,"score_gpt":0.463072148956833,"score_spread":0.29610693279511235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006541492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908669,0.00045967833,0.00013089972,0.00037117765,0.000012094815,0.00003138425,0.0029537966,0.000021554513,0.0051525934],"genre_scores_gemma":[0.99014354,0.0005499611,0.00015155601,0.00007004447,0.000005621974,0.00001236783,0.0011092495,0.00001536658,0.00794221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996526,0.000028989625,0.00002242716,0.000051255516,0.00014749452,0.00009714407],"domain_scores_gemma":[0.9978738,0.00016419395,0.0006284894,0.00006899825,0.0007682728,0.00049632986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035982754,0.00016892861,0.00025982276,0.00076133094,0.0017395713,0.00080139947,0.0008570481,0.00034329327,0.00400636],"category_scores_gemma":[0.0018927951,0.00035046032,0.00041795018,0.0014817534,0.00044468144,0.0003197244,0.0005786402,0.0005122704,0.00038635705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015110602,0.00010357585,0.97971493,0.00005211797,0.000079820275,0.0005376184,0.0025745311,0.00030938644,0.0033080718,0.0003757805,0.0016671661,0.009766],"study_design_scores_gemma":[0.000031089887,0.00018323286,0.99294573,0.000016732034,0.00004613906,0.00023770986,0.0013951797,0.0002075,0.001075964,0.00007466901,0.0037668378,0.000019222343],"about_ca_topic_score_codex":0.9660049,"about_ca_topic_score_gemma":0.98294526,"teacher_disagreement_score":0.033995092,"about_ca_system_score_codex":0.017758826,"about_ca_system_score_gemma":0.017250633,"threshold_uncertainty_score":0.12884986},"labels":[],"label_agreement":null},{"id":"W2006793732","doi":"10.1067/mcp.2002.126409","title":"Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Felodipine; Ascorbyl palmitate; Chemistry; Bioavailability; Grapefruit juice; Pharmacokinetics; Pharmacology; Nifedipine; Food science; Chromatography; Ascorbic acid; Calcium; Endocrinology; Medicine","score_opus":0.2868937453360573,"score_gpt":0.5101501110644951,"score_spread":0.22325636572843782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006793732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468344,0.0031264971,0.0016133628,0.000050440794,0.000020196521,0.000063241234,0.00009431312,0.000025830708,0.00032266547],"genre_scores_gemma":[0.994286,0.0019747787,0.0025795556,0.000045367302,0.000025980275,0.00006187395,0.00024112266,0.000009810319,0.0007755559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981135,0.00008589035,0.000013256827,0.00003950973,0.000029668732,0.000020381942],"domain_scores_gemma":[0.9997924,0.000058146426,0.00006909796,0.000022433142,0.000023740511,0.000034216635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034184897,0.0005450711,0.00034666102,0.00018226387,0.00014349516,0.00021946486,0.00020507004,0.00028730076,0.0011480483],"category_scores_gemma":[0.0004068862,0.00014421187,0.00030061035,0.00015175348,0.00025333164,0.00026447704,0.0001065046,0.00037215595,0.00015842836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0174286,0.00086177303,0.0018146025,0.0002563434,0.00019841999,0.00012985512,0.000053655946,0.00030969584,0.95727646,0.00007854247,0.00008476122,0.021507256],"study_design_scores_gemma":[0.000734774,0.033829596,0.006035754,0.000013117526,0.00027285496,0.00040303572,0.000027555008,0.00079041946,0.9557245,0.00003449244,0.0021247861,0.000009133785],"about_ca_topic_score_codex":0.00054133445,"about_ca_topic_score_gemma":0.00074030703,"teacher_disagreement_score":0.0011480483,"about_ca_system_score_codex":0.0002276247,"about_ca_system_score_gemma":0.00022025852,"threshold_uncertainty_score":0.0038405657},"labels":[],"label_agreement":null},{"id":"W2007200590","doi":"10.1038/clpt.2012.55","title":"Translational Bioinformatics: Data-driven Drug Discovery and Development","year":2012,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"U.S. National Library of Medicine; National Cancer Institute; David and Lucile Packard Foundation","keywords":"Translational bioinformatics; Clinical pharmacology; Data sharing; Translational research; Data science; Drug reaction; Drug discovery; Drug development; Computer science; The Internet; Clinical trial; Medicine; Bioinformatics; Computational biology; Drug; Genomics; Pharmacology; World Wide Web; Genome; Biology; Alternative medicine; Pathology","score_opus":0.12859080116938446,"score_gpt":0.43442698686586195,"score_spread":0.3058361856964775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007200590","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006744363,0.04618617,0.0025505822,0.14563644,0.8038055,0.000037940186,0.00008319413,0.00026737942,0.0013654327],"genre_scores_gemma":[0.0007341536,0.037384607,0.001507572,0.0801072,0.8736024,0.000043538854,0.000062120715,0.00010380161,0.006454597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99067676,0.003062132,0.0012199477,0.00092219724,0.0038004303,0.0003186144],"domain_scores_gemma":[0.95406705,0.028653279,0.0018012653,0.0012933915,0.009968249,0.004216678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015916957,0.0041331355,0.003269991,0.003037981,0.0019919039,0.009076027,0.0047740918,0.016998157,0.0047854055],"category_scores_gemma":[0.030858045,0.001636709,0.003121845,0.0022163063,0.005846875,0.009099984,0.002679209,0.042679932,0.006659985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004993471,0.000019908037,0.00003627185,0.00040095096,0.00005412257,0.00009849833,0.000031517466,0.0000942238,0.0001207612,0.0012891229,0.9748106,0.022994116],"study_design_scores_gemma":[0.000088355904,0.00003962649,0.00015443514,0.0005451736,0.000051139985,0.00043676674,0.000038580478,0.0005110525,0.00015439361,0.0056466353,0.9923045,0.000029377054],"about_ca_topic_score_codex":0.0012021981,"about_ca_topic_score_gemma":0.0028990475,"teacher_disagreement_score":0.016998157,"about_ca_system_score_codex":0.0037076334,"about_ca_system_score_gemma":0.0037859033,"threshold_uncertainty_score":0.08417791},"labels":[],"label_agreement":null},{"id":"W2007339547","doi":"10.1038/clpt.2013.195","title":"Network Medicine: Finding the Links to Personalized Therapy","year":2013,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clinical pharmacology; Systems pharmacology; Personalized medicine; Systems biology; Pharmacology; Medicine; Molecular Pharmacology; Computational biology; Bioinformatics; Biology; Internal medicine; Drug","score_opus":0.14999039163701658,"score_gpt":0.4836010300640656,"score_spread":0.33361063842704897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007339547","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005027983,0.04750806,0.002662431,0.12711975,0.81982464,0.000039952385,0.00010781179,0.00015788656,0.0025291585],"genre_scores_gemma":[0.0009643162,0.04341557,0.0012109645,0.032495476,0.91525775,0.000063533735,0.00005484571,0.00007415814,0.0064633847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99472165,0.0018870296,0.0005895,0.0005544818,0.0021104966,0.00013686698],"domain_scores_gemma":[0.9523356,0.03452578,0.0012729547,0.00093664095,0.008671468,0.002257608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010889459,0.002824197,0.002972673,0.0039882134,0.0018737913,0.00672092,0.00377703,0.014083736,0.009248262],"category_scores_gemma":[0.043594275,0.0011822591,0.0022664603,0.0016012669,0.0048102294,0.006474299,0.0021790462,0.026955908,0.006192206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003341835,0.000008355471,0.000022436572,0.0003972679,0.000052867264,0.00008059619,0.000018544955,0.00011583548,0.00004279615,0.0030823764,0.9787659,0.017379731],"study_design_scores_gemma":[0.00008824172,0.00003331543,0.00015506604,0.0010846414,0.000095475494,0.00035306686,0.000023362336,0.0007468768,0.00012681942,0.012363663,0.9848979,0.000031508596],"about_ca_topic_score_codex":0.0013635774,"about_ca_topic_score_gemma":0.0028099276,"teacher_disagreement_score":0.014083736,"about_ca_system_score_codex":0.0036701893,"about_ca_system_score_gemma":0.0025698228,"threshold_uncertainty_score":0.05758965},"labels":[],"label_agreement":null},{"id":"W2007855317","doi":"10.1016/s0009-9236(03)90662-x","title":"Pharmacokinetics of Trastuzumab in Combination With Paclitaxel Given Every 3 Weeks in Women With HER2 Positive Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency","funders":"","keywords":"Trastuzumab; Paclitaxel; Medicine; Metastatic breast cancer; Pharmacokinetics; Oncology; Breast cancer; Internal medicine; Cancer","score_opus":0.07312905217516238,"score_gpt":0.44980259319497,"score_spread":0.37667354101980766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007855317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940584,0.0027445818,0.00049477554,0.0005844296,0.0001140711,0.000089083514,0.00023463443,0.000079552636,0.0016005134],"genre_scores_gemma":[0.9966378,0.0010689556,0.00037569585,0.00017980121,0.00011073672,0.00007296126,0.00019992006,0.00003170398,0.0013222884],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995976,0.00021626295,0.000012900387,0.000069456946,0.00005010364,0.000053731474],"domain_scores_gemma":[0.99915695,0.00034601483,0.00016728976,0.00005916128,0.000039363516,0.00023123974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062702666,0.00058028556,0.001400371,0.00040848818,0.00034425157,0.0007118654,0.0004092716,0.0010580311,0.0024954122],"category_scores_gemma":[0.0039709285,0.0007656523,0.00048609526,0.00049131404,0.00045249463,0.0008661436,0.0002131262,0.0018510371,0.0005648712],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67109805,0.0072927135,0.041506797,0.00029302863,0.0010232684,0.0017299658,0.00072415534,0.007886119,0.07267993,0.00054800353,0.0044487305,0.19076924],"study_design_scores_gemma":[0.07882109,0.46968573,0.3629435,0.00017196631,0.0031414207,0.0058952556,0.000993219,0.02437359,0.034607127,0.0013160555,0.01782112,0.00022988494],"about_ca_topic_score_codex":0.0016456344,"about_ca_topic_score_gemma":0.0028811782,"teacher_disagreement_score":0.0024954122,"about_ca_system_score_codex":0.00090142916,"about_ca_system_score_gemma":0.00075250835,"threshold_uncertainty_score":0.008347988},"labels":[],"label_agreement":null},{"id":"W2008077991","doi":"10.1038/sj.clpt.6100191","title":"Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; U.S. Public Health Service; Australian Geographic Society","keywords":"Bioavailability; Pharmacokinetics; Cmax; Pharmacology; P-glycoprotein; CYP3A4; Oral administration; Ex vivo; Chemistry; Medicine; Internal medicine; Cytochrome P450; Metabolism; In vitro; Biochemistry; Antibiotics","score_opus":0.08313587851896263,"score_gpt":0.41642578633400573,"score_spread":0.3332899078150431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008077991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940145,0.00033617477,0.00009541438,0.000033159944,0.00000971222,0.000008500145,0.000018541765,0.000011608474,0.00008531188],"genre_scores_gemma":[0.9988726,0.00031958398,0.00021817877,0.000036830064,0.000018628898,0.000013992882,0.00006658686,0.000005139212,0.00044851948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998603,0.00005209485,0.000011043735,0.000023155031,0.000023201628,0.000030166464],"domain_scores_gemma":[0.9997907,0.000045783745,0.000074603005,0.000018168648,0.000011716809,0.000058992988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017208616,0.00026322878,0.0004990625,0.0001201956,0.000094814306,0.0002503963,0.00015418229,0.00022595968,0.0010565756],"category_scores_gemma":[0.00034234274,0.00012839143,0.0002683101,0.00010800939,0.00029013844,0.00017278726,0.000112631635,0.00048254122,0.00015474478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031296086,0.0022153002,0.002180904,0.0002266028,0.00010507041,0.00015745463,0.00007489454,0.00010449104,0.9407124,0.00007151703,0.00022335873,0.022632038],"study_design_scores_gemma":[0.0069154403,0.24943836,0.11424543,0.000040006038,0.00047200196,0.0010114377,0.00023460956,0.0035147578,0.6206027,0.00012989502,0.0033604328,0.00003490833],"about_ca_topic_score_codex":0.0004440156,"about_ca_topic_score_gemma":0.0006734398,"teacher_disagreement_score":0.0010565756,"about_ca_system_score_codex":0.00017064858,"about_ca_system_score_gemma":0.00017395649,"threshold_uncertainty_score":0.003534615},"labels":[],"label_agreement":null},{"id":"W2008228624","doi":"10.1038/clpt.2008.29","title":"Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Joseph’s Healthcare Hamilton; University of British Columbia; University of Ottawa; McMaster University; Child and Family Research Institute","funders":"","keywords":"Medicine; Multidisciplinary approach; Pharmacist; Pharmacy; Medical home; Clinical pharmacy; Family medicine; Health care; MEDLINE; Primary care; Nursing","score_opus":0.5029480220296687,"score_gpt":0.5943371294147648,"score_spread":0.09138910738509609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008228624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004399072,0.9928653,0.00046283018,0.0014827823,0.00017735607,0.00003478865,0.000007938623,0.000016129052,0.0045129023],"genre_scores_gemma":[0.005745631,0.99014753,0.0020374258,0.0011952469,0.00023247382,0.00003244629,0.000013914708,0.0000023083765,0.00059301686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981243,0.00073377555,0.00015443805,0.00017596855,0.0007466805,0.00006482813],"domain_scores_gemma":[0.9975805,0.0013556557,0.00043408605,0.000113842965,0.00040943094,0.00010642018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026287183,0.0005488147,0.000935315,0.0025040633,0.00040372837,0.0013660033,0.00081624713,0.0015311147,0.002169989],"category_scores_gemma":[0.003558699,0.0002657672,0.000634123,0.0035281796,0.0009316942,0.0017692727,0.0011049428,0.0016271725,0.00094900414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021464046,0.0001404145,0.00045427078,0.013332803,0.0001104344,0.0001597873,0.00020778652,0.00020782556,0.00037001935,0.0034375025,0.00770766,0.9738501],"study_design_scores_gemma":[0.000095880176,0.00034997804,0.011860325,0.021494448,0.00021719649,0.0040572635,0.00036587895,0.00019192418,0.0006231386,0.004324326,0.9563837,0.00003587331],"about_ca_topic_score_codex":0.0053582643,"about_ca_topic_score_gemma":0.008754549,"teacher_disagreement_score":0.0053582643,"about_ca_system_score_codex":0.0016307473,"about_ca_system_score_gemma":0.004271835,"threshold_uncertainty_score":0.013902128},"labels":[],"label_agreement":null},{"id":"W2008500593","doi":"10.1016/s0009-9236(03)90532-7","title":"Brain and Spinal Cord Distribution of Reference Compounds With Varying Degrees of CNS Penetration in A Rat Model of Cerebral Inflammation","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; AstraZeneca (Canada)","funders":"","keywords":"Spinal cord; Inflammation; Pharmacology; Medicine; Central nervous system; Penetration (warfare); Neuroscience; Anesthesia; Immunology; Biology; Internal medicine","score_opus":0.18920054382515236,"score_gpt":0.39963630055949023,"score_spread":0.21043575673433787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008500593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97506964,0.010900106,0.0066917227,0.0003669803,0.00019300244,0.0001591263,0.0020398677,0.00029472137,0.0042848084],"genre_scores_gemma":[0.97203606,0.012918054,0.00597175,0.0001261453,0.00007902648,0.00022009113,0.0014392019,0.000087722365,0.0071219206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997106,0.000037700458,0.000017120637,0.00004157148,0.000040563424,0.00015240289],"domain_scores_gemma":[0.9996125,0.0001035856,0.00009195801,0.00004559716,0.00006213082,0.000084200365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044570694,0.0009931022,0.0007545592,0.001076853,0.00046696226,0.00048372088,0.0007037739,0.0009122764,0.0035649033],"category_scores_gemma":[0.0003640965,0.00045999777,0.00066494045,0.0010070902,0.0010065578,0.0011254873,0.00017971465,0.0015652612,0.00063549343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01477508,0.0009870217,0.00023321,0.0005872414,0.0001254806,0.00059272075,0.00020567172,0.0010305445,0.9664845,0.0009758973,0.0007817414,0.013220957],"study_design_scores_gemma":[0.00027823963,0.009239646,0.002529,0.000047901063,0.00022691287,0.00056940666,0.00012369873,0.0010564317,0.98405355,0.00019756693,0.0016489886,0.000028628901],"about_ca_topic_score_codex":0.0071820784,"about_ca_topic_score_gemma":0.010836825,"teacher_disagreement_score":0.0071820784,"about_ca_system_score_codex":0.00074824825,"about_ca_system_score_gemma":0.00108137,"threshold_uncertainty_score":0.014280558},"labels":[],"label_agreement":null},{"id":"W2009420048","doi":"10.1038/clpt.2011.22","title":"iPSC Technology: Platform for Drug Discovery","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; SickKids Foundation; McMaster University; University of Toronto","funders":"","keywords":"Induced pluripotent stem cell; Drug discovery; Embryonic stem cell; Somatic cell; Drug; Stem cell; Biology; Computational biology; Pharmacology; Medicine; Bioinformatics; Cell biology; Genetics; Gene","score_opus":0.11986403750533448,"score_gpt":0.4105239276252117,"score_spread":0.29065989011987725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009420048","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021506386,0.053765416,0.7961504,0.0065449886,0.0048214383,0.0029760886,0.015487396,0.014369352,0.084378585],"genre_scores_gemma":[0.09962909,0.07515078,0.6657613,0.0046036066,0.002278906,0.005321091,0.046564262,0.0024261293,0.09826489],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99894375,0.00016995812,0.000079103615,0.00014109722,0.0006026866,0.000063461484],"domain_scores_gemma":[0.9995235,0.00010877177,0.000048052738,0.00011631587,0.00013297009,0.00007046394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020483725,0.0011759923,0.0014788862,0.0026348736,0.0006040639,0.0019033363,0.0014913242,0.0015188365,0.012136646],"category_scores_gemma":[0.0010588866,0.00070900185,0.00096068735,0.001279196,0.00066691806,0.0012701058,0.001265871,0.0029667616,0.017096933],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039999606,0.00031634944,0.00043779297,0.0012225902,0.00012795418,0.00076029473,0.00013537474,0.0013879875,0.52625453,0.02813139,0.05443422,0.38639155],"study_design_scores_gemma":[0.00017411479,0.00038693426,0.0004973127,0.00021308771,0.00013851938,0.0011149994,0.000030190258,0.0041872635,0.3977033,0.012677967,0.58280456,0.000071674694],"about_ca_topic_score_codex":0.00027485244,"about_ca_topic_score_gemma":0.00023668897,"teacher_disagreement_score":0.012136646,"about_ca_system_score_codex":0.0005458148,"about_ca_system_score_gemma":0.0008465621,"threshold_uncertainty_score":0.040601075},"labels":[],"label_agreement":null},{"id":"W2010038158","doi":"10.1038/clpt.2012.233","title":"Gender Differences in Drug Bioequivalence: Time to Rethink Practices","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Bioequivalence; Drug; Medicine; Pharmacology; Pharmacokinetics","score_opus":0.8652221277144911,"score_gpt":0.6338304453666238,"score_spread":0.23139168234786733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010038158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013969907,0.9094769,0.0039004057,0.08072803,0.0018894082,0.000037585603,0.000096660326,0.000036437832,0.002437585],"genre_scores_gemma":[0.04477465,0.89858526,0.012808624,0.03687069,0.005225213,0.00018399827,0.00011010944,0.00006653885,0.0013748221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9799944,0.010871026,0.002467185,0.0021530276,0.0042519285,0.0002623436],"domain_scores_gemma":[0.77674246,0.20039487,0.005569551,0.0060919635,0.010212175,0.0009889165],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09668872,0.00089683715,0.0050625363,0.002501537,0.00081389496,0.0055687632,0.003568272,0.003692188,0.0044208434],"category_scores_gemma":[0.1101321,0.000767856,0.0017050164,0.003238282,0.008939759,0.013606026,0.0034293318,0.008359237,0.0010322089],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025842153,0.00006539748,0.0023914163,0.008020955,0.000439724,0.00015192672,0.0023558221,0.0003485415,0.00048937544,0.047891933,0.022972539,0.91461396],"study_design_scores_gemma":[0.00026529803,0.00067198096,0.020467531,0.047480997,0.0010152581,0.0015359897,0.0064736158,0.0010380455,0.0010564437,0.23700313,0.68272334,0.0002683769],"about_ca_topic_score_codex":0.0046085985,"about_ca_topic_score_gemma":0.007634341,"teacher_disagreement_score":0.90331125,"about_ca_system_score_codex":0.0036254437,"about_ca_system_score_gemma":0.0065231733,"threshold_uncertainty_score":0.5113449},"labels":[],"label_agreement":null},{"id":"W2010683229","doi":"10.1067/mcp.2000.105152","title":"Growth in use of statins after trials is not targeted to most appropriate patients","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Medicine; Simvastatin; Population; Statin; Clinical trial; Coronary heart disease; Ezetimibe; Defined daily dose; Internal medicine; Medical prescription; Environmental health; Pharmacology","score_opus":0.13488067877343987,"score_gpt":0.42747636411346634,"score_spread":0.29259568534002645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010683229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77124983,0.032718178,0.011640987,0.1324386,0.0018273029,0.0011727735,0.0037762974,0.00060104614,0.044575084],"genre_scores_gemma":[0.96210015,0.005362282,0.0052010533,0.020684257,0.002139431,0.00040704536,0.0012643749,0.00013776755,0.0027036145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9665672,0.01534776,0.005377094,0.0023307942,0.008695944,0.0016811466],"domain_scores_gemma":[0.8397983,0.05807568,0.05749389,0.012066194,0.022717364,0.009848648],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034905054,0.00030783817,0.0010949168,0.0015272959,0.00082150253,0.0031051743,0.0008437744,0.0017020467,0.0031153962],"category_scores_gemma":[0.16439407,0.00028641385,0.0006837125,0.0020960264,0.0010977612,0.0032921156,0.0016114349,0.002252905,0.0017839991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003106311,0.00042866045,0.7233005,0.00061048,0.00041501573,0.0006286903,0.0010699783,0.00070330413,0.0034146016,0.0033368384,0.017270824,0.24571472],"study_design_scores_gemma":[0.00040804798,0.0022025986,0.91040623,0.00073531514,0.00033701077,0.0015139034,0.0008089292,0.0016974402,0.0026799042,0.0044389497,0.07471583,0.000055788198],"about_ca_topic_score_codex":0.0016284976,"about_ca_topic_score_gemma":0.0025060042,"teacher_disagreement_score":0.9650949,"about_ca_system_score_codex":0.0025583603,"about_ca_system_score_gemma":0.0036940621,"threshold_uncertainty_score":0.18459779},"labels":[],"label_agreement":null},{"id":"W2010759425","doi":"10.1038/sj.clpt.6100502","title":"Public Alcohol Policy: Current Directions and New Opportunities","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"Addiction; Alcohol; Public policy; Alcohol addiction; Term (time); Control (management); Psychiatry; Psychology; Public economics; Medicine; Political science; Computer science; Economics; Law; Artificial intelligence","score_opus":0.7415395235250991,"score_gpt":0.560675869909654,"score_spread":0.1808636536154451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010759425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007894571,0.99082655,0.0001096499,0.0077315173,0.00037986113,0.0000037078871,0.000013918541,0.000010016921,0.0008459148],"genre_scores_gemma":[0.0009759106,0.9969885,0.00015776232,0.0011231966,0.0004845414,0.000007040971,0.000014069385,0.0000016061023,0.00024742665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903995,0.00036555974,0.000096345364,0.00012558365,0.00024761513,0.00012497636],"domain_scores_gemma":[0.9948968,0.0033976727,0.00045445337,0.000113662376,0.0007583952,0.00037885093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049734954,0.0011280478,0.003219228,0.0024056355,0.0007419056,0.0045290575,0.001715957,0.005319565,0.015022176],"category_scores_gemma":[0.00419117,0.0005961024,0.0007877721,0.004753564,0.0031078763,0.008625197,0.0021268316,0.004251372,0.0034071852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015225708,0.00015612572,0.0004735321,0.020084504,0.00009907454,0.00020421403,0.00019429383,0.0005530199,0.00018815069,0.03250204,0.0583006,0.8870921],"study_design_scores_gemma":[0.00007393966,0.00013552535,0.0019001141,0.03433824,0.00014429432,0.00054645917,0.001722696,0.0004692346,0.00013153642,0.05001184,0.91045934,0.00006677306],"about_ca_topic_score_codex":0.004298425,"about_ca_topic_score_gemma":0.007827793,"teacher_disagreement_score":0.015022176,"about_ca_system_score_codex":0.0029439882,"about_ca_system_score_gemma":0.008966625,"threshold_uncertainty_score":0.050254226},"labels":[],"label_agreement":null},{"id":"W2011586410","doi":"10.1067/mcp.2002.126174","title":"Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"CYP2C19; Omeprazole; Menstrual cycle; Medicine; Internal medicine; Endocrinology; Cytochrome P450; Physiology; Hormone; Metabolism","score_opus":0.18530976811129077,"score_gpt":0.5257971988813166,"score_spread":0.34048743077002586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011586410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688005,0.0020538424,0.00019650772,0.000087579894,0.00002584298,0.000024962648,0.00014424701,0.000005912948,0.0005811508],"genre_scores_gemma":[0.99864465,0.0005481911,0.00027676122,0.000061141116,0.00002901336,0.000016779733,0.00012079865,0.000006595983,0.00029590804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992322,0.00039829858,0.00005240539,0.00009567548,0.0001692162,0.000052222393],"domain_scores_gemma":[0.99777526,0.001096997,0.00071322086,0.000114513365,0.00014345015,0.00015661855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009006724,0.00023806523,0.00032260965,0.00028945794,0.00013626495,0.00024985516,0.00014491004,0.00018462114,0.0014674865],"category_scores_gemma":[0.0028330442,0.00009179348,0.00029746685,0.00033885083,0.00017841159,0.00013754678,0.00015410513,0.00021526794,0.00016608123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008188118,0.00022061648,0.94269675,0.000096587326,0.00038599133,0.00029461447,0.00011044703,0.00008577572,0.021383688,0.00002705728,0.0002317173,0.026278649],"study_design_scores_gemma":[0.000043409953,0.0025860355,0.99350667,0.000010417236,0.00014753199,0.00047403597,0.000043632586,0.0001957436,0.0024228068,0.000013353322,0.00055286626,0.000003606829],"about_ca_topic_score_codex":0.00038419117,"about_ca_topic_score_gemma":0.0006649094,"teacher_disagreement_score":0.0014674865,"about_ca_system_score_codex":0.00013426822,"about_ca_system_score_gemma":0.00009208341,"threshold_uncertainty_score":0.004909277},"labels":[],"label_agreement":null},{"id":"W2011711268","doi":"10.1038/clpt.2008.57","title":"Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse","keywords":"Bupropion; Placebo; Smoking cessation; Medicine; Quartile; Cotinine; Randomized controlled trial; Internal medicine; Clinical trial; Pharmacology; Nicotine; Anesthesia; Alternative medicine; Confidence interval","score_opus":0.19584756825107305,"score_gpt":0.45079495218444576,"score_spread":0.2549473839333727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011711268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883504,0.0032768329,0.00049456925,0.000840726,0.0004766302,0.004235436,0.00035459932,0.00010816988,0.001377967],"genre_scores_gemma":[0.98605853,0.0019120025,0.0021495786,0.0013659502,0.0008647792,0.005408583,0.00038681366,0.000014896244,0.0018387794],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99853504,0.0009181349,0.000092188864,0.00020110377,0.00011055788,0.00014298306],"domain_scores_gemma":[0.99893636,0.00038404606,0.00026521212,0.00011826627,0.000053326406,0.00024283238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019041137,0.0013302186,0.0028248162,0.00059232174,0.0005796122,0.00089497975,0.0008507452,0.0024638004,0.007105563],"category_scores_gemma":[0.002446606,0.00069550815,0.0014848857,0.00040275985,0.0012786668,0.00096760807,0.0005720974,0.0022878915,0.0007708318],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97188604,0.010858427,0.0003919065,0.0003378107,0.0006779285,0.000022765513,0.00003695838,0.00010775775,0.0014817271,0.000085855536,0.00022101705,0.013891954],"study_design_scores_gemma":[0.9473992,0.050342288,0.0013612862,0.00002083608,0.00027472654,0.000011031146,0.000009025909,0.00019317449,0.00014475871,0.00008273407,0.00015450585,0.0000063587863],"about_ca_topic_score_codex":0.0006093575,"about_ca_topic_score_gemma":0.0013213325,"teacher_disagreement_score":0.007105563,"about_ca_system_score_codex":0.0005075831,"about_ca_system_score_gemma":0.000876367,"threshold_uncertainty_score":0.023770452},"labels":[],"label_agreement":null},{"id":"W2012457277","doi":"10.1016/s0009-9236(03)90450-4","title":"Development of A Concurrent Disorders Training Program for Health Care Professionals","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Health professionals; Training (meteorology); Medical education; Health care; Medicine; Nursing; Psychology; Political science","score_opus":0.4656224147486013,"score_gpt":0.6518131913536417,"score_spread":0.1861907766050404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012457277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89315784,0.00047395044,0.0313613,0.0101333875,0.0013961414,0.021199618,0.00046575515,0.000906815,0.040905215],"genre_scores_gemma":[0.6960265,0.0010057897,0.24359341,0.004114765,0.00036817667,0.012796081,0.001073295,0.00008233803,0.040939666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910283,0.00024030668,0.000048151902,0.000118721524,0.00025489653,0.00023521192],"domain_scores_gemma":[0.9929033,0.00063010165,0.00028274604,0.0002768722,0.0015586608,0.004348367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026098262,0.00033056785,0.00022195496,0.0006690258,0.0018454423,0.0006446731,0.0012667907,0.00083345186,0.00893953],"category_scores_gemma":[0.0044709877,0.00030706197,0.0003443461,0.00026361833,0.000292874,0.00057581015,0.0017394437,0.0013204078,0.0015425244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011733939,0.060953163,0.07261678,0.00045908827,0.000023687571,0.000607126,0.0027726374,0.0013736654,0.015179185,0.0017334503,0.033826336,0.80928147],"study_design_scores_gemma":[0.004955386,0.043424066,0.6546658,0.001625826,0.000251631,0.0023145052,0.013914864,0.013873777,0.04104102,0.0035375052,0.22020754,0.00018816516],"about_ca_topic_score_codex":0.009152919,"about_ca_topic_score_gemma":0.018428583,"teacher_disagreement_score":0.009152919,"about_ca_system_score_codex":0.0018059148,"about_ca_system_score_gemma":0.021188505,"threshold_uncertainty_score":0.029905736},"labels":[],"label_agreement":null},{"id":"W2013161419","doi":"10.1002/cpt.119","title":"Cannabinoids: Friend or foe?","year":2015,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Institute of Mental Health; Canadian Institutes of Health Research; Department of Psychiatry, University of Toronto; Centre for Addiction and Mental Health; National Institutes of Health; University of Toronto; Campbell Family Mental Health Research Institute; GW Pharmaceuticals","keywords":"Cannabis; Clinical pharmacology; Cannabinoid; Pharmacology; Synthetic cannabinoids; Dronabinol; Harm; Addiction; Medicine; Psychology; Psychiatry","score_opus":0.12837458483446987,"score_gpt":0.504768150150853,"score_spread":0.3763935653163831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013161419","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033704895,0.008550519,0.000087343265,0.037139732,0.9524696,0.000010518496,0.000018367724,0.000051792762,0.0016384542],"genre_scores_gemma":[0.0002896254,0.0062658354,0.00007913117,0.031174824,0.95215595,0.000010722771,0.000017423059,0.00002200052,0.009984442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678624,0.0005451402,0.00037043748,0.0004139289,0.0016742314,0.00021001698],"domain_scores_gemma":[0.99130917,0.004215133,0.0005656429,0.00025769966,0.0023213907,0.0013308877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004346092,0.0033847995,0.002580288,0.0020250296,0.0031111948,0.0062560523,0.0025220143,0.01107779,0.013474087],"category_scores_gemma":[0.015231431,0.00092854805,0.0019396787,0.001054466,0.0025740846,0.006387546,0.0015336783,0.016189659,0.011807266],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025015297,0.00001724248,0.000026005468,0.00014364424,0.000008307164,0.00007666962,0.000016536073,0.000022109718,0.00004168502,0.00037602472,0.99110633,0.008140426],"study_design_scores_gemma":[0.000030558782,0.000035659607,0.0002033594,0.00033187142,0.00001881586,0.00025924997,0.000046574187,0.0001028127,0.00007551155,0.0010725519,0.99780744,0.000015474714],"about_ca_topic_score_codex":0.0012735382,"about_ca_topic_score_gemma":0.0032813125,"teacher_disagreement_score":0.013474087,"about_ca_system_score_codex":0.0027386553,"about_ca_system_score_gemma":0.0025391188,"threshold_uncertainty_score":0.045075297},"labels":[],"label_agreement":null},{"id":"W2014144507","doi":"10.1038/clpt.2011.18","title":"Pharmacogenetic Testing: Time for Clinical Practice Guidelines","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute; BC Children's Hospital","funders":"","keywords":"Pharmacogenetics; Clinical pharmacology; Clinical Practice; Drug; Medicine; Genetic testing; Drug reaction; Pharmacology; Drug response; Adverse effect; Intensive care medicine; Medical physics; Internal medicine; Family medicine; Biology; Gene; Genetics; Genotype","score_opus":0.806811082690761,"score_gpt":0.6867118532933741,"score_spread":0.12009922939738682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014144507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031922333,0.6216845,0.026624287,0.3155518,0.015339555,0.00058003224,0.00050998124,0.00077432167,0.018616218],"genre_scores_gemma":[0.004927537,0.7254023,0.13258691,0.107849225,0.012273297,0.0012254103,0.0022155207,0.00022166314,0.013298101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9894069,0.004593222,0.0016892646,0.00059886003,0.0034563192,0.00025553993],"domain_scores_gemma":[0.9601239,0.017893145,0.0022617695,0.0018482503,0.015591527,0.0022814663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0273432,0.0022103975,0.0036419425,0.0044113505,0.0008265029,0.0037734106,0.0053773024,0.009674921,0.010333837],"category_scores_gemma":[0.04092758,0.0011184126,0.001784055,0.003984234,0.002203698,0.008437537,0.0032978097,0.013294238,0.011699921],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035787278,0.0001777728,0.00019228496,0.003897683,0.00005091023,0.00038946304,0.00015785014,0.00068062946,0.00037869113,0.014415721,0.42683017,0.552793],"study_design_scores_gemma":[0.00006075428,0.000047117395,0.00060861936,0.014204367,0.000050582043,0.0009037511,0.0001996122,0.0005041856,0.00014552707,0.023203572,0.9600288,0.00004316134],"about_ca_topic_score_codex":0.0041827643,"about_ca_topic_score_gemma":0.005358137,"teacher_disagreement_score":0.0273432,"about_ca_system_score_codex":0.0036978319,"about_ca_system_score_gemma":0.012281475,"threshold_uncertainty_score":0.14460641},"labels":[],"label_agreement":null},{"id":"W2014151394","doi":"10.1038/sj.clpt.6100261","title":"Why Can’t a Woman Be More Like a Man?","year":2007,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Clinical pharmacology; Pharmacodynamics; Pharmacokinetics; Drug; Pharmacology; Medicine; Population; Gerontology; Physiology; Environmental health","score_opus":0.6000677385811612,"score_gpt":0.5543107777363848,"score_spread":0.04575696084477643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014151394","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027402918,0.0011389183,0.00004381432,0.993526,0.0036532383,0.0000037009236,0.000008595473,0.0000059982044,0.0013457699],"genre_scores_gemma":[0.0022718674,0.0011142384,0.00008529619,0.98867804,0.005500885,0.000012511768,0.0000046770624,0.000007526397,0.002324969],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770266,0.0009095293,0.00018649331,0.00032267626,0.0005925095,0.00028614397],"domain_scores_gemma":[0.99488056,0.0030014708,0.00027512,0.00015176047,0.00065713096,0.0010339038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038807457,0.0006420017,0.0012125745,0.00041199828,0.0050543053,0.0033742145,0.0012028385,0.036266215,0.005160152],"category_scores_gemma":[0.014666825,0.00053998816,0.0009666005,0.00053579814,0.0041737906,0.006806342,0.0012659457,0.045673877,0.0054827966],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004353747,0.00003283542,0.0009420556,0.00005018856,0.000013743327,0.001799594,0.00047933575,0.00003076758,0.00011345179,0.00598469,0.9731127,0.01739703],"study_design_scores_gemma":[0.00008498397,0.00011414172,0.0023953384,0.00048428992,0.00002221278,0.006631325,0.0030595402,0.00023793831,0.00014264628,0.019088702,0.9676734,0.000065352026],"about_ca_topic_score_codex":0.007951012,"about_ca_topic_score_gemma":0.018218238,"teacher_disagreement_score":0.036266215,"about_ca_system_score_codex":0.0036060077,"about_ca_system_score_gemma":0.0033602205,"threshold_uncertainty_score":0.026163518},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2015234747","doi":"10.1016/j.clpt.2006.02.006","title":"Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Center for Research Resources; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"Cotinine; Nicotine; CYP2A6; Odds ratio; Smoking cessation; Medicine; Metabolite; Confidence interval; Abstinence; Pharmacology; Internal medicine; Nicotine withdrawal; Physiology; Metabolism; Cytochrome P450; Psychiatry; CYP1A2","score_opus":0.08963809978074626,"score_gpt":0.42237025566640995,"score_spread":0.3327321558856637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015234747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841475,0.000308263,0.00046633722,0.000047788235,0.0000086555465,0.000020533811,0.00021276914,0.000030486388,0.00049030845],"genre_scores_gemma":[0.99940693,0.0000533499,0.00032467145,0.000010452623,0.000005432496,0.0000069427438,0.000100157355,0.0000033596104,0.00008866919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994703,0.00023334134,0.0000447727,0.000084270796,0.00013668083,0.00003066446],"domain_scores_gemma":[0.9955936,0.0026069777,0.0011049781,0.0001397037,0.00024602783,0.00030871987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013361113,0.00038532217,0.00031459387,0.00031573928,0.00011031098,0.0003940597,0.00019154689,0.00037381807,0.0026310459],"category_scores_gemma":[0.0073198425,0.00016080751,0.00041251746,0.00017889061,0.00016393783,0.0002164491,0.00016693618,0.00054645044,0.00063474826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017787679,0.00031936765,0.9852799,0.000019628467,0.00018802931,0.000030849806,0.000028294608,0.00033214272,0.0029561622,0.000018075836,0.0001157855,0.008932887],"study_design_scores_gemma":[0.000032580105,0.000977965,0.9940017,0.0000056816184,0.0001191032,0.00031205112,0.0000178877,0.0031265477,0.0012327293,0.000038608923,0.00013041863,0.000004736534],"about_ca_topic_score_codex":0.0003712773,"about_ca_topic_score_gemma":0.0003556959,"teacher_disagreement_score":0.0026310459,"about_ca_system_score_codex":0.00013546548,"about_ca_system_score_gemma":0.000101128004,"threshold_uncertainty_score":0.008801699},"labels":[],"label_agreement":null},{"id":"W2016093188","doi":"10.1038/clpt.2009.212","title":"Neonatal Pharmacology: Rational Therapeutics for the Most Vulnerable","year":2009,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Clinical pharmacology; Medicine; Citation; Associate editor; Library science; Family medicine; Pharmacology; Computer science","score_opus":0.09024227698780275,"score_gpt":0.4754122976086613,"score_spread":0.3851700206208586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016093188","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028563787,0.017275942,0.00016331043,0.06532991,0.9160101,0.000013855423,0.000030211813,0.000035236873,0.0011128354],"genre_scores_gemma":[0.00036913613,0.011140496,0.00017893812,0.039939072,0.94389063,0.000016249342,0.000013604465,0.00001832127,0.004433547],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99384946,0.0015371775,0.00090192177,0.0006150099,0.0027635375,0.0003327945],"domain_scores_gemma":[0.96893466,0.016285636,0.0017155752,0.0008243942,0.009009355,0.0032303208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009612098,0.004327118,0.004935835,0.0027588697,0.0028825253,0.0062697893,0.004626008,0.027534561,0.005316969],"category_scores_gemma":[0.03185537,0.001613552,0.0024543842,0.001781785,0.0040816064,0.0050397795,0.0019292131,0.03816641,0.0058028623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023827413,0.000011099422,0.00002052164,0.00020918541,0.000017202488,0.00009699345,0.000010686596,0.000024265226,0.000028462498,0.000350158,0.9943281,0.0048796404],"study_design_scores_gemma":[0.00009798206,0.000042712058,0.00038599366,0.00092297385,0.00010797554,0.0005186133,0.00006146127,0.00023996967,0.00011987921,0.002301019,0.9951663,0.000035060908],"about_ca_topic_score_codex":0.0030285951,"about_ca_topic_score_gemma":0.011527406,"teacher_disagreement_score":0.027534561,"about_ca_system_score_codex":0.0038582948,"about_ca_system_score_gemma":0.004451466,"threshold_uncertainty_score":0.05083424},"labels":[],"label_agreement":null},{"id":"W2016523223","doi":"10.1067/mcp.2000.112363","title":"Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Saquinavir; Ketoconazole; Ritonavir; Pharmacokinetics; Medicine; Confidence interval; Pharmacology; Cerebrospinal fluid; Internal medicine; Human immunodeficiency virus (HIV); Immunology; Viral load; Antiretroviral therapy","score_opus":0.021377398073675405,"score_gpt":0.3672882227734733,"score_spread":0.3459108246997979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016523223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933404,0.00043339797,0.000055047058,0.000022171009,0.0000052054793,0.0000049954065,0.00003821837,0.000004760122,0.00010211364],"genre_scores_gemma":[0.9994961,0.00013035038,0.00013930141,0.000043945976,0.000011410895,0.000006228717,0.00010299181,0.0000014329206,0.0000680981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992918,0.0002849028,0.00007145498,0.000114575465,0.00016034559,0.00007693134],"domain_scores_gemma":[0.9985461,0.0005923952,0.00040901394,0.000083877116,0.00017424104,0.00019439548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006577135,0.00033317713,0.00048826326,0.00024282967,0.00027236305,0.0006366222,0.00013806096,0.0003443067,0.0007230507],"category_scores_gemma":[0.003028696,0.00028684505,0.0002817465,0.00017099062,0.00023756867,0.00035167506,0.0001933527,0.0005166757,0.00018396761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027051749,0.00095763325,0.83647114,0.00024560126,0.00052553724,0.0017450212,0.0010356958,0.00048700388,0.06255881,0.00003199945,0.0003950972,0.06849467],"study_design_scores_gemma":[0.00040931962,0.012935158,0.96905744,0.00003501465,0.00022225137,0.003755718,0.00040019784,0.0011649005,0.011102088,0.000039065508,0.0008507287,0.00002819762],"about_ca_topic_score_codex":0.00081471005,"about_ca_topic_score_gemma":0.0010128615,"teacher_disagreement_score":0.00081471005,"about_ca_system_score_codex":0.00034449156,"about_ca_system_score_gemma":0.00020321354,"threshold_uncertainty_score":0.0034783483},"labels":[],"label_agreement":null},{"id":"W2016646371","doi":"10.1038/clpt.2011.23","title":"Prediction of Infant Drug Exposure Through Breastfeeding: Population PK Modeling and Simulation of Fluoxetine Exposure","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Breastfeeding; Medicine; Breast milk; Pharmacokinetics; Population; Metabolite; Drug; Fluoxetine; Breast feeding; Infant formula; Plasma concentration; Physiology; Pediatrics; Pharmacology; Internal medicine; Environmental health; Chemistry","score_opus":0.17691039059307476,"score_gpt":0.4081107410624852,"score_spread":0.23120035046941043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016646371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9250707,0.00024509648,0.071617775,0.0003716795,0.000020081137,0.00007254427,0.00040018593,0.00012073436,0.0020811914],"genre_scores_gemma":[0.98236865,0.00018111739,0.016536234,0.000069878064,0.000008048374,0.00013101101,0.00020217188,0.000012956725,0.00048988557],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99955386,0.00029260048,0.000017557652,0.000056440913,0.00003987904,0.00003961223],"domain_scores_gemma":[0.99579513,0.003478433,0.00033291854,0.00009856137,0.00022033026,0.00007463538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015966144,0.00047403885,0.00077361264,0.0003419808,0.000244449,0.0005685894,0.000647751,0.0009863493,0.0009315752],"category_scores_gemma":[0.008237305,0.000376316,0.0006953335,0.00033951763,0.00028842656,0.00046040025,0.00047440457,0.00079503,0.00010345133],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001205723,0.000044246186,0.0091602355,0.000020533691,0.000050207545,0.00008208481,0.000051952393,0.9856813,0.0004378773,0.0009949446,0.00010292315,0.0032530578],"study_design_scores_gemma":[0.000021500826,0.00006181656,0.00086167455,0.000003445497,0.000016389835,0.000021130374,0.000014440603,0.99819463,0.000188508,0.0004978477,0.00011340836,0.0000052065207],"about_ca_topic_score_codex":0.017131865,"about_ca_topic_score_gemma":0.005363309,"teacher_disagreement_score":0.017131865,"about_ca_system_score_codex":0.00066733995,"about_ca_system_score_gemma":0.001208625,"threshold_uncertainty_score":0.034064293},"labels":[],"label_agreement":null},{"id":"W2019126421","doi":"10.1038/clpt.2010.125","title":"Communicating Pharmacogenetic Research Results to Breastfeeding Mothers Taking Codeine: A Pilot Study of Perceptions and Benefits","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; Children's & Women's Health Centre of British Columbia; McGill University; Mount Sinai Hospital; SickKids Foundation; University of British Columbia; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Breastfeeding; Codeine; Pharmacogenetics; Medicine; Perception; Psychology; Family medicine; Environmental health; Anesthesia; Pediatrics; Genotype","score_opus":0.4810274459873395,"score_gpt":0.576050962485156,"score_spread":0.09502351649781648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019126421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994437,0.000041974476,0.00004000175,0.00016753163,0.0000056606186,0.000029829434,0.000005277454,9.752008e-7,0.00026500973],"genre_scores_gemma":[0.99885833,0.0002326052,0.00025254957,0.00027740977,0.000009206243,0.00007426962,0.0000071651407,0.0000028480583,0.00028560986],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.994871,0.003479015,0.00020395909,0.00018999497,0.00066001376,0.0005960595],"domain_scores_gemma":[0.9722099,0.019525241,0.0029520483,0.00053215976,0.0022592493,0.002521488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010033922,0.00034866293,0.0005038739,0.0005002596,0.0034174253,0.0022333027,0.00044175584,0.00093837664,0.0021185826],"category_scores_gemma":[0.028807113,0.0006057477,0.00036747847,0.0003340078,0.0018321142,0.0012285291,0.001490182,0.0021496385,0.00023413649],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085792504,0.002470637,0.14271128,0.00026956666,0.000050169147,0.0018910117,0.822118,0.00004082011,0.0039710063,0.00023002704,0.0005486616,0.024840914],"study_design_scores_gemma":[0.000157501,0.006498453,0.09183434,0.00012366203,0.00006394508,0.0011346838,0.89648145,0.0002580858,0.001159763,0.00014114716,0.0020971524,0.00004987719],"about_ca_topic_score_codex":0.006590708,"about_ca_topic_score_gemma":0.00820258,"teacher_disagreement_score":0.010033922,"about_ca_system_score_codex":0.00158122,"about_ca_system_score_gemma":0.0023326166,"threshold_uncertainty_score":0.05306506},"labels":[],"label_agreement":null},{"id":"W2019193819","doi":"10.1038/sj.clpt.6100124","title":"Decreased Skeletal Muscle Mitochondrial DNA in Patients Treated with High-Dose Simvastatin","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia; Michael Smith Health Research BC","keywords":"Simvastatin; Atorvastatin; Mitochondrial DNA; Skeletal muscle; Muscle biopsy; Medicine; Pharmacology; Placebo; Mitochondrial myopathy; Clinical pharmacology; Internal medicine; Endocrinology; Biology; Biopsy; Pathology; Genetics; Gene","score_opus":0.02796687818406735,"score_gpt":0.3389910367451989,"score_spread":0.3110241585611316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019193819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869835,0.0006838493,0.00010846101,0.000055695975,0.000009070604,0.000016966464,0.00010006525,0.000007292552,0.00032011233],"genre_scores_gemma":[0.9994885,0.00012236435,0.00007307602,0.000049517013,0.000019497747,0.000008487697,0.00014199119,0.0000017195242,0.00009482604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942565,0.00014250724,0.00009189927,0.00013441418,0.00013314055,0.00007236607],"domain_scores_gemma":[0.99885535,0.00028194982,0.00044333126,0.0000715357,0.00012715383,0.0002207369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046282346,0.00038013994,0.0011108551,0.00083721115,0.0007763366,0.000558188,0.00028041704,0.0008659979,0.0014106184],"category_scores_gemma":[0.0024636548,0.00036995768,0.00038696855,0.0010270366,0.00046918064,0.00039157155,0.00031874047,0.00055960024,0.00026472224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004168719,0.00011793046,0.9827691,0.000052355987,0.00016107396,0.0018541259,0.000204511,0.00009612095,0.005240747,0.0000270517,0.00013301757,0.0051752734],"study_design_scores_gemma":[0.00018454132,0.001451777,0.9922956,0.000013765711,0.00017436034,0.0041360455,0.00017411856,0.000294487,0.00086855853,0.00005192678,0.0003425614,0.000012184501],"about_ca_topic_score_codex":0.0011473475,"about_ca_topic_score_gemma":0.0015970325,"teacher_disagreement_score":0.0014106184,"about_ca_system_score_codex":0.00037058158,"about_ca_system_score_gemma":0.00028906908,"threshold_uncertainty_score":0.004719019},"labels":[],"label_agreement":null},{"id":"W2019915557","doi":"10.1002/cpt.103","title":"Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Journal of Administrative Sciences; McGill University Health Centre","funders":"","keywords":"Cannabis; Medical cannabis; Curriculum; Subject (documents); Health care; Health professionals; Medicine; Effects of cannabis; Medical education; Psychiatry; Psychology; Political science; Library science; Cannabidiol; Pedagogy","score_opus":0.21885480446735284,"score_gpt":0.46494520257343275,"score_spread":0.2460903981060799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019915557","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005654119,0.013048675,0.0005769275,0.9679413,0.002508799,0.00001492394,0.000008347687,0.000011821989,0.010235149],"genre_scores_gemma":[0.44117522,0.113064826,0.00895473,0.40031126,0.018230716,0.0002129425,0.00008758717,0.00005714073,0.017905654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99367565,0.0037197268,0.00019398546,0.00021364223,0.0009496201,0.0012472859],"domain_scores_gemma":[0.9820211,0.0070930743,0.0008676178,0.00020155161,0.0017350551,0.008081648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01156549,0.00030805304,0.00042368862,0.0013245953,0.0065595713,0.0061078095,0.0011442052,0.007899993,0.010543184],"category_scores_gemma":[0.011976605,0.00028440377,0.00047466916,0.0007200722,0.008311128,0.007954933,0.008862186,0.01112421,0.0010855508],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013602339,0.0012122616,0.009934983,0.0029231685,0.00002838259,0.003178174,0.05380465,0.00035338392,0.0017091391,0.17622924,0.2222427,0.5282479],"study_design_scores_gemma":[0.00008990012,0.00042858795,0.008397518,0.0062274854,0.000028097596,0.0035729667,0.15704477,0.0004991083,0.00074481865,0.09350098,0.7293567,0.00010903726],"about_ca_topic_score_codex":0.0037943027,"about_ca_topic_score_gemma":0.010482719,"teacher_disagreement_score":0.01156549,"about_ca_system_score_codex":0.0047954833,"about_ca_system_score_gemma":0.020772496,"threshold_uncertainty_score":0.061164916},"labels":[],"label_agreement":null},{"id":"W2020026521","doi":"10.1038/clpt.2009.243","title":"The (Possible) Impact of Comparative Effectiveness Research on Pharmaceutical Industry Decision Making","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nickel Institute","funders":"National Institutes of Health","keywords":"Pharmaceutical industry; Comparative effectiveness research; Management science; Business; Medicine; Pharmacology; Economics; Alternative medicine","score_opus":0.637574940144511,"score_gpt":0.6468215544832479,"score_spread":0.009246614338736858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020026521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009296112,0.96121687,0.0043163067,0.02346667,0.0025867415,0.00013431752,0.00018858317,0.000012394903,0.007148577],"genre_scores_gemma":[0.09188009,0.8509076,0.01372088,0.031688366,0.009500556,0.00087948894,0.00020779895,0.000053673735,0.0011615988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7018358,0.25712958,0.011175777,0.0076389876,0.020903716,0.0013162508],"domain_scores_gemma":[0.18689038,0.78893346,0.009382357,0.008219663,0.0060160886,0.00055809465],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.27511358,0.0023458346,0.009338273,0.006839582,0.0008663161,0.008741517,0.0045487667,0.009329279,0.016536519],"category_scores_gemma":[0.51801693,0.0010559597,0.0065860143,0.010625192,0.009227937,0.013853007,0.0044481833,0.007955929,0.0012610435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032296611,0.00020276333,0.0019028722,0.10237677,0.014537714,0.00026431077,0.00046964342,0.0030626394,0.00030057362,0.31021866,0.013229855,0.5502045],"study_design_scores_gemma":[0.0028355566,0.0016961863,0.0076064784,0.17656156,0.017646855,0.0010505838,0.0008311539,0.0031395555,0.0010916434,0.60801136,0.17930622,0.00022285372],"about_ca_topic_score_codex":0.0039934367,"about_ca_topic_score_gemma":0.0039265705,"teacher_disagreement_score":0.27511358,"about_ca_system_score_codex":0.008935868,"about_ca_system_score_gemma":0.009895293,"threshold_uncertainty_score":0.893914},"labels":[],"label_agreement":null},{"id":"W2021250625","doi":"10.1038/sj.clpt.6100240","title":"Current Assessment of Risk–Benefit by Regulators: Is It Time to Introduce Decision Analyses?","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Clinical pharmacology; Risk assessment; Terfenadine; Risk analysis (engineering); Actuarial science; Quality (philosophy); Medicine; Management science; Psychology; Computer science; Business; Pharmacology; Economics","score_opus":0.5122946078377717,"score_gpt":0.6222662990845224,"score_spread":0.10997169124675066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021250625","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00536703,0.08150187,0.22139232,0.66010576,0.009442713,0.00031327608,0.00043337938,0.00043695964,0.021006694],"genre_scores_gemma":[0.34513518,0.08104928,0.3501372,0.18713608,0.030492403,0.0018406545,0.00044695416,0.0005629801,0.0031993256],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8391139,0.11681204,0.009255016,0.0051685967,0.028038006,0.0016124756],"domain_scores_gemma":[0.38156566,0.5399621,0.01693302,0.011898999,0.046572536,0.0030677363],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.29480666,0.0026766136,0.0052095903,0.0054346365,0.002374233,0.01667055,0.0069120885,0.013831254,0.00573627],"category_scores_gemma":[0.41864452,0.001209978,0.0032053678,0.0047401646,0.017134635,0.032537654,0.0049376385,0.028543787,0.0016312103],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004644278,0.00027889435,0.0023111685,0.0030705999,0.0007746098,0.00016062883,0.001356674,0.012270141,0.0005432759,0.59476906,0.075418465,0.308582],"study_design_scores_gemma":[0.00016128644,0.00013405795,0.0007435464,0.0038771476,0.00020486653,0.000087318396,0.0009954663,0.009318467,0.0003548943,0.91216415,0.07174822,0.00021064123],"about_ca_topic_score_codex":0.006530291,"about_ca_topic_score_gemma":0.0052003833,"teacher_disagreement_score":0.29480666,"about_ca_system_score_codex":0.008998125,"about_ca_system_score_gemma":0.01691037,"threshold_uncertainty_score":0.8696289},"labels":[],"label_agreement":null},{"id":"W2021635654","doi":"10.1038/clpt.2013.2","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":453,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Institute of General Medical Sciences; National Institute of Mental Health; National Heart, Lung, and Blood Institute; American Lebanese Syrian Associated Charities; Canadian Institutes of Health Research; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Doxepin; Nortriptyline; Desipramine; Tricyclic; CYP2D6; Pharmacology; Pharmacogenetics; Clomipramine; CYP2C19; Dosing; Active metabolite; Medicine; Imipramine; Pharmacokinetics; Amitriptyline; Genotype; Chemistry; Internal medicine; Antidepressant; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.2465648872691833,"score_gpt":0.5759832517471809,"score_spread":0.3294183644779976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021635654","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02730071,0.055654857,0.21595381,0.27995884,0.009587639,0.016658539,0.022942185,0.005860328,0.36608306],"genre_scores_gemma":[0.12275723,0.04551492,0.50303036,0.15122238,0.005668949,0.028515087,0.049124975,0.0018086239,0.09235746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.972386,0.011563876,0.0071186977,0.0008401446,0.0071286196,0.00096261606],"domain_scores_gemma":[0.94702965,0.015704172,0.0062711644,0.0021890486,0.026985874,0.0018200176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018548682,0.00090154,0.0019433754,0.0024906844,0.0011115215,0.0019154934,0.00453594,0.006701755,0.0065886667],"category_scores_gemma":[0.036987055,0.00079764647,0.0030851082,0.0029768746,0.0007369782,0.0012557774,0.001661238,0.006450461,0.0065963212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052766106,0.00083232915,0.0129487645,0.0015792506,0.0001993081,0.0014487533,0.00054741063,0.0024222217,0.0031643307,0.0063860333,0.6565062,0.31343767],"study_design_scores_gemma":[0.0008679144,0.0007424302,0.055250507,0.007559663,0.00037852855,0.0038992953,0.00046308595,0.0038196538,0.004435182,0.006507307,0.91591966,0.00015684718],"about_ca_topic_score_codex":0.012480809,"about_ca_topic_score_gemma":0.01627866,"teacher_disagreement_score":0.018548682,"about_ca_system_score_codex":0.0017993785,"about_ca_system_score_gemma":0.008742095,"threshold_uncertainty_score":0.09809595},"labels":[],"label_agreement":null},{"id":"W2021997289","doi":"10.1038/clpt.2011.245","title":"Pathways to Drug Development for Autism Spectrum Disorders","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Rett syndrome; Autism; Psychiatry; Medicine; Clinical trial; Neuropathology; Fragile X syndrome; Pharmacotherapy; Autism spectrum disorder; Drug development; Neurochemical; Psychology; Drug; Neuroscience; Disease; Pathology; Biology","score_opus":0.12347155197608628,"score_gpt":0.408684906927953,"score_spread":0.2852133549518667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021997289","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036579825,0.99148566,0.00048587428,0.00088108086,0.00025416352,0.000020037487,0.00006482513,0.000035738743,0.006406742],"genre_scores_gemma":[0.0015407956,0.99414825,0.0006059775,0.0004458074,0.00011028948,0.000023518536,0.00006248447,0.000003968545,0.0030590405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998528,0.000033074622,0.000015630962,0.000024888108,0.000057925332,0.000015739184],"domain_scores_gemma":[0.9998259,0.000070305,0.000027169566,0.000007929456,0.00004596556,0.000022729291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041799442,0.0008051198,0.001003077,0.0019089037,0.00037346277,0.0009878475,0.00072850223,0.0010659889,0.008075422],"category_scores_gemma":[0.00048766276,0.00023919943,0.000455781,0.0013153439,0.0004741227,0.001094619,0.00078424916,0.0019428199,0.0053630723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008340272,0.0001748999,0.00018800132,0.00677782,0.00007743858,0.00057732966,0.000063657026,0.000524671,0.0035926716,0.010514711,0.04670414,0.9307212],"study_design_scores_gemma":[0.000040212297,0.00011649927,0.0005114644,0.0013225052,0.00004265845,0.0014195284,0.000033843815,0.00010247829,0.0006962532,0.0037819594,0.99191827,0.000014394596],"about_ca_topic_score_codex":0.00089208793,"about_ca_topic_score_gemma":0.002663688,"teacher_disagreement_score":0.008075422,"about_ca_system_score_codex":0.0007383529,"about_ca_system_score_gemma":0.00087215815,"threshold_uncertainty_score":0.02701497},"labels":[],"label_agreement":null},{"id":"W2022028441","doi":"10.1067/mcp.2001.112513","title":"Pharmacokinetic interaction between single oral doses of ditiazem and sirolimus in healthy volunteers*1","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Diltiazem; Sirolimus; Pharmacokinetics; Crossover study; Pharmacology; Half-life; Medicine; Drug interaction; Volume of distribution; Chemistry; Internal medicine; Calcium","score_opus":0.18554419111631165,"score_gpt":0.48513317753946295,"score_spread":0.2995889864231513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022028441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853766,0.0006564241,0.00026559367,0.000022891489,0.00001464051,0.000053944783,0.00009443051,0.000017398641,0.00033697393],"genre_scores_gemma":[0.99829274,0.00020956334,0.00050803134,0.00011822005,0.00005117915,0.000075837816,0.00023093203,0.0000066392736,0.0005069342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996232,0.00013451834,0.000024342504,0.00009098147,0.0000825407,0.000044383007],"domain_scores_gemma":[0.99945134,0.00022898466,0.00011533029,0.000028082997,0.000041727617,0.00013455756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048312137,0.00047735218,0.00067079306,0.00020147888,0.00038616848,0.0003693468,0.00012399447,0.0005342586,0.0016043688],"category_scores_gemma":[0.0012236347,0.00029555502,0.00025860264,0.00016473165,0.00023226702,0.0002530618,0.00018376127,0.00048298668,0.00037501522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14361306,0.007842948,0.6016257,0.00043046853,0.0010440915,0.0021117614,0.001048962,0.0010860106,0.15301487,0.00012216176,0.0015414736,0.08651846],"study_design_scores_gemma":[0.002935876,0.095230505,0.87913615,0.000019403862,0.00056657585,0.0041818954,0.0002189024,0.0029204166,0.012203168,0.000114625094,0.0024244192,0.0000479705],"about_ca_topic_score_codex":0.0010822966,"about_ca_topic_score_gemma":0.00095656136,"teacher_disagreement_score":0.0016043688,"about_ca_system_score_codex":0.0002173545,"about_ca_system_score_gemma":0.00025992535,"threshold_uncertainty_score":0.00536716},"labels":[],"label_agreement":null},{"id":"W2023176983","doi":"10.1016/s0009-9236(03)90388-2","title":"Monitoring lithium in breast milk: An individualized approach for breastfeeding mothers","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Breastfeeding; Breast milk; Lithium (medication); Clinical pharmacology; Medicine; Breast feeding; Pharmacology; Lactation; Internal medicine; Obstetrics; Pediatrics; Chemistry; Pregnancy; Biology; Biochemistry; Genetics","score_opus":0.14616759093040865,"score_gpt":0.45379399226021105,"score_spread":0.3076264013298024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023176983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9097276,0.022751082,0.021987263,0.015174846,0.00083163707,0.001168906,0.0006925625,0.0021040929,0.025561905],"genre_scores_gemma":[0.9404724,0.010366053,0.03982351,0.002376169,0.0005651116,0.0013439012,0.00030236537,0.00012964131,0.004620828],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992774,0.00027121961,0.00012214757,0.000046868063,0.0002499624,0.000032455984],"domain_scores_gemma":[0.99896693,0.0004038125,0.00026631923,0.000071537004,0.00016357144,0.00012779122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008243329,0.00064406457,0.0014029265,0.00045738198,0.0005730267,0.00061005715,0.0005723321,0.00085753703,0.0010388409],"category_scores_gemma":[0.004892254,0.00018923252,0.00029660566,0.0003984882,0.00017743983,0.00063032843,0.00041411418,0.0009334063,0.00050524797],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007128241,0.0015615274,0.262834,0.00086651347,0.00030609115,0.0019403372,0.0010353411,0.0013670028,0.01874243,0.00045252335,0.02076207,0.683004],"study_design_scores_gemma":[0.0022188418,0.018298168,0.7523686,0.0014703824,0.0019016435,0.02251628,0.0030447412,0.022135379,0.095365904,0.0036353518,0.07674298,0.00030166228],"about_ca_topic_score_codex":0.001317703,"about_ca_topic_score_gemma":0.0022836428,"teacher_disagreement_score":0.0014029265,"about_ca_system_score_codex":0.0005113032,"about_ca_system_score_gemma":0.00082781404,"threshold_uncertainty_score":0.0043595433},"labels":[],"label_agreement":null},{"id":"W2023380505","doi":"10.1016/j.clpt.2004.12.157","title":"Oxidative activation of linezolid to a reactive species: Implications for linezolid adverse drug reactions","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Linezolid; Viability assay; Pharmacology; Chemistry; Metabolite; Toxicity; Incubation; Biochemistry; Biology; Bacteria; Cell; Staphylococcus aureus","score_opus":0.11335789911548225,"score_gpt":0.4595326298042175,"score_spread":0.3461747306887353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023380505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8594993,0.10381376,0.01914604,0.0070952275,0.000452258,0.00022915319,0.0005945346,0.00021350975,0.008956191],"genre_scores_gemma":[0.98003435,0.015649624,0.0021781912,0.0004537561,0.00015410605,0.000028361648,0.00015067578,0.0000069984826,0.0013439285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996339,0.0001674124,0.000034480257,0.00004532526,0.00007437125,0.0000445955],"domain_scores_gemma":[0.99888283,0.00025683426,0.0005373826,0.00004352108,0.00018068188,0.000098803546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005888821,0.0005908934,0.00039033435,0.00043910308,0.00021473411,0.0006166365,0.00036959612,0.0007794856,0.0037985207],"category_scores_gemma":[0.0011374977,0.00017260415,0.00041332556,0.00028089815,0.00042344193,0.0005629878,0.00019513047,0.00053046,0.0005209258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023830503,0.00035200643,0.03106913,0.0014493864,0.000112663816,0.006426257,0.00020249106,0.0009992461,0.8850004,0.0012917661,0.0014837872,0.069229856],"study_design_scores_gemma":[0.00034308995,0.007940235,0.1826157,0.0003612434,0.0004950371,0.02978352,0.00068792765,0.0059434487,0.7375705,0.0041404087,0.030032998,0.00008592599],"about_ca_topic_score_codex":0.0003657488,"about_ca_topic_score_gemma":0.00045687216,"teacher_disagreement_score":0.0037985207,"about_ca_system_score_codex":0.0005111317,"about_ca_system_score_gemma":0.00032266497,"threshold_uncertainty_score":0.012707293},"labels":[],"label_agreement":null},{"id":"W2023946039","doi":"10.1016/s0009-9236(03)90454-1","title":"Response Surface Analysis of Acetaminophen (APAP) Overdose Hepatotoxicity — Unmasking the Data","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Acetaminophen; acetaminophen overdose; Drug overdose; Pharmacology; Medicine; Clinical pharmacology; Chemistry; Emergency medicine; Poison control; Acetylcysteine; Biochemistry","score_opus":0.46546555481481916,"score_gpt":0.55060402799214,"score_spread":0.08513847317732087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023946039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97971183,0.0010436035,0.0170511,0.00026860271,0.000075962336,0.000050217375,0.00028982558,0.00015813652,0.0013506772],"genre_scores_gemma":[0.9919505,0.00073172565,0.0052799983,0.0001875714,0.000038177353,0.000050950708,0.00052828016,0.000023966288,0.0012087737],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99964666,0.00008604122,0.000018592411,0.00004137368,0.00014583189,0.00006149347],"domain_scores_gemma":[0.9996736,0.00011018998,0.000038069964,0.00004901248,0.00010625719,0.000022911498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004912702,0.00038475142,0.00057598366,0.0002534672,0.0001372935,0.00044889929,0.00019993738,0.0003434265,0.0010440327],"category_scores_gemma":[0.0009855349,0.000116514115,0.0004565641,0.00029353847,0.00020356281,0.00026620133,0.0002406938,0.00055889634,0.000329062],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009182885,0.00010311237,0.00241271,0.00007599369,0.000045506178,0.00007382255,0.000030962223,0.00065563683,0.9752686,0.000100373865,0.00019714306,0.020117834],"study_design_scores_gemma":[0.000041179315,0.0026616845,0.04817762,0.00001306812,0.0001365282,0.0006403255,0.00017855165,0.032452192,0.9122868,0.00043801076,0.0029418475,0.000032054155],"about_ca_topic_score_codex":0.0005742807,"about_ca_topic_score_gemma":0.00060169515,"teacher_disagreement_score":0.0010440327,"about_ca_system_score_codex":0.00017480031,"about_ca_system_score_gemma":0.00017196445,"threshold_uncertainty_score":0.0034926534},"labels":[],"label_agreement":null},{"id":"W2025753477","doi":"10.1038/clpt.2011.311","title":"Uncoupling the Dopamine D1–D2 Receptor Complex: A Novel Target for Antidepressant Treatment","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Antidepressant; Dopamine; Neurotransmitter; Dopamine receptor D2; Major depressive disorder; Norepinephrine; Depression (economics); Neurotransmitter receptor; Mood; Pharmacology; Dopamine receptor D3; Psychiatry; Medicine; Serotonin; Neurotransmitter systems; Psychology; Clinical pharmacology; Neuroscience; Internal medicine; Receptor","score_opus":0.34029955712793747,"score_gpt":0.45619462185437587,"score_spread":0.1158950647264384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025753477","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36907208,0.5518946,0.021858849,0.01791523,0.0024681166,0.0002476058,0.0005489704,0.00047217362,0.035522427],"genre_scores_gemma":[0.8091617,0.1586661,0.007563035,0.003562191,0.00084957125,0.0001483448,0.00046483328,0.00003881415,0.01954533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999441,0.000010919526,0.000003450252,0.000010977831,0.000016664937,0.000013920928],"domain_scores_gemma":[0.9999677,0.0000045877805,0.000007230385,0.0000027993715,0.000007734724,0.000009919505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017192659,0.00026897553,0.00041928864,0.00020671221,0.00020282369,0.0005467489,0.00034763152,0.00045513775,0.0030086236],"category_scores_gemma":[0.000114011986,0.0001138892,0.00021599165,0.00014866373,0.00022497553,0.00038041835,0.00033344975,0.00081876566,0.0008150448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001473378,0.0005624594,0.0014801044,0.0018385034,0.00015192285,0.0008897462,0.00015126102,0.00069409807,0.5711824,0.011586495,0.020872956,0.38911664],"study_design_scores_gemma":[0.0025583552,0.0062495484,0.025341462,0.00050768483,0.00044304162,0.0081054615,0.00033653216,0.0065050274,0.34585756,0.012880152,0.591088,0.00012714024],"about_ca_topic_score_codex":0.00029199632,"about_ca_topic_score_gemma":0.0010310481,"teacher_disagreement_score":0.0030086236,"about_ca_system_score_codex":0.00029994242,"about_ca_system_score_gemma":0.00023741154,"threshold_uncertainty_score":0.0100649},"labels":[],"label_agreement":null},{"id":"W2027045087","doi":"10.1038/sj.clpt.6100157","title":"The Effect of ABCB1 Polymorphism on the Pharmacokinetics of Saquinavir Alone and in Combination with Ritonavir","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa; Ottawa Hospital","funders":"Ontario HIV Treatment Network","keywords":"Saquinavir; Pharmacokinetics; Ritonavir; Pharmacology; P-glycoprotein; Medicine; Genotype; Peripheral blood mononuclear cell; Internal medicine; Immunology; Biology; Genetics; Gene; Viral load","score_opus":0.030320072385052604,"score_gpt":0.37548348537386395,"score_spread":0.34516341298881137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027045087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991642,0.0003946703,0.00013629136,0.00003580361,0.0000048742354,0.000009333323,0.000041624506,0.0000049867567,0.00020815253],"genre_scores_gemma":[0.99951136,0.00009251428,0.00014087021,0.000033081178,0.000013643905,0.0000043127457,0.00005730663,0.000003460481,0.00014347311],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99899143,0.00053135544,0.00004387363,0.00018054855,0.00016976648,0.00008297866],"domain_scores_gemma":[0.9992791,0.00035921915,0.00015343822,0.000049652223,0.00003761668,0.00012098842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007166028,0.00040267385,0.0007958194,0.00024830183,0.00018085695,0.00028206606,0.000120188386,0.00041955174,0.0015590518],"category_scores_gemma":[0.0014230052,0.0002491268,0.00038077086,0.00021669442,0.00018729045,0.00023470445,0.00012744295,0.00049201323,0.00030331212],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06857953,0.0035548909,0.37496457,0.00017354837,0.0027817253,0.0016742856,0.00057915784,0.002386764,0.41781712,0.00013882705,0.000800177,0.1265494],"study_design_scores_gemma":[0.0012610415,0.063277364,0.8937662,0.000016768336,0.0016187247,0.0032811782,0.000103564045,0.005246511,0.02889682,0.00016110281,0.002310758,0.000059976523],"about_ca_topic_score_codex":0.0005734952,"about_ca_topic_score_gemma":0.0010734816,"teacher_disagreement_score":0.0015590518,"about_ca_system_score_codex":0.00016114411,"about_ca_system_score_gemma":0.0001050861,"threshold_uncertainty_score":0.0052155256},"labels":[],"label_agreement":null},{"id":"W2027255015","doi":"10.1038/clpt.2013.74","title":"Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":345,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences","keywords":"Multidrug resistance-associated protein 2; Transporter; Bile Salt Export Pump; Abcg2; Pharmacology; Efflux; Drug; ATP-binding cassette transporter; Cholestasis; Pharmacokinetics; Chemistry; Medicine; Biochemistry; Internal medicine; Gene","score_opus":0.2187098658280976,"score_gpt":0.5060868766921303,"score_spread":0.28737701086403267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027255015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010138518,0.9968285,0.000126411,0.0013439362,0.00079582044,0.000006095241,0.000035177596,0.000010042666,0.000752626],"genre_scores_gemma":[0.00038061736,0.99717724,0.00024506575,0.00080674613,0.00058606983,0.000007263655,0.000078574754,0.0000028952318,0.000715488],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952567,0.00007111584,0.000092747236,0.00007055272,0.00018435107,0.00005563526],"domain_scores_gemma":[0.99883705,0.00036917953,0.00013686206,0.000026962358,0.0004881398,0.0001417669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015800904,0.0011475704,0.0022839666,0.0039856397,0.00039455434,0.0019158471,0.001251824,0.0020415918,0.00549174],"category_scores_gemma":[0.0015386437,0.0004686775,0.00086406514,0.0050147246,0.0005953185,0.0036537033,0.0013519208,0.002940519,0.0034571392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009661603,0.0000589621,0.00026349814,0.011562962,0.0000720904,0.0003420028,0.000068399844,0.00020601318,0.0009216612,0.0034450658,0.09621523,0.88674754],"study_design_scores_gemma":[0.00001629873,0.000053593685,0.00035872485,0.0021677897,0.000078143916,0.000903958,0.00004570613,0.000063657186,0.00012745791,0.0006623184,0.9955064,0.000015877444],"about_ca_topic_score_codex":0.0014664291,"about_ca_topic_score_gemma":0.0032305613,"teacher_disagreement_score":0.00549174,"about_ca_system_score_codex":0.0011060333,"about_ca_system_score_gemma":0.002368188,"threshold_uncertainty_score":0.018371701},"labels":[],"label_agreement":null},{"id":"W2027744617","doi":"10.1038/clpt.2010.184","title":"Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Metformin; Incretin; Glucagon-like peptide-1; In vivo; Dipeptidyl peptidase; Endocrinology; Internal medicine; Chemistry; Glucagon; Pharmacology; Dipeptidyl peptidase-4; Pharmacokinetics; Small intestine; Type 2 diabetes; Diabetes mellitus; Hormone; Medicine; Biology; Biochemistry; Enzyme","score_opus":0.05141449335925543,"score_gpt":0.39199612142172,"score_spread":0.3405816280624646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027744617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332654,0.004794134,0.0006608419,0.00012035813,0.000107494256,0.000038327857,0.000085138745,0.000027627957,0.00083946105],"genre_scores_gemma":[0.9919064,0.0027207367,0.0029151605,0.00019987911,0.00015233985,0.000059440717,0.00019280092,0.000011071883,0.0018422658],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99972004,0.000092095,0.000022840417,0.000044711556,0.000077410994,0.00004281173],"domain_scores_gemma":[0.99980396,0.00005270334,0.000051306954,0.000015459198,0.000011268493,0.00006532369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030431518,0.00062885444,0.00093635503,0.00033033628,0.00013214363,0.00039196198,0.0001605521,0.00039185028,0.00161683],"category_scores_gemma":[0.0002773537,0.00037987315,0.0003788121,0.00019470692,0.00024598578,0.00035669818,0.00021530775,0.0010301415,0.00025940692],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020472014,0.0019059713,0.0017417952,0.00019267497,0.00018978554,0.00022879454,0.000025188972,0.00019057031,0.9497613,0.000091907066,0.00015761783,0.025042396],"study_design_scores_gemma":[0.0020297382,0.089558624,0.029124845,0.000030835763,0.00076108327,0.0010302431,0.000102270686,0.0013570033,0.87065125,0.00011998873,0.0052050296,0.000029097708],"about_ca_topic_score_codex":0.00014031465,"about_ca_topic_score_gemma":0.0004979866,"teacher_disagreement_score":0.00161683,"about_ca_system_score_codex":0.0001999717,"about_ca_system_score_gemma":0.00018263722,"threshold_uncertainty_score":0.005408883},"labels":[],"label_agreement":null},{"id":"W2027851095","doi":"10.1038/clpt.2011.280","title":"Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children; University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Codeine; Medicine; CYP2D6; Odds ratio; Pharmacogenetics; Catechol-O-methyl transferase; Depression (economics); Opioid; Genotype; Clinical pharmacology; Pharmacology; Breastfeeding; Internal medicine; Bioinformatics; Pediatrics; Biology; Genetics; Receptor; Morphine; Gene; Cytochrome P450","score_opus":0.25220514093363794,"score_gpt":0.47173391498590633,"score_spread":0.2195287740522684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027851095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992292,0.0002392595,0.00025472007,0.000028238677,0.0000024970184,0.0000037266045,0.000067018176,0.0000035540218,0.00017180867],"genre_scores_gemma":[0.9991811,0.00018670644,0.00044107123,0.000009806856,0.000002957887,0.0000051614716,0.000084920204,0.0000014724059,0.000086675005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995117,0.00022746748,0.00003410085,0.00008493688,0.00009886387,0.000042851785],"domain_scores_gemma":[0.99889636,0.0004918807,0.00039450877,0.000051899104,0.000082851526,0.00008248666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006825949,0.00044752867,0.00042893132,0.00054352585,0.00015529849,0.00035023937,0.00021346052,0.00038608973,0.00060413417],"category_scores_gemma":[0.0031748763,0.00019920345,0.00033406354,0.00047927757,0.00014300423,0.0002062759,0.0003367516,0.00041621388,0.0001478207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016401162,0.000013816638,0.9961481,0.000005212209,0.00003161683,0.00015312049,0.00003307385,0.00007149663,0.0005039833,0.0000109957255,0.000026161175,0.0028384163],"study_design_scores_gemma":[0.000010437126,0.00026921218,0.9951416,0.000012465542,0.00006996728,0.001066232,0.00011881003,0.0026048874,0.0005017382,0.000059695703,0.00014023027,0.000004700377],"about_ca_topic_score_codex":0.0023504773,"about_ca_topic_score_gemma":0.0019126986,"teacher_disagreement_score":0.0023504773,"about_ca_system_score_codex":0.00020624758,"about_ca_system_score_gemma":0.00018152018,"threshold_uncertainty_score":0.0046735406},"labels":[],"label_agreement":null},{"id":"W2028492424","doi":"10.1016/j.clpt.2005.02.002","title":"The use of tegaserod in critically ill patients with impaired gastric motility","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Tegaserod; Cisapride; Gastroparesis; Medicine; Domperidone; Gastric emptying; Metoclopramide; Partial agonist; Intensive care unit; Irritable bowel syndrome; Intensive care medicine; Internal medicine; Adverse effect; Parenteral nutrition; Gastroenterology; Agonist; Stomach; Vomiting","score_opus":0.1052418375876186,"score_gpt":0.3869726681467358,"score_spread":0.2817308305591172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028492424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9331451,0.048142876,0.0031151648,0.003945948,0.00023549101,0.00009847209,0.000045691824,0.00011753207,0.011153626],"genre_scores_gemma":[0.98969895,0.0077940924,0.0009951338,0.00076302094,0.00032424246,0.000021836713,0.00003055418,0.0000074541235,0.00036471363],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99969316,0.00011620332,0.000057515488,0.00002503297,0.000049296865,0.000058758713],"domain_scores_gemma":[0.99905604,0.00034673116,0.00034816278,0.000050597922,0.000039697083,0.00015879425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038553693,0.0004626481,0.00070333004,0.00071606925,0.0006650884,0.0005035758,0.00037989503,0.0013747966,0.0010397894],"category_scores_gemma":[0.0034639253,0.00014732931,0.00054938096,0.0003845662,0.0005982846,0.0006232695,0.00042372275,0.0012129667,0.00037818696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034466258,0.00043439338,0.16814667,0.0008299269,0.00018687348,0.61941814,0.0009997892,0.0003424185,0.026200386,0.00070512004,0.002142841,0.17714684],"study_design_scores_gemma":[0.00026039992,0.004644163,0.0555583,0.00018940342,0.000197261,0.91893214,0.00055454107,0.0008082642,0.011747543,0.00038269776,0.0066932095,0.000032209868],"about_ca_topic_score_codex":0.00027154243,"about_ca_topic_score_gemma":0.0004305959,"teacher_disagreement_score":0.0013747966,"about_ca_system_score_codex":0.0003343879,"about_ca_system_score_gemma":0.0003353749,"threshold_uncertainty_score":0.0034784675},"labels":[],"label_agreement":null},{"id":"W2028657603","doi":"10.1016/j.clpt.2005.11.010","title":"Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pineapple and bromelain studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"CRANBERRY JUICE; Grapefruit juice; Bioavailability; Pharmacokinetics; Crossover study; Cmax; Pharmacology; Chemistry; Oral administration; CYP3A4; Ciclosporin; Medicine; Food science; Placebo; Internal medicine; Cytochrome P450; Chemotherapy; Biochemistry; Metabolism","score_opus":0.03788078406829018,"score_gpt":0.3734771202042271,"score_spread":0.33559633613593687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028657603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792695,0.0012629939,0.00015425739,0.00004071991,0.000021401785,0.00004335013,0.00007483984,0.000011690173,0.00046375673],"genre_scores_gemma":[0.99873096,0.0004354853,0.00019974473,0.00011878287,0.000025822928,0.00002405509,0.00009664303,0.0000044578915,0.00036406532],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997987,0.000070287475,0.000010752773,0.00006009553,0.000037190955,0.00002303652],"domain_scores_gemma":[0.99977475,0.00007294333,0.000055901837,0.00002524588,0.000012455508,0.00005866004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034419366,0.00028022297,0.00052997604,0.00011781781,0.00023298252,0.0003265824,0.000086911066,0.00040431513,0.001978145],"category_scores_gemma":[0.00074097223,0.00014300834,0.00028817725,0.00011116779,0.00030990003,0.00026988747,0.000091115086,0.00047465673,0.0001756779],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22864205,0.0108476635,0.0737888,0.00087657874,0.0012140763,0.0014837132,0.000412244,0.00047902248,0.5823278,0.00018632742,0.0013604914,0.098381236],"study_design_scores_gemma":[0.009168722,0.22633617,0.6626815,0.00007866632,0.0014637134,0.0044212313,0.00019429442,0.0016380677,0.08349478,0.00024114436,0.010222986,0.000058772166],"about_ca_topic_score_codex":0.00034960473,"about_ca_topic_score_gemma":0.0003510142,"teacher_disagreement_score":0.001978145,"about_ca_system_score_codex":0.00017729538,"about_ca_system_score_gemma":0.00018420107,"threshold_uncertainty_score":0.0066176057},"labels":[],"label_agreement":null},{"id":"W2028783301","doi":"10.1016/s0009-9236(03)90600-x","title":"Long‐term pharmacotherapy for weight loss in patients with obesity","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University of Calgary; Sunnybrook Health Science Centre","funders":"","keywords":"Pharmacotherapy; Medicine; Clinical pharmacology; Obesity; Weight loss; Term (time); Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.05414500022239279,"score_gpt":0.4144085399750633,"score_spread":0.3602635397526705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028783301","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88954407,0.085459575,0.0013739383,0.0068471683,0.00067429256,0.00015032693,0.0005913852,0.0001268686,0.015232422],"genre_scores_gemma":[0.96854454,0.023061136,0.0015638865,0.0020720107,0.000620023,0.00014114767,0.0006577188,0.000010442695,0.0033291304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998511,0.000049368264,0.00002190457,0.000013067523,0.0000403786,0.000024135827],"domain_scores_gemma":[0.99964714,0.00010101138,0.00010658462,0.000015625332,0.000030669536,0.00009911187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037297214,0.0002278792,0.00084370247,0.00023232638,0.00036922217,0.0003391582,0.00021386043,0.00038645262,0.0028288658],"category_scores_gemma":[0.0010480853,0.00009793209,0.0005680388,0.00033864076,0.00015920128,0.00034353213,0.00026573654,0.0011919815,0.00047756766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035465844,0.0066196173,0.15493642,0.0015479953,0.0017008513,0.0012919086,0.00026416132,0.0004130868,0.009762739,0.00066232163,0.010776959,0.77655816],"study_design_scores_gemma":[0.0057201893,0.022712909,0.9465848,0.0004727075,0.0012276057,0.0033952643,0.00023864907,0.00081370206,0.001917537,0.00068957015,0.01617507,0.0000520007],"about_ca_topic_score_codex":0.0005862078,"about_ca_topic_score_gemma":0.0031442347,"teacher_disagreement_score":0.0028288658,"about_ca_system_score_codex":0.00030058654,"about_ca_system_score_gemma":0.00045725447,"threshold_uncertainty_score":0.009463489},"labels":[],"label_agreement":null},{"id":"W2028870144","doi":"10.1016/s0009-9236(03)90393-6","title":"Identification of cellular proteins targeted by reactive sulphonamide metabolites and their relation to adverse drug reactions","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Identification (biology); Pharmacology; Drug reaction; Clinical pharmacology; Chemistry; Drug metabolism; Medicine; Computational biology; Biology","score_opus":0.060915774302148944,"score_gpt":0.4112708383764259,"score_spread":0.35035506407427697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028870144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962973,0.0017779702,0.0009183826,0.00006710443,0.000015162153,0.0000149857515,0.00010459721,0.000013914582,0.00079063],"genre_scores_gemma":[0.99776924,0.00087055477,0.0006273673,0.00003758059,0.000013357808,0.000011582047,0.00019768342,0.000002445216,0.00047012692],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997162,0.00008873885,0.000030896892,0.000034012195,0.00008982745,0.00004030798],"domain_scores_gemma":[0.9995561,0.00014298738,0.00014929559,0.00003054165,0.000073529714,0.000047539274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003812445,0.00023045836,0.00024316259,0.00040054313,0.00017453203,0.00022701544,0.000121288685,0.00036579027,0.0013593781],"category_scores_gemma":[0.0006121411,0.00012791826,0.00029137172,0.00031922795,0.00021474621,0.00013882185,0.0001517435,0.00029433912,0.00029248054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033013148,0.00016588098,0.05124602,0.00016130367,0.00012383585,0.0014186644,0.00012149161,0.00028741645,0.9287952,0.00012942118,0.00018404546,0.014065361],"study_design_scores_gemma":[0.000065113694,0.0033523268,0.36941758,0.000014509112,0.00019241891,0.0060131284,0.00017418749,0.0019673822,0.61566633,0.000157279,0.0029662084,0.000013641363],"about_ca_topic_score_codex":0.00030065418,"about_ca_topic_score_gemma":0.00033438826,"teacher_disagreement_score":0.0013593781,"about_ca_system_score_codex":0.00020839591,"about_ca_system_score_gemma":0.00010120248,"threshold_uncertainty_score":0.0045475364},"labels":[],"label_agreement":null},{"id":"W2030370251","doi":"10.1016/s0009-9236(03)90529-7","title":"The Single‐Dose Pharmacokinetics of Clopidogrel in Healthy Adult Volunteers","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharmaxis (Canada)","funders":"","keywords":"Pharmacokinetics; Clopidogrel; Medicine; Pharmacology; Internal medicine; Aspirin","score_opus":0.06607649872153568,"score_gpt":0.4036290090279938,"score_spread":0.33755251030645816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030370251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951023,0.0016849152,0.0008087751,0.00012515084,0.00007780447,0.00008148529,0.00060327165,0.00007352854,0.0014428099],"genre_scores_gemma":[0.9965205,0.0007620331,0.00043756625,0.0002551878,0.00012742785,0.000066384586,0.0006655762,0.000025937738,0.0011393037],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996644,0.00009356398,0.000021629978,0.0001135342,0.000069795526,0.000037008147],"domain_scores_gemma":[0.9991399,0.00033232287,0.00014776668,0.0000967432,0.000076694414,0.00020654636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048497066,0.00048753148,0.0012001896,0.00023075235,0.00031994365,0.00060411374,0.00020001862,0.0009133697,0.0022418438],"category_scores_gemma":[0.0022219825,0.00062627776,0.0004658037,0.00022847619,0.00037108938,0.00061112794,0.0001784046,0.0011370665,0.0010843591],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40115333,0.006162948,0.19602633,0.0008160197,0.0026954666,0.0031445646,0.0019338859,0.0027604431,0.2053618,0.000901578,0.008604739,0.17043886],"study_design_scores_gemma":[0.006103288,0.06432914,0.8946873,0.00004587902,0.0010665565,0.0062649534,0.00038006346,0.006911734,0.01600372,0.00064007245,0.0034531376,0.000114092465],"about_ca_topic_score_codex":0.001235429,"about_ca_topic_score_gemma":0.001162437,"teacher_disagreement_score":0.0022418438,"about_ca_system_score_codex":0.00025418718,"about_ca_system_score_gemma":0.00034664947,"threshold_uncertainty_score":0.0074997544},"labels":[],"label_agreement":null},{"id":"W2030471578","doi":"10.1016/j.clpt.2004.02.011","title":"Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity*1","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":434,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"National Center for Research Resources; National Institute on Drug Abuse","keywords":"CYP2A6; Cotinine; Nicotine; Metabolite; Chemistry; Saliva; Pharmacology; Oral administration; Metabolism; Internal medicine; Cytochrome P450; Medicine; Biochemistry; CYP1A2","score_opus":0.04141083576189477,"score_gpt":0.41391024601281284,"score_spread":0.3724994102509181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030471578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97351813,0.0070940466,0.012253365,0.00014106071,0.00011399414,0.00023346288,0.0021297967,0.00037281174,0.004143257],"genre_scores_gemma":[0.9883994,0.00091566984,0.007610687,0.00009563891,0.0000748466,0.00014608358,0.0011567647,0.00003979404,0.0015611366],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892455,0.00036086843,0.00007364426,0.0001821745,0.0004104285,0.00004831874],"domain_scores_gemma":[0.9985868,0.00038362367,0.0005237387,0.000099929915,0.00027932567,0.00012661211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091706874,0.00052626233,0.0004599456,0.00083934236,0.00022287064,0.0005165122,0.0003367014,0.0006448409,0.002522277],"category_scores_gemma":[0.0018704713,0.00019072733,0.00029771228,0.00074093585,0.00021737834,0.00027378224,0.00024794106,0.000767122,0.0010296033],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004809515,0.0006545292,0.6820319,0.00041525683,0.00061424554,0.00054752466,0.0002719276,0.00047658765,0.2634734,0.0002093985,0.0015216866,0.04497397],"study_design_scores_gemma":[0.000056753415,0.002241285,0.9223454,0.00001782783,0.00021961138,0.0037017514,0.00009112571,0.0028240373,0.06599679,0.00011618267,0.0023631353,0.00002610342],"about_ca_topic_score_codex":0.0005493886,"about_ca_topic_score_gemma":0.00072865945,"teacher_disagreement_score":0.002522277,"about_ca_system_score_codex":0.00023723503,"about_ca_system_score_gemma":0.000104219995,"threshold_uncertainty_score":0.008437872},"labels":[],"label_agreement":null},{"id":"W2031083224","doi":"10.1038/clpt.2013.12","title":"International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Clinical pharmacology; Transporter; Pharmacodynamics; Pharmacology; Pharmacogenetics; Pharmacokinetics; Allele; Medicine; Biology; Genetics; Computational biology; Gene; Genotype","score_opus":0.04790878477863259,"score_gpt":0.37891199581743323,"score_spread":0.33100321103880065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031083224","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010315339,0.008326376,0.0002180987,0.72376287,0.26224053,0.000041238993,0.00032696716,0.00007553985,0.004905121],"genre_scores_gemma":[0.0010796307,0.005109129,0.00027374984,0.83272165,0.15197997,0.0001136668,0.00016701326,0.000067945046,0.00848729],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914737,0.0018174328,0.0010577956,0.0010460299,0.003688237,0.0009168516],"domain_scores_gemma":[0.9699875,0.014474059,0.0017330187,0.00076088327,0.010054868,0.0029896896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009988935,0.0016915705,0.0027765792,0.002213953,0.0038136297,0.004780029,0.0068501234,0.055546127,0.015385641],"category_scores_gemma":[0.04138801,0.0010497986,0.0033272693,0.0027923777,0.0037965341,0.0040481873,0.0021803,0.04138225,0.009908298],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022062462,0.0000050225663,0.000023902212,0.000075434946,0.000006517691,0.00013192059,0.00001279691,0.000017357203,0.00002889342,0.0006258571,0.99655473,0.0024954195],"study_design_scores_gemma":[0.000077543686,0.000027390857,0.00028199935,0.0008120873,0.000043118176,0.00037407439,0.000056303135,0.00006074893,0.00010428834,0.0015767365,0.99655485,0.00003073572],"about_ca_topic_score_codex":0.014727098,"about_ca_topic_score_gemma":0.01833903,"teacher_disagreement_score":0.055546127,"about_ca_system_score_codex":0.006888437,"about_ca_system_score_gemma":0.015528025,"threshold_uncertainty_score":0.05282718},"labels":[],"label_agreement":null},{"id":"W2031189352","doi":"10.1038/clpt.2012.141","title":"Prenatal and Perinatal Environmental Influences on the Human Fetal and Placental Epigenome","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Birth, Development, and Health","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Epigenome; Epigenetics; Placenta; In utero; Fetus; Physiology; Pregnancy; Fetal programming; Endocrine system; Epigenesis; Bioinformatics; Medicine; Biology; Hormone; Endocrinology; DNA methylation; Genetics","score_opus":0.18853038322307775,"score_gpt":0.4657378177008968,"score_spread":0.27720743447781904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031189352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017159338,0.9977876,0.00020199387,0.00025792402,0.00007794646,0.0000038116766,0.00003855811,0.000009233081,0.0014513443],"genre_scores_gemma":[0.0007476218,0.9982844,0.00021386771,0.00009624937,0.000056415916,0.000005161061,0.000026198833,0.0000011866806,0.0005688302],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986196,0.00002898132,0.00001841246,0.000029135901,0.00004842283,0.000013174099],"domain_scores_gemma":[0.9997776,0.000107948006,0.000035143785,0.0000076008546,0.00005327104,0.000018464625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039000966,0.0006955208,0.0010756555,0.0015502127,0.00024573845,0.0007747584,0.00054177764,0.00086592283,0.0041257883],"category_scores_gemma":[0.00052523374,0.0001948724,0.00031639618,0.0016960478,0.0004481964,0.000854228,0.00059964275,0.0009767783,0.0024049035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048348506,0.00004259386,0.00032308215,0.012374786,0.00006814462,0.00025173422,0.000071667324,0.00023864151,0.0037582444,0.0031971487,0.012219522,0.96740615],"study_design_scores_gemma":[0.000008075044,0.0000928697,0.0026499347,0.0033718713,0.00010951546,0.0019151637,0.000121500794,0.000045368943,0.0015477147,0.0022044955,0.9879088,0.00002471237],"about_ca_topic_score_codex":0.0012503761,"about_ca_topic_score_gemma":0.0018451307,"teacher_disagreement_score":0.0041257883,"about_ca_system_score_codex":0.0004369215,"about_ca_system_score_gemma":0.00090148504,"threshold_uncertainty_score":0.013802111},"labels":[],"label_agreement":null},{"id":"W2031270991","doi":"10.1038/clpt.2011.2","title":"Use of Transgenic and Knockout Mouse Models to Assess Solute Carrier Transporter Function","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Transporter; Solute carrier family; Function (biology); In vivo; Pharmacology; Drug; Endogeny; Knockout mouse; Xenobiotic; Genetically modified mouse; Transgene; Computational biology; Biology; Chemistry; Cell biology; Biochemistry; Genetics; Gene; Enzyme","score_opus":0.4428199905092029,"score_gpt":0.4043460352897484,"score_spread":0.038473955219454514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031270991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6278737,0.011309365,0.29846025,0.0059865285,0.0034522265,0.0040594665,0.019286443,0.005620306,0.023951733],"genre_scores_gemma":[0.6042131,0.022163747,0.27321276,0.0033409637,0.00058239774,0.00893417,0.025721306,0.002988317,0.058843166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973954,0.000437636,0.00048954535,0.0006574831,0.00071073143,0.00030924173],"domain_scores_gemma":[0.9965425,0.0009257468,0.0010696626,0.00037972938,0.00053395145,0.0005483367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035189812,0.0021380577,0.0011571794,0.005020954,0.0010544172,0.0017432467,0.0014324985,0.0030590335,0.008436403],"category_scores_gemma":[0.0021074244,0.0010495951,0.0012988602,0.0013013949,0.0017952721,0.0022606624,0.0010954165,0.0055296766,0.0022566873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005790288,0.00082786643,0.0010461574,0.0002773447,0.000104040664,0.00059803046,0.00016775138,0.00043487255,0.9802899,0.00468489,0.0020088388,0.008981277],"study_design_scores_gemma":[0.0007429141,0.003592443,0.0074095987,0.00030814114,0.00066653447,0.0055409363,0.0003397378,0.0057750186,0.92906356,0.0034669416,0.04290228,0.0001919566],"about_ca_topic_score_codex":0.0017233833,"about_ca_topic_score_gemma":0.0035988411,"teacher_disagreement_score":0.008436403,"about_ca_system_score_codex":0.0010144443,"about_ca_system_score_gemma":0.00090413995,"threshold_uncertainty_score":0.02822262},"labels":[],"label_agreement":null},{"id":"W2032376737","doi":"10.1038/clpt.2008.18","title":"Mass Spectrometry–Based Proteomics: A Useful Tool for Biomarker Discovery?","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Biomarker discovery; False positive paradox; Biomarker; Proteomics; Computational biology; Mass spectrometry; False positives and false negatives; Drug discovery; Computer science; Bioinformatics; Chemistry; Biology; Chromatography; Artificial intelligence","score_opus":0.10526921454691712,"score_gpt":0.41547543097784956,"score_spread":0.31020621643093244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032376737","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092663063,0.52993435,0.03760751,0.40893203,0.018522019,0.000030540472,0.000060796672,0.00018978209,0.0037964743],"genre_scores_gemma":[0.039559506,0.60460126,0.051644675,0.23608807,0.057752773,0.00016151275,0.00007223152,0.00012183858,0.009998092],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99313146,0.0034148593,0.0004219703,0.0007688022,0.0020470775,0.00021587886],"domain_scores_gemma":[0.9931235,0.0038613426,0.0006897887,0.00052017433,0.0014110504,0.0003942496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021887245,0.001645097,0.003623577,0.0024669373,0.0016592471,0.0074488134,0.0025467542,0.0107873,0.0017694371],"category_scores_gemma":[0.009184008,0.0008071916,0.0010377859,0.0015032729,0.020610368,0.0131018795,0.0023820356,0.008017809,0.002940477],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044689083,0.000119814445,0.0021321678,0.005674705,0.00060893997,0.0016643824,0.0014602717,0.00091125607,0.027756255,0.39555183,0.3046413,0.25903216],"study_design_scores_gemma":[0.00007450489,0.0002860903,0.0006688049,0.0017065988,0.00012476674,0.0023650962,0.00085478986,0.0015436197,0.0075039202,0.36462075,0.620047,0.00020419958],"about_ca_topic_score_codex":0.0008025855,"about_ca_topic_score_gemma":0.0011524338,"teacher_disagreement_score":0.021887245,"about_ca_system_score_codex":0.0027144381,"about_ca_system_score_gemma":0.0025588193,"threshold_uncertainty_score":0.11575216},"labels":[],"label_agreement":null},{"id":"W2033129224","doi":"10.1016/s0009-9236(03)90528-5","title":"Bazedoxifene Acetate Metabolic Disposition in Healthy, Postmenopausal Women","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Disposition; Clinical pharmacology; Pharmacology; Medicine; Postmenopausal women; Metabolic clearance rate; Pharmacokinetics; Internal medicine; Physiology; Endocrinology; Psychology","score_opus":0.026213184115484907,"score_gpt":0.37533872057791173,"score_spread":0.34912553646242683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033129224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703836,0.0013792253,0.00012414815,0.00003787908,0.000009158812,0.0000134904585,0.00062787754,0.000013189985,0.0007567996],"genre_scores_gemma":[0.99784076,0.00043755802,0.00013190112,0.000057301382,0.000009599191,0.000015688993,0.00048520268,0.0000049554305,0.0010169197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998988,0.000026729482,0.000009516848,0.000023490627,0.000023138175,0.00001829745],"domain_scores_gemma":[0.9998504,0.000038987837,0.000039724666,0.000013234985,0.000021822048,0.000035843095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014973842,0.00023439445,0.00049048715,0.0004550215,0.0003244071,0.00034978773,0.00011063333,0.00045378896,0.0021352628],"category_scores_gemma":[0.00070469844,0.00032584718,0.00030415537,0.0005425541,0.00015951658,0.00022836053,0.00015162824,0.00033507627,0.00039738012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0990895,0.00080434175,0.7907017,0.00022728757,0.001211574,0.0022531864,0.00092722307,0.00047906564,0.057471476,0.00026429511,0.001009786,0.045560546],"study_design_scores_gemma":[0.0005634951,0.004281803,0.9881131,0.000009431638,0.00046316095,0.0017406924,0.0002805767,0.00046061532,0.0027844585,0.00014922705,0.0011370056,0.000016353046],"about_ca_topic_score_codex":0.0073437616,"about_ca_topic_score_gemma":0.0065495637,"teacher_disagreement_score":0.0073437616,"about_ca_system_score_codex":0.000249238,"about_ca_system_score_gemma":0.00020631975,"threshold_uncertainty_score":0.014602065},"labels":[],"label_agreement":null},{"id":"W2035076759","doi":"10.1038/clpt.2013.55","title":"HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Child and Family Research Institute; University of British Columbia; University of Toronto; BC Children's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Carbamazepine; Human leukocyte antigen; Odds ratio; Medicine; HLA-B; Immunology; Toxic epidermal necrolysis; Anticonvulsant; Antigen; Internal medicine; Epilepsy; Dermatology; Psychiatry","score_opus":0.05152755621598248,"score_gpt":0.4003833235151647,"score_spread":0.3488557672991822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035076759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941194,0.00024459578,0.000051200044,0.000017732726,0.0000017425261,0.0000035092805,0.000063305255,0.0000023398484,0.00020356447],"genre_scores_gemma":[0.99946386,0.00019782869,0.00014936626,0.000014793636,0.0000029791017,0.0000044063127,0.00008695316,0.0000020614057,0.00007777731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941385,0.00018893635,0.000044540717,0.00010372316,0.00014125586,0.00010762487],"domain_scores_gemma":[0.99853396,0.00039963907,0.0006183719,0.00007952324,0.00012922294,0.00023921413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000625665,0.0003862416,0.00031067507,0.0010285822,0.0003457875,0.000618411,0.00033046922,0.00040564223,0.0008209019],"category_scores_gemma":[0.002205028,0.00024130501,0.0003291844,0.0014984509,0.00066500256,0.00024087496,0.0003798503,0.0005777461,0.00013076606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086172404,0.000010617997,0.9977889,0.0000057101665,0.000025877276,0.00032120824,0.00010648759,0.00006092598,0.0006351595,0.000022505756,0.000035604233,0.00090092764],"study_design_scores_gemma":[0.0000057788498,0.000070858965,0.9979652,0.000010471962,0.000035025085,0.0010519894,0.0002698247,0.00014588234,0.00022773519,0.000023318835,0.00019058569,0.0000033948786],"about_ca_topic_score_codex":0.035116762,"about_ca_topic_score_gemma":0.018049499,"teacher_disagreement_score":0.035116762,"about_ca_system_score_codex":0.0005259602,"about_ca_system_score_gemma":0.0007567129,"threshold_uncertainty_score":0.069824696},"labels":[],"label_agreement":null},{"id":"W2035965846","doi":"10.1016/j.clpt.2003.10.007","title":"Systemic Exposure to Morphine and the Risk of Acute Chest Syndrome in Sickle Cell Disease","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Morphine; Acute chest syndrome; Anesthesia; Placebo; Pharmacokinetics; Vaso-occlusive crisis; Area under the curve; Internal medicine; Gastroenterology; Disease; Sickle cell anemia; Pathology","score_opus":0.021496873292248263,"score_gpt":0.3346842541764396,"score_spread":0.31318738088419135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035965846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967693,0.0028171206,0.00013173548,0.00006558326,0.0000102608565,0.000046645593,0.00005397002,0.000002997149,0.000102471226],"genre_scores_gemma":[0.99876875,0.00076632923,0.00021731325,0.000051536786,0.00004048013,0.00004773912,0.000056995235,9.254601e-7,0.000049895843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992924,0.0004386227,0.00005075935,0.0000695002,0.00010086023,0.000047840596],"domain_scores_gemma":[0.9974421,0.0011828756,0.00087593053,0.00005857857,0.000058024732,0.00038245996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001490945,0.00023855081,0.0006583955,0.00014922814,0.000120633646,0.00027432753,0.00017941913,0.00046508052,0.001129501],"category_scores_gemma":[0.0025043634,0.00013094673,0.00043370738,0.00015586698,0.00042680267,0.0001576574,0.00022046147,0.00049127254,0.000057035915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3219747,0.0038527856,0.53553367,0.002410092,0.004065256,0.00041956778,0.0002229062,0.0017075702,0.02256959,0.00020351495,0.00056296174,0.10647737],"study_design_scores_gemma":[0.030455168,0.17597023,0.7839047,0.00016569703,0.0019525883,0.00089439924,0.000086723325,0.0014972627,0.003730113,0.00019772287,0.0011161391,0.000029206203],"about_ca_topic_score_codex":0.00018912555,"about_ca_topic_score_gemma":0.00018867543,"teacher_disagreement_score":0.001490945,"about_ca_system_score_codex":0.000186351,"about_ca_system_score_gemma":0.00031307456,"threshold_uncertainty_score":0.007884979},"labels":[],"label_agreement":null},{"id":"W2036035346","doi":"10.1038/sj.clpt.6100420","title":"Heterologous Prime–Boost Strategy to Immunize Very Young Infants against Measles: Pre-clinical Studies in Rhesus Macaques","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); McGill University","funders":"Centers for Disease Control and Prevention; Johns Hopkins University; Bill and Melinda Gates Foundation","keywords":"Measles; Medicine; Virology; Viremia; Immunology; Vaccination; Rubella; Measles vaccine; DNA vaccination; Immunization; Measles virus; Virus; Antibody","score_opus":0.24621565727239472,"score_gpt":0.5503746806888755,"score_spread":0.3041590234164808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036035346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973348,0.0006520709,0.00098825,0.00014263125,0.000036412555,0.00022623147,0.00006251871,0.000035721085,0.0005213489],"genre_scores_gemma":[0.994632,0.00096104323,0.0025625485,0.0001359665,0.000059377337,0.00027898836,0.00022147535,0.000015488971,0.001133024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998005,0.0000902694,0.000010002651,0.000030565323,0.000018116316,0.000050583552],"domain_scores_gemma":[0.99976605,0.000052839136,0.000028914827,0.000043680742,0.000026076917,0.00008236658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084827066,0.0004509808,0.00057486206,0.00022451096,0.00026369852,0.00031013618,0.000448027,0.00042898822,0.0011098783],"category_scores_gemma":[0.00054653897,0.00017850689,0.0002506662,0.00010602197,0.0006215551,0.00030223976,0.00018230367,0.0010624268,0.00029495824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013696462,0.016642725,0.0034257683,0.0004638922,0.000103299484,0.00046889787,0.00075413566,0.0004987,0.916521,0.00055613107,0.00068765786,0.04618141],"study_design_scores_gemma":[0.0045870678,0.49906227,0.02397512,0.000058703932,0.0003219781,0.0019008932,0.00032523798,0.001339756,0.45710894,0.00038454376,0.010901994,0.00003340409],"about_ca_topic_score_codex":0.0011033235,"about_ca_topic_score_gemma":0.0016460998,"teacher_disagreement_score":0.0011098783,"about_ca_system_score_codex":0.00027714967,"about_ca_system_score_gemma":0.00050231925,"threshold_uncertainty_score":0.004486084},"labels":[],"label_agreement":null},{"id":"W2036297146","doi":"10.1038/sj.clpt.6100064","title":"Safety and Pharmacokinetics of Paracetamol Following Intravenous Administration of 5 g During the First 24 h with a 2-g Starting Dose","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Pharmacokinetics; Cmin; Cmax; Medicine; Pharmacology; Analgesic; Anesthesia; Intravenous Infusions; Adverse effect","score_opus":0.12490080159705448,"score_gpt":0.45394046447457537,"score_spread":0.3290396628775209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036297146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811506,0.00062056415,0.0007399132,0.000021406453,0.000008542285,0.000079953505,0.00008921117,0.00003169255,0.0002936388],"genre_scores_gemma":[0.9984237,0.00026972246,0.0005309543,0.00006264286,0.000025921338,0.0000918067,0.00015635503,0.000008852077,0.000429969],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99959594,0.00019772281,0.000015846052,0.000071226794,0.000077424345,0.000041877865],"domain_scores_gemma":[0.9995054,0.00011177435,0.00019858396,0.000067800516,0.00005485927,0.00006156399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034494675,0.00043776675,0.00075297384,0.0001426496,0.0001904175,0.0003630271,0.00020801972,0.0004478799,0.0009074196],"category_scores_gemma":[0.0009895316,0.00024144932,0.00027689637,0.00014917877,0.0004288371,0.0002504235,0.00011956107,0.0005434736,0.00038268242],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1573732,0.0060495483,0.040704515,0.00038715865,0.00037677074,0.0010999567,0.00061306875,0.0030545075,0.6631735,0.00019312288,0.0008828282,0.12609178],"study_design_scores_gemma":[0.0064357906,0.48988453,0.32711005,0.000071768736,0.00039477478,0.0030987985,0.00033405924,0.0060851104,0.16267714,0.00021934963,0.003604351,0.0000842728],"about_ca_topic_score_codex":0.0005763128,"about_ca_topic_score_gemma":0.00070039596,"teacher_disagreement_score":0.0009074196,"about_ca_system_score_codex":0.00029854052,"about_ca_system_score_gemma":0.00040247507,"threshold_uncertainty_score":0.003035605},"labels":[],"label_agreement":null},{"id":"W2036706177","doi":"10.1038/sj.clpt.6100180","title":"Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Niacin; Medicine; Vasodilation; Antagonist; Pharmacology; Prostaglandin D2; Dyslipidemia; Receptor antagonist; B vitamins; Internal medicine; Endocrinology; Prostaglandin; Receptor","score_opus":0.08715680268425512,"score_gpt":0.43417695683385404,"score_spread":0.3470201541495989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036706177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98062897,0.013656581,0.0015688908,0.00044679496,0.00008139767,0.00029211602,0.00018551192,0.000074556214,0.0030652587],"genre_scores_gemma":[0.9917589,0.004616388,0.0014841045,0.00021060485,0.00011683812,0.00010737796,0.00025311703,0.0000045086686,0.0014481737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998921,0.00005692596,0.000007758986,0.000011352946,0.000017153965,0.00001462815],"domain_scores_gemma":[0.99990106,0.00002993036,0.00003389672,0.0000059227505,0.000008884262,0.00002026905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023012045,0.00016968268,0.00042126578,0.000096653464,0.00008222769,0.00015414099,0.00021487093,0.00021893838,0.0026553127],"category_scores_gemma":[0.0003341177,0.000058154346,0.0001192426,0.00007812779,0.00015338708,0.00013717951,0.0000943751,0.00066511857,0.00033743487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0407191,0.00751736,0.0049926843,0.001526313,0.00028992162,0.0005935746,0.00011909276,0.00029493103,0.5847198,0.00028177656,0.0019422845,0.35700327],"study_design_scores_gemma":[0.04783748,0.4114026,0.14532815,0.00032125917,0.0009920996,0.008430011,0.00034591934,0.004128635,0.3404861,0.00038744413,0.04027815,0.00006214973],"about_ca_topic_score_codex":0.00026441427,"about_ca_topic_score_gemma":0.000987352,"teacher_disagreement_score":0.0026553127,"about_ca_system_score_codex":0.00010856368,"about_ca_system_score_gemma":0.00014540473,"threshold_uncertainty_score":0.00888294},"labels":[],"label_agreement":null},{"id":"W2036939467","doi":"10.1002/cpt.8","title":"Advances, Nuances, and Potential Pitfalls When Exploiting the Therapeutic Potential of RNA Interference","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"RNA interference; Biology; Computational biology; Gene; Function (biology); Bioinformatics; Genetics; RNA","score_opus":0.11238987638161706,"score_gpt":0.4289310045970634,"score_spread":0.31654112821544633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036939467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105871215,0.996412,0.00047824846,0.0015411004,0.0002920022,0.0000033958718,0.0000068017353,0.000009510543,0.0011511112],"genre_scores_gemma":[0.00097551045,0.9964233,0.0006785616,0.00082076323,0.00039627095,0.000008950967,0.000010220347,0.0000036905772,0.0006827852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942446,0.0001527416,0.00007790282,0.000077908764,0.00022860669,0.000038394453],"domain_scores_gemma":[0.9985966,0.001023108,0.000085128224,0.000041775435,0.00018972543,0.0000635854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022232144,0.0007382217,0.0015180382,0.0019251956,0.00047978244,0.0017534314,0.0011973954,0.0018956792,0.0021731176],"category_scores_gemma":[0.0015127611,0.00033029218,0.0005555244,0.0014684176,0.0017995473,0.003140139,0.0010267107,0.004684941,0.0015537773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005437553,0.000055747623,0.00015963122,0.011107672,0.00006689504,0.000623338,0.00022329671,0.0005432507,0.0033238607,0.03171547,0.027664626,0.9244618],"study_design_scores_gemma":[0.000007762925,0.00006511941,0.00022150326,0.0016387132,0.000032497832,0.0016221874,0.000104035316,0.00012147833,0.0006254311,0.010150911,0.98538893,0.000021312213],"about_ca_topic_score_codex":0.00081789267,"about_ca_topic_score_gemma":0.0020328648,"teacher_disagreement_score":0.0022232144,"about_ca_system_score_codex":0.0011071723,"about_ca_system_score_gemma":0.0011498441,"threshold_uncertainty_score":0.011757612},"labels":[],"label_agreement":null},{"id":"W2039185379","doi":"10.1038/clpt.2014.126","title":"Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Glucuronosyltransferase; Uridine; Pharmacogenomics; Clinical pharmacology; Uridine diphosphate; Pharmacology; Drug metabolism; Xenobiotic; Pharmacogenetics; Drug; Chemistry; Computational biology; Enzyme; Biochemistry; Biology; RNA; Gene; Microsome","score_opus":0.2620271041099431,"score_gpt":0.5475852774856149,"score_spread":0.2855581733756718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039185379","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91066015,0.05303916,0.017302435,0.004015157,0.000103035425,0.00014226539,0.0037498008,0.00013907866,0.010849002],"genre_scores_gemma":[0.9895465,0.004788333,0.002717899,0.00068935595,0.00008805329,0.00003127498,0.0009334576,0.00002609342,0.0011791989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989454,0.0005519797,0.0000442866,0.00019538766,0.00022005098,0.000042876178],"domain_scores_gemma":[0.9990522,0.00048433366,0.00019774385,0.000080647165,0.00013953558,0.000045544064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001693504,0.00021634325,0.00046653685,0.0005933984,0.000113485476,0.00087929075,0.00018041051,0.0005127256,0.001113279],"category_scores_gemma":[0.002938448,0.0001221124,0.00025683618,0.00095595635,0.00033512898,0.00017058285,0.0002078932,0.00039656047,0.000284703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045676366,0.00041687742,0.3968137,0.00047981244,0.000999644,0.0014109815,0.0002626694,0.003564526,0.11452566,0.004478637,0.0036179256,0.46886197],"study_design_scores_gemma":[0.00019623945,0.0026640743,0.87282115,0.00010248568,0.0010922105,0.0058346074,0.00019029087,0.007825171,0.06947675,0.006828875,0.032923024,0.000045144152],"about_ca_topic_score_codex":0.0007337557,"about_ca_topic_score_gemma":0.00052315526,"teacher_disagreement_score":0.001693504,"about_ca_system_score_codex":0.00039266737,"about_ca_system_score_gemma":0.00050472165,"threshold_uncertainty_score":0.008956194},"labels":[],"label_agreement":null},{"id":"W2040550914","doi":"10.1038/sj.clpt.6100087","title":"The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institute of General Medical Sciences; National Institute on Drug Abuse; Wellcome Trust","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Addiction; Clinical pharmacology; Pharmacology; Medicine; Drug; Disease; Informatics; Bioinformatics; Computational biology; Biology; Psychiatry; Genetics; Genotype; Internal medicine; Gene","score_opus":0.7589401969495758,"score_gpt":0.7016421437167268,"score_spread":0.05729805323284898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040550914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023403714,0.9887291,0.001976816,0.004196243,0.0005064614,0.000025573518,0.000120759345,0.00007260248,0.00413843],"genre_scores_gemma":[0.0016053584,0.9912888,0.0031943542,0.0014629235,0.0006054563,0.000048707454,0.00020053361,0.000010746035,0.001583081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878234,0.0005497104,0.000105745436,0.00015082714,0.00034881773,0.000062555024],"domain_scores_gemma":[0.99772805,0.0014690658,0.00022623761,0.00006606299,0.00036309395,0.0001475016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030488407,0.0010535135,0.0018968469,0.003764357,0.00024457744,0.0017380385,0.0017217302,0.002088177,0.005136028],"category_scores_gemma":[0.0035995971,0.0004199184,0.0005925701,0.0047575296,0.0006904148,0.001688249,0.0011353694,0.0021452785,0.004444593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065270375,0.000036336194,0.0003692839,0.003851654,0.00011324862,0.00019580692,0.00004268103,0.00048038308,0.0004438584,0.004763514,0.039278064,0.9503599],"study_design_scores_gemma":[0.00006817211,0.0001312649,0.0024034039,0.006794834,0.00020720721,0.0014949042,0.00008174912,0.0006161747,0.0008438697,0.014958547,0.9723591,0.000040862305],"about_ca_topic_score_codex":0.002390316,"about_ca_topic_score_gemma":0.003505407,"teacher_disagreement_score":0.005136028,"about_ca_system_score_codex":0.0017690582,"about_ca_system_score_gemma":0.0028305089,"threshold_uncertainty_score":0.017181754},"labels":[],"label_agreement":null},{"id":"W2040739081","doi":"10.1038/clpt.2009.133","title":"Predicting Age-Specific Dosing of Antipsychotics","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Baycrest Hospital; Centre for Addiction and Mental Health","funders":"","keywords":"Dosing; Tolerability; Medicine; Antipsychotic; Schizophrenia (object-oriented programming); Intensive care medicine; Psychiatry; Pharmacology; Adverse effect","score_opus":0.16210272986398147,"score_gpt":0.472307894345333,"score_spread":0.3102051644813515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040739081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97450477,0.0049684853,0.008975046,0.00054927345,0.00015311691,0.00007678603,0.003642114,0.0001341967,0.006996351],"genre_scores_gemma":[0.98951834,0.0014707594,0.006034661,0.00018649794,0.00011410419,0.000025627833,0.0019658802,0.000025531108,0.00065873296],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99930763,0.00023753985,0.00013768574,0.00012708845,0.00014103841,0.000048995942],"domain_scores_gemma":[0.9915131,0.0030731605,0.0029898938,0.00042928068,0.0015533214,0.00044121043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014670904,0.00051213364,0.00052349665,0.0008957069,0.00015614618,0.0006238751,0.00027937788,0.00066377985,0.0018377607],"category_scores_gemma":[0.01830988,0.00020875389,0.00044704537,0.0006034404,0.00007362581,0.0007353671,0.00032167352,0.0007114252,0.0010757195],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037778637,0.000051735395,0.97311133,0.000036219564,0.00009358407,0.000085952546,0.00004721229,0.0015997681,0.0005449268,0.000120488854,0.0010811511,0.02284977],"study_design_scores_gemma":[0.000029460449,0.00064123055,0.96436775,0.000072155846,0.00030386684,0.0018545068,0.00018137417,0.024980638,0.0021162678,0.0010274077,0.0043926556,0.00003258699],"about_ca_topic_score_codex":0.0024110223,"about_ca_topic_score_gemma":0.002692024,"teacher_disagreement_score":0.0024110223,"about_ca_system_score_codex":0.00032264713,"about_ca_system_score_gemma":0.00028005766,"threshold_uncertainty_score":0.007758856},"labels":[],"label_agreement":null},{"id":"W2043372450","doi":"10.1038/clpt.2013.99","title":"Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Atrial fibrillation; Meta-analysis; Vitamin k; Confidence interval; Major bleeding; Stroke (engine); Internal medicine; Cardiology","score_opus":0.3448723857089284,"score_gpt":0.5164024024212439,"score_spread":0.1715300167123155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043372450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033207855,0.99557245,0.0002743672,0.0001141832,0.00006904076,0.00013724662,0.00032575295,0.0000133334315,0.00017294339],"genre_scores_gemma":[0.081885435,0.91538507,0.0012596041,0.00034572696,0.00010938809,0.000368917,0.00043201348,0.000010003139,0.00020385408],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968297,0.0013748463,0.0009567971,0.00033166705,0.00039454107,0.0001124086],"domain_scores_gemma":[0.9918173,0.0060378807,0.0011497936,0.00016724301,0.0007152455,0.00011261237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057942797,0.0021775123,0.012879578,0.0044464753,0.00049641455,0.0018226304,0.0013634806,0.0015452339,0.0028636847],"category_scores_gemma":[0.016836435,0.00123706,0.021245256,0.005081276,0.00041926306,0.001043144,0.0010300183,0.0012605236,0.0002363942],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017361103,0.000034432825,0.004131746,0.49432242,0.4706565,0.00019016836,0.00008800222,0.00057185197,0.0002838355,0.00014663406,0.0012197437,0.026618585],"study_design_scores_gemma":[0.0004811475,0.00016969454,0.0031748575,0.02746182,0.96604997,0.00017517542,0.000036751906,0.00016839034,0.00013672619,0.00015372863,0.0019706653,0.000021115071],"about_ca_topic_score_codex":0.006169936,"about_ca_topic_score_gemma":0.017707553,"teacher_disagreement_score":0.012879578,"about_ca_system_score_codex":0.0017509317,"about_ca_system_score_gemma":0.002437855,"threshold_uncertainty_score":0.030643463},"labels":[],"label_agreement":null},{"id":"W2045148891","doi":"10.1038/clpt.2011.10","title":"The Value and Benefits of the International Conference on Harmonisation to Drug Regulatory Authorities: Advancing Harmonization for Better Public Health","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Harmonization; Public health; Drug approval; Drug; Value (mathematics); Business; Pharmacology; Medicine; Environmental health; Public administration; Political science; Computer science","score_opus":0.35828282244946014,"score_gpt":0.40471093666152846,"score_spread":0.04642811421206833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045148891","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014913885,0.023601146,0.032499395,0.84078646,0.01974906,0.0006532304,0.00043271077,0.0003741433,0.08041254],"genre_scores_gemma":[0.16415417,0.062121954,0.16302794,0.50801533,0.06308124,0.0028117273,0.0018932503,0.0011309966,0.03376344],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.5936784,0.244969,0.026204092,0.010327342,0.11826684,0.006554352],"domain_scores_gemma":[0.40195382,0.31152064,0.038481813,0.066446416,0.15953499,0.022062387],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.34531003,0.0014843435,0.00376384,0.006715829,0.0060607926,0.029031813,0.00491821,0.020875579,0.01362197],"category_scores_gemma":[0.52033615,0.0013293587,0.002838443,0.0076422854,0.01980145,0.025553754,0.0159758,0.025427764,0.005974638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027022665,0.0001420896,0.0012183612,0.0012110868,0.00018301092,0.00020332656,0.00090932264,0.0012734358,0.0003199363,0.48634428,0.36679572,0.14112926],"study_design_scores_gemma":[0.00019360236,0.00030636715,0.0043063844,0.0027403943,0.00013916571,0.00034978817,0.00064641057,0.0013964626,0.00057823857,0.22719271,0.7619518,0.00019856889],"about_ca_topic_score_codex":0.004767754,"about_ca_topic_score_gemma":0.0036960247,"teacher_disagreement_score":0.34531003,"about_ca_system_score_codex":0.0122982375,"about_ca_system_score_gemma":0.059545785,"threshold_uncertainty_score":0.8073493},"labels":[],"label_agreement":null},{"id":"W2045567622","doi":"10.1067/mcp.2002.121152","title":"Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":606,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences","keywords":"Grapefruit juice; Fexofenadine; Chemistry; Pharmacokinetics; Organic anion-transporting polypeptide; Pharmacology; Organic anion transporter 1; Aspartame; Food science; Crossover study; Terfenadine; Oral administration; Biochemistry; Transporter; Medicine","score_opus":0.08481314750014701,"score_gpt":0.3684336159384128,"score_spread":0.28362046843826577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045567622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938985,0.0049109817,0.00042924634,0.0000890398,0.000027998252,0.00005547303,0.000105792664,0.000035543188,0.00044742427],"genre_scores_gemma":[0.9958449,0.0018085575,0.0011616413,0.000079488236,0.000024196395,0.000025827425,0.00016217702,0.000011581977,0.0008816488],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998864,0.000034222005,0.000006818283,0.000027866163,0.000025975409,0.000018781197],"domain_scores_gemma":[0.99990475,0.000029634966,0.000027191849,0.0000051317725,0.000012996102,0.000020298918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018660312,0.0003907005,0.00039642514,0.00016963592,0.00015100017,0.00025675565,0.00016787526,0.00033999488,0.0023212028],"category_scores_gemma":[0.00036709156,0.00013752423,0.00028863506,0.00012188484,0.000191202,0.0002838119,0.0001348897,0.0004518554,0.00016236395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008761873,0.00086885324,0.003053674,0.0004086739,0.00015218182,0.00012070669,0.00011179823,0.00014143973,0.96555793,0.000059673108,0.00032739277,0.020435864],"study_design_scores_gemma":[0.002495285,0.047879007,0.14563926,0.00010566068,0.00062275666,0.0011178522,0.00029742587,0.0023665968,0.78719664,0.00015911728,0.012081005,0.00003942085],"about_ca_topic_score_codex":0.0007184052,"about_ca_topic_score_gemma":0.0014261445,"teacher_disagreement_score":0.0023212028,"about_ca_system_score_codex":0.00023477785,"about_ca_system_score_gemma":0.00015807722,"threshold_uncertainty_score":0.0077652335},"labels":[],"label_agreement":null},{"id":"W2046426458","doi":"10.1038/clpt.2011.345","title":"Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Health Canada","funders":"","keywords":"Transformative learning; Legislature; Clinical pharmacology; Engineering ethics; Action (physics); Drug approval; Management science; Computer science; Risk analysis (engineering); Medicine; Psychology; Political science; Drug; Pharmacology; Law; Engineering","score_opus":0.7984869042927707,"score_gpt":0.5808708196287621,"score_spread":0.2176160846640086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046426458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01761619,0.37659153,0.19873397,0.2655022,0.003293186,0.00046266333,0.00009550128,0.00036994202,0.13733481],"genre_scores_gemma":[0.59200656,0.23322226,0.1027753,0.054113384,0.0036937403,0.0005917455,0.00009514368,0.00016829204,0.013333536],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9815502,0.0119871795,0.000801342,0.0014799241,0.0034471818,0.00073418184],"domain_scores_gemma":[0.9681649,0.02566168,0.0017641606,0.0017688406,0.0020641864,0.00057624467],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03175149,0.00057803746,0.0011343786,0.0019066755,0.0011887861,0.00665808,0.0024789942,0.0078486595,0.003643521],"category_scores_gemma":[0.0435963,0.0005316693,0.00096713385,0.002019969,0.012947215,0.0183169,0.004023141,0.009599935,0.0007944502],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006953584,0.000056278554,0.00048048282,0.0012067581,0.000043764085,0.00014206594,0.0006720496,0.0017578172,0.00036383414,0.776765,0.003877224,0.21456526],"study_design_scores_gemma":[0.00009118562,0.00019046085,0.00094508944,0.0025447535,0.00006283896,0.00043646555,0.0005061947,0.0030644767,0.0009794437,0.73608005,0.25502145,0.00007750523],"about_ca_topic_score_codex":0.0015021675,"about_ca_topic_score_gemma":0.0016872165,"teacher_disagreement_score":0.9682485,"about_ca_system_score_codex":0.005158853,"about_ca_system_score_gemma":0.008720848,"threshold_uncertainty_score":0.16792},"labels":[],"label_agreement":null},{"id":"W2047284784","doi":"10.1038/clpt.2012.112","title":"Ammonia-Lowering Strategies for the Treatment of Hepatic Encephalopathy","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Saint-Luc","funders":"","keywords":"Hyperammonemia; Ammonia; Hepatic encephalopathy; Glutamine; Context (archaeology); Glutaminase; Chemistry; Biochemistry; Glutamine synthetase; Pharmacology; Medicine; Internal medicine; Biology; Amino acid","score_opus":0.29207939716270587,"score_gpt":0.5116914126780111,"score_spread":0.21961201551530524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047284784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003102491,0.99813783,0.00014563538,0.00019008949,0.000104286184,0.000008436485,0.000013136641,0.000008065689,0.0010822954],"genre_scores_gemma":[0.0016863509,0.9969637,0.00034233107,0.00019088386,0.000120662844,0.000013044929,0.00003453924,0.000001794144,0.0006467335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989843,0.000020224918,0.000014316946,0.000014847257,0.00004088153,0.000011254896],"domain_scores_gemma":[0.99989617,0.00004216346,0.000021236374,0.000003162257,0.000025316362,0.000011980142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031124428,0.00068492716,0.0011561303,0.0020109382,0.00023803824,0.00056707725,0.00067341287,0.00085250865,0.0038054124],"category_scores_gemma":[0.00032586613,0.00017666224,0.0005532491,0.0012421646,0.0002934243,0.00069241034,0.0004650366,0.0018867025,0.001977408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010463881,0.0002170585,0.00013165992,0.009962206,0.00010054737,0.00039477757,0.00005506584,0.0003145672,0.0028217826,0.0019829348,0.014519552,0.9693952],"study_design_scores_gemma":[0.00012322358,0.0004245916,0.0018764604,0.004382758,0.00021698946,0.0043341997,0.00008491151,0.00022914546,0.0015979107,0.002652946,0.9840464,0.000030409123],"about_ca_topic_score_codex":0.0007156334,"about_ca_topic_score_gemma":0.0019352176,"teacher_disagreement_score":0.0038054124,"about_ca_system_score_codex":0.00033791934,"about_ca_system_score_gemma":0.0004449191,"threshold_uncertainty_score":0.0127303},"labels":[],"label_agreement":null},{"id":"W2047398257","doi":"10.1016/j.clpt.2005.06.005","title":"Cytochrome P450 2C9 genotype: Impact on celecoxib safety and pharmacokinetics in a pediatric patient","year":2005,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical pharmacology; Associate editor; Internal medicine; Family medicine; Oncology; Pharmacology; Library science","score_opus":0.13295563203773855,"score_gpt":0.48423952665964093,"score_spread":0.35128389462190235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047398257","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4046192,0.005383877,0.0011120816,0.5569245,0.005614469,0.000048598657,0.000889443,0.00020536226,0.025202455],"genre_scores_gemma":[0.795347,0.0051334514,0.0016284221,0.1720855,0.013758412,0.000051206596,0.0003944109,0.00009735141,0.011504297],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99958855,0.000108219174,0.00006433174,0.000064109234,0.00009268392,0.000082084276],"domain_scores_gemma":[0.99872416,0.0006866853,0.00018051351,0.000029091783,0.000121706325,0.00025791756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003745938,0.00042029427,0.0010143033,0.00028500528,0.0007075516,0.00076601934,0.0004075972,0.0058678165,0.0025587257],"category_scores_gemma":[0.004079151,0.0002722488,0.00072994287,0.0004889714,0.0005512604,0.00059479504,0.00022520195,0.00498466,0.00061192416],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012207559,0.00033046445,0.16121477,0.00016172194,0.00020669034,0.5814129,0.00089279364,0.00095876417,0.0042867255,0.0028211912,0.19483487,0.0516584],"study_design_scores_gemma":[0.00075616967,0.002108972,0.18997292,0.00038391995,0.00067449996,0.6617491,0.0017932269,0.0054295897,0.0046856524,0.004201225,0.12810631,0.00013844046],"about_ca_topic_score_codex":0.0059224195,"about_ca_topic_score_gemma":0.01035931,"teacher_disagreement_score":0.0059224195,"about_ca_system_score_codex":0.0016032609,"about_ca_system_score_gemma":0.0012495304,"threshold_uncertainty_score":0.011775851},"labels":[],"label_agreement":null},{"id":"W2047641559","doi":"10.1002/cpt.111","title":"Young brains on cannabis: It's time to clear the smoke","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Canadian Centre on Substance Use and Addiction","funders":"","keywords":"Cannabis; Smoke; Illicit drug; Substance use; Psychology; Psychiatry; Medicine; Criminology; Drug; Geography","score_opus":0.16843819352847555,"score_gpt":0.47534360627246,"score_spread":0.3069054127439844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047641559","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05172314,0.20965071,0.0010627283,0.695983,0.009802579,0.00004808003,0.00019576515,0.00015605825,0.031377945],"genre_scores_gemma":[0.34288502,0.350997,0.0033712417,0.26022848,0.00804447,0.00009138283,0.00020658746,0.0002020871,0.033973742],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9990497,0.00034941058,0.00003858966,0.000082198385,0.00025319657,0.00022687476],"domain_scores_gemma":[0.9974074,0.0007911796,0.00029622627,0.00010100347,0.00061983743,0.0007844504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019849015,0.0002615287,0.00067746214,0.0004707548,0.002915237,0.0040958794,0.0005967993,0.0028674502,0.00903031],"category_scores_gemma":[0.0059194416,0.00023228893,0.0004714799,0.00038848436,0.0038448735,0.004668345,0.0018138868,0.005493928,0.0026130949],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007317935,0.0002873525,0.02416121,0.0016036686,0.00016760659,0.0027295533,0.015298794,0.00008042918,0.005205046,0.030181376,0.30372322,0.6158299],"study_design_scores_gemma":[0.0001474663,0.00066873356,0.04114298,0.0065437965,0.00026737328,0.005729186,0.054343756,0.00010827126,0.003724733,0.05980217,0.8273658,0.0001557133],"about_ca_topic_score_codex":0.013181313,"about_ca_topic_score_gemma":0.036111664,"teacher_disagreement_score":0.013181313,"about_ca_system_score_codex":0.0020303947,"about_ca_system_score_gemma":0.0053729657,"threshold_uncertainty_score":0.030209422},"labels":[],"label_agreement":null},{"id":"W2047667596","doi":"10.1016/j.clpt.2003.11.301","title":"Evaluation of herbal products as potential inhibitors of MDR1","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"Pharmacology; Black cohosh; Verapamil; Traditional medicine; Digoxin; Valerian; Phytochemical; Chemistry; Kava; Phytotherapy; Ginseng; Medicine","score_opus":0.2840747636108134,"score_gpt":0.5431562213857632,"score_spread":0.25908145777494984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047667596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96590906,0.026470251,0.0016385604,0.00035170803,0.0001391239,0.0005992788,0.0009828776,0.00007173864,0.0038374714],"genre_scores_gemma":[0.95437,0.03160962,0.006507226,0.00029494718,0.0001463468,0.000399259,0.0013945607,0.000025695677,0.0052523543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998031,0.000058750047,0.000021063403,0.000026223805,0.000061869774,0.000029007762],"domain_scores_gemma":[0.999826,0.000050654886,0.000031274907,0.000010041387,0.000050837192,0.000031217038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035744262,0.00042552463,0.00071385043,0.0007090366,0.00030485707,0.00040261302,0.00032097963,0.00033089038,0.0028322672],"category_scores_gemma":[0.0003443663,0.00019469447,0.000523616,0.0006267623,0.00017184824,0.00031575194,0.00024863702,0.00066725595,0.0002526011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039520264,0.005251572,0.0018278492,0.0025785335,0.00027657862,0.00063036324,0.00018321817,0.000576349,0.9296388,0.0004154246,0.0006799319,0.053989373],"study_design_scores_gemma":[0.0018850247,0.11196163,0.029752426,0.00040778963,0.0017526975,0.0013779185,0.00046521454,0.0025679779,0.80153185,0.00034881505,0.047855612,0.00009308009],"about_ca_topic_score_codex":0.00042707476,"about_ca_topic_score_gemma":0.0013101902,"teacher_disagreement_score":0.0028322672,"about_ca_system_score_codex":0.00016539883,"about_ca_system_score_gemma":0.00030013124,"threshold_uncertainty_score":0.009474874},"labels":[],"label_agreement":null},{"id":"W2048099302","doi":"10.1016/j.clpt.2006.08.011","title":"CYP2A6 genotype and the metabolism and disposition kinetics of nicotine","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Center for Research Resources; National Institute on Drug Abuse","keywords":"CYP2A6; Cotinine; Nicotine; Metabolism; Pharmacology; Endocrinology; Internal medicine; Chemistry; Medicine; Cytochrome P450; CYP1A2","score_opus":0.016639488836465984,"score_gpt":0.33754144905568967,"score_spread":0.3209019602192237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048099302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983979,0.0007201188,0.00027358328,0.000042944557,0.000007603174,0.0000053858357,0.00015119917,0.0000060566304,0.00039526258],"genre_scores_gemma":[0.99919766,0.00015244866,0.00022611774,0.000008847845,0.000011673165,0.0000028391962,0.000106249856,0.000004001847,0.00029011315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984336,0.000058457987,0.000012544544,0.00004107596,0.000028074379,0.000016488611],"domain_scores_gemma":[0.99940753,0.00016513151,0.0002511393,0.000040428487,0.00007129593,0.00006451299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024837593,0.00017918629,0.0001928311,0.0001751851,0.00013558762,0.00024563327,0.000081499034,0.00026461904,0.0019701472],"category_scores_gemma":[0.001163593,0.00009507686,0.00015020533,0.00022924776,0.00009111847,0.00010878763,0.000055988512,0.00022984023,0.00041336636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026459715,0.00011456385,0.97319084,0.000026986669,0.00014851843,0.00026888907,0.00004614852,0.0003063786,0.012794851,0.000085505795,0.00018921669,0.010182157],"study_design_scores_gemma":[0.0000364516,0.0004794268,0.9935249,0.0000042980905,0.000071854476,0.0016966733,0.000019406252,0.000887962,0.0025767393,0.00008282152,0.00061538455,0.0000040469613],"about_ca_topic_score_codex":0.00079931546,"about_ca_topic_score_gemma":0.00062889635,"teacher_disagreement_score":0.0019701472,"about_ca_system_score_codex":0.000105432286,"about_ca_system_score_gemma":0.00006526113,"threshold_uncertainty_score":0.0065907836},"labels":[],"label_agreement":null},{"id":"W2049901733","doi":"10.1038/clpt.2013.159","title":"Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black, and Asian Nonsmokers","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Center for Research Resources; NIH Clinical Center; National Institutes of Health; National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; University of California, San Francisco","keywords":"Nicotine; CYP2A6; Pharmacokinetics; Pharmacology; Cotinine; Medicine; Toxicity; Clinical pharmacology; Physiology; Internal medicine; Metabolism","score_opus":0.024496806444383897,"score_gpt":0.3651095928134981,"score_spread":0.3406127863691142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049901733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997857,0.000029013814,0.000042828102,0.000007825169,0.0000012622776,0.0000021555077,0.00001736878,7.285868e-7,0.000113143586],"genre_scores_gemma":[0.9997067,0.000023426699,0.000059808594,0.000013604703,0.000003194984,0.0000033626122,0.000038360162,0.0000019877232,0.00014939885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997211,0.00010434437,0.000020060195,0.00006453502,0.000048768805,0.00004124061],"domain_scores_gemma":[0.9992592,0.00023190986,0.00023323244,0.0000510539,0.000054003485,0.00017065734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042866936,0.00024321313,0.0002081715,0.0004284612,0.00025524772,0.00025271386,0.0001498264,0.0003236234,0.0012355314],"category_scores_gemma":[0.0012978096,0.00020854658,0.00022491248,0.00023110241,0.00025093686,0.00016718773,0.00016542233,0.00032047083,0.00021945794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059489603,0.00019151729,0.9897713,0.0000060052316,0.00008198036,0.00020394688,0.0002940913,0.000033741937,0.0067428234,0.000033462213,0.000030239504,0.002015985],"study_design_scores_gemma":[0.0000066245684,0.00025011293,0.99879265,0.0000012972309,0.000020760604,0.00035902765,0.00013391321,0.00014514616,0.00021387928,0.000022704655,0.00005168672,0.0000021825308],"about_ca_topic_score_codex":0.0022852742,"about_ca_topic_score_gemma":0.002064796,"teacher_disagreement_score":0.0022852742,"about_ca_system_score_codex":0.00011586199,"about_ca_system_score_gemma":0.000100776444,"threshold_uncertainty_score":0.0045440197},"labels":[],"label_agreement":null},{"id":"W2050094658","doi":"10.1038/clpt.2008.59","title":"Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism and Transport","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Drug metabolism; Kidney disease; Transporter; Medicine; Drug; Kidney; Disease; Metabolism; Pharmacology; Renal function; Gastrointestinal tract; Efflux; Liver disease; Internal medicine; Biology; Biochemistry","score_opus":0.1333107435689933,"score_gpt":0.48076003684806873,"score_spread":0.3474492932790754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050094658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001757748,0.99852496,0.00010795062,0.00029539922,0.000083278675,0.0000010856356,0.00000847321,0.000004529443,0.0007985147],"genre_scores_gemma":[0.00092943857,0.99852353,0.0001084803,0.0001413706,0.000093181305,0.0000013524174,0.000010247163,6.174711e-7,0.00019180014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997235,0.000054196713,0.000034616394,0.000050600203,0.00011402182,0.000023094351],"domain_scores_gemma":[0.999076,0.0005548492,0.00011847031,0.000026784748,0.00017760262,0.00004622542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088988076,0.0006881882,0.0017812033,0.0017796287,0.0001940238,0.0010721484,0.0007599392,0.0011412003,0.0041487],"category_scores_gemma":[0.0009692352,0.00024595644,0.00050069246,0.0025711847,0.00063201546,0.0014754097,0.000685753,0.0013021444,0.0018310229],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098483906,0.000059722744,0.0005733019,0.016989367,0.00016380918,0.00044381924,0.00006019976,0.000534206,0.002720067,0.0037270943,0.013248195,0.9613817],"study_design_scores_gemma":[0.000027265329,0.00018398806,0.003757907,0.00464326,0.00028937825,0.003058633,0.0001798702,0.00022206028,0.0014265372,0.005365167,0.9808142,0.000031714655],"about_ca_topic_score_codex":0.0011356403,"about_ca_topic_score_gemma":0.0018204369,"teacher_disagreement_score":0.0041487,"about_ca_system_score_codex":0.0006171871,"about_ca_system_score_gemma":0.001036604,"threshold_uncertainty_score":0.013878763},"labels":[],"label_agreement":null},{"id":"W2050701148","doi":"10.1038/clpt.2011.334","title":"PhRMA Survey of Pharmacogenomic and Pharmacodynamic Evaluations: What Next?","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada","funders":"","keywords":"Pharmacogenomics; Pharmacodynamics; Clinical pharmacology; Pharmaceutical industry; Drug development; Pharmacology; Drug; Medicine; Pharmacokinetics","score_opus":0.47578842760430606,"score_gpt":0.5873528190965384,"score_spread":0.1115643914922323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050701148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8093011,0.018791687,0.039166078,0.07315783,0.00062815816,0.002140996,0.023472568,0.0015951621,0.031746447],"genre_scores_gemma":[0.92684907,0.01270891,0.027236253,0.01818013,0.0007086713,0.0013656303,0.010035911,0.00017043344,0.0027449934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95031226,0.023687365,0.008926786,0.0023594848,0.013252453,0.0014616421],"domain_scores_gemma":[0.80928904,0.07557716,0.042134963,0.013738224,0.05305508,0.006205554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.063988134,0.0003688366,0.0009892955,0.005166091,0.00055273913,0.0025034975,0.0010657137,0.0012190035,0.0025923674],"category_scores_gemma":[0.114008814,0.00032674344,0.0009121382,0.006127042,0.00079431175,0.003341374,0.0021315718,0.0011367383,0.0014122315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028398406,0.00024061142,0.6891804,0.000995815,0.00022718614,0.00019734135,0.0010709763,0.00041139117,0.0018414481,0.0010701079,0.019031072,0.2854496],"study_design_scores_gemma":[0.000033557793,0.0010736277,0.9162489,0.0005587621,0.00012187341,0.0009472807,0.0026871657,0.0012734126,0.0016996632,0.0009584697,0.07432076,0.00007645534],"about_ca_topic_score_codex":0.0029267026,"about_ca_topic_score_gemma":0.0023756442,"teacher_disagreement_score":0.063988134,"about_ca_system_score_codex":0.0012013968,"about_ca_system_score_gemma":0.003045923,"threshold_uncertainty_score":0.33840567},"labels":[],"label_agreement":null},{"id":"W2051146972","doi":"10.1038/clpt.2014.90","title":"Response to “Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity”","year":2014,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Columbia university; Medicine; Family medicine; Library science; Media studies; Sociology","score_opus":0.10528048524803607,"score_gpt":0.4159134253206307,"score_spread":0.3106329400725946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051146972","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015065575,0.000566722,0.00021709668,0.9831844,0.012006651,0.000043086417,0.00016949173,0.000042198077,0.0022637567],"genre_scores_gemma":[0.007262257,0.00042206753,0.0004716197,0.97124535,0.016561048,0.00008386354,0.000074229145,0.00001908239,0.003860459],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739575,0.00088510936,0.00031723472,0.0003740369,0.0006374312,0.0003905038],"domain_scores_gemma":[0.99417096,0.003144818,0.00046542884,0.00023411134,0.0012547065,0.00072998775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027286082,0.00081551867,0.0016080184,0.00062629627,0.002152237,0.0027018546,0.0016593144,0.03214202,0.0038625873],"category_scores_gemma":[0.02161121,0.00052368204,0.001339341,0.00068706664,0.0018664615,0.0016510339,0.0010474354,0.021905344,0.0037473463],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000594301,0.00022986077,0.0042193243,0.00008871224,0.00009329124,0.0059680175,0.000116806485,0.00038210955,0.0006939444,0.0021870036,0.9650374,0.020389203],"study_design_scores_gemma":[0.0014160979,0.0010957418,0.010393497,0.0005362746,0.00030217966,0.010098274,0.00086944783,0.0051999954,0.0028771325,0.017560333,0.94938284,0.0002682899],"about_ca_topic_score_codex":0.0036557487,"about_ca_topic_score_gemma":0.0062671606,"teacher_disagreement_score":0.03214202,"about_ca_system_score_codex":0.0042568925,"about_ca_system_score_gemma":0.0031038607,"threshold_uncertainty_score":0.030886054},"labels":[],"label_agreement":null},{"id":"W2051592959","doi":"10.1038/clpt.2014.124","title":"Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Economic and Social Research Council; Medical Research Council","keywords":"Varenicline; Medicine; Smoking cessation; Placebo; Randomized controlled trial; Pharmacology; Anesthesia; Internal medicine; Alternative medicine","score_opus":0.06995092750868709,"score_gpt":0.4159428427791987,"score_spread":0.3459919152705116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051592959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98519105,0.008378699,0.00048594316,0.00040846592,0.00043912572,0.0033681607,0.00044384756,0.000101578386,0.0011831861],"genre_scores_gemma":[0.98765695,0.0045985132,0.0013433489,0.00059440976,0.00059798587,0.003267272,0.0004037974,0.000011079131,0.0015266711],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99927264,0.00042964917,0.00006492451,0.00010609936,0.00005650764,0.00007023402],"domain_scores_gemma":[0.9993381,0.00024291381,0.00015203696,0.00004740243,0.00004719908,0.00017234699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019340725,0.0007667292,0.0023471855,0.00040728474,0.00044297264,0.000610746,0.0008500038,0.0018250332,0.004158358],"category_scores_gemma":[0.0016837929,0.00049117213,0.001417414,0.0003053332,0.00070110324,0.00056470215,0.0002272047,0.0014769834,0.0005425047],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9642571,0.007906767,0.0005729902,0.0008587,0.0007061628,0.00003905451,0.00004219619,0.00012332751,0.0036712398,0.00006404814,0.00039258233,0.021365829],"study_design_scores_gemma":[0.93095493,0.06573073,0.0019693254,0.0000407552,0.0003680542,0.00002834498,0.00001274758,0.0002124001,0.00033495118,0.000030850657,0.00030946033,0.0000074814693],"about_ca_topic_score_codex":0.00083306996,"about_ca_topic_score_gemma":0.002112419,"teacher_disagreement_score":0.004158358,"about_ca_system_score_codex":0.00044836217,"about_ca_system_score_gemma":0.0007543147,"threshold_uncertainty_score":0.013911068},"labels":[],"label_agreement":null},{"id":"W2051643304","doi":"10.1038/clpt.2013.178","title":"Challenges in Interpreting the Evidence for Genetic Predictors of Ototoxicity","year":2013,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of General Medical Sciences; University of British Columbia; Genome Canada","keywords":"Ototoxicity; Clinical pharmacology; Psychology; Medicine; Pharmacology; Internal medicine; Cisplatin","score_opus":0.4914424834688712,"score_gpt":0.48816098741478975,"score_spread":0.0032814960540814564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051643304","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028758147,0.031649172,0.0031554569,0.93912846,0.01996671,0.000037410417,0.0003784086,0.00007993083,0.0027286077],"genre_scores_gemma":[0.05086797,0.025471432,0.008894455,0.7619322,0.15131125,0.00016342152,0.0002486703,0.00009538568,0.0010152286],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9410139,0.032438297,0.011689725,0.0040763905,0.009781085,0.0010006245],"domain_scores_gemma":[0.46362638,0.48418513,0.013706035,0.008631466,0.027559653,0.002291332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07681199,0.001046466,0.003261372,0.0035632371,0.0021937108,0.005174808,0.0055746255,0.013002235,0.0031644655],"category_scores_gemma":[0.349543,0.0008339878,0.0021613848,0.0028726798,0.008560985,0.007922054,0.002754819,0.023495227,0.003342232],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013313316,0.00025229246,0.06607807,0.004689267,0.0024032672,0.0144802425,0.00219827,0.0010778146,0.0017070777,0.035974987,0.56575555,0.3040519],"study_design_scores_gemma":[0.00092242943,0.0007271378,0.051155582,0.012750385,0.00222585,0.028042505,0.0051811086,0.0056352876,0.0020790163,0.45371634,0.43695363,0.0006107883],"about_ca_topic_score_codex":0.0047811316,"about_ca_topic_score_gemma":0.005256215,"teacher_disagreement_score":0.07681199,"about_ca_system_score_codex":0.0026968394,"about_ca_system_score_gemma":0.0040356256,"threshold_uncertainty_score":0.4062255},"labels":[],"label_agreement":null},{"id":"W2052080148","doi":"10.1038/clpt.2010.67","title":"Subjective and Objective Effects of the Novel Triple Reuptake Inhibitor Tesofensine in Recreational Stimulant Users","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Kensington Health","funders":"","keywords":"Atomoxetine; Bupropion; Stimulant; Amphetamine; Placebo; Pharmacology; Dextroamphetamine; Psychology; Reuptake inhibitor; Medicine; Reboxetine; Antidepressant; Dopamine; Methylphenidate; Psychiatry; Attention deficit hyperactivity disorder; Internal medicine; Anxiety","score_opus":0.03957003734388431,"score_gpt":0.3882556617029775,"score_spread":0.34868562435909317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052080148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990721,0.00037406696,0.000094452036,0.00001434093,0.000005183519,0.000031563093,0.000057149344,0.0000032901291,0.00034776333],"genre_scores_gemma":[0.99866056,0.00039314202,0.0002461161,0.00003622549,0.000015068014,0.000034981433,0.00006976129,0.0000014646215,0.00054264074],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997137,0.00015852234,0.000025553703,0.000023334396,0.000053287247,0.000025675208],"domain_scores_gemma":[0.9993357,0.00024008343,0.00021399638,0.000044127813,0.00004979749,0.00011635979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003839814,0.00031235305,0.0004661048,0.00012007121,0.00015617658,0.00018215008,0.0000900844,0.00026658588,0.0019649991],"category_scores_gemma":[0.0011789713,0.00019444403,0.00022961046,0.00010619317,0.00026278995,0.000216756,0.0001323411,0.00047912754,0.00015486404],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2513713,0.02668264,0.11106486,0.0013759936,0.0010071123,0.000668206,0.0009899224,0.00080574665,0.4185415,0.00015602975,0.0007491685,0.1865875],"study_design_scores_gemma":[0.0051701027,0.3148237,0.64109373,0.000040859504,0.0006788746,0.00081536773,0.0004299336,0.0011349047,0.03477349,0.0000646266,0.000926022,0.00004829556],"about_ca_topic_score_codex":0.00056969636,"about_ca_topic_score_gemma":0.0013869465,"teacher_disagreement_score":0.0019649991,"about_ca_system_score_codex":0.00011501604,"about_ca_system_score_gemma":0.00012454407,"threshold_uncertainty_score":0.006573558},"labels":[],"label_agreement":null},{"id":"W2052474126","doi":"10.1002/cpt.77","title":"Blood–brain barrier: An impediment to neuropharmaceuticals","year":2015,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Drug Policy Research Network; University of Toronto","funders":"","keywords":"Blood–brain barrier; Central nervous system; Medicine; Systemic circulation; Drug; Drug delivery; Neuroscience; Site of action; Blood circulation; Intensive care medicine; Pharmacology; Biology; Chemistry; Internal medicine","score_opus":0.16445871331618378,"score_gpt":0.4914402294245855,"score_spread":0.3269815161084017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052474126","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007205197,0.041657384,0.00034103837,0.034527525,0.92209953,0.000016084281,0.000025206244,0.00005803452,0.0012030114],"genre_scores_gemma":[0.0007371044,0.046237174,0.00024661102,0.02300218,0.9228761,0.000018024655,0.000024034787,0.000032354525,0.006826499],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962423,0.00062152534,0.0006035882,0.00045094368,0.0018464205,0.0002353294],"domain_scores_gemma":[0.9897684,0.004666236,0.0006006881,0.0003016221,0.003547545,0.0011154278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006084234,0.0032432075,0.002924882,0.0019302369,0.0018440132,0.0059844246,0.0037128262,0.013884375,0.0047819754],"category_scores_gemma":[0.012983659,0.0010319287,0.0019279225,0.0010636031,0.0035203293,0.0053586937,0.0021216946,0.024740843,0.0053902604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005184854,0.000019439643,0.000030399075,0.0006746356,0.000032237236,0.00024404282,0.000025615316,0.000052312032,0.0002540974,0.0012344035,0.97707725,0.020303681],"study_design_scores_gemma":[0.00003724818,0.00003912927,0.000109235276,0.000430071,0.000039368413,0.0004550728,0.000027689604,0.00010825246,0.00024254559,0.0014239061,0.9970708,0.000016688899],"about_ca_topic_score_codex":0.0009983963,"about_ca_topic_score_gemma":0.0025422922,"teacher_disagreement_score":0.013884375,"about_ca_system_score_codex":0.0024721106,"about_ca_system_score_gemma":0.0021378023,"threshold_uncertainty_score":0.03217691},"labels":[],"label_agreement":null},{"id":"W2054470265","doi":"10.1002/cpt.107","title":"Medical cannabis vs. synthetic cannabinoids: What does the future hold?","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Synthetic cannabinoids; Cannabis; Cannabinoid; Cannabinoid receptor; Tetrahydrocannabinol; Pharmacology; Dronabinol; Medicine; Chemistry; Receptor; Psychiatry; Internal medicine","score_opus":0.060511334569782506,"score_gpt":0.4244928312992699,"score_spread":0.3639814967294874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054470265","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075491564,0.73684716,0.0003220078,0.25290045,0.0040432317,0.000008154453,0.00008635968,0.000025969375,0.0050117234],"genre_scores_gemma":[0.017211221,0.8874811,0.0007676322,0.07683327,0.014329508,0.000048449914,0.00011343306,0.000032075517,0.003183271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977151,0.0008639078,0.00017246646,0.0003187491,0.00059522636,0.00033452827],"domain_scores_gemma":[0.98158777,0.0125346035,0.00073490734,0.00047136878,0.0031167625,0.0015545952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012308111,0.00079592445,0.0030881735,0.0016157666,0.0022824772,0.0063900673,0.002069487,0.008254811,0.019876936],"category_scores_gemma":[0.013754179,0.0004749611,0.0012172979,0.0013584956,0.00906595,0.017852016,0.0029345027,0.012163459,0.0041666697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015768408,0.00051516865,0.0016933834,0.009243754,0.00019791354,0.0005909898,0.0010186575,0.0003808649,0.0013886864,0.16191058,0.16452894,0.65695417],"study_design_scores_gemma":[0.00015338215,0.000590822,0.0019714946,0.0082864575,0.00016817916,0.0007089368,0.0031110004,0.00034062407,0.0004556224,0.14954077,0.8345443,0.00012839488],"about_ca_topic_score_codex":0.0047429665,"about_ca_topic_score_gemma":0.008024408,"teacher_disagreement_score":0.019876936,"about_ca_system_score_codex":0.0037281818,"about_ca_system_score_gemma":0.0072972868,"threshold_uncertainty_score":0.06649494},"labels":[],"label_agreement":null},{"id":"W2054531404","doi":"10.1016/s0009-9236(03)90395-x","title":"Sulfamethoxazole hydroxylamine (SMX‐HA): Induces increased necrotic versus apoptotic cell death in sensitive lymphocytes","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Hydroxylamine; Apoptosis; Programmed cell death; Chemistry; Molecular biology; Medicine; Pharmacology; Biology; Biochemistry","score_opus":0.09180987277864083,"score_gpt":0.40075909169272234,"score_spread":0.3089492189140815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054531404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980869,0.00053380546,0.00033821625,0.000049290647,0.000017944833,0.0000106492835,0.00005693319,0.00001715132,0.00088912103],"genre_scores_gemma":[0.9985557,0.0002627614,0.00026205718,0.000034174933,0.000015327094,0.000012025521,0.00010825313,0.00000395553,0.00074563985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999678,0.00008300419,0.000027476595,0.000033515586,0.00006321229,0.000114779556],"domain_scores_gemma":[0.9998029,0.00007684125,0.000030067999,0.000030350968,0.000014443468,0.000045535875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025378953,0.00022705246,0.00031560386,0.00022334332,0.00025934412,0.00033347358,0.00016371132,0.0005249177,0.0024043315],"category_scores_gemma":[0.00014804752,0.00020019873,0.0002478439,0.00020193333,0.0002916886,0.0002961403,0.00015935529,0.0006973592,0.00037892262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010890241,0.00009223611,0.0005008355,0.000035156558,0.000007545568,0.00012850894,0.000027359047,0.00003548491,0.99604994,0.000101265425,0.00005695159,0.0018756281],"study_design_scores_gemma":[0.0000889947,0.0024097036,0.01544426,0.000007009387,0.000024303847,0.00084735616,0.000103327744,0.0005078615,0.979875,0.000056664852,0.00063140073,0.000004033391],"about_ca_topic_score_codex":0.00044826025,"about_ca_topic_score_gemma":0.00075702526,"teacher_disagreement_score":0.0024043315,"about_ca_system_score_codex":0.00025493908,"about_ca_system_score_gemma":0.00018160172,"threshold_uncertainty_score":0.008043289},"labels":[],"label_agreement":null},{"id":"W2055705126","doi":"10.1038/clpt.2012.186","title":"CYP2B6 and Bupropion’s Smoking-Cessation Pharmacology: The Role of Hydroxybupropion","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; National Institute on Minority Health and Health Disparities; Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"Bupropion; Pharmacology; Active metabolite; Smoking cessation; Medicine; CYP2B6; Internal medicine; Pharmacokinetics; Cytochrome P450; Metabolism","score_opus":0.08222645907467754,"score_gpt":0.4376251572673109,"score_spread":0.35539869819263337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055705126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7053896,0.26970267,0.0057463823,0.01138348,0.0002573734,0.00019700523,0.0003945961,0.00007103336,0.0068578147],"genre_scores_gemma":[0.9603104,0.03432522,0.0016210267,0.0014407077,0.00054413895,0.00007157521,0.0002435915,0.000012045372,0.0014313118],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99917716,0.0005022144,0.000046039633,0.00008793101,0.00014866043,0.000037918617],"domain_scores_gemma":[0.9989491,0.0004857893,0.00033852388,0.00006620941,0.00008034316,0.000079975456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016850333,0.00024013565,0.0005757586,0.00023087976,0.0001376398,0.00064397004,0.00024595106,0.00081715966,0.002661381],"category_scores_gemma":[0.0022119505,0.000098949095,0.00053129415,0.00046772044,0.000326344,0.00030223888,0.00019929901,0.0007807967,0.00032346766],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03776529,0.0022564512,0.1188285,0.0034901302,0.002841851,0.00072215765,0.00023911816,0.0013176702,0.12068648,0.0025082023,0.0031386935,0.7062055],"study_design_scores_gemma":[0.00774016,0.029434983,0.86442155,0.00091481727,0.0023532473,0.0051757246,0.00027876283,0.0074769496,0.044008892,0.004576399,0.03353382,0.000084711035],"about_ca_topic_score_codex":0.00066233944,"about_ca_topic_score_gemma":0.0007674829,"teacher_disagreement_score":0.002661381,"about_ca_system_score_codex":0.00023927106,"about_ca_system_score_gemma":0.0002690853,"threshold_uncertainty_score":0.008911431},"labels":[],"label_agreement":null},{"id":"W2056107554","doi":"10.1067/mcp.2000.104737","title":"Assessment and reporting of clinical pharmacology information in drug labeling","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Food and drug administration; Medicine; Family medicine; Library science; Environmental health","score_opus":0.2816947961897552,"score_gpt":0.5885005010261709,"score_spread":0.3068057048364157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056107554","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08174486,0.019812161,0.32770312,0.105843894,0.0053875507,0.009098867,0.013799996,0.0036064868,0.43300307],"genre_scores_gemma":[0.5082025,0.0115954755,0.39284623,0.02922837,0.0046408405,0.0028144913,0.012072011,0.0007013112,0.03789879],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.6128722,0.20214567,0.06239372,0.005815631,0.11211185,0.004661018],"domain_scores_gemma":[0.2387773,0.4815289,0.07363277,0.057414714,0.14345986,0.005186512],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24213113,0.0008248994,0.0011570251,0.02290889,0.0038341752,0.01992006,0.005455897,0.0062233415,0.0049718674],"category_scores_gemma":[0.4737843,0.0011345801,0.0016191616,0.015021696,0.004115433,0.012353989,0.0054151504,0.006230969,0.00352295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090584095,0.00088766497,0.068448685,0.003459212,0.0002551304,0.00090233434,0.008595711,0.0027550394,0.006221008,0.13125348,0.088250555,0.68806535],"study_design_scores_gemma":[0.00024477582,0.0013581193,0.060167834,0.0082778325,0.0008955709,0.0026168171,0.0050432924,0.011892447,0.048635725,0.0742093,0.7861898,0.00046851626],"about_ca_topic_score_codex":0.009930552,"about_ca_topic_score_gemma":0.0071985093,"teacher_disagreement_score":0.7578689,"about_ca_system_score_codex":0.008474891,"about_ca_system_score_gemma":0.035725165,"threshold_uncertainty_score":0.93458724},"labels":[],"label_agreement":null},{"id":"W2057311010","doi":"10.1038/sj.clpt.6100474","title":"Monoamine Oxidase Inhibition for Tobacco Pharmacotherapy","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse","keywords":"Bupropion; Varenicline; Monoamine oxidase; Medicine; Pharmacology; Nicotine replacement therapy; Addiction; Smoking cessation; Pharmacotherapy; Nicotine; Tobacco harm reduction; Drug; Psychiatry; Tobacco use; Environmental health; Population; Biology","score_opus":0.21264644841810137,"score_gpt":0.5321928604893975,"score_spread":0.31954641207129614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057311010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021343378,0.99257654,0.00064905745,0.001056913,0.0007603691,0.000017566792,0.000020691714,0.000040517814,0.0046649207],"genre_scores_gemma":[0.0012996531,0.99249166,0.0008332563,0.0009085531,0.00049888476,0.000020349895,0.000038649407,0.0000051212864,0.0039039697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977154,0.00003949693,0.000021877317,0.0000338815,0.000114812196,0.000018348765],"domain_scores_gemma":[0.99982786,0.00006354394,0.000023535353,0.0000100246425,0.000050906034,0.00002413149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005081299,0.0010517717,0.0012242566,0.001855981,0.00036736482,0.00084689044,0.0009497287,0.0016530842,0.0072789504],"category_scores_gemma":[0.0004694685,0.00023723728,0.0005851536,0.0013147377,0.0006115285,0.0012495855,0.00063238456,0.0032657802,0.0068146153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062325904,0.00020436833,0.00011054397,0.004408157,0.0000648821,0.00048486376,0.000041448653,0.00033641566,0.003906616,0.005211402,0.06411917,0.9210498],"study_design_scores_gemma":[0.000042221865,0.00009970787,0.00052873185,0.0014275765,0.00004474765,0.00240525,0.000024975294,0.00012774765,0.00069020357,0.0030691954,0.9915241,0.00001568681],"about_ca_topic_score_codex":0.0006575653,"about_ca_topic_score_gemma":0.001789291,"teacher_disagreement_score":0.0072789504,"about_ca_system_score_codex":0.0007539759,"about_ca_system_score_gemma":0.00079895527,"threshold_uncertainty_score":0.024350524},"labels":[],"label_agreement":null},{"id":"W2057926673","doi":"10.1067/mcp.2000.104616","title":"Nonlinear kinetics and pharmacologic response to mibefradil","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Mibefradil; Pharmacokinetics; Heart rate; Internal medicine; Pharmacology; Chemistry; Oral administration; Medicine; Endocrinology; Blood pressure; Antagonist; Receptor","score_opus":0.05877223310805539,"score_gpt":0.42353618010371014,"score_spread":0.36476394699565473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057926673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98740315,0.0027492035,0.0068881074,0.0002089192,0.000019638492,0.000116896925,0.00050360453,0.00013583175,0.0019746139],"genre_scores_gemma":[0.9953864,0.0006841395,0.0017721433,0.0000821755,0.000014099549,0.00005298408,0.00033041267,0.000024362627,0.0016533117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999742,0.00006434707,0.000010936973,0.000057688154,0.00008873284,0.00003625925],"domain_scores_gemma":[0.99930596,0.00025561082,0.00023091832,0.00006740047,0.000094839656,0.000045339868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039019,0.00033268673,0.00034082748,0.0002354986,0.0001315097,0.00036003118,0.00020341824,0.00036654883,0.0024947715],"category_scores_gemma":[0.0015371916,0.00024239134,0.00031575162,0.0001518237,0.00023539018,0.00023817513,0.00014458665,0.00066426117,0.0008471261],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004096048,0.00022450794,0.020205835,0.00020796306,0.00010207169,0.00028193678,0.0001345102,0.0017013993,0.95275766,0.00030055604,0.00030065523,0.01968684],"study_design_scores_gemma":[0.0003236,0.006929231,0.2792406,0.000029903185,0.00017968213,0.0033347886,0.00015227945,0.039359417,0.66461426,0.00064443523,0.0051253964,0.00006645583],"about_ca_topic_score_codex":0.0021046705,"about_ca_topic_score_gemma":0.0011310574,"teacher_disagreement_score":0.0024947715,"about_ca_system_score_codex":0.0006535427,"about_ca_system_score_gemma":0.00039238803,"threshold_uncertainty_score":0.008345902},"labels":[],"label_agreement":null},{"id":"W2057948342","doi":"10.1016/j.clpt.2004.11.005","title":"Identification of a dysfunctional missense single nucleotide variant of human adenylyl cyclase VI","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Adenylyl cyclase; ADCY9; ADCY3; ADCY10; Gs alpha subunit; ADCY6; cAMP-dependent pathway; Missense mutation; Forskolin; Biology; G protein; Molecular biology; Chemistry; Receptor; Internal medicine; Endocrinology; Mutation; Genetics; Gene; Medicine","score_opus":0.0516003922526732,"score_gpt":0.37043372810379693,"score_spread":0.3188333358511237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057948342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990808,0.00011749434,0.00039641032,0.00003663053,0.0000132496025,0.000009376488,0.000102695725,0.000013582306,0.00022979258],"genre_scores_gemma":[0.9991248,0.000056849683,0.00030872828,0.000026178539,0.000015967435,0.000003466011,0.0001304666,0.0000034805062,0.0003301981],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99979216,0.000036569072,0.000027018632,0.000066187036,0.00004519008,0.00003286595],"domain_scores_gemma":[0.99965644,0.00011352831,0.00008099996,0.000023595612,0.000031944044,0.00009347878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014745425,0.0006702109,0.0003411716,0.0005056592,0.00030411652,0.0002423123,0.00020479121,0.0006363698,0.0015485198],"category_scores_gemma":[0.00067079917,0.00017058772,0.0002943666,0.00027812112,0.00041516495,0.00007418489,0.00024819508,0.00037462093,0.00025472138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022027814,0.00028470464,0.2083077,0.00013690196,0.00027200824,0.055223875,0.0009950654,0.0005671356,0.7114842,0.0009028191,0.0009427336,0.01868015],"study_design_scores_gemma":[0.0002688755,0.004016862,0.71574616,0.0000568889,0.00033066198,0.16916676,0.0006531361,0.004551616,0.10010183,0.0007893389,0.0042095645,0.00010830585],"about_ca_topic_score_codex":0.0019820547,"about_ca_topic_score_gemma":0.0016280891,"teacher_disagreement_score":0.0019820547,"about_ca_system_score_codex":0.00020411865,"about_ca_system_score_gemma":0.00016965534,"threshold_uncertainty_score":0.005180359},"labels":[],"label_agreement":null},{"id":"W2057990093","doi":"10.1067/mcp.2000.108948","title":"A century of discovery: The pharmacologic revolution","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Clinical pharmacology; Medicine; Pharmacology","score_opus":0.2759039125807195,"score_gpt":0.5438591686339532,"score_spread":0.2679552560532337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057990093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031892322,0.5421954,0.0044875084,0.36955342,0.012165725,0.000025207351,0.00010758897,0.00018081778,0.068095274],"genre_scores_gemma":[0.1372358,0.5525117,0.0070736487,0.22611262,0.035105456,0.00012648587,0.00015331992,0.00023126278,0.041449793],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99662673,0.0011536096,0.0001522015,0.00038976345,0.0013093421,0.00036829934],"domain_scores_gemma":[0.9920683,0.0042669787,0.0004569107,0.0008524082,0.0011691805,0.0011863647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009328317,0.0007939303,0.0016329795,0.0017702002,0.0026410224,0.007325108,0.0012081722,0.006102575,0.013546121],"category_scores_gemma":[0.012684719,0.00045084537,0.00074275205,0.0013484336,0.015061694,0.012563173,0.0043430645,0.012917986,0.004315407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004014745,0.00017921775,0.00043455718,0.00082956906,0.000055795026,0.00032169162,0.001085478,0.0002728885,0.0015995335,0.59724253,0.19890349,0.19867381],"study_design_scores_gemma":[0.00004997625,0.00010441505,0.0002625312,0.0005944822,0.000015843441,0.0003650489,0.0005055696,0.00012278873,0.00045799222,0.15814935,0.8393476,0.000024396231],"about_ca_topic_score_codex":0.0014478988,"about_ca_topic_score_gemma":0.0017774353,"teacher_disagreement_score":0.013546121,"about_ca_system_score_codex":0.0048372857,"about_ca_system_score_gemma":0.005555718,"threshold_uncertainty_score":0.049333453},"labels":[],"label_agreement":null},{"id":"W2058860931","doi":"10.1016/s0009-9236(01)90121-3","title":"QTc prolongation and drugs","year":2001,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Prolongation; Clinical pharmacology; Medicine; QT interval; Pharmacology; Internal medicine","score_opus":0.058218744531903927,"score_gpt":0.4061024109679679,"score_spread":0.34788366643606394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058860931","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022074387,0.052517533,0.0004092497,0.89496833,0.014102954,0.00003120558,0.000085943495,0.000053175307,0.035624202],"genre_scores_gemma":[0.026568325,0.040670514,0.0006039174,0.8042866,0.09702653,0.000096573116,0.0001208121,0.00003470454,0.03059197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791473,0.00061177847,0.00031053135,0.00023932196,0.00070516946,0.00021849277],"domain_scores_gemma":[0.9972671,0.0015758348,0.00034957903,0.00011289291,0.00036501355,0.00032950778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016059574,0.0006184033,0.0015056947,0.0006790277,0.0018904652,0.001814404,0.0008632285,0.024514265,0.006506923],"category_scores_gemma":[0.011431819,0.00037126365,0.00096830254,0.00070081395,0.0020822682,0.0023822838,0.0011212928,0.016122127,0.0049840547],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002751373,0.00008157684,0.0021289971,0.0003968656,0.000044033266,0.024462577,0.00017548873,0.00027303424,0.0008273208,0.016475148,0.8547535,0.10010633],"study_design_scores_gemma":[0.00021493282,0.0002009757,0.0040844087,0.0009368459,0.00003416774,0.036336444,0.00016423193,0.00042696056,0.00027297996,0.019190319,0.93810666,0.00003106034],"about_ca_topic_score_codex":0.002222251,"about_ca_topic_score_gemma":0.006896992,"teacher_disagreement_score":0.024514265,"about_ca_system_score_codex":0.002807872,"about_ca_system_score_gemma":0.0018257857,"threshold_uncertainty_score":0.021767795},"labels":[],"label_agreement":null},{"id":"W2059515941","doi":"10.1067/mcp.2001.117612","title":"A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University Health Network; Toronto General Hospital","funders":"","keywords":"Rifabutin; Saquinavir; Ritonavir; Virology; Pharmacokinetics; Medicine; Dosing; Pharmacology; Human immunodeficiency virus (HIV); Clarithromycin; Internal medicine; Viral load; Antiretroviral therapy","score_opus":0.05535563122780661,"score_gpt":0.415445246932836,"score_spread":0.3600896157050294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059515941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995759,0.00019067497,0.00012584854,0.000013223832,0.0000025372717,0.000014037511,0.000014695775,0.0000042405723,0.00005882224],"genre_scores_gemma":[0.99952185,0.00006254692,0.00024489395,0.000029316547,0.00001411718,0.000016172344,0.000049830996,0.0000012596408,0.000059998725],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995945,0.00018480737,0.000021335061,0.00007477853,0.000078375444,0.000046218545],"domain_scores_gemma":[0.99924755,0.00021313963,0.00026777558,0.000059478713,0.00003854584,0.0001734759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006834815,0.00037711536,0.0004864248,0.00014167953,0.00021649677,0.0003465622,0.0001897925,0.00033694942,0.0008149058],"category_scores_gemma":[0.0019148835,0.0002589547,0.00034691178,0.00012911431,0.00026519084,0.00031699703,0.00015053725,0.0004301325,0.00015373484],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10950313,0.00647782,0.62027776,0.00030420665,0.0010045844,0.0016537086,0.0012508677,0.0020936579,0.11964985,0.000097418786,0.00054106454,0.13714595],"study_design_scores_gemma":[0.0069454005,0.23850235,0.73149985,0.000037596285,0.00052303384,0.004141113,0.0002650753,0.00563035,0.010201229,0.00007378981,0.0021339608,0.000046139598],"about_ca_topic_score_codex":0.00030211787,"about_ca_topic_score_gemma":0.000312056,"teacher_disagreement_score":0.0008149058,"about_ca_system_score_codex":0.00027038815,"about_ca_system_score_gemma":0.00026727302,"threshold_uncertainty_score":0.003614664},"labels":[],"label_agreement":null},{"id":"W2059952793","doi":"10.1002/cpt.93","title":"Cannabis legalization with strict regulation, the overall superior policy option for public health","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Legalization; Decriminalization; Cannabis; Harm; Public health; Public economics; Business; Economics; Political science; Medicine; Law; Psychiatry","score_opus":0.23174140033858345,"score_gpt":0.48384529889528494,"score_spread":0.25210389855670146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059952793","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06984739,0.016069105,0.009994518,0.5181307,0.0031497744,0.00023465414,0.00034845775,0.00024443024,0.38198096],"genre_scores_gemma":[0.8418475,0.007262253,0.0104066655,0.11975909,0.0017489064,0.00017746468,0.00026393536,0.000113828406,0.018420363],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9658955,0.011258159,0.0018878372,0.0034307654,0.011996917,0.0055308766],"domain_scores_gemma":[0.9762716,0.0071975756,0.004110282,0.00285949,0.006883532,0.002677421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019846836,0.00046818278,0.00087973115,0.0017655551,0.0060773436,0.016345555,0.0015905784,0.0074395896,0.01057933],"category_scores_gemma":[0.031241992,0.0003606834,0.0010723579,0.0015395808,0.015345125,0.009388646,0.008059925,0.009817064,0.00095324335],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014472722,0.00020476115,0.0105919195,0.0006997153,0.00011157893,0.00030415255,0.0025878618,0.000693916,0.0017496411,0.9059288,0.020359281,0.056623742],"study_design_scores_gemma":[0.00023846094,0.0006974964,0.044286225,0.0048684995,0.0005264941,0.0014172546,0.011287169,0.0016587505,0.005496333,0.43049842,0.4987234,0.0003016128],"about_ca_topic_score_codex":0.02806764,"about_ca_topic_score_gemma":0.04665028,"teacher_disagreement_score":0.02806764,"about_ca_system_score_codex":0.009622699,"about_ca_system_score_gemma":0.036897305,"threshold_uncertainty_score":0.104961395},"labels":[],"label_agreement":null},{"id":"W2060479633","doi":"10.1016/s0009-9236(03)90618-7","title":"Treatment for psychiatric disorders is a predictor of problem drinking in pregnant women","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Psychiatry; Medicine; Clinical pharmacology; Pharmacology","score_opus":0.04924505697009422,"score_gpt":0.3924211302661901,"score_spread":0.34317607329609584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060479633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522614,0.0012499541,0.0001316657,0.0012181734,0.00006448572,0.000013796954,0.00029252266,0.000012206089,0.0017909822],"genre_scores_gemma":[0.9981597,0.00090533146,0.00022178613,0.00017363428,0.000060446586,0.000009304175,0.00013273182,0.0000066375464,0.00033046136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992899,0.00028505744,0.00007154505,0.000070867405,0.00015572218,0.0001268605],"domain_scores_gemma":[0.9924654,0.0028591666,0.0028382994,0.0002993081,0.00030059417,0.0012372993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005994301,0.00029412928,0.00055249577,0.0006669006,0.0007522857,0.0007747251,0.0004292488,0.0012662092,0.003471545],"category_scores_gemma":[0.008329951,0.00070501614,0.00073732814,0.0011822557,0.00042838464,0.0005178946,0.0004376553,0.0025376254,0.00026816025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012568255,0.00008756459,0.9970919,0.000010800782,0.00004968734,0.0001989407,0.00006956754,0.000018982792,0.00026677476,0.00002152058,0.00013043292,0.001928217],"study_design_scores_gemma":[0.000005950327,0.00009526063,0.99867344,0.000018582246,0.000053411146,0.0005066523,0.00020976143,0.00021358857,0.000076250086,0.00003594298,0.00010722766,0.0000039206275],"about_ca_topic_score_codex":0.015446277,"about_ca_topic_score_gemma":0.020854503,"teacher_disagreement_score":0.015446277,"about_ca_system_score_codex":0.00045186357,"about_ca_system_score_gemma":0.0012423339,"threshold_uncertainty_score":0.030712724},"labels":[],"label_agreement":null},{"id":"W2060894663","doi":"10.1038/clpt.2014.145","title":"Accelerated Access to Innovative Medicines for Patients in Need","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Institut National d'Excellence en Santé et en Services Sociaux","funders":"Innovative Medicines Initiative; National Comprehensive Cancer Network; European Federation of Pharmaceutical Industries and Associations; Bill and Melinda Gates Foundation","keywords":"Clinical pharmacology; Variety (cybernetics); Access to medicines; Business; Health care; Medicine; Pharmacology; Economic growth; Computer science; Economics; Nursing; Public health","score_opus":0.27197532223787846,"score_gpt":0.47316314814981514,"score_spread":0.20118782591193668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060894663","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47277677,0.01969823,0.018043071,0.31200314,0.00096247834,0.0003653375,0.0020535642,0.00035143748,0.17374595],"genre_scores_gemma":[0.9516977,0.01059974,0.00838686,0.013460939,0.002243263,0.00012473587,0.00070347014,0.00005183021,0.01273149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805707,0.0009850346,0.000103047634,0.00012418757,0.0003616855,0.00036890528],"domain_scores_gemma":[0.9899635,0.004360581,0.0026412772,0.00038899566,0.0008119366,0.0018337925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030598321,0.00014917209,0.00028081995,0.00100638,0.0006397286,0.002706076,0.00044755344,0.0016515708,0.028864289],"category_scores_gemma":[0.014499436,0.00014247424,0.0007998412,0.0009020886,0.0006559041,0.0022023302,0.003046395,0.002319706,0.0015136539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000877032,0.0009705999,0.17590785,0.001042168,0.00021619929,0.0012223913,0.0016929128,0.003076801,0.0025294148,0.19246192,0.0725409,0.5474618],"study_design_scores_gemma":[0.0009870735,0.0016881465,0.33574745,0.0017044726,0.00036036313,0.0049678776,0.0051530977,0.0061154356,0.002528184,0.14068873,0.49993485,0.00012427679],"about_ca_topic_score_codex":0.0020426745,"about_ca_topic_score_gemma":0.0029867399,"teacher_disagreement_score":0.028864289,"about_ca_system_score_codex":0.0017792138,"about_ca_system_score_gemma":0.004256395,"threshold_uncertainty_score":0.09656066},"labels":[],"label_agreement":null},{"id":"W2060975315","doi":"10.1038/clpt.2012.231","title":"The State of Clinical Pharmacology Today","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Clinical pharmacology; Pharmacology; Medicine; Position paper; Engineering ethics; Engineering; Pathology","score_opus":0.22981202993049338,"score_gpt":0.54599887420174,"score_spread":0.3161868442712466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060975315","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009952465,0.59565103,0.010724064,0.3347004,0.013109327,0.00010662626,0.00013186615,0.0003054388,0.044275902],"genre_scores_gemma":[0.03645216,0.7169188,0.015975652,0.1442373,0.070185766,0.0003050661,0.0003753429,0.00019191412,0.015357925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97495985,0.009338532,0.002077879,0.002966804,0.009473843,0.0011831574],"domain_scores_gemma":[0.8908935,0.057262894,0.0055259936,0.011643056,0.024384122,0.010290391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049833946,0.0009309039,0.0026905304,0.0034739925,0.0028254997,0.014137704,0.0037265245,0.0112208035,0.016154282],"category_scores_gemma":[0.05825373,0.00075871084,0.0012575375,0.004472652,0.017367842,0.014115273,0.005801855,0.020863853,0.0108081605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002681574,0.00033818948,0.0011137506,0.0038807169,0.00007426023,0.00020493155,0.0007431248,0.00028997826,0.0007047927,0.13566466,0.14679283,0.7099247],"study_design_scores_gemma":[0.000049097547,0.00020967344,0.00080437044,0.0031192307,0.000026988757,0.00070981,0.00025952767,0.00016427992,0.00034458446,0.05015792,0.9441049,0.00004955384],"about_ca_topic_score_codex":0.0025011613,"about_ca_topic_score_gemma":0.00198347,"teacher_disagreement_score":0.049833946,"about_ca_system_score_codex":0.00710262,"about_ca_system_score_gemma":0.017681181,"threshold_uncertainty_score":0.26355022},"labels":[],"label_agreement":null},{"id":"W2061572390","doi":"10.1016/s0009-9236(03)90597-2","title":"Influence of omeprazole (O) on the bioavailability of BI from a single‐triple (ST) capsule of bismuth biskalcitrate (BK) + tetracycline (T) + metronidazole (M) for eradication of helicobacter pylori","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Omeprazole; Metronidazole; Bioavailability; Tetracycline; Helicobacter pylori; Capsule; Bismuth; Pharmacology; Medicine; Chemistry; Gastroenterology; Antibiotics; Biology; Biochemistry","score_opus":0.08615274834982316,"score_gpt":0.37747404165394927,"score_spread":0.2913212933041261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061572390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989178,0.0004635127,0.0001116094,0.000045308734,0.0000316966,0.000016825095,0.00003940551,0.000008590705,0.00036531847],"genre_scores_gemma":[0.99854374,0.00028014998,0.0002556927,0.000047918275,0.00004789036,0.000012316117,0.00007837508,0.0000080357095,0.000726058],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997054,0.00012354746,0.000025384003,0.00004667751,0.00002848263,0.0000704558],"domain_scores_gemma":[0.9992198,0.00037828332,0.00010734056,0.000057968657,0.000042558495,0.00019406267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056719535,0.00031886355,0.00050734077,0.00014641313,0.00023384001,0.0003617809,0.00027796841,0.00047720474,0.00241535],"category_scores_gemma":[0.0016554419,0.0003075621,0.00032786862,0.00013358092,0.0005252187,0.0006509043,0.00024930216,0.000892139,0.00036503733],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24303849,0.0026095628,0.0013632716,0.00028285073,0.00012967967,0.0003508481,0.00029000078,0.0005999966,0.72583365,0.00019167077,0.00045954197,0.024850395],"study_design_scores_gemma":[0.013384599,0.21793547,0.046367284,0.000056129782,0.0006678241,0.00058504916,0.00028698158,0.00492963,0.7119017,0.00017105193,0.003625703,0.00008853946],"about_ca_topic_score_codex":0.0019599434,"about_ca_topic_score_gemma":0.0020081173,"teacher_disagreement_score":0.00241535,"about_ca_system_score_codex":0.00022091893,"about_ca_system_score_gemma":0.0003736604,"threshold_uncertainty_score":0.008080184},"labels":[],"label_agreement":null},{"id":"W2062113679","doi":"10.1038/clpt.2009.192","title":"Pediatric Drug Development: Concepts and Applications","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Citation; Library science; Columbia university; Medicine; Computer science; Sociology; Media studies","score_opus":0.13275033498730893,"score_gpt":0.5103151283283531,"score_spread":0.3775647933410442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062113679","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018814398,0.5058515,0.23139542,0.031754185,0.0013640227,0.00035499482,0.00029060696,0.00045120198,0.20972362],"genre_scores_gemma":[0.29115352,0.47271097,0.19186187,0.004600156,0.0028765032,0.0007519201,0.00017189274,0.00008721457,0.03578597],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9991216,0.00038967692,0.00006698661,0.00008912621,0.00027436603,0.00005828368],"domain_scores_gemma":[0.998621,0.0006711821,0.00021066477,0.0001032003,0.00024280873,0.0001510319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017694118,0.0007390917,0.00047571142,0.0020659273,0.0006275585,0.0027091573,0.00071710383,0.0013487976,0.00515229],"category_scores_gemma":[0.0020070635,0.00026601637,0.00035555183,0.0016347566,0.0035685843,0.0029156168,0.0013566789,0.0018160277,0.0011290347],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059227586,0.00018027898,0.002246309,0.0010147606,0.000018416236,0.0003046386,0.00087427214,0.0012301144,0.0016556233,0.5686988,0.016476855,0.40724063],"study_design_scores_gemma":[0.00003152974,0.00047003513,0.0033768686,0.0013791085,0.00004340801,0.0032433122,0.0010834588,0.0038215448,0.003890442,0.35213336,0.63049006,0.000036872552],"about_ca_topic_score_codex":0.0009321074,"about_ca_topic_score_gemma":0.0011868803,"teacher_disagreement_score":0.00515229,"about_ca_system_score_codex":0.0019057539,"about_ca_system_score_gemma":0.0029470343,"threshold_uncertainty_score":0.017236114},"labels":[],"label_agreement":null},{"id":"W2062587894","doi":"10.1038/sj.clpt.6100060","title":"Biomedical Communications: Collaborative Research in Scientific Visualization, Online Learning, and Knowledge Translation","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; The Wilson Centre","funders":"Health Canada","keywords":"Visualization; Data visualization; Computer science; Visual media; Knowledge translation; Scientific communication; Visual communication; Engineering ethics; Medical education; Data science; Multimedia; Knowledge management; Medicine; Library science; Engineering","score_opus":0.5213258929393779,"score_gpt":0.6131139110420502,"score_spread":0.09178801810267223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062587894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014855523,0.98191756,0.002808011,0.0022730478,0.0010774605,0.000027467877,0.000011127912,0.000047906793,0.011688832],"genre_scores_gemma":[0.005497812,0.97773105,0.0042694784,0.00240911,0.002828226,0.00012538901,0.000046774087,0.000025343326,0.0070667802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685884,0.0013455115,0.00024214461,0.00033827237,0.0010494546,0.0001657134],"domain_scores_gemma":[0.9916374,0.0060237944,0.0005848632,0.00038920608,0.0009493511,0.0004153117],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0042791795,0.0015190699,0.0021985518,0.005850166,0.0014002196,0.0063150045,0.0021851645,0.0061968914,0.010181299],"category_scores_gemma":[0.006149275,0.00052381883,0.00076789956,0.010003365,0.007915252,0.009664683,0.0033288258,0.004747691,0.006248204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038874165,0.00009943173,0.00017690024,0.0077773333,0.000047054524,0.00022020629,0.00066909706,0.00038833392,0.0006261188,0.04696142,0.036834866,0.9061604],"study_design_scores_gemma":[0.000021196887,0.00007869893,0.000835027,0.0052831504,0.000033120676,0.0021589424,0.0004891685,0.00023311855,0.0004323004,0.036955625,0.9534296,0.00005009613],"about_ca_topic_score_codex":0.0024391355,"about_ca_topic_score_gemma":0.0022431775,"teacher_disagreement_score":0.993685,"about_ca_system_score_codex":0.002731541,"about_ca_system_score_gemma":0.003403266,"threshold_uncertainty_score":0.034059882},"labels":[],"label_agreement":null},{"id":"W2062906696","doi":"10.1038/clpt.2009.127","title":"Macrolide-Induced Digoxin Toxicity: A Population-Based Study","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Confidence interval; Odds ratio; Azithromycin; Clarithromycin; Digoxin; Cefuroxime; Erythromycin; Toxicity; Clinical pharmacology; Population; Pharmacology; Internal medicine; Antibiotics; Biology; Microbiology; Environmental health","score_opus":0.08299471890286968,"score_gpt":0.4509136339232717,"score_spread":0.367918915020402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062906696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989335,0.00023458608,0.0003990491,0.000025301444,0.000011747966,0.000046764886,0.00013356844,0.000005640908,0.00020971024],"genre_scores_gemma":[0.9986992,0.00014632303,0.00044516192,0.000103507744,0.000035865974,0.00005629942,0.0002984443,0.0000048213465,0.00021035402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981766,0.0006390096,0.0001365095,0.000575175,0.0003443858,0.00012845178],"domain_scores_gemma":[0.99788034,0.0005077052,0.0004464584,0.00045863105,0.00031708938,0.00038978897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020954031,0.00085366936,0.0011044808,0.0008733294,0.0012581174,0.0010007794,0.0007483039,0.0013191898,0.001147823],"category_scores_gemma":[0.0044218507,0.0011980183,0.0012432976,0.0008407816,0.0008882221,0.00078309356,0.00072100945,0.0013612626,0.00041052027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013054392,0.0010339256,0.989514,0.00006200291,0.00082722993,0.0011870281,0.0007348188,0.00010490063,0.0033376368,0.00007012676,0.00019353851,0.0016292526],"study_design_scores_gemma":[0.00044667048,0.00403088,0.9885632,0.000022127728,0.00072319293,0.0040568435,0.00046029434,0.0004847323,0.0003644506,0.00007542023,0.00073416805,0.00003793004],"about_ca_topic_score_codex":0.0076336944,"about_ca_topic_score_gemma":0.009528149,"teacher_disagreement_score":0.0076336944,"about_ca_system_score_codex":0.00062378147,"about_ca_system_score_gemma":0.00078241364,"threshold_uncertainty_score":0.015178502},"labels":[],"label_agreement":null},{"id":"W2063194647","doi":"10.1038/clpt.2009.17","title":"Pharmacogenetics of Pharmacoecology: Which Route to Personalized Medicine?","year":2009,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Miller; Clinical pharmacology; Pharmacy; Library science; Medicine; Citation; Family medicine; Pharmacology; Computer science; Biology","score_opus":0.20988326001252208,"score_gpt":0.5630251880812913,"score_spread":0.3531419280687692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063194647","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002262125,0.021688849,0.0002024167,0.058130838,0.9189041,0.000009668325,0.000031341297,0.000033853623,0.0009763354],"genre_scores_gemma":[0.00034903007,0.012337233,0.00018745108,0.029507697,0.9542163,0.00001170332,0.000015089917,0.000016465778,0.0033590314],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950177,0.0015908048,0.0008067182,0.0004806919,0.0018718386,0.00023220037],"domain_scores_gemma":[0.96988636,0.016454749,0.0015612246,0.00069225824,0.009337263,0.0020681878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009273159,0.0030929646,0.0052595423,0.002839666,0.0020011093,0.0060254633,0.003255563,0.016927231,0.0079248175],"category_scores_gemma":[0.030274011,0.0012562273,0.002649926,0.0014064654,0.0029687888,0.004148213,0.0012864212,0.026155164,0.0057956814],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034281038,0.0000118978205,0.000031804168,0.0003128403,0.000049045506,0.00012509192,0.00000862963,0.00003142548,0.00003736241,0.000446469,0.9909999,0.007911253],"study_design_scores_gemma":[0.00013977893,0.000044509794,0.0005363085,0.001383956,0.00024243294,0.00078883686,0.00005170948,0.00037051298,0.00014366787,0.0033517492,0.99290127,0.000045170207],"about_ca_topic_score_codex":0.0023650122,"about_ca_topic_score_gemma":0.007079884,"teacher_disagreement_score":0.016927231,"about_ca_system_score_codex":0.0028391152,"about_ca_system_score_gemma":0.0032994305,"threshold_uncertainty_score":0.049041748},"labels":[],"label_agreement":null},{"id":"W2063970227","doi":"10.1067/mcp.2001.116714","title":"Pharmacogenetics, pharmacogenomics, and pharmacobiology","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Clinical pharmacology; Medicine; Pharmacology; Biopharmaceutics; Biology; Pharmacognosy; Genotype; Genetics; Gene","score_opus":0.5125665708794018,"score_gpt":0.6075484237968155,"score_spread":0.09498185291741368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063970227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011975774,0.9897467,0.0013470362,0.0015599598,0.00051017944,0.000010611864,0.000019452349,0.000035917074,0.0066503845],"genre_scores_gemma":[0.0009088663,0.99197537,0.0015180289,0.0007808396,0.00080114935,0.00001403148,0.00004004076,0.0000040061436,0.003957682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960715,0.00010792764,0.000030816896,0.000056615252,0.00017107074,0.000026370477],"domain_scores_gemma":[0.9992405,0.00041960922,0.00006083288,0.000036836078,0.00018078707,0.000061382954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001378734,0.001185841,0.0017382477,0.0026788036,0.00033053473,0.0016780165,0.00094077893,0.0014235332,0.00897789],"category_scores_gemma":[0.0012380235,0.00035919226,0.0003498199,0.0033661104,0.0014173554,0.0020370376,0.0007971218,0.0022728746,0.008353523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003192453,0.000050820046,0.00020415115,0.0022610365,0.000038569786,0.00015448144,0.000034618406,0.00027285295,0.0010900954,0.006816343,0.038644753,0.95040035],"study_design_scores_gemma":[0.000015117365,0.000048804897,0.0008937352,0.0015321573,0.00003616355,0.0020059636,0.000060580693,0.00016425033,0.00045326632,0.013867264,0.98090726,0.000015469193],"about_ca_topic_score_codex":0.0011267832,"about_ca_topic_score_gemma":0.0028901868,"teacher_disagreement_score":0.00897789,"about_ca_system_score_codex":0.0010575862,"about_ca_system_score_gemma":0.0011922113,"threshold_uncertainty_score":0.030034006},"labels":[],"label_agreement":null},{"id":"W2063972278","doi":"10.1016/s0009-9236(03)00051-1","title":"Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3a4 activity: comparison with grapefruit juice,","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Grapefruit juice; Chemistry; Felodipine; Lime; Wine; Citrus paradisi; Food science; Metabolite; Pharmacokinetics; Pharmacology; Biochemistry; Botany; Medicine; Endocrinology","score_opus":0.1754512454019363,"score_gpt":0.5006417785127449,"score_spread":0.32519053311080864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063972278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183357,0.0074272705,0.00017685574,0.00005248292,0.000038730745,0.000040471896,0.00006128869,0.0000119944725,0.00035729865],"genre_scores_gemma":[0.99636924,0.00233646,0.00044641644,0.00006311239,0.000041166673,0.000016657414,0.00014621938,0.0000046077475,0.0005760726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964404,0.0001792561,0.000020749072,0.00007014415,0.000054336273,0.000031469743],"domain_scores_gemma":[0.99962854,0.00012775265,0.00009964911,0.000018540353,0.000029417395,0.000096109674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005508124,0.00044261385,0.00060821883,0.00027601232,0.00014259738,0.000563406,0.00017217103,0.00038845383,0.0012406069],"category_scores_gemma":[0.00089504494,0.00016802916,0.0005338773,0.00022440139,0.00026204536,0.00044162344,0.00018488643,0.00033177232,0.00011587149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34058228,0.0062553775,0.03373293,0.0015013027,0.003380411,0.000516234,0.00033591094,0.0011720307,0.4367362,0.0003012778,0.00074025855,0.17474583],"study_design_scores_gemma":[0.013053681,0.37975088,0.3275309,0.00014353558,0.0057066423,0.0019536063,0.0003745376,0.0072403657,0.2510442,0.0003602702,0.012707043,0.00013428341],"about_ca_topic_score_codex":0.0011540597,"about_ca_topic_score_gemma":0.0020246771,"teacher_disagreement_score":0.0012406069,"about_ca_system_score_codex":0.00047249172,"about_ca_system_score_gemma":0.00019200842,"threshold_uncertainty_score":0.0041502714},"labels":[],"label_agreement":null},{"id":"W2064179817","doi":"10.1038/clpt.2013.95","title":"Legal Foundations of Adaptive Licensing","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"History of Medical Practice","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"Health Canada; European Commission","keywords":"Statute; Reimbursement; Agency (philosophy); Food and drug administration; Inspector general; Clinical pharmacology; Drug approval; Law; Business; Political science; Public administration; Pharmacology; Medicine; Drug; Health care; Accounting; Sociology","score_opus":0.1709712301570355,"score_gpt":0.47613482848748384,"score_spread":0.30516359833044837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064179817","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029467458,0.0057492875,0.06972599,0.15627111,0.0013515003,0.00026779887,0.00021554944,0.00016006884,0.73679125],"genre_scores_gemma":[0.90854836,0.0020917254,0.01722456,0.036734432,0.001942671,0.0004462122,0.00012207862,0.00008761537,0.03280234],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9741073,0.008147617,0.001549355,0.0045967074,0.008204647,0.0033944554],"domain_scores_gemma":[0.9565124,0.028168783,0.003433387,0.004006834,0.0062022735,0.0016763227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027676832,0.0004797539,0.0007730798,0.002047025,0.009584719,0.011217751,0.0024365056,0.014220647,0.009117035],"category_scores_gemma":[0.0571029,0.0007045953,0.0012541238,0.0015344804,0.053170152,0.014417154,0.008841272,0.018414402,0.0012235647],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034586014,0.0000074784202,0.000116526,0.000007455121,0.0000022148247,0.000033386117,0.0002530688,0.00012301133,0.00002473988,0.99653924,0.001368188,0.0015213103],"study_design_scores_gemma":[0.000025985593,0.000014379611,0.00029399758,0.00010925601,0.0000070377596,0.00008534368,0.00019668708,0.00069652166,0.00012843765,0.9601501,0.03826613,0.000025970456],"about_ca_topic_score_codex":0.012864329,"about_ca_topic_score_gemma":0.0076188883,"teacher_disagreement_score":0.027676832,"about_ca_system_score_codex":0.009854573,"about_ca_system_score_gemma":0.0146329235,"threshold_uncertainty_score":0.14637083},"labels":[],"label_agreement":null},{"id":"W2064401742","doi":"10.1016/j.clpt.2004.10.005","title":"Effect of Grapefruit Juice Volume on the Reduction of Fexofenadine Bioavailability: Possible Role of Organic Anion Transporting Polypeptides*","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lawson Health Research Institute; London Health Sciences Centre","funders":"National Institute of General Medical Sciences","keywords":"Grapefruit juice; Fexofenadine; Chemistry; Bioavailability; Pharmacokinetics; Terfenadine; Crossover study; Pharmacology; Volume (thermodynamics); Volume of distribution; Food science; Chromatography; Medicine","score_opus":0.03041097844041151,"score_gpt":0.35909094045437595,"score_spread":0.32867996201396443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064401742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811375,0.0013266699,0.00022270043,0.000031582505,0.00001782534,0.000047835783,0.000042394382,0.000016557196,0.00018056824],"genre_scores_gemma":[0.99849534,0.00039506558,0.00066592824,0.000042338423,0.000027095655,0.000026295667,0.000049022034,0.000005885531,0.00029301454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997528,0.00011339804,0.0000132233345,0.0000476355,0.000049331124,0.000023570807],"domain_scores_gemma":[0.99962664,0.00018081779,0.000089224595,0.00002685485,0.00002558974,0.000050762384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003631747,0.00034933884,0.0004736035,0.00011221367,0.00010871617,0.00037152923,0.00018600324,0.00047187196,0.0013447931],"category_scores_gemma":[0.0008338061,0.00015514722,0.00034723277,0.00008310918,0.00032141202,0.0003252919,0.00012451496,0.00037779816,0.000107657506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14792173,0.0028728743,0.011450976,0.00060178357,0.00046100322,0.0002505719,0.00016855923,0.0006023256,0.7864822,0.00010956409,0.00019628825,0.04888223],"study_design_scores_gemma":[0.0071725124,0.25029448,0.31807584,0.00007739671,0.000996628,0.00084384205,0.00021458366,0.00462343,0.4123883,0.00022218953,0.005010596,0.00008030497],"about_ca_topic_score_codex":0.0005917794,"about_ca_topic_score_gemma":0.00055338145,"teacher_disagreement_score":0.0013447931,"about_ca_system_score_codex":0.00020882254,"about_ca_system_score_gemma":0.00017237636,"threshold_uncertainty_score":0.00449878},"labels":[],"label_agreement":null},{"id":"W2064869484","doi":"10.1038/sj.clpt.6100443","title":"Emergency Contraception Update: A Canadian Perspective","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Health Canada; Ministry of Health, British Columbia","keywords":"Emergency contraception; Levonorgestrel; Medicine; Food and drug administration; Pharmacy; Medical prescription; Family medicine; Family planning; Over-the-counter; Environmental health; Population; Nursing; Research methodology","score_opus":0.09016223894076374,"score_gpt":0.4795986425978645,"score_spread":0.38943640365710075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064869484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009460795,0.59557605,0.00039115577,0.26242602,0.03398698,0.00006695953,0.0022682198,0.00015470725,0.10418385],"genre_scores_gemma":[0.00969683,0.8522835,0.0012380886,0.06506495,0.019936845,0.00004734117,0.0020997203,0.000047526413,0.04958524],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984577,0.00011180327,0.00015787476,0.0001235362,0.00086562085,0.00028346785],"domain_scores_gemma":[0.9902187,0.00062910584,0.00034326332,0.00007596773,0.0067181974,0.0020147176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021767458,0.0009542493,0.0010084093,0.006662705,0.0024283908,0.004062944,0.0017784729,0.0048081367,0.033538956],"category_scores_gemma":[0.004700337,0.00040361946,0.0006394958,0.010900672,0.0013744569,0.0022935346,0.001081486,0.004256921,0.0048216567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000226871,0.000035993748,0.0007712746,0.0007161343,0.000012255604,0.00045430602,0.00007546978,0.00008979985,0.00006796514,0.0021124622,0.86586803,0.12977365],"study_design_scores_gemma":[0.000008665579,0.0000108382665,0.0018637433,0.00069655123,0.000016663818,0.00051703246,0.00013323981,0.000030979227,0.00001755224,0.00013990457,0.9965527,0.00001212743],"about_ca_topic_score_codex":0.78863275,"about_ca_topic_score_gemma":0.91968554,"teacher_disagreement_score":0.21136725,"about_ca_system_score_codex":0.018626768,"about_ca_system_score_gemma":0.07654943,"threshold_uncertainty_score":0.425224},"labels":[],"label_agreement":null},{"id":"W2065390851","doi":"10.1038/clpt.2010.355","title":"A Fresh Look at the Mechanism of Isoniazid-Induced Hepatotoxicity","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Idiosyncrasy; Isoniazid; Metabolite; Clinical pharmacology; Mechanism (biology); Pharmacology; Medicine; Internal medicine; Tuberculosis; Pathology; Economics; Epistemology","score_opus":0.5197160465884401,"score_gpt":0.5517765724236009,"score_spread":0.032060525835160836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065390851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012531446,0.9970535,0.00018079097,0.0010314011,0.00045568025,0.0000030254562,0.000015475161,0.00001135587,0.0011235164],"genre_scores_gemma":[0.00062954304,0.9969363,0.00018327842,0.0005683172,0.00063517084,0.000003831854,0.000021187529,0.0000015555082,0.0010208868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985766,0.000021812117,0.000021515254,0.000028021524,0.000055763663,0.000015079216],"domain_scores_gemma":[0.9997273,0.00010389055,0.000028614459,0.0000132943,0.00009675679,0.00003010934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006393492,0.0010566154,0.0017527413,0.0021455267,0.00033248094,0.0011984732,0.0011768709,0.0015562567,0.0058878805],"category_scores_gemma":[0.00047505758,0.0002928969,0.0005092286,0.0015418386,0.00069332425,0.0034531758,0.00058898143,0.0027720698,0.0040624384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010277615,0.00018000057,0.00019684574,0.010820008,0.000057773665,0.0006904152,0.00007690167,0.0004450144,0.00588949,0.0060848068,0.049042527,0.9264135],"study_design_scores_gemma":[0.000025885538,0.00023711548,0.00122572,0.003179065,0.000065989494,0.0030619297,0.00009773433,0.00014287303,0.0011592075,0.0053100893,0.98546463,0.00002962885],"about_ca_topic_score_codex":0.00095052127,"about_ca_topic_score_gemma":0.0018010802,"teacher_disagreement_score":0.0058878805,"about_ca_system_score_codex":0.000732457,"about_ca_system_score_gemma":0.00081552175,"threshold_uncertainty_score":0.019696891},"labels":[],"label_agreement":null},{"id":"W2065424662","doi":"10.1038/clpt.2011.124","title":"Profile of Serum Bile Acids in Noncholestatic Volunteers: Gender-Related Differences in Response to Fenofibrate","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Centre Hospitalier Universitaire de Québec; University of Minnesota","keywords":"Fenofibrate; Ursodeoxycholic acid; Chenodeoxycholic acid; Deoxycholic acid; Internal medicine; Lithocholic acid; Bile acid; Endocrinology; Medicine; Hepatology; Chemistry","score_opus":0.14608194178824763,"score_gpt":0.38992635435075096,"score_spread":0.24384441256250333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065424662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841154,0.00063506846,0.00011169569,0.000019147954,0.00001273188,0.000017291379,0.00018778164,0.000005257614,0.0005995452],"genre_scores_gemma":[0.99842334,0.00019393185,0.00010383383,0.00005935109,0.000013669535,0.000026250353,0.00024032174,0.0000031729546,0.0009360646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984455,0.000040956395,0.000013726068,0.000041406027,0.000033512635,0.000025807456],"domain_scores_gemma":[0.9997589,0.000037484373,0.0000586717,0.000022611262,0.000051158408,0.0000712306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002226557,0.000285005,0.0005317281,0.0003236234,0.00019813376,0.00020240348,0.000077960416,0.00024570306,0.0011778953],"category_scores_gemma":[0.000601152,0.00014177589,0.0001639336,0.00021052324,0.00013212283,0.00010262922,0.0001667976,0.00018071145,0.00026673437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04854179,0.0011740221,0.6720399,0.00020591714,0.0002701491,0.0014880969,0.0009901954,0.00013995003,0.24157025,0.00007999781,0.00040321777,0.03309649],"study_design_scores_gemma":[0.00010680021,0.0045922427,0.9873537,0.0000062747763,0.00007517495,0.00063269044,0.00023770871,0.00013140736,0.0062123113,0.000044413748,0.00059789885,0.0000093493],"about_ca_topic_score_codex":0.00080676365,"about_ca_topic_score_gemma":0.0011170316,"teacher_disagreement_score":0.0011778953,"about_ca_system_score_codex":0.00011685737,"about_ca_system_score_gemma":0.00012910816,"threshold_uncertainty_score":0.003940463},"labels":[],"label_agreement":null},{"id":"W2065633317","doi":"10.1016/s0009-9236(03)90368-7","title":"Introduction of intravenous amiodarone has little impact on survival of in‐hospital resuscitation","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac Arrest and Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Western University","funders":"","keywords":"Resuscitation; Medicine; Amiodarone; Anesthesia; Emergency medicine; Intensive care medicine; Internal medicine; Atrial fibrillation","score_opus":0.05522399341226303,"score_gpt":0.4093298903989015,"score_spread":0.35410589698663847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065633317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97569793,0.008079625,0.00050348754,0.005322125,0.0011085513,0.000044156837,0.0007063107,0.00024816568,0.008289706],"genre_scores_gemma":[0.9909958,0.004008485,0.0003547978,0.0014601324,0.0005502867,0.0000151629265,0.0008261736,0.000044153763,0.0017450367],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996828,0.00016534863,0.000023241066,0.00002933486,0.00003588661,0.00006344862],"domain_scores_gemma":[0.9941671,0.002951053,0.00076940097,0.00046412743,0.00039275968,0.0012555342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077197194,0.00034787916,0.001037015,0.00016411878,0.00028676412,0.0007586921,0.00040420165,0.00077007007,0.00991389],"category_scores_gemma":[0.00635125,0.00011388887,0.00074737635,0.00030196382,0.0002877956,0.0008609007,0.0003134195,0.0017657644,0.0012463155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19994667,0.0058049895,0.094873354,0.0015567236,0.002130451,0.0016663119,0.00052601116,0.001091451,0.019474238,0.0012378752,0.024797255,0.64689475],"study_design_scores_gemma":[0.0087727625,0.08704285,0.8452723,0.0012068797,0.004514199,0.0026933427,0.0009753506,0.0024166054,0.013808965,0.0017805474,0.03139191,0.00012431107],"about_ca_topic_score_codex":0.000800912,"about_ca_topic_score_gemma":0.0015177376,"teacher_disagreement_score":0.00991389,"about_ca_system_score_codex":0.000373628,"about_ca_system_score_gemma":0.00060845306,"threshold_uncertainty_score":0.033165276},"labels":[],"label_agreement":null},{"id":"W2065863432","doi":"10.1038/clpt.2010.68","title":"An Individualized Approach to Tracking and Treating Alzheimer’s Disease","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Atlantic Canada Opportunities Agency; Dalhousie Medical Research Foundation","keywords":"Disease; Dementia; Cognition; Alzheimer's disease; Medicine; Psychology; Gerontology; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.15026689970404464,"score_gpt":0.5022433162928386,"score_spread":0.35197641658879397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065863432","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09150907,0.034935974,0.5882319,0.12526515,0.0025956582,0.0025150497,0.00076404243,0.00410689,0.15007629],"genre_scores_gemma":[0.42594072,0.026991824,0.51170146,0.014337115,0.0017887679,0.0016843717,0.0006300398,0.00024608205,0.01667958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979122,0.00091687596,0.00019430433,0.00032153755,0.0005437444,0.000111368245],"domain_scores_gemma":[0.9987494,0.0003010872,0.0001803023,0.00022977575,0.0003245621,0.00021495702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029085213,0.00068543485,0.00089312904,0.0018380177,0.001108444,0.0019435078,0.0016300613,0.0016461994,0.003627954],"category_scores_gemma":[0.0046275584,0.00024049677,0.00086996367,0.0008875313,0.0007710702,0.0017832945,0.0025455542,0.0033319613,0.0016432906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002549187,0.0013051464,0.008376857,0.00042603037,0.00022794827,0.00045525286,0.00075841474,0.0054752836,0.003190624,0.010354445,0.03487541,0.9342997],"study_design_scores_gemma":[0.0008658186,0.0052539753,0.09246534,0.0034456688,0.0013614562,0.008035527,0.003687037,0.034289468,0.01279377,0.1985197,0.63871706,0.00056514406],"about_ca_topic_score_codex":0.003602155,"about_ca_topic_score_gemma":0.0068084314,"teacher_disagreement_score":0.003627954,"about_ca_system_score_codex":0.0016921061,"about_ca_system_score_gemma":0.0035147134,"threshold_uncertainty_score":0.015381932},"labels":[],"label_agreement":null},{"id":"W2066221966","doi":"10.1038/clpt.2013.133","title":"Do Anticoagulants or Antiplatelet Drugs Have a Role in Treating Heart Failure in the Absence of Atrial Fibrillation?","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Atrial fibrillation; Clinical pharmacology; Heart failure; Cardiology; Stroke (engine); Intensive care medicine; Risk stratification; Sinus rhythm; Internal medicine; Pharmacology","score_opus":0.12044952822858218,"score_gpt":0.45067808223645933,"score_spread":0.33022855400787715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066221966","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052098576,0.5432531,0.00041008572,0.4355347,0.006951616,0.000014876362,0.00014339329,0.00002396571,0.008458361],"genre_scores_gemma":[0.11911304,0.6035217,0.0023608657,0.21353239,0.05755301,0.0000760416,0.0002298065,0.000040196766,0.0035730014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567324,0.0018407952,0.0007690719,0.00033794867,0.0011524863,0.00022650123],"domain_scores_gemma":[0.9580782,0.024364213,0.006763739,0.0010708839,0.0070136013,0.0027093599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012065721,0.00054532994,0.0028946495,0.0010880744,0.0008194345,0.0027060644,0.0014622193,0.00555601,0.008668312],"category_scores_gemma":[0.047554083,0.00032302816,0.0014703366,0.0011664778,0.0041375207,0.0060654683,0.0007876907,0.0056269686,0.0023855916],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037320822,0.0010141683,0.02987063,0.006734111,0.0012244667,0.0008299327,0.00043738078,0.00027329166,0.0006447295,0.01383596,0.14636672,0.7950365],"study_design_scores_gemma":[0.0040891576,0.004205045,0.12187191,0.04114199,0.0044391663,0.006932391,0.004756956,0.001531575,0.000856061,0.07742892,0.7323096,0.00043726296],"about_ca_topic_score_codex":0.0034942266,"about_ca_topic_score_gemma":0.010373432,"teacher_disagreement_score":0.012065721,"about_ca_system_score_codex":0.0011493952,"about_ca_system_score_gemma":0.0029391116,"threshold_uncertainty_score":0.06381041},"labels":[],"label_agreement":null},{"id":"W2066766920","doi":"10.1038/clpt.2009.115","title":"Clozapine, GABAB, and the Treatment of Resistant Schizophrenia","year":2009,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse","keywords":"Clozapine; Schizophrenia (object-oriented programming); GABAergic; Antipsychotic; Long-term potentiation; Neurotransmission; Neuroscience; Pharmacology; Cognition; Clinical pharmacology; Psychology; Medicine; Psychiatry; Internal medicine; Inhibitory postsynaptic potential; Receptor","score_opus":0.3171689902228804,"score_gpt":0.5262549587221403,"score_spread":0.20908596849925992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066766920","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004947717,0.99628794,0.000115036986,0.00038387664,0.00010720744,0.0000050478448,0.000013010055,0.000013230923,0.0025797538],"genre_scores_gemma":[0.0024045298,0.99546367,0.00021006662,0.00024681323,0.00014990152,0.0000059694153,0.000026894833,0.0000018708602,0.001490229],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998901,0.00002530409,0.000014097164,0.0000138582,0.00004776697,0.00000887253],"domain_scores_gemma":[0.99989235,0.000038007183,0.000021985295,0.0000038910707,0.000024844558,0.000018989236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035771413,0.00050876936,0.0006715514,0.0014456607,0.00021856734,0.00043349242,0.0004984732,0.0008670519,0.0026597779],"category_scores_gemma":[0.00039049718,0.00014510141,0.00021143976,0.0012280197,0.00034781036,0.00048321302,0.00029661076,0.00083977834,0.0028867456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111185625,0.0000873577,0.00017580876,0.002758086,0.000036455927,0.00047893755,0.00004060287,0.00021921923,0.002063529,0.0014042219,0.020186296,0.97243834],"study_design_scores_gemma":[0.00009136397,0.00022425037,0.002446209,0.0013243161,0.00006506519,0.0042670416,0.0000648639,0.00012815902,0.000705906,0.001616238,0.989051,0.000015691961],"about_ca_topic_score_codex":0.002181564,"about_ca_topic_score_gemma":0.0063796877,"teacher_disagreement_score":0.0026597779,"about_ca_system_score_codex":0.0005132623,"about_ca_system_score_gemma":0.0006388945,"threshold_uncertainty_score":0.008897781},"labels":[],"label_agreement":null},{"id":"W2066843681","doi":"10.1067/mcp.2000.104943","title":"Venous responsiveness to norepinephrine in healthy subjects: Effects of single doses of 325 mg aspirin","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diagnosis and Treatment of Venous Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Norepinephrine; Aspirin; Anesthesia; Placebo; Vasoconstriction; Cold pressor test; Epinephrine; Distension; Hemodynamics; Internal medicine; Catecholamine; Blood pressure; Heart rate","score_opus":0.06563553532904264,"score_gpt":0.4269213811049608,"score_spread":0.36128584577591816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066843681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993767,0.00024594733,0.000034843284,0.000009968061,0.000006199115,0.000017413493,0.000046558234,0.000003212889,0.00025923832],"genre_scores_gemma":[0.99958736,0.000097146716,0.000051143732,0.00003093371,0.00001863293,0.0000147129385,0.00007811364,0.0000012609132,0.00012065869],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997458,0.00008400993,0.00001598353,0.0000519701,0.00006350838,0.000038758706],"domain_scores_gemma":[0.99947363,0.00016751522,0.00011328445,0.000034098117,0.000032510103,0.00017890891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031354648,0.0004134824,0.0006078166,0.00025300073,0.0002762414,0.00031373365,0.00011042265,0.00048813113,0.0011161806],"category_scores_gemma":[0.001070976,0.00027083504,0.00024929858,0.0001630651,0.00026423155,0.00014067248,0.000171197,0.00036627517,0.00024205414],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027299173,0.0018164762,0.8979422,0.00012702975,0.00032558964,0.0020825786,0.0005381156,0.00018064764,0.05310222,0.00004280409,0.00025105613,0.01629228],"study_design_scores_gemma":[0.00012479095,0.008153406,0.9898164,0.000004425269,0.000057769947,0.0007378837,0.000052767948,0.00008830322,0.000798614,0.000012577958,0.00014802243,0.00000515196],"about_ca_topic_score_codex":0.00086755847,"about_ca_topic_score_gemma":0.001169067,"teacher_disagreement_score":0.0011161806,"about_ca_system_score_codex":0.00016907784,"about_ca_system_score_gemma":0.00011803192,"threshold_uncertainty_score":0.0037339926},"labels":[],"label_agreement":null},{"id":"W2067623051","doi":"10.1038/clpt.2008.6","title":"Marijuana as Medicine: Does It Have a Future?","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cannabis; Marijuana smoking; Medical cannabis; Randomized controlled trial; Alternative medicine; Medicine; MEDLINE; Clinical trial; Psychiatry; Psychology; Political science; Law; Substance use; Surgery","score_opus":0.10508287234666604,"score_gpt":0.47224164807318686,"score_spread":0.36715877572652084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067623051","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046498814,0.19278465,0.00028229048,0.7972278,0.0063808355,0.0000040768973,0.00001710958,0.000015613477,0.0028226327],"genre_scores_gemma":[0.038661722,0.51465476,0.0013502741,0.39909935,0.040134937,0.00004584694,0.000055895933,0.000048549846,0.005948735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99601835,0.0020109839,0.00021583616,0.00036280704,0.0010244007,0.00036750123],"domain_scores_gemma":[0.97784734,0.013179943,0.0010893302,0.00092039304,0.0041470136,0.0028159702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01143564,0.0007321851,0.0027945705,0.0012493321,0.003351102,0.008307348,0.0020194328,0.014121486,0.013351963],"category_scores_gemma":[0.017551951,0.00036962135,0.0009643179,0.0012829797,0.019070385,0.02641159,0.0036872241,0.01937747,0.0034913074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068169757,0.00029369455,0.0021619948,0.0037234921,0.0001701789,0.0007208326,0.0027298396,0.00024471828,0.0008108625,0.29593676,0.3409558,0.35157013],"study_design_scores_gemma":[0.0000993174,0.00027626805,0.002418325,0.0055501806,0.00011586426,0.0010493262,0.008664515,0.00030337725,0.00016952967,0.28577906,0.6954586,0.000115717834],"about_ca_topic_score_codex":0.0065999124,"about_ca_topic_score_gemma":0.012091223,"teacher_disagreement_score":0.014121486,"about_ca_system_score_codex":0.0043803146,"about_ca_system_score_gemma":0.011819902,"threshold_uncertainty_score":0.06047821},"labels":[],"label_agreement":null},{"id":"W2067981076","doi":"10.1016/s0009-9236(03)90530-3","title":"Domperidone As A Substrate Marker Drug for CYP3A4 and CYP3A5","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Domperidone; CYP3A4; Drug; Pharmacology; Medicine; Clinical pharmacology; Internal medicine; Cytochrome P450","score_opus":0.21800424138292177,"score_gpt":0.527010602900353,"score_spread":0.3090063615174312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067981076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91871655,0.032610256,0.029309915,0.0015549537,0.0008158829,0.00029276265,0.0015851961,0.0013141606,0.013800204],"genre_scores_gemma":[0.9752622,0.002819998,0.017372923,0.00033706066,0.00008654767,0.000053523447,0.0006141446,0.00006657004,0.003387042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986859,0.00081386266,0.000055007895,0.00014314274,0.00023294907,0.000069124704],"domain_scores_gemma":[0.9994735,0.00015898062,0.00010510753,0.00005784309,0.000100079815,0.000104519386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007734811,0.0005055416,0.0010471067,0.0006245134,0.00056302483,0.00086164346,0.0002784042,0.00088597706,0.0011612268],"category_scores_gemma":[0.0017202719,0.00038013846,0.0003573457,0.00052844087,0.00035725677,0.0005013826,0.00038711558,0.0007924137,0.0006050276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042321704,0.0008139972,0.06644198,0.0009050401,0.00046928172,0.002529921,0.0003819533,0.0019786283,0.6202586,0.0036661031,0.009701092,0.25053167],"study_design_scores_gemma":[0.001469525,0.012079841,0.09281712,0.00009863567,0.0008037586,0.014752943,0.00018402052,0.021556057,0.81442034,0.0012682845,0.0404146,0.00013489615],"about_ca_topic_score_codex":0.0018414757,"about_ca_topic_score_gemma":0.005112667,"teacher_disagreement_score":0.0018414757,"about_ca_system_score_codex":0.00075294904,"about_ca_system_score_gemma":0.00068712654,"threshold_uncertainty_score":0.0054631233},"labels":[],"label_agreement":null},{"id":"W2068075375","doi":"10.1016/j.clpt.2003.10.006","title":"A novel functional polymorphism in the uridine diphosphate–glucuronosyltransferase 2B7 promoter with significant impact on promoter activity","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Single-nucleotide polymorphism; UGT2B7; Morphine; Glucuronosyltransferase; Glucuronide; Chemistry; Uridine; Internal medicine; Glucuronidation; Biology; Pharmacology; Genotype; Biochemistry; Medicine; In vitro; Gene; Metabolism; RNA","score_opus":0.20729445862948895,"score_gpt":0.47151952957898674,"score_spread":0.26422507094949776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068075375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988188,0.00018188912,0.0006728258,0.000042840908,0.0000062341264,0.0000060540606,0.000092661314,0.000008264793,0.00017041496],"genre_scores_gemma":[0.9991466,0.00004970035,0.00047682907,0.000022017137,0.00001042928,0.000004979839,0.0001471611,0.0000053773883,0.00013688736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999835,0.000046410827,0.000015223495,0.000041809497,0.000035810874,0.000025771351],"domain_scores_gemma":[0.9995703,0.00016645566,0.00013207142,0.000028453263,0.00003210171,0.000070640024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013423365,0.00026752107,0.00023068415,0.0002929494,0.00012562025,0.00015623466,0.00012487918,0.00021759856,0.00091953663],"category_scores_gemma":[0.00049208006,0.000095643656,0.00026840324,0.00025426596,0.00019438379,0.000055493427,0.00013693029,0.00027262833,0.00016617546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017072344,0.0002748073,0.33373895,0.00007608429,0.00016947022,0.0051191915,0.00029921933,0.0004140872,0.6431017,0.0005476293,0.00022347835,0.014328116],"study_design_scores_gemma":[0.0002624381,0.002145666,0.87188077,0.000038169645,0.00032012493,0.03011283,0.0002314597,0.0047215815,0.08699088,0.00059838645,0.0026596882,0.000037929854],"about_ca_topic_score_codex":0.0006032343,"about_ca_topic_score_gemma":0.0006542946,"teacher_disagreement_score":0.00091953663,"about_ca_system_score_codex":0.00015670001,"about_ca_system_score_gemma":0.00013250273,"threshold_uncertainty_score":0.0030761957},"labels":[],"label_agreement":null},{"id":"W2069218640","doi":"10.1038/clpt.2011.66","title":"The Human Placental Perfusion Model: A Systematic Review and Development of a Model to Predict In Vivo Transfer of Therapeutic Drugs","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Perfusion; In vivo; Pharmacokinetics; Placenta; Fetus; Drug; Pharmacology; Medicine; Pregnancy; Internal medicine; Biology; Biotechnology","score_opus":0.21791089192654664,"score_gpt":0.45878184820454326,"score_spread":0.24087095627799662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069218640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006271481,0.99732035,0.0013008779,0.00014179671,0.00004165847,0.00005923528,0.00014094115,0.000015117728,0.00035293083],"genre_scores_gemma":[0.0040208804,0.9936347,0.0019713726,0.00006345412,0.000021132388,0.00006514451,0.000105569685,0.0000049232185,0.00011289395],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99913126,0.0003187249,0.00019750504,0.00010271531,0.00022460135,0.000025160718],"domain_scores_gemma":[0.9972799,0.0019404633,0.00040015287,0.00006087238,0.00029178476,0.000026898768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027902354,0.0013538323,0.003954827,0.0037961071,0.00023326125,0.0013457452,0.0016760661,0.0013145587,0.001712683],"category_scores_gemma":[0.0046014143,0.0007781842,0.0028089604,0.0038178603,0.00038898818,0.0016997706,0.00055424316,0.0007037856,0.00060890586],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031550328,0.000121130666,0.0012445597,0.28943875,0.0022027781,0.00044567077,0.00012285225,0.0084044915,0.0022956526,0.004103402,0.00863842,0.6826669],"study_design_scores_gemma":[0.00039287118,0.0018565294,0.010597426,0.15022343,0.025207754,0.0045895674,0.00050301536,0.021061586,0.008342584,0.0076296343,0.76920056,0.00039509137],"about_ca_topic_score_codex":0.0058374978,"about_ca_topic_score_gemma":0.0059171887,"teacher_disagreement_score":0.0058374978,"about_ca_system_score_codex":0.0010598394,"about_ca_system_score_gemma":0.0030394876,"threshold_uncertainty_score":0.0147563815},"labels":[],"label_agreement":null},{"id":"W2069667220","doi":"10.1038/sj.clpt.6100135","title":"Using HapMap Tools in Pharmacogenomic Discovery: The Thiopurine Methyltransferase Polymorphism","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of General Medical Sciences; American Lebanese Syrian Associated Charities; McGill University","keywords":"International HapMap Project; Thiopurine methyltransferase; Pharmacogenomics; Single-nucleotide polymorphism; Haplotype; Pharmacogenetics; Linkage disequilibrium; SNP; Biology; Genetics; 1000 Genomes Project; Candidate gene; Genotyping; SNP genotyping; Imputation (statistics); Computational biology; Gene; Allele; Genotype; Medicine; Internal medicine; Computer science; Azathioprine","score_opus":0.235715593926217,"score_gpt":0.496782670510655,"score_spread":0.261067076584438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069667220","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14905797,0.0052266847,0.8042055,0.0063605113,0.0005623553,0.0005804033,0.016345888,0.009468791,0.008191883],"genre_scores_gemma":[0.4434965,0.0016245337,0.5409552,0.0009853713,0.00032729187,0.0010723835,0.008756239,0.0007157747,0.0020667186],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9922995,0.0064485287,0.00017356501,0.00052578177,0.0004199879,0.00013278419],"domain_scores_gemma":[0.9779158,0.019066922,0.00084426586,0.0013980928,0.00043260638,0.00034225537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0112473555,0.0010230049,0.001414121,0.0038042772,0.00069193804,0.0012598267,0.0010463394,0.0009132235,0.008537313],"category_scores_gemma":[0.039815728,0.0006938788,0.00094840256,0.0049477275,0.0005334327,0.0010862144,0.0018792436,0.0011281386,0.0014592459],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017341401,0.00043447668,0.18152215,0.0020597158,0.00454924,0.0027118926,0.0020370632,0.033012465,0.012178944,0.02291906,0.07840023,0.65844065],"study_design_scores_gemma":[0.0023573104,0.000822506,0.32120693,0.0008263877,0.0030166449,0.0035369168,0.001432642,0.31521466,0.010519525,0.21586345,0.12448711,0.00071584125],"about_ca_topic_score_codex":0.0042594057,"about_ca_topic_score_gemma":0.0055821245,"teacher_disagreement_score":0.0112473555,"about_ca_system_score_codex":0.0002790438,"about_ca_system_score_gemma":0.0011154738,"threshold_uncertainty_score":0.059482396},"labels":[],"label_agreement":null},{"id":"W2070911028","doi":"10.1038/sj.clpt.6100509","title":"Reducing the Harm of “Harm Reduction”","year":2008,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre on Substance Use and Addiction","funders":"","keywords":"Harm reduction; CLARITY; Harm; Phrase; Reduction (mathematics); Psychological intervention; Political science; Public health; Psychology; Law; Medicine; Computer science; Psychiatry; Nursing; Chemistry; Artificial intelligence","score_opus":0.22450925386584372,"score_gpt":0.4810841791239577,"score_spread":0.256574925258114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070911028","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020205151,0.0009523094,0.000119389806,0.9918572,0.004862916,0.000005771186,0.000007540481,0.000011422776,0.0019814423],"genre_scores_gemma":[0.0011167915,0.00034274752,0.0001792379,0.9928069,0.0041951877,0.000009549435,0.000003216985,0.000004672622,0.0013416581],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98957974,0.005098305,0.00082485133,0.00093230966,0.0027119576,0.0008528899],"domain_scores_gemma":[0.9828688,0.012850659,0.00076972623,0.00043552121,0.0019462609,0.0011290933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075564226,0.00093370915,0.001145772,0.0005169353,0.00607316,0.0037808083,0.0021287927,0.06556096,0.005076977],"category_scores_gemma":[0.03604093,0.00057573064,0.0014684757,0.00049047224,0.006919637,0.007474448,0.0023541835,0.070995316,0.004931186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005153291,0.00005844491,0.00048943097,0.000096264026,0.000019459643,0.0008991575,0.000634448,0.00006792484,0.00025412577,0.013185242,0.9661271,0.018116755],"study_design_scores_gemma":[0.00008438719,0.00013608814,0.0010042557,0.00046403176,0.000025186886,0.002748346,0.0013175701,0.00035459572,0.00044159172,0.02107173,0.97228247,0.000069768415],"about_ca_topic_score_codex":0.005786893,"about_ca_topic_score_gemma":0.009553419,"teacher_disagreement_score":0.06556096,"about_ca_system_score_codex":0.0040336116,"about_ca_system_score_gemma":0.005610563,"threshold_uncertainty_score":0.03996265},"labels":[],"label_agreement":null},{"id":"W2071573249","doi":"10.1038/clpt.2011.279","title":"The Role and Impact of Research Agendas on the Comparative-Effectiveness Research Among Antihyperlipidemics","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Medical Research Council; U.S. National Library of Medicine; National Institute of Child Health and Human Development; National Health and Medical Research Council; National Institutes of Health","keywords":"Clinical trial; Clinical study design; Clinical research; Research design; Medicine; Alternative medicine; Set (abstract data type); Pharmaceutical industry; Clinical pharmacology; Medical education; Family medicine; Pharmacology; Internal medicine; Computer science; Sociology; Social science; Pathology","score_opus":0.8977318306422296,"score_gpt":0.7546349108145095,"score_spread":0.1430969198277201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071573249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68667966,0.035783973,0.13145068,0.06548524,0.00093759777,0.0028623645,0.0023601302,0.00035522532,0.07408505],"genre_scores_gemma":[0.9464721,0.003045984,0.046068616,0.0013401941,0.00041556254,0.0016385994,0.00029818818,0.00011793668,0.00060281536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.21413061,0.68728864,0.04276874,0.012654832,0.0383924,0.0047648284],"domain_scores_gemma":[0.024628608,0.90402967,0.043922976,0.017232979,0.0086573595,0.001528396],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6117032,0.0014609783,0.0040013953,0.019443389,0.005636125,0.020275708,0.0044059632,0.0046983142,0.0058248397],"category_scores_gemma":[0.8433373,0.0025658768,0.00392517,0.022348935,0.014020347,0.024552077,0.012937865,0.003891389,0.000652043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00623865,0.00042084893,0.45844948,0.007114506,0.0046604257,0.0011940325,0.014875812,0.021186057,0.0018924298,0.1833639,0.002607136,0.2979968],"study_design_scores_gemma":[0.0019687575,0.0013980514,0.39975378,0.0068287835,0.0055533713,0.0011128535,0.008068119,0.056984723,0.0050852145,0.4721476,0.040447112,0.0006516307],"about_ca_topic_score_codex":0.0041893814,"about_ca_topic_score_gemma":0.0042195814,"teacher_disagreement_score":0.38829678,"about_ca_system_score_codex":0.014681825,"about_ca_system_score_gemma":0.017928356,"threshold_uncertainty_score":0.4788391},"labels":[],"label_agreement":null},{"id":"W2072837835","doi":"10.1016/s0009-9236(03)90390-0","title":"The prevalence of prenatal alcohol exposure in neonates suspected of multiple drug exposure","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Mount Sinai Hospital","funders":"","keywords":"Prenatal exposure; Medicine; Drug; Prenatal alcohol exposure; Fetal alcohol; Clinical pharmacology; Alcohol; Pharmacology; Physiology; Pregnancy; Gestation; Biology","score_opus":0.04367244063006616,"score_gpt":0.3707738045924394,"score_spread":0.32710136396237327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072837835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896944,0.00021392039,0.00006206326,0.00010171015,0.000010725161,0.00000427688,0.00015379892,0.000005777795,0.00047823382],"genre_scores_gemma":[0.9994405,0.00024154059,0.00009699035,0.00002853369,0.000014012631,0.000007441953,0.00009580326,0.0000022392924,0.00007285777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907637,0.00020721387,0.00015193655,0.00016870096,0.00022649903,0.00016921823],"domain_scores_gemma":[0.99380857,0.00240686,0.002213571,0.00023049819,0.00047219312,0.00086836354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058577355,0.0003448177,0.00043546368,0.0017704943,0.00045610237,0.0006241225,0.0005737517,0.0013526491,0.0028593796],"category_scores_gemma":[0.009847247,0.0005104557,0.0003798005,0.0008308934,0.00061239494,0.0006577135,0.0006236543,0.0011320113,0.00033186688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058490547,0.000022450142,0.9976325,0.000007849373,0.0000092804885,0.0007980115,0.00008862842,0.000014464604,0.00039478368,0.000013536759,0.00004282191,0.0009172682],"study_design_scores_gemma":[0.0000028511738,0.00017523611,0.98823345,0.00002065748,0.000023248102,0.010438525,0.0005278903,0.00018187732,0.00027266302,0.000028669025,0.00008808796,0.00000680021],"about_ca_topic_score_codex":0.0056592748,"about_ca_topic_score_gemma":0.0039426642,"teacher_disagreement_score":0.0056592748,"about_ca_system_score_codex":0.00030756707,"about_ca_system_score_gemma":0.0004825095,"threshold_uncertainty_score":0.011252701},"labels":[],"label_agreement":null},{"id":"W2073056252","doi":"10.1067/mcp.2001.116892","title":"Red wine–cisapride interaction: Comparison with grapefruit juice","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Cisapride; Grapefruit juice; Pharmacokinetics; Crossover study; Citrus paradisi; Pharmacology; Area under the curve; Chemistry; Wine; Drug interaction; Oral administration; Medicine; Food science; Placebo; Rutaceae; Botany; Biology","score_opus":0.36433467423857135,"score_gpt":0.5632199207657329,"score_spread":0.19888524652716155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073056252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786735,0.0017103313,0.000093733164,0.000025015912,0.000018937626,0.000040886785,0.000054815195,0.0000051350585,0.0001837772],"genre_scores_gemma":[0.9981608,0.0008688217,0.0002849921,0.000088604844,0.0000543428,0.000025570667,0.00015080474,0.00000467376,0.00036149207],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99945194,0.0002847613,0.00003112766,0.000107144355,0.000082840554,0.00004230892],"domain_scores_gemma":[0.99943155,0.00022559786,0.0001564645,0.00002933023,0.00005191671,0.00010506554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074516324,0.00054101675,0.0010380514,0.00018521426,0.00019345188,0.00048205594,0.00020150558,0.0005065959,0.0013472082],"category_scores_gemma":[0.0011310914,0.00021242951,0.0010250492,0.00015047297,0.00031841427,0.00037201867,0.00016668742,0.00040485358,0.00013733761],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6665439,0.0056820414,0.11791112,0.0014261741,0.0064402306,0.00061481504,0.00037688145,0.00078692386,0.13854128,0.00011477809,0.00032722394,0.061234545],"study_design_scores_gemma":[0.013682613,0.27931875,0.66413915,0.000079610545,0.006235134,0.0011756473,0.00021871708,0.0036494639,0.02793451,0.00016083167,0.0033267303,0.000078812365],"about_ca_topic_score_codex":0.001496942,"about_ca_topic_score_gemma":0.0018490956,"teacher_disagreement_score":0.001496942,"about_ca_system_score_codex":0.00035777845,"about_ca_system_score_gemma":0.0002612436,"threshold_uncertainty_score":0.004506886},"labels":[],"label_agreement":null},{"id":"W2073582856","doi":"10.1038/sj.clpt.6100246","title":"Identification of Novel CYP2A6*1B Variants: The CYP2A6*1B Allele is Associated With Faster In Vivo Nicotine Metabolism","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; NIH Clinical Center; National Institutes of Health; National Center for Research Resources; National Institute on Drug Abuse; Canada Research Chairs","keywords":"CYP2A6; Nicotine; Cotinine; In vivo; Genotype; Pharmacology; Metabolism; Chemistry; Biology; Medicine; Endocrinology; Internal medicine; Genetics; Cytochrome P450; Biochemistry; CYP1A2; Gene","score_opus":0.17446933955008317,"score_gpt":0.4823130279593351,"score_spread":0.3078436884092519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073582856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998147,0.00042562562,0.0008251724,0.000087985565,0.000016120075,0.000016403093,0.00014972774,0.00001585122,0.0003161612],"genre_scores_gemma":[0.998211,0.00009130357,0.00078717264,0.00008485629,0.000034269873,0.000013849132,0.00018470653,0.000023463102,0.0005693693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961805,0.00010339067,0.000029661807,0.00014594234,0.00007235191,0.000030630443],"domain_scores_gemma":[0.99948573,0.00009819407,0.00018624314,0.000047298698,0.000048853854,0.00013371698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005110345,0.00043713537,0.0006254677,0.00047990071,0.00026065373,0.0004148564,0.00018519237,0.0005804664,0.0024750612],"category_scores_gemma":[0.0009425886,0.00018992646,0.00031021363,0.00040345022,0.00029475865,0.0001133744,0.00017703812,0.000642553,0.00041684168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055665327,0.0006514459,0.7540733,0.00009226638,0.00036856078,0.0033127984,0.00057761243,0.0001245396,0.21873726,0.00044210049,0.00066257926,0.015391016],"study_design_scores_gemma":[0.0001691251,0.0008065099,0.9831724,0.000010052715,0.00010105674,0.008532748,0.00006975665,0.00047069334,0.005412473,0.0001371886,0.0011051215,0.00001298215],"about_ca_topic_score_codex":0.0007520982,"about_ca_topic_score_gemma":0.0005090054,"teacher_disagreement_score":0.0024750612,"about_ca_system_score_codex":0.00011115931,"about_ca_system_score_gemma":0.000074510885,"threshold_uncertainty_score":0.00827986},"labels":[],"label_agreement":null},{"id":"W2074061848","doi":"10.1016/s0009-9236(03)90531-5","title":"The single‐Dose Pharmacokinetics of Pergolide in Healthy Adult Volunteers","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Pergolide; Pharmacokinetics; Medicine; Pharmacology; Internal medicine; Dopamine agonist; Agonist","score_opus":0.07537746891542815,"score_gpt":0.420606312668151,"score_spread":0.3452288437527229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074061848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568176,0.0012775755,0.0007804078,0.00008653957,0.00004825208,0.000119067845,0.0005139998,0.00010342181,0.001388957],"genre_scores_gemma":[0.99699426,0.00059337995,0.0003583537,0.000169222,0.00006723994,0.00007255742,0.00049504475,0.000027943088,0.0012220519],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973243,0.000074896765,0.000016285105,0.00008884047,0.0000502602,0.00003715517],"domain_scores_gemma":[0.9991529,0.00036021933,0.00012323612,0.00008862037,0.0000746131,0.0002004215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042758987,0.0005806429,0.0011630866,0.00027170012,0.00034399176,0.0005437881,0.00021189466,0.0008425552,0.0028279435],"category_scores_gemma":[0.0017795254,0.00064598065,0.00037819744,0.00019762188,0.00052499055,0.0007266987,0.00020275329,0.0009929664,0.0012127154],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37930083,0.005661372,0.15109988,0.00077784684,0.0014864841,0.003720322,0.0021452373,0.002749053,0.28260744,0.00074020604,0.0051815943,0.16452968],"study_design_scores_gemma":[0.009433565,0.12763074,0.80634725,0.00005404407,0.0010470509,0.008575179,0.0007462561,0.008708864,0.032582656,0.0006051887,0.0041359416,0.00013327776],"about_ca_topic_score_codex":0.0021245051,"about_ca_topic_score_gemma":0.0015516195,"teacher_disagreement_score":0.0028279435,"about_ca_system_score_codex":0.00037021274,"about_ca_system_score_gemma":0.0004204832,"threshold_uncertainty_score":0.00946039},"labels":[],"label_agreement":null},{"id":"W2074179782","doi":"10.1016/j.clpt.2004.11.111","title":"Grapefruit juice ingestion significantly reduces talinolol bioavailability","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Institute of General Medical Sciences","keywords":"Grapefruit juice; Ingestion; Cmax; Pharmacokinetics; Bioavailability; Chemistry; Pharmacology; Food science; Medicine; Biochemistry","score_opus":0.31361967455627265,"score_gpt":0.5246484012204284,"score_spread":0.21102872666415579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074179782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990741,0.0006621842,0.00009206165,0.000021113141,0.0000066010034,0.000007818279,0.000025177857,0.000019518737,0.0000914513],"genre_scores_gemma":[0.9987961,0.0003748758,0.00032722813,0.000035169607,0.000014504972,0.000005569635,0.00007277151,0.0000080147765,0.00036580526],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998652,0.000038451813,0.0000074530435,0.000037849677,0.00003046602,0.000020489802],"domain_scores_gemma":[0.99981433,0.000051961764,0.000070595175,0.000015574666,0.000015863985,0.000031774252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015203028,0.00034245956,0.0005756697,0.00013146909,0.00012614072,0.00027929986,0.0001728296,0.00034581206,0.0012349066],"category_scores_gemma":[0.00051822886,0.00013600585,0.0003163012,0.00009706726,0.0002065731,0.00017603421,0.00012701396,0.0003045616,0.00015036397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028250774,0.0011422732,0.015411668,0.00034412392,0.00041278606,0.000447069,0.00012348038,0.00023509705,0.9176845,0.000021431413,0.0002638978,0.035662934],"study_design_scores_gemma":[0.0012976982,0.0697493,0.56233656,0.00006001874,0.0007558262,0.0014152671,0.00026437454,0.0030857783,0.35656136,0.000076015,0.0043520085,0.000045768233],"about_ca_topic_score_codex":0.0011847601,"about_ca_topic_score_gemma":0.0016354254,"teacher_disagreement_score":0.0012349066,"about_ca_system_score_codex":0.0002326409,"about_ca_system_score_gemma":0.00013902015,"threshold_uncertainty_score":0.004131198},"labels":[],"label_agreement":null},{"id":"W2074621558","doi":"10.1038/clpt.2008.219","title":"The Increasing Complexity of Mercaptopurine Pharmacogenomics","year":2009,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Mercaptopurine; Computational biology; Biopharmaceutics; Pharmacology; Medicine; Biology; Genetics; Pharmacognosy","score_opus":0.3632518415847661,"score_gpt":0.5371047459326055,"score_spread":0.1738529043478394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074621558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041256368,0.995084,0.00093930936,0.0013197857,0.0001608345,0.000006395861,0.000038522132,0.00001576875,0.0020228177],"genre_scores_gemma":[0.0014777044,0.99585766,0.00091411214,0.0004808007,0.00030459263,0.000009017906,0.000052652253,0.000003408108,0.0009000611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996172,0.00009657146,0.000038115842,0.000069855894,0.00015931495,0.000018873965],"domain_scores_gemma":[0.9987921,0.0007807543,0.000106938714,0.0000371437,0.00024208517,0.000041050385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012407511,0.0007553142,0.0020859127,0.002265019,0.00021466677,0.0013655482,0.0010322753,0.001459779,0.0037331798],"category_scores_gemma":[0.0011860026,0.0003409144,0.0005483964,0.0026869834,0.0005429584,0.0018723595,0.0005597563,0.0018852106,0.0019599071],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042034102,0.00007434196,0.0004748613,0.008310546,0.00014160936,0.00037923132,0.000058227262,0.00064621767,0.0025131796,0.0058088135,0.015268367,0.96628267],"study_design_scores_gemma":[0.00002232421,0.000109395725,0.002929355,0.0024796412,0.00014712272,0.0029065546,0.00013162174,0.00041796805,0.001310601,0.0069230166,0.9825812,0.00004115444],"about_ca_topic_score_codex":0.0012163665,"about_ca_topic_score_gemma":0.0017446944,"teacher_disagreement_score":0.0037331798,"about_ca_system_score_codex":0.0008449366,"about_ca_system_score_gemma":0.0010741963,"threshold_uncertainty_score":0.012488782},"labels":[],"label_agreement":null},{"id":"W2075497716","doi":"10.1038/sj.clpt.6100497","title":"Smoked Marijuana as Medicine: Not Much Future","year":2008,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Toronto","funders":"","keywords":"Clinical pharmacology; Citation; Counterpoint; Point (geometry); Library science; Medicine; Psychology; Computer science; Pharmacology; Mathematics","score_opus":0.12816215568624473,"score_gpt":0.46578547536629195,"score_spread":0.3376233196800472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075497716","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001908449,0.0038932231,0.000041337906,0.98277825,0.011784118,0.0000029201929,0.000006439302,0.000006821057,0.0012960385],"genre_scores_gemma":[0.0023052457,0.003465516,0.00012950007,0.93991214,0.04988831,0.000013482344,0.0000056212743,0.0000072999464,0.004272783],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966619,0.001172786,0.00030731564,0.00050388486,0.0009989018,0.00035526752],"domain_scores_gemma":[0.9870149,0.0074811503,0.000781911,0.00039003286,0.0018481085,0.0024839875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041109365,0.00093222107,0.0023578329,0.0007507717,0.0062366794,0.0057847532,0.0025530462,0.07841501,0.010733775],"category_scores_gemma":[0.017082226,0.00078100356,0.0012163469,0.0007152124,0.008513791,0.0108891465,0.0032994857,0.070677295,0.005215292],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014483131,0.000102688624,0.00051818613,0.00022465544,0.000031604948,0.0027915873,0.00029703457,0.00004224928,0.00025781497,0.012773009,0.95314366,0.029672619],"study_design_scores_gemma":[0.00021992731,0.00012183325,0.0007390335,0.0008389663,0.000060514743,0.0035080363,0.0012983269,0.00024602405,0.00014072582,0.03828298,0.9544672,0.00007640907],"about_ca_topic_score_codex":0.0046357913,"about_ca_topic_score_gemma":0.0144565385,"teacher_disagreement_score":0.07841501,"about_ca_system_score_codex":0.0067135454,"about_ca_system_score_gemma":0.0072929156,"threshold_uncertainty_score":0.048710346},"labels":[],"label_agreement":null},{"id":"W2075657812","doi":"10.1002/cpt.102","title":"Cannabis and the maturing brain: Role in psychosis development","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cannabis; Psychosis; Psychology; Psychiatry; Brain development; Effects of cannabis; Medicine; Neuroscience; Cannabidiol","score_opus":0.09737075642580405,"score_gpt":0.4441014599707155,"score_spread":0.3467307035449114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075657812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44689006,0.38649043,0.0020588075,0.058423962,0.0004379115,0.000060654562,0.0005151431,0.00008904793,0.10503405],"genre_scores_gemma":[0.89725727,0.09659028,0.0007480095,0.0010027058,0.00014977613,0.000018685887,0.00005604705,0.000010581648,0.0041666883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977416,0.00008496397,0.000007801332,0.00002798986,0.00004569509,0.000059514994],"domain_scores_gemma":[0.99953437,0.00016391554,0.00011065248,0.00002028865,0.000046838824,0.00012394736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032983717,0.00030287233,0.00028397812,0.0011176117,0.0010421497,0.0018983678,0.00038965288,0.0009493279,0.006280473],"category_scores_gemma":[0.0009269335,0.00017657838,0.00022789203,0.0004740303,0.0028756792,0.0012457377,0.001587451,0.001332343,0.00034869916],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018416103,0.00057727104,0.15538694,0.0027944476,0.00029429086,0.018169638,0.014671106,0.0008243248,0.028600212,0.27720118,0.012176754,0.4874622],"study_design_scores_gemma":[0.0001272826,0.0010901808,0.5102235,0.002983514,0.00023576048,0.024892274,0.016451422,0.0010846984,0.0061637205,0.29781294,0.13869579,0.00023889882],"about_ca_topic_score_codex":0.010642094,"about_ca_topic_score_gemma":0.01621338,"teacher_disagreement_score":0.010642094,"about_ca_system_score_codex":0.0019307074,"about_ca_system_score_gemma":0.0023396784,"threshold_uncertainty_score":0.021160305},"labels":[],"label_agreement":null},{"id":"W2075872237","doi":"10.1016/s0009-9236(03)90512-1","title":"Transient Downregulation of MDR1A Gene Expression in Brains of Endotoxin‐Treated Rats","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Downregulation and upregulation; Pharmacology; Transient (computer programming); Gene; Gene expression; Cell biology; Biology; Medicine; Genetics; Computer science","score_opus":0.033757211325320134,"score_gpt":0.3633216319907018,"score_spread":0.32956442066538166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075872237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228436,0.0011053837,0.0031919745,0.00037568892,0.00017825566,0.00006207045,0.0010662985,0.00017965991,0.0015563855],"genre_scores_gemma":[0.9795202,0.0021623408,0.0055973143,0.00019456705,0.00008597789,0.00030479662,0.00151318,0.00009040661,0.010531264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977225,0.000016320892,0.000014346698,0.000053986816,0.00004495453,0.000098214725],"domain_scores_gemma":[0.9997422,0.000035236473,0.00007899354,0.000027576647,0.000037995575,0.00007788338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020363249,0.0007275146,0.00068074954,0.0005525595,0.00039653492,0.00041083974,0.00031905755,0.00053334783,0.0038363978],"category_scores_gemma":[0.00019314133,0.00036508517,0.0004492983,0.00036959632,0.0011155355,0.0007441818,0.00028619246,0.002254274,0.00054433336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017590688,0.00014068423,0.0001459071,0.00005060389,0.000013154904,0.00015626119,0.00005073518,0.000029192055,0.99568945,0.00018308552,0.0000891074,0.0016928065],"study_design_scores_gemma":[0.00012815539,0.0017241888,0.0042849397,0.000011126812,0.00005461157,0.00028315376,0.00016925517,0.0003640808,0.99206465,0.00018505238,0.00072015263,0.00001053395],"about_ca_topic_score_codex":0.0013529952,"about_ca_topic_score_gemma":0.002354562,"teacher_disagreement_score":0.0038363978,"about_ca_system_score_codex":0.00051432085,"about_ca_system_score_gemma":0.00067501026,"threshold_uncertainty_score":0.0128340125},"labels":[],"label_agreement":null},{"id":"W2076194172","doi":"10.1038/sj.clpt.6100056","title":"Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; U.S. Public Health Service; Health Canada; Deutsche Forschungsgemeinschaft; Vanderbilt University; GlaxoSmithKline","keywords":"Fexofenadine; Grapefruit juice; Pharmacology; Transporter; CYP3A4; Efflux; Chemistry; Organic anion-transporting polypeptide; Terfenadine; Pharmacokinetics; Biochemistry; Biology; Cytochrome P450; Metabolism; Gene","score_opus":0.05382730719279665,"score_gpt":0.43285645951449836,"score_spread":0.3790291523217017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076194172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925996,0.0054104547,0.00033946964,0.00007796428,0.00001179262,0.00002094849,0.0002755546,0.000020718435,0.0012433274],"genre_scores_gemma":[0.99830234,0.0007214091,0.00020682046,0.000071767434,0.000008822559,0.000009004182,0.0001957123,0.0000055171004,0.00047865702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979836,0.00005875033,0.0000103663315,0.00007957202,0.00003520281,0.000017781826],"domain_scores_gemma":[0.9998301,0.00003806082,0.00006767801,0.000020747613,0.000020770736,0.000022607634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026063932,0.000257347,0.00047945968,0.0002618421,0.00026895117,0.0003771006,0.00009792546,0.0003929892,0.0010549458],"category_scores_gemma":[0.0004700679,0.00018105347,0.00032665403,0.0003397169,0.00021844149,0.00021918946,0.0001236352,0.0003559527,0.00016226196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015477079,0.00057424424,0.8260172,0.0004409247,0.00084482646,0.0028927678,0.00035793768,0.0002942339,0.11288918,0.0002630728,0.00074057246,0.039207924],"study_design_scores_gemma":[0.000047420468,0.0020976777,0.9906764,0.000013706651,0.00023499015,0.0017360632,0.000073024894,0.000291625,0.0030733815,0.000066044886,0.001679137,0.00001063144],"about_ca_topic_score_codex":0.0017060221,"about_ca_topic_score_gemma":0.0017553671,"teacher_disagreement_score":0.0017060221,"about_ca_system_score_codex":0.00029329985,"about_ca_system_score_gemma":0.00010206268,"threshold_uncertainty_score":0.0035291314},"labels":[],"label_agreement":null},{"id":"W2077136462","doi":"10.1067/mcp.2001.113185","title":"Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"American Association of Pharmaceutical Scientists; U.S. Public Health Service; Medical Research Council Canada; National Center for Research Resources; National Institute of General Medical Sciences; Medical Research Council; University of Washington","keywords":"Grapefruit juice; Chemistry; Felodipine; Orange juice; Furocoumarins; Orange (colour); Food science; Citrus paradisi; Pharmacokinetics; Metabolite; Pharmacology; Chromatography; Biochemistry; Rutaceae; Botany; Medicine; Endocrinology","score_opus":0.3144994907808211,"score_gpt":0.5280572764054656,"score_spread":0.2135577856246445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077136462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991436,0.00056614773,0.000078415884,0.000012478322,0.000005543435,0.000040621533,0.000027731823,0.000005687843,0.00011968403],"genre_scores_gemma":[0.9989588,0.00030025758,0.00035208525,0.000035308523,0.000017884498,0.000028672304,0.000075244585,0.0000031502095,0.0002285841],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996724,0.00013105276,0.000021594,0.0000712565,0.000071314695,0.00003244223],"domain_scores_gemma":[0.9997242,0.000081362996,0.00009756048,0.000018426033,0.000017676832,0.000060702747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042934273,0.0004134852,0.0007705285,0.00014775842,0.00014479512,0.0003044603,0.00018227239,0.0004949541,0.0014006997],"category_scores_gemma":[0.0006941328,0.00014642849,0.00046374174,0.00015568755,0.00028949766,0.00026869975,0.00015005702,0.00032513813,0.00007398073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2124079,0.0050209956,0.021825181,0.00079053146,0.0010684981,0.00038290815,0.00018172464,0.00041826852,0.71340466,0.00008564839,0.00017850522,0.044235233],"study_design_scores_gemma":[0.017258959,0.384841,0.43639258,0.000057975372,0.002180676,0.0013538032,0.00017688837,0.0026957032,0.1515023,0.000098735654,0.003365353,0.00007601818],"about_ca_topic_score_codex":0.00096862036,"about_ca_topic_score_gemma":0.0016112078,"teacher_disagreement_score":0.0014006997,"about_ca_system_score_codex":0.00027526284,"about_ca_system_score_gemma":0.00022118365,"threshold_uncertainty_score":0.004685819},"labels":[],"label_agreement":null},{"id":"W2077489654","doi":"10.1038/clpt.2013.127","title":"Regulatory Review: How Do Agencies Ensure the Quality of Decision Making?","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research","funders":"","keywords":"Multinational corporation; Quality (philosophy); Business; Clinical pharmacology; Regulatory science; Public relations; Pharmacology; Political science; Medicine; Finance","score_opus":0.5983493181868063,"score_gpt":0.5783310968958172,"score_spread":0.02001822129098907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077489654","genre_codex":"commentary","genre_gemma":"review","domain_codex":"methods","domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023944986,0.022636907,0.027856627,0.91094536,0.008258141,0.00050178164,0.00010986639,0.00036088948,0.026935901],"genre_scores_gemma":[0.34991193,0.037942275,0.09353663,0.47751954,0.022560824,0.0032385392,0.00036024835,0.0013495439,0.013580405],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.3491767,0.43955922,0.042375345,0.021842964,0.12634026,0.020705521],"domain_scores_gemma":[0.12812445,0.4901481,0.049892418,0.043212704,0.26532507,0.023297282],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5790363,0.0015084278,0.007132074,0.0097012175,0.014116421,0.063724525,0.009355965,0.036335193,0.008709795],"category_scores_gemma":[0.7359053,0.002441975,0.0030526796,0.01121829,0.044068802,0.052486036,0.015747482,0.041011695,0.005625686],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025688746,0.0002389313,0.0038817069,0.002914597,0.00063145906,0.00023687327,0.007837791,0.0017732641,0.00048063137,0.42121193,0.3428878,0.21764822],"study_design_scores_gemma":[0.00040713235,0.00023570292,0.0034315365,0.005826884,0.00032291934,0.0001692549,0.004929452,0.0020123895,0.000832688,0.35544232,0.6259305,0.00045916074],"about_ca_topic_score_codex":0.0269872,"about_ca_topic_score_gemma":0.015361914,"teacher_disagreement_score":0.4209637,"about_ca_system_score_codex":0.030848285,"about_ca_system_score_gemma":0.16892418,"threshold_uncertainty_score":0.5191232},"labels":[],"label_agreement":null},{"id":"W2079813147","doi":"10.1038/clpt.2008.83","title":"Translational Pharmacology: Harnessing Increased Specialization of Research Within the Basic Biological Sciences","year":2008,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Translational research; Clinical pharmacology; Biological sciences; Translational medicine; Computational biology; Medicine; Biology; Pharmacology; Biotechnology; Pathology","score_opus":0.5693454162406317,"score_gpt":0.6218048982235849,"score_spread":0.05245948198295314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079813147","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022086585,0.24468045,0.2507163,0.30900782,0.006174043,0.00060142245,0.00031901215,0.0019757927,0.16443856],"genre_scores_gemma":[0.33391494,0.34448415,0.19503659,0.07582033,0.023329597,0.00093412865,0.00035359996,0.0008379798,0.025288634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99502003,0.0024544445,0.0002512456,0.00050123985,0.0012964875,0.00047661216],"domain_scores_gemma":[0.9833143,0.009947186,0.0010425487,0.00212998,0.0011977493,0.0023682055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018021837,0.0009604626,0.0012668546,0.0030274233,0.001227266,0.007067375,0.0019529623,0.0038319118,0.012782429],"category_scores_gemma":[0.0106427865,0.0006261697,0.0010007389,0.0017730412,0.010561162,0.010879767,0.008032644,0.007448115,0.004059361],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028026354,0.00046792167,0.001792942,0.0023847918,0.00014068226,0.0006149227,0.0019353676,0.0012761987,0.013296605,0.43280047,0.053882286,0.49112755],"study_design_scores_gemma":[0.00025122872,0.00084291515,0.0026972552,0.0011319263,0.00007198245,0.0019204833,0.0008759771,0.0017548746,0.0048604333,0.47373945,0.51176035,0.000093086586],"about_ca_topic_score_codex":0.0004451637,"about_ca_topic_score_gemma":0.00070105976,"teacher_disagreement_score":0.018021837,"about_ca_system_score_codex":0.0025057073,"about_ca_system_score_gemma":0.0064141876,"threshold_uncertainty_score":0.095309734},"labels":[],"label_agreement":null},{"id":"W2082018725","doi":"10.1038/clpt.2010.309","title":"Science Spin: iPS Cell Research in the News","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Stem Cell Network","keywords":"Induced pluripotent stem cell; Reprogramming; Embryonic stem cell; Context (archaeology); Stem cell; Cell biology; Phenomenon; Biology; Neuroscience; Cell; Genetics; Epistemology; Gene; Philosophy","score_opus":0.35425265112825316,"score_gpt":0.5173011750355407,"score_spread":0.16304852390728758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082018725","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086041965,0.036588673,0.0011812157,0.57755363,0.35642982,0.000051389252,0.00044823848,0.00039294205,0.026493777],"genre_scores_gemma":[0.009905111,0.055735547,0.0018254644,0.57334405,0.21932031,0.00009631483,0.0008889331,0.00036125348,0.13852294],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99734265,0.00031735492,0.00020035414,0.00019455842,0.0017189127,0.00022616271],"domain_scores_gemma":[0.98942715,0.004547067,0.00053058105,0.00048240554,0.0024405124,0.0025722934],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.007903522,0.0009627339,0.00053267693,0.0013581049,0.0022332731,0.0071641314,0.0010168382,0.009079287,0.013692974],"category_scores_gemma":[0.013287672,0.00049505604,0.0010313744,0.0009759538,0.0021291727,0.0065880613,0.0017015298,0.022304427,0.0088574635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049549657,0.000031160194,0.00007670699,0.00008179484,0.000008809881,0.0001589627,0.000062103514,0.000024502766,0.00035302193,0.0036179742,0.9718939,0.023641435],"study_design_scores_gemma":[0.0000169455,0.000038120543,0.00020421988,0.0001401091,0.0000094225015,0.00013068113,0.00012851815,0.000038797185,0.00041442175,0.0028999294,0.99596727,0.000011633395],"about_ca_topic_score_codex":0.0011587114,"about_ca_topic_score_gemma":0.0026212502,"teacher_disagreement_score":0.99776673,"about_ca_system_score_codex":0.0017440177,"about_ca_system_score_gemma":0.0018678432,"threshold_uncertainty_score":0.04580754},"labels":[],"label_agreement":null},{"id":"W2085993091","doi":"10.1038/sj.clpt.6100272","title":"Stimulation of Cholecystokinin-A Receptors With GI181771X does not Cause Weight Loss in Overweight or Obese Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Cholecystokinin; Overweight; Weight loss; Stimulation; Receptor; Medicine; Endocrinology; Internal medicine; Obesity; Cholecystokinin receptor","score_opus":0.09015561396236035,"score_gpt":0.4032381747137445,"score_spread":0.3130825607513842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085993091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997259,0.0017385819,0.00013142417,0.00013105982,0.000041842643,0.00008843215,0.000099444194,0.000019698637,0.00049047795],"genre_scores_gemma":[0.99699426,0.001388451,0.00040379533,0.00032169366,0.00008036738,0.00016042271,0.0003229811,0.0000055428745,0.0003225803],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979156,0.00006510316,0.00003087053,0.000034616045,0.000036922494,0.00004091897],"domain_scores_gemma":[0.9996455,0.00009908505,0.00008955953,0.00003452814,0.0000145595395,0.0001168151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044831325,0.00037685878,0.0019647707,0.0002017055,0.00029801187,0.00030563903,0.00029555307,0.0005464673,0.002213297],"category_scores_gemma":[0.0009631903,0.00029083443,0.00067448936,0.00019471082,0.0005610617,0.0003246187,0.00017300091,0.00082820066,0.00040637876],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70131737,0.013790692,0.025974274,0.0009847031,0.0021170406,0.0006969703,0.00013814372,0.0007374283,0.10231088,0.0003050014,0.0018514385,0.14977607],"study_design_scores_gemma":[0.4250347,0.40330252,0.14147809,0.0001344629,0.0025882812,0.0021057955,0.00019438108,0.0015021852,0.01860128,0.0004973512,0.0045056967,0.00005528861],"about_ca_topic_score_codex":0.00033124167,"about_ca_topic_score_gemma":0.0004449725,"teacher_disagreement_score":0.002213297,"about_ca_system_score_codex":0.00027623665,"about_ca_system_score_gemma":0.00041308117,"threshold_uncertainty_score":0.007404208},"labels":[],"label_agreement":null},{"id":"W2086282994","doi":"10.1038/clpt.2011.37","title":"Human Induced Pluripotent Stem Cells: The Past, Present, and Future","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Induced pluripotent stem cell; Reprogramming; Regenerative medicine; Stem cell; Drug discovery; Somatic cell; Biology; Neuroscience; Engineering ethics; Embryonic stem cell; Cell biology; Bioinformatics; Cell; Engineering; Genetics","score_opus":0.18575731096352333,"score_gpt":0.4484902227186909,"score_spread":0.26273291175516755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086282994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012911893,0.9959942,0.00082311314,0.0011310673,0.0002844226,0.000004548108,0.0000144308,0.000014597619,0.0016045527],"genre_scores_gemma":[0.0010186367,0.99646324,0.00069083535,0.0005444498,0.0002266641,0.0000069642624,0.000020237965,0.000002387463,0.0010266182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997024,0.000068125286,0.000041141553,0.00004242466,0.00012537903,0.000020524209],"domain_scores_gemma":[0.9995253,0.00024847078,0.000050922812,0.000024331557,0.00010637312,0.000044620432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015891478,0.0006309806,0.0006971486,0.0011820102,0.00022782033,0.0009877547,0.000864965,0.0014299355,0.0025590872],"category_scores_gemma":[0.00084968517,0.00022940214,0.00029061877,0.0015313625,0.0009935393,0.002197505,0.0005899545,0.0019039932,0.002348843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034542983,0.000027554857,0.0001211875,0.0026909802,0.000014653072,0.00017719578,0.00006147174,0.00019090579,0.002254495,0.009054027,0.0142106395,0.97116226],"study_design_scores_gemma":[0.00001496734,0.00008449401,0.00037237667,0.0015059484,0.00003155444,0.0010761024,0.000087886685,0.00009592275,0.0014476025,0.007985746,0.9872815,0.000015934778],"about_ca_topic_score_codex":0.0006203115,"about_ca_topic_score_gemma":0.0009529545,"teacher_disagreement_score":0.0025590872,"about_ca_system_score_codex":0.00057593285,"about_ca_system_score_gemma":0.0008115701,"threshold_uncertainty_score":0.008561015},"labels":[],"label_agreement":null},{"id":"W2086349371","doi":"10.1038/clpt.2012.171","title":"A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; St. Michael's Hospital; St. Joseph’s Healthcare Hamilton; Institute for Clinical Evaluative Sciences; McMaster University; University of Toronto","funders":"Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences","keywords":"Levothyroxine; Warfarin; Medicine; Odds ratio; Drug interaction; Confidence interval; Drug; Population; Internal medicine; Pharmacology; Atrial fibrillation; Hormone","score_opus":0.23197241596887405,"score_gpt":0.5234777862234357,"score_spread":0.2915053702545616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086349371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730104,0.0006841878,0.000984711,0.000072011775,0.0000068114673,0.000031744716,0.0003307563,0.000012074449,0.00057671283],"genre_scores_gemma":[0.9992052,0.00012823929,0.0003995875,0.000022853616,0.000016760006,0.000009104995,0.00016126173,0.0000011727175,0.000055923025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975642,0.0011025617,0.00024627298,0.0003550893,0.0006639156,0.00006799578],"domain_scores_gemma":[0.99365,0.002520233,0.0023009623,0.0006949113,0.0006088161,0.00022508502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028331103,0.00025498722,0.0005206805,0.0015584737,0.0003376184,0.0005472033,0.0004982119,0.0004315953,0.0006705432],"category_scores_gemma":[0.010194552,0.00020860544,0.0006777162,0.0010468508,0.0002664789,0.00045373075,0.0003132283,0.00043954892,0.0001350981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023518523,0.000037100937,0.99667895,0.000014588375,0.00035183728,0.000086838896,0.00005689041,0.00008153691,0.0005103605,0.000036769936,0.000049028287,0.0018608968],"study_design_scores_gemma":[0.000015793352,0.00043930166,0.99756265,0.0000033252745,0.0001813543,0.0006227319,0.000060515147,0.0006523873,0.00019695496,0.00006342405,0.00019606871,0.000005503105],"about_ca_topic_score_codex":0.0032561524,"about_ca_topic_score_gemma":0.0033513168,"teacher_disagreement_score":0.0032561524,"about_ca_system_score_codex":0.00035783232,"about_ca_system_score_gemma":0.00037006522,"threshold_uncertainty_score":0.014983118},"labels":[],"label_agreement":null},{"id":"W2089308487","doi":"10.1038/sj.clpt.6100068","title":"Clinical Pharmacology Education: Looking into the Future","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada; Dalhousie University","funders":"International Union of Basic and Clinical Pharmacology","keywords":"Clinical pharmacology; Accreditation; Pharmacology; Medicine; Clinical Practice; Engineering ethics; Medical education; Drug development; Drug; Family medicine; Engineering","score_opus":0.31771547726393434,"score_gpt":0.6228767785474149,"score_spread":0.3051613012834805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089308487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008277325,0.9859424,0.00010987615,0.011330579,0.00083107123,0.0000038114858,0.0000060291654,0.000010856018,0.001682746],"genre_scores_gemma":[0.0009925071,0.99343055,0.00034461112,0.0038103748,0.00065638043,0.0000072835473,0.000012095627,0.0000016080844,0.00074453576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999014,0.00032636692,0.00008661623,0.00009806633,0.00037053108,0.00010443508],"domain_scores_gemma":[0.9974986,0.0010255906,0.00028993707,0.000059316255,0.00074515777,0.00038142342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031392034,0.00079428824,0.0014427148,0.001920619,0.0008017669,0.0028115257,0.0012973178,0.004534024,0.007887551],"category_scores_gemma":[0.0031263446,0.00033371945,0.0006216384,0.0029973767,0.0014309564,0.0070743356,0.0012424813,0.005905843,0.0028806606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008599412,0.00011569257,0.00028652875,0.014183986,0.0000490786,0.00023093312,0.00021694326,0.00028251647,0.0005507104,0.01453274,0.095684834,0.87378013],"study_design_scores_gemma":[0.00003850209,0.00008665384,0.0012666988,0.012478843,0.000050487262,0.0011087196,0.000557804,0.00012704825,0.000105082494,0.0069212355,0.97723836,0.00002060605],"about_ca_topic_score_codex":0.004981494,"about_ca_topic_score_gemma":0.008175605,"teacher_disagreement_score":0.007887551,"about_ca_system_score_codex":0.0028672146,"about_ca_system_score_gemma":0.00804098,"threshold_uncertainty_score":0.02638644},"labels":[],"label_agreement":null},{"id":"W2089354656","doi":"10.1038/clpt.2009.311","title":"Obesity, Inflammation, and Cardiovascular Risk","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Adipose tissue; Context (archaeology); Inflammation; Obesity; Disease; Medicine; Bioinformatics; Epidemiology; Metabolic syndrome; Dysfunctional family; Internal medicine; Endocrinology; Biology","score_opus":0.09156070844176087,"score_gpt":0.427290571305833,"score_spread":0.33572986286407214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089354656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009207891,0.998626,0.00006778326,0.0001923318,0.00014718293,0.0000033254717,0.000008306954,0.0000048564325,0.00085824815],"genre_scores_gemma":[0.0004444513,0.998637,0.000110527,0.000085519336,0.00015359122,0.000004941454,0.000014324599,5.408847e-7,0.000548951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998258,0.000033241544,0.00002265329,0.00002679708,0.0000762896,0.000015257526],"domain_scores_gemma":[0.99986553,0.00004615658,0.00002306532,0.0000046304212,0.00004033573,0.000020228243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041290815,0.0009807182,0.0015322596,0.0018236145,0.0003143873,0.0008008532,0.0006515982,0.0010424401,0.003819941],"category_scores_gemma":[0.00036991603,0.00023761626,0.00029597798,0.002255483,0.00042082366,0.0008304355,0.00064185,0.0014146469,0.0031909843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081608225,0.00012059925,0.0003165052,0.009613933,0.00008733935,0.00023391197,0.00006315144,0.0002627857,0.0018810406,0.0035842739,0.030447332,0.95330757],"study_design_scores_gemma":[0.00002358622,0.00012113094,0.002303216,0.0035506885,0.00009170795,0.0018917817,0.000087052205,0.00010148329,0.0004104296,0.003294553,0.9881031,0.000021306101],"about_ca_topic_score_codex":0.0011393619,"about_ca_topic_score_gemma":0.0019315978,"teacher_disagreement_score":0.003819941,"about_ca_system_score_codex":0.0005190846,"about_ca_system_score_gemma":0.0011469121,"threshold_uncertainty_score":0.012778997},"labels":[],"label_agreement":null},{"id":"W2089453005","doi":"10.1038/clpt.2009.179","title":"Expediting Patients’ Access to Medicines by Improving the Predictability of Drug Development and the Regulatory Approval Process","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Expediting; Drug development; Clinical pharmacology; Regulatory science; Risk analysis (engineering); Drug approval; Business; Access to medicines; Process (computing); Medicine; Drug; Process management; Pharmacology; Computer science; Engineering","score_opus":0.08671489304942995,"score_gpt":0.38417699705932334,"score_spread":0.29746210400989337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089453005","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20758381,0.00905348,0.54096496,0.12889197,0.00066991925,0.003217235,0.00052981026,0.002144544,0.106944196],"genre_scores_gemma":[0.8680929,0.0035345047,0.12142145,0.0029300267,0.00096903025,0.00061647024,0.00020640877,0.00017482738,0.0020543954],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8796181,0.08563541,0.008135385,0.0042534512,0.018912144,0.0034456586],"domain_scores_gemma":[0.53138524,0.35414782,0.06437185,0.022121916,0.023399977,0.0045731748],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14627741,0.0007935559,0.0012401491,0.0033939069,0.0020757844,0.014617929,0.0020316842,0.0021041606,0.008409804],"category_scores_gemma":[0.2653387,0.0010675524,0.0014812018,0.0033933823,0.0025671916,0.0110442145,0.006165958,0.006372957,0.0018123671],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011971071,0.0008452276,0.053935185,0.0012691171,0.00036943523,0.00052714,0.0036667653,0.06574216,0.0041104225,0.18512028,0.02329747,0.6599197],"study_design_scores_gemma":[0.0015660165,0.003644966,0.12360187,0.0020700318,0.000611577,0.0020851474,0.004117315,0.15774865,0.023640709,0.43546537,0.24457851,0.00086987216],"about_ca_topic_score_codex":0.0027752526,"about_ca_topic_score_gemma":0.003952153,"teacher_disagreement_score":0.8537226,"about_ca_system_score_codex":0.0069327955,"about_ca_system_score_gemma":0.029843424,"threshold_uncertainty_score":0.77359813},"labels":[],"label_agreement":null},{"id":"W2090321716","doi":"10.1038/sj.clpt.6100510","title":"Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Varenicline; Placebo; Partial agonist; Drug; Abuse liability; Medicine; Pharmacology; Smoking cessation; Crossover study; Agonist; Nicotinic agonist; Clinical pharmacology; Amphetamine; Anesthesia; Nicotine; Psychiatry; Internal medicine; Receptor; Alternative medicine","score_opus":0.11335708213670695,"score_gpt":0.4271345216535918,"score_spread":0.31377743951688486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090321716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991924,0.0003307641,0.000054069034,0.000017596989,0.0000035276537,0.000016471733,0.000018292983,0.000001583806,0.00036516966],"genre_scores_gemma":[0.99895155,0.00048338066,0.00010925476,0.000032559285,0.000010054827,0.000016311507,0.000049495462,0.0000010285081,0.00034638276],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994124,0.00035264023,0.000030129899,0.000044997145,0.00011340992,0.000046405497],"domain_scores_gemma":[0.9994235,0.00025008668,0.00011483112,0.00005873547,0.000038844366,0.000114062306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008544075,0.0001583743,0.00024150664,0.0003184601,0.00022538024,0.00024356703,0.00010296574,0.00038945998,0.001847383],"category_scores_gemma":[0.0015703652,0.00021820357,0.0002096319,0.00009745326,0.0003205934,0.00022526573,0.00021141497,0.00034300835,0.00022689838],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055752534,0.015214212,0.42824933,0.0002882516,0.00066181156,0.0010701322,0.0022605255,0.0004584368,0.3632363,0.00096290355,0.0005821993,0.13126342],"study_design_scores_gemma":[0.00097404193,0.13718481,0.82292295,0.000034378507,0.00028150788,0.0030311772,0.0009380049,0.0017538291,0.03026301,0.00047266373,0.0021081283,0.00003545566],"about_ca_topic_score_codex":0.0006863418,"about_ca_topic_score_gemma":0.00085603725,"teacher_disagreement_score":0.001847383,"about_ca_system_score_codex":0.0001412126,"about_ca_system_score_gemma":0.00016374128,"threshold_uncertainty_score":0.0061801076},"labels":[],"label_agreement":null},{"id":"W2091899294","doi":"10.1038/clpt.2011.155","title":"In Vitro Testing for Hypersensitivity-Mediated Adverse Drug Reactions: Challenges and Future Directions","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug reaction; Drug; Clinical pharmacology; Medicine; In vitro; Pharmacology; Gold standard (test); Presentation (obstetrics); Adverse effect; Intensive care medicine; Chemistry; Internal medicine; Surgery","score_opus":0.28181353493323713,"score_gpt":0.4664910402929285,"score_spread":0.18467750535969135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091899294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015066902,0.99570775,0.0007027757,0.0015366253,0.0002711176,0.000012115193,0.000017102915,0.000026010624,0.0015757754],"genre_scores_gemma":[0.0012099821,0.9944238,0.0017990387,0.00083539175,0.0005236313,0.000017289392,0.000033231157,0.0000063439466,0.0011512514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979572,0.00054681115,0.00024715837,0.0001863775,0.0009918074,0.00007049483],"domain_scores_gemma":[0.9899194,0.0058803787,0.0007601227,0.00026474387,0.0028416486,0.00033372262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067014,0.001434163,0.0035712402,0.003389023,0.00033543646,0.0022284288,0.0020910406,0.0028116785,0.0052956818],"category_scores_gemma":[0.005238633,0.0004884604,0.0009832666,0.0024512853,0.0013830464,0.004260077,0.0008250888,0.0036200495,0.0051107095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051936637,0.0001551102,0.00047201908,0.005126053,0.00004273275,0.00025883314,0.000057501613,0.00026292494,0.0017309133,0.0019355069,0.017319495,0.97258705],"study_design_scores_gemma":[0.00004891805,0.00046272296,0.0026503664,0.00672193,0.00015545577,0.005506652,0.00027076772,0.00040977454,0.0022181384,0.005120172,0.9763633,0.00007191427],"about_ca_topic_score_codex":0.001282179,"about_ca_topic_score_gemma":0.002376659,"teacher_disagreement_score":0.0067014,"about_ca_system_score_codex":0.00089909125,"about_ca_system_score_gemma":0.0014699965,"threshold_uncertainty_score":0.035440803},"labels":[],"label_agreement":null},{"id":"W2091956683","doi":"10.1038/clpt.2008.143","title":"Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Paul University","funders":"","keywords":"QT interval; Rotigotine; Medicine; Moxifloxacin; Placebo; Internal medicine; Anesthesia; Cardiology; Heart rate; Confidence interval; Parkinson's disease; Disease; Antibiotics","score_opus":0.032528974817792364,"score_gpt":0.3625169162245537,"score_spread":0.3299879414067613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091956683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685574,0.0020338288,0.00026310928,0.00009177141,0.000022278413,0.00015762584,0.00021246566,0.000009729516,0.00035348136],"genre_scores_gemma":[0.99788386,0.00063197396,0.00046440586,0.00017291102,0.000093353694,0.00019040139,0.00030337833,0.0000030686572,0.00025658036],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995297,0.0002649562,0.000042210446,0.00008265862,0.00004903067,0.00003150677],"domain_scores_gemma":[0.9990195,0.00024055789,0.0002660591,0.00010282937,0.00009056444,0.00028052597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010180585,0.00058193103,0.0016378664,0.0001734616,0.00025582124,0.0002638474,0.00021940627,0.00070540124,0.0013877962],"category_scores_gemma":[0.0013731754,0.00020061395,0.0005646658,0.00025058305,0.00032507925,0.00036716773,0.00020920878,0.0007986123,0.00026581052],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74052435,0.008078908,0.07824912,0.0011288862,0.001561531,0.0007741227,0.000372836,0.0008748184,0.09133149,0.00017088473,0.00096197077,0.07597108],"study_design_scores_gemma":[0.14522299,0.49867013,0.3373702,0.00006651036,0.0016347815,0.0017995393,0.000133429,0.0015052407,0.0089911865,0.00028075147,0.0042687063,0.00005645953],"about_ca_topic_score_codex":0.00020289679,"about_ca_topic_score_gemma":0.0003441218,"teacher_disagreement_score":0.0016378664,"about_ca_system_score_codex":0.00018129671,"about_ca_system_score_gemma":0.00022221499,"threshold_uncertainty_score":0.0053840876},"labels":[],"label_agreement":null},{"id":"W2092261835","doi":"10.1016/s0009-9236(03)90386-9","title":"Pregnancy outcome and maternal changes in smoking habits with gestational exposure to bupropion","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Bupropion; Medicine; Pregnancy; Obstetrics; Gestation; Gestational age; Smoking cessation; Biology","score_opus":0.11165288277075909,"score_gpt":0.43743774961807347,"score_spread":0.3257848668473144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092261835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981207,0.0002944447,0.000098028075,0.00012897953,0.000013842678,0.000008718303,0.00035313927,0.0000077617815,0.0009743396],"genre_scores_gemma":[0.9985898,0.00029518435,0.00010098193,0.000044149154,0.000016928758,0.000018100778,0.00030957488,0.000005785081,0.0006194787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994092,0.0001956563,0.00005769547,0.00009123949,0.00012762136,0.000118670076],"domain_scores_gemma":[0.9948061,0.002199188,0.00170814,0.00034591966,0.00019921189,0.0007413849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069413014,0.00022780057,0.0003386411,0.0006548757,0.00035589043,0.0006811519,0.0004787929,0.0007994769,0.003215859],"category_scores_gemma":[0.008128291,0.00051546487,0.0005151355,0.0009897377,0.00047914372,0.00073800614,0.0005060158,0.0014402797,0.00044006456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020484333,0.00019630705,0.99117106,0.000018514393,0.00010801631,0.0006449521,0.00025241612,0.00008884688,0.001351493,0.000058316404,0.00007961274,0.0039820066],"study_design_scores_gemma":[0.00000918977,0.000539483,0.99804616,0.000007945313,0.000041262556,0.00060804404,0.00014050685,0.00017908173,0.00027580908,0.000041537784,0.00010368192,0.000007400833],"about_ca_topic_score_codex":0.004909236,"about_ca_topic_score_gemma":0.0039330977,"teacher_disagreement_score":0.004909236,"about_ca_system_score_codex":0.00044084556,"about_ca_system_score_gemma":0.00061774795,"threshold_uncertainty_score":0.010758102},"labels":[],"label_agreement":null},{"id":"W2092855364","doi":"10.1016/s0009-9236(03)90700-4","title":"CYP3A and P‐glycoprotein induction with St. John's wort in healthy volunteers of selected ethnic populations","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Phytochemistry and biological activity of medicinal plants","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP3A; Ethnic group; Traditional medicine; Glycoprotein; Medicine; Pharmacology; Internal medicine; Biology; Anthropology; Genetics; Sociology; Metabolism; Cytochrome P450","score_opus":0.15026811057444686,"score_gpt":0.3859513797236898,"score_spread":0.23568326914924295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092855364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904984,0.00031213142,0.0000673832,0.000034837336,0.000011482328,0.000014097937,0.00008960096,0.0000050599997,0.00041568495],"genre_scores_gemma":[0.9991227,0.00018254842,0.000052809064,0.000057068577,0.000029120078,0.000011961323,0.00013822028,0.0000027311557,0.00040297443],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998004,0.00007824385,0.000015119131,0.000041840754,0.000031040905,0.000033420387],"domain_scores_gemma":[0.9997521,0.00006594472,0.000056431763,0.000018738941,0.000028674254,0.00007795437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027474895,0.0003651736,0.0005526488,0.0002489575,0.00041342288,0.0003549258,0.00010519017,0.00044746042,0.0016105152],"category_scores_gemma":[0.0008293379,0.00023424368,0.00028836937,0.00029846482,0.00028400545,0.00023091192,0.00016601551,0.00044064238,0.00034909844],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036986206,0.0019018697,0.87925595,0.00023416945,0.0007026443,0.0034591998,0.0014931256,0.00014880499,0.04639877,0.00015734996,0.0013037724,0.027958248],"study_design_scores_gemma":[0.0003496702,0.006068982,0.98897374,0.0000052698465,0.0001930648,0.0018597014,0.00026674697,0.00020566542,0.0015713685,0.0000742468,0.00042182681,0.000009701997],"about_ca_topic_score_codex":0.0013300027,"about_ca_topic_score_gemma":0.0016590742,"teacher_disagreement_score":0.0016105152,"about_ca_system_score_codex":0.00015429068,"about_ca_system_score_gemma":0.00013224082,"threshold_uncertainty_score":0.0053877234},"labels":[],"label_agreement":null},{"id":"W2094049166","doi":"10.1067/mcp.2002.129322","title":"Single‐dose and steady‐state pharmacokinetics of celecoxib in children","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Celecoxib; Pharmacokinetics; Volume of distribution; Pharmacology; Clearance; Medicine; Cyclooxygenase; Dosing; Drug; Oral administration; Steady state (chemistry); Bioavailability; Half-life; Distribution (mathematics); Chemistry; Urology; Enzyme; Biochemistry","score_opus":0.06713841475158734,"score_gpt":0.3718759105382496,"score_spread":0.30473749578666226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094049166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558485,0.0029678394,0.0005916834,0.00004186572,0.0000069442945,0.000014499401,0.00026317307,0.0000248937,0.0005041463],"genre_scores_gemma":[0.99682117,0.0013859519,0.00083554065,0.000066928624,0.000014036884,0.000034511493,0.0004963502,0.000013936724,0.00033165727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997842,0.00005275349,0.000011949556,0.00005518636,0.00006000337,0.000036081958],"domain_scores_gemma":[0.9994286,0.00018526052,0.00021555148,0.000020373984,0.00006232007,0.00008795422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029612475,0.00024924322,0.00068954023,0.00017293246,0.00018470037,0.0004423285,0.0001330743,0.0003199528,0.0009316048],"category_scores_gemma":[0.0013872518,0.00020662825,0.00031693777,0.0002988492,0.0002813283,0.00033154816,0.00013127453,0.0006423851,0.0002674823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028835077,0.0008631213,0.7473951,0.00050704007,0.00045922198,0.0020048104,0.001062655,0.0037525976,0.068448275,0.0005248917,0.003276381,0.14287093],"study_design_scores_gemma":[0.000987117,0.021864004,0.93104804,0.00006603351,0.00050066935,0.009735794,0.00045850818,0.003397316,0.023429053,0.0002130245,0.008257112,0.000043369277],"about_ca_topic_score_codex":0.001686469,"about_ca_topic_score_gemma":0.0011408357,"teacher_disagreement_score":0.001686469,"about_ca_system_score_codex":0.0006039946,"about_ca_system_score_gemma":0.00042028463,"threshold_uncertainty_score":0.0043822527},"labels":[],"label_agreement":null},{"id":"W2095075931","doi":"10.1038/clpt.2011.73","title":"Ethical Considerations Regarding Disparities Pertaining to Kidney Transplant Patients","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Health equity; Referral; Medicine; Ethnic group; Equity (law); Organ transplantation; Health care; Family medicine; Intensive care medicine; Transplantation; Kidney transplant; Kidney transplantation; Nursing; Public health; Internal medicine; Political science","score_opus":0.1924929813423124,"score_gpt":0.437175941495525,"score_spread":0.24468296015321261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095075931","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019036425,0.002284859,0.013113155,0.9148472,0.008417816,0.00193499,0.0001777436,0.00007988186,0.040107947],"genre_scores_gemma":[0.23168784,0.002729162,0.031985126,0.70137465,0.011444226,0.005804637,0.00015262773,0.000085507876,0.0147361215],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8060468,0.15446338,0.012691977,0.004417399,0.015005322,0.0073750904],"domain_scores_gemma":[0.72437733,0.20523737,0.012031856,0.021172019,0.02246042,0.014721003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17324848,0.0008198809,0.001719866,0.0014558655,0.008317123,0.00919783,0.004429806,0.030914964,0.008528604],"category_scores_gemma":[0.27927747,0.0009640216,0.0018135424,0.0018002437,0.015144269,0.006152202,0.007112046,0.030711526,0.0020136924],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009306012,0.00076012337,0.0095681595,0.0006021245,0.0001894994,0.0060864203,0.054121792,0.0012181127,0.002004855,0.4120249,0.40886897,0.10362451],"study_design_scores_gemma":[0.0006862977,0.00051684957,0.004669627,0.0033863352,0.00020707517,0.00917696,0.028438699,0.0055941097,0.0025655767,0.28322008,0.66124207,0.0002963204],"about_ca_topic_score_codex":0.0021834944,"about_ca_topic_score_gemma":0.0041099214,"teacher_disagreement_score":0.17324848,"about_ca_system_score_codex":0.003393026,"about_ca_system_score_gemma":0.020672694,"threshold_uncertainty_score":0.9162365},"labels":[],"label_agreement":null},{"id":"W2095161324","doi":"10.1038/clpt.2011.328","title":"Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":503,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ulcerative colitis; Monoclonal antibody; Inflammatory bowel disease; Pharmacokinetics; Immunogenicity; Immunology; Crohn's disease; Dosing; Immune system; Disease; Concomitant; Antibody; Inflammation; Tumor necrosis factor alpha; Internal medicine; Pharmacology","score_opus":0.09053051746378393,"score_gpt":0.42431111061237775,"score_spread":0.3337805931485938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095161324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016076532,0.9980882,0.00041102988,0.0003272823,0.00012608318,0.000010039634,0.000013278035,0.000009524707,0.0008537677],"genre_scores_gemma":[0.0012377303,0.9971765,0.0005237157,0.0002254599,0.00017757798,0.000015802934,0.00002411616,0.0000021932678,0.000616882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999607,0.000094739844,0.000048899223,0.000056842684,0.00016736735,0.00002517791],"domain_scores_gemma":[0.99958533,0.00017856923,0.0000793128,0.000016152144,0.0001053447,0.0000352459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012569119,0.001148104,0.0019951616,0.0017861334,0.00024120795,0.0011653862,0.0017046073,0.0015654825,0.002415119],"category_scores_gemma":[0.0010414083,0.00035064996,0.00072382763,0.0018618106,0.00065350876,0.0016075477,0.00068322587,0.0027545164,0.002109482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015717551,0.0001555399,0.00016847861,0.0102098305,0.000093329756,0.00023645029,0.000049272876,0.00081190345,0.0022395833,0.0055334223,0.014565612,0.9657795],"study_design_scores_gemma":[0.00008258843,0.00035767665,0.00087632873,0.003210559,0.00017320484,0.002360998,0.00005312904,0.0003749352,0.0011526498,0.004113766,0.9872098,0.000034502427],"about_ca_topic_score_codex":0.000784725,"about_ca_topic_score_gemma":0.0012709172,"teacher_disagreement_score":0.002415119,"about_ca_system_score_codex":0.00092640205,"about_ca_system_score_gemma":0.00092061755,"threshold_uncertainty_score":0.00807941},"labels":[],"label_agreement":null},{"id":"W2095835387","doi":"10.1016/j.clpt.2004.12.165","title":"Impact of formulary policy on thiazolidinedione (TZD) use in the ontario drug benefit (ODB) program","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Formulary; Medicine; Reimbursement; Prior authorization; Pharmacy; Clinical pharmacology; Drug; Intensive care medicine; Pharmacology; Family medicine","score_opus":0.29668922440862244,"score_gpt":0.5518831633697046,"score_spread":0.2551939389610821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095835387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864869,0.0003055298,0.00008410601,0.00523844,0.00003321941,0.00011305079,0.00039097844,0.000020270088,0.007327585],"genre_scores_gemma":[0.99735415,0.0001367483,0.000111997004,0.00082534924,0.00002371179,0.000025395164,0.00016108707,0.0000034865259,0.0013580677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649006,0.00093838817,0.00012479999,0.00015151217,0.0010907316,0.0012043869],"domain_scores_gemma":[0.99073166,0.0022075502,0.0025648517,0.00020308646,0.0011218282,0.0031709683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019754996,0.00011507374,0.00022420184,0.00031965796,0.0016514341,0.001621235,0.00086455554,0.0008752267,0.002822653],"category_scores_gemma":[0.015527014,0.00019747214,0.00043615015,0.0006522782,0.00079145527,0.0004496711,0.00083896174,0.0007252383,0.00015438693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022110222,0.0017307836,0.9137293,0.00012497872,0.00012392251,0.0007036646,0.0018854052,0.0018561129,0.0014147856,0.0020865393,0.010770186,0.06336334],"study_design_scores_gemma":[0.00014649637,0.00039075577,0.991824,0.000048283262,0.000053062384,0.00006291166,0.0007487361,0.0018703003,0.00020966813,0.000109981265,0.004523167,0.000012589797],"about_ca_topic_score_codex":0.82830507,"about_ca_topic_score_gemma":0.89339185,"teacher_disagreement_score":0.9758791,"about_ca_system_score_codex":0.024120914,"about_ca_system_score_gemma":0.029159725,"threshold_uncertainty_score":0.34541214},"labels":[],"label_agreement":null},{"id":"W2097851755","doi":"10.1038/clpt.2013.114","title":"CYP2A6 Genotype but not Age Determines Cotinine Half-Life in Infants and Children","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Cotinine; Genotype; Medicine; Pediatrics; Biology; Genetics; Nicotine; Internal medicine; Gene; Metabolism","score_opus":0.11882131918336536,"score_gpt":0.4010143497930177,"score_spread":0.28219303060965234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097851755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831676,0.00104482,0.00019813475,0.000025960762,0.000004951137,0.0000042959896,0.00016219661,0.00000525512,0.00023755069],"genre_scores_gemma":[0.9987521,0.0006141285,0.00021392811,0.00002373529,0.0000044795156,0.0000060891903,0.00016232027,0.000007385839,0.00021579646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995771,0.00010886374,0.000038040595,0.000107558306,0.000106336236,0.00006218968],"domain_scores_gemma":[0.998809,0.00044216475,0.0004689238,0.00006513663,0.00011233668,0.00010259742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073340995,0.00021930548,0.0004981438,0.00028885005,0.00016765881,0.00044993457,0.00016127386,0.00034227208,0.001139801],"category_scores_gemma":[0.0027590862,0.00030793648,0.0005047873,0.00034034223,0.00020995874,0.00031051162,0.00020294786,0.000355573,0.000285644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005649973,0.000024088704,0.98666453,0.00003784744,0.0000710238,0.00023019924,0.00030501734,0.000050742747,0.006404176,0.00002680496,0.00006285439,0.005557699],"study_design_scores_gemma":[0.000003398005,0.00019737826,0.9976676,0.000005223635,0.000044374443,0.00059179385,0.00008736676,0.000056173787,0.0011587596,0.00001565556,0.00016908019,0.0000030284918],"about_ca_topic_score_codex":0.0028074752,"about_ca_topic_score_gemma":0.002697315,"teacher_disagreement_score":0.0028074752,"about_ca_system_score_codex":0.00019563011,"about_ca_system_score_gemma":0.0002071514,"threshold_uncertainty_score":0.0055823326},"labels":[],"label_agreement":null},{"id":"W2098436801","doi":"10.1016/j.clpt.2004.10.011","title":"Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence*","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":265,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2A6; Nicotine; Addiction; Context (archaeology); Nicotine dependence; Cotinine; Smoking cessation; Cigarette smoke; Abstinence; Pharmacology; Medicine; Psychology; Psychiatry; Biology; Cytochrome P450; Internal medicine; Environmental health","score_opus":0.11756665421989938,"score_gpt":0.48392796129094773,"score_spread":0.36636130707104836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098436801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023600966,0.99716693,0.00019536204,0.00054911716,0.00017675817,0.0000037983723,0.000022879496,0.0000068333416,0.0016422323],"genre_scores_gemma":[0.0013234239,0.99686074,0.00028906195,0.0002432389,0.00022262968,0.000005417349,0.000036109406,0.0000012987706,0.0010180076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998466,0.00003028871,0.000019481644,0.000037544258,0.000055707656,0.000010528097],"domain_scores_gemma":[0.9997205,0.00014266897,0.000034634257,0.000008011789,0.000071211354,0.000022871574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000504924,0.0005423811,0.0010711944,0.0010109021,0.00020379583,0.00058072765,0.0006240621,0.0010953216,0.004032738],"category_scores_gemma":[0.00064620236,0.00017500628,0.00034548843,0.0013122894,0.0002724246,0.00076977105,0.00029121037,0.0009717229,0.0026962238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086742126,0.000050145503,0.00073634397,0.005701451,0.00007407548,0.0004991379,0.00003789783,0.0002481702,0.0017198257,0.0024196391,0.019511385,0.96891505],"study_design_scores_gemma":[0.00003092727,0.00013976959,0.004356013,0.0020416183,0.00015195986,0.0043665343,0.00007070888,0.00013953107,0.00087517354,0.0028985331,0.98490477,0.00002445466],"about_ca_topic_score_codex":0.0013197749,"about_ca_topic_score_gemma":0.0019678178,"teacher_disagreement_score":0.004032738,"about_ca_system_score_codex":0.00052939623,"about_ca_system_score_gemma":0.0007596043,"threshold_uncertainty_score":0.013490856},"labels":[],"label_agreement":null},{"id":"W2099539451","doi":"10.1038/clpt.2012.179","title":"Epigenetics: A New Link Toward Understanding Human Disease and Drug Response","year":2012,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenomics; Epigenetics; Clinical pharmacology; Human disease; Computational biology; Drug response; Human health; Genomics; Phenotype; Biology; Drug; Pharmacology; Genetics; Gene; Medicine; Genome; Gene expression; DNA methylation","score_opus":0.12100400323660812,"score_gpt":0.4349502218091449,"score_spread":0.3139462185725368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099539451","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008035622,0.05977561,0.0008066473,0.10855747,0.82908916,0.000014103379,0.00004357536,0.0000693912,0.0015637721],"genre_scores_gemma":[0.0007630446,0.036399152,0.00040731643,0.027549768,0.9286984,0.000014468122,0.000017663666,0.00002151525,0.006128614],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781525,0.00057496043,0.00028054154,0.00030455462,0.0009376873,0.00008694826],"domain_scores_gemma":[0.9903019,0.005952011,0.00039839646,0.0002697169,0.0022605949,0.0008173321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004881446,0.002829084,0.0021712221,0.0017759933,0.0014430082,0.004441448,0.0023360136,0.009872753,0.004778881],"category_scores_gemma":[0.011225999,0.0007496233,0.0015206345,0.0008199352,0.0036721183,0.0052156188,0.0017033484,0.024858102,0.0030133887],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055085373,0.000014720951,0.000049378777,0.00042121808,0.000035556568,0.00016625604,0.000043406148,0.00006246099,0.00023680732,0.0020610439,0.9704718,0.0263823],"study_design_scores_gemma":[0.000031297543,0.00002940292,0.00020452576,0.0003222568,0.000043235446,0.00049341837,0.000048252456,0.00014683497,0.00015480787,0.004644974,0.9938623,0.00001878192],"about_ca_topic_score_codex":0.00094995624,"about_ca_topic_score_gemma":0.0023448798,"teacher_disagreement_score":0.009872753,"about_ca_system_score_codex":0.0019352454,"about_ca_system_score_gemma":0.0016619468,"threshold_uncertainty_score":0.025815845},"labels":[],"label_agreement":null},{"id":"W2100464321","doi":"10.1038/clpt.2011.212","title":"StaR Child Health: Developing Evidence-Based Guidance for the Design, Conduct, and Reporting of Pediatric Trials","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba; Health Sciences Centre; Winnipeg Regional Health Authority; University of Alberta","funders":"","keywords":"Pediatric research; Star (game theory); MEDLINE; Medicine; Pediatrics; Political science","score_opus":0.8890412768937818,"score_gpt":0.6229892954052657,"score_spread":0.26605198148851605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100464321","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025565783,0.035498884,0.5829102,0.2138458,0.013218029,0.08300884,0.019722242,0.010647088,0.03859236],"genre_scores_gemma":[0.0038595987,0.01046294,0.9427736,0.014658958,0.00092003867,0.019444212,0.0044422774,0.0006367512,0.002801668],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.43452102,0.38338235,0.122141674,0.0048736813,0.050362896,0.004718412],"domain_scores_gemma":[0.2228723,0.4589196,0.08284472,0.033169292,0.18705577,0.015138328],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.49920455,0.004641813,0.008583282,0.021544266,0.0029671635,0.012422936,0.017475285,0.028254393,0.010166309],"category_scores_gemma":[0.614379,0.005813201,0.012523715,0.021862222,0.0072936853,0.008311509,0.011359063,0.027872425,0.015100722],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010378693,0.00044486136,0.0031663608,0.026441824,0.0014012443,0.00055843213,0.0024485632,0.0063671907,0.0011441695,0.03606752,0.66139597,0.25952604],"study_design_scores_gemma":[0.00262708,0.00086997676,0.007078284,0.06984788,0.0015132327,0.00096686225,0.0011352703,0.009900905,0.0033774415,0.053763945,0.8482734,0.0006457863],"about_ca_topic_score_codex":0.02191656,"about_ca_topic_score_gemma":0.024218475,"teacher_disagreement_score":0.5007955,"about_ca_system_score_codex":0.012971004,"about_ca_system_score_gemma":0.101219125,"threshold_uncertainty_score":0.6175699},"labels":[],"label_agreement":null},{"id":"W2100964614","doi":"10.1067/mcp.2000.107507","title":"Quetiapine fumarate overdose: Clinical and pharmacokinetic lessons from extreme conditions","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Quetiapine; Drug overdose; Medicine; Pharmacokinetics; Clinical pharmacology; Atypical antipsychotic; Clozapine; Pharmacology; Antipsychotic; Antipsychotic Agent; Anesthesia; Poison control; Emergency medicine; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.20610934837080574,"score_gpt":0.5020234828529074,"score_spread":0.2959141344821017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100964614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6828787,0.1773851,0.012396718,0.08715186,0.0018985001,0.00016224901,0.00027027025,0.00032109086,0.037535463],"genre_scores_gemma":[0.936396,0.05028194,0.0024036276,0.0052106404,0.0048267837,0.000022320904,0.000081657774,0.000029842562,0.00074718165],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9996933,0.00009884214,0.000039518476,0.000044982626,0.000071264374,0.000052100306],"domain_scores_gemma":[0.9985336,0.00069850945,0.000266397,0.00012517393,0.00016779317,0.00020846642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006406161,0.0005690175,0.0007122437,0.0004809753,0.0004996215,0.0011369924,0.0006262727,0.0025043932,0.00070301944],"category_scores_gemma":[0.0043271403,0.00020744353,0.00037754525,0.00038946792,0.0019956108,0.0016959186,0.0006382159,0.0027498493,0.00032754653],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014222772,0.0005417649,0.15055549,0.0008179751,0.00016369771,0.3831869,0.0028680377,0.0019975584,0.0065666474,0.008393124,0.016947513,0.426539],"study_design_scores_gemma":[0.00029650528,0.0021512208,0.13977641,0.00090844516,0.00014153229,0.77451235,0.002800994,0.0031074747,0.0034346294,0.024355285,0.048337944,0.00017719547],"about_ca_topic_score_codex":0.0011909202,"about_ca_topic_score_gemma":0.0012853532,"teacher_disagreement_score":0.0025043932,"about_ca_system_score_codex":0.00073881674,"about_ca_system_score_gemma":0.0005163257,"threshold_uncertainty_score":0.005360484},"labels":[],"label_agreement":null},{"id":"W2101566038","doi":"10.1038/clpt.2009.19","title":"Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Cotinine; Odds ratio; Nicotine; Confidence interval; Smoking cessation; Genotype; Medicine; Quartile; Internal medicine; Pharmacogenetics; Pharmacology; Physiology; Genetics; Biology; CYP1A2; Cytochrome P450; Pathology; Metabolism","score_opus":0.04995220118061289,"score_gpt":0.3952817783533171,"score_spread":0.34532957717270424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101566038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992387,0.00034405725,0.00005686045,0.00004231102,0.0000026730504,0.0000052283153,0.00004700331,0.000002686521,0.0002604765],"genre_scores_gemma":[0.9996302,0.00010114712,0.00006692306,0.000020135918,0.0000060767843,0.0000044130775,0.000043371976,0.0000020346758,0.00012558166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996251,0.00016357686,0.000030311674,0.00005697331,0.00006725888,0.000056843444],"domain_scores_gemma":[0.9985065,0.00047905088,0.00068034994,0.0000712015,0.00008664061,0.0001761891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058706716,0.00016993057,0.00034366938,0.0005394716,0.0003234729,0.0003392361,0.00019875739,0.0005568784,0.0019748642],"category_scores_gemma":[0.002877932,0.00017807611,0.00033769873,0.00053675065,0.00017620936,0.00023241987,0.00017093193,0.00048755258,0.00018206117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005407505,0.00009614209,0.9965585,0.000007093749,0.0000543662,0.000069650385,0.000049388378,0.0000202096,0.00064935104,0.0000142640765,0.000033336044,0.0019069613],"study_design_scores_gemma":[0.000007441462,0.00014468479,0.9992506,0.0000035639716,0.00003426495,0.00015457913,0.000043898577,0.00019573834,0.00007869272,0.0000143019815,0.000070190275,0.0000019551221],"about_ca_topic_score_codex":0.003036013,"about_ca_topic_score_gemma":0.0029647509,"teacher_disagreement_score":0.003036013,"about_ca_system_score_codex":0.00014952042,"about_ca_system_score_gemma":0.00015136287,"threshold_uncertainty_score":0.006606519},"labels":[],"label_agreement":null},{"id":"W2101785485","doi":"10.1016/j.clpt.2003.11.313","title":"Drug-disease interaction:effect of rheumatoid arthritis (RA) on the pharmacodynamics (PD) and pharmacokinetics (PK) of AT1 receptor antagonists","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Active metabolite; Rheumatoid arthritis; Pharmacokinetics; Pharmacology; Medicine; Losartan; Downregulation and upregulation; Pharmacodynamics; Valsartan; Angiotensin II receptor type 1; Arthritis; Metabolite; Internal medicine; Receptor; Endocrinology; Angiotensin II; Blood pressure; Chemistry","score_opus":0.02375094706231464,"score_gpt":0.3514826693637446,"score_spread":0.32773172230143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101785485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902722,0.006864963,0.00041115016,0.0002060997,0.00007187102,0.00005194078,0.00017780735,0.000023314977,0.0019205001],"genre_scores_gemma":[0.9983689,0.0005813847,0.0002240196,0.00007274107,0.00005740705,0.000021698535,0.000078918514,0.0000028489628,0.00059226213],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997684,0.0016158773,0.00018474445,0.00014932454,0.0002546164,0.00011140905],"domain_scores_gemma":[0.9978149,0.0013962751,0.00035737344,0.000104481565,0.00010728097,0.00021977386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014641136,0.00023614505,0.0009327675,0.0001503307,0.00014194525,0.0003530059,0.00012915753,0.00046762303,0.0022192113],"category_scores_gemma":[0.002680366,0.00012806435,0.00061252306,0.00022081153,0.00019737745,0.0002759447,0.00021461501,0.0004919122,0.00030196036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37378034,0.008442805,0.26018846,0.0022167575,0.012348893,0.0018701949,0.00034657374,0.0025287368,0.13748647,0.00052806037,0.0020346371,0.198228],"study_design_scores_gemma":[0.003567983,0.15374625,0.80263937,0.00005361333,0.005919521,0.0023739506,0.00010371877,0.0047053513,0.018169083,0.000484402,0.00818068,0.000056026885],"about_ca_topic_score_codex":0.00018105622,"about_ca_topic_score_gemma":0.0004910701,"teacher_disagreement_score":0.0022192113,"about_ca_system_score_codex":0.00017027669,"about_ca_system_score_gemma":0.0001953803,"threshold_uncertainty_score":0.0077430606},"labels":[],"label_agreement":null},{"id":"W2103438776","doi":"10.1038/clpt.2010.3","title":"Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Nicotine; Transdermal; Pharmacology; Medicine; Duration (music); Internal medicine","score_opus":0.029506908108715247,"score_gpt":0.3638098091640545,"score_spread":0.3343029010553392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103438776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984768,0.000901928,0.000092845556,0.000053120002,0.000046229077,0.00014552264,0.000087804874,0.000010103883,0.00018568696],"genre_scores_gemma":[0.9986539,0.00033142458,0.00022149151,0.00008401363,0.000093459865,0.00015626481,0.00014322362,0.0000026817754,0.000313479],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99879175,0.00076080527,0.00009265192,0.00018116989,0.00008978804,0.00008384176],"domain_scores_gemma":[0.99807835,0.00087787287,0.0004248435,0.00014311746,0.00009243196,0.0003833139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027369822,0.00095408247,0.002428189,0.00030552567,0.00035411902,0.00049828144,0.0005558027,0.0015153404,0.002055173],"category_scores_gemma":[0.0029259776,0.00038478148,0.0012059871,0.00026580697,0.00071758474,0.00056758476,0.00024652318,0.0012478431,0.00026045475],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9573852,0.007905394,0.011850167,0.00013816378,0.0013645598,0.00004692661,0.000048814385,0.00023313862,0.0059102913,0.00003235678,0.00012045679,0.014964584],"study_design_scores_gemma":[0.26996884,0.5579061,0.16471517,0.00004276121,0.0023780311,0.0001372444,0.000049877766,0.0018001552,0.0021816818,0.00015181897,0.00062192307,0.000046390473],"about_ca_topic_score_codex":0.00047143045,"about_ca_topic_score_gemma":0.00065015163,"teacher_disagreement_score":0.0027369822,"about_ca_system_score_codex":0.00028936137,"about_ca_system_score_gemma":0.0002855672,"threshold_uncertainty_score":0.01447475},"labels":[],"label_agreement":null},{"id":"W2103510620","doi":"10.1038/clpt.2008.51","title":"Lazarus's Gate: Challenges and Potential of Epigenetic Reprogramming of Somatic Cells","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Reprogramming; Somatic cell nuclear transfer; Somatic cell; Epigenetics; Induced pluripotent stem cell; Biology; Cell biology; Biotechnology; Genetics; Cell; Embryonic stem cell; Embryo; Blastocyst; Gene; Embryogenesis","score_opus":0.14188711957956865,"score_gpt":0.4420112161389818,"score_spread":0.3001240965594132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103510620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004334539,0.98613226,0.0020471145,0.0049341507,0.0012633546,0.000004432043,0.000009629112,0.000028304235,0.0051472946],"genre_scores_gemma":[0.0054448335,0.98416084,0.0013105558,0.0031109229,0.0011137578,0.000012795877,0.0000142822255,0.000009846258,0.0048221643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965096,0.00011118597,0.00002996885,0.000053021984,0.00013206052,0.000022834154],"domain_scores_gemma":[0.9995776,0.000280286,0.000024956329,0.000027089554,0.000052189996,0.00003794525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015374984,0.0005460076,0.0009742382,0.0010033953,0.0004593114,0.0014871527,0.00095137657,0.0015999303,0.0022301886],"category_scores_gemma":[0.0009213502,0.00015096476,0.00041452254,0.00082091166,0.0024268124,0.003384494,0.0010282936,0.0034778041,0.0018181907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008034336,0.000041450126,0.00014439727,0.0032439744,0.00005251133,0.00058573694,0.00032148886,0.0005371035,0.0039214096,0.13485582,0.042950805,0.81326497],"study_design_scores_gemma":[0.000011301786,0.00006862961,0.00016093552,0.0007058677,0.000015599735,0.0010206171,0.00009379402,0.00011060725,0.0014508632,0.035267487,0.96107715,0.000017149125],"about_ca_topic_score_codex":0.00059857895,"about_ca_topic_score_gemma":0.00079796044,"teacher_disagreement_score":0.0022301886,"about_ca_system_score_codex":0.00080343254,"about_ca_system_score_gemma":0.000957267,"threshold_uncertainty_score":0.008131206},"labels":[],"label_agreement":null},{"id":"W2104356666","doi":"10.1016/s0009-9236(03)90423-1","title":"Induction of the MRP3 transporter by activators of the pregnane X receptor","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pregnane X receptor; Transporter; Pharmacology; Clinical pharmacology; Receptor; Chemistry; Medicine; Nuclear receptor; Internal medicine; Biochemistry; Transcription factor; Gene","score_opus":0.07615868952795583,"score_gpt":0.3804708564681049,"score_spread":0.30431216694014906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104356666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718493,0.006142246,0.004782147,0.0019633719,0.0003790257,0.00013700852,0.00076182256,0.0006234589,0.013361627],"genre_scores_gemma":[0.98849314,0.0021962288,0.0019693985,0.00027432307,0.00015895521,0.00009038211,0.000660214,0.00009969434,0.006057567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969614,0.000108545566,0.000017449134,0.000020757656,0.000041069325,0.00011606843],"domain_scores_gemma":[0.9994978,0.00018640087,0.00008892649,0.000081844984,0.000039911192,0.000105204555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027277364,0.00043688877,0.00054828037,0.0003886357,0.0003086319,0.00086705934,0.00025474105,0.0004513281,0.011052755],"category_scores_gemma":[0.00074630417,0.00032740133,0.00059546524,0.00033874958,0.0007060792,0.0005287452,0.0005043542,0.0016521567,0.001990505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056281625,0.00028760362,0.00080391805,0.00016127779,0.0000439213,0.00078144483,0.00012354752,0.00028218213,0.9728315,0.003982084,0.0015387547,0.013535594],"study_design_scores_gemma":[0.000673612,0.0025842264,0.0065952567,0.000025660607,0.00006423156,0.0018083346,0.00019197848,0.0012877915,0.97281635,0.0014817578,0.012440907,0.000029810628],"about_ca_topic_score_codex":0.0005232148,"about_ca_topic_score_gemma":0.0005432267,"teacher_disagreement_score":0.011052755,"about_ca_system_score_codex":0.00058361323,"about_ca_system_score_gemma":0.0006311625,"threshold_uncertainty_score":0.036975145},"labels":[],"label_agreement":null},{"id":"W2104497498","doi":"10.1016/s0009-9236(03)90424-3","title":"Organic cation transport in the human mammary gland","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Mammary gland; Chemistry; Pharmacology; Medicine; Internal medicine; Cancer","score_opus":0.035462801144672054,"score_gpt":0.37332007933238254,"score_spread":0.3378572781877105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104497498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9414122,0.04257727,0.0038193606,0.0014854412,0.00013220056,0.000038601844,0.00081627147,0.00015453025,0.0095640365],"genre_scores_gemma":[0.9793642,0.009234992,0.0009909968,0.00015307964,0.00003981768,0.000013852884,0.000541888,0.000027403848,0.009633629],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982435,0.000037988728,0.000008145891,0.00004450389,0.000047707425,0.00003745159],"domain_scores_gemma":[0.99985564,0.00004161611,0.000023057613,0.00001699092,0.000041327552,0.00002140782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022523674,0.00013062636,0.00034964885,0.00038269977,0.00034548584,0.0008033005,0.00025717018,0.00042106985,0.0025314954],"category_scores_gemma":[0.00045371478,0.0002677525,0.00025941757,0.000347316,0.0003169789,0.0005205942,0.0002614048,0.0003041916,0.0007175068],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004588416,0.00015070073,0.020075044,0.0005931603,0.00007805891,0.0023304976,0.00081298774,0.00058160484,0.9172633,0.0027576508,0.0015081295,0.049260378],"study_design_scores_gemma":[0.0005703358,0.0027775792,0.24638036,0.0001361114,0.00039583314,0.01712358,0.0042265435,0.005457155,0.6392947,0.0048334002,0.078709796,0.00009462065],"about_ca_topic_score_codex":0.009072721,"about_ca_topic_score_gemma":0.0043934793,"teacher_disagreement_score":0.009072721,"about_ca_system_score_codex":0.0007196259,"about_ca_system_score_gemma":0.0006281868,"threshold_uncertainty_score":0.018039823},"labels":[],"label_agreement":null},{"id":"W2105940326","doi":"10.1038/clpt.2010.340","title":"Pharmacogenomics at the Tipping Point: Challenges and Opportunities","year":2011,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Pharmacogenomics; Citation; Clinical pharmacology; Library science; Addiction; Medicine; Psychology; Psychiatry; Pharmacology; Computer science","score_opus":0.46675862260967427,"score_gpt":0.5089552714008087,"score_spread":0.042196648791134383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105940326","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024571144,0.025594816,0.00030127756,0.06170094,0.91155434,0.000009110461,0.000025810621,0.000049128677,0.0007399802],"genre_scores_gemma":[0.00023574482,0.012890959,0.0002489484,0.024380904,0.95923555,0.000010639291,0.000013138298,0.000021406251,0.002962693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99165547,0.001994086,0.0011877987,0.00078295416,0.0039604222,0.00041919327],"domain_scores_gemma":[0.928813,0.040514257,0.0025274262,0.0013812721,0.021041699,0.0057222964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017643413,0.00333584,0.0048654317,0.003736377,0.0029014675,0.010298993,0.0038289113,0.019103443,0.0062303497],"category_scores_gemma":[0.042723946,0.0013159843,0.0028759146,0.0019463329,0.0043871305,0.007983892,0.0021610311,0.031030538,0.005808436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025033569,0.000012554856,0.000026441323,0.0003132599,0.000029110264,0.00010943269,0.00001807306,0.000037002155,0.000051840398,0.0006622297,0.9889137,0.009801393],"study_design_scores_gemma":[0.00005967376,0.000042201827,0.0002615374,0.0009777381,0.000091615235,0.0006033757,0.00008993385,0.00025574025,0.000103667735,0.004390877,0.9930782,0.000045345307],"about_ca_topic_score_codex":0.0016877305,"about_ca_topic_score_gemma":0.0065221437,"teacher_disagreement_score":0.019103443,"about_ca_system_score_codex":0.002886037,"about_ca_system_score_gemma":0.0051745432,"threshold_uncertainty_score":0.09330839},"labels":[],"label_agreement":null},{"id":"W2106499597","doi":"10.1038/clpt.2011.20","title":"Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT2C) Receptor Agonist, in Recreational Polydrug Users","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Zolpidem; Placebo; Pharmacology; Agonist; Ketamine; Crossover study; Medicine; Psychology; Anesthesia; Internal medicine; Receptor; Insomnia","score_opus":0.19277405444319573,"score_gpt":0.43768074783623734,"score_spread":0.2449066933930416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106499597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939966,0.00027081696,0.00010715755,0.0000126092955,0.0000029536147,0.000033266853,0.000029240315,0.0000023031707,0.00014188734],"genre_scores_gemma":[0.99858105,0.0005837928,0.00046968766,0.000029349963,0.000011971142,0.000035479945,0.000059355254,0.0000013999827,0.0002277977],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999605,0.00022895435,0.000024869889,0.000041422256,0.00007128269,0.00002851336],"domain_scores_gemma":[0.9994252,0.00018890983,0.00020566663,0.00003868871,0.000055595825,0.00008597122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045008922,0.0002864294,0.00052032754,0.00022484816,0.00022217729,0.00022967592,0.00016599447,0.0002652212,0.0012133925],"category_scores_gemma":[0.0010441472,0.0002236555,0.00020499791,0.0001951392,0.00041888634,0.00030048253,0.00016342745,0.00035612017,0.000118110285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13930814,0.01646354,0.11020703,0.0010667426,0.00070116174,0.00082584954,0.00097187085,0.00044527536,0.5908259,0.00024626724,0.00029148188,0.13864666],"study_design_scores_gemma":[0.0033157377,0.44488543,0.4614182,0.000049590966,0.00075805106,0.0021915878,0.00078155054,0.0019995864,0.08299719,0.00014267815,0.0014126513,0.000047770463],"about_ca_topic_score_codex":0.00046513038,"about_ca_topic_score_gemma":0.0011883661,"teacher_disagreement_score":0.0012133925,"about_ca_system_score_codex":0.00017432746,"about_ca_system_score_gemma":0.00016487668,"threshold_uncertainty_score":0.004059255},"labels":[],"label_agreement":null},{"id":"W2107194313","doi":"10.1067/mcp.2000.104610","title":"Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Neuropeptide Y receptor; Internal medicine; Ejection fraction; Medicine; Heart failure; Neuropeptide; Endocrinology; Norepinephrine; Venous blood; Cardiology; Receptor; Dopamine","score_opus":0.044431932608536805,"score_gpt":0.34557983647349294,"score_spread":0.30114790386495616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107194313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999511,0.00023089895,0.0000491556,0.000015918995,0.0000036500453,0.000002660529,0.000028947507,0.000002175604,0.00015559557],"genre_scores_gemma":[0.9998161,0.00005101726,0.00003088372,0.000016660815,0.000009253159,0.0000038617327,0.000038236736,4.2627656e-7,0.00003346952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998628,0.000039025635,0.000011505576,0.000031248775,0.000023189386,0.000032146432],"domain_scores_gemma":[0.9995728,0.00013543577,0.00013301535,0.000015320962,0.000029835392,0.0001136785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015915377,0.00027620897,0.00032587358,0.0002716553,0.0002401327,0.00026125507,0.000088643596,0.00031771016,0.0010908163],"category_scores_gemma":[0.00071143237,0.00010220323,0.00014275654,0.0001583533,0.00018561223,0.00013537574,0.00014431476,0.00030066166,0.000095483636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006801669,0.000057249632,0.9898533,0.000026755655,0.00004177861,0.000733915,0.0000958473,0.00006495244,0.0052245036,0.000010488942,0.00007688932,0.003134073],"study_design_scores_gemma":[0.00002506654,0.00047640805,0.9972633,0.000007188221,0.000023986528,0.0016336174,0.00008227009,0.00013904047,0.0002472045,0.000012328908,0.000086290864,0.0000033288197],"about_ca_topic_score_codex":0.0005872905,"about_ca_topic_score_gemma":0.0007673659,"teacher_disagreement_score":0.0010908163,"about_ca_system_score_codex":0.000116861826,"about_ca_system_score_gemma":0.00008985662,"threshold_uncertainty_score":0.0036491752},"labels":[],"label_agreement":null},{"id":"W2109007642","doi":"10.1038/clpt.2009.211","title":"Can We Afford It?: Ethical Consideration of Expensive Drug Treatment for Neonates and Infants","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Charter; Clinical pharmacology; Health care; Drug; Medicine; Law and economics; Intensive care medicine; Psychology; Engineering ethics; Law; Political science; Pharmacology; Economics","score_opus":0.24045810408401275,"score_gpt":0.5321726234636605,"score_spread":0.2917145193796477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109007642","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012148117,0.010264643,0.0030607276,0.93431324,0.0016318806,0.000037719936,0.000019674251,0.000012698642,0.038511354],"genre_scores_gemma":[0.57258,0.011286455,0.00819078,0.39094085,0.0035312043,0.000112629714,0.000021861813,0.00006002554,0.013276202],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9607687,0.022602396,0.0013704856,0.0012973362,0.01019179,0.0037692185],"domain_scores_gemma":[0.9585794,0.026544852,0.002579703,0.0010723897,0.005235692,0.005987959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03810431,0.00036634918,0.0006835317,0.00066166813,0.013023739,0.008896884,0.0020483367,0.0182713,0.0016791606],"category_scores_gemma":[0.0859282,0.00037422794,0.00060696766,0.0007642112,0.02785798,0.006007364,0.0056763366,0.01935903,0.00028889882],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000783767,0.000060489612,0.002922223,0.00014659952,0.0000296317,0.0034647896,0.03768159,0.00046443657,0.000691427,0.75719476,0.14910296,0.048162695],"study_design_scores_gemma":[0.00005932944,0.00013424654,0.0054279366,0.0019725023,0.00006460333,0.0061004106,0.05132438,0.0013149168,0.0011098167,0.32101634,0.6111991,0.00027640726],"about_ca_topic_score_codex":0.11375835,"about_ca_topic_score_gemma":0.21937205,"teacher_disagreement_score":0.11375835,"about_ca_system_score_codex":0.018290613,"about_ca_system_score_gemma":0.066525586,"threshold_uncertainty_score":0.22619241},"labels":[],"label_agreement":null},{"id":"W2111819588","doi":"10.1038/clpt.2011.79","title":"Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"Wellcome Trust","keywords":"Toxic epidermal necrolysis; Acute generalized exanthematous pustulosis; Pharmacogenomics; Medicine; Drug; Biopharmaceutics; Clinical pharmacology; Dermatology; Intensive care medicine; Immunology; Pharmacology; Bioinformatics; Biology; Genetics","score_opus":0.23693289434562287,"score_gpt":0.5141582324764793,"score_spread":0.2772253381308564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111819588","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008677624,0.9888517,0.0031391534,0.0011815284,0.00078388595,0.00008201738,0.0001416151,0.00006285649,0.004889469],"genre_scores_gemma":[0.0057226946,0.98202443,0.007631281,0.0012143629,0.00035958792,0.00011711266,0.00050874427,0.000017533333,0.0024043173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989681,0.00028914755,0.0002384811,0.00014514479,0.00031708676,0.00004194802],"domain_scores_gemma":[0.9987888,0.00044513584,0.00024690898,0.00008190245,0.0003916226,0.00004572316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002240348,0.0010137333,0.0019424214,0.003754529,0.00024016885,0.0009623313,0.0013898714,0.00096341333,0.0019015273],"category_scores_gemma":[0.0021189232,0.00024840978,0.0009302903,0.0031703115,0.00086916244,0.0014293614,0.0006537361,0.0019948075,0.0020485246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008108031,0.00009305233,0.00074302143,0.013128831,0.000076968725,0.0003207195,0.000090996524,0.00028069539,0.004424693,0.009099736,0.022428801,0.9492313],"study_design_scores_gemma":[0.000038978247,0.00016143605,0.004584977,0.0039822054,0.00017270558,0.004192658,0.00012001259,0.0002123841,0.0026530004,0.0035498377,0.9802956,0.000036169207],"about_ca_topic_score_codex":0.0011038333,"about_ca_topic_score_gemma":0.0013869909,"teacher_disagreement_score":0.003754529,"about_ca_system_score_codex":0.00064049184,"about_ca_system_score_gemma":0.0012320711,"threshold_uncertainty_score":0.011848211},"labels":[],"label_agreement":null},{"id":"W2112547742","doi":"10.1067/mcp.2000.110774","title":"Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Grapefruit juice; Naringin; Felodipine; Naringenin; Chemistry; Pharmacology; Furanocoumarin; Citrus paradisi; CYP3A4; Drug interaction; Pharmacokinetics; Food science; Flavonoid; Rutaceae; Chromatography; Biochemistry; Botany; Cytochrome P450; Medicine; Metabolism; Biology","score_opus":0.15016354409023558,"score_gpt":0.5123970513687449,"score_spread":0.36223350727850934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112547742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897087,0.00060863234,0.00010621541,0.000015761816,0.00001058911,0.000045109915,0.00006472058,0.000008642283,0.00016950657],"genre_scores_gemma":[0.99834144,0.00031795583,0.00053938583,0.000037680147,0.00002513172,0.000025326992,0.00015304534,0.0000075133817,0.00055262394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975985,0.00009053584,0.00001596986,0.00006560756,0.00004274062,0.00002526641],"domain_scores_gemma":[0.99959964,0.00017240855,0.000094664545,0.00003054805,0.000025124595,0.000077614335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034495728,0.00038838235,0.0007007335,0.00013374865,0.00012380473,0.00038392516,0.00019451986,0.00038992602,0.0022544437],"category_scores_gemma":[0.0007663381,0.00014143846,0.00050264684,0.0001244206,0.00023439848,0.00028425196,0.00011354566,0.00033156553,0.00011438266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3238608,0.0078719435,0.0145820705,0.00058991765,0.0018157706,0.0003984512,0.00011161266,0.0005273967,0.60831153,0.00008461425,0.00019734682,0.041648608],"study_design_scores_gemma":[0.012465752,0.35788944,0.34688294,0.000051123796,0.003247727,0.0014145522,0.00012991516,0.004879372,0.2685816,0.00020003552,0.0041932305,0.000064270906],"about_ca_topic_score_codex":0.0010548482,"about_ca_topic_score_gemma":0.001491734,"teacher_disagreement_score":0.0022544437,"about_ca_system_score_codex":0.00031791133,"about_ca_system_score_gemma":0.0002060351,"threshold_uncertainty_score":0.007541895},"labels":[],"label_agreement":null},{"id":"W2112841525","doi":"10.1016/s0009-9236(03)90696-5","title":"Digoxin‐carvedilol interactions in children","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Digoxin; Carvedilol; Medicine; Pharmacology; Internal medicine; Cardiology; Heart failure","score_opus":0.20920861865490625,"score_gpt":0.527686402183443,"score_spread":0.31847778352853673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112841525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778788,0.013191169,0.00018381445,0.0017291048,0.00005600349,0.000025098365,0.00072196964,0.000017756225,0.0061964155],"genre_scores_gemma":[0.99171865,0.006867393,0.00025786835,0.0003575067,0.000033386605,0.000013919732,0.00023831372,0.0000045792044,0.0005084632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992778,0.00025989808,0.00007377316,0.00006286708,0.00016166104,0.00016408003],"domain_scores_gemma":[0.998221,0.0007621725,0.0005792107,0.00003422273,0.00014570446,0.00025775345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054354215,0.00027164677,0.0007134621,0.0004271271,0.000592743,0.0005753088,0.00020305181,0.00047787456,0.0021639667],"category_scores_gemma":[0.003284077,0.00021159303,0.0004261845,0.0008404632,0.00046215623,0.00041602962,0.00039612217,0.0009716127,0.0002550616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000831232,0.00015645601,0.9681798,0.00022955384,0.00013700293,0.003590679,0.00066062313,0.00012366282,0.00060241413,0.0003551245,0.0014671201,0.023666186],"study_design_scores_gemma":[0.00012248657,0.0016846547,0.9690726,0.00021078096,0.00039421357,0.016550211,0.0018834895,0.00019904129,0.0012111962,0.00022528363,0.008421406,0.000024744984],"about_ca_topic_score_codex":0.013253555,"about_ca_topic_score_gemma":0.017663838,"teacher_disagreement_score":0.013253555,"about_ca_system_score_codex":0.0011768456,"about_ca_system_score_gemma":0.0015505207,"threshold_uncertainty_score":0.026352823},"labels":[],"label_agreement":null},{"id":"W2115647563","doi":"10.1038/clpt.2014.82","title":"Pharmacogenomics, Lipid Disorders, and Treatment Options","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Clinical pharmacology; Pharmacodynamics; Pharmacology; Medicine; Bioinformatics; Pharmacogenetics; Adverse effect; Pharmacokinetics; Intensive care medicine; Biology; Gene; Genetics; Genotype","score_opus":0.15900569609211934,"score_gpt":0.4827303659860899,"score_spread":0.3237246698939706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115647563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065935405,0.9982487,0.00010021918,0.0005308804,0.00010448274,0.0000034381799,0.000013926208,0.000004800466,0.000927552],"genre_scores_gemma":[0.00040795055,0.998755,0.00014613569,0.00021223172,0.00013218763,0.000003956836,0.000021258633,7.7290696e-7,0.00032051568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971086,0.00007233104,0.000036986512,0.000045498004,0.000111586625,0.00002279451],"domain_scores_gemma":[0.99957615,0.00023734958,0.000052867807,0.00001447919,0.000084793435,0.000034307905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094434194,0.0008520595,0.0017595507,0.003107785,0.00028057242,0.0011601539,0.0007965458,0.0011685754,0.0049813907],"category_scores_gemma":[0.0010653888,0.00028760938,0.00066007243,0.0028669515,0.00061280717,0.0012092233,0.0007292729,0.0020485714,0.0021192005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004079616,0.00007765331,0.00024914573,0.013487799,0.00016384065,0.00019095217,0.000060511364,0.0003581436,0.0006077384,0.007681193,0.024172805,0.95290947],"study_design_scores_gemma":[0.000019573801,0.00005996635,0.0012364135,0.0082883695,0.00015176096,0.0012119557,0.00008654315,0.00010785619,0.00019983658,0.0074227056,0.98119295,0.000022002881],"about_ca_topic_score_codex":0.0016407132,"about_ca_topic_score_gemma":0.0027633037,"teacher_disagreement_score":0.0049813907,"about_ca_system_score_codex":0.000759109,"about_ca_system_score_gemma":0.001418822,"threshold_uncertainty_score":0.016664445},"labels":[],"label_agreement":null},{"id":"W2116823219","doi":"10.1038/sj.clpt.6100073","title":"The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier de l'Université Laval; Hôpital de l'Enfant-Jésus","funders":"Hydro-Québec; Canada Research Chairs; Canadian Institutes of Health Research; Université Laval","keywords":"UGT2B7; Mycophenolate; Pharmacokinetics; Mycophenolic acid; Pharmacology; Chemistry; Allele; Medicine; Glucuronidation; Internal medicine; Biochemistry; Enzyme; Gene; Microsome; Transplantation","score_opus":0.08041892493863081,"score_gpt":0.44067127996674765,"score_spread":0.3602523550281168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116823219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953425,0.00016887844,0.00008854958,0.0000079668025,0.0000023043422,0.000010030495,0.0000495783,0.0000028196284,0.00013568831],"genre_scores_gemma":[0.9996283,0.00003988981,0.00009428362,0.00001567653,0.0000062457925,0.000009416549,0.00008527349,0.0000031713657,0.000117758245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994215,0.00023268019,0.000032435997,0.0001547748,0.00009386384,0.00006485879],"domain_scores_gemma":[0.9994024,0.00022122606,0.0001407269,0.000064049505,0.000047654965,0.00012394684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055187155,0.000414518,0.00055092137,0.00031076986,0.00031723193,0.00038184444,0.000120947174,0.0004293177,0.0007469452],"category_scores_gemma":[0.0015725731,0.00028395889,0.00029010276,0.00025436876,0.00030598976,0.00026283806,0.00014325578,0.00030636982,0.00021762968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014536569,0.0008603659,0.9293833,0.0000560745,0.00043992922,0.000847689,0.00049725396,0.0004025676,0.039082527,0.00008781065,0.00018753315,0.013618414],"study_design_scores_gemma":[0.00023875931,0.0075347126,0.98419327,0.000005237471,0.00024919648,0.001572613,0.00011480559,0.0010367148,0.00446858,0.00009229948,0.00048066137,0.000013127831],"about_ca_topic_score_codex":0.0013721073,"about_ca_topic_score_gemma":0.0010058758,"teacher_disagreement_score":0.0013721073,"about_ca_system_score_codex":0.00017149042,"about_ca_system_score_gemma":0.00014194728,"threshold_uncertainty_score":0.002918601},"labels":[],"label_agreement":null},{"id":"W2117518921","doi":"10.1016/s0009-9236(03)90707-7","title":"Teaching pharmacokinetic logic through example: Application of modeling to observations from three perplexing overdoses","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pharmacokinetics; Computer science; Intensive care medicine; Medicine; Pharmacology","score_opus":0.47775503349477993,"score_gpt":0.5345246530623515,"score_spread":0.056769619567571594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117518921","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12689698,0.00034193005,0.85720706,0.0017746078,0.000091267815,0.00018706985,0.00046275023,0.003639986,0.009398379],"genre_scores_gemma":[0.55265033,0.00045415462,0.44199955,0.00025599083,0.00004136862,0.00022757778,0.0003208945,0.00027287542,0.0037772425],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9995383,0.00023214771,0.000029981196,0.00008965614,0.00007903724,0.000030949483],"domain_scores_gemma":[0.98949045,0.009645328,0.00018211351,0.00021728124,0.00036452673,0.00010039478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001189255,0.0011891106,0.00054689514,0.0003084945,0.00045451347,0.001043054,0.0013289213,0.0015395215,0.0059915567],"category_scores_gemma":[0.010417454,0.00040063495,0.00062147813,0.00031235337,0.00041443782,0.0008827779,0.0010399678,0.001661745,0.0007074569],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082934275,0.0004600163,0.006323086,0.00045653436,0.0000854509,0.0009126652,0.0017719493,0.6902928,0.0055589536,0.018086432,0.0076501723,0.26757267],"study_design_scores_gemma":[0.000060193695,0.00008664908,0.00043246645,0.000031632,0.000020439638,0.00012555292,0.000098292985,0.97542405,0.0029077209,0.017611999,0.0031803662,0.000020744337],"about_ca_topic_score_codex":0.0076859305,"about_ca_topic_score_gemma":0.009067232,"teacher_disagreement_score":0.0076859305,"about_ca_system_score_codex":0.0008479624,"about_ca_system_score_gemma":0.00082043116,"threshold_uncertainty_score":0.02004373},"labels":[],"label_agreement":null},{"id":"W2119045235","doi":"10.1038/clpt.2009.194","title":"Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuroscience of respiration and sleep","field":"Neuroscience","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Alfentanil; Opioid; Anesthesia; (+)-Naloxone; Medicine; Placebo; Depression (economics); Clinical pharmacology; Ventilation (architecture); Ketamine; Pharmacology; Propofol; Internal medicine; Receptor","score_opus":0.08222327603796387,"score_gpt":0.42837084720153984,"score_spread":0.346147571163576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119045235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980192,0.0010789403,0.0004086831,0.000053079057,0.000008479157,0.00002275214,0.000017871767,0.00000929766,0.0003817503],"genre_scores_gemma":[0.9986933,0.00059267407,0.0003677206,0.000060723596,0.000010664862,0.000020854457,0.00003518326,0.0000011319254,0.00021772685],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998987,0.00003340035,0.0000058630308,0.000014537431,0.000024154775,0.000023338514],"domain_scores_gemma":[0.99993336,0.000013778464,0.000019244195,0.0000074518034,0.0000051873303,0.00002094733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020321799,0.00022891404,0.00041389294,0.00010592142,0.00016560855,0.00017792487,0.00010283936,0.0002490413,0.00086691685],"category_scores_gemma":[0.00037814913,0.00011260361,0.00009694044,0.00003953462,0.00034616812,0.00012330167,0.00013603401,0.00030995643,0.00015093885],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013137466,0.0015514486,0.023027113,0.00026981355,0.00010776564,0.0017056271,0.00021160666,0.00027301564,0.89714664,0.0003783235,0.0005620738,0.061629094],"study_design_scores_gemma":[0.0028997331,0.2117564,0.50761133,0.0000972243,0.0004132301,0.015397323,0.000498895,0.0028384938,0.2480491,0.00072419597,0.009666105,0.000047956008],"about_ca_topic_score_codex":0.00026839864,"about_ca_topic_score_gemma":0.00046714253,"teacher_disagreement_score":0.00086691685,"about_ca_system_score_codex":0.00014677475,"about_ca_system_score_gemma":0.00015637283,"threshold_uncertainty_score":0.0029001236},"labels":[],"label_agreement":null},{"id":"W2119389223","doi":"10.1038/sj.clpt.6100377","title":"Pharmacokinetic Studies in Pregnant Women","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Miller; Pharmacy; Anger; Citation; Medicine; Clinical pharmacology; Library science; Psychology; Family medicine; Pharmacology; Psychiatry; Computer science","score_opus":0.263882189193164,"score_gpt":0.5560746804986478,"score_spread":0.29219249130548386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119389223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5851674,0.1929506,0.03493139,0.0070332303,0.0019485496,0.0050865435,0.010635098,0.00082805107,0.16141912],"genre_scores_gemma":[0.85620433,0.08506717,0.017365018,0.00523864,0.00090401067,0.0029802823,0.0038111154,0.00017944764,0.028249985],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985983,0.00062688836,0.0001461129,0.00021221969,0.0003325281,0.00008406505],"domain_scores_gemma":[0.9989974,0.0003665583,0.00021155065,0.00012226366,0.00022884879,0.00007344475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019037938,0.00037931945,0.00058298645,0.00055258896,0.0005065444,0.00061470625,0.00027869418,0.0006011093,0.0055345297],"category_scores_gemma":[0.0050692903,0.00026992607,0.00061717327,0.00095487316,0.00027529066,0.0003953051,0.00038383662,0.0010233202,0.0022711807],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010795986,0.0033427759,0.11662109,0.003772853,0.0009675203,0.0079576485,0.00484038,0.0016822156,0.07766643,0.006537832,0.036480524,0.7293348],"study_design_scores_gemma":[0.002028537,0.05037491,0.19287053,0.0012555573,0.0014457352,0.039870072,0.0018917299,0.0022189924,0.056777243,0.0042411326,0.6468165,0.00020911072],"about_ca_topic_score_codex":0.0014318929,"about_ca_topic_score_gemma":0.0015385469,"teacher_disagreement_score":0.0055345297,"about_ca_system_score_codex":0.00057657604,"about_ca_system_score_gemma":0.0010399544,"threshold_uncertainty_score":0.018514872},"labels":[],"label_agreement":null},{"id":"W2119478252","doi":"10.1016/j.clpt.2003.11.278","title":"Neurodevelopment in children exposed in utero to cyclosporine and azathioprine following maternal renal transplant: preliminary results","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital; SickKids Foundation","funders":"","keywords":"Azathioprine; Wechsler Adult Intelligence Scale; Wechsler Preschool and Primary Scale of Intelligence; Medicine; Pregnancy; Neuropsychology; In utero; Transplantation; Pediatrics; Wechsler Intelligence Scale for Children; Cohort; Fetus; Internal medicine; Psychiatry; Cognition","score_opus":0.0509365811838767,"score_gpt":0.38739739547548346,"score_spread":0.3364608142916068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119478252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995425,0.000085872816,0.000029678722,0.000011914128,0.0000028795232,0.000010292446,0.00010352057,0.0000022894437,0.00021110504],"genre_scores_gemma":[0.99885106,0.00041125264,0.0001588345,0.000023986873,0.00000950403,0.000027520078,0.00025353086,0.0000016295896,0.00026269126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996526,0.00008148248,0.000033331868,0.000053972173,0.000084224535,0.0000942913],"domain_scores_gemma":[0.99941707,0.00014951432,0.00017525429,0.000047434216,0.00009203916,0.00011869139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006243022,0.0004558761,0.00029954693,0.0006782289,0.0004973732,0.0004188428,0.00023944658,0.0003242834,0.0011267156],"category_scores_gemma":[0.0013953382,0.00016685693,0.00043427912,0.00042025742,0.0003704521,0.00025862656,0.00051805086,0.0003553109,0.0001997817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013762452,0.0011662327,0.97821087,0.0000641577,0.00007352336,0.004960329,0.0012460018,0.00006724561,0.0026892486,0.000038998056,0.00017305985,0.009934136],"study_design_scores_gemma":[0.000044806806,0.0051249512,0.98563945,0.000016936401,0.0001257435,0.005110599,0.0010170991,0.000073278774,0.0022974547,0.00005046314,0.0004890531,0.000010194704],"about_ca_topic_score_codex":0.004760366,"about_ca_topic_score_gemma":0.004531788,"teacher_disagreement_score":0.004760366,"about_ca_system_score_codex":0.00036587156,"about_ca_system_score_gemma":0.00041472353,"threshold_uncertainty_score":0.009465277},"labels":[],"label_agreement":null},{"id":"W2121718651","doi":"10.1038/clpt.2010.133","title":"Deep Brain Stimulation in Clinical Practice and in Animal Models","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Toronto Western Hospital","funders":"","keywords":"Deep brain stimulation; Neuroscience; Medicine; Movement disorders; Stimulation; Therapeutic window; Clinical pharmacology; Neurosurgery; Psychology; Pharmacology; Psychiatry; Internal medicine","score_opus":0.2707123432835973,"score_gpt":0.5559429947071708,"score_spread":0.2852306514235735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121718651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044443074,0.9912196,0.001986628,0.00049717544,0.00022237065,0.000034481487,0.000049101778,0.000037158356,0.0055090543],"genre_scores_gemma":[0.0037457775,0.99100775,0.0022736301,0.0004222083,0.00022717316,0.000080626065,0.000097038566,0.000008687334,0.0021371904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996314,0.00009292987,0.00004420532,0.00006293812,0.00014257098,0.000026009084],"domain_scores_gemma":[0.99972147,0.00012742367,0.000035193458,0.000022693543,0.000065930806,0.000027297307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013157837,0.0011147886,0.0016057013,0.0020108386,0.00025843258,0.0011637,0.0010965869,0.001585916,0.004549501],"category_scores_gemma":[0.0007118549,0.00035535527,0.0004659609,0.0016245586,0.00097254117,0.0014898557,0.0007396434,0.0021287631,0.0039902027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013912414,0.0002435379,0.00016226433,0.009956987,0.00006467263,0.00038004454,0.000090102585,0.0006170185,0.016614322,0.006707481,0.018817369,0.94620705],"study_design_scores_gemma":[0.00007662133,0.0006057238,0.0012473685,0.0027058623,0.000095001866,0.0033886628,0.00007685866,0.00024434834,0.0056786262,0.006741224,0.97909385,0.00004586907],"about_ca_topic_score_codex":0.00065581227,"about_ca_topic_score_gemma":0.0011085453,"teacher_disagreement_score":0.004549501,"about_ca_system_score_codex":0.0006643966,"about_ca_system_score_gemma":0.00069277437,"threshold_uncertainty_score":0.015219629},"labels":[],"label_agreement":null},{"id":"W2123304989","doi":"10.1038/sj.clpt.6100492","title":"Assessing Abuse Liability During Drug Development: Changing Standards and Expectations","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Abuse liability; Clinical pharmacology; Recreational Drug; Stimulant; Liability; Mood; Pharmacology; Medicine; Hallucinogen; Drugs of abuse; Substance abuse; Drug; Psychology; Psychiatry; Business","score_opus":0.13923717806136543,"score_gpt":0.5067391924256456,"score_spread":0.36750201436428015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123304989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012197398,0.9798274,0.005068638,0.00895624,0.00048451775,0.000028829485,0.00004610362,0.00005476095,0.0043138],"genre_scores_gemma":[0.005379486,0.9833733,0.006423856,0.0028369194,0.0006583918,0.000055798733,0.00007449895,0.000017694445,0.0011801046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98916966,0.002664254,0.0018211231,0.00087503984,0.005274433,0.00019544878],"domain_scores_gemma":[0.9625595,0.021921618,0.0050197677,0.0011207607,0.008403932,0.0009744854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026869755,0.0011477154,0.0033488648,0.0046996637,0.00051936746,0.0038168863,0.0035263563,0.0031082781,0.0011200828],"category_scores_gemma":[0.017954148,0.00069862476,0.00081484247,0.0040107104,0.0036951348,0.009027725,0.0020870056,0.0049474835,0.0012033834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006133605,0.00010082512,0.0009220426,0.010215415,0.00005524418,0.00024612976,0.00029301978,0.0008655203,0.002024474,0.013307585,0.011197014,0.96071136],"study_design_scores_gemma":[0.000042731328,0.00051375496,0.003600709,0.0148076955,0.00016618217,0.002951573,0.00090042065,0.0011279264,0.0041265856,0.028228955,0.9434183,0.000115242845],"about_ca_topic_score_codex":0.0023056944,"about_ca_topic_score_gemma":0.0032519782,"teacher_disagreement_score":0.026869755,"about_ca_system_score_codex":0.002865038,"about_ca_system_score_gemma":0.0048181457,"threshold_uncertainty_score":0.14210254},"labels":[],"label_agreement":null},{"id":"W2124154653","doi":"10.1016/j.clpt.2005.12.304","title":"A therapeutic substitution policy for proton pump inhibitors: Clinical and economic consequences","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria","funders":"National Institute on Aging; Agency for Healthcare Research and Quality","keywords":"Medicine; Lansoprazole; Rabeprazole; Discontinuation; Omeprazole; Proton-pump inhibitor; Medical prescription; Drug; Esomeprazole; Internal medicine; Pharmacy; Intensive care medicine; Emergency medicine; Pharmacology; Family medicine","score_opus":0.09484999997130361,"score_gpt":0.4614651855137237,"score_spread":0.36661518554242006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124154653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619305,0.00027044618,0.00033786948,0.0014361432,0.000014746573,0.00011904734,0.00046767338,0.0000072575585,0.0011538276],"genre_scores_gemma":[0.997999,0.0001411229,0.0004958907,0.00068936654,0.000023861001,0.00004781318,0.00020489912,0.0000013071017,0.00039673183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669087,0.0019044612,0.00014877736,0.0002544588,0.00060203654,0.00039942903],"domain_scores_gemma":[0.9863855,0.0060461327,0.0050268243,0.000596067,0.0010092709,0.00093628303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060386597,0.00027872712,0.0003523162,0.00029629053,0.0006142266,0.0010586986,0.0006064424,0.0013149694,0.001847951],"category_scores_gemma":[0.013785864,0.00020012124,0.00041359474,0.0005302689,0.0013631366,0.0004902324,0.0005229506,0.0008745343,0.0001225794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011700561,0.004144767,0.91989803,0.00026595138,0.0006965777,0.00081097864,0.0002864398,0.015894532,0.004903315,0.0030866396,0.0028715723,0.035440624],"study_design_scores_gemma":[0.0013973903,0.0037920417,0.9741417,0.000054721357,0.0003002359,0.00032585513,0.00048874354,0.013809153,0.001156766,0.0013344486,0.0031602771,0.000038669747],"about_ca_topic_score_codex":0.082494,"about_ca_topic_score_gemma":0.08288794,"teacher_disagreement_score":0.082494,"about_ca_system_score_codex":0.0055629644,"about_ca_system_score_gemma":0.005885154,"threshold_uncertainty_score":0.16402763},"labels":[],"label_agreement":null},{"id":"W2125160586","doi":"10.1067/mcp.2000.107047","title":"Population pharmacokinetics of long-term oral amiodarone therapy","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pharmacokinetics; Bioavailability; Dosing; Regimen; Amiodarone; Medicine; Population; Discontinuation; NONMEM; Pharmacology; Half-life; Elimination rate constant; Internal medicine; Volume of distribution; Atrial fibrillation","score_opus":0.07404740526852116,"score_gpt":0.43506687604539046,"score_spread":0.3610194707768693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125160586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9390839,0.0025099255,0.05580808,0.00032827418,0.000015760901,0.00008045288,0.0005890045,0.0002235154,0.0013612253],"genre_scores_gemma":[0.9959518,0.0003039557,0.0029684056,0.00005996761,0.000014936873,0.00007038551,0.00045945885,0.000011608323,0.00015940842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988927,0.00059552956,0.0000518272,0.00019124134,0.00021254196,0.00005618406],"domain_scores_gemma":[0.996051,0.0026466798,0.0006452474,0.0002898097,0.00025834705,0.00010892714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032997255,0.00030462083,0.0005736344,0.00023895531,0.00012270722,0.00070687226,0.00039833342,0.00046068907,0.0006913804],"category_scores_gemma":[0.007864188,0.00020106818,0.0005764757,0.00020728931,0.00021057345,0.00046484137,0.00029100277,0.00067173893,0.00015585375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005239089,0.00048613796,0.6155966,0.00034659632,0.0035434002,0.0010837939,0.00087496825,0.2027335,0.02621015,0.0036912865,0.002343205,0.13785133],"study_design_scores_gemma":[0.00028855223,0.005230904,0.5254314,0.00006839205,0.0014616272,0.0032158387,0.00018441059,0.4440186,0.0071470444,0.0059518614,0.0068993703,0.00010200877],"about_ca_topic_score_codex":0.0008000908,"about_ca_topic_score_gemma":0.0005022424,"teacher_disagreement_score":0.0032997255,"about_ca_system_score_codex":0.0005666515,"about_ca_system_score_gemma":0.00045383268,"threshold_uncertainty_score":0.01745081},"labels":[],"label_agreement":null},{"id":"W2125223264","doi":"10.1067/mcp.2000.104642","title":"Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Midazolam; CYP3A; Ciclosporin; Pharmacokinetics; Pharmacology; Drug interaction; Trough level; Chemistry; Oral administration; Cytochrome P450; Transplantation; Medicine; Internal medicine; Metabolism; Tacrolimus","score_opus":0.16495915294152005,"score_gpt":0.39984445039307165,"score_spread":0.2348852974515516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125223264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992599,0.00022597724,0.00038179313,0.00001358022,0.0000018860804,0.0000048125794,0.000024425659,0.000007464859,0.00008012235],"genre_scores_gemma":[0.9995474,0.00006632575,0.00027173903,0.000010242295,0.000004436418,0.0000054412917,0.000053930682,0.0000015349699,0.00003891838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974674,0.00010103858,0.000023034268,0.00003014423,0.00007263343,0.000026529353],"domain_scores_gemma":[0.9986473,0.00060405734,0.00041555768,0.00006023735,0.00011421288,0.00015869916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008154833,0.00031482492,0.00032346457,0.00039438665,0.00016958821,0.00034538374,0.0001182331,0.000248343,0.0005970232],"category_scores_gemma":[0.00248736,0.00013976143,0.00020402177,0.00016686696,0.00017228942,0.00019532035,0.00013107155,0.00037007072,0.00024879994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003087511,0.00014539284,0.9751297,0.000015157405,0.000057323046,0.00016457641,0.000047181755,0.0007915995,0.00843757,0.000013387441,0.00009278699,0.012017851],"study_design_scores_gemma":[0.00011247732,0.0044943644,0.9737612,0.00000828364,0.00008244813,0.0013469202,0.000066350985,0.00937506,0.010342185,0.00004931553,0.00034757442,0.00001384526],"about_ca_topic_score_codex":0.000374799,"about_ca_topic_score_gemma":0.00036080822,"teacher_disagreement_score":0.0008154833,"about_ca_system_score_codex":0.00027728154,"about_ca_system_score_gemma":0.00014431847,"threshold_uncertainty_score":0.0043127537},"labels":[],"label_agreement":null},{"id":"W2126333303","doi":"10.1038/clpt.2012.184","title":"Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of General Medical Sciences; National Institutes of Health; National Institute for Health and Care Research","keywords":"VKORC1; Confidence interval; Coumarin; Meta-analysis; Internal medicine; Clinical pharmacology; Medicine; CYP2C9; Polymorphism (computer science); Allele; Pharmacology; Oncology; Biology; Genetics","score_opus":0.617369271961051,"score_gpt":0.6106917275112662,"score_spread":0.006677544449784745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126333303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021574185,0.99675024,0.00026463097,0.00014216371,0.000062589774,0.00012069731,0.00033791343,0.000010211412,0.00015413914],"genre_scores_gemma":[0.061190877,0.9357912,0.0012483546,0.000379317,0.00012160923,0.0004583015,0.00055115216,0.000011187328,0.00024800733],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954501,0.0019360868,0.0012829085,0.00049130083,0.00066028396,0.0001794202],"domain_scores_gemma":[0.98584855,0.0106601985,0.0019365918,0.00025860075,0.001152336,0.00014364447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009032188,0.0022937187,0.01449276,0.006740037,0.0004661788,0.0023278897,0.0017569319,0.0017443058,0.003162249],"category_scores_gemma":[0.020508077,0.0010387276,0.019413788,0.008719624,0.00046645908,0.0011407019,0.001119558,0.001116705,0.00026175246],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015222848,0.000030536215,0.003929273,0.6553782,0.29835632,0.00028218998,0.00008556362,0.00063217175,0.00037702644,0.00018617373,0.0014064641,0.037813727],"study_design_scores_gemma":[0.0004726057,0.00022752391,0.0055331774,0.048116654,0.93994355,0.00028742824,0.000059305123,0.0002118189,0.0002606672,0.00023819004,0.0046228967,0.00002624816],"about_ca_topic_score_codex":0.005918482,"about_ca_topic_score_gemma":0.014008598,"teacher_disagreement_score":0.01449276,"about_ca_system_score_codex":0.0023693654,"about_ca_system_score_gemma":0.0038814775,"threshold_uncertainty_score":0.04776734},"labels":[],"label_agreement":null},{"id":"W2130770322","doi":"10.1016/j.clpt.2003.11.133","title":"Absence of circadian variation in the pharmacokinetics (PK) of lopinavir/ritonavir (LPV/R) in a once-daily (QD) dosing regimen in hiv-1-infected subjects","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Dosing; Cmax; Ritonavir; Lopinavir/ritonavir; Pharmacokinetics; Lopinavir; Medicine; Pharmacology; Regimen; Human immunodeficiency virus (HIV); Geometric mean; Internal medicine; Chemistry; Gastroenterology; Viral load; Mathematics; Antiretroviral therapy; Immunology","score_opus":0.05824986706197384,"score_gpt":0.39219260239882797,"score_spread":0.33394273533685415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130770322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998494,0.000567944,0.0004711372,0.000020810823,0.000012692075,0.000023787072,0.00010345124,0.000011864142,0.00029418906],"genre_scores_gemma":[0.9992593,0.00009750599,0.00034328102,0.000031692955,0.000019340767,0.00001628527,0.000087587716,0.0000050872013,0.00013997905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995167,0.0002429503,0.000028317203,0.00010764354,0.00006912918,0.000035274177],"domain_scores_gemma":[0.99888664,0.00035015543,0.00035609247,0.00016553095,0.00009774777,0.00014383224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014280056,0.00019266349,0.00033497214,0.00014050168,0.00021018428,0.00038666194,0.00013199451,0.00018179542,0.00092029216],"category_scores_gemma":[0.0015864061,0.00020488085,0.00016917233,0.00014099745,0.0002925185,0.00019752918,0.00012729345,0.0002803018,0.00012558671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041925088,0.001537424,0.7446706,0.0003484093,0.00048757732,0.00035720022,0.00042974987,0.0006832161,0.15168452,0.00017977692,0.00049262797,0.05720382],"study_design_scores_gemma":[0.00030493346,0.0112025235,0.9824379,0.000005981449,0.00012622066,0.00047584486,0.000065741464,0.00063706574,0.0042199213,0.00007356589,0.00044096343,0.000009381744],"about_ca_topic_score_codex":0.0007882708,"about_ca_topic_score_gemma":0.0007091265,"teacher_disagreement_score":0.0014280056,"about_ca_system_score_codex":0.00015642248,"about_ca_system_score_gemma":0.00020783831,"threshold_uncertainty_score":0.007552147},"labels":[],"label_agreement":null},{"id":"W2133049351","doi":"10.1016/j.clpt.2003.11.097","title":"Time-dependent toxicity of sulfonamide reactive metabolites in cells of patients with sulfonamide hypersensitivity","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Sulfonamide; Peripheral blood mononuclear cell; Toxicity; Pharmacology; Programmed cell death; Viability assay; Necrosis; Drug; Apoptosis; Hydroxylamine; Medicine; Chemistry; Immunology; In vitro; Biochemistry; Internal medicine; Stereochemistry","score_opus":0.033758052400297264,"score_gpt":0.34993151975444997,"score_spread":0.3161734673541527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133049351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998145,0.0008459528,0.0003241625,0.000023580795,0.000011004872,0.000017805016,0.00014928871,0.000008243707,0.0004749637],"genre_scores_gemma":[0.998733,0.00029002136,0.00028719442,0.000025691073,0.0000093428725,0.000023856519,0.00031052885,0.0000019743702,0.00031844503],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997428,0.000062458326,0.000035252626,0.00005223408,0.00006525482,0.000041903037],"domain_scores_gemma":[0.9996519,0.000099395744,0.00010588818,0.00003255332,0.000070447866,0.00003981242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020748605,0.00018916703,0.00036545444,0.00032843833,0.00018325192,0.0002972188,0.00012730838,0.00037479255,0.0021369979],"category_scores_gemma":[0.0005861067,0.00013449835,0.00016585366,0.00030241528,0.00015646934,0.00017107428,0.00015106627,0.00033105415,0.0004505846],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077261287,0.0004952032,0.22685555,0.00021791799,0.00009534169,0.006231766,0.0007009052,0.0004341838,0.73566103,0.00014137862,0.0003718399,0.021068709],"study_design_scores_gemma":[0.00018773125,0.014207563,0.6893785,0.000026245472,0.00017666255,0.028256938,0.0008539633,0.0016208158,0.26112676,0.00022230115,0.003907787,0.00003483193],"about_ca_topic_score_codex":0.00032085084,"about_ca_topic_score_gemma":0.00038462525,"teacher_disagreement_score":0.0021369979,"about_ca_system_score_codex":0.0001982286,"about_ca_system_score_gemma":0.0000872745,"threshold_uncertainty_score":0.007148981},"labels":[],"label_agreement":null},{"id":"W2134431157","doi":"10.1038/sj.clpt.6100104","title":"Naringin is a Major and Selective Clinical Inhibitor of Organic Anion-Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"National Institute of General Medical Sciences","keywords":"Grapefruit juice; Fexofenadine; Naringin; Chemistry; Bioavailability; Pharmacology; Orange juice; Hesperidin; Pharmacokinetics; Chromatography; Food science; Medicine","score_opus":0.05285124708051807,"score_gpt":0.4164629260516325,"score_spread":0.3636116789711144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134431157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98811996,0.008619344,0.0017819424,0.00014701909,0.00002988216,0.00012914652,0.00017070753,0.00006641924,0.0009355477],"genre_scores_gemma":[0.99377596,0.0022732313,0.002085971,0.00004788663,0.000024908328,0.00004555151,0.00036552656,0.0000084558715,0.0013725142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998349,0.000039515817,0.000011614495,0.000059260507,0.000038064198,0.000016692797],"domain_scores_gemma":[0.9998971,0.000018631596,0.000039067563,0.000009123386,0.000011213548,0.000024799792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002291726,0.00030901728,0.00038002306,0.000115843985,0.00015951901,0.00021885741,0.00016819153,0.00021260863,0.0009332377],"category_scores_gemma":[0.00032272097,0.00013342612,0.00021687095,0.000116158786,0.0002388314,0.0002131262,0.00011575752,0.00038907773,0.000170631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023195534,0.00020729638,0.0020228745,0.00020175763,0.00004937131,0.00014623815,0.000046551057,0.00014326705,0.9708582,0.000052520012,0.00018672044,0.02376561],"study_design_scores_gemma":[0.001449951,0.037980907,0.11143423,0.000037037425,0.00026738533,0.00302524,0.00008771471,0.0017496344,0.82517064,0.0001014556,0.018669434,0.000026488116],"about_ca_topic_score_codex":0.001263959,"about_ca_topic_score_gemma":0.0029628132,"teacher_disagreement_score":0.001263959,"about_ca_system_score_codex":0.00034626317,"about_ca_system_score_gemma":0.00022469148,"threshold_uncertainty_score":0.003121972},"labels":[],"label_agreement":null},{"id":"W2135850268","doi":"10.1067/mcp.2000.107524","title":"Grapefruit juice–felodipine interaction in the elderly","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Ginkgo biloba and Cashew Applications","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Felodipine; Grapefruit juice; Pharmacokinetics; Bioavailability; Chemistry; Pharmacology; Metabolite; Area under the curve; Active metabolite; Blood pressure; Medicine; Endocrinology; Biochemistry","score_opus":0.12192521159463282,"score_gpt":0.47607692678771113,"score_spread":0.3541517151930783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135850268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988637,0.00086327404,0.000050287454,0.000014995425,0.0000030836454,0.0000068825875,0.000028017172,0.000003544647,0.00016620115],"genre_scores_gemma":[0.99917644,0.00044813467,0.00014319515,0.000046468314,0.00001064246,0.000004134221,0.000041790565,7.8066637e-7,0.00012839725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986744,0.000048565955,0.000010162596,0.000022677514,0.00003524089,0.000015867763],"domain_scores_gemma":[0.9997453,0.00006964551,0.00008747259,0.00001636768,0.00003674912,0.00004445736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039770867,0.00021829741,0.00044656027,0.00015756002,0.0002308177,0.00019398239,0.00008494718,0.00025293682,0.00064661604],"category_scores_gemma":[0.00063815876,0.00008340786,0.00028947394,0.00015515967,0.00010959582,0.00012493349,0.00009284858,0.00017598369,0.000096153926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018584324,0.0011656405,0.8249349,0.0004133841,0.00083623396,0.0028425814,0.0005633477,0.00029983182,0.09198954,0.00005311074,0.00055725727,0.0577598],"study_design_scores_gemma":[0.00015056442,0.010876567,0.9791708,0.00001703945,0.00042665083,0.0024972078,0.00011281185,0.00031006828,0.005092035,0.00003658635,0.0013000648,0.000009577783],"about_ca_topic_score_codex":0.0016607787,"about_ca_topic_score_gemma":0.0023166167,"teacher_disagreement_score":0.0016607787,"about_ca_system_score_codex":0.00024033745,"about_ca_system_score_gemma":0.0001261091,"threshold_uncertainty_score":0.0033022165},"labels":[],"label_agreement":null},{"id":"W2135905495","doi":"10.1038/clpt.2014.76","title":"The Ebbs and Flows in the Development of Cholesterol-Lowering Drugs: Prospects for the Future","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Clinical pharmacology; Medicine; Cholesterol; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.09926709391705164,"score_gpt":0.46066391303830856,"score_spread":0.36139681912125693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135905495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060291302,0.9972223,0.00008790045,0.0013350545,0.0004196632,0.000002624808,0.000008249191,0.0000059563463,0.00085789716],"genre_scores_gemma":[0.00035007775,0.9978892,0.000216734,0.0005453683,0.00036751566,0.000003578011,0.000011924565,0.0000014894572,0.0006140872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995975,0.000094047944,0.00005184181,0.00004652719,0.00015840796,0.000051694984],"domain_scores_gemma":[0.99918944,0.00033634697,0.000097323784,0.000027833836,0.00023434227,0.00011482985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001507897,0.00084537634,0.0014985964,0.0019309103,0.00042345666,0.0018285112,0.0009906745,0.0023863497,0.0076477122],"category_scores_gemma":[0.0014423728,0.00031462387,0.0006691426,0.0029696866,0.0009436611,0.00366089,0.0013530931,0.0032535023,0.0043310043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009622513,0.000087562024,0.0001678742,0.01167653,0.00007247464,0.00014257642,0.00008617672,0.00022307097,0.0008706122,0.010681302,0.048378095,0.9275176],"study_design_scores_gemma":[0.000019770245,0.000062316925,0.00039678934,0.004462761,0.000058067704,0.00039234318,0.000084261104,0.00006390683,0.00012921164,0.0053323032,0.9889839,0.0000143243105],"about_ca_topic_score_codex":0.0011320334,"about_ca_topic_score_gemma":0.0020479066,"teacher_disagreement_score":0.0076477122,"about_ca_system_score_codex":0.0008369508,"about_ca_system_score_gemma":0.0022385472,"threshold_uncertainty_score":0.025584161},"labels":[],"label_agreement":null},{"id":"W2138509705","doi":"10.1002/cpt.269","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>UGT1A1</i> and Atazanavir Prescribing","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Guideline; Atazanavir; Medicine; Pharmacogenetics; Medical physics; Family medicine; Biology; Genotype","score_opus":0.2694700399285668,"score_gpt":0.5659185183564023,"score_spread":0.2964484784278355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138509705","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008745558,0.02158508,0.060050245,0.5217276,0.013203575,0.008686823,0.01761488,0.004904136,0.34348208],"genre_scores_gemma":[0.057598516,0.046853226,0.29899883,0.41704848,0.008261741,0.017093496,0.03168017,0.0018821657,0.12058341],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9824269,0.0068383636,0.003923691,0.0005852555,0.005272884,0.00095301593],"domain_scores_gemma":[0.95633817,0.012604289,0.0046148165,0.0013528941,0.021623358,0.0034666175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014133028,0.000645044,0.0010180959,0.0021776003,0.0013998536,0.0026635232,0.0033149458,0.007888819,0.013548899],"category_scores_gemma":[0.04652309,0.00073025347,0.002255655,0.002366652,0.0008030889,0.0017349222,0.0017925815,0.0074366466,0.008962587],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007552679,0.00029275837,0.0024248234,0.0004851333,0.000030595187,0.00047194384,0.00023478434,0.000540504,0.0005184622,0.00447663,0.8729303,0.117518544],"study_design_scores_gemma":[0.00029374822,0.00018473185,0.0111426115,0.0058152466,0.00010315623,0.0010285226,0.0002976953,0.0011925837,0.0010102444,0.006040076,0.97280324,0.00008813042],"about_ca_topic_score_codex":0.027423896,"about_ca_topic_score_gemma":0.039947893,"teacher_disagreement_score":0.027423896,"about_ca_system_score_codex":0.0029401921,"about_ca_system_score_gemma":0.01839372,"threshold_uncertainty_score":0.07474345},"labels":[],"label_agreement":null},{"id":"W2138604875","doi":"10.1038/clpt.2009.98","title":"New Antithrombotic Drugs","year":2009,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Antithrombotic; Hemostasis; Medicine; Thrombosis; Intensive care medicine; Fibrinolytic agent; Platelet; Pharmacology; Internal medicine","score_opus":0.15986582646157363,"score_gpt":0.4988658099130718,"score_spread":0.3389999834514982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138604875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030730778,0.9917082,0.00033876506,0.00061778305,0.0005703286,0.000015530255,0.000031465523,0.000020074063,0.006390653],"genre_scores_gemma":[0.0017993739,0.98941946,0.0007525016,0.0008284436,0.0006836166,0.000017496463,0.0000822057,0.000003016636,0.0064139445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972135,0.00003883135,0.000029457831,0.000039233964,0.00014775766,0.000023340206],"domain_scores_gemma":[0.9998448,0.00004718893,0.00002393205,0.000008069479,0.00005387721,0.00002215494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004402788,0.00085439766,0.0011519607,0.0020498119,0.00031985523,0.0008005061,0.0006448102,0.000935634,0.007464885],"category_scores_gemma":[0.00044684214,0.00022165528,0.00038694363,0.0013476446,0.00037567256,0.0009812639,0.0005128053,0.0018550871,0.0065871445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074462136,0.00016060064,0.00013394009,0.004332892,0.00005454051,0.0004210874,0.000043502692,0.00018185459,0.004116873,0.0033959283,0.040097684,0.9469866],"study_design_scores_gemma":[0.000039510367,0.00009085586,0.00052757055,0.0009974474,0.00004160692,0.0017854583,0.00001876208,0.0000620717,0.0006941174,0.0013839465,0.9943494,0.000009241984],"about_ca_topic_score_codex":0.0005721178,"about_ca_topic_score_gemma":0.0014552868,"teacher_disagreement_score":0.007464885,"about_ca_system_score_codex":0.0004384134,"about_ca_system_score_gemma":0.0006593708,"threshold_uncertainty_score":0.024972558},"labels":[],"label_agreement":null},{"id":"W2139470198","doi":"10.1038/clpt.2010.165","title":"The Development of New Therapeutics for Alzheimer's Disease","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Disease; Medicine; Biomarker; Alzheimer's disease; Intervention (counseling); Drug development; Amyloid β; Intensive care medicine; Neuroscience; Bioinformatics; Psychology; Drug; Psychiatry; Biology; Pathology","score_opus":0.36473471343936925,"score_gpt":0.553366885370989,"score_spread":0.18863217193161974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139470198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025555302,0.99684817,0.0003265071,0.00027215804,0.00020628654,0.0000128611755,0.000016112861,0.000015282554,0.0020471069],"genre_scores_gemma":[0.0008436793,0.9971656,0.0004740546,0.00017471715,0.00014037392,0.000011950697,0.000023206523,0.0000016785966,0.0011646738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999778,0.00003714269,0.000025075884,0.00003650726,0.000101030564,0.000022302931],"domain_scores_gemma":[0.9998073,0.00007028205,0.000031782332,0.00001075744,0.00005504724,0.000024814788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063043326,0.00092943676,0.0015262092,0.0021887128,0.0003570884,0.00088516076,0.0007435763,0.0010784196,0.0046852413],"category_scores_gemma":[0.0004710994,0.0002997109,0.00045561764,0.0017470889,0.00055320107,0.0016075952,0.00068678183,0.0019428207,0.00405021],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055248154,0.00014933312,0.00010325426,0.0092974305,0.00006310199,0.00018782607,0.000071740185,0.00034045937,0.006328955,0.0054285326,0.01929895,0.95867527],"study_design_scores_gemma":[0.000028231549,0.00015326487,0.000587887,0.0018676356,0.00006336071,0.0008855141,0.00004999499,0.000092576505,0.0012224244,0.0026923232,0.9923415,0.000015154353],"about_ca_topic_score_codex":0.0007444467,"about_ca_topic_score_gemma":0.0014440846,"teacher_disagreement_score":0.0046852413,"about_ca_system_score_codex":0.0005240434,"about_ca_system_score_gemma":0.0009790321,"threshold_uncertainty_score":0.015673757},"labels":[],"label_agreement":null},{"id":"W2139550411","doi":"10.1002/cpt.87","title":"Rational use of medicines in older adults: Can we do better during clinical development?","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kellogg's (Canada)","funders":"","keywords":"Extrapolation; Bridging (networking); Clinical trial; Regimen; Medicine; Population; Gerontology; Intensive care medicine; Computer science; Environmental health; Internal medicine; Computer security; Statistics","score_opus":0.3811203374204423,"score_gpt":0.5203174305524702,"score_spread":0.13919709313202783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139550411","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05660217,0.12936379,0.031103084,0.7432884,0.0038019572,0.001248174,0.0011384431,0.0007938372,0.032660153],"genre_scores_gemma":[0.48861417,0.22888443,0.16688326,0.10146979,0.004907941,0.0025856192,0.0014438661,0.00031429806,0.0048966953],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9712161,0.019504739,0.003476637,0.0009741681,0.0038194675,0.0010089165],"domain_scores_gemma":[0.890875,0.05467384,0.020876331,0.008067464,0.016745437,0.008761953],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06684331,0.0010379499,0.0033518774,0.0014458171,0.0013518237,0.010993806,0.0024355808,0.004689372,0.008610813],"category_scores_gemma":[0.21903566,0.00072342664,0.0019517832,0.0018295959,0.0030915416,0.015638849,0.0058047357,0.0063527822,0.003172028],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012963687,0.0013190075,0.033355635,0.0054516783,0.0003526173,0.00045500786,0.0034978346,0.0040980554,0.00047321385,0.021376258,0.06059446,0.86772984],"study_design_scores_gemma":[0.003135459,0.010516889,0.079272,0.06577065,0.0019953393,0.0019465612,0.019060927,0.01807438,0.003979122,0.21603204,0.57917756,0.0010390708],"about_ca_topic_score_codex":0.0076935096,"about_ca_topic_score_gemma":0.011893075,"teacher_disagreement_score":0.93315667,"about_ca_system_score_codex":0.0042392616,"about_ca_system_score_gemma":0.024343595,"threshold_uncertainty_score":0.35350543},"labels":[],"label_agreement":null},{"id":"W2140042090","doi":"10.1016/j.clpt.2003.12.008","title":"Use of population modeling to define rational monitoring of amiodarone hepatic effects*1","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Amiodarone; Medicine; Internal medicine; Albumin; Lactate dehydrogenase; Gastroenterology; NONMEM; Population; Bilirubin; Pharmacology; Endocrinology; Pharmacokinetics; Chemistry; Enzyme; Atrial fibrillation; Biochemistry","score_opus":0.3997537084719063,"score_gpt":0.5196891367941098,"score_spread":0.1199354283222035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140042090","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10794777,0.0007687622,0.8858955,0.001030944,0.00009042299,0.00033188635,0.00062977086,0.000603887,0.0027012173],"genre_scores_gemma":[0.86530244,0.00047789697,0.13166286,0.00027494712,0.000078191,0.0005581832,0.0006277681,0.00008868231,0.00092907646],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99720263,0.0022622524,0.00007988758,0.00025247308,0.00012978514,0.000072908544],"domain_scores_gemma":[0.99293387,0.0057408996,0.00055357104,0.0002782293,0.00037287088,0.00012053426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006938904,0.0013293611,0.0012197858,0.0008832213,0.00030114473,0.001269139,0.00097008556,0.0008967197,0.00095524674],"category_scores_gemma":[0.016845625,0.0005591356,0.0013333408,0.000390876,0.00034462463,0.0006878823,0.0009889817,0.0011670175,0.00017612],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032610988,0.00015600071,0.051165037,0.00010081302,0.00083852967,0.00021462745,0.00012894809,0.9041012,0.0009916145,0.00817831,0.0013775926,0.032421343],"study_design_scores_gemma":[0.000028370272,0.00011944821,0.0023129454,0.000017837367,0.00008742652,0.00006982398,0.000020379033,0.9918589,0.00022290382,0.0045250566,0.0007238685,0.000012984126],"about_ca_topic_score_codex":0.0071105873,"about_ca_topic_score_gemma":0.004840887,"teacher_disagreement_score":0.0071105873,"about_ca_system_score_codex":0.0010036683,"about_ca_system_score_gemma":0.0019048223,"threshold_uncertainty_score":0.03669685},"labels":[],"label_agreement":null},{"id":"W2140050122","doi":"10.1067/mcp.2001.119814","title":"Red wine decreases cyclosporine bioavailability","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"National Center for Research Resources","keywords":"Wine; Bioavailability; Ciclosporin; Pharmacology; CYP3A4; Chemistry; Crossover study; Pharmacokinetics; Grapefruit juice; Fluorescence polarization immunoassay; Whole blood; Medicine; Food science; Chromatography; Internal medicine; Biochemistry; Cytochrome P450; Placebo; Chemotherapy; Metabolism","score_opus":0.31722550838377744,"score_gpt":0.5350868564341703,"score_spread":0.21786134805039287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140050122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978138,0.0012816691,0.00024284604,0.00007754657,0.000036294325,0.00001756879,0.00006194124,0.000044535194,0.0004238262],"genre_scores_gemma":[0.99696237,0.000949225,0.00052690937,0.00013692655,0.000058453817,0.000014769168,0.00014198339,0.000012698157,0.0011966318],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998735,0.00003847737,0.00001053923,0.000025243702,0.000030118914,0.000022054452],"domain_scores_gemma":[0.9997092,0.00007076617,0.0001010531,0.000025135352,0.000034806577,0.00005906197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017193051,0.00030414696,0.00035820488,0.00011850987,0.00011737678,0.0002785316,0.000120773504,0.00025923882,0.002424528],"category_scores_gemma":[0.00040013777,0.000120177945,0.00021993954,0.00008780743,0.00013404306,0.00015272974,0.00014995004,0.00042219748,0.00025999328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02359873,0.0018175786,0.008422508,0.00044297968,0.00027060037,0.00024933534,0.000060704802,0.00023079153,0.9090139,0.000087838336,0.00074515207,0.05505977],"study_design_scores_gemma":[0.0034744057,0.084159166,0.20728591,0.00013464643,0.00089677185,0.0023156432,0.00015070399,0.0030478525,0.68334883,0.0002670557,0.014877267,0.000041640968],"about_ca_topic_score_codex":0.0003191835,"about_ca_topic_score_gemma":0.00040732702,"teacher_disagreement_score":0.002424528,"about_ca_system_score_codex":0.00016915395,"about_ca_system_score_gemma":0.00014172224,"threshold_uncertainty_score":0.008110881},"labels":[],"label_agreement":null},{"id":"W2140768254","doi":"10.1038/clpt.2009.151","title":"Risk to the Breast-Fed Neonate From Codeine Treatment to the Mother: A Quantitative Mechanistic Modeling Study","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Codeine; Morphine; Medicine; Dosing; Opioid; Pharmacology; Pharmacokinetics; Clinical pharmacology; CYP2D6; Anesthesia; Breast feeding; Internal medicine; Pediatrics; Receptor; Cytochrome P450; Metabolism","score_opus":0.23207828621092713,"score_gpt":0.5160018537051443,"score_spread":0.28392356749421716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140768254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97463006,0.00039016956,0.020384165,0.00035070788,0.00000869312,0.000058404417,0.00025479926,0.00003293194,0.0038900112],"genre_scores_gemma":[0.9948473,0.00033083928,0.003584559,0.00006173901,0.0000052134856,0.000061754436,0.00010359967,0.000009110596,0.0009958358],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999754,0.00013470025,0.00000853181,0.000035366804,0.000037938196,0.000029408746],"domain_scores_gemma":[0.99767965,0.0018218334,0.00027419903,0.00005039828,0.00012660751,0.000047389156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000780739,0.0005308454,0.00067639345,0.00030360027,0.00024619364,0.00061635446,0.00083945,0.0009791002,0.001211281],"category_scores_gemma":[0.0032457444,0.00032277114,0.00078565464,0.00022329007,0.00036706062,0.0004394666,0.00045303366,0.0005081747,0.000111459376],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015492817,0.00011476308,0.0069440873,0.000053562377,0.000075753276,0.00024259389,0.000059677404,0.9845291,0.0021033762,0.0027605647,0.00015026367,0.0028113378],"study_design_scores_gemma":[0.000034702323,0.0002069693,0.0016217073,0.000008513422,0.000048737613,0.00012679138,0.00004140791,0.9954999,0.00088049436,0.0012512285,0.00026750605,0.000011968752],"about_ca_topic_score_codex":0.007967639,"about_ca_topic_score_gemma":0.0031273358,"teacher_disagreement_score":0.007967639,"about_ca_system_score_codex":0.0011562217,"about_ca_system_score_gemma":0.00090766646,"threshold_uncertainty_score":0.015842557},"labels":[],"label_agreement":null},{"id":"W2141288222","doi":"10.1016/j.clpt.2003.11.104","title":"Natural health product use in Canada: patterns of use and the risk of interactions with pharmaceuticals","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clinical pharmacology; Population; Drug; Adverse effect; Drug interaction; Pharmacology; Environmental health","score_opus":0.17262110777362327,"score_gpt":0.4637054418829783,"score_spread":0.291084334109355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141288222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9449453,0.015871435,0.00041928346,0.0050126966,0.00005619905,0.00014987028,0.018875834,0.000053894004,0.014615532],"genre_scores_gemma":[0.9891972,0.0059681763,0.00046578492,0.00047553825,0.00001620874,0.000020461024,0.0022633618,0.00001055556,0.0015827288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979488,0.00012096121,0.00019045066,0.00019289348,0.0012933156,0.0002536105],"domain_scores_gemma":[0.9958911,0.0002488824,0.0013738569,0.00008153955,0.0016810677,0.0007235514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088656275,0.00023155966,0.00033815202,0.002300328,0.0015944579,0.0015210616,0.0011334983,0.0005355309,0.0026983889],"category_scores_gemma":[0.0031129215,0.00026936663,0.0007850074,0.007814894,0.0006208414,0.0004712914,0.0007723111,0.00076945865,0.00029294885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009391515,0.000035962013,0.9809147,0.00016888033,0.00010838843,0.00011849477,0.00061709323,0.00008895592,0.00018112514,0.00016082586,0.0020681531,0.015443628],"study_design_scores_gemma":[0.00000351073,0.000019954161,0.9970577,0.000060643462,0.00002579159,0.000108107735,0.000546425,0.00020063529,0.000046975827,0.000027591366,0.001892411,0.000010220993],"about_ca_topic_score_codex":0.98753124,"about_ca_topic_score_gemma":0.9893713,"teacher_disagreement_score":0.017671552,"about_ca_system_score_codex":0.017671552,"about_ca_system_score_gemma":0.023743095,"threshold_uncertainty_score":0.12821668},"labels":[],"label_agreement":null},{"id":"W2141414647","doi":"10.1016/j.clpt.2004.08.019","title":"Bergamottin contribution to the grapefruit juice?felodipine interaction and disposition in humans","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Medical Research Council; Pfizer","keywords":"Felodipine; Cmax; Grapefruit juice; Chemistry; Metabolite; Pharmacology; Pharmacokinetics; Crossover study; Bioavailability; Oral administration; Medicine; Biochemistry; Internal medicine; Placebo","score_opus":0.17119421496437587,"score_gpt":0.5234489298046765,"score_spread":0.35225471484030063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141414647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612206,0.0029694894,0.0002484904,0.00006700842,0.000010275809,0.00003925365,0.00007690513,0.000011880743,0.000454604],"genre_scores_gemma":[0.9983803,0.0007335355,0.00035093713,0.00009721316,0.000016862099,0.000018200275,0.00005743399,0.0000027770757,0.00034274603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998474,0.00006468299,0.000007147149,0.00004105212,0.000023880108,0.000015798592],"domain_scores_gemma":[0.99988043,0.000034964996,0.000039367384,0.000012853754,0.000007009998,0.000025365092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035941065,0.00033912927,0.00053650927,0.000109331835,0.0002282876,0.00040167055,0.00011936855,0.00054550666,0.0014938172],"category_scores_gemma":[0.00052745175,0.00017630433,0.00026643748,0.00012047121,0.00025533023,0.00021440841,0.00008456578,0.00029831915,0.0001549568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19239114,0.004266933,0.36405748,0.0012961421,0.0025135106,0.002206076,0.00059144193,0.0009833361,0.28161263,0.0005427252,0.0011662893,0.14837223],"study_design_scores_gemma":[0.0028449085,0.03892144,0.9316251,0.000043385855,0.0010866319,0.0025834544,0.00011668436,0.001765569,0.016054448,0.00031387605,0.004603127,0.000041282536],"about_ca_topic_score_codex":0.0014326253,"about_ca_topic_score_gemma":0.0018589956,"teacher_disagreement_score":0.0014938172,"about_ca_system_score_codex":0.0003119403,"about_ca_system_score_gemma":0.0001968925,"threshold_uncertainty_score":0.004997313},"labels":[],"label_agreement":null},{"id":"W2141540589","doi":"10.1016/j.clpt.2004.12.098","title":"Clopidogrel use in children","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Regimen; Antithrombotic; Warfarin; Ticlopidine; Population; Internal medicine; Anesthesia; Atrial fibrillation","score_opus":0.18226745382654194,"score_gpt":0.5097639497444308,"score_spread":0.3274964959178889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141540589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9558701,0.024199694,0.00029624108,0.0013861288,0.0001048571,0.000051528048,0.0015197159,0.000031312833,0.016540416],"genre_scores_gemma":[0.988054,0.009518491,0.00024905137,0.0005387424,0.00010101911,0.000041071125,0.0006063399,0.0000066448983,0.00088463514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997298,0.00004527055,0.000029207491,0.000040230796,0.000079984085,0.000075460666],"domain_scores_gemma":[0.9994562,0.00011062294,0.00027593708,0.000012905576,0.000040747866,0.0001036195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001381563,0.00018921863,0.0003472713,0.0004544814,0.0004146996,0.00034147716,0.00012217727,0.00027427208,0.0027240408],"category_scores_gemma":[0.0011132599,0.00008450121,0.00026822928,0.0008346715,0.0002466572,0.00017280885,0.00021288391,0.0003860912,0.00029699985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021336752,0.00007198933,0.9556449,0.00022948392,0.00005875766,0.0084125055,0.00044543805,0.00009321426,0.0008213164,0.000327495,0.0036886279,0.029992824],"study_design_scores_gemma":[0.000044490662,0.00049349334,0.89540327,0.00028242753,0.00015742714,0.07532908,0.00086785073,0.00011384343,0.0006391122,0.00023669467,0.026416881,0.000015522868],"about_ca_topic_score_codex":0.0045176237,"about_ca_topic_score_gemma":0.0042292555,"teacher_disagreement_score":0.0045176237,"about_ca_system_score_codex":0.0005567826,"about_ca_system_score_gemma":0.00080393377,"threshold_uncertainty_score":0.009112835},"labels":[],"label_agreement":null},{"id":"W2144051898","doi":"10.1038/clpt.2011.241","title":"Clearing the Smoke Around Medical Marijuana","year":2011,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Pfizer; Amgen","keywords":"Clinical pharmacology; Oxycodone; Chronic pain; Medicine; Opioid; Cannabis; Clinical Practice; Pharmacology; Clearing; Psychology; Psychiatry; Family medicine; Internal medicine; Business","score_opus":0.19313804329592957,"score_gpt":0.4637556231135128,"score_spread":0.2706175798175833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144051898","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002892958,0.0013466873,0.00003788122,0.9874687,0.009056959,0.000006411162,0.000011699373,0.00001198142,0.0017703415],"genre_scores_gemma":[0.0026779347,0.0013912879,0.00010847901,0.9693869,0.022374786,0.000016596308,0.0000067500546,0.000009223714,0.004028052],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996447,0.0015504457,0.00035303412,0.00033907683,0.0009478607,0.0003625904],"domain_scores_gemma":[0.99355716,0.003961249,0.0004411147,0.0002127115,0.0010123365,0.0008154703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034300345,0.000728864,0.0011157086,0.00067236857,0.0060813976,0.002956012,0.0016429315,0.052447148,0.0053457096],"category_scores_gemma":[0.022355724,0.0006450788,0.0011816696,0.00048960315,0.0039708796,0.0051894323,0.0013347593,0.040861897,0.0051057152],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005524578,0.000049806265,0.0005197759,0.00007617739,0.000013484017,0.0030993503,0.0002996298,0.00003776838,0.00021258305,0.0022787973,0.9819441,0.011413307],"study_design_scores_gemma":[0.000131363,0.00012831192,0.0013728751,0.0005655381,0.00003693709,0.0057691154,0.0010303453,0.00031078907,0.00028835263,0.00985131,0.98045987,0.000055254095],"about_ca_topic_score_codex":0.009727117,"about_ca_topic_score_gemma":0.018040398,"teacher_disagreement_score":0.052447148,"about_ca_system_score_codex":0.005383615,"about_ca_system_score_gemma":0.0046960446,"threshold_uncertainty_score":0.03906101},"labels":[],"label_agreement":null},{"id":"W2146907829","doi":"10.1038/sj.clpt.6100074","title":"Tackling Corruption in the Pharmaceutical Systems Worldwide with Courage and Conviction","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"World Bank Group","keywords":"Language change; Poverty; Counterfeit; Conviction; Business; Pharmaceutical industry; Economics; Economic growth; Law; Medicine; Political science; Pharmacology","score_opus":0.33285393291899273,"score_gpt":0.4837387517086571,"score_spread":0.15088481878966437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146907829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039859442,0.98524183,0.0003372273,0.010342383,0.00023443278,0.0000026093599,0.00000302086,0.0000051979596,0.0034346867],"genre_scores_gemma":[0.004776922,0.9916442,0.00035978234,0.0015980621,0.00054105715,0.000003727675,0.0000048212196,0.0000019634383,0.0010693452],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889886,0.00039812093,0.000061646206,0.00008111174,0.00046994738,0.00009020631],"domain_scores_gemma":[0.99763,0.0013927949,0.00034163918,0.00009609953,0.00043798072,0.00010138583],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018358136,0.0005366067,0.00092850206,0.0017858334,0.0007018931,0.00291899,0.0006175525,0.0023573213,0.0018755712],"category_scores_gemma":[0.0028131185,0.00027147512,0.00040153923,0.0035665773,0.002369831,0.003567767,0.000990944,0.0027275456,0.00080301694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029017872,0.0000685304,0.00061967317,0.0065661096,0.0001006453,0.00026401342,0.0005031821,0.0013011589,0.00054919324,0.093392864,0.049835138,0.84677047],"study_design_scores_gemma":[0.000014132631,0.000058135793,0.0022676003,0.007386167,0.00005648973,0.0006689587,0.0005446701,0.0003531137,0.0004290982,0.04394134,0.94425666,0.000023632789],"about_ca_topic_score_codex":0.003140754,"about_ca_topic_score_gemma":0.0038330606,"teacher_disagreement_score":0.9981642,"about_ca_system_score_codex":0.001596974,"about_ca_system_score_gemma":0.00437803,"threshold_uncertainty_score":0.0115869045},"labels":[],"label_agreement":null},{"id":"W2148553478","doi":"10.1016/s0009-9236(03)00227-3","title":"Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria","funders":"Agency for Healthcare Research and Quality","keywords":"Dihydropyridine; Medicine; Odds ratio; Confidence interval; Drug class; Drug; Demography; Internal medicine; Calcium; Pharmacology","score_opus":0.28652901146753074,"score_gpt":0.49971780329760757,"score_spread":0.21318879183007683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148553478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998014,0.00030454586,0.00006108048,0.00061314955,0.000008227138,0.000027742743,0.0002461109,0.0000022161823,0.000722995],"genre_scores_gemma":[0.9993826,0.00009069452,0.0000771855,0.00015673762,0.0000118105745,0.0000099098825,0.00015187923,7.2342664e-7,0.00011836401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950885,0.002620835,0.00024354464,0.00025852898,0.0010461442,0.0007424764],"domain_scores_gemma":[0.9837156,0.0048431647,0.007854353,0.00053682,0.0018361642,0.0012139187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041817296,0.00022564278,0.0002153207,0.0005295726,0.00071608875,0.00089604885,0.0004970782,0.0007803459,0.0013800083],"category_scores_gemma":[0.021188425,0.00026374377,0.0004774552,0.001147713,0.0007961892,0.00045336198,0.0005312554,0.0010778701,0.0001185786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012256952,0.00082399696,0.98702955,0.000026662365,0.00012641816,0.0003535261,0.00013818732,0.0014202349,0.00023951476,0.00020499252,0.000862168,0.007549126],"study_design_scores_gemma":[0.000040866147,0.00024602184,0.9979031,0.000011637402,0.00002655668,0.0001172441,0.00015994786,0.0010865848,0.000065936845,0.000059932758,0.00027474525,0.0000072689495],"about_ca_topic_score_codex":0.121862,"about_ca_topic_score_gemma":0.1573522,"teacher_disagreement_score":0.121862,"about_ca_system_score_codex":0.005592889,"about_ca_system_score_gemma":0.0028694798,"threshold_uncertainty_score":0.24230534},"labels":[],"label_agreement":null},{"id":"W2149041141","doi":"10.1038/sj.clpt.6100125","title":"Identification and Characterization of CYP2D6*56B, an Allele Associated with the Poor Metabolizer Phenotype","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"CYP2D6; Genotype; Allele; Phenotype; Dextromethorphan; Pharmacogenetics; Genetics; Genotype-phenotype distinction; Biology; Allele frequency; Pharmacology; Gene","score_opus":0.15461644015628376,"score_gpt":0.4811678891458,"score_spread":0.32655144898951627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149041141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997703,0.00030946042,0.00046961897,0.00040053914,0.000030277288,0.000028258162,0.00016921994,0.000012453118,0.0008771604],"genre_scores_gemma":[0.99798125,0.00030808419,0.00060077745,0.00015808306,0.0000433994,0.000009943439,0.00022024043,0.000015595795,0.0006626441],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998265,0.000024329167,0.000019097566,0.00004676341,0.00003779469,0.000045602053],"domain_scores_gemma":[0.99972695,0.000085816864,0.000057657697,0.000018770557,0.00002468202,0.00008614469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017096355,0.00043067904,0.00043564406,0.00077972526,0.00047918348,0.00037136296,0.000276244,0.0009073582,0.0015332234],"category_scores_gemma":[0.0011386517,0.00028305608,0.00031298024,0.00038945867,0.0004453025,0.0001882072,0.00024268686,0.00086421863,0.00057996373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008887149,0.00055004365,0.18947788,0.000077116885,0.000049740378,0.63380814,0.0010799101,0.00017337818,0.15676379,0.00050674495,0.0013743751,0.015250099],"study_design_scores_gemma":[0.00009049991,0.00090300204,0.22142558,0.000025140675,0.00006258669,0.7538763,0.00046679136,0.0007491242,0.017722843,0.00021035482,0.0044433163,0.000024416353],"about_ca_topic_score_codex":0.001495024,"about_ca_topic_score_gemma":0.0008547396,"teacher_disagreement_score":0.0015332234,"about_ca_system_score_codex":0.00019478286,"about_ca_system_score_gemma":0.0001542751,"threshold_uncertainty_score":0.005129099},"labels":[],"label_agreement":null},{"id":"W2149799880","doi":"10.1038/clpt.2010.242","title":"Demonstrating Utility of Pharmacogenetics in Pediatric Populations: Methodological Considerations","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Pharmacogenetics; Clinical pharmacology; Quality (philosophy); Medicine; Computer science; Psychology; Intensive care medicine; Pharmacology; Biology; Genetics","score_opus":0.8109777463779481,"score_gpt":0.6636165452362309,"score_spread":0.14736120114171714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149799880","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029467966,0.93413305,0.03145291,0.024458177,0.0014737713,0.00091073103,0.00055822864,0.00005452366,0.0040119127],"genre_scores_gemma":[0.057129428,0.85942346,0.06557128,0.010629609,0.0023669421,0.003441229,0.00054880296,0.00007072916,0.00081854453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9134575,0.06523973,0.008653874,0.0027374872,0.009508632,0.00040277577],"domain_scores_gemma":[0.6792477,0.27300557,0.011710508,0.01281723,0.022323867,0.0008951612],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16400589,0.0010843518,0.0049156295,0.0030139422,0.00045511065,0.0041413796,0.0051272763,0.0018556286,0.0017887778],"category_scores_gemma":[0.2631954,0.00062312576,0.002024287,0.0042848415,0.0035152447,0.00436026,0.0023222233,0.0035213246,0.000701675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004548391,0.000089098234,0.009362757,0.043143246,0.0026152427,0.00029951567,0.00078048767,0.0010140919,0.00092284416,0.013648063,0.012632456,0.9150373],"study_design_scores_gemma":[0.0006915164,0.0012695278,0.06640947,0.15522654,0.008184171,0.004792839,0.0024266236,0.004190995,0.004345451,0.14037026,0.61180925,0.00028329104],"about_ca_topic_score_codex":0.004187112,"about_ca_topic_score_gemma":0.005983418,"teacher_disagreement_score":0.8359941,"about_ca_system_score_codex":0.001713753,"about_ca_system_score_gemma":0.008205917,"threshold_uncertainty_score":0.8673564},"labels":[],"label_agreement":null},{"id":"W2150635997","doi":"10.1038/clpt.2010.303","title":"Ethical Issues in Developing Pharmacogenetic Research Partnerships With American Indigenous Communities","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Indigenous; Pharmacogenetics; Economic Justice; Social justice; Clinical pharmacology; Engineering ethics; Medicine; Political science; Pharmacology; Sociology; Criminology; Engineering; Biology; Law","score_opus":0.8997290871352671,"score_gpt":0.6985059746058667,"score_spread":0.2012231125294004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150635997","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12022335,0.003191354,0.029094929,0.7779381,0.0021999544,0.0012002869,0.000024776951,0.000075011885,0.066052206],"genre_scores_gemma":[0.8215387,0.0021185172,0.03522522,0.12630177,0.0011722682,0.0023941013,0.000020392472,0.00003610802,0.011192878],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.81386954,0.15627499,0.0033765573,0.00280127,0.015136368,0.008541219],"domain_scores_gemma":[0.80257285,0.12767738,0.0100943,0.010933684,0.016701639,0.03202017],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.19132626,0.000326121,0.00055127614,0.00091658876,0.027594086,0.010882327,0.0035853125,0.009559458,0.0035060148],"category_scores_gemma":[0.15521048,0.00074546254,0.00055802765,0.00095766067,0.020114625,0.008451263,0.014261092,0.016296385,0.0007163023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016255396,0.00075491914,0.010690854,0.0002963507,0.00006130982,0.0032814778,0.33741042,0.0007110622,0.0019065979,0.51799285,0.041984294,0.084747255],"study_design_scores_gemma":[0.00019194433,0.0003930851,0.0056018233,0.0016983958,0.000063812564,0.0035880501,0.3310184,0.0030150816,0.0018645083,0.28950277,0.3629224,0.00013972174],"about_ca_topic_score_codex":0.009551881,"about_ca_topic_score_gemma":0.020516837,"teacher_disagreement_score":0.19132626,"about_ca_system_score_codex":0.0054111276,"about_ca_system_score_gemma":0.0595165,"threshold_uncertainty_score":0.9972387},"labels":[],"label_agreement":null},{"id":"W2151985832","doi":"10.1038/clpt.2011.285","title":"Neuroimaging Markers of Cellular Function in Major Depressive Disorder: Implications for Therapeutics, Personalized Medicine, and Prevention","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Neuroimaging; Monoamine neurotransmitter; Anterior cingulate cortex; Neuroscience; Psychology; Prefrontal cortex; Psychiatry; Major depressive disorder; Dopamine; Anxiety; Clinical trial; Medicine; Serotonin; Internal medicine; Receptor; Mood","score_opus":0.2268093899742329,"score_gpt":0.49264736164671563,"score_spread":0.26583797167248274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151985832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056384375,0.99934036,0.000055341385,0.00024043031,0.00003831386,0.0000025469517,0.000010171818,0.000003318134,0.00025312585],"genre_scores_gemma":[0.00054297905,0.9990044,0.00015517775,0.00008498393,0.00005963262,0.0000054700804,0.000010846244,5.043695e-7,0.00013597202],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985397,0.00004479301,0.00002234723,0.000023373997,0.00004434193,0.000011264446],"domain_scores_gemma":[0.9995196,0.0002719464,0.00006772212,0.000011974888,0.00010244018,0.000026403824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088594545,0.00089259906,0.002395493,0.002284209,0.00018578769,0.0008743527,0.0008106723,0.0011237672,0.0025228001],"category_scores_gemma":[0.0009962005,0.0003357489,0.0005536112,0.0023150193,0.0005728039,0.0011658935,0.00048885914,0.0015602398,0.001253692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008468255,0.00006693647,0.00040037633,0.0138451895,0.00014586872,0.00013972314,0.000046706817,0.00027214072,0.00083752617,0.0027396227,0.017596519,0.9638246],"study_design_scores_gemma":[0.00008898572,0.00025779044,0.008291206,0.014829349,0.0006300138,0.0027814775,0.0002619127,0.00035845448,0.00067528954,0.008708817,0.9630502,0.00006654459],"about_ca_topic_score_codex":0.0023634296,"about_ca_topic_score_gemma":0.0038314494,"teacher_disagreement_score":0.0025228001,"about_ca_system_score_codex":0.0007860033,"about_ca_system_score_gemma":0.0010559577,"threshold_uncertainty_score":0.0084396005},"labels":[],"label_agreement":null},{"id":"W2153126387","doi":"10.1067/mcp.2000.108023","title":"Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings*1","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Mexiletine; Propafenone; Pharmacokinetics; Pharmacology; CYP2D6; Medicine; Pharmacodynamics; Drug interaction; Oral administration; Active metabolite; Antiarrhythmic agent; Anesthesia; Cytochrome P450; Internal medicine; Metabolism; Atrial fibrillation","score_opus":0.1979069222556447,"score_gpt":0.5324100385057167,"score_spread":0.33450311625007195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153126387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963831,0.0013847041,0.0006594629,0.00006146058,0.000014503085,0.000020682313,0.00010093198,0.000019008992,0.0013560748],"genre_scores_gemma":[0.9979401,0.00055695977,0.0006482751,0.000093516595,0.000049419185,0.000028495258,0.00016639971,0.000006015071,0.00051078614],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998202,0.00007609392,0.000010299862,0.000034835615,0.00004336458,0.000015270221],"domain_scores_gemma":[0.9996619,0.00014733548,0.000070690316,0.000024909072,0.00002971648,0.000065528155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002451733,0.00022921235,0.00030057653,0.00015268635,0.0002505637,0.00027198627,0.00006687334,0.00026769075,0.0014862325],"category_scores_gemma":[0.0009094077,0.000117363576,0.0001453343,0.00013816565,0.00017634653,0.0001640021,0.00010031153,0.000262997,0.00032517905],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018131623,0.001863824,0.70675224,0.00029046115,0.0005732073,0.0037681533,0.00085189997,0.0010135808,0.14883383,0.00017765525,0.001843812,0.11589962],"study_design_scores_gemma":[0.00024349218,0.016004788,0.95525587,0.000022053126,0.00030395447,0.009128802,0.0002236514,0.0017223372,0.012126659,0.00020006459,0.0047418196,0.000026613252],"about_ca_topic_score_codex":0.00048265944,"about_ca_topic_score_gemma":0.00048093242,"teacher_disagreement_score":0.0014862325,"about_ca_system_score_codex":0.00010392683,"about_ca_system_score_gemma":0.00011943901,"threshold_uncertainty_score":0.004971981},"labels":[],"label_agreement":null},{"id":"W2153902825","doi":"10.1038/sj.clpt.6100448","title":"Drug Safety in Pregnant Women and Their Babies: Ignorance Not Bliss","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"BLISS; Clinical pharmacology; Ignorance; Medicine; Pregnancy; Population; Alternative medicine; Drug; Clinical trial; Family medicine; Intensive care medicine; Psychiatry; Pharmacology; Environmental health; Internal medicine; Computer science; Pathology; Political science; Law","score_opus":0.06821664335244795,"score_gpt":0.4213123777783116,"score_spread":0.3530957344258636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153902825","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02239538,0.054680932,0.0013245674,0.9074097,0.0016738297,0.000014686399,0.000075568656,0.000028314826,0.012397018],"genre_scores_gemma":[0.44737998,0.14489046,0.0018809898,0.39474103,0.0069663064,0.000036284455,0.000067260684,0.000039028982,0.0039986665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921634,0.004421576,0.00071301125,0.0005577154,0.0017533929,0.0003909156],"domain_scores_gemma":[0.9640304,0.023353858,0.005775409,0.0015840239,0.003178804,0.0020775187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020651055,0.0003056157,0.00075353665,0.0010297219,0.0024117506,0.0033247103,0.00088176026,0.0049595213,0.0033914542],"category_scores_gemma":[0.06198164,0.00045744673,0.0003645152,0.00069936155,0.011499673,0.00816696,0.0033346447,0.011558695,0.001018045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044418487,0.00027263703,0.081523456,0.0018810304,0.00023795578,0.004479802,0.053732455,0.0003738894,0.0024318872,0.064828746,0.21466912,0.57512486],"study_design_scores_gemma":[0.000101008045,0.0009372518,0.04317859,0.012872764,0.00024368246,0.017397672,0.09951133,0.0007646103,0.0017519873,0.17869242,0.6442962,0.00025244826],"about_ca_topic_score_codex":0.0076370765,"about_ca_topic_score_gemma":0.0072891368,"teacher_disagreement_score":0.020651055,"about_ca_system_score_codex":0.0024600003,"about_ca_system_score_gemma":0.0033765594,"threshold_uncertainty_score":0.109214544},"labels":[],"label_agreement":null},{"id":"W2157100678","doi":"10.1038/sj.clpt.6100145","title":"Clinical Pharmacology: A Discipline Called to Action for Maternal and Child Health","year":2007,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Action (physics); Clinical pharmacology; Theme (computing); Medicine; Diligence; Engineering ethics; Psychology; Pharmacology; Social psychology","score_opus":0.22771736900203712,"score_gpt":0.6035752243865298,"score_spread":0.3758578553844927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157100678","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015436135,0.15706445,0.00088832714,0.3472723,0.4867119,0.000017071574,0.000020868372,0.00006674988,0.0078040343],"genre_scores_gemma":[0.0045535956,0.10806054,0.0006820652,0.19726643,0.6790512,0.000022655411,0.000024009001,0.000081475875,0.010258031],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884929,0.0048038894,0.00085157825,0.0013151577,0.004040684,0.00049576827],"domain_scores_gemma":[0.9644153,0.023351572,0.0016650946,0.0010417313,0.006832124,0.002694168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074845115,0.0011047223,0.0013572528,0.0012655696,0.0036142324,0.012906025,0.002374748,0.010689586,0.005052512],"category_scores_gemma":[0.029555341,0.0005813698,0.0007214102,0.0008668302,0.008851064,0.006989788,0.002277764,0.02262239,0.0028768007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029311708,0.000015482492,0.000094251,0.0007555484,0.000014350983,0.00015343071,0.00071493274,0.000032211163,0.00010361127,0.020391518,0.9512496,0.026445713],"study_design_scores_gemma":[0.000012080808,0.000027421516,0.00012577248,0.0008965093,0.000010465533,0.00037065148,0.00030793858,0.000039002425,0.00007512417,0.007331824,0.9907895,0.000013774341],"about_ca_topic_score_codex":0.0015306838,"about_ca_topic_score_gemma":0.0030311258,"teacher_disagreement_score":0.012906025,"about_ca_system_score_codex":0.0032577468,"about_ca_system_score_gemma":0.008487029,"threshold_uncertainty_score":0.03958237},"labels":[],"label_agreement":null},{"id":"W2159542081","doi":"10.1038/clpt.2008.157","title":"Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":306,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of British Columbia; SickKids Foundation; Pacific Centre for Reproductive Medicine; Western University","funders":"Genome British Columbia","keywords":"Medicine; Breastfeeding; Codeine; Opiate; Opioid; Depression (economics); Pediatrics; Asymptomatic; Anesthesia; Obstetrics; Internal medicine; Morphine","score_opus":0.11082312515559271,"score_gpt":0.41462047369216576,"score_spread":0.30379734853657303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159542081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945205,0.00018247959,0.00010819129,0.0000147647925,0.0000034997756,0.0000130880435,0.000048975362,0.000001843482,0.00017516688],"genre_scores_gemma":[0.999413,0.00016700964,0.00017471207,0.000022199569,0.0000098641885,0.000018678567,0.000100328994,0.000002423787,0.00009168005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987047,0.0004357929,0.00012870446,0.0003360836,0.0002856686,0.00010917246],"domain_scores_gemma":[0.9977252,0.0007588034,0.0007409285,0.0003469663,0.00022412575,0.00020395988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001346794,0.000414007,0.0004473737,0.00081173633,0.0005580689,0.000515003,0.0004674218,0.0006104314,0.0008694893],"category_scores_gemma":[0.0051846295,0.00045676614,0.00041768514,0.00062194536,0.00038251063,0.00029875865,0.00034020824,0.00044887577,0.00013146784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028625235,0.00013959596,0.99535817,0.000014466739,0.00012747636,0.00088593713,0.00024257296,0.000020719863,0.00082217023,0.000024384992,0.00007085202,0.0020074013],"study_design_scores_gemma":[0.000028778717,0.0004686208,0.9949014,0.00001009861,0.00010593871,0.0035853232,0.00015491522,0.00023392057,0.000279485,0.000016729118,0.0002079033,0.0000068875993],"about_ca_topic_score_codex":0.007438051,"about_ca_topic_score_gemma":0.0055314177,"teacher_disagreement_score":0.007438051,"about_ca_system_score_codex":0.00044391296,"about_ca_system_score_gemma":0.00030506612,"threshold_uncertainty_score":0.014789522},"labels":[],"label_agreement":null},{"id":"W2161620765","doi":"10.1002/cpt.147","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and <i>CYP2C19</i> Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":975,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institute of Mental Health; National Heart, Lung, and Blood Institute","keywords":"Fluvoxamine; Escitalopram; Citalopram; CYP2C19; Paroxetine; Pharmacogenetics; Sertraline; Dosing; Medicine; Pharmacology; CYP2D6; Fluoxetine; Psychiatry; Anxiety; Serotonin; Internal medicine; Genotype; Antidepressant; Biology","score_opus":0.294731120690238,"score_gpt":0.567269353284168,"score_spread":0.27253823259393006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161620765","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011194002,0.036517806,0.14095032,0.4023223,0.015822269,0.013785518,0.028588708,0.006784952,0.34403417],"genre_scores_gemma":[0.0707724,0.040000096,0.37880924,0.34171903,0.008223399,0.022073831,0.045622353,0.0021044493,0.090675235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9704014,0.012374651,0.0062290896,0.0010374684,0.008671718,0.0012857359],"domain_scores_gemma":[0.93157506,0.021636408,0.006707125,0.0027167758,0.033556968,0.0038076607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025839278,0.00081958214,0.0015012944,0.0024769856,0.0012249051,0.002844032,0.004162837,0.009051238,0.010914114],"category_scores_gemma":[0.059795942,0.00086469634,0.0031630746,0.0028433856,0.0010377147,0.0016473777,0.0020830461,0.009615181,0.007039742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028118587,0.00053031644,0.003967255,0.0012486689,0.0001209934,0.00064895535,0.0003597022,0.00085892336,0.0014130063,0.00978035,0.78707075,0.19371988],"study_design_scores_gemma":[0.0006351756,0.0003827201,0.0144266095,0.0050725183,0.00032314283,0.0012386871,0.00024226437,0.0013534902,0.002020613,0.0068254415,0.96738315,0.00009610628],"about_ca_topic_score_codex":0.020655483,"about_ca_topic_score_gemma":0.024182426,"teacher_disagreement_score":0.025839278,"about_ca_system_score_codex":0.0025000195,"about_ca_system_score_gemma":0.019542934,"threshold_uncertainty_score":0.13665283},"labels":[],"label_agreement":null},{"id":"W2163924971","doi":"10.1016/j.clpt.2004.12.004","title":"The reproductive effects of beta interferon therapy for multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pregnancy; Multiple sclerosis; Reproductive medicine; Cohort study; Obstetrics; Fetus; Prospective cohort study; Observational study; Live birth; Interferon beta-1b; Cohort; Physiology; Pediatrics; Internal medicine; Interferon beta; Immunology","score_opus":0.1112040781430695,"score_gpt":0.38106014438539076,"score_spread":0.2698560662423213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163924971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96595454,0.027119521,0.00037658986,0.0006878645,0.000035423713,0.000032840097,0.00019406606,0.000016734715,0.0055823475],"genre_scores_gemma":[0.9941544,0.0049259467,0.00019114839,0.00011956777,0.00004499606,0.000012446349,0.000053812884,0.0000017101062,0.0004959369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954,0.00028015868,0.000017895552,0.00003863799,0.00008570481,0.00003770391],"domain_scores_gemma":[0.99884844,0.0006045892,0.0003925513,0.00004267149,0.00003710087,0.0000745474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006340348,0.00012213498,0.00015749678,0.00026973544,0.00024019081,0.0003167016,0.00012216003,0.00020914814,0.0017993683],"category_scores_gemma":[0.002030669,0.00008843092,0.00023605974,0.00018323323,0.00029068915,0.000099543606,0.00017144873,0.0002921932,0.0001440916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036690722,0.00073026627,0.7582544,0.00049739267,0.00026505356,0.003907453,0.0004313402,0.00024535548,0.01831675,0.000645843,0.0012558253,0.2117812],"study_design_scores_gemma":[0.000050592414,0.0048173196,0.9799921,0.00010185951,0.00012584496,0.008681394,0.0001630426,0.00014756806,0.0018497254,0.00026663978,0.0037957847,0.000008040797],"about_ca_topic_score_codex":0.00049919257,"about_ca_topic_score_gemma":0.00042613453,"teacher_disagreement_score":0.0017993683,"about_ca_system_score_codex":0.0003078103,"about_ca_system_score_gemma":0.00024837285,"threshold_uncertainty_score":0.0060195327},"labels":[],"label_agreement":null},{"id":"W2164985616","doi":"10.1016/s0009-9236(03)90554-6","title":"Frequency of adverse drug reactions (ADRS) in SLE","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug reaction; Clinical pharmacology; Pharmacology; Drug; Medicine; Adverse effect; Adverse drug reaction","score_opus":0.1481425757128565,"score_gpt":0.4903538507634385,"score_spread":0.342211275050582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164985616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98753786,0.0072893556,0.0006175985,0.00016435566,0.000035956942,0.000030809682,0.00060793944,0.00004852861,0.0036676468],"genre_scores_gemma":[0.9981735,0.0009894741,0.00022278684,0.00008339143,0.000047885293,0.00000813885,0.00018309592,0.000004180306,0.0002875486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771535,0.0008649229,0.00047331213,0.00027415474,0.0005396962,0.00013249848],"domain_scores_gemma":[0.9884476,0.0037760548,0.005839821,0.0005409344,0.0007134874,0.0006819832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001632879,0.0002798124,0.0006373376,0.0015153231,0.0003138623,0.0005636119,0.00018751866,0.0006492197,0.0024128235],"category_scores_gemma":[0.006969988,0.00017288252,0.0007416695,0.0011036547,0.00021598279,0.000474424,0.00030218903,0.00087495905,0.00052058225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011542665,0.00007935534,0.9729119,0.0001400659,0.00023428675,0.0012140324,0.000106336214,0.00011304749,0.0015779028,0.000037980597,0.00026134582,0.022169543],"study_design_scores_gemma":[0.000026071864,0.0011480841,0.986446,0.00003624407,0.00015287392,0.010487441,0.000117133735,0.00016070846,0.00045846874,0.000061386185,0.00089370046,0.0000118491125],"about_ca_topic_score_codex":0.000457098,"about_ca_topic_score_gemma":0.0005545423,"teacher_disagreement_score":0.0024128235,"about_ca_system_score_codex":0.00023112513,"about_ca_system_score_gemma":0.00014802367,"threshold_uncertainty_score":0.00863564},"labels":[],"label_agreement":null},{"id":"W2165021451","doi":"10.1038/clpt.2014.88","title":"Association of CHRNA5-A3-B4 SNP rs2036527 With Smoking Cessation Therapy Response in African-American Smokers","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; National Institute on Drug Abuse; National Institute on Minority Health and Health Disparities; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Abstinence; Smoking cessation; Medicine; Bupropion; Nicotine; Internal medicine; Odds ratio; Pharmacotherapy; SNP; Genotype; Psychiatry; Single-nucleotide polymorphism; Genetics; Biology; Pathology","score_opus":0.08890473931006727,"score_gpt":0.42910344538360223,"score_spread":0.340198706073535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165021451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920434,0.00035877476,0.000054937023,0.000056424353,0.000004797588,0.000004695597,0.00010845917,0.0000018171617,0.0002058529],"genre_scores_gemma":[0.99965477,0.000070855574,0.000051281342,0.000038549308,0.000006680892,0.0000065508416,0.00008355486,0.0000016320678,0.00008612229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944514,0.00023390226,0.00005653427,0.00012964774,0.000065767104,0.000068950685],"domain_scores_gemma":[0.99886274,0.00039778036,0.0005060445,0.00006968105,0.00005519195,0.00010845901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009104056,0.00020252143,0.0003556359,0.00044426622,0.00036477885,0.00032980292,0.00024525487,0.0005518471,0.0019194284],"category_scores_gemma":[0.003078901,0.00014482578,0.0006068497,0.00056845724,0.00024373567,0.00015135955,0.0001745202,0.00040242285,0.00014620721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036203254,0.00014323689,0.98292196,0.00004053485,0.0006109404,0.00019644333,0.00015520958,0.00017849919,0.005009575,0.00008120586,0.00019470113,0.006847277],"study_design_scores_gemma":[0.00008089945,0.00026352407,0.998257,0.000013696616,0.00021772349,0.00016432718,0.000063491076,0.00037958997,0.00024829377,0.000065661676,0.00024048846,0.0000052015653],"about_ca_topic_score_codex":0.0057904576,"about_ca_topic_score_gemma":0.004831287,"teacher_disagreement_score":0.0057904576,"about_ca_system_score_codex":0.00022830632,"about_ca_system_score_gemma":0.00022218424,"threshold_uncertainty_score":0.011513531},"labels":[],"label_agreement":null},{"id":"W2166210552","doi":"10.1002/cpt.280","title":"Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Human Genome Research Institute; National Institute on Drug Abuse; Wellcome Trust","keywords":"Workgroup; Standardization; Confusion; Pharmacogenetics; Nomenclature; Chemical nomenclature; Transparency (behavior); Computer science; Computational biology; Medicine; Biology; Genetics; Psychology; Gene; Taxonomy (biology); Genotype","score_opus":0.7130136977464977,"score_gpt":0.6624251810135845,"score_spread":0.0505885167329132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166210552","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038052546,0.5428125,0.12398876,0.17858523,0.026216948,0.004973473,0.011295055,0.003617397,0.10470535],"genre_scores_gemma":[0.023520885,0.48014536,0.33641842,0.075545885,0.008006455,0.007695498,0.030154876,0.001310163,0.03720246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9736039,0.010573743,0.006584542,0.0010848755,0.0074405144,0.0007123699],"domain_scores_gemma":[0.95473564,0.015437073,0.005707568,0.0027277123,0.020266691,0.0011253278],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.038746458,0.0014959844,0.002438515,0.0098529495,0.0011186054,0.003697521,0.006163349,0.0046689147,0.0071518878],"category_scores_gemma":[0.055343684,0.00085334125,0.003109267,0.007673485,0.0026994324,0.0027426614,0.0027551083,0.008084188,0.008778172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018539409,0.00019714572,0.002142851,0.005193467,0.00013353422,0.00055153493,0.0007854595,0.00053864915,0.0022039253,0.026175704,0.35096866,0.6109237],"study_design_scores_gemma":[0.000078781915,0.00009543528,0.0019894545,0.00749649,0.00020526665,0.0014150693,0.00031335713,0.0002579964,0.001496304,0.009081248,0.9775114,0.000059165184],"about_ca_topic_score_codex":0.0066077826,"about_ca_topic_score_gemma":0.00415896,"teacher_disagreement_score":0.9612535,"about_ca_system_score_codex":0.0020572706,"about_ca_system_score_gemma":0.012771007,"threshold_uncertainty_score":0.20491332},"labels":[],"label_agreement":null},{"id":"W2167566912","doi":"10.1016/j.clpt.2004.12.198","title":"Renal ontogeny of ifosfamide nephrotoxicity","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Nephrotoxicity; CYP3A; Ontogeny; Kidney; Internal medicine; Ifosfamide; Endocrinology; Biology; Microsome; Metabolism; Cytochrome P450; Medicine; Enzyme; Biochemistry; Chemotherapy; Cisplatin","score_opus":0.09245326862491451,"score_gpt":0.4327089877712129,"score_spread":0.3402557191462984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167566912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895188,0.002822368,0.0020542038,0.0001029499,0.000038319115,0.00004544678,0.0008169226,0.00008834598,0.004512691],"genre_scores_gemma":[0.9886778,0.0016217706,0.0009150817,0.00007962269,0.000022041453,0.000073644434,0.00062916736,0.00003864885,0.007942238],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998041,0.000020865133,0.000008742756,0.00007991721,0.000048186983,0.000038255974],"domain_scores_gemma":[0.9993075,0.000069061745,0.00021163933,0.00004495502,0.00016715868,0.00019966133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023851306,0.0002160215,0.0003645812,0.0009666056,0.0003607589,0.0006950976,0.00022337463,0.0004546003,0.002956542],"category_scores_gemma":[0.0004703814,0.00024052427,0.0002882935,0.00022184261,0.00035420735,0.00051517534,0.0006015013,0.00065571506,0.00071080314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096391496,0.00011202791,0.08858851,0.00012419024,0.000042618314,0.0008452267,0.0005743552,0.00015371115,0.8814995,0.0009134422,0.0004365497,0.025745848],"study_design_scores_gemma":[0.000007920182,0.00048410342,0.93958086,0.000032464162,0.00003709575,0.0012072581,0.00034959498,0.00031298932,0.052734297,0.00027640842,0.0049538026,0.000023248846],"about_ca_topic_score_codex":0.0018901592,"about_ca_topic_score_gemma":0.0021405923,"teacher_disagreement_score":0.002956542,"about_ca_system_score_codex":0.00053950946,"about_ca_system_score_gemma":0.00041240538,"threshold_uncertainty_score":0.009890616},"labels":[],"label_agreement":null},{"id":"W2167742437","doi":"10.1038/clpt.2013.235","title":"Progress in Pharmacogenomics: Bridging the Gap From Research to Practice","year":2014,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Clinical pharmacology; Pharmacogenetics; Viewpoints; Drug response; Epigenetics; Clinical Practice; Computational biology; Medicine; Pharmacology; Bioinformatics; Drug; Biology; Gene; Genetics; Genotype","score_opus":0.356520977217391,"score_gpt":0.6184123225768028,"score_spread":0.2618913453594118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167742437","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041170824,0.07700202,0.0006126793,0.113608696,0.8071304,0.000018068173,0.000033305303,0.000074304146,0.001479384],"genre_scores_gemma":[0.00033291485,0.06037621,0.0005173511,0.037939254,0.8978264,0.000014269626,0.000023205977,0.00003732502,0.0029331034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.991771,0.00203802,0.0011055782,0.000673101,0.0041662455,0.000246068],"domain_scores_gemma":[0.9457183,0.035195544,0.00166664,0.0010769939,0.0130341435,0.0033084839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016713604,0.0029293632,0.0035640546,0.003627344,0.0020328977,0.0076298444,0.0033100226,0.0121695455,0.006549114],"category_scores_gemma":[0.042685837,0.0011337672,0.002251242,0.0022477969,0.004174575,0.009639041,0.0023824049,0.034038175,0.0051916013],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002920637,0.00001756653,0.00003994296,0.0007087844,0.000041484225,0.00010437033,0.0000459663,0.00007896535,0.00009390566,0.0017981292,0.96873915,0.028302474],"study_design_scores_gemma":[0.000034812652,0.000026316764,0.00018616169,0.0011651979,0.00004886697,0.0003063731,0.00006968592,0.00017995533,0.000073883675,0.0053265262,0.99256057,0.000021589214],"about_ca_topic_score_codex":0.0012222787,"about_ca_topic_score_gemma":0.0036251163,"teacher_disagreement_score":0.016713604,"about_ca_system_score_codex":0.0031596408,"about_ca_system_score_gemma":0.0050584883,"threshold_uncertainty_score":0.088391066},"labels":[],"label_agreement":null},{"id":"W2168040447","doi":"10.1002/cpt.98","title":"Cannabinoids suppress acute and anticipatory nausea in preclinical rat models of conditioned gaping","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Nausea; Vomiting; Antiemetic; Medicine; Anesthesia; Pharmacology; Psychology","score_opus":0.2642276612433556,"score_gpt":0.5072025898914954,"score_spread":0.24297492864813974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168040447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435174,0.0011819906,0.0017190599,0.00030557517,0.00012845904,0.00013661556,0.00044873703,0.00020969573,0.0015181439],"genre_scores_gemma":[0.9866062,0.003169629,0.0040511144,0.00015441042,0.000071241564,0.0004252191,0.0007641497,0.00006004413,0.00469795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99960726,0.00007459899,0.00003618059,0.000042391388,0.00009756414,0.00014196351],"domain_scores_gemma":[0.9989862,0.00012784782,0.0003094769,0.00015640166,0.00008664702,0.00033337215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005611454,0.0015075118,0.00092599215,0.0014041736,0.0005548296,0.00039836555,0.00080184627,0.0006562912,0.0041289437],"category_scores_gemma":[0.0007157933,0.0005254549,0.00086794584,0.0004933423,0.0011344656,0.00077947753,0.0005544984,0.0030602291,0.0006865917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009469785,0.006018744,0.00047721234,0.00024593444,0.000067968715,0.00026147295,0.00019328429,0.00047298663,0.9721458,0.0008502708,0.0004939404,0.009302736],"study_design_scores_gemma":[0.0012844244,0.04119885,0.00617472,0.00007132531,0.00016218035,0.0005582207,0.00027999148,0.0029556288,0.9447358,0.00066899246,0.0018464597,0.00006333763],"about_ca_topic_score_codex":0.003682905,"about_ca_topic_score_gemma":0.008533435,"teacher_disagreement_score":0.0041289437,"about_ca_system_score_codex":0.00081137486,"about_ca_system_score_gemma":0.0012977121,"threshold_uncertainty_score":0.013812661},"labels":[],"label_agreement":null},{"id":"W2168285948","doi":"10.1038/clpt.2011.325","title":"Current Understanding of Rheumatoid Arthritis Therapy","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Rheumatoid arthritis; Medicine; Intensive care medicine; Current (fluid); Arthritis; Internal medicine; Engineering","score_opus":0.41308115145794067,"score_gpt":0.5159239256736493,"score_spread":0.10284277421570864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168285948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006744788,0.9917556,0.0002805217,0.0013622801,0.0006348097,0.000008470787,0.00002474199,0.0000149699545,0.005851095],"genre_scores_gemma":[0.00076695543,0.9942878,0.00044949,0.00095123466,0.00068531785,0.000014286376,0.000040443087,0.000002518679,0.0028019466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994935,0.00009553508,0.00006196012,0.00007533398,0.00023694502,0.000036721365],"domain_scores_gemma":[0.9995701,0.00016313787,0.000058219604,0.000021591399,0.00014189785,0.00004506583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008609224,0.0009239259,0.0012907948,0.00155032,0.00041730743,0.0016710955,0.0010490507,0.0016656885,0.012429443],"category_scores_gemma":[0.00092973036,0.00026343917,0.00047700785,0.0014537355,0.0007100391,0.0015620519,0.00092366314,0.0024594094,0.010181012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053724467,0.00006195738,0.00008464048,0.008103079,0.00003420189,0.00015374369,0.000074103,0.00015660356,0.0014815719,0.006251944,0.05738566,0.92615885],"study_design_scores_gemma":[0.000009977851,0.000032207696,0.00019205015,0.0020185169,0.000020913087,0.00062830903,0.000029387988,0.00002904641,0.00014094549,0.0021646048,0.9947265,0.0000074797817],"about_ca_topic_score_codex":0.00095746905,"about_ca_topic_score_gemma":0.0012589751,"teacher_disagreement_score":0.012429443,"about_ca_system_score_codex":0.0008580315,"about_ca_system_score_gemma":0.0019196968,"threshold_uncertainty_score":0.041580617},"labels":[],"label_agreement":null},{"id":"W2168739582","doi":"10.1016/s0009-9236(01)90120-1","title":"Deficient C‐oxidation of nicotine continued","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nicotine; Pharmacology; Chemistry; Medicine; Internal medicine","score_opus":0.053980509274,"score_gpt":0.41097425320951797,"score_spread":0.35699374393551797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168739582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522757,0.0036232274,0.009293666,0.0012796541,0.0009196155,0.00017167805,0.00488104,0.00037288532,0.027182449],"genre_scores_gemma":[0.9573643,0.0012841804,0.0024997997,0.00029397212,0.000044441942,0.0000732533,0.0022734816,0.00009819328,0.036068544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980146,0.000025755915,0.000021485832,0.00006657674,0.00004710209,0.000037707374],"domain_scores_gemma":[0.99976176,0.000030805644,0.000035611305,0.00004777651,0.00004702979,0.00007693927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017079167,0.00032428,0.0002694766,0.0003665104,0.00020966247,0.000322269,0.00036127339,0.00045842805,0.010061047],"category_scores_gemma":[0.00021472634,0.00011539361,0.00031559242,0.00017844341,0.00034103502,0.00021549733,0.00025976283,0.00071951136,0.0023195755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059623446,0.000110845926,0.0004863728,0.00005837517,0.000022308399,0.00030279858,0.000029428671,0.000032025717,0.98967314,0.0013439298,0.00068493665,0.006659534],"study_design_scores_gemma":[0.00006175831,0.00059337384,0.0056109745,0.00003226107,0.00005601048,0.0021428925,0.000056764402,0.00035435116,0.9663285,0.00064454455,0.024105186,0.000013419447],"about_ca_topic_score_codex":0.001630787,"about_ca_topic_score_gemma":0.0011433961,"teacher_disagreement_score":0.010061047,"about_ca_system_score_codex":0.0004145502,"about_ca_system_score_gemma":0.00036259473,"threshold_uncertainty_score":0.03365761},"labels":[],"label_agreement":null},{"id":"W2168886412","doi":"10.1038/clpt.2014.150","title":"Inflammation: The Dynamic Force of Health and Disease","year":2014,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Inflammation; Clinical pharmacology; Disease; Medicine; Drug development; Happiness; Balance (ability); Immune system; Drug; Clinical disease; Intensive care medicine; Immunology; Pharmacology; Psychology; Internal medicine; Physical therapy; Psychotherapist","score_opus":0.04048254774790951,"score_gpt":0.4185567842207609,"score_spread":0.37807423647285143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168886412","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029206687,0.03520282,0.00013041034,0.059154816,0.9045305,0.00000708156,0.000015657966,0.000030086827,0.00089925056],"genre_scores_gemma":[0.0004742546,0.027407946,0.00013621588,0.03350172,0.9334372,0.000012776512,0.000011861697,0.000020635935,0.004997339],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99549246,0.0011895159,0.00052548107,0.00054962916,0.0020337007,0.0002092062],"domain_scores_gemma":[0.9851645,0.008832337,0.00060898566,0.0003611532,0.0037056014,0.0013273825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062949136,0.0035936418,0.0037280775,0.0021507088,0.002957048,0.007839012,0.003033728,0.010053355,0.0049935654],"category_scores_gemma":[0.017570898,0.00083184877,0.0018106048,0.0015025216,0.005561166,0.007045835,0.002239116,0.026342606,0.004556912],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030855983,0.000009506754,0.00002576983,0.00035734798,0.000017713017,0.00007370556,0.000070533795,0.000026619542,0.00005673709,0.0015172871,0.9857282,0.0120858215],"study_design_scores_gemma":[0.000026995942,0.000032372736,0.00017550058,0.0006802081,0.000033901273,0.00024585912,0.00012661827,0.00008621582,0.00006512289,0.003588741,0.9949195,0.00001883474],"about_ca_topic_score_codex":0.0015202573,"about_ca_topic_score_gemma":0.0036643874,"teacher_disagreement_score":0.010053355,"about_ca_system_score_codex":0.0025502355,"about_ca_system_score_gemma":0.0036858227,"threshold_uncertainty_score":0.0332911},"labels":[],"label_agreement":null},{"id":"W2169510951","doi":"10.1002/cpt.186","title":"Targeting the gastrointestinal tract to develop novel therapies for HIV","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Human immunodeficiency virus (HIV); Gastrointestinal tract; Antiretroviral therapy; Medicine; Pathogenesis; Immunology; Intensive care medicine; Viral load; Internal medicine","score_opus":0.31660872934648343,"score_gpt":0.5375770974254633,"score_spread":0.2209683680789799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169510951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027464153,0.9976804,0.00020423508,0.0003310624,0.00016397046,0.000009639091,0.000021948588,0.000009726789,0.0013043587],"genre_scores_gemma":[0.0015438589,0.99690634,0.0003384492,0.00026233913,0.00014781844,0.000010532796,0.000035161425,0.0000015061046,0.00075401104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990463,0.000018715224,0.000012909618,0.000015272006,0.00003570533,0.000012731442],"domain_scores_gemma":[0.99987876,0.00005803815,0.000017531409,0.0000044670255,0.000030002908,0.0000112161015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030356206,0.0005310939,0.00082578254,0.0015827022,0.0002133714,0.0007178683,0.00048074362,0.0008078111,0.0047966917],"category_scores_gemma":[0.00038339538,0.0001664076,0.00048770272,0.00077682576,0.0002664911,0.00078702666,0.0005220016,0.0018057249,0.0017411354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007441609,0.00016866255,0.00022085442,0.018392913,0.00012328853,0.00022977844,0.00006315804,0.00030286965,0.0050656493,0.004229405,0.018349731,0.9527792],"study_design_scores_gemma":[0.000040960862,0.00024185203,0.0010811978,0.0047023194,0.00018505457,0.0016542237,0.00006952252,0.00016348228,0.0015818499,0.0022931702,0.9879655,0.000020907479],"about_ca_topic_score_codex":0.00049083657,"about_ca_topic_score_gemma":0.0011876797,"teacher_disagreement_score":0.0047966917,"about_ca_system_score_codex":0.00025284712,"about_ca_system_score_gemma":0.00054193335,"threshold_uncertainty_score":0.016046524},"labels":[],"label_agreement":null},{"id":"W2169845877","doi":"10.1038/clpt.2014.144","title":"Adjusted Indirect Treatment Comparison of the Bioavailability of WHO-Prequalified First-Line Generic Antituberculosis Medicines","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Bioequivalence; Interchangeability; Medicine; Confidence interval; Pharmacology; Bioavailability; Innovator; Clinical pharmacology; Isoniazid; Ethambutol; Pyrazinamide; Internal medicine; Tuberculosis; Computer science","score_opus":0.2971360709396938,"score_gpt":0.4304960972344246,"score_spread":0.13336002629473082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169845877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9507337,0.005169685,0.02865348,0.00025911682,0.000220559,0.0007560182,0.0060690646,0.00009793931,0.008040388],"genre_scores_gemma":[0.9909285,0.00024077133,0.005201671,0.0001238293,0.00004255342,0.00039705078,0.0020084889,0.000020990909,0.0010362585],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96057177,0.032286264,0.001531406,0.0018624611,0.003058756,0.0006892306],"domain_scores_gemma":[0.9421457,0.04430264,0.0050350344,0.0060333377,0.002196645,0.00028667206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02357314,0.00071156427,0.0016930818,0.0008559908,0.00018325122,0.0010778254,0.00082645845,0.0008494589,0.0054451646],"category_scores_gemma":[0.04708773,0.00024411362,0.003139345,0.00087056524,0.00061288016,0.0007233977,0.0010237249,0.0017266694,0.00042490082],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25538564,0.0025889813,0.33890006,0.0046116384,0.073090896,0.0006250755,0.0012849156,0.02714913,0.014357088,0.019018298,0.005500869,0.25748745],"study_design_scores_gemma":[0.01162614,0.06144656,0.76807034,0.0004396124,0.039030477,0.0011276869,0.0007700854,0.04118259,0.040190984,0.013464737,0.022232065,0.00041868936],"about_ca_topic_score_codex":0.0007552573,"about_ca_topic_score_gemma":0.000553199,"teacher_disagreement_score":0.02357314,"about_ca_system_score_codex":0.0010168871,"about_ca_system_score_gemma":0.0005713633,"threshold_uncertainty_score":0.12466818},"labels":[],"label_agreement":null},{"id":"W2292946704","doi":"10.1002/cpt.364","title":"Disease–drug database for pharmacogenomic‐based prescribing","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Ontario; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Pharmacogenomics; Drug; Disease; Medicine; Database; Pharmacology; Computer science; Internal medicine","score_opus":0.3552165596201565,"score_gpt":0.5361870192128482,"score_spread":0.18097045959269165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292946704","genre_codex":"dataset","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012918756,0.0027991352,0.05370481,0.003249685,0.0003698454,0.0015226894,0.86710817,0.017662985,0.040664002],"genre_scores_gemma":[0.06833167,0.0028195821,0.11453272,0.0026267625,0.0004079733,0.0021412652,0.80226314,0.0013893936,0.0054874523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755716,0.0006121924,0.0008046426,0.0004648883,0.0004876845,0.00007350937],"domain_scores_gemma":[0.9859266,0.0067351237,0.0026708138,0.0023326764,0.0014461068,0.00088862225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033691255,0.0006620791,0.001483757,0.0059225457,0.0005272392,0.0021723362,0.0019485042,0.0012562147,0.037140854],"category_scores_gemma":[0.020099804,0.0006404488,0.0010783555,0.007726057,0.0002338333,0.0014591007,0.0013737523,0.0015012095,0.017193582],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002818307,0.000673791,0.05205983,0.0054803197,0.0014325466,0.0014550977,0.00035571243,0.0106951585,0.004846948,0.033597875,0.62886345,0.25772107],"study_design_scores_gemma":[0.0011745341,0.0002621651,0.041916203,0.00061993336,0.0005319864,0.0012531457,0.000095164025,0.020071708,0.0046847877,0.020590413,0.9086395,0.00016041947],"about_ca_topic_score_codex":0.0033595515,"about_ca_topic_score_gemma":0.004407148,"teacher_disagreement_score":0.037140854,"about_ca_system_score_codex":0.0010701887,"about_ca_system_score_gemma":0.003601559,"threshold_uncertainty_score":0.124248505},"labels":[],"label_agreement":null},{"id":"W2295757311","doi":"10.1002/cpt.366","title":"The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes","year":2016,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Diet and metabolism studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Bill and Melinda Gates Foundation","keywords":"Xenobiotic; Drug metabolism; Metabolism; Microbial metabolism; Physiology; Medicine; Biology; Internal medicine; Biochemistry; Bacteria; Genetics","score_opus":0.31136748687768595,"score_gpt":0.5701217997395129,"score_spread":0.258754312861827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295757311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002350669,0.9983278,0.00018078704,0.00059491274,0.00007630457,0.0000030893832,0.000020322761,0.000004479184,0.0005572816],"genre_scores_gemma":[0.0016870819,0.99743575,0.00031149757,0.00020809408,0.00011373595,0.0000060691486,0.00001881303,0.0000015767181,0.00021748235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997116,0.00008040594,0.000051623334,0.00005150973,0.00008680053,0.000018128236],"domain_scores_gemma":[0.99923134,0.0004921682,0.000088834815,0.000019885343,0.00013067914,0.000037046553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095366116,0.00054328324,0.00136811,0.0016421145,0.00021653828,0.001189923,0.00047988692,0.000957226,0.0025981907],"category_scores_gemma":[0.0014334598,0.00015095051,0.00055369723,0.0014478774,0.00056972186,0.0009369449,0.00065876334,0.0012174891,0.0009286543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011110031,0.00009311452,0.000929094,0.017022908,0.00022442323,0.00019681593,0.00007184752,0.00031793077,0.0014462491,0.0057909405,0.008111005,0.96568453],"study_design_scores_gemma":[0.000036875103,0.00037927038,0.006740097,0.01712157,0.00071108696,0.003022785,0.00030862045,0.00030767536,0.0017659457,0.01211486,0.957424,0.00006730898],"about_ca_topic_score_codex":0.00074805756,"about_ca_topic_score_gemma":0.001480599,"teacher_disagreement_score":0.0025981907,"about_ca_system_score_codex":0.0004472325,"about_ca_system_score_gemma":0.0010177057,"threshold_uncertainty_score":0.008691847},"labels":[],"label_agreement":null},{"id":"W2316038236","doi":"10.1002/cpt.376","title":"Maternal use of selective serotonin‐reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Persistent pulmonary hypertension; Medicine; Pregnancy; Pulmonary hypertension; Population; Prenatal exposure; Pediatrics; Intensive care medicine; Internal medicine; Gestation; Environmental health; Biology","score_opus":0.0875578418309108,"score_gpt":0.36197586267468057,"score_spread":0.27441802084376976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316038236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036473,0.0069896225,0.00016035377,0.00039606233,0.000029678678,0.000004469556,0.0003131411,0.0000063208063,0.0017355913],"genre_scores_gemma":[0.9976463,0.0019820097,0.0000904346,0.00003114096,0.000021516062,0.0000023424645,0.000064520646,9.519577e-7,0.00016075562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972564,0.00010260944,0.00003136573,0.00003340425,0.00006293259,0.00004405759],"domain_scores_gemma":[0.99810743,0.0006282805,0.0009601647,0.00006953095,0.0000790502,0.0001555811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037448973,0.00010432509,0.0001719297,0.00035035575,0.00010829568,0.00026478712,0.00018846436,0.0003500354,0.0011890987],"category_scores_gemma":[0.003706089,0.00014746678,0.00024945312,0.0004090183,0.00013253861,0.00016209541,0.00017688559,0.00039430187,0.00010828453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001999399,0.000016919563,0.99320686,0.000030746753,0.0000907802,0.00034678818,0.000053462594,0.000040723582,0.00024844296,0.00009248456,0.00012604677,0.005546746],"study_design_scores_gemma":[0.000006026325,0.00014085184,0.9973635,0.00005773094,0.00009237448,0.0014439771,0.00008033843,0.0002925005,0.00013332482,0.00007564174,0.00031013467,0.0000036380616],"about_ca_topic_score_codex":0.0035175234,"about_ca_topic_score_gemma":0.003187822,"teacher_disagreement_score":0.0035175234,"about_ca_system_score_codex":0.00020515003,"about_ca_system_score_gemma":0.00021087803,"threshold_uncertainty_score":0.0069940686},"labels":[],"label_agreement":null},{"id":"W2316079417","doi":"10.1016/j.clpt.2005.12.020","title":"OII-C-3Prenatal multivitamin supplementation and the rates of leukemia and two common pediatric tumours: A meta-analysis","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Multivitamin; Meta-analysis; Odds ratio; Pediatrics; Pregnancy; MEDLINE; Confidence interval; Neuroblastoma; Internal medicine; Vitamin","score_opus":0.13519955733451736,"score_gpt":0.47635645515316544,"score_spread":0.3411568978186481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316079417","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047325235,0.9456364,0.0027850375,0.00043609005,0.00050889846,0.0004951773,0.0018646823,0.00010718794,0.0008413563],"genre_scores_gemma":[0.71258014,0.27432045,0.0065543544,0.001068736,0.00044220738,0.0017155483,0.0017656324,0.00008359396,0.0014692718],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98982555,0.0059000845,0.0016951859,0.0013247879,0.00081947295,0.00043499641],"domain_scores_gemma":[0.98406315,0.01172507,0.0019298998,0.0008629577,0.0010660201,0.00035291264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012874209,0.0031175206,0.011410204,0.005699094,0.0007825676,0.0033474406,0.0024458542,0.0031904501,0.0041923323],"category_scores_gemma":[0.026242377,0.001964799,0.06347587,0.006481286,0.00053154514,0.0011739994,0.0016469824,0.0021577617,0.000396217],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046011047,0.00003117934,0.010617381,0.027854193,0.9522835,0.00015165261,0.000033834494,0.0006367322,0.00025910244,0.00006578947,0.000271228,0.0031943691],"study_design_scores_gemma":[0.0005911895,0.00021589348,0.0048366725,0.0012801498,0.99203813,0.000074506126,0.000018887711,0.0003053274,0.00009469424,0.000079795245,0.00045138237,0.000013361409],"about_ca_topic_score_codex":0.012288864,"about_ca_topic_score_gemma":0.0143019175,"teacher_disagreement_score":0.012874209,"about_ca_system_score_codex":0.0018577114,"about_ca_system_score_gemma":0.0023038348,"threshold_uncertainty_score":0.06808615},"labels":[],"label_agreement":null},{"id":"W2317752050","doi":"10.1016/j.clpt.2005.12.064","title":"PI-43Gene expression in human mononuclear cells in response to reactive sulfonamide metabolites","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Peripheral blood mononuclear cell; Gene expression; Apoptosis; Molecular biology; Gene; Jurkat cells; RNA; Metabolite; Chemistry; Biology; Pharmacology; Immune system; Biochemistry; Immunology; T cell; In vitro","score_opus":0.08365145022968416,"score_gpt":0.44767528110079063,"score_spread":0.36402383087110646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317752050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967134,0.0010969786,0.00060948636,0.0000489011,0.000015502419,0.000019395866,0.0005941337,0.000021286392,0.00088104286],"genre_scores_gemma":[0.9942016,0.0008110826,0.0013229599,0.00010170601,0.000025658768,0.00011339019,0.0009149571,0.000009586318,0.0024991622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998317,0.000023550014,0.000006651639,0.000060586714,0.000047427377,0.000030068577],"domain_scores_gemma":[0.99993825,0.000013311619,0.000015514033,0.0000056011017,0.00001206637,0.000015315021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013096123,0.0001546194,0.00024594192,0.0003569169,0.00023856446,0.0002963784,0.00006476682,0.00026116517,0.002128197],"category_scores_gemma":[0.00016851917,0.00012060479,0.00012329649,0.0003174991,0.00014671053,0.00006369907,0.000112366455,0.00017614654,0.0004534305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008853267,0.000045063298,0.008707319,0.00005215508,0.000016079817,0.00021536788,0.00013924317,0.00004776899,0.9862303,0.00003436192,0.00013929231,0.0034876743],"study_design_scores_gemma":[0.000097003795,0.0018340055,0.53918153,0.00002355379,0.00011733285,0.002682356,0.00063455047,0.00093677104,0.44878808,0.00026595587,0.0054244595,0.000014413832],"about_ca_topic_score_codex":0.00047866785,"about_ca_topic_score_gemma":0.00060589786,"teacher_disagreement_score":0.002128197,"about_ca_system_score_codex":0.00014622032,"about_ca_system_score_gemma":0.0001114681,"threshold_uncertainty_score":0.007119477},"labels":[],"label_agreement":null},{"id":"W2318253638","doi":"10.1016/j.clpt.2005.12.033","title":"PI-12Amantadine acetylation as a biomarker for malignancy","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Sputum; Medicine; Internal medicine; Gastroenterology; Urine; Biomarker; Cancer; Bladder cancer; Amantadine; Lung cancer; Malignancy; Pharmacology; Pathology; Tuberculosis; Biology","score_opus":0.05670395556665674,"score_gpt":0.4073980869101964,"score_spread":0.35069413134353966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318253638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955388,0.0022983013,0.0005900509,0.00013324241,0.00003605911,0.00020451355,0.00018744591,0.000026481508,0.0009851163],"genre_scores_gemma":[0.99744797,0.0003904462,0.0012951789,0.00011944127,0.00006015606,0.00013162468,0.00023103452,0.0000032019086,0.00032097969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885654,0.00072722737,0.000062780324,0.00010168478,0.0001784792,0.000073344185],"domain_scores_gemma":[0.9972065,0.0010161701,0.0011313073,0.000099214274,0.00021865257,0.0003281024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019642846,0.000504217,0.0008830143,0.0005114097,0.00026981308,0.000675725,0.00042371106,0.0006039324,0.0017890979],"category_scores_gemma":[0.0028018795,0.00026796883,0.00031925412,0.0004195545,0.00041168538,0.0004020475,0.00033442586,0.000689717,0.00030629215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041368533,0.0015669853,0.87958837,0.00026809465,0.00028674825,0.00038152604,0.00008392849,0.0007668222,0.033790108,0.00009401284,0.0005751378,0.041229837],"study_design_scores_gemma":[0.0034205345,0.10201183,0.85051936,0.000069319634,0.0008274938,0.0027475394,0.00014158357,0.0071186824,0.029794687,0.00039888037,0.002903612,0.0000464614],"about_ca_topic_score_codex":0.00016546114,"about_ca_topic_score_gemma":0.0002623006,"teacher_disagreement_score":0.0019642846,"about_ca_system_score_codex":0.00023415546,"about_ca_system_score_gemma":0.00026793638,"threshold_uncertainty_score":0.010388255},"labels":[],"label_agreement":null},{"id":"W2318810481","doi":"10.1016/j.clpt.2005.12.223","title":"PIII-15Prioritizing treatment preferences in patients with type 2 diabetes","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pill; Autonomy; Type 2 diabetes; Statement (logic); Diabetes management; Diabetes mellitus; Scale (ratio); Family medicine; Visual analogue scale; Set (abstract data type); Clinical pharmacology; Diabetes treatment; Alternative medicine; Physical therapy; Nursing; Pharmacology; Endocrinology","score_opus":0.05789577721439459,"score_gpt":0.3886293507942092,"score_spread":0.3307335735798146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318810481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670464,0.00050289807,0.00012727527,0.00054321025,0.000009073414,0.000016766953,0.000041399235,0.0000023252505,0.0020524582],"genre_scores_gemma":[0.9989544,0.00029140466,0.00028613815,0.00021250766,0.00000875177,0.000011478341,0.000029701285,0.0000010183954,0.00020471305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882764,0.0006489637,0.000107855514,0.000054956443,0.0002240783,0.00013642709],"domain_scores_gemma":[0.9963702,0.0018730739,0.001126612,0.000051986233,0.00020370871,0.00037442832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017863588,0.00012337575,0.0002895722,0.00035008966,0.0005622542,0.000980535,0.00015707205,0.0003477578,0.0035988654],"category_scores_gemma":[0.008293488,0.00011235992,0.00028146568,0.0004457571,0.0003612498,0.000527838,0.00045406178,0.00071238424,0.00019875399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008989773,0.0006257597,0.9031262,0.00028116666,0.00013074728,0.00046114015,0.0108411405,0.0003148497,0.001009755,0.00034098868,0.0013861323,0.08058314],"study_design_scores_gemma":[0.00024656422,0.0021073422,0.93276155,0.0002283186,0.00017888969,0.0040366426,0.048691742,0.001801324,0.00088664686,0.001579296,0.007406962,0.000074672666],"about_ca_topic_score_codex":0.0015425532,"about_ca_topic_score_gemma":0.0033186323,"teacher_disagreement_score":0.0035988654,"about_ca_system_score_codex":0.00055682665,"about_ca_system_score_gemma":0.0006637754,"threshold_uncertainty_score":0.012039423},"labels":[],"label_agreement":null},{"id":"W2319955874","doi":"10.1016/j.clpt.2005.12.052","title":"PI-31Genotype frequencies for ten polymorphisms of the renin-angiotensin-aldosterone system between healthy French-Canadians and other ethnic groups","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Genotype; Internal medicine; Population; Bradykinin; Endocrinology; Polymorphism (computer science); Angiotensin-converting enzyme; Aldosterone synthase; Gene polymorphism; Biology; Genetics; Medicine; Renin–angiotensin system; Gene; Receptor; Blood pressure","score_opus":0.12038914565371191,"score_gpt":0.38840558561240823,"score_spread":0.26801643995869634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319955874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998359,0.00021521037,0.00010694169,0.000025153862,0.0000039878405,0.000010089731,0.00052338355,0.0000056870094,0.00075052894],"genre_scores_gemma":[0.9986492,0.0000939615,0.00016259588,0.000019847468,0.0000049216296,0.0000081277085,0.00037926406,0.0000031313361,0.0006789449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996586,0.000026416816,0.000016532198,0.00010419108,0.000080941994,0.000113343776],"domain_scores_gemma":[0.9996499,0.00005537817,0.00007731681,0.000021361286,0.00009055895,0.00010546248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002555063,0.0003702459,0.00028300536,0.0012285829,0.0010904595,0.00039827818,0.00031130124,0.00034730192,0.003984667],"category_scores_gemma":[0.0007246911,0.00013703648,0.00038712518,0.00087678846,0.00036587226,0.00012064089,0.00022512318,0.00022834899,0.00026755268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027936214,0.000048117752,0.99131656,0.000017473494,0.000080409576,0.00037754895,0.00066568336,0.00007159207,0.0017628478,0.0000992638,0.00027728462,0.0050039366],"study_design_scores_gemma":[0.000006737462,0.0000868112,0.9983394,0.0000035586816,0.000029544306,0.0004532538,0.0003044204,0.00008195613,0.00014638698,0.000021445861,0.00052007474,0.0000062890676],"about_ca_topic_score_codex":0.5394792,"about_ca_topic_score_gemma":0.44507396,"teacher_disagreement_score":0.4605208,"about_ca_system_score_codex":0.0013133055,"about_ca_system_score_gemma":0.00124487,"threshold_uncertainty_score":0.9264658},"labels":[],"label_agreement":null},{"id":"W2321773228","doi":"10.1016/j.clpt.2005.12.063","title":"PI-42Methamphetamine detection in maternal and neonatal hair","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Methamphetamine; Transplacental; Pregnancy; Medicine; Hair analysis; Fetus; Polysubstance dependence; Obstetrics; Placenta; Pharmacokinetics; Drug; Physiology; Pharmacology; Substance abuse; Psychiatry; Biology","score_opus":0.03366169745112063,"score_gpt":0.3708012681566218,"score_spread":0.33713957070550116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321773228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493754,0.0009156387,0.0010734262,0.00010681085,0.000015748095,0.000028427572,0.00016194524,0.000036831156,0.002723579],"genre_scores_gemma":[0.996114,0.0006998154,0.001879613,0.0000603528,0.000005811408,0.000019174602,0.00008897188,0.000006145005,0.0011261165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993445,0.00012950422,0.000038676662,0.0000914641,0.00030635716,0.00008936536],"domain_scores_gemma":[0.9995316,0.00012969607,0.00010005624,0.000026618087,0.00014008344,0.0000718966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048253592,0.00025137365,0.00021280821,0.00091725535,0.00038281397,0.00033286185,0.0002945842,0.0004292422,0.0020234452],"category_scores_gemma":[0.0015373885,0.00030313173,0.00014556135,0.00038995166,0.00047510825,0.00013397432,0.0003817844,0.00032741943,0.0004036156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026632586,0.00005601164,0.80366534,0.00012594233,0.00002631386,0.007126016,0.00094580324,0.000054096286,0.16681208,0.0000775991,0.0003151604,0.020529406],"study_design_scores_gemma":[0.000010681673,0.00069445884,0.89725417,0.00005473005,0.000045813966,0.020335836,0.0009449166,0.00061722996,0.078049235,0.000058056783,0.0019254464,0.0000094798415],"about_ca_topic_score_codex":0.009540925,"about_ca_topic_score_gemma":0.012802825,"teacher_disagreement_score":0.009540925,"about_ca_system_score_codex":0.000554832,"about_ca_system_score_gemma":0.00040437144,"threshold_uncertainty_score":0.018970788},"labels":[],"label_agreement":null},{"id":"W2322128527","doi":"10.1016/j.clpt.2005.12.074","title":"PI-53Effects of propafenone on the pharmacokinetics of caffeine","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Propafenone; Caffeine; Pharmacokinetics; Pharmacology; CYP1A2; CYP2D6; Medicine; Drug; Drug interaction; Internal medicine; Metabolism; Cytochrome P450","score_opus":0.09898817495081592,"score_gpt":0.4184030477813123,"score_spread":0.3194148728304964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322128527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697447,0.0012976052,0.00062460586,0.00007219485,0.000026672056,0.000053735763,0.00010973392,0.000025953861,0.0008150873],"genre_scores_gemma":[0.9982944,0.00032090608,0.0003598563,0.00004705343,0.000026127385,0.0000247159,0.00012346018,0.0000072904368,0.00079610694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981767,0.00006655243,0.000010331632,0.000028064476,0.00004810302,0.000029260356],"domain_scores_gemma":[0.99970824,0.000118424716,0.00007196686,0.000030212947,0.000021203707,0.000049952974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017498659,0.00035942058,0.00043673682,0.000094990864,0.00014630999,0.00021021294,0.00009942227,0.00023549143,0.0030006832],"category_scores_gemma":[0.0007757842,0.00017611378,0.00033561303,0.000087640365,0.00018698142,0.00018421352,0.00013088394,0.00043351226,0.0004031736],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0895196,0.002211101,0.022986112,0.00047342392,0.0003328248,0.0014765484,0.00023505169,0.0013849343,0.7518009,0.0001447363,0.00081880635,0.12861603],"study_design_scores_gemma":[0.005814628,0.24861161,0.3891979,0.0000537239,0.0010195398,0.004708769,0.00020315754,0.010433712,0.32677785,0.00039499914,0.012725776,0.000058347334],"about_ca_topic_score_codex":0.0003354777,"about_ca_topic_score_gemma":0.0003714635,"teacher_disagreement_score":0.0030006832,"about_ca_system_score_codex":0.00015482018,"about_ca_system_score_gemma":0.00015102277,"threshold_uncertainty_score":0.010038257},"labels":[],"label_agreement":null},{"id":"W2324734459","doi":"10.1016/j.clpt.2005.12.254","title":"PIII-46Generation of reactive oxygen species by sulfonamide reactive intermediates","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Reactive oxygen species; Chemistry; Hydroxylamine; Reactive intermediate; Sulfonamide; Metabolite; Reactive nitrogen species; Pharmacology; Oxidative stress; Biochemistry; Stereochemistry; Biology","score_opus":0.056764183530258236,"score_gpt":0.3943139702117567,"score_spread":0.33754978668149843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324734459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616252,0.009864818,0.018036481,0.00043721774,0.0001775305,0.00030149546,0.0005034839,0.0002054656,0.008848145],"genre_scores_gemma":[0.9850795,0.0034909195,0.0069381343,0.000111650945,0.000070691756,0.00011661438,0.00043067962,0.000016637821,0.0037452278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997004,0.00008322013,0.000021701382,0.000042392992,0.0000754255,0.00007682253],"domain_scores_gemma":[0.9997656,0.000048678412,0.00009070428,0.000027549324,0.000036509246,0.000030976957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036199065,0.0006155719,0.0002934576,0.0001781979,0.00018771758,0.00039704278,0.00022443454,0.00038365883,0.0034168602],"category_scores_gemma":[0.00024779004,0.00019122918,0.00034451226,0.00016806072,0.0002351116,0.00022575424,0.00017475517,0.0005473585,0.0008220636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004097206,0.00007947798,0.0005324916,0.00011571424,0.00001479949,0.00017094053,0.000017793123,0.00017611246,0.99433655,0.00021405276,0.00012652684,0.0038057202],"study_design_scores_gemma":[0.00003891475,0.00094463833,0.0016629354,0.000006975294,0.000019398522,0.000334128,0.0000167792,0.0005851244,0.9936237,0.00008745946,0.0026757044,0.000004303522],"about_ca_topic_score_codex":0.00032287854,"about_ca_topic_score_gemma":0.00032499834,"teacher_disagreement_score":0.0034168602,"about_ca_system_score_codex":0.00030451312,"about_ca_system_score_gemma":0.00025540765,"threshold_uncertainty_score":0.011430562},"labels":[],"label_agreement":null},{"id":"W2325591307","doi":"10.1016/j.clpt.2005.12.259","title":"PIII-51In utero exposure to HMG-CoA reductase inhibitors; effects on fetal and neonatal outcome","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pregnancy; HMG-CoA reductase; Abortion; Fetus; In utero; Hyperlipidemia; Obstetrics; Therapeutic abortion; Clinical pharmacology; Gestational age; Reductase; Endocrinology; Pharmacology; Biology","score_opus":0.04301270185536927,"score_gpt":0.39303096523366216,"score_spread":0.3500182633782929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325591307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687153,0.0008419935,0.00014680406,0.000112331225,0.000011098372,0.000005499057,0.00013179827,0.000008529534,0.00187054],"genre_scores_gemma":[0.99871206,0.00061382423,0.00006581583,0.000029371344,0.000010541193,0.0000060496623,0.00008293355,0.0000017130037,0.00047761705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982786,0.00007114467,0.000009218757,0.000025446448,0.000035894554,0.00003046227],"domain_scores_gemma":[0.99941826,0.0002523617,0.00017907961,0.00005889553,0.000027799166,0.0000637016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003597044,0.00013036504,0.00019395426,0.00027950577,0.00017526848,0.00023933656,0.00011735194,0.00022875561,0.0020801509],"category_scores_gemma":[0.0019847013,0.00008772975,0.00013316453,0.000166217,0.00028034003,0.000112290516,0.00021671735,0.00026018173,0.00018653338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069387835,0.00060920557,0.8554485,0.00014393372,0.00027949843,0.015133302,0.0005824111,0.00038339812,0.028846579,0.00066235085,0.0008834204,0.09008876],"study_design_scores_gemma":[0.000095161915,0.0041469154,0.96083516,0.000056704295,0.0002549294,0.02085886,0.00030550768,0.00052647025,0.010466114,0.00062122906,0.001821074,0.0000119404],"about_ca_topic_score_codex":0.0010647568,"about_ca_topic_score_gemma":0.00071487844,"teacher_disagreement_score":0.0020801509,"about_ca_system_score_codex":0.00023514254,"about_ca_system_score_gemma":0.00013359264,"threshold_uncertainty_score":0.0069587827},"labels":[],"label_agreement":null},{"id":"W2326875227","doi":"10.1016/j.clpt.2005.12.237","title":"PIII-29Genotype frequencies for ten polymorphisms of the renin-angiotensin-aldosterone system between healthy and heart failure patients in the French-Canadian population","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Genotype; Internal medicine; Bradykinin; Population; Enos; Aldosterone; Medicine; Heart failure; Allele frequency; Angiotensin-converting enzyme; Gene polymorphism; Gastroenterology; Endocrinology; Genotype frequency; Biology; Genetics; Receptor; Gene","score_opus":0.05062803313372751,"score_gpt":0.34856484111864433,"score_spread":0.29793680798491684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326875227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842477,0.0004198833,0.00010480217,0.000036088677,0.000005464113,0.000011390308,0.00034799872,0.0000049759383,0.00064456405],"genre_scores_gemma":[0.9989747,0.0001724436,0.00011677613,0.000023098917,0.00000643433,0.000006567145,0.00031253955,0.000002175397,0.00038535226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995009,0.00003800818,0.000025052417,0.00015342266,0.00013017248,0.00015238735],"domain_scores_gemma":[0.99965084,0.000054161876,0.00007683176,0.000024040857,0.00009372953,0.00010028341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035196365,0.00040961098,0.0003533884,0.0013687551,0.0013581326,0.00051457144,0.00042732828,0.00039416185,0.003420218],"category_scores_gemma":[0.00085416937,0.00018091334,0.00048456955,0.0009098588,0.0005017682,0.00012164891,0.00027332138,0.00026384438,0.00018454564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003163611,0.00005302973,0.99032354,0.000025115058,0.00010246401,0.00060406944,0.0006783466,0.00006439353,0.0014781619,0.00012889599,0.00034784048,0.0058777267],"study_design_scores_gemma":[0.000010281616,0.00008020519,0.9981509,0.0000055715764,0.000044298453,0.00067792274,0.00028144373,0.000085750486,0.00010888272,0.000021637554,0.00052608026,0.0000070702267],"about_ca_topic_score_codex":0.66581035,"about_ca_topic_score_gemma":0.59184456,"teacher_disagreement_score":0.33418965,"about_ca_system_score_codex":0.0020271249,"about_ca_system_score_gemma":0.001754364,"threshold_uncertainty_score":0.6723155},"labels":[],"label_agreement":null},{"id":"W2378259067","doi":"10.1002/cpt.390","title":"The effect of an abuse‐deterrent opioid formulation (OxyContin) on opioid abuse‐related outcomes in the postmarketing setting","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Purdue Pharma; University of Kentucky; Purdue University","keywords":"Medicine; Substance abuse; Medical prescription; Opioid; Psychiatry; Chronic pain; Psychological intervention; Postmarketing surveillance; Opioid abuse; Adverse effect; Pharmacology; Internal medicine","score_opus":0.027591232814806355,"score_gpt":0.40215247584193026,"score_spread":0.3745612430271239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2378259067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387026,0.0052570184,0.000053220207,0.00017623817,0.000020458954,0.000024420515,0.00019228566,0.0000017237361,0.0004044008],"genre_scores_gemma":[0.99867475,0.00085946586,0.00007210753,0.00005681898,0.000036412308,0.000013558658,0.000139454,8.3405297e-7,0.00014661209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973628,0.0013699972,0.00029456647,0.00026816592,0.0004239862,0.00028046628],"domain_scores_gemma":[0.9784879,0.007815758,0.010691492,0.0005536993,0.0015183251,0.0009327788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066373833,0.00021156236,0.0003353012,0.00084610924,0.0004534465,0.0007787414,0.00035171548,0.00047969556,0.00081630587],"category_scores_gemma":[0.017109944,0.00018016658,0.0013217768,0.00092063716,0.00036101844,0.0008130753,0.00057821133,0.0007265554,0.00007407447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037557022,0.00051503367,0.9764107,0.00025885593,0.001488267,0.0001213658,0.00025584456,0.0001815686,0.00047980648,0.0000694179,0.00022956426,0.016233826],"study_design_scores_gemma":[0.000047868016,0.0025529317,0.9958293,0.000039804472,0.0006559939,0.00008789426,0.00012547181,0.00013436752,0.0001904081,0.000017134847,0.0003121509,0.0000066933576],"about_ca_topic_score_codex":0.010676705,"about_ca_topic_score_gemma":0.021032657,"teacher_disagreement_score":0.010676705,"about_ca_system_score_codex":0.0010322487,"about_ca_system_score_gemma":0.0011544109,"threshold_uncertainty_score":0.03510225},"labels":[],"label_agreement":null},{"id":"W2382331551","doi":"10.1002/cpt.371","title":"The Bugs Within Our Body: The Human Microbiota","year":2016,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Human microbiome; Biology; Human health; Microbiome; Dysbiosis; Medicine; Bioinformatics; Environmental health","score_opus":0.03909348001864643,"score_gpt":0.44652651274041183,"score_spread":0.4074330327217654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2382331551","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006075522,0.03002719,0.00013253857,0.042675905,0.92623526,0.000009017754,0.000020670921,0.00004616925,0.0007924783],"genre_scores_gemma":[0.0006020688,0.026760725,0.00012629149,0.02559743,0.9426298,0.000012517354,0.000018041927,0.00002337711,0.0042296886],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708885,0.0006763663,0.00040228898,0.00037240738,0.0012821757,0.00017796636],"domain_scores_gemma":[0.99115235,0.004432584,0.0004906239,0.0002535187,0.0023313768,0.001339539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053327717,0.004088724,0.0029394974,0.0016066066,0.002077908,0.005702524,0.002858064,0.010273901,0.0051617725],"category_scores_gemma":[0.0123796975,0.00090731186,0.0018584259,0.0007017677,0.002996898,0.0048285625,0.0018456532,0.02311255,0.005239632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006158093,0.000020496393,0.000062711064,0.00041974668,0.000026893069,0.00018491545,0.000046198937,0.000037268426,0.00015837698,0.0006425377,0.9797513,0.01858789],"study_design_scores_gemma":[0.000040133735,0.000053070282,0.000327117,0.0005551853,0.00004792521,0.00050938193,0.000082661216,0.00010977317,0.00017105779,0.0014402046,0.99664366,0.000019808122],"about_ca_topic_score_codex":0.0010643617,"about_ca_topic_score_gemma":0.002452875,"teacher_disagreement_score":0.010273901,"about_ca_system_score_codex":0.0018340818,"about_ca_system_score_gemma":0.0019086137,"threshold_uncertainty_score":0.028202713},"labels":[],"label_agreement":null},{"id":"W2413113571","doi":"10.1002/cpt.383","title":"Mother and Child: Medication Use in Pregnancy and Lactation","year":2016,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Breastfeeding; Pregnancy; In utero; Medicine; Drug; Lactation; Obstetrics; Fetus; Pharmacokinetics; Breast feeding; Pediatrics; Pharmacology; Biology","score_opus":0.061487130839002084,"score_gpt":0.44224379232295086,"score_spread":0.38075666148394877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413113571","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038376944,0.046172507,0.00008210882,0.039690167,0.9128047,0.000010961476,0.000033989454,0.000035810906,0.0011313595],"genre_scores_gemma":[0.00049977994,0.040440146,0.00010373072,0.031382617,0.9235229,0.000019035208,0.000023643363,0.000024004037,0.0039841942],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99464273,0.0014655107,0.0011013611,0.00055567303,0.0019528286,0.0002818136],"domain_scores_gemma":[0.97780085,0.01406336,0.0012660048,0.000487834,0.0047449158,0.0016370107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006909591,0.0040737307,0.0048266742,0.0024699077,0.0036459693,0.0064922944,0.003972149,0.018006891,0.0066433847],"category_scores_gemma":[0.024513895,0.0015747208,0.0026498302,0.0018112428,0.0032681264,0.005316102,0.0021905496,0.026168048,0.0060562817],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004525181,0.000016312773,0.00006233153,0.0007830886,0.000036687434,0.0002038215,0.00005699204,0.000034488556,0.000053166674,0.00046571656,0.9788777,0.01936447],"study_design_scores_gemma":[0.000042628624,0.00005205901,0.0005778717,0.0020877593,0.00008837246,0.0005781285,0.0001120423,0.00010608012,0.00007729581,0.0011248329,0.9951243,0.000028750374],"about_ca_topic_score_codex":0.0044717626,"about_ca_topic_score_gemma":0.011578989,"teacher_disagreement_score":0.018006891,"about_ca_system_score_codex":0.003589323,"about_ca_system_score_gemma":0.0040662833,"threshold_uncertainty_score":0.03654188},"labels":[],"label_agreement":null},{"id":"W2473575438","doi":"10.1002/cpt.421","title":"Understanding the Link Between Cannabinoids and Psychosis","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Cannabis; Psychosis; Synthetic cannabinoids; Psychiatry; Public health; Effects of cannabis; Medicine; Psychology; Environmental health; Cannabinoid; Cannabidiol","score_opus":0.2782695212036547,"score_gpt":0.4703346766586735,"score_spread":0.1920651554550188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473575438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25819314,0.4743001,0.003942875,0.20498641,0.00091943133,0.00008086355,0.00044703417,0.000045128552,0.057084963],"genre_scores_gemma":[0.6487833,0.33580363,0.0023919924,0.008846193,0.00083185296,0.000033234206,0.0001458774,0.0000045244465,0.0031593745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999718,0.000100087585,0.000021463664,0.000040004405,0.000072811104,0.000047567795],"domain_scores_gemma":[0.99917346,0.00045877733,0.00017673658,0.000025669557,0.000089865105,0.000075500575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007734461,0.00022814833,0.00034916287,0.00092418917,0.00051704276,0.0015726343,0.00033648204,0.0012576986,0.003404013],"category_scores_gemma":[0.0022301695,0.00018301653,0.00022500493,0.0003963991,0.0012322253,0.0023631542,0.0010618657,0.0017446497,0.0003778765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007519695,0.0009154104,0.13444683,0.005031928,0.00031444256,0.0059254705,0.006244337,0.0021046319,0.018723505,0.117572896,0.017388824,0.6905797],"study_design_scores_gemma":[0.00010105921,0.00049501314,0.30821824,0.0066720205,0.00034097274,0.00814573,0.013702377,0.0036037622,0.0033460378,0.48190117,0.17332785,0.00014580644],"about_ca_topic_score_codex":0.010536004,"about_ca_topic_score_gemma":0.018180724,"teacher_disagreement_score":0.010536004,"about_ca_system_score_codex":0.0013098919,"about_ca_system_score_gemma":0.0029000456,"threshold_uncertainty_score":0.020949364},"labels":[],"label_agreement":null},{"id":"W2495375730","doi":"10.1002/cpt.438","title":"The Effects of Different Aspirin Dosing Frequencies and the Timing of Aspirin Intake in Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Universidade de Vigo; Leids Universitair Medisch Centrum; Karolinska Institutet; Universiteit Leiden","keywords":"Aspirin; Dosing; Medicine; Chronotherapy (sleep phase); Primary prevention; Intensive care medicine; Disease; Low dose aspirin; Internal medicine; Blood pressure","score_opus":0.05694217177846646,"score_gpt":0.3829627969252457,"score_spread":0.32602062514677926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495375730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008410321,0.99852425,0.00006975609,0.00009837843,0.00005736973,0.00010814571,0.0001566626,0.0000035744915,0.0001407786],"genre_scores_gemma":[0.012495501,0.9863409,0.0004006123,0.0002817844,0.000055427878,0.00019163593,0.00014355485,0.0000028870943,0.000087725864],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960898,0.0013702413,0.0014996999,0.0002964651,0.0006299408,0.00011379129],"domain_scores_gemma":[0.9835286,0.0128570665,0.0024261272,0.00016766223,0.0008756572,0.00014476234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049964394,0.0013501311,0.0072754505,0.0047554844,0.00045569343,0.0018838242,0.0012533912,0.0015902467,0.0040050363],"category_scores_gemma":[0.023805484,0.0008979812,0.00867882,0.0058693183,0.0005834219,0.0015201205,0.001023664,0.0010531709,0.0002643036],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041548556,0.000022992792,0.0007328002,0.9386954,0.019126343,0.00006975657,0.00009451006,0.00011335196,0.00015389895,0.0001622969,0.0010097291,0.039403476],"study_design_scores_gemma":[0.0008637972,0.00047448443,0.007433785,0.6429024,0.3244313,0.00047381475,0.00022912765,0.00014580783,0.00033916096,0.0004891705,0.022159608,0.000057578127],"about_ca_topic_score_codex":0.0061430307,"about_ca_topic_score_gemma":0.020809527,"teacher_disagreement_score":0.0072754505,"about_ca_system_score_codex":0.0019148363,"about_ca_system_score_gemma":0.005191397,"threshold_uncertainty_score":0.02642399},"labels":[],"label_agreement":null},{"id":"W2512011249","doi":"10.1002/cpt.460","title":"An International Asset Map of Clinicians, Educators, and Researchers Pursuing Better Medicine Use in Children: Initial Findings","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Waterloo; University of Waterloo; Western University; Robarts Clinical Trials; Child and Family Research Institute; Children's Hospital of Western Ontario; University of Toronto; BC Children's Hospital; Hospital for Sick Children; University of British Columbia","funders":"American College of Clinical Pharmacy; European Society of Clinical Pharmacy; Hospital for Sick Children; AGE-WELL; World Bank Group","keywords":"Economic shortage; Medicine; Asset (computer security); Medical education; Clinical pharmacology; Latin Americans; Family medicine; Political science; Pharmacology","score_opus":0.2908080334891536,"score_gpt":0.5650958529598014,"score_spread":0.2742878194706478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512011249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88431036,0.008002811,0.0023671598,0.024581222,0.00022431105,0.0002745406,0.013668789,0.000112269976,0.06645848],"genre_scores_gemma":[0.9875551,0.0035632798,0.002267261,0.0009947277,0.000099507066,0.00016693596,0.0037493617,0.000017935587,0.0015859408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982864,0.00039313379,0.00023688965,0.00015648614,0.0004935613,0.00043351046],"domain_scores_gemma":[0.9846518,0.003429446,0.0039339424,0.0007813881,0.004149191,0.0030542817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003896029,0.00040497474,0.00030243836,0.005041729,0.0011784621,0.0022057688,0.0006980551,0.0004938582,0.008685087],"category_scores_gemma":[0.013711527,0.00020530052,0.0003437695,0.0064940876,0.00074850215,0.0033492006,0.00497397,0.0009262802,0.0009556226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015956693,0.00010385367,0.87772256,0.00053870515,0.00005304413,0.00024984416,0.0067325206,0.00025032688,0.00026538508,0.0038034916,0.018702757,0.09141798],"study_design_scores_gemma":[0.000009197211,0.00012362724,0.9361763,0.00068196363,0.00004308774,0.0004936504,0.02170595,0.0004783182,0.00018076788,0.0008721167,0.039211083,0.000023933866],"about_ca_topic_score_codex":0.016670212,"about_ca_topic_score_gemma":0.013652135,"teacher_disagreement_score":0.016670212,"about_ca_system_score_codex":0.0017390124,"about_ca_system_score_gemma":0.004072601,"threshold_uncertainty_score":0.03314638},"labels":[],"label_agreement":null},{"id":"W2514206116","doi":"10.1002/cpt.462","title":"Deconstructing Designer Drugs","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Headline; Designer drug; Stimulant; Medicine; Sedative; Pharmacology; Business; Drug; Advertising","score_opus":0.11479067319973531,"score_gpt":0.45846096209010506,"score_spread":0.34367028889036977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514206116","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03394239,0.0882881,0.14361727,0.1855515,0.010178309,0.00029919692,0.00043591348,0.0008783049,0.5368091],"genre_scores_gemma":[0.56368816,0.09731644,0.08969089,0.09660542,0.007924687,0.00053374993,0.0005303825,0.0011993556,0.14251095],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952467,0.0022289213,0.00021666363,0.0004406987,0.0014432538,0.0004236996],"domain_scores_gemma":[0.992878,0.003420974,0.0004549807,0.0014372041,0.0013633934,0.00044537327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070138373,0.0011135644,0.0009470197,0.0019769047,0.0024730207,0.0070938254,0.001813457,0.003980052,0.008874701],"category_scores_gemma":[0.011663158,0.00060321647,0.00090144505,0.00081143784,0.019518457,0.010107906,0.0059317383,0.009049079,0.0034006725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040726096,0.00004610692,0.00022489746,0.0001999551,0.000009575115,0.00014642901,0.0012865529,0.00035994579,0.00073806534,0.9504405,0.010738713,0.035768542],"study_design_scores_gemma":[0.000033899505,0.00012437491,0.0002303182,0.00057406817,0.000025462155,0.00040473157,0.0010541733,0.00084364606,0.001486618,0.50227296,0.4929183,0.00003141375],"about_ca_topic_score_codex":0.0033351916,"about_ca_topic_score_gemma":0.0045119063,"teacher_disagreement_score":0.008874701,"about_ca_system_score_codex":0.0031987424,"about_ca_system_score_gemma":0.004825149,"threshold_uncertainty_score":0.037093163},"labels":[],"label_agreement":null},{"id":"W2517953645","doi":"10.1002/cpt.461","title":"Harmonizing Global Biospecimen Consent Practices to Advance Translational Research: A Call to Action","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Informed consent; Biobank; Call to action; Translational research; Translational medicine; Action (physics); Biorepository; Ethical standards; Medical research; Engineering ethics; Medicine; Alternative medicine; Medical education; Business; Bioinformatics; Pathology; Engineering; Biology","score_opus":0.924173956648261,"score_gpt":0.7454248348351911,"score_spread":0.1787491218130699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517953645","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017134112,0.0040441887,0.03834795,0.9436633,0.004755646,0.000712597,0.00009887552,0.00033491835,0.006329135],"genre_scores_gemma":[0.050209306,0.0072727734,0.22947626,0.6974669,0.0060065994,0.0033823685,0.0006229302,0.00047005792,0.0050928],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.5069462,0.35587293,0.04328889,0.016610643,0.0615132,0.015768135],"domain_scores_gemma":[0.25715974,0.46934453,0.026920345,0.10852997,0.09505769,0.042987663],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6026355,0.0021849016,0.004709311,0.004152484,0.009619245,0.028015407,0.010802596,0.049361277,0.007174151],"category_scores_gemma":[0.4594023,0.0024589135,0.0053429417,0.003487164,0.056349322,0.04874562,0.036625948,0.084421925,0.004194505],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003357214,0.00085053925,0.005209553,0.002752897,0.000293361,0.0016720669,0.026509065,0.0022976596,0.003711578,0.37398827,0.33830792,0.24407129],"study_design_scores_gemma":[0.0002312674,0.00042079546,0.0034199045,0.0059368196,0.00011178946,0.0012979113,0.014234983,0.0011913934,0.0015639182,0.42292798,0.54822606,0.0004370886],"about_ca_topic_score_codex":0.0045583486,"about_ca_topic_score_gemma":0.0056029037,"teacher_disagreement_score":0.9506387,"about_ca_system_score_codex":0.011246194,"about_ca_system_score_gemma":0.1393519,"threshold_uncertainty_score":0.49002123},"labels":[{"model":"gemma","categories":["research_integrity"],"domain":null,"study_design":"theoretical_or_conceptual","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2519711882","doi":"10.1002/cpt.509","title":"Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Alfred P. Sloan Foundation; Ewing Marion Kauffman Foundation","keywords":"Process management; Pace; Knowledge management; Business; Business process reengineering; Structuring; Maturity (psychological); Sustainability; Process (computing); Product (mathematics); Risk analysis (engineering); New product development; Computer science; Marketing","score_opus":0.036100106016181896,"score_gpt":0.35400336371243146,"score_spread":0.31790325769624955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519711882","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11961225,0.011781059,0.4315586,0.23308945,0.0026727272,0.0012670747,0.00029172376,0.001265625,0.19846147],"genre_scores_gemma":[0.76823884,0.008114628,0.19099994,0.021159517,0.0012044938,0.000690653,0.00027978903,0.0002019907,0.0091102235],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9877989,0.0059562433,0.0007081235,0.0015820462,0.0025613671,0.0013932287],"domain_scores_gemma":[0.9881875,0.004567805,0.0018896054,0.001492894,0.0015801319,0.0022819354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020811241,0.000938995,0.00060502416,0.0024031159,0.00402163,0.013276192,0.0028880842,0.0068866923,0.0055948864],"category_scores_gemma":[0.016977636,0.00031460737,0.0011644163,0.001902532,0.012831991,0.0131636355,0.01425382,0.0041479846,0.001799399],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001256015,0.00049808394,0.016318552,0.0014994844,0.00027200152,0.0007868479,0.009849801,0.011988384,0.00920018,0.6185599,0.02591848,0.30498257],"study_design_scores_gemma":[0.00008241764,0.00081857765,0.0066839578,0.001187486,0.00016090735,0.00091801846,0.009278974,0.012460138,0.0036774308,0.66250855,0.30202287,0.00020070518],"about_ca_topic_score_codex":0.0017855563,"about_ca_topic_score_gemma":0.001738698,"teacher_disagreement_score":0.020811241,"about_ca_system_score_codex":0.004884416,"about_ca_system_score_gemma":0.01866344,"threshold_uncertainty_score":0.110061705},"labels":[],"label_agreement":null},{"id":"W2521539014","doi":"10.1002/cpt.515","title":"“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Medical Research Council","keywords":"Counterfactual thinking; Harm; Outcome (game theory); Randomized controlled trial; Clinical trial; Counterfactual conditional; Computer science; Randomized experiment; Actuarial science; Econometrics; Medicine; Psychology; Economics; Social psychology; Microeconomics","score_opus":0.8085835664795291,"score_gpt":0.6822660510648504,"score_spread":0.12631751541467873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521539014","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002470319,0.00605951,0.9768276,0.0075379787,0.0014643136,0.0015708482,0.0003481214,0.00027731163,0.003443964],"genre_scores_gemma":[0.15957463,0.0039010644,0.80825704,0.012998316,0.0023262817,0.01133956,0.00044368935,0.00026851168,0.00089086796],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.30834505,0.6310354,0.021360256,0.019075207,0.019124288,0.0010598418],"domain_scores_gemma":[0.1710461,0.7309434,0.02993187,0.060137913,0.0066768844,0.0012639224],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.55972624,0.0047069243,0.012501974,0.008800001,0.002846692,0.01480665,0.008532843,0.0109334085,0.008470869],"category_scores_gemma":[0.7381624,0.0022383598,0.012074733,0.007775175,0.027188938,0.02668765,0.011703667,0.022789007,0.0012647657],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012283365,0.000110417925,0.0024858706,0.0038680488,0.0049203043,0.00030948344,0.0018108177,0.009670545,0.0005080979,0.88709104,0.004916535,0.08308045],"study_design_scores_gemma":[0.0003100026,0.0005006276,0.0005377759,0.0015867146,0.0008288662,0.0001949063,0.0001527659,0.0148201985,0.0007646943,0.9698547,0.010309556,0.00013923387],"about_ca_topic_score_codex":0.0014152317,"about_ca_topic_score_gemma":0.0006991159,"teacher_disagreement_score":0.44027376,"about_ca_system_score_codex":0.0067990124,"about_ca_system_score_gemma":0.007270882,"threshold_uncertainty_score":0.54293597},"labels":[],"label_agreement":null},{"id":"W2523823607","doi":"10.1002/cpt.512","title":"Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision‐Making","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Real world evidence; Clinical decision making; Computer science; Data science; MEDLINE; Medical decision making; Management science; Medicine; Intensive care medicine; Engineering; Internal medicine; Political science; Medical emergency","score_opus":0.5963858748892129,"score_gpt":0.5456894304575541,"score_spread":0.05069644443165877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523823607","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003571938,0.0025058454,0.9746859,0.011019806,0.00019446746,0.0010317423,0.00072710816,0.00020803153,0.0060550994],"genre_scores_gemma":[0.16338474,0.0021221484,0.82598984,0.0020888115,0.00048240036,0.0041151894,0.00076355506,0.000082496306,0.00097080134],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8207498,0.15262567,0.0073418245,0.0074639088,0.010333055,0.0014857712],"domain_scores_gemma":[0.5767976,0.3862652,0.0125720715,0.012368539,0.009533102,0.0024635443],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17343794,0.0036255969,0.0050655347,0.014270338,0.002250046,0.01599853,0.009920814,0.008959006,0.008470189],"category_scores_gemma":[0.30557352,0.002528903,0.005355897,0.013533403,0.015163199,0.016465371,0.010963294,0.0088625215,0.0011969164],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027601726,0.000207971,0.003718654,0.0013923877,0.00078782596,0.00061227265,0.0014635937,0.09870836,0.00020952417,0.82008934,0.0031093536,0.069424726],"study_design_scores_gemma":[0.00012028662,0.00011207777,0.00036277992,0.0005523035,0.00012567792,0.000119221986,0.00022842828,0.091491245,0.00018492143,0.89949137,0.007135887,0.00007574865],"about_ca_topic_score_codex":0.0071482826,"about_ca_topic_score_gemma":0.0043652887,"teacher_disagreement_score":0.82656205,"about_ca_system_score_codex":0.008820308,"about_ca_system_score_gemma":0.010667255,"threshold_uncertainty_score":0.9172385},"labels":[],"label_agreement":null},{"id":"W2528414212","doi":"10.1002/cpt.526","title":"Development and Validation of Algorithms for the Detection of Statin Myopathy Signals From Electronic Medical Records","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Myopathy; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Algorithm; Medical record; Computer science; Medicine; Internal medicine","score_opus":0.21957639952806643,"score_gpt":0.5056059265231236,"score_spread":0.28602952699505724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528414212","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4181976,0.0012669761,0.5665769,0.00069092726,0.00014862281,0.001809697,0.0028872553,0.0067230645,0.0016990928],"genre_scores_gemma":[0.43205693,0.00025103707,0.5619277,0.00025442094,0.000053875174,0.0006006531,0.004314558,0.00010075003,0.00044008912],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9887639,0.0048981393,0.0020527546,0.0020429792,0.0018821335,0.00036009087],"domain_scores_gemma":[0.9562553,0.031579647,0.0030267453,0.0019601649,0.0068137236,0.00036441543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01764839,0.0013077466,0.0011329083,0.006775271,0.00066672044,0.0023677903,0.0019276501,0.0016297929,0.0008161099],"category_scores_gemma":[0.053846333,0.0004778543,0.0010471372,0.002046505,0.00046785196,0.001794124,0.0011140853,0.001206746,0.00060830056],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001283475,0.0016381599,0.29869863,0.0005573675,0.0011742634,0.00044222618,0.00044507705,0.11198948,0.022346018,0.001781283,0.004245801,0.5553983],"study_design_scores_gemma":[0.00021986435,0.00048652294,0.046037752,0.00011997743,0.00021483039,0.00059670163,0.0001920579,0.9209374,0.02684879,0.001644092,0.002646306,0.00005573209],"about_ca_topic_score_codex":0.0044411,"about_ca_topic_score_gemma":0.0029630612,"teacher_disagreement_score":0.01764839,"about_ca_system_score_codex":0.0011539205,"about_ca_system_score_gemma":0.0021560243,"threshold_uncertainty_score":0.093334675},"labels":[],"label_agreement":null},{"id":"W2529901602","doi":"10.1002/cpt.533","title":"Exercise Mimetics: Running Without a Road Map","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mitochondrial biogenesis; Regulator; Skeletal muscle; Peroxisome proliferator-activated receptor; Peroxisome; Oxidative phosphorylation; Chemistry; Biogenesis; Receptor; Pharmacology; Mitochondrion; Cell biology; Endocrinology; Internal medicine; Biochemistry; Biology; Medicine; Gene","score_opus":0.09634437818454925,"score_gpt":0.441387316113056,"score_spread":0.3450429379285067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529901602","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04054838,0.14328629,0.08335728,0.11848235,0.037218053,0.0010748644,0.0019968294,0.006138552,0.56789744],"genre_scores_gemma":[0.20012055,0.1711993,0.06776983,0.075804636,0.01590379,0.0017996927,0.0022500397,0.0010689752,0.4640832],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99954116,0.00013686152,0.000025472997,0.000059683836,0.00018379901,0.00005299326],"domain_scores_gemma":[0.9996594,0.0000823908,0.0000369607,0.000032345448,0.00006115994,0.00012780228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069648353,0.0006506109,0.00047397154,0.0005546924,0.00058719475,0.0017270353,0.00080573926,0.0017744241,0.038531393],"category_scores_gemma":[0.0011108763,0.00018961415,0.00050707994,0.00026908686,0.0007901423,0.0023696262,0.0015559663,0.0021296488,0.01921119],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011824117,0.0008805476,0.00062401843,0.0021760191,0.00007817727,0.0005184975,0.00021299075,0.00055343384,0.013794679,0.033782728,0.21381158,0.7323849],"study_design_scores_gemma":[0.00016798964,0.0009343922,0.0012294629,0.00067610794,0.00005806442,0.0006458155,0.0001728445,0.00028705006,0.003896722,0.015564044,0.9763324,0.000035103778],"about_ca_topic_score_codex":0.00034522687,"about_ca_topic_score_gemma":0.0007985416,"teacher_disagreement_score":0.038531393,"about_ca_system_score_codex":0.00028372533,"about_ca_system_score_gemma":0.00071570737,"threshold_uncertainty_score":0.12890035},"labels":[],"label_agreement":null},{"id":"W2535831098","doi":"10.1002/cpt.538","title":"Novel psychoactive substances: What educators need to know","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Carleton University; Canadian Centre on Substance Use and Addiction","funders":"","keywords":"Medicine; Pharmacology; Psychology","score_opus":0.17150211717467698,"score_gpt":0.5101212911496056,"score_spread":0.3386191739749286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535831098","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017623791,0.115354404,0.0030032147,0.8365268,0.027028386,0.00013187046,0.00016368371,0.00040798206,0.015621252],"genre_scores_gemma":[0.016744494,0.28544286,0.020052647,0.6145654,0.03695375,0.00040758486,0.00037940362,0.00023221159,0.025221637],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958935,0.0011459442,0.00037110574,0.0003567613,0.0017993641,0.00043337716],"domain_scores_gemma":[0.95575833,0.013469041,0.001728562,0.0015681131,0.015024849,0.012451049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008652235,0.001317872,0.0024210082,0.0023288478,0.0033337304,0.0067025777,0.0026068375,0.014147325,0.032521382],"category_scores_gemma":[0.029256493,0.0005907124,0.00135545,0.0009747912,0.004324661,0.019355278,0.004938346,0.01818974,0.015820462],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077604374,0.0005244476,0.0020105434,0.0029468373,0.000030275176,0.0011676417,0.0011333779,0.00008120436,0.0004114026,0.0045600357,0.611824,0.37523267],"study_design_scores_gemma":[0.000088781315,0.00028626836,0.002401639,0.011938108,0.00006157237,0.0056964043,0.008788944,0.00017781249,0.00025341733,0.038561437,0.9316386,0.00010698598],"about_ca_topic_score_codex":0.003808729,"about_ca_topic_score_gemma":0.009997936,"teacher_disagreement_score":0.032521382,"about_ca_system_score_codex":0.0023592273,"about_ca_system_score_gemma":0.011888918,"threshold_uncertainty_score":0.10879493},"labels":[],"label_agreement":null},{"id":"W2561831579","doi":"10.1002/cpt.597","title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for <i>CYP2D6</i> and <i>CYP2C19</i> genotypes and dosing of tricyclic antidepressants: 2016 update","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":678,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institute of General Medical Sciences; National Institute of Mental Health; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Dosing; Pharmacogenetics; Guideline; CYP2C19; CYP2D6; Tricyclic; Medicine; Pharmacology; Internal medicine; Genotype; Biology; Genetics","score_opus":0.19379102528921807,"score_gpt":0.5511572408294994,"score_spread":0.35736621554028125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561831579","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009176486,0.13838892,0.07751295,0.4574609,0.02544258,0.006473005,0.029612081,0.0052565667,0.25067654],"genre_scores_gemma":[0.049969804,0.19573869,0.26809534,0.2808834,0.015474319,0.011807032,0.09142127,0.0019658653,0.08464431],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97544235,0.0068528214,0.007086213,0.00086317665,0.008841082,0.0009142948],"domain_scores_gemma":[0.932613,0.017203089,0.0064267246,0.0020816193,0.039162904,0.0025126177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02014396,0.0010362077,0.0023816978,0.0035038267,0.0009914067,0.0031657352,0.005269953,0.008842861,0.007982027],"category_scores_gemma":[0.060057033,0.0010489528,0.0033297893,0.0041078534,0.001021314,0.0020089678,0.0026830074,0.008285037,0.0063590407],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012333535,0.00027121181,0.0022499328,0.0016193014,0.000104421604,0.00045712272,0.00020146286,0.00060215115,0.00067601766,0.0034059328,0.747423,0.24286616],"study_design_scores_gemma":[0.00028915316,0.00012837359,0.007710365,0.0056919935,0.00030177223,0.0012775799,0.0001275303,0.00064738555,0.00083739695,0.0023405675,0.98057866,0.000069266236],"about_ca_topic_score_codex":0.027724981,"about_ca_topic_score_gemma":0.041854396,"teacher_disagreement_score":0.027724981,"about_ca_system_score_codex":0.0035962842,"about_ca_system_score_gemma":0.02102856,"threshold_uncertainty_score":0.10653269},"labels":[],"label_agreement":null},{"id":"W2562778159","doi":"10.1002/cpt.583","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP2C19</i> and Voriconazole Therapy","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; National Cancer Institute; Children's Mercy Hospital; National Institutes of Health; Sick Kids Foundation; Instituto de Salud Carlos III; Federación Española de Enfermedades Raras","keywords":"CYP2C19; Pharmacogenetics; Voriconazole; Medicine; Medical physics; Internal medicine; Biology; Genotype","score_opus":0.3670090222705866,"score_gpt":0.582856070294495,"score_spread":0.21584704802390842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562778159","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010552203,0.034583632,0.19249895,0.41657537,0.013552674,0.017160524,0.009923628,0.0076140775,0.29753903],"genre_scores_gemma":[0.06354946,0.037854683,0.54574925,0.22403109,0.009290414,0.024376888,0.023932865,0.0024322208,0.068783134],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95568293,0.021982392,0.008490475,0.0012863256,0.010804381,0.001753521],"domain_scores_gemma":[0.91487604,0.025505835,0.0101815155,0.0049015447,0.038908787,0.005626285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03575373,0.0010111723,0.0015464717,0.0033902314,0.0017715043,0.0037798388,0.0045510517,0.008804353,0.011049471],"category_scores_gemma":[0.07242527,0.0007720716,0.002822657,0.0038296573,0.0014640021,0.002071967,0.003036341,0.010320493,0.0076405285],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026589356,0.0009086922,0.004059681,0.0010790112,0.000101078906,0.0009227257,0.00051978044,0.0011322304,0.001710588,0.012954975,0.6913841,0.28496128],"study_design_scores_gemma":[0.00044427105,0.00030204825,0.009253966,0.003790305,0.00016759077,0.0018073783,0.00028246106,0.0016522706,0.0021154638,0.010367629,0.96972287,0.000093750255],"about_ca_topic_score_codex":0.010601809,"about_ca_topic_score_gemma":0.015314039,"teacher_disagreement_score":0.03575373,"about_ca_system_score_codex":0.002640231,"about_ca_system_score_gemma":0.019883879,"threshold_uncertainty_score":0.18908602},"labels":[],"label_agreement":null},{"id":"W2574948240","doi":"10.1002/cpt.575","title":"Designer Drugs 2.0","year":2017,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institutes of Health","keywords":"Synthetic cannabinoids; Hallucinogen; Pharmacology; Psilocybin; Designer drug; Medicine; Repurposing; Psychosis; Cannabinoid Receptor Agonists; Lysergic acid diethylamide; Neuropharmacology; Cannabinoid; Drug; Psychology; Psychiatry; Cannabinoid receptor; Receptor; Serotonin","score_opus":0.09317065327596848,"score_gpt":0.4980223541213104,"score_spread":0.40485170084534194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574948240","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006622779,0.021275666,0.0003854089,0.027960615,0.9157627,0.000057280067,0.00008441631,0.00034995243,0.034057662],"genre_scores_gemma":[0.00066583575,0.027457748,0.00041424064,0.069704115,0.74646926,0.00007052588,0.0001722385,0.00017056061,0.1548755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99624383,0.00063846237,0.00040238388,0.00050067797,0.0019399141,0.00027471696],"domain_scores_gemma":[0.9933448,0.0023259912,0.0006867481,0.00043644602,0.0018551352,0.0013510142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030182018,0.002821463,0.0021699322,0.0020563614,0.0018657037,0.007181589,0.002762942,0.011141938,0.086487256],"category_scores_gemma":[0.0092855515,0.00093924155,0.0015958027,0.0011156369,0.0025082345,0.0057855896,0.0025920714,0.013060553,0.08683524],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002395454,0.00002917836,0.000026923133,0.00026049654,0.0000059862314,0.000074780066,0.000011832071,0.000024614736,0.00013314078,0.0013841236,0.96907914,0.028945766],"study_design_scores_gemma":[0.000009122853,0.0000100002,0.000027609229,0.0000874433,0.0000022132049,0.00006238989,0.000007763381,0.000017877494,0.00002494438,0.0003038642,0.999443,0.000003651576],"about_ca_topic_score_codex":0.0006732213,"about_ca_topic_score_gemma":0.0018252002,"teacher_disagreement_score":0.086487256,"about_ca_system_score_codex":0.0021490045,"about_ca_system_score_gemma":0.0027363603,"threshold_uncertainty_score":0.2893287},"labels":[],"label_agreement":null},{"id":"W2581158237","doi":"10.1002/cpt.635","title":"Improving Medicine Use for Children: A Global Imperative","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Low and middle income countries; Medical education; Family medicine; Intensive care medicine; Developing country; Economic growth","score_opus":0.29269317816025386,"score_gpt":0.5600611820816216,"score_spread":0.2673680039213677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581158237","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007623041,0.08149693,0.0018193165,0.88431364,0.0026379067,0.00003712269,0.0008665892,0.00024987673,0.020955583],"genre_scores_gemma":[0.22300069,0.39334783,0.021569988,0.32705164,0.01794343,0.00027817686,0.0025785824,0.0002554063,0.013974283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99557424,0.0016014979,0.00041833209,0.0003935518,0.0012195894,0.0007927464],"domain_scores_gemma":[0.9655289,0.010164362,0.004334723,0.0012633267,0.0066243475,0.012084393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00849474,0.00088409067,0.0011414373,0.0016658233,0.0013318456,0.004780376,0.0018071772,0.0052312533,0.021305367],"category_scores_gemma":[0.015022055,0.0002974728,0.00076459214,0.002653761,0.0033844989,0.006646079,0.006405627,0.007890864,0.0045141596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013948376,0.00042518263,0.03220328,0.0032796306,0.00010814074,0.00062944496,0.0013143424,0.0005006489,0.0016801793,0.028639099,0.4198465,0.51123405],"study_design_scores_gemma":[0.000034600624,0.00026816694,0.054937486,0.004714893,0.00007920101,0.0019094291,0.004145663,0.00027926976,0.00053287286,0.013009004,0.9200299,0.000059503465],"about_ca_topic_score_codex":0.009152029,"about_ca_topic_score_gemma":0.009232681,"teacher_disagreement_score":0.021305367,"about_ca_system_score_codex":0.0033256302,"about_ca_system_score_gemma":0.019311422,"threshold_uncertainty_score":0.071273506},"labels":[],"label_agreement":null},{"id":"W2591531144","doi":"10.1002/cpt.673","title":"Response to “PPARδ Modulation by GW501516: An Unsuccessful Exercise Mimetic”","year":2017,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Beijing; Citation; China; Library science; Sports medicine; Peroxisome proliferator; Medicine; Psychology; Computer science; Political science; Internal medicine; Physical therapy; Peroxisome proliferator-activated receptor","score_opus":0.11218188674188513,"score_gpt":0.4648383322771874,"score_spread":0.3526564455353023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591531144","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038245225,0.0014569376,0.00032772298,0.9702435,0.01857336,0.00006693239,0.00015324133,0.0001029003,0.0052508563],"genre_scores_gemma":[0.01932919,0.0015853426,0.0005425691,0.93747866,0.03168484,0.000114969225,0.0001192421,0.000040298994,0.009104886],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878746,0.00034274772,0.00016032734,0.00014953318,0.00030008986,0.0002598927],"domain_scores_gemma":[0.9980509,0.0010608946,0.00020971308,0.0000717313,0.00028246312,0.00032425625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001475258,0.0009267521,0.0010591712,0.00035223053,0.001992248,0.001940991,0.0009778739,0.025000343,0.00351907],"category_scores_gemma":[0.012336198,0.00038493465,0.0013222408,0.00035090747,0.0012948655,0.001145862,0.00097172335,0.019959737,0.0034115305],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063164276,0.00023064936,0.0015229495,0.00016797775,0.000088471556,0.033066172,0.00027522206,0.00052011607,0.0018019646,0.005498363,0.9219367,0.034259792],"study_design_scores_gemma":[0.0014782079,0.001270252,0.0032085073,0.00047677904,0.0002176173,0.02495283,0.00078142254,0.002946754,0.002761045,0.016807368,0.94496167,0.00013758814],"about_ca_topic_score_codex":0.0015667396,"about_ca_topic_score_gemma":0.0019951805,"teacher_disagreement_score":0.025000343,"about_ca_system_score_codex":0.0029703348,"about_ca_system_score_gemma":0.0017415663,"threshold_uncertainty_score":0.02155143},"labels":[],"label_agreement":null},{"id":"W2605398561","doi":"","title":"St Johns wort reduces oral bioavailability of talinolol in healthy volunteers","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Natural Products and Biological Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioavailability; Medicine; Pharmacology; Traditional medicine","score_opus":0.2927404578473435,"score_gpt":0.49873534345682036,"score_spread":0.20599488560947687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605398561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986082,0.00047784936,0.00009202301,0.00006631938,0.000033198812,0.00002381083,0.00011630481,0.000031289554,0.0005510497],"genre_scores_gemma":[0.9977714,0.0003152782,0.00011192435,0.00007908179,0.00004710046,0.000012583171,0.00016344815,0.0000056727126,0.001493619],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99987316,0.000038576483,0.000009548586,0.000026184782,0.000021965592,0.000030570343],"domain_scores_gemma":[0.99974865,0.00007226716,0.00004721955,0.000019540803,0.000027167052,0.00008512692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021219511,0.00042881872,0.0005485156,0.00026661408,0.00023799649,0.00023022338,0.00015874712,0.0004458157,0.0037329828],"category_scores_gemma":[0.00071689684,0.00022532156,0.0002610835,0.00009478971,0.00015628146,0.00016823933,0.00014587371,0.00037146194,0.0005584075],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37008116,0.010939048,0.10618821,0.00074719626,0.0007980243,0.0021623152,0.00090828864,0.00031422905,0.36535314,0.00017343035,0.0047275354,0.13760746],"study_design_scores_gemma":[0.008353532,0.13852054,0.79989177,0.00005879279,0.00097298075,0.0018822291,0.0007224985,0.0018831994,0.04488823,0.00018176848,0.0025924325,0.000052046813],"about_ca_topic_score_codex":0.0018596674,"about_ca_topic_score_gemma":0.0022668778,"teacher_disagreement_score":0.0037329828,"about_ca_system_score_codex":0.00013250513,"about_ca_system_score_gemma":0.0001724436,"threshold_uncertainty_score":0.012488067},"labels":[],"label_agreement":null},{"id":"W2608178729","doi":"10.1002/cpt.677","title":"Adverse Drug Reactions in Children: The Double‐Edged Sword of Therapeutics","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Drug reaction; Epidemiology; Drug; Intensive care medicine; Population; Incidence (geometry); Pediatrics; Pharmacology; Internal medicine; Environmental health","score_opus":0.4612497991793427,"score_gpt":0.5873537751746787,"score_spread":0.12610397599533596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608178729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015386657,0.9979469,0.00008975445,0.00065788993,0.00016232372,0.0000044821577,0.000023444638,0.0000067364517,0.00095447496],"genre_scores_gemma":[0.0009583542,0.99810493,0.00015285345,0.00031590313,0.00019658262,0.0000036090587,0.000020820975,0.0000014497996,0.0002455917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913764,0.00019641533,0.00017157273,0.000090331705,0.00036158814,0.000042413358],"domain_scores_gemma":[0.99822587,0.0010864383,0.00029436738,0.000036115878,0.0002924802,0.00006466862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008420544,0.00063933333,0.0014425609,0.0017780226,0.00028279552,0.0013600296,0.0006674964,0.0010666293,0.0036046216],"category_scores_gemma":[0.002532959,0.00021840069,0.0008569256,0.0018879034,0.00064665213,0.0014124803,0.0006616088,0.0021383956,0.00090202026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057276866,0.000041279738,0.0010016088,0.024826325,0.00019082623,0.00035999622,0.00015550532,0.00014127695,0.00040793678,0.0034010329,0.028077744,0.9413392],"study_design_scores_gemma":[0.000026968384,0.000115211085,0.0044302717,0.026479134,0.0003626462,0.0071129384,0.00027259736,0.00009832878,0.00036704558,0.0033514337,0.95735055,0.000032938027],"about_ca_topic_score_codex":0.0016803346,"about_ca_topic_score_gemma":0.0027679102,"teacher_disagreement_score":0.0036046216,"about_ca_system_score_codex":0.00063949917,"about_ca_system_score_gemma":0.0017805361,"threshold_uncertainty_score":0.012058675},"labels":[],"label_agreement":null},{"id":"W2614410056","doi":"10.1002/cpt.675","title":"Drugs for Children","year":2017,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Clinical pharmacology; Medicine; Orphan drug; SAFER; Global health; Drug; Population; Intensive care medicine; Pharmacology; Environmental health; Public health; Bioinformatics; Biology; Pathology","score_opus":0.15219260213663838,"score_gpt":0.5431166467122077,"score_spread":0.39092404457556934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614410056","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058531583,0.09166351,0.00022836844,0.06491552,0.8343424,0.000036204816,0.00008635561,0.000114274044,0.008554785],"genre_scores_gemma":[0.0007724468,0.10304815,0.00044994807,0.08820903,0.7679858,0.000054962824,0.0001087907,0.000071747345,0.03929911],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971426,0.00054370443,0.0004367026,0.00029719475,0.001424232,0.00015544909],"domain_scores_gemma":[0.99212945,0.003946382,0.00070532976,0.0003742254,0.0018458407,0.0009987742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003807092,0.0018647877,0.001599443,0.001854576,0.001501923,0.0043214103,0.0022628724,0.00912424,0.01612812],"category_scores_gemma":[0.01498506,0.00064968277,0.0015887136,0.00084546494,0.0017155029,0.0042448123,0.0016138331,0.01894479,0.015251908],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014967663,0.000011890026,0.000021552407,0.00037127308,0.0000102711165,0.00007951066,0.000018035089,0.000023075525,0.00006050266,0.0012499555,0.97002554,0.02811355],"study_design_scores_gemma":[0.0000108565955,0.000008481347,0.000052304644,0.0003006717,0.0000064010005,0.00014321505,0.000010238384,0.00001578261,0.000022899858,0.000579267,0.99884653,0.0000034270195],"about_ca_topic_score_codex":0.0013396223,"about_ca_topic_score_gemma":0.0036998948,"teacher_disagreement_score":0.01612812,"about_ca_system_score_codex":0.00231584,"about_ca_system_score_gemma":0.0031020406,"threshold_uncertainty_score":0.053953946},"labels":[],"label_agreement":null},{"id":"W2614636769","doi":"10.1002/cpt.676","title":"Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health","keywords":"Lactation; Food and drug administration; Medicine; Breastfeeding; Environmental health; Pregnancy; Pediatrics; Biology","score_opus":0.5132854166828362,"score_gpt":0.5604566358928957,"score_spread":0.04717121921005951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614636769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018356518,0.98740035,0.00052409753,0.0041998816,0.0010337064,0.00022044875,0.00016683678,0.000012268972,0.004606698],"genre_scores_gemma":[0.005319405,0.98975337,0.00068687025,0.001220542,0.00055624655,0.00013986698,0.00016468701,0.0000037983434,0.002155292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984825,0.0005100641,0.0002715821,0.00010352536,0.00055176864,0.000080524354],"domain_scores_gemma":[0.9973896,0.0010702693,0.00035101915,0.00006362652,0.0010283226,0.00009720297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058686677,0.0006829076,0.00091813895,0.0013553016,0.0002501994,0.0010390521,0.0009615464,0.0013324934,0.0029976775],"category_scores_gemma":[0.004344609,0.0002639322,0.0009880117,0.0010286013,0.0002695953,0.00115688,0.00094222673,0.0013548292,0.0010079128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021361893,0.00027751058,0.00037888956,0.052255303,0.00022570317,0.00037209343,0.00042935734,0.00032494066,0.0036494797,0.0028325117,0.03615151,0.9028891],"study_design_scores_gemma":[0.000060900744,0.0009616793,0.0022806854,0.04274911,0.00045370078,0.0011667695,0.00042690075,0.00008042349,0.0045537706,0.0010906631,0.94613415,0.00004124588],"about_ca_topic_score_codex":0.0010465836,"about_ca_topic_score_gemma":0.0018536564,"teacher_disagreement_score":0.0058686677,"about_ca_system_score_codex":0.00070229993,"about_ca_system_score_gemma":0.0027591307,"threshold_uncertainty_score":0.031036854},"labels":[],"label_agreement":null},{"id":"W2614866669","doi":"10.1016/j.clpt.2005.12.016","title":"OII-B-3Effect of maternal inflammation on the expression of ABCB1 and ABCG2 in placenta","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Transplacental; Placenta; Abcg2; Fetus; P-glycoprotein; Inflammation; Internal medicine; Endocrinology; Pharmacology; Efflux; Transporter; Andrology; Medicine; Biology; ATP-binding cassette transporter; Pregnancy; Drug resistance; Multiple drug resistance; Biochemistry","score_opus":0.0623512798074885,"score_gpt":0.42085504127187257,"score_spread":0.35850376146438406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614866669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806506,0.012459274,0.0018435421,0.000540548,0.000116120864,0.00004111865,0.00068966293,0.00009222045,0.0035669233],"genre_scores_gemma":[0.9860582,0.0048495247,0.0013612824,0.00025028206,0.00004005452,0.0000987835,0.0007940718,0.000023209275,0.0065245475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979407,0.000032977878,0.000015358708,0.0000340177,0.000042526142,0.00008101475],"domain_scores_gemma":[0.9998685,0.000020315067,0.00004232324,0.00001255956,0.000022439901,0.00003387713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020761449,0.00024527076,0.00037232824,0.00026046069,0.00016300942,0.0004859827,0.00012414271,0.00030930524,0.003903898],"category_scores_gemma":[0.00022417451,0.00020879527,0.0002511049,0.00019248226,0.00024887777,0.00017138236,0.00024076129,0.00076996,0.0005935749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014800266,0.0000725569,0.0015978198,0.00015940239,0.00001476883,0.00024034019,0.00008537421,0.00003091229,0.99083734,0.00024204483,0.00016172696,0.00507782],"study_design_scores_gemma":[0.00013975691,0.0033353623,0.08172007,0.000097693606,0.00014378625,0.001899913,0.00060324604,0.00093835074,0.8938424,0.0004409622,0.016817246,0.000021197191],"about_ca_topic_score_codex":0.0010033131,"about_ca_topic_score_gemma":0.00077560934,"teacher_disagreement_score":0.003903898,"about_ca_system_score_codex":0.00042475195,"about_ca_system_score_gemma":0.0003218812,"threshold_uncertainty_score":0.0130598545},"labels":[],"label_agreement":null},{"id":"W2619242792","doi":"10.1002/cpt.697","title":"Psilocybin: Good Trip or Bad Trip","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Psilocybin; Clinical pharmacology; Medicine; Hallucinogen; Pharmacology; Psychology","score_opus":0.34652269791209483,"score_gpt":0.5706991515937575,"score_spread":0.22417645368166267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619242792","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14545292,0.2767925,0.0074790632,0.15866666,0.037044693,0.00032329248,0.0054427045,0.0015894965,0.3672087],"genre_scores_gemma":[0.62581336,0.15280533,0.0061024865,0.053692065,0.0068665775,0.00018540607,0.0018987446,0.00029800748,0.15233798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986637,0.000038458606,0.000012148843,0.000025351703,0.000037453596,0.000020233621],"domain_scores_gemma":[0.9998342,0.00003307,0.000034821787,0.000020702277,0.00002475433,0.000052376035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035985978,0.00034183834,0.0002916683,0.00026728908,0.000543116,0.0006399058,0.00026523636,0.0007292183,0.024881149],"category_scores_gemma":[0.00059794396,0.00007588023,0.00018271296,0.000234466,0.00084578,0.0008812967,0.0005127007,0.0014233291,0.006575363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004350439,0.0002928041,0.0020027207,0.0023232733,0.00015182844,0.0009174897,0.00026370885,0.0001374163,0.031125097,0.026220217,0.24716973,0.6850452],"study_design_scores_gemma":[0.00037599882,0.0030281425,0.012592937,0.0007215086,0.00011620351,0.0037025071,0.00065602915,0.00013614113,0.012604833,0.017820407,0.94818234,0.00006300258],"about_ca_topic_score_codex":0.0005003435,"about_ca_topic_score_gemma":0.0010450667,"teacher_disagreement_score":0.024881149,"about_ca_system_score_codex":0.00027881455,"about_ca_system_score_gemma":0.00023259124,"threshold_uncertainty_score":0.08323574},"labels":[],"label_agreement":null},{"id":"W2624697901","doi":"10.1002/cpt.708","title":"Within Our Skin","year":2017,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dermatology","score_opus":0.09090138755619306,"score_gpt":0.4903581688068058,"score_spread":0.3994567812506128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624697901","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050285846,0.038315043,0.000121779936,0.044692095,0.91237247,0.000011829465,0.000028044213,0.000056875517,0.0043514255],"genre_scores_gemma":[0.0009452514,0.045838084,0.0001474278,0.058264203,0.8690075,0.000019294144,0.000037437898,0.000044833883,0.025695821],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796695,0.00042895437,0.00025626546,0.0002974969,0.00091564126,0.0001346851],"domain_scores_gemma":[0.9973622,0.0011497644,0.00016300294,0.00014312514,0.0008291582,0.00035276863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021150662,0.002432965,0.001666611,0.0011794491,0.0018546369,0.005125283,0.0020285696,0.008880873,0.017386025],"category_scores_gemma":[0.0070666554,0.0006037082,0.0014597401,0.00056410045,0.0031718127,0.004987615,0.002000168,0.022745674,0.01631999],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017343325,0.0000074941167,0.00002048384,0.0003552297,0.000008195931,0.00011842487,0.000037246344,0.000012950649,0.00009461042,0.0011814337,0.9812564,0.016890211],"study_design_scores_gemma":[0.000008957622,0.000010264305,0.00006289155,0.0002751177,0.000007842509,0.0002464535,0.00004004704,0.000013373524,0.000054147335,0.00057614606,0.99870026,0.000004562527],"about_ca_topic_score_codex":0.0010373179,"about_ca_topic_score_gemma":0.002052666,"teacher_disagreement_score":0.017386025,"about_ca_system_score_codex":0.0016365133,"about_ca_system_score_gemma":0.0018609955,"threshold_uncertainty_score":0.058162034},"labels":[],"label_agreement":null},{"id":"W2734427898","doi":"10.1002/cpt.747","title":"Fecal Microbial Transplantation in Inflammatory Bowel Disease: A Movement Too Big to Be Ignored","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of Alberta","funders":"","keywords":"Inflammatory bowel disease; Fecal bacteriotherapy; Medicine; Feces; Disease; Transplantation; Ulcerative colitis; Intensive care medicine; Clinical trial; Immunology; Internal medicine; Biology; Antibiotics; Microbiology","score_opus":0.1205949463531807,"score_gpt":0.43800236333091347,"score_spread":0.3174074169777328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734427898","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014677274,0.5843721,0.0012490647,0.3989881,0.010089035,0.000013808781,0.000075735225,0.00007271871,0.003671678],"genre_scores_gemma":[0.033549026,0.76718074,0.0036929068,0.13068305,0.05899214,0.00004932944,0.00010157425,0.00012574316,0.0056255516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965076,0.001831059,0.0004054801,0.00027029766,0.0008377629,0.00014781568],"domain_scores_gemma":[0.98247266,0.0105750775,0.0010364294,0.0011627023,0.0033111128,0.0014420416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01204905,0.0005899978,0.002286885,0.0010090114,0.0010061839,0.003686138,0.0012031822,0.004947629,0.005643169],"category_scores_gemma":[0.014354879,0.00019963525,0.00075560686,0.0012433721,0.0049341205,0.0072912653,0.0018841317,0.010049741,0.0030799974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010912456,0.0002142275,0.0020973515,0.003609206,0.00017001863,0.00037078772,0.00021224703,0.0002606885,0.0014048184,0.026940983,0.21743979,0.7461886],"study_design_scores_gemma":[0.00053960184,0.0020874315,0.0068019624,0.014849471,0.00036667302,0.0024238876,0.001208025,0.0007311299,0.0010009075,0.088724636,0.8810928,0.00017345515],"about_ca_topic_score_codex":0.0017194581,"about_ca_topic_score_gemma":0.0032909298,"teacher_disagreement_score":0.01204905,"about_ca_system_score_codex":0.0013627543,"about_ca_system_score_gemma":0.0032597557,"threshold_uncertainty_score":0.06372225},"labels":[],"label_agreement":null},{"id":"W2745723818","doi":"10.1002/cpt.776","title":"Psychedelic Drugs as Therapeutics: No Illusions About the Challenges","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; Uniformed Services University of the Health Sciences; University of Michigan","keywords":"Psilocybin; Psychotomimetic; Hallucinogen; Illusion; Variety (cybernetics); Pharmacology; Medicine; Psychology; Neuroscience; Computer science; Artificial intelligence","score_opus":0.2882514157639476,"score_gpt":0.5342440168939404,"score_spread":0.24599260112999283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745723818","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016332618,0.2872911,0.0032464801,0.67544997,0.014054273,0.000023306286,0.00006169756,0.000108381755,0.018131424],"genre_scores_gemma":[0.10184963,0.40968123,0.010021585,0.39498776,0.06341514,0.00019469897,0.000089705594,0.00021382091,0.019546492],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99135536,0.0042276806,0.0006336198,0.0006861039,0.0027435399,0.00035367568],"domain_scores_gemma":[0.96740115,0.019711861,0.0017905012,0.0036160685,0.0048723626,0.0026080299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026017254,0.0012157185,0.002300639,0.0016985874,0.003473048,0.010152249,0.0024462475,0.010335925,0.0060981633],"category_scores_gemma":[0.024930308,0.00056261953,0.00072196795,0.0008586105,0.040789906,0.02513477,0.006471799,0.028395683,0.00378665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054644956,0.00032341565,0.00093041384,0.002506881,0.00012256185,0.0004609088,0.0020942448,0.00040350997,0.0019132701,0.58954686,0.16298546,0.238166],"study_design_scores_gemma":[0.00012987916,0.00032845125,0.0006909981,0.002171833,0.000067366156,0.00067293184,0.0019779566,0.0003615587,0.00079280237,0.41703653,0.57566524,0.00010441848],"about_ca_topic_score_codex":0.001652314,"about_ca_topic_score_gemma":0.0029218171,"teacher_disagreement_score":0.026017254,"about_ca_system_score_codex":0.0028738668,"about_ca_system_score_gemma":0.004467593,"threshold_uncertainty_score":0.13759398},"labels":[],"label_agreement":null},{"id":"W2751834855","doi":"10.1002/cpt.860","title":"Safety and Ergogenic Properties of Combined Aminophylline and Ambrisentan in Hypoxia","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"High Altitude and Hypoxia","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences; Defense Advanced Research Projects Agency; National Institutes of Health; Office of Naval Research; Gilead Sciences","keywords":"Aminophylline; Ambrisentan; Medicine; Hypoxia (environmental); Placebo; Pharmacology; Anesthesia; Internal medicine; Endothelin receptor; Bosentan; Oxygen; Chemistry","score_opus":0.05968574799120665,"score_gpt":0.36452549010356194,"score_spread":0.3048397421123553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751834855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995837,0.0025649115,0.0006719728,0.00008330429,0.000025524936,0.00005973126,0.00005736121,0.00001989517,0.000680331],"genre_scores_gemma":[0.9983713,0.00060746184,0.00051974354,0.000050799114,0.000052728446,0.000037099308,0.000050556107,0.0000029958346,0.00030731445],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99973637,0.00013191208,0.000018660447,0.000029609666,0.00006390274,0.000019556037],"domain_scores_gemma":[0.99979275,0.00005038802,0.00006286033,0.000023944935,0.000022217177,0.00004794491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036231763,0.00023097158,0.00055732916,0.00016373504,0.00017632112,0.00018671792,0.00023912944,0.00031759022,0.0009862747],"category_scores_gemma":[0.00040367988,0.00009770357,0.00020114642,0.000098839504,0.00023940434,0.00022265888,0.0001236062,0.0003780082,0.00015489048],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07987787,0.0036287964,0.00817533,0.000524372,0.00042951244,0.0005713715,0.0001271557,0.00066235394,0.8012578,0.0002127263,0.0002818687,0.10425089],"study_design_scores_gemma":[0.013961689,0.47024402,0.12269805,0.00013233988,0.0011521912,0.003892445,0.00027079694,0.0038114905,0.37505236,0.00027464252,0.008469829,0.00004018824],"about_ca_topic_score_codex":0.00023100528,"about_ca_topic_score_gemma":0.0005890875,"teacher_disagreement_score":0.0009862747,"about_ca_system_score_codex":0.0001115554,"about_ca_system_score_gemma":0.0001976296,"threshold_uncertainty_score":0.003299415},"labels":[],"label_agreement":null},{"id":"W2754167240","doi":"10.1002/cpt.885","title":"Note of Republication: A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Drug; Medicine; Pharmacology; Internal medicine; Family medicine","score_opus":0.11355134187311544,"score_gpt":0.5072650220054349,"score_spread":0.39371368013231944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754167240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734086,0.00018729123,0.00013716822,0.0001229969,0.000010478962,0.00005876414,0.0011986603,0.0000054161496,0.0009382417],"genre_scores_gemma":[0.99831176,0.000056331388,0.00012938197,0.00016273063,0.000013244734,0.000045053075,0.0009137982,0.0000036416766,0.00036400137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843186,0.0005822809,0.0002543666,0.00022159646,0.0003143624,0.00019552014],"domain_scores_gemma":[0.99540734,0.00070468377,0.0021967443,0.00060445844,0.00039585406,0.0006909594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021743507,0.0003083751,0.00060953957,0.00085556554,0.00080521073,0.0009335104,0.0004231387,0.0008072878,0.00198836],"category_scores_gemma":[0.0039163786,0.00033827036,0.00074699044,0.0014677221,0.000370226,0.00088423636,0.00051960687,0.0014371414,0.00065563637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002838054,0.00015998071,0.9979054,0.000009531949,0.000051161194,0.00003954381,0.00019645842,0.000022697168,0.00011440832,0.000016664506,0.00014733462,0.0010529963],"study_design_scores_gemma":[0.000024713718,0.00026078886,0.9990262,0.000005107445,0.000023203374,0.00009321951,0.000143296,0.000114840666,0.000043813692,0.000011356536,0.00024740567,0.0000062370445],"about_ca_topic_score_codex":0.006292093,"about_ca_topic_score_gemma":0.0056399056,"teacher_disagreement_score":0.006292093,"about_ca_system_score_codex":0.00048338648,"about_ca_system_score_gemma":0.000454578,"threshold_uncertainty_score":0.012510955},"labels":[],"label_agreement":null},{"id":"W2761667289","doi":"10.1002/cpt.807","title":"Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; U.S. Food and Drug Administration; National Institutes of Health","keywords":"CYP2C8; CYP2C9; CYP2C19; CYP1A2; Pharmacology; CYP3A4; Cytochrome P450; Tolbutamide; Pharmacokinetics; CYP2D6; Chemistry; Kidney disease; Medicine; Biochemistry; Metabolism; Internal medicine","score_opus":0.1731719731352774,"score_gpt":0.537432668628869,"score_spread":0.3642606954935915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761667289","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26045725,0.72835314,0.0067391973,0.0007378299,0.00007849535,0.00007752087,0.0011268806,0.000040470422,0.002389173],"genre_scores_gemma":[0.8143086,0.17720935,0.0053483546,0.0008381546,0.00020665098,0.00007005546,0.0011948699,0.000052755513,0.0007712935],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966899,0.0013271377,0.00061049376,0.0006913642,0.00059912296,0.00008205335],"domain_scores_gemma":[0.988649,0.0063552163,0.0023314352,0.00088201975,0.0015671201,0.00021513538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055369395,0.00037115236,0.001213422,0.0017839838,0.0002923774,0.0010432567,0.0002461066,0.00033890188,0.00094921625],"category_scores_gemma":[0.0058931913,0.00019591159,0.001882373,0.0031401122,0.0004568103,0.0006764763,0.00066631834,0.00052519125,0.00016328837],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001877122,0.00008839435,0.55432916,0.008382034,0.0099293785,0.00042174727,0.00037660918,0.0006403511,0.00798079,0.0005703991,0.0009931879,0.41441077],"study_design_scores_gemma":[0.00006661864,0.0011186103,0.9343912,0.0019772183,0.0155526865,0.0029642342,0.00022056383,0.0008461666,0.006172047,0.00057594414,0.03606651,0.000048318914],"about_ca_topic_score_codex":0.001764007,"about_ca_topic_score_gemma":0.0033365854,"teacher_disagreement_score":0.0055369395,"about_ca_system_score_codex":0.0004165088,"about_ca_system_score_gemma":0.0009686406,"threshold_uncertainty_score":0.02928251},"labels":[],"label_agreement":null},{"id":"W2767469906","doi":"10.1002/cpt.890","title":"Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Human Genome Research Institute; National Institutes of Health; National Cancer Institute; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Toxic epidermal necrolysis; Drug reaction; Medicine; Incidence (geometry); Drug; Dermatology; Genetic predisposition; Complication; Intensive care medicine; Allele; Surgery; Pharmacology; Internal medicine; Genetics; Disease; Biology","score_opus":0.4810342900692436,"score_gpt":0.6054057728166243,"score_spread":0.12437148274738075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767469906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007591442,0.9985562,0.00006872426,0.0005022844,0.00015564184,0.000003026559,0.000014715643,0.000004923659,0.0006186012],"genre_scores_gemma":[0.00044078357,0.9988256,0.00012320165,0.00024262606,0.00013140611,0.0000033092942,0.000018078985,7.937044e-7,0.00021417474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997317,0.00006508393,0.000045604513,0.000049217357,0.00008574872,0.000022458216],"domain_scores_gemma":[0.99904484,0.00059604214,0.00010861957,0.000021922002,0.00017608365,0.000052456613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010194542,0.0006086595,0.0012170718,0.0024573444,0.00023153162,0.0010513564,0.0008097251,0.0011899762,0.0064422153],"category_scores_gemma":[0.0013282367,0.00020929197,0.00079409976,0.0020969433,0.00045968613,0.0015092726,0.0006206553,0.0019012422,0.0016164328],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076536635,0.00009185885,0.00035404242,0.034641054,0.00013842351,0.0003023032,0.0000944159,0.00025966688,0.0010053549,0.0055766115,0.025333805,0.93212587],"study_design_scores_gemma":[0.000028412798,0.00011798777,0.0011379864,0.013872533,0.00026918418,0.0017251611,0.00012976515,0.00007092866,0.000289465,0.0042571877,0.9780814,0.000019977082],"about_ca_topic_score_codex":0.0010536044,"about_ca_topic_score_gemma":0.0018269818,"teacher_disagreement_score":0.0064422153,"about_ca_system_score_codex":0.00047695645,"about_ca_system_score_gemma":0.0014636576,"threshold_uncertainty_score":0.02155137},"labels":[],"label_agreement":null},{"id":"W2770199471","doi":"10.1002/cpt.921","title":"Commentary on “The Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio”","year":2017,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clinical pharmacology; Pharmacokinetics; Clearance; Drug; Metabolic clearance rate; Drug development; Subject (documents); Pharmacology; Medicine; Intensive care medicine; Nothing; Computer science; Epistemology; Philosophy; Urology","score_opus":0.2219440488571743,"score_gpt":0.4991478039572035,"score_spread":0.27720375510002915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770199471","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013407826,0.0010335314,0.00008198142,0.9706104,0.02703843,0.00001024569,0.00007102321,0.000022462355,0.0009978375],"genre_scores_gemma":[0.0009834537,0.0005553464,0.00009895797,0.9645972,0.032136124,0.000024379344,0.000022016335,0.000016375541,0.0015661122],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99474573,0.0015776535,0.0006928957,0.00085573766,0.0016217123,0.000506284],"domain_scores_gemma":[0.9874966,0.007573749,0.00086742325,0.0002879706,0.0026344631,0.0011397976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058024414,0.0012242211,0.0017547823,0.0008180595,0.0035861542,0.0029129607,0.0038041256,0.055915594,0.0049194377],"category_scores_gemma":[0.034038488,0.0010226391,0.0017875666,0.0008899838,0.003934914,0.0048260973,0.0014784603,0.05438742,0.009025558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036080553,0.000010667672,0.00010584327,0.000029613066,0.00000489834,0.00051749055,0.00005752162,0.00003058186,0.00006638211,0.0008621951,0.9962999,0.0019789378],"study_design_scores_gemma":[0.0001572243,0.000079843536,0.00088546495,0.00053932826,0.00004330994,0.0022193878,0.0003737877,0.00050773687,0.0005339087,0.011108831,0.9834411,0.00011009416],"about_ca_topic_score_codex":0.007798569,"about_ca_topic_score_gemma":0.009519005,"teacher_disagreement_score":0.055915594,"about_ca_system_score_codex":0.005482227,"about_ca_system_score_gemma":0.007169581,"threshold_uncertainty_score":0.039776504},"labels":[],"label_agreement":null},{"id":"W2773691289","doi":"10.1002/cpt.973","title":"Food Effect on Rosuvastatin Disposition and Low‐Density Lipoprotein Cholesterol","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Rosuvastatin; Medicine; Rosuvastatin Calcium; Internal medicine; Endocrinology; Cholesterol; Low-density lipoprotein; Pharmacology","score_opus":0.05393566413035072,"score_gpt":0.4060748040629718,"score_spread":0.3521391399326211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773691289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950397,0.00020949608,0.000045372,0.000012843917,0.000003603098,0.0000037037848,0.000053370095,0.0000035096907,0.00016409965],"genre_scores_gemma":[0.99919456,0.00009042434,0.00013568698,0.000021587484,0.0000035343828,0.000005120543,0.00009000012,0.0000027932351,0.00045616846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984753,0.000052817748,0.000011182663,0.00002772475,0.000028688015,0.000031932243],"domain_scores_gemma":[0.9996793,0.000060510214,0.00012564784,0.000033977907,0.000028406908,0.00007228669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019169322,0.00017787126,0.00029524803,0.00024937015,0.00014640782,0.00027539016,0.00007097127,0.00019406859,0.0013899349],"category_scores_gemma":[0.00044997167,0.00012355918,0.00027998158,0.00019909863,0.00020593357,0.00015270295,0.00014526794,0.00030254218,0.00021617893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06618673,0.0022961174,0.29126158,0.00017128047,0.00046201158,0.0005832345,0.0003211374,0.00019978477,0.6065953,0.00016387006,0.00024246052,0.031516522],"study_design_scores_gemma":[0.000295127,0.01702943,0.9169994,0.00001461254,0.00027660598,0.0006612123,0.00016597903,0.00056907244,0.06252052,0.00011158682,0.001332416,0.000023977036],"about_ca_topic_score_codex":0.00048470768,"about_ca_topic_score_gemma":0.0007738785,"teacher_disagreement_score":0.0013899349,"about_ca_system_score_codex":0.00015973423,"about_ca_system_score_gemma":0.00013661142,"threshold_uncertainty_score":0.0046497583},"labels":[],"label_agreement":null},{"id":"W2792603962","doi":"10.1002/cpt.1078","title":"Dosing of Ceftriaxone and Metronidazole for Children With Severe Acute Malnutrition","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Department for International Development; University College London; Great Ormond Street Hospital for Children; Wellcome Trust; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Bill and Melinda Gates Foundation","keywords":"Ceftriaxone; Metronidazole; Pharmacokinetics; Medicine; Dosing; Antibiotics; Volume of distribution; Pharmacology; Antibacterial agent; Cmax; Population; Internal medicine; Gastroenterology; Microbiology; Biology","score_opus":0.06454998006914155,"score_gpt":0.42406018583241323,"score_spread":0.3595102057632717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792603962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932133,0.003054101,0.0023202377,0.0002823056,0.000027496384,0.0001328815,0.0001492129,0.00005817511,0.0007622099],"genre_scores_gemma":[0.9946532,0.0010770579,0.003794925,0.0000489601,0.000014918947,0.00008413525,0.00011907231,0.000007010131,0.0002007297],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99955183,0.00019613394,0.00004165758,0.00003802045,0.00013296664,0.000039334147],"domain_scores_gemma":[0.9995234,0.00013439129,0.00022742696,0.000024349594,0.000027051585,0.00006338976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043059955,0.00026177318,0.0005050005,0.00021045981,0.00016573982,0.0002895203,0.00031851354,0.00035847427,0.0006658394],"category_scores_gemma":[0.0025621804,0.00016515392,0.0003504551,0.00023172196,0.00021070476,0.00024213953,0.00030774102,0.00058318564,0.00018295685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032111708,0.002879379,0.20468983,0.0012395326,0.00047812308,0.00200813,0.0010331783,0.021877998,0.083095975,0.0012229834,0.0038057382,0.6455574],"study_design_scores_gemma":[0.006156072,0.113107555,0.6236622,0.0005546354,0.00078529527,0.011143444,0.0010118058,0.06068966,0.124508746,0.0015378606,0.05667628,0.00016656258],"about_ca_topic_score_codex":0.0014264461,"about_ca_topic_score_gemma":0.001913558,"teacher_disagreement_score":0.0014264461,"about_ca_system_score_codex":0.00054802565,"about_ca_system_score_gemma":0.00073096954,"threshold_uncertainty_score":0.0039761662},"labels":[],"label_agreement":null},{"id":"W2793349513","doi":"10.1002/cpt.1048","title":"Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"U.S. National Library of Medicine; National Institute of General Medical Sciences; National Cancer Institute; National Human Genome Research Institute","keywords":"Pharmacogenomics; Harm; Precision medicine; Matching (statistics); Dosing; Medicine; Pharmacogenetics; Intensive care medicine; Computer science; Data science; Pharmacology; Psychology; Biology","score_opus":0.8349589273527223,"score_gpt":0.7219242324363636,"score_spread":0.11303469491635865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793349513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013238285,0.99296486,0.0005058532,0.0045546987,0.00027071958,0.000015509326,0.00004161966,0.000016126407,0.0014981534],"genre_scores_gemma":[0.0011055653,0.9960913,0.0011131786,0.0010940019,0.00026152414,0.000018942974,0.000041115964,0.00000535274,0.0002689605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976834,0.000850053,0.0003864002,0.0003192659,0.0006133142,0.0001475645],"domain_scores_gemma":[0.9868395,0.009212369,0.0008853891,0.00029059337,0.0022048443,0.0005673557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009566558,0.0008272144,0.0010084113,0.004510146,0.00050322426,0.0027271283,0.0014294079,0.0026412697,0.0056081186],"category_scores_gemma":[0.010847727,0.00043798442,0.0010659447,0.0056344154,0.0014239651,0.003787508,0.0017215769,0.0033038636,0.0016957113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057078,0.00008427693,0.0006663221,0.020901835,0.000085190295,0.00012981202,0.00018956995,0.0004128798,0.0003831091,0.019851761,0.023942249,0.9332959],"study_design_scores_gemma":[0.000019829906,0.00011986642,0.0016192349,0.025227617,0.00014985305,0.0007195279,0.00027799406,0.00020288656,0.00038766747,0.008137825,0.9631062,0.000031604082],"about_ca_topic_score_codex":0.0038314988,"about_ca_topic_score_gemma":0.0050726985,"teacher_disagreement_score":0.009566558,"about_ca_system_score_codex":0.002504173,"about_ca_system_score_gemma":0.01150925,"threshold_uncertainty_score":0.050593436},"labels":[],"label_agreement":null},{"id":"W2794417831","doi":"10.1002/cpt.1004","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>HLA</i> Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research; Canadian Institutes of Health Research; National Institutes of Health; Canada Foundation for Innovation; National Institute of Allergy and Infectious Diseases; Australian Centre for HIV and Hepatitis Virology Research","keywords":"Oxcarbazepine; Carbamazepine; Toxic epidermal necrolysis; Pharmacogenetics; Medicine; Genotype; Allele; Eosinophilia; Pharmacology; Guideline; Human leukocyte antigen; Epilepsy; Immunology; Dermatology; Genetics; Psychiatry; Biology; Pathology; Gene","score_opus":0.18471971328602335,"score_gpt":0.5213460437019938,"score_spread":0.33662633041597045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794417831","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008621285,0.38407683,0.06136727,0.3335262,0.013464868,0.004064782,0.022630632,0.0044097365,0.1678384],"genre_scores_gemma":[0.053040404,0.47317323,0.17244388,0.16904584,0.012111603,0.0095182,0.0581176,0.0015346638,0.051014587],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916795,0.0030110772,0.0026250186,0.0003196552,0.00207208,0.00029261905],"domain_scores_gemma":[0.9783176,0.0075126966,0.0035264667,0.0006267002,0.009155809,0.0008605988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073245573,0.00094840216,0.002250835,0.0022552395,0.0005542701,0.0018923312,0.0032008258,0.003913201,0.008214979],"category_scores_gemma":[0.023260945,0.0005891229,0.0022927958,0.0026776309,0.00057514757,0.0014489914,0.0015695489,0.005639199,0.006325285],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016400056,0.00025571627,0.002981763,0.0027708982,0.00015998057,0.0004719974,0.00014751276,0.000662609,0.00077879016,0.0023522184,0.59800744,0.39124706],"study_design_scores_gemma":[0.000537295,0.00020589464,0.015379975,0.01492924,0.00059476966,0.0023344285,0.00021936148,0.0011160065,0.0011191624,0.005003336,0.95846945,0.00009101229],"about_ca_topic_score_codex":0.011662114,"about_ca_topic_score_gemma":0.018768227,"teacher_disagreement_score":0.011662114,"about_ca_system_score_codex":0.0014972962,"about_ca_system_score_gemma":0.006192274,"threshold_uncertainty_score":0.038736463},"labels":[],"label_agreement":null},{"id":"W2794951931","doi":"10.1002/cpt.1061","title":"Critiquing the CDC Opioid Guideline: Some Light From the Heat","year":2018,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Guideline; Medicine; SAFER; Praise; Opioid; Disease control; Family medicine; Harm; Intensive care medicine; Psychology; Internal medicine; Environmental health; Computer science; Pathology","score_opus":0.08100730503199681,"score_gpt":0.4311709022143147,"score_spread":0.3501635971823179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794951931","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000104915045,0.00042016982,0.000032945554,0.9905792,0.008279495,0.0000038081785,0.000010273192,0.000009776701,0.00055939244],"genre_scores_gemma":[0.0010532371,0.00046075182,0.0001479681,0.97947603,0.01807553,0.000014420262,0.0000133110225,0.000013762089,0.00074493774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9768754,0.008357219,0.0037972995,0.0016878473,0.007272839,0.0020093643],"domain_scores_gemma":[0.9229989,0.042622898,0.0042078523,0.0016176593,0.021707524,0.006845163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017665286,0.0008694084,0.0016410797,0.0017569446,0.008302824,0.007970202,0.0054314025,0.08598361,0.0044090897],"category_scores_gemma":[0.11281001,0.0011022048,0.0017057322,0.0018609167,0.0076386924,0.009052167,0.0033786334,0.07861247,0.0041546575],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000073931383,0.000014606689,0.0001925706,0.00003472857,0.0000029833739,0.0005213836,0.00027229838,0.000022241635,0.00003259869,0.0015303803,0.9942795,0.0030892193],"study_design_scores_gemma":[0.00007100867,0.000042058928,0.00082679617,0.0009953206,0.000020724481,0.002061045,0.001997421,0.0003483117,0.00016719685,0.009627697,0.9837316,0.00011081421],"about_ca_topic_score_codex":0.016880471,"about_ca_topic_score_gemma":0.026976917,"teacher_disagreement_score":0.08598361,"about_ca_system_score_codex":0.009691524,"about_ca_system_score_gemma":0.01947048,"threshold_uncertainty_score":0.09342408},"labels":[],"label_agreement":null},{"id":"W2799695746","doi":"10.1002/cpt.1098","title":"Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institutes of Health","keywords":"SLCO1B1; Transporter; Pharmacogenomics; Solute carrier family; Drug; Biology; Abcg2; Disposition; Pharmacology; Pharmacogenetics; Computational biology; ATP-binding cassette transporter; Genetics; Gene; Genotype; Psychology","score_opus":0.07482595988161794,"score_gpt":0.4273965982165845,"score_spread":0.35257063833496655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799695746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001310662,0.99729055,0.0000807913,0.0017070415,0.00015264968,0.0000017255031,0.000013692729,0.0000022263453,0.00062024675],"genre_scores_gemma":[0.0011202154,0.99761117,0.00014398653,0.0005719605,0.00027665313,0.0000046938985,0.000021161186,0.000001067984,0.00024924663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996232,0.00013897914,0.000060597595,0.000058866775,0.000094765586,0.000023570941],"domain_scores_gemma":[0.9984195,0.001034972,0.00010860594,0.0000265455,0.00035342865,0.00005698878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015960003,0.00044360248,0.001156044,0.0014064099,0.00017501262,0.00095508876,0.00052214146,0.0010805529,0.00227268],"category_scores_gemma":[0.002036422,0.00014808508,0.0005514491,0.0016475,0.0003961465,0.0010819966,0.00049345515,0.001730559,0.00065734383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001227542,0.000051033592,0.000789193,0.008688512,0.00015734692,0.00019747717,0.00009681833,0.00024871988,0.0005912003,0.007108559,0.024177263,0.9577712],"study_design_scores_gemma":[0.0000332161,0.00020003886,0.0026260382,0.008410015,0.00034321702,0.0014221622,0.00013107863,0.00016137362,0.00036041555,0.004413271,0.9818687,0.00003042583],"about_ca_topic_score_codex":0.0009714262,"about_ca_topic_score_gemma":0.0019557516,"teacher_disagreement_score":0.00227268,"about_ca_system_score_codex":0.00053716707,"about_ca_system_score_gemma":0.001355421,"threshold_uncertainty_score":0.008440554},"labels":[],"label_agreement":null},{"id":"W2800492785","doi":"10.1002/cpt.1110","title":"Therapeutic Agents Targeting Cardiometabolic Risk for Preventing and Treating Atherosclerotic Cardiovascular Diseases","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ezetimibe; PCSK9; Statin; Atherosclerotic cardiovascular disease; Pharmacology; Canakinumab; Type 2 diabetes; Diabetes mellitus; Internal medicine; Lipoprotein; Endocrinology; Disease; Cholesterol; LDL receptor","score_opus":0.14605455818238083,"score_gpt":0.45191468108929117,"score_spread":0.30586012290691034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800492785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001840559,0.9974591,0.00018596656,0.00026809337,0.00019751514,0.0000115418225,0.00003474838,0.0000143979605,0.0016445349],"genre_scores_gemma":[0.00086157833,0.9976739,0.00030162555,0.00018879512,0.00013189454,0.000011625125,0.00004143436,0.0000020854748,0.000787058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998246,0.000029229768,0.000031617757,0.000028241659,0.00006940398,0.000017004026],"domain_scores_gemma":[0.99977106,0.00009912264,0.000039025555,0.00000943152,0.000064106935,0.00001729649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003980605,0.00073843804,0.0011063794,0.002549418,0.0002784302,0.0008101217,0.00061323924,0.0009099182,0.0061283233],"category_scores_gemma":[0.000525382,0.0002157389,0.00072503684,0.0016672863,0.00031097705,0.00092384673,0.0005693028,0.0021743865,0.0028607573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007504134,0.00012754144,0.00015629863,0.022476371,0.00013723306,0.00018003077,0.00006343006,0.0002654235,0.0024417865,0.003782054,0.02354399,0.9467507],"study_design_scores_gemma":[0.000028642959,0.00011164317,0.00073742,0.004306484,0.00020826703,0.0013684751,0.00004378936,0.000090491274,0.00058023987,0.001448383,0.99105936,0.000016693113],"about_ca_topic_score_codex":0.0007140672,"about_ca_topic_score_gemma":0.0013454324,"teacher_disagreement_score":0.0061283233,"about_ca_system_score_codex":0.00039264842,"about_ca_system_score_gemma":0.0008844252,"threshold_uncertainty_score":0.020501256},"labels":[],"label_agreement":null},{"id":"W2800824879","doi":"","title":"An open trial of nifedipine-herb interactions Nifedipine with St Johns wort, Ginseng or Ginkgo biloba","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Ginkgo biloba and Cashew Applications","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ginkgo biloba; Nifedipine; Ginseng; Traditional medicine; Herb; Medicine; SAGE; Pharmacology; Pharmacognosy; Ginkgo; Medicinal herbs; Chemistry; Internal medicine; Alternative medicine; Calcium; Biochemistry; Biological activity","score_opus":0.20409685353656296,"score_gpt":0.5211432356594783,"score_spread":0.31704638212291536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800824879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884117,0.002191878,0.00061983505,0.0010946704,0.0012421666,0.001853361,0.0013566605,0.00014474413,0.0030850123],"genre_scores_gemma":[0.9843001,0.0022179552,0.001262048,0.0007867384,0.0014802826,0.0019486787,0.0014315989,0.000045253422,0.006527322],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989095,0.00042158895,0.00009232676,0.00025349174,0.00008071566,0.00024245004],"domain_scores_gemma":[0.99752265,0.0008749092,0.00020380024,0.00021584223,0.00008643671,0.0010963657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017051527,0.002590939,0.005128897,0.0007155201,0.0012089913,0.0010351002,0.0016872165,0.0033999006,0.01030261],"category_scores_gemma":[0.0028530376,0.0008255324,0.0020996958,0.00057515583,0.0026597767,0.0026207652,0.00060206745,0.005487718,0.002029341],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9712601,0.01681433,0.0001628266,0.00017224245,0.00030691014,0.000081628066,0.000043165746,0.00009537611,0.003329336,0.00008429949,0.00038381445,0.0072659524],"study_design_scores_gemma":[0.7450048,0.25010294,0.0014367326,0.000020084675,0.00040042118,0.000073381336,0.00004216544,0.0003045576,0.0014240891,0.00014483022,0.001020036,0.00002583093],"about_ca_topic_score_codex":0.0018489681,"about_ca_topic_score_gemma":0.0040032202,"teacher_disagreement_score":0.01030261,"about_ca_system_score_codex":0.00093397475,"about_ca_system_score_gemma":0.0018334995,"threshold_uncertainty_score":0.03446567},"labels":[],"label_agreement":null},{"id":"W2802614347","doi":"10.1002/cpt.1086","title":"Real‐World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)","year":2018,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Observational study; Pharmacoepidemiology; Medicine; Food and drug administration; Real world evidence; Confounding; Comparative effectiveness research; Quality (philosophy); Alternative medicine; Family medicine; Medical education; Pharmacology; Internal medicine; Pathology","score_opus":0.8657431941736702,"score_gpt":0.6546872114441983,"score_spread":0.2110559827294719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802614347","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006482934,0.0020425613,0.000100207515,0.9955533,0.001667349,0.000005684824,0.000016398148,0.000004720784,0.0005448653],"genre_scores_gemma":[0.0026407451,0.0032037818,0.00072643673,0.97162205,0.021064095,0.000032956123,0.000021682708,0.00001971161,0.0006684658],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.93214875,0.03845356,0.009654705,0.004300458,0.013758079,0.0016843936],"domain_scores_gemma":[0.5958047,0.3508217,0.014660429,0.0075579816,0.023441734,0.0077134543],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06637736,0.00090171694,0.0031818408,0.0026705957,0.004306389,0.012201987,0.003598506,0.059885852,0.005724582],"category_scores_gemma":[0.29790753,0.0012616178,0.0017468533,0.0028385418,0.016994843,0.01715412,0.004227091,0.07234174,0.0050559905],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001306015,0.000052073938,0.0016501212,0.0006585714,0.000085269865,0.0012982766,0.0007140964,0.00015981896,0.00024763917,0.027599616,0.9213113,0.04609264],"study_design_scores_gemma":[0.0002485822,0.000117034324,0.0019609227,0.006064624,0.00010022923,0.0030189638,0.0017005407,0.0011594523,0.0003962718,0.1866422,0.79835916,0.00023198356],"about_ca_topic_score_codex":0.0048092892,"about_ca_topic_score_gemma":0.0072136666,"teacher_disagreement_score":0.93362266,"about_ca_system_score_codex":0.011361318,"about_ca_system_score_gemma":0.0100636585,"threshold_uncertainty_score":0.3510412},"labels":[],"label_agreement":null},{"id":"W2803768334","doi":"10.1002/cpt.1074","title":"Opioids: The Painful Public Health Reality","year":2018,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Centre for Addiction and Mental Health","keywords":"Surprise; Opium; Public health; Analgesic; Addiction; Medicine; Antidepressant; Psychiatry; Political science; Psychology; Anxiety; Law; Social psychology; Nursing","score_opus":0.18047064376481972,"score_gpt":0.5008985782838596,"score_spread":0.32042793451903995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803768334","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000646884,0.04314682,0.00007505789,0.148911,0.8059122,0.0000069999187,0.000025869349,0.000050109844,0.0018071934],"genre_scores_gemma":[0.00073167356,0.025397763,0.00007449591,0.054464404,0.9159398,0.000009017148,0.00001584972,0.000015429912,0.0033516383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996073,0.0009782767,0.0004134111,0.00046505555,0.0017877381,0.0002824073],"domain_scores_gemma":[0.9805517,0.011866576,0.000856604,0.00050396234,0.004517496,0.0017037335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005044464,0.0024972588,0.0027691794,0.0018127132,0.0027850724,0.0070488006,0.0021373122,0.014748092,0.008379106],"category_scores_gemma":[0.019655082,0.0006848524,0.0011989794,0.0010971794,0.004118555,0.0073202383,0.0016944847,0.023830658,0.004601545],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019768402,0.000015477202,0.000025149428,0.0003898646,0.000012364922,0.00015231477,0.000058802205,0.000025554196,0.000048001522,0.0012559085,0.98509187,0.012904917],"study_design_scores_gemma":[0.000027860244,0.000027538865,0.00017067803,0.00080730196,0.000024038893,0.0003316502,0.00015732535,0.000058438385,0.00004741239,0.002682799,0.9956475,0.00001731625],"about_ca_topic_score_codex":0.001160407,"about_ca_topic_score_gemma":0.0024672716,"teacher_disagreement_score":0.014748092,"about_ca_system_score_codex":0.002446762,"about_ca_system_score_gemma":0.004264608,"threshold_uncertainty_score":0.028030872},"labels":[],"label_agreement":null},{"id":"W2804552830","doi":"10.1002/cpt.1115","title":"Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"ADME; Transporter; Pharmacokinetics; Pharmacology; Drug; Disease; Toxicity; Drug development; Distribution (mathematics); Medicine; Drug metabolism; Biology; Internal medicine; Genetics; Gene","score_opus":0.049590659468452467,"score_gpt":0.3878315960804222,"score_spread":0.33824093661196974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804552830","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018243034,0.3215009,0.0040755845,0.4492221,0.20583984,0.0001232867,0.00039942595,0.00018026783,0.016834307],"genre_scores_gemma":[0.01043179,0.53676784,0.0033246765,0.16836743,0.20337683,0.00014422301,0.00061635085,0.00027130987,0.07669952],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99850285,0.0002922373,0.00013640887,0.00030155704,0.00059328624,0.00017366797],"domain_scores_gemma":[0.9945102,0.0015472152,0.0003911842,0.00017617246,0.0023817944,0.000993473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043832334,0.0009315494,0.0009623937,0.001355148,0.0009770287,0.003847698,0.00087313214,0.003763143,0.00524304],"category_scores_gemma":[0.004510414,0.00030134866,0.0008192507,0.0013725851,0.0011127302,0.003495178,0.0014434479,0.005577439,0.0037690252],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012484474,0.000051211802,0.00039788947,0.0002874803,0.000028037035,0.00022400479,0.00006717325,0.00006798283,0.0008046508,0.0027822964,0.8657952,0.12936933],"study_design_scores_gemma":[0.000023218568,0.00009375117,0.0007197128,0.0004933118,0.000043108907,0.0005194656,0.00006937115,0.00011053027,0.0010239145,0.002543889,0.99433494,0.000024737874],"about_ca_topic_score_codex":0.0017217966,"about_ca_topic_score_gemma":0.003486352,"teacher_disagreement_score":0.00524304,"about_ca_system_score_codex":0.0014478741,"about_ca_system_score_gemma":0.0032728128,"threshold_uncertainty_score":0.023181021},"labels":[],"label_agreement":null},{"id":"W2804866893","doi":"10.1002/cpt.1114","title":"Lipids, Apolipoproteins, and Inflammatory Biomarkers of Cardiovascular Risk: What Have We Learned?","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Surrogate endpoint; Trimethylamine N-oxide; Medicine; Biomarker; Cholesterol; Apolipoprotein B; Residual risk; Internal medicine; Lipoprotein; Clinical endpoint; Bioinformatics; Endocrinology; Biology; Genetics; Biochemistry; Clinical trial; Trimethylamine","score_opus":0.1278205173086226,"score_gpt":0.4186626093528992,"score_spread":0.2908420920442766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804866893","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047327147,0.9985638,0.000046273773,0.0009641368,0.00018719997,0.0000017885501,0.000011296603,0.0000035342948,0.00017470069],"genre_scores_gemma":[0.0003017754,0.9989047,0.00010174333,0.00031880612,0.00023776178,0.0000032760656,0.000013351855,7.9695906e-7,0.00011770723],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99956256,0.00011387775,0.0000815721,0.00007173021,0.00013281612,0.00003737283],"domain_scores_gemma":[0.99784267,0.0012535584,0.00020367403,0.00006541952,0.000504376,0.00013037896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020820582,0.0009769729,0.0025227522,0.002308088,0.00040913024,0.0020191993,0.0011748318,0.0018841971,0.0035611687],"category_scores_gemma":[0.0030813096,0.0003947479,0.00090901565,0.0026538684,0.00094030844,0.0031862692,0.0009670657,0.0034855055,0.0016931413],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014846012,0.000097406075,0.00045297237,0.02963787,0.00028566184,0.00012889045,0.00011172584,0.00020390814,0.0005501877,0.004376171,0.028884158,0.9351226],"study_design_scores_gemma":[0.000041670643,0.00019123689,0.0019567283,0.017898478,0.00048508903,0.000973115,0.00023425471,0.00012698659,0.00028478215,0.007070174,0.97069,0.00004752293],"about_ca_topic_score_codex":0.0016541493,"about_ca_topic_score_gemma":0.0025068554,"teacher_disagreement_score":0.0035611687,"about_ca_system_score_codex":0.00074475113,"about_ca_system_score_gemma":0.002580714,"threshold_uncertainty_score":0.0119133},"labels":[],"label_agreement":null},{"id":"W2809978686","doi":"10.1002/cpt.1166","title":"A Novel Method to Estimate Long‐Term Chronological Changes From Fragmented Observations in Disease Progression","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods and Inference","field":"Mathematics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Genentech; Servier; Eisai; Ministry of Health, Labour and Welfare; Alzheimer's Disease Neuroimaging Initiative; GE Healthcare; Pfizer; BioClinica; Eli Lilly and Company; U.S. Department of Defense; Johnson and Johnson; Meso Scale Diagnostics; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb; Roche; Alzheimer's Drug Discovery Foundation; Takeda Pharmaceutical Company; AbbVie; National Institute on Aging; Fujirebio Europe; Alzheimer's Association; Foundation for the National Institutes of Health","keywords":"Disease; Covariate; Clinical trial; Medicine; Time point; Apolipoprotein E; Chronic disease; Internal medicine; Oncology; Bioinformatics; Biology; Statistics","score_opus":0.45493917138774165,"score_gpt":0.6065675190215114,"score_spread":0.15162834763376976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809978686","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009231627,0.00012741177,0.99003905,0.000068137364,0.000029131164,0.00004213893,0.00014439641,0.00017843196,0.00013965328],"genre_scores_gemma":[0.23850255,0.00037475573,0.75701416,0.00014824497,0.00016887022,0.0006980405,0.0011387761,0.00013309851,0.0018215579],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9985801,0.00063737377,0.000092305556,0.0004032458,0.00022996082,0.000057094512],"domain_scores_gemma":[0.99115646,0.006150378,0.0009271797,0.0010296128,0.0005445688,0.00019180635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006049311,0.00059290597,0.00083082845,0.0014092803,0.000438594,0.00067224324,0.0013662428,0.00095707417,0.0013417457],"category_scores_gemma":[0.019625127,0.00048879016,0.0011265856,0.0012363372,0.000726038,0.0010248652,0.0011841338,0.0014980664,0.00038844347],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010146555,0.00027675627,0.051095653,0.0004279472,0.0010401637,0.00036488374,0.000627086,0.31287834,0.018697832,0.04606267,0.0037138048,0.5638003],"study_design_scores_gemma":[0.00007063594,0.00016790927,0.009323331,0.000032934237,0.00009549025,0.00024602548,0.000037725422,0.9628079,0.0019725345,0.02090651,0.0042851157,0.000053830285],"about_ca_topic_score_codex":0.004384505,"about_ca_topic_score_gemma":0.004932637,"teacher_disagreement_score":0.006049311,"about_ca_system_score_codex":0.00045788017,"about_ca_system_score_gemma":0.0014540995,"threshold_uncertainty_score":0.031992137},"labels":[],"label_agreement":null},{"id":"W2810329335","doi":"10.1002/cpt.1162","title":"Cinnamon and Cassia Nomenclature Confusion: A Challenge to the Applicability of Clinical Data","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Phytochemistry and biological activity of medicinal plants","field":"Agricultural and Biological Sciences","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"United States Pharmacopeia","keywords":"Cinnamomum; Cassia; Confusion; Traditional medicine; Cinnamomum zeylanicum; Medicine; Lauraceae; Cinnamaldehyde; Biology; Botany; Psychology; Alternative medicine; Essential oil; Traditional Chinese medicine; Biochemistry","score_opus":0.5505821327320457,"score_gpt":0.5383740406933131,"score_spread":0.012208092038732632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810329335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032034185,0.96661055,0.0016481846,0.025330255,0.0027947575,0.00003826729,0.00011731577,0.00003364809,0.0031067284],"genre_scores_gemma":[0.007334906,0.9629893,0.0042808414,0.019173745,0.00430683,0.00011265228,0.00029445696,0.00004312022,0.0014642368],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99006665,0.00397711,0.0025591499,0.00074629724,0.0024741539,0.00017660837],"domain_scores_gemma":[0.9473483,0.036664423,0.0032713322,0.0020687063,0.009851585,0.00079570885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020525962,0.00051847444,0.0032005778,0.0037810295,0.00073457847,0.0040615937,0.0032993646,0.0026964457,0.0036690612],"category_scores_gemma":[0.036878653,0.00044947633,0.0011889985,0.003994469,0.0043333718,0.0055630757,0.002339509,0.008384837,0.0018166275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014807314,0.0000639925,0.00041047612,0.023237532,0.0001557075,0.0004473789,0.0007130445,0.00016990454,0.0007343765,0.03126887,0.0846704,0.8579803],"study_design_scores_gemma":[0.000044293727,0.000082001956,0.00072864036,0.018489564,0.0001439212,0.0018478326,0.00047974536,0.000113213646,0.00030725304,0.014117845,0.9636115,0.000034331497],"about_ca_topic_score_codex":0.0022517145,"about_ca_topic_score_gemma":0.0035256594,"teacher_disagreement_score":0.020525962,"about_ca_system_score_codex":0.001993737,"about_ca_system_score_gemma":0.006443226,"threshold_uncertainty_score":0.10855293},"labels":[],"label_agreement":null},{"id":"W2834973095","doi":"10.1002/cpt.1179","title":"Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; BC Children’s Hospital Foundation; BC Children's Hospital; Children's Hospital Foundation; London Health Sciences Centre","keywords":"Pharmacogenomics; Peripheral neuropathy; Pharmacokinetics; Medicine; Pharmacogenetics; Pharmacology; Vincristine; Gene; Bioinformatics; Internal medicine; Genetics; Biology; Chemotherapy; Genotype; Endocrinology","score_opus":0.24322484068939612,"score_gpt":0.5059146346413825,"score_spread":0.26268979395198644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2834973095","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380394,0.050811317,0.0038347994,0.0011018378,0.0000478342,0.000025041722,0.0039635114,0.000045876317,0.0021303678],"genre_scores_gemma":[0.9917066,0.0056401147,0.0009159692,0.00025452435,0.000038860457,0.000013709407,0.0009887835,0.000014891074,0.0004265097],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991689,0.00034927466,0.00006318883,0.00023897461,0.00014097847,0.000038621216],"domain_scores_gemma":[0.99846715,0.00084862934,0.00041366776,0.00014299554,0.00008815054,0.000039441107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010764598,0.00035287166,0.0005428647,0.0005335977,0.00015840691,0.0006593739,0.00018715908,0.00029956322,0.0015893528],"category_scores_gemma":[0.0022981546,0.00012735598,0.0009703319,0.0015544365,0.0001948986,0.00019521196,0.0002852192,0.00042654626,0.00011266999],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037965113,0.00010417322,0.8363957,0.0017328031,0.026237233,0.0007237644,0.000162463,0.0043966575,0.019386861,0.0014405578,0.0023146858,0.103308596],"study_design_scores_gemma":[0.00019460804,0.0004499865,0.9628664,0.00020582187,0.017805954,0.0013713543,0.00008343887,0.0038699037,0.0042119124,0.0023917768,0.00652286,0.000025885009],"about_ca_topic_score_codex":0.0024049927,"about_ca_topic_score_gemma":0.003695254,"teacher_disagreement_score":0.0024049927,"about_ca_system_score_codex":0.00030381745,"about_ca_system_score_gemma":0.0002708004,"threshold_uncertainty_score":0.005692959},"labels":[],"label_agreement":null},{"id":"W2885748302","doi":"10.1002/cpt.1183","title":"Advancing Predictions of Tissue and Intracellular Drug Concentrations Using <i>In Vitro</i>, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; National Institutes of Health","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Drug; Pharmacology; Drug development; In vivo; Disposition; In vitro; Medicine; Computational biology; Computer science; Chemistry; Biology; Biotechnology; Psychology","score_opus":0.07653526175492847,"score_gpt":0.37466407569362564,"score_spread":0.29812881393869717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885748302","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015702985,0.0066264407,0.9683546,0.0019004034,0.00015606903,0.000078072364,0.00042514363,0.0007978132,0.0059584836],"genre_scores_gemma":[0.4624502,0.038197946,0.48796907,0.0015850074,0.00034265424,0.0004983206,0.0012153739,0.0006947904,0.007046603],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99844885,0.00072327105,0.00010788167,0.0002602522,0.00040125623,0.000058494705],"domain_scores_gemma":[0.9957806,0.0026118075,0.0006735163,0.00033195148,0.000541753,0.00006032633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031879279,0.001657116,0.0013481034,0.0011142073,0.0004409033,0.0037617865,0.0016011974,0.0016687568,0.0015544445],"category_scores_gemma":[0.005902339,0.0008498305,0.0020548657,0.00062803534,0.00095406425,0.0027496587,0.001112743,0.0021336267,0.0014479851],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016135059,0.00027380543,0.0043525547,0.0011769035,0.00022273646,0.00026542135,0.00020917608,0.74687827,0.075682975,0.025187159,0.003350872,0.14223883],"study_design_scores_gemma":[0.00002129744,0.00047428606,0.0012400468,0.00021028118,0.00015059783,0.0004734631,0.00012852797,0.8653272,0.08782432,0.01729702,0.026733281,0.00011969297],"about_ca_topic_score_codex":0.004358252,"about_ca_topic_score_gemma":0.004326284,"teacher_disagreement_score":0.004358252,"about_ca_system_score_codex":0.0017506933,"about_ca_system_score_gemma":0.002042412,"threshold_uncertainty_score":0.016859531},"labels":[],"label_agreement":null},{"id":"W2887240487","doi":"10.1002/cpt.1212","title":"Current State of Microbicide Development","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Microbicide; Microbicides for sexually transmitted diseases; Medicine; Human immunodeficiency virus (HIV); Condom; Immunology; Developing country; Virology; Transmission (telecommunications); Vaginal microbicide; Sexual transmission; Population; Intensive care medicine; Biology; Environmental health; Health services; Syphilis; Computer science","score_opus":0.28995171830574307,"score_gpt":0.5407717705448669,"score_spread":0.25082005223912385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887240487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003297426,0.9942729,0.00043514525,0.0004035608,0.00027834505,0.000018474906,0.00006307163,0.000025050074,0.0041737068],"genre_scores_gemma":[0.0015161114,0.9954739,0.0006194512,0.0002832446,0.00021389152,0.000023169121,0.00009137647,0.0000044497397,0.0017744005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959487,0.000057809415,0.000057954476,0.00007379319,0.00017995054,0.000035685993],"domain_scores_gemma":[0.9993079,0.00032877314,0.000100175224,0.000025837353,0.00018532365,0.00005197716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010568046,0.0008269335,0.0009966732,0.0016083668,0.0003652704,0.0014362541,0.0011033703,0.0013984438,0.007903346],"category_scores_gemma":[0.0011651786,0.00044951806,0.0005541909,0.0013990273,0.00044631746,0.0016063924,0.0006898505,0.0016326769,0.004712615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056381316,0.00008701634,0.00014545878,0.013266788,0.000030930085,0.00012159575,0.000058479814,0.0002879606,0.00335456,0.004282643,0.017841877,0.9604663],"study_design_scores_gemma":[0.0000096921285,0.00012776107,0.00030390007,0.0025762622,0.00004667495,0.00055036077,0.00003872905,0.00010012066,0.001525967,0.0012175263,0.99348927,0.000013673593],"about_ca_topic_score_codex":0.0010387349,"about_ca_topic_score_gemma":0.001123091,"teacher_disagreement_score":0.007903346,"about_ca_system_score_codex":0.00054169865,"about_ca_system_score_gemma":0.0015785536,"threshold_uncertainty_score":0.02643931},"labels":[],"label_agreement":null},{"id":"W2887652885","doi":"10.1002/cpt.1101","title":"Safety Surveillance of Dietary Supplements: Importance, Challenges, and New Horizons","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Pharmacovigilance; Medicine; Medical prescription; Postmarketing surveillance; Environmental health; Adverse effect; Pharmacology; Risk analysis (engineering)","score_opus":0.24888158128334328,"score_gpt":0.47494564000962536,"score_spread":0.22606405872628207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887652885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011789169,0.4919718,0.021205232,0.46167377,0.0030880694,0.00013188968,0.00056438707,0.00019699334,0.0093787545],"genre_scores_gemma":[0.2864264,0.51603884,0.06647614,0.100696385,0.026478436,0.00031696152,0.0010606057,0.00015230099,0.0023539343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9621156,0.017329618,0.0047927755,0.0030190952,0.012016251,0.00072664436],"domain_scores_gemma":[0.7359028,0.16949633,0.020339213,0.0071399156,0.060051244,0.007070566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08700364,0.0010143294,0.002141441,0.0038220172,0.001605956,0.008545199,0.00289925,0.0072506242,0.0036384284],"category_scores_gemma":[0.12750752,0.00045963746,0.0012202483,0.0029889515,0.006052061,0.013236947,0.003618562,0.0078080017,0.0009528502],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004495855,0.00027600277,0.0298303,0.005365479,0.00024975327,0.00056509784,0.001532794,0.0014301047,0.001256118,0.033213545,0.041795123,0.8840361],"study_design_scores_gemma":[0.00021013046,0.0024986567,0.04656613,0.034498494,0.00071798987,0.007927507,0.012107971,0.01569921,0.0057302215,0.27584547,0.59763354,0.0005646472],"about_ca_topic_score_codex":0.0070052315,"about_ca_topic_score_gemma":0.007909633,"teacher_disagreement_score":0.08700364,"about_ca_system_score_codex":0.0053277914,"about_ca_system_score_gemma":0.014048336,"threshold_uncertainty_score":0.46012473},"labels":[],"label_agreement":null},{"id":"W2887655204","doi":"10.1002/cpt.1112","title":"Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute on Drug Abuse","keywords":"Transporter; Organic anion transporter 1; Organic cation transport proteins; Drug; Pharmacology; Organic anion-transporting polypeptide; Drug development; Disposition; Chemistry; Medicine; Biochemistry; Psychology","score_opus":0.2865857439642586,"score_gpt":0.5248841825983547,"score_spread":0.23829843863409605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887655204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008071404,0.73254365,0.008969527,0.1287472,0.037148174,0.0007622036,0.0039915843,0.0013587378,0.08567187],"genre_scores_gemma":[0.0035479313,0.8463271,0.020754075,0.052809197,0.008639454,0.00089514354,0.007122039,0.000371809,0.05953337],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961903,0.0008335948,0.0007446565,0.00021299228,0.0016169492,0.00040142826],"domain_scores_gemma":[0.989674,0.0021569275,0.0016121505,0.00041777856,0.00522728,0.00091195496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068024076,0.0011533496,0.0017029283,0.004134443,0.0007218571,0.0034846363,0.0025872139,0.005263333,0.019861355],"category_scores_gemma":[0.010401548,0.0007195302,0.0018568019,0.004216875,0.0009714595,0.0036040638,0.0032988568,0.0063432506,0.018768955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007873879,0.0000836344,0.00013504943,0.0043021194,0.000031973974,0.00015057737,0.0000780815,0.00023216904,0.001100649,0.0063991877,0.59052163,0.39688626],"study_design_scores_gemma":[0.000012426408,0.00002519144,0.00013695087,0.001578879,0.00001958608,0.000112109876,0.000014791316,0.00003359709,0.00016283822,0.00083849236,0.9970567,0.0000085657175],"about_ca_topic_score_codex":0.00343067,"about_ca_topic_score_gemma":0.0058486937,"teacher_disagreement_score":0.019861355,"about_ca_system_score_codex":0.0023788433,"about_ca_system_score_gemma":0.009077511,"threshold_uncertainty_score":0.06644291},"labels":[],"label_agreement":null},{"id":"W2890573975","doi":"10.1002/cpt.1238","title":"Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Center for Research Resources; Canadian Institutes of Health Research; National Institute on Drug Abuse; Canada Research Chairs; Campbell Family Mental Health Research Institute; University of Pennsylvania; Pfizer","keywords":"Nicotine; Abstinence; Cotinine; Craving; CYP2A6; Smoking cessation; Nicotine withdrawal; Metabolite; Medicine; Cigarette smoking; Anesthesia; Saliva; Internal medicine; Pharmacology; Metabolism; Psychiatry; Addiction","score_opus":0.03246406918592148,"score_gpt":0.39480707592511677,"score_spread":0.3623430067391953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890573975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99957937,0.00012101843,0.00004616432,0.0000069093803,0.0000021353007,0.000005806248,0.00004426972,0.0000022811416,0.00019202786],"genre_scores_gemma":[0.9996489,0.00004259765,0.000051309224,0.000007092719,0.0000036837273,0.0000042480547,0.000084855594,0.000002653436,0.00015459329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995715,0.00018930831,0.000031892145,0.00005505688,0.00009602292,0.000056205674],"domain_scores_gemma":[0.9980981,0.0008297363,0.0005212167,0.0001265965,0.00012393024,0.00030035072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000689195,0.00026886453,0.00036076867,0.00036614458,0.00014824148,0.00031980276,0.00013019398,0.0002602075,0.0010314416],"category_scores_gemma":[0.0030656806,0.00016807675,0.00039523726,0.0002130447,0.00016455549,0.00021509519,0.00024392492,0.00035632768,0.00019150434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009814099,0.0003467455,0.96004814,0.000022853625,0.00031270093,0.00015037216,0.00013060574,0.00014410708,0.01801321,0.000024180494,0.000043709744,0.010949222],"study_design_scores_gemma":[0.000007951216,0.0005396647,0.9987237,0.0000011332907,0.00002542475,0.00009196277,0.00001624148,0.00016164029,0.0003960707,0.000006537878,0.000027125436,0.0000025565857],"about_ca_topic_score_codex":0.0009200813,"about_ca_topic_score_gemma":0.00094479456,"teacher_disagreement_score":0.0010314416,"about_ca_system_score_codex":0.00014016501,"about_ca_system_score_gemma":0.000097041164,"threshold_uncertainty_score":0.003644824},"labels":[],"label_agreement":null},{"id":"W2891332020","doi":"10.1002/cpt.1182","title":"Treating a Child With Mental Illness","year":2018,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Methylphenidate; Druggability; Autism spectrum disorder; Psychiatry; Attention deficit hyperactivity disorder; Medicine; Mental illness; Autism; Drug; Psychology; Mental health; Genetics","score_opus":0.06558694036130114,"score_gpt":0.4586917552477939,"score_spread":0.39310481488649274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891332020","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001061445,0.08719813,0.0002202673,0.07567261,0.83034897,0.000023524775,0.000043073447,0.0000663635,0.0063209655],"genre_scores_gemma":[0.0012148719,0.099583514,0.00035079004,0.09178181,0.7930594,0.000031502663,0.000056970886,0.000045020257,0.013876185],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981554,0.00045115087,0.00028946192,0.00024305338,0.0007551682,0.0001056297],"domain_scores_gemma":[0.9950872,0.0029383257,0.00030447482,0.00012989748,0.0009777606,0.0005621977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024900413,0.0022969358,0.001665261,0.0013226136,0.0017109149,0.0030561846,0.0018652715,0.010223535,0.00715071],"category_scores_gemma":[0.013265672,0.000578659,0.00126721,0.0006345529,0.0016150582,0.0034312082,0.0016256139,0.019021332,0.0049567786],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016672224,0.000014905076,0.000043471842,0.00041511338,0.0000141246055,0.00032237038,0.000050445156,0.000029286768,0.000052463663,0.0005857932,0.96721745,0.031237857],"study_design_scores_gemma":[0.000017041557,0.000022562965,0.00021719182,0.0010784281,0.000021008203,0.0010369327,0.00007218276,0.000037354934,0.0000423534,0.0006913881,0.9967542,0.000009330899],"about_ca_topic_score_codex":0.001912288,"about_ca_topic_score_gemma":0.0065075583,"teacher_disagreement_score":0.010223535,"about_ca_system_score_codex":0.0022954457,"about_ca_system_score_gemma":0.0022741724,"threshold_uncertainty_score":0.02392149},"labels":[],"label_agreement":null},{"id":"W2897647360","doi":"10.1002/cpt.1255","title":"Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Artificial Intelligence in Medicine (Canada)","funders":"Pfizer","keywords":"Pharmacovigilance; Adverse effect; Event (particle physics); Complex event processing; Adverse Event Reporting System; Artificial intelligence; Computer science; Medicine; Pharmacology","score_opus":0.4092247310207464,"score_gpt":0.5705374598262889,"score_spread":0.16131272880554248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897647360","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2773281,0.0008935601,0.69393486,0.0036342107,0.00011916168,0.0026274053,0.00038611318,0.0034519765,0.017624585],"genre_scores_gemma":[0.42261297,0.00024043092,0.5754886,0.00033434195,0.00004579041,0.00030948684,0.00025489047,0.00007340533,0.00064013764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97731656,0.012798183,0.0019472128,0.0016511627,0.0058921995,0.00039462306],"domain_scores_gemma":[0.92630637,0.052821446,0.0056379596,0.006167106,0.008390008,0.00067714805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0238436,0.00087123696,0.0006003541,0.0048570717,0.0006467236,0.0041499883,0.0016522368,0.0010659564,0.0012983921],"category_scores_gemma":[0.055691715,0.00041861428,0.00078045746,0.0028019086,0.0015785513,0.00284629,0.0023944415,0.0014469691,0.00048001914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012055753,0.0012711778,0.052375156,0.0010582521,0.00052242115,0.0007635986,0.002786552,0.036582638,0.03401413,0.016578915,0.0032147537,0.84962684],"study_design_scores_gemma":[0.00054173934,0.0031437213,0.085578434,0.000840673,0.0005365775,0.002502964,0.0022852493,0.71690726,0.08624762,0.07235815,0.028474351,0.0005832103],"about_ca_topic_score_codex":0.0022356203,"about_ca_topic_score_gemma":0.0020800924,"teacher_disagreement_score":0.0238436,"about_ca_system_score_codex":0.0019485859,"about_ca_system_score_gemma":0.0022018494,"threshold_uncertainty_score":0.12609851},"labels":[],"label_agreement":null},{"id":"W2899206436","doi":"10.1002/cpt.1270","title":"Opportunities and Challenges Related to the Implementation of Model‐Based Bioequivalence Criteria","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"American Association of Pharmaceutical Scientists","keywords":"Bioequivalence; Strengths and weaknesses; Computer science; Management science; Econometrics; Mathematics; Medicine; Economics; Pharmacology; Psychology; Pharmacokinetics","score_opus":0.8623221871967739,"score_gpt":0.6812235939164175,"score_spread":0.18109859328035638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899206436","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030520854,0.005211148,0.96331537,0.022618478,0.00049502804,0.00016280015,0.00009289024,0.00024744286,0.00480476],"genre_scores_gemma":[0.12337892,0.005795748,0.8649133,0.0026357037,0.0011435995,0.0008058152,0.0001557194,0.00020758873,0.0009636494],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8823966,0.0987411,0.004510822,0.0025350903,0.011247653,0.0005687052],"domain_scores_gemma":[0.687416,0.27169943,0.008318915,0.016606918,0.014987477,0.00097110734],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14567061,0.0013339409,0.0033588682,0.0025173905,0.00082503306,0.007462617,0.004311565,0.0032158284,0.0029676035],"category_scores_gemma":[0.26468253,0.0008584829,0.0020223977,0.0023130653,0.0043821246,0.0069872793,0.0040821605,0.008847476,0.00083385577],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010860154,0.00014357541,0.0015730276,0.00084956456,0.00031025437,0.000088366556,0.00030187125,0.061388616,0.0005505378,0.7483627,0.0069080004,0.17941491],"study_design_scores_gemma":[0.00006311261,0.0001743155,0.00060036307,0.00057367876,0.00005001549,0.0001382689,0.0001739928,0.2242318,0.0006429107,0.7523841,0.02089857,0.00006876461],"about_ca_topic_score_codex":0.0027380225,"about_ca_topic_score_gemma":0.0021880537,"teacher_disagreement_score":0.8543294,"about_ca_system_score_codex":0.003235628,"about_ca_system_score_gemma":0.009690769,"threshold_uncertainty_score":0.770389},"labels":[],"label_agreement":null},{"id":"W2899872209","doi":"10.1002/cpt.1202","title":"Battling the <scp>HIV</scp>/<scp>AIDS</scp> Epidemic: Triumphs and Barriers","year":2018,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Life expectancy; Human immunodeficiency virus (HIV); Disease; Medicine; Intensive care medicine; Antiretroviral therapy; Immunology; Virology; Environmental health; Viral load; Population; Pathology","score_opus":0.07434085570788461,"score_gpt":0.4580666668073135,"score_spread":0.3837258110994289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899872209","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033306194,0.018220553,0.000106651816,0.03296449,0.9463312,0.0000117037125,0.000022198223,0.00004914166,0.0022607783],"genre_scores_gemma":[0.0003063963,0.016108349,0.00011633941,0.01914016,0.9540715,0.000010625377,0.000017797349,0.000028750583,0.010200173],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649423,0.0007095704,0.00039452603,0.00031962644,0.0019031176,0.00017889896],"domain_scores_gemma":[0.98627037,0.006236098,0.0006775036,0.00037572777,0.0047282246,0.0017122062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054383515,0.002954718,0.0024472752,0.0021461414,0.0025527074,0.00644798,0.0025718524,0.011223549,0.012754071],"category_scores_gemma":[0.015491892,0.00079486636,0.0018219409,0.0011201419,0.0026164302,0.005895438,0.0014108442,0.018528389,0.013025193],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021971631,0.000018635223,0.000020962338,0.0002930937,0.000010786772,0.000070936396,0.000023692357,0.000025474706,0.000052163294,0.0005662269,0.9870151,0.011880958],"study_design_scores_gemma":[0.000022418279,0.000020103264,0.00012398289,0.00044601888,0.000019132025,0.00018120946,0.00004045586,0.000055783526,0.00006497835,0.0010249155,0.99799097,0.000010108873],"about_ca_topic_score_codex":0.0012247622,"about_ca_topic_score_gemma":0.0037099468,"teacher_disagreement_score":0.012754071,"about_ca_system_score_codex":0.0022982443,"about_ca_system_score_gemma":0.0027603214,"threshold_uncertainty_score":0.042666674},"labels":[],"label_agreement":null},{"id":"W2901716698","doi":"10.1002/cpt.1317","title":"Recognizing that Evidence is Made, not Born","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance; Canadian Agency for Drugs and Technologies in Health; Health Canada","funders":"Health Canada","keywords":"Reimbursement; Context (archaeology); Quality (philosophy); Business; Risk analysis (engineering); Product (mathematics); Process (computing); Process management; Evidence-based practice; Operations management; Marketing; Medicine; Economics; Computer science; Health care; Economic growth","score_opus":0.8440868573545443,"score_gpt":0.6056367973435256,"score_spread":0.23845006001101865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901716698","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025168788,0.06022622,0.04768676,0.81130105,0.030721074,0.0002655555,0.00035457328,0.00020020326,0.046727657],"genre_scores_gemma":[0.24035595,0.11129274,0.1888156,0.39419016,0.03046216,0.001039039,0.0007322557,0.00058702845,0.032525074],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8646899,0.06304393,0.015751444,0.009276723,0.045227613,0.0020105224],"domain_scores_gemma":[0.5908622,0.2594252,0.021819217,0.05124079,0.0693763,0.007276335],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.1521628,0.00094086863,0.0026163145,0.004554853,0.0035136465,0.023991792,0.0043377993,0.012222401,0.0054765493],"category_scores_gemma":[0.405407,0.0012845705,0.0012816828,0.0034349146,0.030478586,0.033897337,0.011275909,0.028971571,0.0041679204],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014314237,0.00009840648,0.0027905065,0.0059364205,0.0007072529,0.00077019,0.005102412,0.00072563445,0.0016076848,0.6561316,0.14916284,0.17682388],"study_design_scores_gemma":[0.00005316116,0.00007455188,0.00091975305,0.010786485,0.0001975399,0.0006280913,0.0022395563,0.0005407052,0.0006192488,0.5850094,0.3988274,0.00010404718],"about_ca_topic_score_codex":0.0036398114,"about_ca_topic_score_gemma":0.004667324,"teacher_disagreement_score":0.99648637,"about_ca_system_score_codex":0.0077258847,"about_ca_system_score_gemma":0.033017736,"threshold_uncertainty_score":0.80472344},"labels":[],"label_agreement":null},{"id":"W2902167120","doi":"10.1002/cpt.1323","title":"Effect of <i> <scp>CYP</scp> 4F2 </i> , <i> <scp>VKORC</scp> 1 </i> , and <i> <scp>CYP</scp> 2C9 </i> in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Western University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Queen's University Belfast; Queen's University; British Heart Foundation; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Dosing; Coumarin; Pharmacology; Acenocoumarol; Confidence interval; Meta-analysis; Medicine; Cytochrome P450; Internal medicine; Chemistry; Metabolism","score_opus":0.30353908317061196,"score_gpt":0.5164399306452812,"score_spread":0.2129008474746692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902167120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13610929,0.85282296,0.004767679,0.00091377203,0.00063480577,0.00032759327,0.0028765895,0.00014773589,0.001399594],"genre_scores_gemma":[0.90434974,0.088135384,0.0032987823,0.0010397204,0.00034551474,0.00032960984,0.0017450149,0.000087471104,0.0006688729],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931704,0.0038133333,0.0012265184,0.0011203242,0.00046173556,0.00020760493],"domain_scores_gemma":[0.9870292,0.010018437,0.0013161316,0.00089977775,0.0005805624,0.00015591657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010909215,0.0019244591,0.007130048,0.0021202061,0.00042840277,0.0022625509,0.0008988146,0.0015214584,0.0017924955],"category_scores_gemma":[0.016333293,0.0009900838,0.034978505,0.0034751692,0.00043854487,0.00088123366,0.00076493755,0.00174594,0.00030301933],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007304984,0.000033028464,0.02234406,0.019169286,0.9418631,0.00014653057,0.00003920963,0.0009832382,0.0006745582,0.000104400584,0.0004676188,0.0068699736],"study_design_scores_gemma":[0.00068184367,0.00022324441,0.008768843,0.0006730213,0.98813707,0.00006900479,0.0000111018235,0.00031587796,0.00025682925,0.00015783109,0.00069241744,0.000012841745],"about_ca_topic_score_codex":0.0048033935,"about_ca_topic_score_gemma":0.006893156,"teacher_disagreement_score":0.010909215,"about_ca_system_score_codex":0.0010312028,"about_ca_system_score_gemma":0.00088121893,"threshold_uncertainty_score":0.057694137},"labels":[],"label_agreement":null},{"id":"W2908525626","doi":"10.1002/cpt.1375","title":"Drug‐Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"NIHR Nottingham Biomedical Research Centre; European Regional Development Fund; Medical Research Council; Svenska Läkaresällskapet; Uppsala Universitet; Radboud Universitair Medisch Centrum; Karolinska Institutet; University of Nottingham; King's College London; Daiichi-Sankyo; Abbott Laboratories; National Institute for Health and Care Research; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Nottingham University Hospitals NHS Trust; King’s College London; Roche; Instituto de Salud Carlos III; Amgen; Radboud Universiteit; Newcastle University; Novartis; AstraZeneca; Vetenskapsrådet; University of Warwick; Pfizer; Merck; Directorate for Biological Sciences; GlaxoSmithKline; Sanofi; Wellcome; Universiteit Utrecht","keywords":"Flucloxacillin; Human leukocyte antigen; Odds ratio; Allele; Medicine; Immunology; Penicillin; HLA-B; Genotype; Internal medicine; Biology; Antigen; Antibiotics; Gene; Genetics; Staphylococcus aureus","score_opus":0.22223027141294577,"score_gpt":0.4858570597651821,"score_spread":0.26362678835223635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908525626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989089,0.00043363063,0.00025173658,0.00004592296,0.0000020230166,0.0000036608317,0.000037232243,0.0000043259265,0.00031258035],"genre_scores_gemma":[0.99961627,0.00010135872,0.0001218406,0.000027668053,0.0000041022377,0.0000014006004,0.0000504119,0.0000018083402,0.00007502088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999495,0.0002054924,0.000055348206,0.00009256325,0.00009102604,0.000060520586],"domain_scores_gemma":[0.99871695,0.00060765794,0.00039808222,0.0001243574,0.00006401431,0.00008888906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061809807,0.00019551972,0.00038861067,0.0003946249,0.0001810281,0.00038463788,0.00014281973,0.00023735948,0.002308188],"category_scores_gemma":[0.0020661985,0.00014864502,0.00040581045,0.00054559874,0.000294409,0.00018786942,0.00023235782,0.00034297368,0.00018810405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006216829,0.000051169583,0.9794266,0.000036155205,0.00016831131,0.0010102503,0.000059857888,0.00009235637,0.0061777164,0.00005324409,0.00006122014,0.012241442],"study_design_scores_gemma":[0.00001781449,0.00018481005,0.9953825,0.0000076789165,0.000093091985,0.002255635,0.000049188468,0.00032519514,0.0013979228,0.000053356667,0.00022971026,0.000003023942],"about_ca_topic_score_codex":0.0017383149,"about_ca_topic_score_gemma":0.0021125316,"teacher_disagreement_score":0.002308188,"about_ca_system_score_codex":0.00019783399,"about_ca_system_score_gemma":0.00017498109,"threshold_uncertainty_score":0.0077216625},"labels":[],"label_agreement":null},{"id":"W2912908908","doi":"10.1002/cpt.1385","title":"Human Cardiac Ventricular‐Like Organoid Chambers and Tissue Strips From Pluripotent Stem Cells as a Two‐Tiered Assay for Inotropic Responses","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novelis (Canada)","funders":"Innovation and Technology Commission; Pfizer","keywords":"Inotrope; Organoid; Induced pluripotent stem cell; False positive paradox; Drug discovery; Drug; Pharmacology; Stem cell; Assay sensitivity; Biology; Medicine; Internal medicine; Bioinformatics; Pathology; Cell biology; Computer science; Embryonic stem cell","score_opus":0.043833239253223785,"score_gpt":0.3851340446593681,"score_spread":0.3413008054061443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912908908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81605065,0.0056928014,0.16757438,0.00033219514,0.00035109863,0.00084070105,0.0034465322,0.00064535765,0.00506627],"genre_scores_gemma":[0.89808244,0.0029552146,0.088207565,0.00048261855,0.000071852126,0.00083106884,0.0047307224,0.00007977249,0.0045588487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998609,0.0004614914,0.00015117074,0.00021149764,0.0004669438,0.00009995215],"domain_scores_gemma":[0.99914813,0.00035946196,0.00019750498,0.00009613,0.000117173724,0.00008161919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012377776,0.0007135192,0.00036842874,0.00039616277,0.00017895388,0.000448596,0.00028806957,0.0004932887,0.001261771],"category_scores_gemma":[0.000718663,0.00022868649,0.0002994307,0.00027786032,0.0003491479,0.00023937399,0.00040181068,0.0007703262,0.00035716043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004194659,0.000020642217,0.0005131333,0.00003965353,0.000009671124,0.000020012678,0.000017834765,0.00012645918,0.9976926,0.00006927494,0.000057654517,0.0013911658],"study_design_scores_gemma":[0.000006021335,0.0003757676,0.0033577492,0.00000816756,0.000024302342,0.00012097717,0.000019860981,0.0010193931,0.99375325,0.000044213622,0.0012586049,0.000011632335],"about_ca_topic_score_codex":0.00034435643,"about_ca_topic_score_gemma":0.0009488902,"teacher_disagreement_score":0.001261771,"about_ca_system_score_codex":0.00016201336,"about_ca_system_score_gemma":0.0003190314,"threshold_uncertainty_score":0.00654608},"labels":[],"label_agreement":null},{"id":"W2914208687","doi":"10.1002/cpt.1392","title":"No Clinically Relevant Interactions of St. John's Wort Extract Ze 117 Low in Hyperforin With Cytochrome P450 Enzymes and P‐glycoprotein","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dextromethorphan; Hypericum perforatum; Hyperforin; Pharmacokinetics; Pharmacology; CYP3A4; CYP2D6; Cytochrome P450; Chemistry; P-glycoprotein; Hypericum; CYP2C9; Enzyme; Medicine; Biochemistry; Traditional medicine; Antibiotics","score_opus":0.045489493036994795,"score_gpt":0.35762090363204346,"score_spread":0.3121314105950487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914208687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966767,0.0013866916,0.0008560122,0.00008791287,0.000021760065,0.00020031261,0.00016381424,0.000025656229,0.00058125897],"genre_scores_gemma":[0.99823356,0.00037429197,0.00043115497,0.00007562114,0.000016649825,0.000068507856,0.00025444877,0.0000056790163,0.0005400847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958175,0.00020479629,0.000034216933,0.00007171565,0.0000779645,0.000029631497],"domain_scores_gemma":[0.9993636,0.0003253147,0.00014306649,0.000071121394,0.000041087194,0.000055848745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005961762,0.0003149603,0.0006742914,0.000118314754,0.00013774904,0.00024322589,0.0001713002,0.00052870484,0.002137713],"category_scores_gemma":[0.0011141308,0.00012572031,0.00036166675,0.00016204952,0.00040710557,0.0002947182,0.0001600863,0.0006472218,0.00020051374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.124264404,0.004551528,0.0126585765,0.0015726996,0.0012305643,0.00090845267,0.00033222657,0.0006274627,0.75485456,0.00041448197,0.0010056101,0.09757953],"study_design_scores_gemma":[0.016796593,0.5123361,0.114677966,0.000119403296,0.0021490639,0.0031300497,0.00023403739,0.002436114,0.33200338,0.00048028157,0.015587414,0.000049581213],"about_ca_topic_score_codex":0.00030461795,"about_ca_topic_score_gemma":0.00085253257,"teacher_disagreement_score":0.002137713,"about_ca_system_score_codex":0.0002447209,"about_ca_system_score_gemma":0.00025822668,"threshold_uncertainty_score":0.0071513653},"labels":[],"label_agreement":null},{"id":"W2917080169","doi":"10.1002/cpt.1409","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <scp>Cytochrome P450 (<i>CYP</i>)</scp><i>2D6</i> Genotype and Atomoxetine Therapy","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institutes of Health","keywords":"Atomoxetine; CYP2D6; Pharmacogenetics; Pharmacology; Medicine; Cytochrome P450; Guideline; Genotype; Atomoxetine hydrochloride; Pharmacokinetics; Attention deficit hyperactivity disorder; Internal medicine; Psychiatry; Metabolism; Biology; Genetics; Methylphenidate","score_opus":0.1334353888882253,"score_gpt":0.5070233472240556,"score_spread":0.37358795833583036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917080169","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072020823,0.05590318,0.07185558,0.44293717,0.013066521,0.011201439,0.022160342,0.0055305795,0.3701431],"genre_scores_gemma":[0.05522039,0.08721118,0.28154027,0.3427546,0.012079901,0.029026117,0.05000086,0.0021508608,0.14001594],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9826261,0.007220693,0.00397936,0.0006835342,0.0046710107,0.0008193264],"domain_scores_gemma":[0.96257323,0.012442166,0.0037085062,0.0012323714,0.017914204,0.0021295694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014847389,0.0009063433,0.0016186698,0.0020460745,0.0009687279,0.0024637193,0.004082971,0.008371048,0.016341316],"category_scores_gemma":[0.04026809,0.00070749363,0.0031156954,0.0020282539,0.0008349379,0.0016620117,0.0018150891,0.008264322,0.012304158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020545242,0.0003609377,0.0019968406,0.0012406234,0.00007416064,0.0006184897,0.00022401025,0.00062334654,0.0009331962,0.005691106,0.80429566,0.18373622],"study_design_scores_gemma":[0.0008000215,0.00029721274,0.009125709,0.009041941,0.00023879412,0.0013479632,0.00021514921,0.0010655357,0.0012499496,0.007469886,0.96906954,0.00007841553],"about_ca_topic_score_codex":0.0154956225,"about_ca_topic_score_gemma":0.023906931,"teacher_disagreement_score":0.016341316,"about_ca_system_score_codex":0.0021582125,"about_ca_system_score_gemma":0.013987737,"threshold_uncertainty_score":0.07852143},"labels":[],"label_agreement":null},{"id":"W2933349877","doi":"10.1002/cpt.1446","title":"Variability in the Analgesic Response to Ibuprofen Is Associated With Cyclooxygenase Activation in Inflammatory Pain","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Biomedical Imaging and Bioengineering; University of Pennsylvania; Pfizer; Pharmaceutical Research and Manufacturers of America Foundation","keywords":"Ibuprofen; Medicine; Analgesic; Cyclooxygenase; Pharmacodynamics; Pharmacokinetics; Prostaglandin E2; Inflammation; Pharmacology; Dosing; Anesthesia; Placebo; Internal medicine; Pathology; Biology","score_opus":0.034840341964970316,"score_gpt":0.3726062647159205,"score_spread":0.3377659227509502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933349877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989213,0.00032653028,0.0004887558,0.000010504881,0.000002807157,0.000011429702,0.000078549616,0.0000047767926,0.00015536428],"genre_scores_gemma":[0.99935037,0.000103310645,0.00028394407,0.000013416361,0.0000062109407,0.000011692164,0.00012366587,0.0000022910065,0.00010507484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996617,0.00010355711,0.00003385656,0.00009407533,0.00007311371,0.000033726465],"domain_scores_gemma":[0.99928194,0.0002550967,0.00027404472,0.00008468429,0.000060498503,0.000043684497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004234502,0.00015602341,0.00034488493,0.0004408857,0.00013795108,0.00028609397,0.00010404899,0.0002161614,0.00062764547],"category_scores_gemma":[0.0009253862,0.00012513557,0.00014812379,0.00034515432,0.00023480471,0.00013731286,0.00016558408,0.00020489296,0.00011157135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004518768,0.00035068992,0.60393345,0.00014864077,0.00029046458,0.000485129,0.0005197616,0.0002917103,0.3642022,0.000077631,0.00011078391,0.025070745],"study_design_scores_gemma":[0.000008803755,0.0002957978,0.9948094,0.0000020768612,0.000027903558,0.0003788084,0.00005797637,0.00018831805,0.0040954445,0.000041952328,0.00008985475,0.0000036420092],"about_ca_topic_score_codex":0.00043734233,"about_ca_topic_score_gemma":0.00057888904,"teacher_disagreement_score":0.00062764547,"about_ca_system_score_codex":0.00008913947,"about_ca_system_score_gemma":0.000077165096,"threshold_uncertainty_score":0.002239406},"labels":[],"label_agreement":null},{"id":"W2937367049","doi":"10.1002/cpt.1477","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2B6</i> and Efavirenz‐Containing Antiretroviral Therapy","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"European and Developing Countries Clinical Trials Partnership; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institute on Minority Health and Health Disparities; Canadian Institutes of Health Research; National Institutes of Health; Partnership for Advanced Computing in Europe AISBL","keywords":"Efavirenz; CYP2B6; Discontinuation; Medicine; Reverse-transcriptase inhibitor; Pharmacogenetics; Adverse effect; Guideline; Pharmacology; Internal medicine; Oncology; Antiretroviral therapy; Human immunodeficiency virus (HIV); Virology; Genotype; Cytochrome P450; Biology; CYP1A2; Viral load; Pathology; Genetics","score_opus":0.10445328640151225,"score_gpt":0.4935270597406963,"score_spread":0.389073773339184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937367049","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050016996,0.05552799,0.074865416,0.4616271,0.016249096,0.008894,0.0143337855,0.003410183,0.36009076],"genre_scores_gemma":[0.046144903,0.077302106,0.2808393,0.4051983,0.009476727,0.01866048,0.032589123,0.001416221,0.12837291],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97881657,0.0088441055,0.0044255797,0.00067045854,0.0061285547,0.0011146886],"domain_scores_gemma":[0.9634508,0.0106181,0.0037073586,0.0011987386,0.018687705,0.0023373147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015753938,0.0008798568,0.0014102886,0.0019435246,0.0011904825,0.0030122446,0.00406791,0.009828264,0.010812],"category_scores_gemma":[0.0381587,0.0007744779,0.002852358,0.0022648727,0.0012155008,0.0017430693,0.001916251,0.011070944,0.008043305],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001415062,0.00032650575,0.0012104441,0.0012785412,0.000058731588,0.000652027,0.00024289581,0.00073036726,0.0009121402,0.011403357,0.8307925,0.15225092],"study_design_scores_gemma":[0.00029158374,0.000161752,0.0042275772,0.0056657884,0.00012198519,0.0010147432,0.00015358118,0.00072740176,0.00081313116,0.0064435224,0.9803191,0.000059960563],"about_ca_topic_score_codex":0.019581221,"about_ca_topic_score_gemma":0.027953854,"teacher_disagreement_score":0.019581221,"about_ca_system_score_codex":0.0025627546,"about_ca_system_score_gemma":0.021481488,"threshold_uncertainty_score":0.08331579},"labels":[],"label_agreement":null},{"id":"W2939463022","doi":"10.1002/cpt.1472","title":"Use of 4β‐Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CYP3A; Type 2 diabetes; Biomarker; Endocrinology; Internal medicine; Diabetes mellitus; Midazolam; Endogeny; Population; Cholesterol; Pharmacology; Medicine; Chemistry; Biology; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.37673199915207994,"score_gpt":0.5106181238650749,"score_spread":0.13388612471299494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939463022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969195,0.0011874696,0.0007917906,0.000058424557,0.000016708898,0.00004688912,0.0001633773,0.000014777295,0.00080101617],"genre_scores_gemma":[0.99856985,0.00023589697,0.0007601127,0.000058839356,0.000014415479,0.000038310438,0.00013483962,0.0000032980922,0.0001843739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987626,0.00053238554,0.00014128166,0.00025480028,0.00025613443,0.000052802818],"domain_scores_gemma":[0.9988593,0.0003675202,0.00031487964,0.00012203546,0.0001973402,0.00013906576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019579756,0.00039477315,0.00063563,0.00032494817,0.00035798145,0.00066611014,0.00025343554,0.0005186232,0.0005172535],"category_scores_gemma":[0.0031922448,0.000196718,0.00022743508,0.0004394865,0.00039733754,0.00021861901,0.00026604024,0.0006075108,0.00019644489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035238883,0.00026603066,0.9620028,0.00007466549,0.00015003479,0.00020460616,0.00024232069,0.00016240026,0.016370093,0.000034756864,0.00014631289,0.016821979],"study_design_scores_gemma":[0.00014274141,0.0024940073,0.9886185,0.000016682903,0.0001207859,0.00083632855,0.00013762793,0.00075531524,0.0062730834,0.00005287566,0.00054016995,0.000011887785],"about_ca_topic_score_codex":0.0008262954,"about_ca_topic_score_gemma":0.0012256964,"teacher_disagreement_score":0.0019579756,"about_ca_system_score_codex":0.000230327,"about_ca_system_score_gemma":0.00026924725,"threshold_uncertainty_score":0.010354936},"labels":[],"label_agreement":null},{"id":"W2941831619","doi":"10.1002/cpt.1483","title":"Pharmacogenomics of Cisplatin‐Induced Ototoxicity: Successes, Shortcomings, and Future Avenues of Research","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Ototoxicity; Cisplatin; Medicine; Consistency (knowledge bases); Intensive care medicine; Pharmacology; Computer science; Internal medicine; Chemotherapy; Artificial intelligence","score_opus":0.5535828575587237,"score_gpt":0.5868099747994561,"score_spread":0.03322711724073235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941831619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000103628554,0.99841654,0.00016175247,0.00084669713,0.00010994694,0.0000021146836,0.000011770005,0.0000046456603,0.000342851],"genre_scores_gemma":[0.0005971041,0.9986223,0.00019666633,0.0002680313,0.00017902865,0.000003180392,0.000014351408,0.0000010643148,0.00011829021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996698,0.000100911406,0.000053086787,0.000060872775,0.00008980255,0.00002558877],"domain_scores_gemma":[0.99837923,0.0011231605,0.00011209009,0.000038798527,0.00028249272,0.00006408677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017870596,0.0006194917,0.001573265,0.0017352467,0.00023098566,0.0014222093,0.00087138684,0.0012646725,0.0015441977],"category_scores_gemma":[0.0018406475,0.00021789441,0.00061355816,0.0017220031,0.0008269902,0.0014490548,0.0007614673,0.0020156885,0.0006561318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072952964,0.00005814598,0.0005633923,0.01299054,0.00017676545,0.00024282708,0.000068573165,0.00040476062,0.00108308,0.00788727,0.016992424,0.95945925],"study_design_scores_gemma":[0.00003237898,0.00021258373,0.0035536694,0.012410098,0.0004696927,0.0030039412,0.0002077646,0.00042464028,0.001027119,0.013841025,0.96475995,0.00005718897],"about_ca_topic_score_codex":0.0011395453,"about_ca_topic_score_gemma":0.0022663926,"teacher_disagreement_score":0.0017870596,"about_ca_system_score_codex":0.00088973064,"about_ca_system_score_gemma":0.0019530756,"threshold_uncertainty_score":0.009451032},"labels":[],"label_agreement":null},{"id":"W2944279315","doi":"10.1002/cpt.1493","title":"Shared Genetic Risk Factors Across Carbamazepine‐Induced Hypersensitivity Reactions","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Daiichi Sankyo Europe; European Regional Development Fund; National Institute of Allergy and Infectious Diseases; Medical Research Council; Svenska Läkaresällskapet; National Institutes of Health; Pfizer; Vetenskapsrådet; National Institute of General Medical Sciences; National Institute for Health and Care Research; University of Nottingham; Nottingham University Hospitals NHS Trust; AstraZeneca; National Institute of Diabetes and Digestive and Kidney Diseases; Instituto de Salud Carlos III; Amgen; Wellcome Trust; GlaxoSmithKline","keywords":"Carbamazepine; Hypersensitivity reaction; Delayed hypersensitivity; Medicine; Pharmacology; Epilepsy; Immunology; Psychiatry; Antigen","score_opus":0.3573320228502688,"score_gpt":0.5316509958784539,"score_spread":0.17431897302818505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944279315","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816212,0.014218959,0.0017461969,0.00022046069,0.00007249626,0.000047510028,0.0008855298,0.00005272897,0.0011348961],"genre_scores_gemma":[0.9973832,0.0013996004,0.0005299009,0.000070124675,0.000029888834,0.000018195351,0.00039842504,0.00001307925,0.00015766142],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9980202,0.00051402854,0.00025188757,0.00081433763,0.00023995589,0.00015963743],"domain_scores_gemma":[0.99815327,0.0007837448,0.00044084995,0.00033532368,0.00015691295,0.00012980458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013807393,0.0008389334,0.0012162959,0.0013742888,0.00042771685,0.0009648219,0.00050163525,0.0007824502,0.0028368982],"category_scores_gemma":[0.0031310383,0.00039401103,0.003786812,0.0024140002,0.0003980592,0.00035374114,0.000588712,0.00063971855,0.00016506892],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026854174,0.000093415125,0.9410768,0.0006997671,0.02735311,0.0017660052,0.00020434019,0.0007183935,0.011090475,0.0004129581,0.00047995706,0.013419541],"study_design_scores_gemma":[0.00019661951,0.00026197903,0.9814046,0.00009358376,0.012999209,0.0016125982,0.00012996611,0.0008911649,0.0012473612,0.00040167454,0.0007398858,0.000021318037],"about_ca_topic_score_codex":0.004225203,"about_ca_topic_score_gemma":0.004414655,"teacher_disagreement_score":0.004225203,"about_ca_system_score_codex":0.0002958217,"about_ca_system_score_gemma":0.00035415162,"threshold_uncertainty_score":0.00949043},"labels":[],"label_agreement":null},{"id":"W2944956458","doi":"10.1002/cpt.1496","title":"Modulation of <scp>CYP</scp>450 Activities in Patients With Type 2 Diabetes","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Tolbutamide; CYP2B6; CYP2C19; CYP1A2; Chlorzoxazone; Type 2 diabetes; Pharmacology; CYP3A; CYP2D6; CYP2C9; Medicine; Diabetes mellitus; CYP2E1; Internal medicine; Dextromethorphan; Cytochrome P450; Endocrinology; Metabolism","score_opus":0.09800917757700978,"score_gpt":0.4363264046354054,"score_spread":0.3383172270583956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944956458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986933,0.00082716905,0.00014424323,0.00002019291,0.0000059567474,0.000009234185,0.00008677689,0.0000050977633,0.00020812149],"genre_scores_gemma":[0.9991167,0.00025969095,0.00017285079,0.000045157307,0.000013129225,0.0000091041275,0.00017950768,0.0000024826313,0.00020136105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997209,0.00011319647,0.000023120294,0.00006394088,0.00004385863,0.00003501527],"domain_scores_gemma":[0.9997377,0.00006547628,0.00007640767,0.000026563972,0.00002289272,0.00007103154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034917635,0.000270843,0.0004869036,0.00025961254,0.00021975697,0.00037180822,0.000091182534,0.00028411267,0.0008001934],"category_scores_gemma":[0.00049600354,0.0001641737,0.00028352387,0.00032865195,0.00016838136,0.00013640823,0.00013692924,0.0004830732,0.00015409368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018567918,0.0010511158,0.85455006,0.00009485708,0.0005306601,0.00067643577,0.00025031634,0.00022869115,0.09520331,0.000029913359,0.00023161406,0.028585065],"study_design_scores_gemma":[0.00016385796,0.0038734945,0.988926,0.00000420925,0.00012430422,0.00061159185,0.00006416433,0.00026076203,0.0055041355,0.00002183904,0.00043929063,0.0000064609294],"about_ca_topic_score_codex":0.00081808795,"about_ca_topic_score_gemma":0.0009604613,"teacher_disagreement_score":0.00081808795,"about_ca_system_score_codex":0.00015780042,"about_ca_system_score_gemma":0.00010872416,"threshold_uncertainty_score":0.0026769042},"labels":[],"label_agreement":null},{"id":"W2949245773","doi":"10.1002/cpt.1550","title":"An Update on Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Transcranial magnetic stimulation; Depression (economics); Dorsolateral prefrontal cortex; Stimulation; Neuroscience; Prefrontal cortex; Medicine; Major depressive disorder; Psychology; Treatment-resistant depression; Brain stimulation; Deep transcranial magnetic stimulation; Physical medicine and rehabilitation; Cognition","score_opus":0.25466970509798215,"score_gpt":0.5031502682251587,"score_spread":0.2484805631271766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949245773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000103023245,0.9978332,0.00010390259,0.00041530764,0.00040185623,0.000007689686,0.00003624245,0.0000069169396,0.0010917196],"genre_scores_gemma":[0.00033024276,0.99827325,0.00019766223,0.0003902983,0.00028857877,0.00000824531,0.000045730867,0.0000016523456,0.00046430054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999798,0.000041043593,0.000048769765,0.000030621202,0.000068465226,0.000013209211],"domain_scores_gemma":[0.9995751,0.00023347088,0.000056520435,0.00000737855,0.00010060609,0.000026989384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058178935,0.00072355935,0.0010945227,0.0020650928,0.00022367194,0.0008346655,0.0008122927,0.0010031278,0.005531048],"category_scores_gemma":[0.00094295415,0.00021628385,0.000638599,0.0018055618,0.00024027124,0.0010846778,0.0005009355,0.0014913455,0.0021867112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000684633,0.00007167049,0.00010083003,0.030424949,0.0001121138,0.0002001729,0.000061351035,0.00016440418,0.0011530233,0.0018625685,0.04457432,0.9212061],"study_design_scores_gemma":[0.000031352043,0.00014350103,0.00072375673,0.011461634,0.00025727449,0.0013054609,0.000045155375,0.00006877248,0.00021919934,0.0010439863,0.98468196,0.000017968783],"about_ca_topic_score_codex":0.0009961406,"about_ca_topic_score_gemma":0.002781786,"teacher_disagreement_score":0.005531048,"about_ca_system_score_codex":0.00041684622,"about_ca_system_score_gemma":0.0010735763,"threshold_uncertainty_score":0.01850319},"labels":[],"label_agreement":null},{"id":"W2949442333","doi":"10.1002/cpt.1541","title":"The Current and Future Potential of Transcranial Magnetic Stimulation With Electroencephalography in Psychiatry","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; University of Ottawa; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Canadian Institutes of Health Research; Ontario Mental Health Foundation; Campbell Institute","keywords":"Transcranial magnetic stimulation; Electroencephalography; Neuroscience; Dorsolateral prefrontal cortex; Schizophrenia (object-oriented programming); Prefrontal cortex; Psychology; Major depressive disorder; Medicine; Psychiatry; Stimulation; Cognition","score_opus":0.08977580616819512,"score_gpt":0.41961425132900865,"score_spread":0.3298384451608135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949442333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000068737274,0.99891675,0.0000904997,0.00029748995,0.00009853693,0.0000023661416,0.000009127401,0.0000043087744,0.00051218475],"genre_scores_gemma":[0.0005011973,0.9987753,0.00016809824,0.00017928626,0.00017689762,0.0000040183513,0.000011842861,9.131798e-7,0.00018242473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977416,0.00005752761,0.000037164158,0.000040874107,0.00007141656,0.000018907955],"domain_scores_gemma":[0.9991248,0.00058633403,0.000083643354,0.000021851782,0.00013739354,0.000045904162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010809695,0.0008077229,0.0013473282,0.002054031,0.00023187272,0.0011032752,0.0008393143,0.0013232462,0.0051857904],"category_scores_gemma":[0.0011221697,0.00028561786,0.0006136897,0.0020146864,0.0006374573,0.0019168678,0.0007562281,0.0017360912,0.0021712861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070836984,0.00005342871,0.00015560887,0.01707537,0.00008565669,0.00012496134,0.00005264288,0.00019221289,0.0010720196,0.0028942227,0.009201607,0.9690214],"study_design_scores_gemma":[0.000045139004,0.00024821176,0.0025777589,0.011113554,0.00029703372,0.0016228508,0.00016258853,0.00020711908,0.000533872,0.0071942178,0.9759497,0.0000478696],"about_ca_topic_score_codex":0.0010043446,"about_ca_topic_score_gemma":0.0020433257,"teacher_disagreement_score":0.0051857904,"about_ca_system_score_codex":0.00058395375,"about_ca_system_score_gemma":0.0012610927,"threshold_uncertainty_score":0.01734817},"labels":[],"label_agreement":null},{"id":"W2949540323","doi":"10.1002/cpt.1539","title":"Investigation on the Existence of Sex‐By‐Formulation Interaction in Bioequivalence Trials","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Bioequivalence; Confidence interval; Demography; Medicine; Sex ratio; Food and drug administration; Statistics; Internal medicine; Mathematics; Pharmacokinetics; Population; Environmental health","score_opus":0.578268039446847,"score_gpt":0.5455355756224989,"score_spread":0.032732463824348135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949540323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6842394,0.19696058,0.07929405,0.0028103616,0.0012135685,0.0103146825,0.0021191875,0.00016356261,0.02288466],"genre_scores_gemma":[0.97799623,0.005001059,0.01226148,0.00072490034,0.0002334841,0.0023517963,0.00037236858,0.000039149116,0.0010195429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.74726355,0.19706339,0.028337993,0.005828614,0.020270549,0.0012359143],"domain_scores_gemma":[0.5494858,0.37656745,0.049169697,0.014483434,0.009573473,0.000720137],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21275383,0.00069614704,0.0023439273,0.0013108498,0.0005921532,0.002114358,0.0010730273,0.0022426194,0.0053194417],"category_scores_gemma":[0.24545074,0.00046786582,0.004871285,0.0025343287,0.001866322,0.0022944403,0.0014024583,0.001353343,0.00038449396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1090167,0.0017569573,0.4194369,0.034760103,0.06293573,0.0013636639,0.005108854,0.0014862508,0.0097160265,0.0104594445,0.0029025667,0.34105685],"study_design_scores_gemma":[0.011512326,0.11856917,0.6491387,0.010091476,0.08148794,0.007929786,0.0021614803,0.009415188,0.028011762,0.016919302,0.06436656,0.0003963447],"about_ca_topic_score_codex":0.0002693276,"about_ca_topic_score_gemma":0.000394766,"teacher_disagreement_score":0.21275383,"about_ca_system_score_codex":0.0010485606,"about_ca_system_score_gemma":0.0016308848,"threshold_uncertainty_score":0.9708147},"labels":[],"label_agreement":null},{"id":"W2950225668","doi":"10.1002/cpt.1542","title":"Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: Clinical Effects and Future Perspectives","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Transcranial magnetic stimulation; Deep brain stimulation; Transcranial alternating current stimulation; Neuroscience; Parkinson's disease; Transcranial direct-current stimulation; Motor cortex; Stimulation; Brain stimulation; Deep transcranial magnetic stimulation; Medicine; Neuroplasticity; Psychology; Physical medicine and rehabilitation; Disease; Internal medicine","score_opus":0.1264158307223851,"score_gpt":0.4791668057454216,"score_spread":0.3527509750230365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950225668","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094061055,0.99906594,0.00006940458,0.00017390598,0.000091022026,0.000002838267,0.00000736746,0.00000326387,0.0004922118],"genre_scores_gemma":[0.0004793558,0.9988362,0.0001494843,0.00015977833,0.000110023895,0.0000056171584,0.000013010262,9.947008e-7,0.00024563618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984133,0.000031996606,0.000028527445,0.000030077817,0.00005236932,0.000015783648],"domain_scores_gemma":[0.99966395,0.00020303932,0.000033768025,0.000009008804,0.00006855332,0.000021816128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075604115,0.0007998343,0.0014314314,0.0016850685,0.00020956516,0.00096575916,0.0007214878,0.0012138555,0.003326765],"category_scores_gemma":[0.0006253881,0.0002173139,0.00057870115,0.0014705439,0.00047417084,0.0011832528,0.0005098473,0.0015019344,0.0016018968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009427307,0.000088915185,0.00011365486,0.019916132,0.00008928532,0.00020390716,0.000060291048,0.0002923887,0.0020017473,0.002712091,0.011584158,0.9628431],"study_design_scores_gemma":[0.00005807711,0.00034563913,0.0014823737,0.009593295,0.0002513346,0.0026473124,0.00014556233,0.00020875194,0.00071101426,0.0047494597,0.97976786,0.000039249822],"about_ca_topic_score_codex":0.00059963844,"about_ca_topic_score_gemma":0.0014066758,"teacher_disagreement_score":0.003326765,"about_ca_system_score_codex":0.00038724867,"about_ca_system_score_gemma":0.00078379497,"threshold_uncertainty_score":0.011129141},"labels":[],"label_agreement":null},{"id":"W2954818509","doi":"10.1002/cpt.1471","title":"Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Horizon 2020 Framework Programme; Medical Research Council; National Institute for Health and Care Research; European Commission; Bundesinstitut für Arzneimittel und Medizinprodukte","keywords":"Pharmacogenomics; Agency (philosophy); Harmonization; Regulatory science; Specialty; Precision medicine; Medical education; Medicine; Family medicine; Pharmacology; Sociology","score_opus":0.3948679866942507,"score_gpt":0.55277601827374,"score_spread":0.1579080315794893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954818509","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003323536,0.02948948,0.0025190825,0.9507496,0.0043278737,0.000083678235,0.00011141451,0.000107459426,0.009287989],"genre_scores_gemma":[0.14435935,0.122493304,0.035385318,0.67391586,0.012432654,0.0008572381,0.0010209111,0.0003199958,0.009215369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97989094,0.011116607,0.0011020113,0.0015319725,0.0028460156,0.0035124402],"domain_scores_gemma":[0.9014932,0.03734022,0.0043496015,0.002654237,0.012374105,0.04178859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0480707,0.0010842258,0.0012073439,0.0033691812,0.005853864,0.013485259,0.0032617364,0.013039383,0.018826034],"category_scores_gemma":[0.04885667,0.0007509667,0.001424857,0.0023323682,0.008729657,0.029385244,0.022341939,0.018316636,0.0046026246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014714457,0.00084422587,0.009699894,0.00504307,0.0000845197,0.0012744112,0.034123104,0.00039443668,0.0010696357,0.06712334,0.36378977,0.5164065],"study_design_scores_gemma":[0.00013461636,0.00029417165,0.0076492736,0.016483497,0.00006497366,0.0019179867,0.06139823,0.00062549877,0.00043665353,0.10473339,0.80611116,0.00015061226],"about_ca_topic_score_codex":0.0037364052,"about_ca_topic_score_gemma":0.0037566323,"teacher_disagreement_score":0.0480707,"about_ca_system_score_codex":0.00548822,"about_ca_system_score_gemma":0.037043955,"threshold_uncertainty_score":0.2542252},"labels":[],"label_agreement":null},{"id":"W2964240041","doi":"10.1002/cpt.1574","title":"Transcranial Magnetic and Electrical Stimulation in Alzheimer's Disease and Mild Cognitive Impairment: A Review of Randomized Controlled Trials","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Transcranial magnetic stimulation; Randomized controlled trial; Transcranial direct-current stimulation; Dementia; Brain stimulation; Stimulation; Physical medicine and rehabilitation; Alzheimer's disease; Psychological intervention; Deep transcranial magnetic stimulation; Medicine; Psychology; Neuroscience; Disease; Psychiatry; Internal medicine","score_opus":0.27803764855153024,"score_gpt":0.5043927439523119,"score_spread":0.2263550954007817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964240041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016423238,0.9994561,0.000043623662,0.00007164552,0.000051423496,0.000045980734,0.00004879593,0.0000036401498,0.000114530936],"genre_scores_gemma":[0.0024445478,0.9967519,0.00025868224,0.00019952275,0.00008313341,0.00011400383,0.000065030814,0.0000023103075,0.00008095192],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978974,0.00069267926,0.00070277456,0.0002428548,0.00038956967,0.00007462238],"domain_scores_gemma":[0.9923149,0.005939359,0.0010348117,0.000085610685,0.0005259943,0.000099293655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045625176,0.0014612525,0.007737449,0.0029565392,0.00034157725,0.0013047329,0.0017474431,0.001440521,0.006787193],"category_scores_gemma":[0.011166516,0.0005018935,0.005530159,0.0035384358,0.000520246,0.0010664648,0.0006436319,0.0013123602,0.00046812947],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029809729,0.00011691428,0.00030813063,0.6590808,0.00950051,0.00007523959,0.000052155825,0.00028140587,0.0003688031,0.00045858775,0.006413881,0.3203626],"study_design_scores_gemma":[0.0088583045,0.0036492953,0.0082559185,0.6770522,0.15136036,0.0010690271,0.00021571711,0.00045462258,0.0009266829,0.0022095775,0.14581832,0.00012995786],"about_ca_topic_score_codex":0.001971375,"about_ca_topic_score_gemma":0.004471493,"teacher_disagreement_score":0.007737449,"about_ca_system_score_codex":0.0013028427,"about_ca_system_score_gemma":0.0023370942,"threshold_uncertainty_score":0.024129152},"labels":[],"label_agreement":null},{"id":"W2967546963","doi":"10.1002/cpt.1532","title":"The Age of Omics‐Driven Precision Medicine","year":2019,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Omics; Precision medicine; Medicine; Computational biology; Computer science; Bioinformatics; Biology; Pathology","score_opus":0.06096806224417636,"score_gpt":0.44244562694052586,"score_spread":0.3814775646963495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967546963","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048992597,0.60618556,0.1469649,0.20111568,0.009929351,0.00022485157,0.002356677,0.0017644855,0.026559183],"genre_scores_gemma":[0.08200014,0.63667655,0.12403118,0.111382276,0.033922732,0.0005563546,0.0027681862,0.0008002419,0.007862317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98920757,0.0044453247,0.00052414223,0.001515583,0.0038082954,0.00049905374],"domain_scores_gemma":[0.95725876,0.030696949,0.0014959926,0.003448054,0.005508756,0.0015914239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025572658,0.0016773776,0.0040544844,0.0038070646,0.0014713459,0.0074941204,0.0038146735,0.007034878,0.010318896],"category_scores_gemma":[0.03865551,0.00079692807,0.0017451936,0.003323096,0.007835067,0.012838619,0.0063116304,0.010708892,0.0040272875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007643868,0.00018238653,0.0032968833,0.0063806786,0.0005498498,0.0006389325,0.0010908213,0.0047514252,0.006757318,0.34515655,0.12693456,0.5034961],"study_design_scores_gemma":[0.00009016918,0.00023283088,0.0014179315,0.0033026098,0.00014979398,0.0007295396,0.000420892,0.0043261177,0.0026364634,0.3809516,0.60558164,0.00016039544],"about_ca_topic_score_codex":0.0024212836,"about_ca_topic_score_gemma":0.0013615977,"teacher_disagreement_score":0.025572658,"about_ca_system_score_codex":0.00441591,"about_ca_system_score_gemma":0.007653146,"threshold_uncertainty_score":0.13524276},"labels":[],"label_agreement":null},{"id":"W2972681847","doi":"10.1002/cpt.1611","title":"Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics‐Based Patient Care Program in a Real‐World Setting","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Citation; Associate editor; Precision medicine; Library science; Medicine; Psychology; Computer science","score_opus":0.2889980624840852,"score_gpt":0.5879891898422483,"score_spread":0.29899112735816313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972681847","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07660357,0.010497201,0.10980212,0.7598947,0.003560566,0.0015674628,0.00038876076,0.0013294984,0.036355987],"genre_scores_gemma":[0.64668185,0.008855755,0.23668893,0.09954118,0.0024009193,0.0017247009,0.00044021016,0.00034525016,0.003321211],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9554568,0.0302001,0.0021626987,0.0032193519,0.005677984,0.003282995],"domain_scores_gemma":[0.8812662,0.061108865,0.005192691,0.010954225,0.015158308,0.02631975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06726998,0.0010060109,0.0011444914,0.001273904,0.00412121,0.011323711,0.0060641603,0.006978029,0.007612296],"category_scores_gemma":[0.10024092,0.0006925413,0.0013648863,0.0014778367,0.006005881,0.007454368,0.010469946,0.011919367,0.0010382339],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009836775,0.008341721,0.055931225,0.002592111,0.00062274473,0.0022988298,0.0095318295,0.012451325,0.0016338209,0.06437286,0.07838789,0.76285195],"study_design_scores_gemma":[0.0053539583,0.012930854,0.18661368,0.02227927,0.00097300415,0.004434915,0.036475066,0.031612743,0.00835422,0.27838928,0.4113366,0.0012463073],"about_ca_topic_score_codex":0.019274054,"about_ca_topic_score_gemma":0.032483663,"teacher_disagreement_score":0.06726998,"about_ca_system_score_codex":0.010939144,"about_ca_system_score_gemma":0.06422392,"threshold_uncertainty_score":0.3557619},"labels":[],"label_agreement":null},{"id":"W2972702245","doi":"10.1002/cpt.1625","title":"Secondary Stroke Prevention: A Population‐Based Cohort Study on Anticoagulation and Antiplatelet Treatments, and the Risk of Death or Recurrence","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Stroke (engine); Cohort; Internal medicine; Confidence interval; Cohort study; Proportional hazards model; Clinical trial; Surgery","score_opus":0.06890834805972829,"score_gpt":0.4178344151945049,"score_spread":0.34892606713477664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972702245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473554,0.0003679133,0.00019211438,0.000106446605,0.000013925587,0.00010488089,0.003958181,0.0000064442834,0.00051458826],"genre_scores_gemma":[0.99679095,0.00016406631,0.0002027833,0.00012181087,0.0000212072,0.00007267806,0.0021839177,0.000004218422,0.000438364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878734,0.00026676955,0.00011920049,0.000291036,0.0002832928,0.00025239054],"domain_scores_gemma":[0.9978644,0.00023949302,0.00072276394,0.00023882564,0.0005603453,0.00037406015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016219537,0.0005682441,0.00064047385,0.0012198444,0.0012629379,0.0011082133,0.0010107134,0.00084970705,0.0018361965],"category_scores_gemma":[0.0025743062,0.00061679696,0.0013648772,0.0025251363,0.00042885574,0.0006851181,0.0007855956,0.0012523666,0.00031615133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039396432,0.00014219776,0.9975768,0.00001808454,0.00043188414,0.00004740511,0.00008847686,0.00004844781,0.00011214301,0.000031128337,0.00042275514,0.0006866795],"study_design_scores_gemma":[0.000109504814,0.00014890508,0.99846494,0.00001260606,0.000177611,0.00007933876,0.00014001912,0.0004920278,0.000028097213,0.000022571727,0.00031390818,0.000010658906],"about_ca_topic_score_codex":0.59814364,"about_ca_topic_score_gemma":0.61338514,"teacher_disagreement_score":0.59814364,"about_ca_system_score_codex":0.003569937,"about_ca_system_score_gemma":0.004274073,"threshold_uncertainty_score":0.80844593},"labels":[],"label_agreement":null},{"id":"W2972996415","doi":"10.1002/cpt.1572","title":"Deep Brain Stimulation in Depression: Even if Successful, Will It Ever Be Scalable?","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Library science; Mental health; Citation; Psychology; Medicine; Psychiatry; Computer science","score_opus":0.06912674434156954,"score_gpt":0.42471037554815094,"score_spread":0.35558363120658143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972996415","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044147436,0.44797727,0.018530123,0.448568,0.012198911,0.00038103553,0.0013126057,0.0003700278,0.02651467],"genre_scores_gemma":[0.34576568,0.5160693,0.033725757,0.06793833,0.018105319,0.00085724925,0.0011251683,0.00016575876,0.016247496],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9994728,0.00022024316,0.00004661154,0.000059903618,0.00011660228,0.00008385318],"domain_scores_gemma":[0.99538773,0.0026803652,0.00037771158,0.00022411474,0.00078064256,0.0005494665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004102097,0.00046154446,0.001186784,0.0001764249,0.0002129501,0.0015751588,0.000865082,0.0018299697,0.012751213],"category_scores_gemma":[0.0082957875,0.00014985126,0.00068789214,0.00025498722,0.0012002992,0.00269207,0.000781123,0.0033807005,0.0022429738],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002397241,0.00054275437,0.0027296015,0.001970133,0.0004852997,0.00022879508,0.00008582992,0.002132676,0.0031646828,0.023229232,0.07906677,0.88396686],"study_design_scores_gemma":[0.0054928265,0.01423886,0.051483214,0.02111967,0.0018415132,0.0014458008,0.0014116563,0.012059598,0.007832363,0.22218335,0.6605829,0.00030828203],"about_ca_topic_score_codex":0.0035535155,"about_ca_topic_score_gemma":0.007369435,"teacher_disagreement_score":0.012751213,"about_ca_system_score_codex":0.0010084829,"about_ca_system_score_gemma":0.0031829616,"threshold_uncertainty_score":0.042657077},"labels":[],"label_agreement":null},{"id":"W2976816195","doi":"10.1002/cpt.2166","title":"PharmVar GeneFocus: <i>CYP2B6</i>","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Medical Research Council; National Institutes of Health; Canada Research Chairs; Robert Bosch Stiftung; Horizon 2020 Framework Programme; European Federation of Pharmaceutical Industries and Associations; National Research Foundation; Canadian Institutes of Health Research; Australian Centre for HIV and Hepatitis Virology Research; European Commission; Vetenskapsrådet; Centre for Addiction and Mental Health; McGill University","keywords":"Medicine; Pharmacology","score_opus":0.5691523363200172,"score_gpt":0.6343200664153339,"score_spread":0.06516773009531673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976816195","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041440157,0.21896331,0.020651182,0.009555732,0.0019714818,0.0008629481,0.5724406,0.015637204,0.15577348],"genre_scores_gemma":[0.014103561,0.24647555,0.035800815,0.006131663,0.0009981839,0.00080714066,0.6544774,0.003279583,0.03792612],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937916,0.0001138385,0.00012714835,0.00009077728,0.00023123846,0.000057795838],"domain_scores_gemma":[0.9979049,0.0008720625,0.00038697154,0.0001637348,0.00050035166,0.00017200236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012071386,0.0009353675,0.0014274156,0.006151922,0.00033404218,0.0022574004,0.0016513687,0.0013572728,0.060299613],"category_scores_gemma":[0.004253371,0.00036049655,0.0008132128,0.010703589,0.00041929624,0.0017757289,0.0015206764,0.0011544697,0.042961735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018224512,0.00004975457,0.000758612,0.015257738,0.00011630464,0.00027792453,0.0001698078,0.00041593608,0.0030915863,0.008721922,0.48648113,0.48447707],"study_design_scores_gemma":[0.000013175978,0.000008785602,0.00080074265,0.00090594275,0.000038800918,0.00018801185,0.000013531315,0.000047414323,0.0005502687,0.00073234586,0.9966912,0.000009790239],"about_ca_topic_score_codex":0.004728802,"about_ca_topic_score_gemma":0.004390454,"teacher_disagreement_score":0.060299613,"about_ca_system_score_codex":0.0007433943,"about_ca_system_score_gemma":0.0031748281,"threshold_uncertainty_score":0.20172226},"labels":[],"label_agreement":null},{"id":"W2977861177","doi":"10.1002/cpt.1622","title":"The Future of Precision Medicine","year":2019,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Pharmacogenomics; Precision medicine; Therapeutic drug monitoring; Personalized medicine; Medicine; Intensive care medicine; Key (lock); Clinical pharmacology; Drug; Medical physics; Pharmacology; Bioinformatics; Computer science; Biology; Pathology","score_opus":0.05672421129191929,"score_gpt":0.4516181753745289,"score_spread":0.3948939640826096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977861177","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044141383,0.1004907,0.00076871295,0.12408762,0.7720018,0.000013423874,0.00005337798,0.00012542252,0.0024148358],"genre_scores_gemma":[0.00082246936,0.050654627,0.0005387177,0.051641215,0.8894912,0.000015691498,0.000035259975,0.000044671513,0.0067562386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9868775,0.0038279023,0.0012077097,0.0011986815,0.0064201998,0.00046784958],"domain_scores_gemma":[0.9408894,0.034278233,0.002047496,0.0017505077,0.017306877,0.0037274538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014220313,0.0022295148,0.0026592845,0.0029040843,0.002149839,0.0102474075,0.003346121,0.014760714,0.009350495],"category_scores_gemma":[0.038035475,0.0008404555,0.0026639781,0.0011974483,0.005771131,0.007116124,0.0023499003,0.03072125,0.007047964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004204982,0.000010100893,0.0000332013,0.00060589204,0.000057796457,0.00009153431,0.00004134838,0.00009778667,0.00010585257,0.0057644146,0.96228975,0.030860363],"study_design_scores_gemma":[0.000022886383,0.00002106045,0.000070016504,0.00045552812,0.00002263548,0.00014376486,0.000033017895,0.00013781355,0.00005669212,0.010544939,0.9884737,0.000018020266],"about_ca_topic_score_codex":0.0013196059,"about_ca_topic_score_gemma":0.0024438715,"teacher_disagreement_score":0.014760714,"about_ca_system_score_codex":0.004517845,"about_ca_system_score_gemma":0.0060156784,"threshold_uncertainty_score":0.07520509},"labels":[],"label_agreement":null},{"id":"W2980883791","doi":"10.1002/cpt.1698","title":"Reproducing Protocol‐Based Studies Using Parameterizable Tools—Comparison of Analytic Approaches Used by Two Medical Product Surveillance Networks","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Society of Nephrology; Institut universitaire en santé mentale de Montréal; Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; U.S. Food and Drug Administration","keywords":"Protocol (science); Medicine; Observational study; Hazard; Acute pancreatitis; Emergency medicine; Pharmacology; Computer science; Internal medicine; Pathology; Alternative medicine","score_opus":0.7218767300534139,"score_gpt":0.6223373168771107,"score_spread":0.09953941317630322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980883791","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10685164,0.0007142109,0.87635034,0.0012733279,0.00033680515,0.00964227,0.0013141937,0.00075508974,0.0027620324],"genre_scores_gemma":[0.57816756,0.00031121916,0.4039041,0.00066373695,0.00011300576,0.0149729615,0.0012155927,0.00021921491,0.00043253214],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.2610403,0.7058179,0.013170546,0.007636078,0.011314612,0.0010206476],"domain_scores_gemma":[0.12611593,0.7296189,0.024157241,0.10688067,0.012059073,0.0011682175],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.56774753,0.0016935855,0.0025265624,0.0027056746,0.0008670337,0.0040932917,0.004476471,0.0038227271,0.0026481724],"category_scores_gemma":[0.7787768,0.0017765786,0.005857384,0.0028413178,0.003925679,0.0046313927,0.005437266,0.003655818,0.00039050667],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03430159,0.002861611,0.10538891,0.005170525,0.0385045,0.0005894319,0.00906373,0.27890116,0.0042026495,0.124081425,0.0052450644,0.3916895],"study_design_scores_gemma":[0.023848591,0.016430277,0.070982434,0.0022638468,0.013336778,0.00066471664,0.0015315633,0.60784805,0.008771992,0.24066192,0.012740985,0.0009188902],"about_ca_topic_score_codex":0.0042967126,"about_ca_topic_score_gemma":0.002409118,"teacher_disagreement_score":0.43225247,"about_ca_system_score_codex":0.0041612224,"about_ca_system_score_gemma":0.007361601,"threshold_uncertainty_score":0.5330443},"labels":[],"label_agreement":null},{"id":"W2986767939","doi":"10.1002/cpt.1715","title":"Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; University College London","keywords":"Treosulfan; Medicine; Hazard ratio; Hematopoietic stem cell transplantation; Confidence interval; Internal medicine; Cumulative incidence; Transplantation; Oncology; Surgery; Busulfan","score_opus":0.06178584043855033,"score_gpt":0.36371784059020607,"score_spread":0.3019320001516557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986767939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929739,0.0046062157,0.0006670921,0.00035203758,0.000043060292,0.000350916,0.00023995283,0.000026028147,0.0007406241],"genre_scores_gemma":[0.9951256,0.0024218753,0.0009505665,0.00033281752,0.00005896277,0.00044034488,0.00036246475,0.000008353254,0.00029907806],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986318,0.0009858189,0.000077641074,0.00011255877,0.000107425636,0.00008476311],"domain_scores_gemma":[0.99841523,0.00078117236,0.00032869316,0.00013827872,0.00006279833,0.00027376393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004013355,0.00044368705,0.0008548277,0.00018977115,0.00014523415,0.00078572286,0.0003970151,0.0006759385,0.0013587544],"category_scores_gemma":[0.0021768347,0.00013580706,0.0010323535,0.00024513423,0.00049067213,0.0006265557,0.0002303896,0.0016519333,0.00018946234],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.724812,0.020139996,0.01902331,0.0007074118,0.0019281029,0.00016482055,0.00027615967,0.0074046566,0.016463943,0.0016207821,0.0013814615,0.20607735],"study_design_scores_gemma":[0.4315495,0.5221834,0.028836356,0.00019672928,0.0017219648,0.00031971242,0.00007435522,0.0047368016,0.005170426,0.00095089397,0.0042212754,0.000038571925],"about_ca_topic_score_codex":0.00023012725,"about_ca_topic_score_gemma":0.000586667,"teacher_disagreement_score":0.004013355,"about_ca_system_score_codex":0.0004841411,"about_ca_system_score_gemma":0.00069449045,"threshold_uncertainty_score":0.021224916},"labels":[],"label_agreement":null},{"id":"W3001449808","doi":"10.1002/cpt.1795","title":"Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?","year":2020,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Context (archaeology); Drug discovery; Clinical pharmacology; Identification (biology); Clinical trial; Clinical Practice; Generative grammar; Drug; Pharmacology; Medicine; Data science; Artificial intelligence; Computer science; Bioinformatics; Internal medicine; Biology","score_opus":0.35856944796641615,"score_gpt":0.5906098123856323,"score_spread":0.2320403644192161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001449808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005785807,0.9925466,0.00031156014,0.004337568,0.0006405673,0.000003838521,0.000013351351,0.000008276984,0.0020805104],"genre_scores_gemma":[0.0009663303,0.99417144,0.00050422526,0.0026999954,0.0009124377,0.000009199707,0.000018084462,0.0000041414596,0.0007141171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934417,0.0002571149,0.0000469894,0.00008917012,0.0002095465,0.0000530003],"domain_scores_gemma":[0.99680233,0.0023305905,0.00013704122,0.00009295418,0.000500211,0.00013682745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002973251,0.0007734708,0.0011573358,0.002365979,0.00036980162,0.0022112655,0.0011526127,0.0027688371,0.0058039264],"category_scores_gemma":[0.004521406,0.00031968905,0.00069334114,0.0023705708,0.0018834162,0.004232106,0.001036772,0.004985485,0.003802848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006128474,0.00008319612,0.00015076096,0.008859134,0.00009341778,0.0000690132,0.000081532206,0.00067314703,0.00036693484,0.064564675,0.054786853,0.87021005],"study_design_scores_gemma":[0.000028088452,0.000075190605,0.00046152854,0.006326295,0.00005401916,0.00033192965,0.000072131654,0.00030650262,0.00015255786,0.034569684,0.95759445,0.000027502492],"about_ca_topic_score_codex":0.0018203979,"about_ca_topic_score_gemma":0.0026059104,"teacher_disagreement_score":0.0058039264,"about_ca_system_score_codex":0.001809024,"about_ca_system_score_gemma":0.00314587,"threshold_uncertainty_score":0.019416034},"labels":[],"label_agreement":null},{"id":"W3016766421","doi":"10.1002/cpt.1852","title":"Response to Inhibition of Receptor‐Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo‐Controlled Study","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"GlaxoSmithKline","keywords":"Placebo; Medicine; Psoriasis; Tolerability; Pharmacology; Pharmacodynamics; Internal medicine; Adverse effect; Randomized controlled trial; Pharmacokinetics; Gastroenterology; Pathology; Immunology","score_opus":0.06489494980480552,"score_gpt":0.37355454547704975,"score_spread":0.3086595956722442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016766421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759438,0.008505645,0.0014844785,0.00082006416,0.0011865515,0.007988993,0.0014070036,0.00026366816,0.0023997475],"genre_scores_gemma":[0.9809136,0.00417787,0.0016798775,0.0013218219,0.0012653599,0.0067678764,0.0011277561,0.00004564996,0.0027002248],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988514,0.0006161933,0.00010049194,0.00019118583,0.00009261646,0.00014804471],"domain_scores_gemma":[0.9986318,0.00038852336,0.00029568645,0.00013570797,0.00012447053,0.0004237836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031029372,0.0017994497,0.004558106,0.00059651927,0.0005243024,0.0012410969,0.00090135913,0.002144893,0.0060094376],"category_scores_gemma":[0.0022921297,0.00075512676,0.0019291636,0.0005924002,0.0013840505,0.0011143857,0.00038989962,0.0028411436,0.00096216716],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98592746,0.0040593552,0.00016406308,0.00037359586,0.00041173748,0.0000178149,0.000014450713,0.000084942,0.002773575,0.000029821287,0.00024320898,0.0058999853],"study_design_scores_gemma":[0.93578386,0.062292125,0.00086168275,0.000019567524,0.0002895998,0.0000138824,0.000007729667,0.00013371541,0.0003301736,0.000047430218,0.00021253,0.0000076250053],"about_ca_topic_score_codex":0.0005379456,"about_ca_topic_score_gemma":0.000831928,"teacher_disagreement_score":0.0060094376,"about_ca_system_score_codex":0.00048605754,"about_ca_system_score_gemma":0.0009874057,"threshold_uncertainty_score":0.020103574},"labels":[],"label_agreement":null},{"id":"W3023705814","doi":"10.1002/cpt.1882","title":"The Implausibility of Neonatal Opioid Toxicity from Breastfeeding","year":2020,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Breastfeeding; Opioid; Toxicity; Medicine; Pediatrics; Internal medicine; Receptor","score_opus":0.12008092285021382,"score_gpt":0.4605603057464848,"score_spread":0.340479382896271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023705814","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8336553,0.08717294,0.0066052354,0.023715276,0.00095983467,0.00007729707,0.00038342577,0.00019283738,0.047237948],"genre_scores_gemma":[0.96877563,0.024014158,0.0017268125,0.00340007,0.0006003759,0.000020454663,0.00010845146,0.000019582636,0.001334339],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.998623,0.0004093108,0.00026167423,0.00015590555,0.0003713031,0.000178779],"domain_scores_gemma":[0.9939435,0.0031541742,0.001898967,0.0004962688,0.00034253128,0.00016445956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012133139,0.0003774581,0.00038616022,0.00077748933,0.00071826007,0.001073767,0.0009239761,0.0018598852,0.0015752271],"category_scores_gemma":[0.010398148,0.00025567957,0.00043584948,0.00051685696,0.0019755794,0.0012186366,0.0009786452,0.0018942008,0.000496522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020549973,0.000034089695,0.15153652,0.0007178058,0.000081835904,0.7830375,0.0034698313,0.00027674672,0.0040447144,0.005711174,0.003807077,0.047077317],"study_design_scores_gemma":[0.000008950568,0.0001274011,0.03131688,0.00088366115,0.0001030698,0.93689644,0.0023244398,0.00030826413,0.004841182,0.0029803833,0.020179028,0.000030254616],"about_ca_topic_score_codex":0.0030107182,"about_ca_topic_score_gemma":0.003328451,"teacher_disagreement_score":0.0030107182,"about_ca_system_score_codex":0.00097646425,"about_ca_system_score_gemma":0.0009359234,"threshold_uncertainty_score":0.0070847273},"labels":[],"label_agreement":null},{"id":"W3038651714","doi":"10.1002/cpt.1981","title":"Comparing Onset of Biosimilar Versus Generic Competition in the United States","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk Fonden","keywords":"Biosimilar; Statutory law; Competition (biology); Medicine; Generic drug; Business; Pharmacology; Drug; Internal medicine; Law; Political science","score_opus":0.40271137957245057,"score_gpt":0.4240386167015656,"score_spread":0.02132723712911505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038651714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837586,0.00276628,0.0004095793,0.0010136012,0.000045411092,0.000047014084,0.0038131054,0.000023721854,0.008122741],"genre_scores_gemma":[0.9956027,0.0005538227,0.0001853871,0.00052785187,0.000041275805,0.00001787978,0.0026859066,0.000009306939,0.00037576456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996851,0.0008113531,0.00033608472,0.0007371767,0.0007298916,0.0005344647],"domain_scores_gemma":[0.98092616,0.0047394643,0.010156903,0.0003911188,0.0019912724,0.0017950282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004711095,0.00016037966,0.00037363247,0.0014298176,0.00039537423,0.0020432782,0.0005315023,0.0007052167,0.003887042],"category_scores_gemma":[0.012755638,0.00019511188,0.0007036401,0.0017952124,0.00065268995,0.0014845832,0.0008696603,0.0011588698,0.00032115597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094529573,0.00022738345,0.9756763,0.00014281578,0.0002246917,0.00016234902,0.00035561612,0.00082641444,0.00038917884,0.0021185386,0.0034066674,0.0155248195],"study_design_scores_gemma":[0.000047733,0.00039661909,0.9908693,0.000111011555,0.000072457864,0.00035027694,0.0005058036,0.0012248127,0.00032980624,0.00030181423,0.005765743,0.0000246588],"about_ca_topic_score_codex":0.01601642,"about_ca_topic_score_gemma":0.018424641,"teacher_disagreement_score":0.01601642,"about_ca_system_score_codex":0.0017888586,"about_ca_system_score_gemma":0.001393832,"threshold_uncertainty_score":0.031846404},"labels":[],"label_agreement":null},{"id":"W3044445445","doi":"10.1002/cpt.1990","title":"Physiologically‐Based Pharmacokinetic Modeling Characterizes the CYP3A‐Mediated Drug‐Drug Interaction Between Fluconazole and Sildenafil in Infants","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; United Therapeutics Corporation","keywords":"Sildenafil; Fluconazole; Drug; Pharmacokinetics; Pharmacology; Drug interaction; Pharmacokinetic interaction; Medicine; Internal medicine; Antifungal","score_opus":0.22670036944470984,"score_gpt":0.46322307438537763,"score_spread":0.2365227049406678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044445445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59943014,0.002028153,0.39018878,0.0003740369,0.000028830858,0.00012840032,0.0009074134,0.000426839,0.0064874385],"genre_scores_gemma":[0.97458726,0.0015305934,0.02194884,0.00006670553,0.0000102894455,0.000121157296,0.00033986664,0.00003516033,0.0013599535],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998294,0.00007126823,0.000008476572,0.00002845548,0.000044640565,0.000017633733],"domain_scores_gemma":[0.999828,0.00009654383,0.000032988053,0.000009462383,0.000026787326,0.0000061414676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025979406,0.0005428246,0.0004379865,0.00014580153,0.00015700316,0.00044542702,0.00045262728,0.000565242,0.000558959],"category_scores_gemma":[0.00082873786,0.00022933281,0.0004757849,0.00015086259,0.00014708929,0.0002698396,0.00023786674,0.0004939721,0.00024788504],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018030022,0.000107079446,0.016253192,0.00019626899,0.00010461331,0.00054890197,0.00009549691,0.88573945,0.061205283,0.0029946289,0.00069118384,0.031883605],"study_design_scores_gemma":[0.000011110586,0.00019579337,0.0047668014,0.000009222654,0.000033000768,0.00027541205,0.000018611965,0.98456556,0.007850627,0.0005938677,0.0016676317,0.00001226391],"about_ca_topic_score_codex":0.006712191,"about_ca_topic_score_gemma":0.0036320968,"teacher_disagreement_score":0.006712191,"about_ca_system_score_codex":0.00042106665,"about_ca_system_score_gemma":0.0006563866,"threshold_uncertainty_score":0.013346255},"labels":[],"label_agreement":null},{"id":"W3047711333","doi":"10.1002/cpt.2010","title":"Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University","funders":"National Health and Medical Research Council; Medical Research Council; Australian Government; Canadian Institutes of Health Research; Arnold Ventures; Harvard University","keywords":"European union; Public health; Environmental health; Public administration; Business; Political science; International trade; Medicine","score_opus":0.694770904423468,"score_gpt":0.5987181050380871,"score_spread":0.09605279938538092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047711333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5965995,0.010907121,0.0030335996,0.09101364,0.00031433962,0.00061204645,0.00048309992,0.000103399965,0.29693323],"genre_scores_gemma":[0.9833456,0.0022300836,0.0009387278,0.008033099,0.00005608263,0.00006947951,0.00007458686,0.000018291443,0.005234021],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.9342563,0.013942383,0.0022170295,0.002152214,0.035845168,0.011586858],"domain_scores_gemma":[0.82788724,0.06048322,0.020045888,0.0038637319,0.07175852,0.015961405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04099855,0.00026101954,0.0005283799,0.004203639,0.010229606,0.01594888,0.0020156233,0.003112028,0.0032201954],"category_scores_gemma":[0.08475889,0.0005252055,0.00083643774,0.0066729505,0.010791453,0.00440538,0.004035062,0.0045009903,0.00018119128],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000816339,0.0007485002,0.1985433,0.0012472149,0.00029776135,0.0010028784,0.10219893,0.003858404,0.0022619104,0.48124453,0.029111948,0.17866829],"study_design_scores_gemma":[0.00015993865,0.00035919025,0.68673533,0.0018619578,0.00031179845,0.00025440956,0.063006595,0.0031970893,0.0022666,0.015837802,0.22565459,0.00035466414],"about_ca_topic_score_codex":0.9502644,"about_ca_topic_score_gemma":0.948481,"teacher_disagreement_score":0.8357978,"about_ca_system_score_codex":0.16420223,"about_ca_system_score_gemma":0.2906838,"threshold_uncertainty_score":0.96940696},"labels":[],"label_agreement":null},{"id":"W3048301534","doi":"10.1002/cpt.2012","title":"Use of Real‐World Data to Emulate a Clinical Trial and Support Regulatory Decision Making: Assessing the Impact of Temporality, Comparator Choice, and Method of Adjustment","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Liraglutide; Hazard ratio; Propensity score matching; Confidence interval; Clinical trial; Internal medicine; Comparator; Type 2 diabetes; Diabetes mellitus; Endocrinology","score_opus":0.9099604995971161,"score_gpt":0.7418507534591007,"score_spread":0.16810974613801544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048301534","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19575627,0.01212195,0.73867,0.009314209,0.0038270394,0.019072412,0.009556401,0.0012709809,0.010410762],"genre_scores_gemma":[0.74432826,0.0013045077,0.22174081,0.0031531868,0.00054045493,0.023010662,0.0050116964,0.0002479433,0.00066235545],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.24024662,0.6926296,0.034461208,0.014314143,0.016951546,0.0013968747],"domain_scores_gemma":[0.17399038,0.59346735,0.09397627,0.121562906,0.01548349,0.0015195716],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.68467826,0.0029404995,0.00469144,0.0036554066,0.0013579535,0.008168115,0.006580841,0.0058912947,0.004251275],"category_scores_gemma":[0.77655995,0.0022893928,0.009071238,0.0058318963,0.0050204163,0.008786888,0.0063943374,0.0062822886,0.00084333995],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06007395,0.0032068915,0.31320786,0.01074691,0.08791653,0.001044652,0.0035780782,0.14984637,0.002744919,0.09589564,0.016032409,0.2557058],"study_design_scores_gemma":[0.035684183,0.04159739,0.18826474,0.008955949,0.042918913,0.0020903163,0.0014550799,0.3851681,0.012145821,0.16238277,0.11737704,0.0019596857],"about_ca_topic_score_codex":0.0018266453,"about_ca_topic_score_gemma":0.0012945061,"teacher_disagreement_score":0.31532174,"about_ca_system_score_codex":0.004033867,"about_ca_system_score_gemma":0.006068125,"threshold_uncertainty_score":0.3888479},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W3084337600","doi":"10.1002/cpt.2042","title":"Potential Cost Implications of Mandatory Non‐Medical Switching Policies for Biologics for Rheumatic Conditions and Inflammatory Bowel Disease in Canada","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"","keywords":"Biosimilar; Infliximab; Etanercept; Adalimumab; Medicine; Medical prescription; Market share; Business; Disease; Marketing; Pharmacology; Rheumatoid arthritis; Internal medicine","score_opus":0.0712620760253613,"score_gpt":0.40832476443640914,"score_spread":0.3370626884110478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084337600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90735584,0.005325606,0.0019448987,0.04179518,0.00025440866,0.00033753758,0.019123545,0.00012362629,0.02373933],"genre_scores_gemma":[0.9921285,0.0009793133,0.0008037328,0.0024695802,0.000035343863,0.00003825922,0.0020697291,0.000017679457,0.001457828],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99164844,0.0018127398,0.00042778862,0.00058585336,0.0020914967,0.00343365],"domain_scores_gemma":[0.9839841,0.0054061115,0.0028889456,0.00057323754,0.0050519165,0.0020957282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004944658,0.000485863,0.00071901886,0.0018235059,0.0026381651,0.0040119733,0.0021517712,0.0011962559,0.0046313815],"category_scores_gemma":[0.028408123,0.00054622,0.0021547608,0.0037782933,0.0012357098,0.0010937273,0.0014888197,0.002465764,0.00013276187],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013025942,0.0003501606,0.84118384,0.00052271516,0.0015494039,0.0009344663,0.0012423013,0.048237126,0.0004886737,0.032906037,0.027641768,0.043640956],"study_design_scores_gemma":[0.0004858314,0.00020231068,0.882703,0.00079169916,0.0017080948,0.00043020098,0.005168897,0.07663354,0.00090855063,0.008772079,0.021932729,0.00026299036],"about_ca_topic_score_codex":0.99197704,"about_ca_topic_score_gemma":0.99233633,"teacher_disagreement_score":0.106777176,"about_ca_system_score_codex":0.106777176,"about_ca_system_score_gemma":0.118572585,"threshold_uncertainty_score":0.7747263},"labels":[],"label_agreement":null},{"id":"W3092948288","doi":"10.1002/cpt.2082","title":"Inosine 5'‐Monophosphate to Raise Serum Uric Acid Level in Multiple System Atrophy (IMPROVE‐MSA study)","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Placebo; Internal medicine; Medicine; Montreal Cognitive Assessment; Uric acid; Adverse effect; Atrophy; Hyperuricemia; Gastroenterology; Cognitive impairment; Pathology; Disease","score_opus":0.1794911471958729,"score_gpt":0.40261411148438553,"score_spread":0.22312296428851264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092948288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742553,0.020511206,0.0005257319,0.00041437248,0.000267825,0.0010130332,0.0005593628,0.0001337853,0.0023194645],"genre_scores_gemma":[0.98305225,0.008408423,0.002152644,0.0009838967,0.00066169124,0.0012961348,0.00091805507,0.000021355947,0.0025056545],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997842,0.00009892543,0.000019371477,0.00003484472,0.00002920195,0.00003339493],"domain_scores_gemma":[0.99963844,0.00009306463,0.00012652576,0.000020276872,0.00003227803,0.00008939275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009420979,0.00076264126,0.002161675,0.0003267596,0.0001994412,0.0004778848,0.0005233794,0.0009886039,0.0029927264],"category_scores_gemma":[0.000672941,0.00029227763,0.0011224289,0.00022513453,0.00029029837,0.00032984064,0.00022783336,0.0017902342,0.0004447887],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79631567,0.018613828,0.003744524,0.0048955213,0.0030720294,0.0002969849,0.0001469684,0.00080211734,0.04417169,0.00043995032,0.0027180875,0.124782644],"study_design_scores_gemma":[0.61644137,0.35832834,0.01373407,0.00022581268,0.0018953887,0.0003339162,0.00003808498,0.0007864702,0.0042839483,0.0001999612,0.0037081428,0.000024578681],"about_ca_topic_score_codex":0.00024104633,"about_ca_topic_score_gemma":0.0007613523,"teacher_disagreement_score":0.0029927264,"about_ca_system_score_codex":0.00015805899,"about_ca_system_score_gemma":0.0002843387,"threshold_uncertainty_score":0.010011673},"labels":[],"label_agreement":null},{"id":"W3111115779","doi":"10.1002/cpt.2135","title":"Transferability of Ancestry‐Specific and Cross‐Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; Campbell Family Mental Health Research Institute; University of Pennsylvania; Centre for Addiction and Mental Health; RIKEN; Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation; University of Toronto; National Cancer Institute; National Institutes of Health; University of Southern California","keywords":"Cotinine; CYP2A6; Pharmacogenetics; Medicine; Nicotine; Biology; Demography; Genetics; Internal medicine; Genotype","score_opus":0.32005411119911287,"score_gpt":0.4748715624802107,"score_spread":0.1548174512810978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111115779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866882,0.00012640697,0.011876445,0.000052515217,0.000021492187,0.00004760662,0.00035903248,0.00003390291,0.000794445],"genre_scores_gemma":[0.99430627,0.000057547226,0.0047304253,0.000049361897,0.000012701629,0.000055418786,0.000497149,0.000036391346,0.00025472982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99478394,0.0029541403,0.00024482285,0.0014458802,0.00034787404,0.00022348891],"domain_scores_gemma":[0.9965528,0.0014824502,0.00045741504,0.0010513249,0.00031431887,0.00014167516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008349277,0.00078720297,0.00050347927,0.0012400693,0.0007385957,0.001003621,0.00060183654,0.0007027006,0.0016949291],"category_scores_gemma":[0.015338325,0.00034229312,0.0011635802,0.0011081684,0.00061618,0.000576384,0.001185885,0.00062812964,0.0003129143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012405983,0.0001506742,0.93765926,0.00003211795,0.0024139103,0.0005047716,0.0018852848,0.004467815,0.012455922,0.002483982,0.0005425624,0.036163155],"study_design_scores_gemma":[0.00012866313,0.00049332064,0.9519027,0.000060566814,0.0009787527,0.0012514401,0.00052998995,0.033826966,0.00415295,0.0032829694,0.0033104995,0.00008113127],"about_ca_topic_score_codex":0.004114997,"about_ca_topic_score_gemma":0.0029995493,"teacher_disagreement_score":0.008349277,"about_ca_system_score_codex":0.00024642356,"about_ca_system_score_gemma":0.00025574784,"threshold_uncertainty_score":0.044155777},"labels":[],"label_agreement":null},{"id":"W3111851331","doi":"10.1002/cpt.2143","title":"Individual Atrasentan Exposure is Associated With Long‐term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Novo Nordisk Fonden; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; AbbVie","keywords":"Medicine; Kidney disease; Type 2 diabetes; Heart failure; Diabetes mellitus; Term (time); Internal medicine; Kidney; Disease; Renal function; Cardiology; Intensive care medicine; Endocrinology","score_opus":0.05209039457128074,"score_gpt":0.34278787985949494,"score_spread":0.2906974852882142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111851331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980566,0.0013199433,0.00022833454,0.000051992836,0.000009100879,0.0000054287325,0.00007471768,0.0000046664095,0.00024925807],"genre_scores_gemma":[0.99939597,0.00023159481,0.00011254074,0.00003771484,0.00001763769,0.0000063941657,0.00008459514,0.0000016022211,0.0001118935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990074,0.0005417367,0.000074789365,0.00017340493,0.00012343223,0.000079318816],"domain_scores_gemma":[0.99598867,0.00175356,0.0014652717,0.00036409777,0.00011372875,0.00031469567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022714087,0.00021340842,0.00058302534,0.00022465357,0.00015937154,0.0005176096,0.000245475,0.00050564716,0.001086527],"category_scores_gemma":[0.00301009,0.00025893818,0.0009896698,0.0003171095,0.000198725,0.00033026293,0.00029736364,0.000992356,0.00009715264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019160196,0.00054554315,0.9530722,0.00014005858,0.0035415785,0.00015310696,0.00011535846,0.0008870253,0.0030638804,0.00009177027,0.0002225001,0.01900687],"study_design_scores_gemma":[0.00033732958,0.0034393754,0.99306196,0.000016478452,0.0007492225,0.00018872104,0.000052944553,0.0013706153,0.0003808963,0.00014287807,0.00024459377,0.000014962908],"about_ca_topic_score_codex":0.0005480593,"about_ca_topic_score_gemma":0.00090973533,"teacher_disagreement_score":0.0022714087,"about_ca_system_score_codex":0.00015423862,"about_ca_system_score_gemma":0.00019916946,"threshold_uncertainty_score":0.012012541},"labels":[],"label_agreement":null},{"id":"W3114326816","doi":"10.1002/cpt.2149","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":399,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Institute on Drug Abuse; National Health and Medical Research Council; National Institute of General Medical Sciences; Medical Research Council; National Institutes of Health","keywords":"Pharmacogenetics; CYP2D6; Guideline; Opioid; Medicine; Pharmacology; Genotype; Internal medicine; Biology; Genetics; Gene; Cytochrome P450","score_opus":0.24691550981230617,"score_gpt":0.5716757893882056,"score_spread":0.3247602795758995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114326816","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009994241,0.06627764,0.083279826,0.43427196,0.011216462,0.011559338,0.022516843,0.0050773127,0.3558064],"genre_scores_gemma":[0.07262451,0.09274871,0.24918686,0.38217324,0.00874362,0.022082364,0.052045092,0.0016792327,0.11871634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97869635,0.007838729,0.0048313644,0.0007155113,0.0069844513,0.0009335966],"domain_scores_gemma":[0.96337456,0.012180308,0.003830398,0.001290632,0.017520433,0.0018036857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012946228,0.0008133802,0.0016230698,0.0021986407,0.00095749326,0.0025683786,0.0039842054,0.008146314,0.012735017],"category_scores_gemma":[0.042644843,0.00068143633,0.003695022,0.0019865287,0.0010693825,0.001720231,0.002426757,0.006926164,0.0073693227],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002095376,0.00035439315,0.0028999634,0.0017328912,0.00011743665,0.00093351677,0.00037798003,0.00087061146,0.0010196639,0.009583808,0.7652492,0.21665104],"study_design_scores_gemma":[0.00055055035,0.00021033389,0.006559412,0.00855429,0.00029472684,0.0017160872,0.00022262834,0.00093990285,0.0010764602,0.0075494875,0.9722455,0.00008064441],"about_ca_topic_score_codex":0.017083677,"about_ca_topic_score_gemma":0.027022706,"teacher_disagreement_score":0.017083677,"about_ca_system_score_codex":0.002673751,"about_ca_system_score_gemma":0.014882693,"threshold_uncertainty_score":0.06846702},"labels":[],"label_agreement":null},{"id":"W3125345026","doi":"10.1002/cpt.2173","title":"StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"GlaxoSmithKline foundation; National Research Foundation","keywords":"Genotyping; Genetics; Computational biology; 1000 Genomes Project; Biology; Haplotype; Pharmacogenomics; Genome; Gene; Allele; Genotype; Single-nucleotide polymorphism","score_opus":0.342208073002502,"score_gpt":0.5455487412779744,"score_spread":0.20334066827547237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125345026","genre_codex":"methods","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023755535,0.00057933043,0.59152913,0.00049841695,0.00018095144,0.00047518796,0.023217399,0.35712567,0.0026384569],"genre_scores_gemma":[0.1406633,0.00064933865,0.7372009,0.0012522736,0.00011233896,0.0024530757,0.08867635,0.022058267,0.0069341143],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992955,0.0001258832,0.00006112124,0.00026084352,0.00016807854,0.00008863175],"domain_scores_gemma":[0.999209,0.00039453403,0.00007422049,0.000115515955,0.00013813654,0.00006863775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022205906,0.0020295128,0.0010099342,0.0013100273,0.0009877759,0.0016230126,0.0017536733,0.0008596579,0.013315147],"category_scores_gemma":[0.0030724283,0.0011551039,0.0016888703,0.0007908843,0.0004781605,0.0015896979,0.0018179087,0.0020637223,0.0037434495],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004361971,0.0006340565,0.027702257,0.0023330855,0.0014120016,0.0012382447,0.002132208,0.056794077,0.13362896,0.01535646,0.26862067,0.48578593],"study_design_scores_gemma":[0.0009506027,0.00038630102,0.015885875,0.00014979609,0.00026519815,0.00041967104,0.00016923189,0.73163295,0.09127318,0.03409235,0.124414854,0.0003600045],"about_ca_topic_score_codex":0.008101065,"about_ca_topic_score_gemma":0.006876069,"teacher_disagreement_score":0.013315147,"about_ca_system_score_codex":0.0010961707,"about_ca_system_score_gemma":0.0022886482,"threshold_uncertainty_score":0.044543564},"labels":[],"label_agreement":null},{"id":"W3126174921","doi":"10.1002/cpt.2180","title":"Variation in Target Attainment of Beta‐Lactam Antibiotic Dosing Between International Pediatric Formularies","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"University College London; Medical Research Council; National Institute for Health and Care Research; King’s College London","keywords":"Dosing; Medicine; Meropenem; Piperacillin; Intensive care medicine; Antibiotics; Pharmacology; Antibiotic resistance; Biology; Microbiology","score_opus":0.16263676581859351,"score_gpt":0.49171027780818555,"score_spread":0.329073511989592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126174921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001028945,0.99608696,0.00047614932,0.0004713494,0.000090015805,0.00002206578,0.00014809116,0.000010247585,0.0016661346],"genre_scores_gemma":[0.008296226,0.9899317,0.0009824297,0.0002671857,0.000049572038,0.00003268142,0.00014417862,0.000005669627,0.0002904198],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99858594,0.00045252836,0.0003223892,0.00018184427,0.00039725334,0.000060084258],"domain_scores_gemma":[0.9966788,0.0022586652,0.00048296535,0.00008176202,0.00046087845,0.00003692828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025541612,0.00048545023,0.0012963142,0.002027314,0.00014217525,0.0012151923,0.0009884471,0.00084004365,0.0021480294],"category_scores_gemma":[0.006423475,0.00023771435,0.0012744665,0.0024229507,0.00029558293,0.0009787076,0.00048425372,0.00094418944,0.0005004921],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016909589,0.000056519915,0.0011476959,0.07125327,0.0005888078,0.000118639335,0.00012725279,0.0013122921,0.001175445,0.0053508617,0.007862681,0.91083753],"study_design_scores_gemma":[0.00011313699,0.0005857462,0.01063066,0.06481499,0.0027963475,0.0016625994,0.00033007047,0.00077982375,0.0037557208,0.0035948465,0.9108605,0.00007550346],"about_ca_topic_score_codex":0.0024628711,"about_ca_topic_score_gemma":0.0029536532,"teacher_disagreement_score":0.0025541612,"about_ca_system_score_codex":0.0009857763,"about_ca_system_score_gemma":0.0028064542,"threshold_uncertainty_score":0.013507843},"labels":[],"label_agreement":null},{"id":"W3126879320","doi":"10.1002/cpt.2198","title":"Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Drug development; Medicine; Drug; Resistance (ecology); Drug resistance; Intensive care medicine; Pharmacology; Biology","score_opus":0.15549309197528785,"score_gpt":0.4835599761925407,"score_spread":0.32806688421725283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126879320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028425732,0.76041114,0.19143999,0.027515683,0.0016226195,0.00019455643,0.00059849216,0.0009809529,0.014393959],"genre_scores_gemma":[0.0407882,0.798691,0.14837937,0.0069244634,0.0014139066,0.00043601528,0.000936749,0.00023110025,0.0021992442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958262,0.0020967089,0.0003179476,0.0004009776,0.0011704706,0.00018764616],"domain_scores_gemma":[0.9877796,0.008783846,0.0007603438,0.00086387503,0.001427945,0.0003843051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01290181,0.0016219422,0.0024775264,0.0016183932,0.000553935,0.0059157778,0.0032292306,0.0034891828,0.0054428517],"category_scores_gemma":[0.011948178,0.0009216496,0.001869235,0.0016309081,0.0032580346,0.0073091653,0.003426947,0.006146254,0.0026140423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023425688,0.00021103203,0.0010051237,0.010102785,0.00024484348,0.00021305728,0.00029825524,0.036260623,0.0028171306,0.31074962,0.025227722,0.6126356],"study_design_scores_gemma":[0.000110060166,0.0007060136,0.00041830234,0.0049456065,0.00020458238,0.000538791,0.00026968188,0.03881484,0.0032805216,0.23676336,0.713767,0.00018136787],"about_ca_topic_score_codex":0.0022492774,"about_ca_topic_score_gemma":0.0021479381,"teacher_disagreement_score":0.01290181,"about_ca_system_score_codex":0.0030203306,"about_ca_system_score_gemma":0.00559746,"threshold_uncertainty_score":0.06823212},"labels":[],"label_agreement":null},{"id":"W3129971886","doi":"10.1002/cpt.2213","title":"Defining Clinically Relevant Target Populations Using Real‐World Data to Guide the Design of Representative Antidiabetic Drug Trials","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Liraglutide; Medicine; Clinical trial; Type 2 diabetes; Population; Representativeness heuristic; Diabetes mellitus; Disease; Internal medicine; Endocrinology; Environmental health; Psychology","score_opus":0.5210139882154484,"score_gpt":0.5680565267547004,"score_spread":0.047042538539252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129971886","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07201784,0.010795115,0.7449315,0.009609228,0.0016627326,0.1457461,0.0040288456,0.0006204758,0.01058822],"genre_scores_gemma":[0.34469908,0.0013805588,0.49570972,0.005057921,0.0003945147,0.149738,0.0021858546,0.0001347093,0.0006996692],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.3419459,0.6038997,0.030938162,0.008331629,0.013110118,0.0017745814],"domain_scores_gemma":[0.5400879,0.35505813,0.042498905,0.03618991,0.023388619,0.0027765965],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5234671,0.0025313173,0.0038401482,0.0049403803,0.001793914,0.007446444,0.0046667615,0.0051069097,0.003248155],"category_scores_gemma":[0.56909466,0.0019369296,0.005071277,0.0032384403,0.0037882926,0.004807528,0.006216645,0.0063147596,0.0008904282],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04185205,0.0050530145,0.24298033,0.013447181,0.025065647,0.0019231534,0.013320076,0.09273032,0.0052886195,0.13819453,0.04239048,0.37775454],"study_design_scores_gemma":[0.042367734,0.02400229,0.101413116,0.01466365,0.017374132,0.0016901472,0.0036482052,0.25886688,0.012251556,0.3332881,0.18949303,0.0009411846],"about_ca_topic_score_codex":0.0011054208,"about_ca_topic_score_gemma":0.0014284913,"teacher_disagreement_score":0.47653288,"about_ca_system_score_codex":0.002816064,"about_ca_system_score_gemma":0.0070511443,"threshold_uncertainty_score":0.58764994},"labels":[],"label_agreement":null},{"id":"W3134241111","doi":"10.1002/cpt.2223","title":"Systematic Review and Patient‐Level Meta‐Analysis of SARS‐CoV‐2 Viral Dynamics to Model Response to Antiviral Therapies","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; Action Medical Research; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; University College London; Great Ormond Street Hospital for Children; Wellcome Trust","keywords":"Viral load; Medicine; Proportional hazards model; Hazard ratio; Meta-analysis; Ribavirin; Internal medicine; Respiratory system; Confidence interval; Immunology; Virus","score_opus":0.3737928707146751,"score_gpt":0.5548009881660153,"score_spread":0.1810081174513402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134241111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008620283,0.98111665,0.0045547187,0.00063983176,0.0004020989,0.0009081129,0.0029877066,0.00011488126,0.0006558181],"genre_scores_gemma":[0.35141012,0.62230223,0.013344355,0.0021675522,0.00045259303,0.004744467,0.0045844084,0.00014606336,0.00084827864],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98139626,0.01268298,0.003161124,0.001323117,0.0011436533,0.00029278907],"domain_scores_gemma":[0.97136974,0.02342081,0.0025060254,0.0012116624,0.0013092078,0.00018261182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02259922,0.0025203007,0.015658274,0.0052308682,0.00042386272,0.0032378137,0.0021030237,0.0020697776,0.0038387713],"category_scores_gemma":[0.056916285,0.0013586351,0.03923218,0.005393027,0.00046748776,0.001503464,0.0012820985,0.0019136302,0.0004998547],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010771464,0.00002377348,0.0033667344,0.19694902,0.7844169,0.000083606064,0.0000469341,0.0026972108,0.00018837648,0.00033374628,0.00083253084,0.00998397],"study_design_scores_gemma":[0.0007164685,0.00023702983,0.0031390693,0.01830507,0.97154486,0.00006596358,0.000033125547,0.0013834144,0.00012538239,0.000824476,0.0035968386,0.000028212795],"about_ca_topic_score_codex":0.007853214,"about_ca_topic_score_gemma":0.0117040295,"teacher_disagreement_score":0.02259922,"about_ca_system_score_codex":0.0023271965,"about_ca_system_score_gemma":0.004506448,"threshold_uncertainty_score":0.119517505},"labels":[],"label_agreement":null},{"id":"W3155322721","doi":"10.1002/cpt.2269","title":"Rational Clinical Dose Selection of Adeno‐Associated Virus‐Mediated Gene Therapy Based on Allometric Principles","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Adeno-associated virus; Genetic enhancement; In vivo; Computational biology; Gene transfer; Vector (molecular biology); Biology; Gene; Allometry; Medicine; Bioinformatics; Recombinant DNA; Genetics","score_opus":0.15284503367886842,"score_gpt":0.4556251334500514,"score_spread":0.302780099771183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155322721","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37203148,0.016146746,0.5831762,0.0019782486,0.00041255765,0.0024956563,0.00043685787,0.0014132877,0.021908943],"genre_scores_gemma":[0.88013244,0.0044635995,0.111140065,0.00074843067,0.00014050759,0.0011300799,0.00019989038,0.00029342753,0.001751637],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99815434,0.00070298905,0.00010730283,0.0002456856,0.0006939249,0.000095708354],"domain_scores_gemma":[0.9986028,0.000644391,0.0004153589,0.00014494082,0.00012584671,0.000066712375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038029694,0.00079042354,0.00082437217,0.0012401101,0.00030835127,0.0013852088,0.0007502614,0.0006344435,0.0013013677],"category_scores_gemma":[0.0053499304,0.00039219487,0.00037134523,0.0005622234,0.0010498887,0.0011776872,0.00063469383,0.0015394686,0.0005924665],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001096307,0.0012249413,0.00554867,0.00045028058,0.00009344586,0.00017056547,0.00040268962,0.046279155,0.6846668,0.014908213,0.0025594376,0.24259952],"study_design_scores_gemma":[0.00044699258,0.016387677,0.020074362,0.00026148543,0.00024376587,0.0017170154,0.0002938166,0.13344595,0.74785936,0.015188553,0.0638475,0.00023354548],"about_ca_topic_score_codex":0.0003335919,"about_ca_topic_score_gemma":0.0004331942,"teacher_disagreement_score":0.0038029694,"about_ca_system_score_codex":0.0008113285,"about_ca_system_score_gemma":0.0009190754,"threshold_uncertainty_score":0.020112276},"labels":[],"label_agreement":null},{"id":"W3164768471","doi":"10.1002/cpt.2311","title":"Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early‐Stage Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Cancer Society","keywords":"Exemestane; Anastrozole; Oncology; Breast cancer; Single-nucleotide polymorphism; Medicine; Aromatase inhibitor; Internal medicine; Aromatase; SNP; Tamoxifen; Genotype; Cancer; Bioinformatics; Biology; Genetics; Gene","score_opus":0.04359414938016718,"score_gpt":0.4054828458177262,"score_spread":0.361888696437559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164768471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937963,0.00023878373,0.00010063372,0.000046346926,0.000011672551,0.0000019732686,0.000100695645,0.000003525604,0.00011675765],"genre_scores_gemma":[0.9996865,0.000025224688,0.00006670393,0.000018260536,0.0000063794055,0.000002724396,0.000067500136,0.0000020787159,0.00012464978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992206,0.0004131058,0.00007314971,0.0001264911,0.00008434107,0.00008236554],"domain_scores_gemma":[0.99784756,0.0014892383,0.00032563385,0.000100587305,0.000052459243,0.0001845106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007128049,0.00015204695,0.00042989742,0.00022810049,0.00014536633,0.00030503934,0.0001654668,0.0004495185,0.0013022784],"category_scores_gemma":[0.0021565764,0.000113231785,0.0006941331,0.00024185554,0.00016084615,0.00012533943,0.00013330289,0.00046058637,0.00016129213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02470748,0.00032271462,0.92701674,0.000057574256,0.0024910097,0.0006530558,0.00015558384,0.0010501774,0.030682107,0.00015758784,0.00032483548,0.012381061],"study_design_scores_gemma":[0.00023032879,0.0023973638,0.99113476,0.00000809613,0.0008468116,0.00054746174,0.000063033825,0.0020623968,0.002108697,0.00014862863,0.00043969942,0.000012833227],"about_ca_topic_score_codex":0.00079314725,"about_ca_topic_score_gemma":0.0013314538,"teacher_disagreement_score":0.0013022784,"about_ca_system_score_codex":0.00014195811,"about_ca_system_score_gemma":0.00017078107,"threshold_uncertainty_score":0.004356563},"labels":[],"label_agreement":null},{"id":"W3164819010","doi":"10.1002/cpt.2307","title":"Trends in Postpartum Opioid Prescribing: A Time Series Analysis","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Codeine; Medicine; Hydromorphone; Medical prescription; Oxycodone; Opioid; Breastfeeding; Hydrocodone; Interrupted Time Series Analysis; Morphine; Postpartum period; Obstetrics; Anesthesia; Pregnancy; Pediatrics; Internal medicine; Pharmacology","score_opus":0.056725964097367666,"score_gpt":0.3995204168444509,"score_spread":0.3427944527470832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164819010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98644674,0.0013668477,0.0015862298,0.00034888918,0.000042497322,0.000115193616,0.00916484,0.00004045744,0.00088835583],"genre_scores_gemma":[0.9894944,0.0006396589,0.0007988145,0.00008120067,0.000044244607,0.00014685605,0.008200246,0.000014426859,0.0005800702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967416,0.0009870206,0.0005565456,0.0006214443,0.0006797805,0.00041364183],"domain_scores_gemma":[0.990335,0.003518478,0.0036154103,0.0007189523,0.0013026398,0.0005095204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004274278,0.00029156235,0.0006678311,0.0026407936,0.00035460416,0.00081921404,0.0007151132,0.0005773682,0.0028393257],"category_scores_gemma":[0.010189274,0.0003141461,0.0015625843,0.005185901,0.0002952576,0.00071564154,0.00062125956,0.0010805597,0.0003825823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021662883,0.00005642802,0.99355066,0.00007448499,0.0005280213,0.00013822078,0.00015098401,0.00064404483,0.0001080622,0.00013830017,0.0008827686,0.003511307],"study_design_scores_gemma":[0.000026431535,0.00026342363,0.9869782,0.0000475529,0.0002837482,0.00026741534,0.00055985316,0.009901815,0.00008939557,0.00010224222,0.0014598967,0.000020105595],"about_ca_topic_score_codex":0.059847016,"about_ca_topic_score_gemma":0.034693144,"teacher_disagreement_score":0.059847016,"about_ca_system_score_codex":0.0014432762,"about_ca_system_score_gemma":0.0013731642,"threshold_uncertainty_score":0.118997335},"labels":[],"label_agreement":null},{"id":"W3168682140","doi":"10.1002/cpt.2339","title":"Pharmacogenetics‐Guided Advances in Antipsychotic Treatment","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenetics; Antipsychotic; Tardive dyskinesia; Medicine; Clozapine; Adverse effect; Tolerability; CYP2D6; Dosing; Pharmacology; Schizophrenia (object-oriented programming); Psychiatry; Genotype; Internal medicine; Genetics; Gene; Biology","score_opus":0.3489785414320632,"score_gpt":0.5963113076902017,"score_spread":0.2473327662581385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168682140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000831559,0.99921083,0.000073319345,0.00024312528,0.00006011641,0.0000027359642,0.000014889153,0.0000033370259,0.00030846792],"genre_scores_gemma":[0.0011539585,0.998218,0.00018138868,0.00021399975,0.00007845944,0.0000046984387,0.000025818726,0.0000012763442,0.00012243012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957067,0.00013949527,0.00008746106,0.00006619182,0.00010844618,0.000027726988],"domain_scores_gemma":[0.99925417,0.00046334456,0.000103040264,0.00002247047,0.00013154351,0.00002546131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014302656,0.0006672642,0.0013415662,0.0016953044,0.00012236125,0.00086596824,0.0007462153,0.00074994616,0.0032344472],"category_scores_gemma":[0.001970375,0.0002308113,0.0013036602,0.0014182439,0.0002732539,0.0007188257,0.000571243,0.001447211,0.00078267354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015421314,0.000048580183,0.0003335629,0.042660743,0.0005924704,0.000107302025,0.000041423213,0.0005649865,0.00065911683,0.003539188,0.01112978,0.9401687],"study_design_scores_gemma":[0.0001737155,0.00023785273,0.0035794193,0.03722991,0.0020544264,0.0014269035,0.00008423292,0.00045626305,0.0007363146,0.0063335304,0.94764453,0.000042909855],"about_ca_topic_score_codex":0.001470894,"about_ca_topic_score_gemma":0.0032782727,"teacher_disagreement_score":0.0032344472,"about_ca_system_score_codex":0.00081171736,"about_ca_system_score_gemma":0.001507244,"threshold_uncertainty_score":0.010820329},"labels":[],"label_agreement":null},{"id":"W3174118295","doi":"10.1002/cpt.2345","title":"The Role of Pharmacogenetics in Smoking","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Genome-wide association study; Nicotine; Varenicline; Candidate gene; Smoking cessation; CYP2A6; Nicotinic agonist; Heritability; Twin study; Pharmacogenetics; Genetic association; Nicotine replacement therapy; Single-nucleotide polymorphism; Medicine; Genetics; Bioinformatics; Biology; Gene; Genotype; Psychiatry; Receptor","score_opus":0.20673550538778504,"score_gpt":0.5280580195504998,"score_spread":0.32132251416271473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174118295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012618101,0.99767166,0.00022501276,0.0006684709,0.00013622592,0.000002851503,0.000023715085,0.000007564242,0.001138385],"genre_scores_gemma":[0.0011989742,0.9976895,0.00016127975,0.00031866436,0.00022370284,0.0000057307525,0.000028398314,0.0000019552426,0.0003718085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996829,0.0000921747,0.000036910034,0.00007543885,0.000089663976,0.000022896049],"domain_scores_gemma":[0.99928075,0.00053010153,0.000051635547,0.000019762909,0.00008629327,0.000031536165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084648543,0.000627099,0.0012560503,0.0012298306,0.0001933136,0.0010278246,0.0006431901,0.0012906675,0.0035133862],"category_scores_gemma":[0.0013365829,0.00019656123,0.0006774883,0.0013495595,0.00049254444,0.00079566054,0.0006965977,0.0017157496,0.0013079391],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005355303,0.000046561236,0.0006533933,0.0081766555,0.00016668941,0.00016648797,0.00004367367,0.0003359261,0.0005217568,0.0060886955,0.012475136,0.9712715],"study_design_scores_gemma":[0.000020188441,0.00010338704,0.0042711487,0.007215012,0.0003482006,0.0019635467,0.00005784011,0.00022810807,0.00038106562,0.0085390285,0.9768404,0.00003205018],"about_ca_topic_score_codex":0.0015878704,"about_ca_topic_score_gemma":0.0017801565,"teacher_disagreement_score":0.0035133862,"about_ca_system_score_codex":0.00060623226,"about_ca_system_score_gemma":0.0011969323,"threshold_uncertainty_score":0.0117534995},"labels":[],"label_agreement":null},{"id":"W3181496761","doi":"10.1002/cpt.2355","title":"Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome‐Wide Interaction Meta‐Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Neurological Disorders and Stroke; Barts Charity; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; National Institutes of Health","keywords":"Medicine; Pharmacogenomics; Antihypertensive drug; Internal medicine; Thiazide; Pharmacogenetics; Genome-wide association study; Blood pressure; Single-nucleotide polymorphism; Odds ratio; Pharmacology; Cardiology; Bioinformatics; Genotype; Genetics; Biology","score_opus":0.49062669163725126,"score_gpt":0.531260397962451,"score_spread":0.04063370632519969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181496761","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47752923,0.47216347,0.033285737,0.0040491833,0.0013002635,0.0006141861,0.0073222145,0.0007516375,0.002984129],"genre_scores_gemma":[0.97342235,0.014120726,0.007861511,0.00094551645,0.0003526946,0.00054062763,0.0021838502,0.00014754075,0.0004252603],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9534842,0.032445204,0.0038551285,0.006118416,0.002809361,0.0012876982],"domain_scores_gemma":[0.954704,0.033537924,0.0036517612,0.005425253,0.0019817639,0.0006992637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030872628,0.004177044,0.0077087265,0.0055974363,0.0012460076,0.004065712,0.0026394075,0.0026758474,0.0023907165],"category_scores_gemma":[0.04262941,0.0016092262,0.038857076,0.009320569,0.0007432441,0.0013010572,0.0027227015,0.003196075,0.00024547454],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004447151,0.00004465274,0.12596452,0.0026448937,0.8595247,0.00026422375,0.00007341758,0.0012853025,0.0007188545,0.0002405264,0.00065404054,0.004137696],"study_design_scores_gemma":[0.0011621381,0.0003091894,0.07905705,0.0004578967,0.91396576,0.00023774838,0.00007385724,0.002740472,0.0003275266,0.00064840744,0.0009768063,0.000043122927],"about_ca_topic_score_codex":0.009935663,"about_ca_topic_score_gemma":0.012527336,"teacher_disagreement_score":0.030872628,"about_ca_system_score_codex":0.0009859749,"about_ca_system_score_gemma":0.0015733181,"threshold_uncertainty_score":0.16327202},"labels":[],"label_agreement":null},{"id":"W3201928742","doi":"10.1002/cpt.2430","title":"Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Internal medicine; Incretin; Gastroenterology; Type 2 diabetes; Confidence interval; Adverse effect; Diabetes mellitus; Proportional hazards model; Exenatide; Vildagliptin; Glucagon-like peptide-1; Endocrinology","score_opus":0.02719847512076245,"score_gpt":0.3351393835277968,"score_spread":0.30794090840703436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201928742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548316,0.0023071931,0.00014713785,0.00008535459,0.000027799622,0.00001352047,0.0014286055,0.0000058402193,0.00050156086],"genre_scores_gemma":[0.9979746,0.0005912242,0.00009972893,0.00006088928,0.0000346934,0.000013379262,0.001060325,0.000002836494,0.00016231381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930954,0.00020981541,0.000104974504,0.00016318171,0.00011689752,0.00009562031],"domain_scores_gemma":[0.9976285,0.0005149064,0.0013620554,0.00017867744,0.00010593054,0.00020996004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091997074,0.00024380891,0.00050065527,0.00083601306,0.00025863372,0.0007823033,0.00033607185,0.0005976184,0.0011440984],"category_scores_gemma":[0.0031283053,0.00034037954,0.0011288992,0.0016725305,0.00019943873,0.0004218939,0.0004605901,0.00085342454,0.0001889399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076948735,0.000046153633,0.9969891,0.00004550066,0.00023739022,0.00006234269,0.000021951248,0.00007666965,0.00007296728,0.00002499947,0.0001750875,0.0014783423],"study_design_scores_gemma":[0.000073326424,0.00015838312,0.9984919,0.000023362914,0.000189582,0.00017459717,0.00005642678,0.00039427064,0.00003749318,0.000060274062,0.00033269185,0.000007685389],"about_ca_topic_score_codex":0.005104962,"about_ca_topic_score_gemma":0.0044041965,"teacher_disagreement_score":0.005104962,"about_ca_system_score_codex":0.00035960684,"about_ca_system_score_gemma":0.0002608991,"threshold_uncertainty_score":0.010150492},"labels":[],"label_agreement":null},{"id":"W3202017675","doi":"10.1002/cpt.2431","title":"Pharmacokinetics, Pharmacodynamics, and Therapeutic Drug Monitoring of Valganciclovir and Ganciclovir in Transplantation","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Valganciclovir; Ganciclovir; Pharmacokinetics; Medicine; Pharmacodynamics; Therapeutic drug monitoring; Transplantation; Pharmacology; Internal medicine; Intensive care medicine; Human cytomegalovirus; Immunology","score_opus":0.15462390531955592,"score_gpt":0.4995614486638928,"score_spread":0.3449375433443369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202017675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.085973755,0.8126832,0.0902333,0.0021044477,0.000243444,0.0002058253,0.0010008907,0.00030491356,0.0072501865],"genre_scores_gemma":[0.6913169,0.2679701,0.036022373,0.0013478295,0.00090763654,0.00023704937,0.00080094894,0.00008811738,0.0013090954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971675,0.0016246098,0.0003094838,0.00027693095,0.00055247446,0.000068833906],"domain_scores_gemma":[0.99556905,0.002911895,0.00094747357,0.000112648886,0.00038791788,0.000071044386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005845617,0.00032892305,0.0013035293,0.0014338183,0.0001478362,0.001420491,0.00041785976,0.00054654805,0.00074513094],"category_scores_gemma":[0.011252515,0.00022238943,0.0008842402,0.0019691337,0.00040415558,0.0007333272,0.00040228193,0.00076189195,0.00020558808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016155748,0.00017185595,0.05358594,0.0074430737,0.0010342661,0.00070002937,0.00020290853,0.009995516,0.010600145,0.0025485456,0.0029879345,0.90911424],"study_design_scores_gemma":[0.0009713392,0.0066643455,0.40253314,0.011744696,0.011296624,0.019182643,0.0007425467,0.107727446,0.11304801,0.038401093,0.28702888,0.0006592039],"about_ca_topic_score_codex":0.0016564534,"about_ca_topic_score_gemma":0.0011721061,"teacher_disagreement_score":0.005845617,"about_ca_system_score_codex":0.0005996344,"about_ca_system_score_gemma":0.0010940306,"threshold_uncertainty_score":0.030914962},"labels":[],"label_agreement":null},{"id":"W3206617408","doi":"10.1002/cpt.2452","title":"Roadmap to 2030 for Drug Evaluation in Older Adults","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"National Institutes of Health; Medical Research Council; National Institute for Health and Care Research; U.S. Department of Health and Human Services","keywords":"Drug; Medicine; Gerontology; Drug development; Intensive care medicine; Pharmacology","score_opus":0.5514141914017356,"score_gpt":0.5828578909313099,"score_spread":0.031443699529574265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206617408","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007661662,0.07056223,0.047076438,0.5633265,0.025005959,0.0049366322,0.015247195,0.0053911563,0.2607922],"genre_scores_gemma":[0.08111625,0.18232575,0.2870345,0.24750511,0.017693786,0.01994562,0.047946848,0.0018306301,0.11460157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98567235,0.0066544265,0.0016272808,0.0005828897,0.0035057052,0.0019573653],"domain_scores_gemma":[0.93584955,0.015712209,0.0051101344,0.0017615091,0.02480521,0.016761376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046736058,0.002228624,0.0016670482,0.0027204498,0.001197595,0.005436451,0.0037621916,0.013626546,0.10035452],"category_scores_gemma":[0.049560532,0.0007878693,0.004448819,0.0014293704,0.0012578196,0.00836472,0.00680073,0.0062909303,0.044438176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001339697,0.00059109303,0.0015230633,0.003943423,0.00018230671,0.00045436437,0.000090754824,0.0022279958,0.0010903096,0.03500448,0.47403476,0.4795177],"study_design_scores_gemma":[0.000827786,0.0014174497,0.0052094785,0.0055306465,0.0001714738,0.000510157,0.00017942712,0.0023738847,0.0007676485,0.02421114,0.95871603,0.00008493354],"about_ca_topic_score_codex":0.0060327416,"about_ca_topic_score_gemma":0.0060044806,"teacher_disagreement_score":0.10035452,"about_ca_system_score_codex":0.005450686,"about_ca_system_score_gemma":0.054850034,"threshold_uncertainty_score":0.33571935},"labels":[],"label_agreement":null},{"id":"W3207687648","doi":"10.1002/cpt.2453","title":"The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"","keywords":"Real world data; Clinical trial; Medicine; Consistency (knowledge bases); Identification (biology); Oncology; Clinical Oncology; Lung cancer; MEDLINE; Internal medicine; Medical physics; Cancer; Family medicine; Data science; Computer science","score_opus":0.6741482432695717,"score_gpt":0.6587737536001147,"score_spread":0.015374489669456981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207687648","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05374927,0.015593238,0.615154,0.0985154,0.0074002226,0.18627645,0.0062657106,0.0008904839,0.016155228],"genre_scores_gemma":[0.077944756,0.0015143772,0.67840236,0.012078163,0.00057991716,0.2272036,0.0012574854,0.00032682245,0.00069253537],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.07338892,0.8775511,0.032527376,0.003708237,0.011350863,0.0014736119],"domain_scores_gemma":[0.048364732,0.76262945,0.026706478,0.10628739,0.05242408,0.0035879747],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.820122,0.0023246894,0.004292335,0.008992306,0.006278937,0.01741659,0.013533556,0.008175756,0.008405789],"category_scores_gemma":[0.8870057,0.0049432036,0.008118367,0.011311908,0.011399033,0.014987325,0.024288513,0.011192366,0.0016868453],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015009016,0.003903755,0.10492774,0.06138891,0.015847389,0.0038878869,0.08331596,0.01670358,0.0022060024,0.28258407,0.11267553,0.2975502],"study_design_scores_gemma":[0.011298824,0.005848288,0.03221036,0.14467822,0.013006917,0.0026039232,0.058613323,0.043807156,0.005493497,0.26828736,0.41293222,0.0012199152],"about_ca_topic_score_codex":0.008578791,"about_ca_topic_score_gemma":0.013617038,"teacher_disagreement_score":0.179878,"about_ca_system_score_codex":0.009696986,"about_ca_system_score_gemma":0.03791418,"threshold_uncertainty_score":0.22182167},"labels":[],"label_agreement":null},{"id":"W3217362361","doi":"10.1002/cpt.2499","title":"Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Genome Canada; Canadian Institutes of Health Research; University of Ottawa; World Health Organization; Heart and Stroke Foundation of Canada","keywords":"Coronavirus disease 2019 (COVID-19); Vaccination; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Virology; Immunology; Internal medicine; Outbreak","score_opus":0.19642267703817928,"score_gpt":0.5143449396845047,"score_spread":0.3179222626463254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217362361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965174,0.0014774782,0.00034889305,0.000030965133,0.000010652075,0.000035355202,0.00027440747,0.0000057630086,0.0012990233],"genre_scores_gemma":[0.9991492,0.00033253425,0.000116052186,0.000022740762,0.000023411447,0.000012674969,0.00021759473,0.0000014166952,0.00012435713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998863,0.00036824445,0.00017703872,0.0002383089,0.00019484514,0.00015858862],"domain_scores_gemma":[0.9966607,0.00044189126,0.0024443362,0.0001428323,0.00014936739,0.00016095297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010463768,0.00022406914,0.00035396073,0.00085232296,0.00016418718,0.0004772134,0.00012056258,0.00021830596,0.0014876124],"category_scores_gemma":[0.0017374273,0.00012994703,0.0004395887,0.0005922334,0.000276628,0.0004210831,0.0003949,0.0003139542,0.00019840107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000251069,0.00003369212,0.99422026,0.000063363936,0.000051789284,0.00032638508,0.000089669666,0.000027425116,0.00091318943,0.000019735719,0.00005308067,0.00395029],"study_design_scores_gemma":[0.0000047687026,0.00038232317,0.9968491,0.00001575389,0.000034182114,0.00200079,0.00018840244,0.000033291308,0.00024210368,0.000018661449,0.00022758332,0.0000030852782],"about_ca_topic_score_codex":0.00030184438,"about_ca_topic_score_gemma":0.00045760392,"teacher_disagreement_score":0.0014876124,"about_ca_system_score_codex":0.00014098818,"about_ca_system_score_gemma":0.0001597935,"threshold_uncertainty_score":0.0055338144},"labels":[],"label_agreement":null},{"id":"W4200424936","doi":"10.1002/cpt.2520","title":"A Systematic Review and Analysis of the Use of Polygenic Scores in Pharmacogenomics","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Health Sciences Centre; Manitoba Health; Children's Hospital Research Institute of Manitoba; University of Manitoba","funders":"Natural Environment Research Council; Medical Research Council; Mitacs; Health Sciences Centre Foundation; Health Research","keywords":"Pharmacogenomics; Precision medicine; Medicine; Trait; Demography; Pharmacology; Computer science; Sociology","score_opus":0.18662149865401398,"score_gpt":0.46797509607897086,"score_spread":0.2813535974249569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200424936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001185878,0.9946432,0.00074039056,0.0006977785,0.00019424659,0.00025624488,0.0018239114,0.000022385007,0.00043598536],"genre_scores_gemma":[0.017356098,0.9779613,0.0017395503,0.00096507993,0.00016035371,0.0006163193,0.0010611812,0.000016217453,0.00012386887],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98077023,0.006867206,0.00733303,0.0014340933,0.0032711253,0.00032434548],"domain_scores_gemma":[0.893469,0.08763226,0.010929297,0.0019276541,0.0056099272,0.00043178248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019771958,0.0014904311,0.0066469195,0.017013589,0.0006015973,0.0026842528,0.0018970518,0.0015092661,0.0039376696],"category_scores_gemma":[0.08687332,0.0008701693,0.009468811,0.020522544,0.0009999841,0.0022362832,0.0018815051,0.0013343749,0.00040589733],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002064141,0.000013795992,0.0039727325,0.8838657,0.02046769,0.00022508221,0.0002575206,0.00035472235,0.00019680231,0.0009185231,0.005450351,0.0840705],"study_design_scores_gemma":[0.00021756977,0.00015392853,0.014607097,0.8247315,0.112485394,0.0006867546,0.00023427086,0.00026922475,0.00023897827,0.0014708064,0.044839602,0.00006484772],"about_ca_topic_score_codex":0.009519463,"about_ca_topic_score_gemma":0.02389077,"teacher_disagreement_score":0.019771958,"about_ca_system_score_codex":0.0034779396,"about_ca_system_score_gemma":0.013215862,"threshold_uncertainty_score":0.10456538},"labels":[],"label_agreement":null},{"id":"W4214770147","doi":"10.1002/cpt.2563","title":"PharmVar GeneFocus: <i>CYP3A5</i>","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; CancerCare Manitoba","funders":"National Human Genome Research Institute; Erzincan Üniversitesi; National Institutes of Health; Vetenskapsrådet; Ontario Institute for Cancer Research; National Institute of General Medical Sciences; European Federation of Pharmaceutical Industries and Associations; Kungliga Tekniska Högskolan; Robert Bosch Stiftung; McGill University","keywords":"Pharmacogenomics; CYP3A5; Pharmacogenetics; Allele; Locus (genetics); Tacrolimus; Biology; Genetics; Computational biology; Medicine; Gene; Bioinformatics; Transplantation; Genotype; Internal medicine","score_opus":0.6241503739757894,"score_gpt":0.6259530102670595,"score_spread":0.0018026362912700877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214770147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027351778,0.8195942,0.010309436,0.00922371,0.0030311537,0.00044676574,0.046889205,0.003184871,0.10458545],"genre_scores_gemma":[0.008993674,0.8586643,0.017321981,0.0061453898,0.0013921421,0.0003733899,0.07536711,0.0007587269,0.030983264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944884,0.000105523155,0.000104842155,0.00007591442,0.00021181525,0.000053069583],"domain_scores_gemma":[0.99882334,0.00044424494,0.00023990475,0.000067947214,0.0003285714,0.0000958765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010941911,0.00072177395,0.0013044159,0.0041687237,0.0002559969,0.0015758008,0.0012208662,0.0009658465,0.031054234],"category_scores_gemma":[0.0023875432,0.00021576048,0.00086326886,0.006543374,0.00036736115,0.0013435078,0.0010940202,0.001261583,0.024765074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012080786,0.000037841997,0.00044774023,0.0132789835,0.00009020314,0.00018291839,0.0000901892,0.00016428254,0.0025880889,0.005577997,0.1988713,0.7785496],"study_design_scores_gemma":[0.000009225324,0.000013489164,0.0005359068,0.0012096101,0.000044301283,0.00031418525,0.00001097693,0.000023283546,0.00040805424,0.00050962344,0.99691415,0.0000073133274],"about_ca_topic_score_codex":0.0022986478,"about_ca_topic_score_gemma":0.002756483,"teacher_disagreement_score":0.031054234,"about_ca_system_score_codex":0.00059647375,"about_ca_system_score_gemma":0.0024701627,"threshold_uncertainty_score":0.10388672},"labels":[],"label_agreement":null},{"id":"W4214826920","doi":"10.1002/cpt.2525","title":"Hepatic clearance models and <i>IVIVE</i> predictions","year":2022,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Library science; Citation; Pharmacy; Associate editor; Operations research; Medicine; Computer science; Mathematics; Family medicine","score_opus":0.1004050219349011,"score_gpt":0.38816384701812806,"score_spread":0.287758825083227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214826920","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029765416,0.0118777305,0.3323307,0.45142147,0.011300495,0.0001572886,0.0031497527,0.0026662087,0.15733092],"genre_scores_gemma":[0.80547434,0.00928637,0.03576877,0.058996685,0.009925574,0.00031483633,0.0012273848,0.00082974037,0.07817619],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992461,0.00032850617,0.000037704296,0.00008077922,0.00020874591,0.00009817765],"domain_scores_gemma":[0.9972144,0.0019269721,0.00018443522,0.0002060791,0.000382385,0.000085763786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013115099,0.0009672915,0.0010294424,0.0006262906,0.00049092894,0.002370447,0.001727832,0.0030812097,0.0069266134],"category_scores_gemma":[0.007834747,0.0005069137,0.0016049226,0.00041973373,0.0008509856,0.0015623708,0.00077278557,0.0036866302,0.0038000238],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007784084,0.00017579015,0.003349194,0.00046420065,0.00016195931,0.0034420537,0.00013460623,0.2848393,0.0034532342,0.32891485,0.2647154,0.109570935],"study_design_scores_gemma":[0.00012152655,0.00012497784,0.0004971925,0.0001249558,0.000072162955,0.0010310157,0.000046955007,0.6523872,0.003705794,0.2792559,0.062584326,0.000048042024],"about_ca_topic_score_codex":0.008177786,"about_ca_topic_score_gemma":0.0042023957,"teacher_disagreement_score":0.008177786,"about_ca_system_score_codex":0.0038366695,"about_ca_system_score_gemma":0.0013073413,"threshold_uncertainty_score":0.027837157},"labels":[],"label_agreement":null},{"id":"W4214845839","doi":"10.1002/cpt.2570","title":"Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational Studies","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Observational study; Type 2 diabetes; Hazard ratio; Cardiology; Ventricular tachycardia; Confidence interval; Sudden cardiac death; Meta-analysis; Diabetes mellitus; Endocrinology","score_opus":0.19009107634780928,"score_gpt":0.4510741831559829,"score_spread":0.2609831068081736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214845839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022924298,0.99650013,0.00012587765,0.00018054817,0.00007878048,0.00019375238,0.0005065748,0.0000050709054,0.00011680925],"genre_scores_gemma":[0.033353828,0.9640838,0.00092726905,0.0005336917,0.0000816321,0.00053120207,0.00040589977,0.000005233552,0.00007748521],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98502284,0.0046248846,0.007006072,0.001068466,0.0020303184,0.00024740148],"domain_scores_gemma":[0.94811815,0.03525252,0.011792285,0.00071143644,0.0037290899,0.00039642403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012060488,0.0012085963,0.007677734,0.010325399,0.00054145907,0.0020396556,0.0013790946,0.0013635728,0.0020215511],"category_scores_gemma":[0.052829336,0.0011909317,0.008887338,0.011387748,0.0008259078,0.001509716,0.0013920288,0.0010095076,0.00016313055],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002853839,0.000014120541,0.003606904,0.9519164,0.025504457,0.00010336047,0.00021057682,0.000097594486,0.0001325035,0.00011413934,0.0007900266,0.01722462],"study_design_scores_gemma":[0.0005180353,0.00031019398,0.019668274,0.74468654,0.2216529,0.0005611921,0.00038276528,0.00013405007,0.00024213913,0.00036221833,0.011417692,0.00006404842],"about_ca_topic_score_codex":0.01192975,"about_ca_topic_score_gemma":0.03090456,"teacher_disagreement_score":0.012060488,"about_ca_system_score_codex":0.0032745183,"about_ca_system_score_gemma":0.008991885,"threshold_uncertainty_score":0.06378275},"labels":[],"label_agreement":null},{"id":"W4224235286","doi":"10.1002/cpt.2605","title":"Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Transporter; Biology; Computational biology; Pharmacology; Function (biology); Drug discovery; Transport protein; Bioinformatics; Cell biology; Gene; Genetics","score_opus":0.12546130704385555,"score_gpt":0.450526811696567,"score_spread":0.32506550465271145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224235286","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010554584,0.099301256,0.0040626037,0.5712191,0.29305962,0.00021122883,0.00038100223,0.0004104642,0.030299336],"genre_scores_gemma":[0.011770203,0.26131025,0.0068538273,0.17123273,0.31273505,0.00051942223,0.0011725186,0.0008407658,0.2335652],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99297476,0.0010779763,0.0005457118,0.0011973077,0.0033595613,0.0008447861],"domain_scores_gemma":[0.97968173,0.0034479036,0.0016981643,0.00079049997,0.009383164,0.004998568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0121480115,0.0012764236,0.0014911714,0.0018281344,0.0024002017,0.010492403,0.00271622,0.011405761,0.012366254],"category_scores_gemma":[0.01157109,0.0005401532,0.0010650931,0.0025514949,0.004119574,0.008022749,0.0028956998,0.012908997,0.013107226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081243,0.00005986086,0.00025176996,0.00030739754,0.000017066608,0.00013376363,0.000067214605,0.00013981899,0.0010022064,0.0088184625,0.87388426,0.115236945],"study_design_scores_gemma":[0.00001124311,0.000039376067,0.00023712183,0.00033449364,0.000010002309,0.00012089949,0.000054748758,0.00024033878,0.0005780965,0.0025427467,0.9958134,0.000017513965],"about_ca_topic_score_codex":0.003178955,"about_ca_topic_score_gemma":0.003707445,"teacher_disagreement_score":0.012366254,"about_ca_system_score_codex":0.0038581227,"about_ca_system_score_gemma":0.01578433,"threshold_uncertainty_score":0.06424558},"labels":[],"label_agreement":null},{"id":"W4224291920","doi":"10.1002/cpt.2618","title":"Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of General Medical Sciences; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration","keywords":"Physiologically based pharmacokinetic modelling; Dosing; Pharmacokinetics; Obesity; Medicine; Pharmacology; Childhood obesity; Renal function; Disposition; Internal medicine; Overweight","score_opus":0.20845782886564637,"score_gpt":0.4167351816970661,"score_spread":0.2082773528314197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224291920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86857134,0.0010355308,0.124371774,0.0007002613,0.000036653382,0.0001482176,0.002551618,0.00029686908,0.0022877606],"genre_scores_gemma":[0.9735398,0.0005576875,0.024118835,0.000118322976,0.000010861142,0.00010301767,0.0012707895,0.000035473946,0.00024527215],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99922025,0.00041176713,0.000062599516,0.00015733151,0.00010733058,0.000040648756],"domain_scores_gemma":[0.9967885,0.0020776666,0.0005750975,0.00021574469,0.00028177537,0.00006125698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020405555,0.00072623836,0.0005581795,0.00043336724,0.00016471969,0.0010762756,0.0005130498,0.00058968127,0.00070128497],"category_scores_gemma":[0.008608627,0.0004095944,0.0010995913,0.00048267576,0.00030808095,0.00080983306,0.00047138505,0.0009913519,0.00019001757],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072568766,0.00022646047,0.21559428,0.00018146526,0.00049008615,0.0005143377,0.00024217935,0.73557854,0.0035213018,0.0022479836,0.0011034339,0.039574347],"study_design_scores_gemma":[0.000060805236,0.00036375233,0.04417599,0.00005275127,0.00015135309,0.00037772098,0.00012389854,0.94866776,0.002607535,0.0013939771,0.0019781124,0.00004628117],"about_ca_topic_score_codex":0.013652989,"about_ca_topic_score_gemma":0.0076589896,"teacher_disagreement_score":0.013652989,"about_ca_system_score_codex":0.00091843767,"about_ca_system_score_gemma":0.0012547439,"threshold_uncertainty_score":0.027146995},"labels":[],"label_agreement":null},{"id":"W4224657289","doi":"10.1002/cpt.2620","title":"Exposure‐Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Antitoxin; Botulism; Botulinum neurotoxin; Potency; Dosing; Neurotoxin; Serotype; Medicine; Neutralization; Toxin; Botulinum toxin; Pharmacology; Immunology; Biology; Antibody; Anesthesia; Microbiology; Internal medicine","score_opus":0.14067646145126642,"score_gpt":0.45146537200993897,"score_spread":0.3107889105586725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224657289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79998213,0.0008801813,0.1702021,0.0012671122,0.00016171735,0.00048385552,0.0016970064,0.00078905706,0.024536807],"genre_scores_gemma":[0.98467064,0.00022826492,0.010654063,0.0001268026,0.000013679917,0.00021264277,0.00037257027,0.000047314083,0.0036739607],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996803,0.00014629118,0.000014026009,0.000042155247,0.00006214736,0.000055164],"domain_scores_gemma":[0.9980546,0.0014503878,0.00015383563,0.000045164146,0.00023495888,0.00006103859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089645793,0.0007038762,0.0008144823,0.00039515324,0.00030616747,0.00075438735,0.00086243596,0.0014877887,0.003430442],"category_scores_gemma":[0.0028456403,0.00046661493,0.0009414824,0.00032360983,0.00027524502,0.00040893428,0.00041121725,0.0010256408,0.0003752393],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007845906,0.00004770587,0.00085383875,0.000018076173,0.000017875514,0.000038396993,0.00001164867,0.9970011,0.00036756403,0.0003877458,0.00013416215,0.0010433787],"study_design_scores_gemma":[0.000014185129,0.000045303153,0.0002090753,0.0000027467281,0.0000074030654,0.000007481193,0.0000059509925,0.9990596,0.00020370571,0.00021910005,0.00022190694,0.0000035106204],"about_ca_topic_score_codex":0.02148556,"about_ca_topic_score_gemma":0.007950174,"teacher_disagreement_score":0.02148556,"about_ca_system_score_codex":0.001068551,"about_ca_system_score_gemma":0.0015865156,"threshold_uncertainty_score":0.042721033},"labels":[],"label_agreement":null},{"id":"W4235605449","doi":"10.1016/j.clpt.2004.01.006","title":"Reply","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Clinical pharmacology; Citation; Sick child; Psychology; Medicine; Library science; Computer science; Pharmacology; Pediatrics","score_opus":0.24167310496199226,"score_gpt":0.5310736219903486,"score_spread":0.28940051702835634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235605449","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003324448,0.0011478335,0.00007396181,0.9443736,0.052008327,0.000010009824,0.000059687005,0.000022535944,0.001971594],"genre_scores_gemma":[0.0014102194,0.0002850028,0.000055883196,0.9798591,0.011822754,0.000018686707,0.000015462952,0.0000121628045,0.006520785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958858,0.00078753993,0.00049621967,0.0008424638,0.0010984945,0.0008894755],"domain_scores_gemma":[0.98248196,0.008389231,0.0011681182,0.0006800425,0.0050164065,0.0022641495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004815407,0.00080850796,0.0012711799,0.0011438095,0.0050863097,0.007364902,0.002690698,0.05800273,0.019559346],"category_scores_gemma":[0.046038803,0.0009128594,0.0016829498,0.0010280722,0.0036315585,0.005070608,0.0039675655,0.050625503,0.014084165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032630578,0.000008637977,0.00042143592,0.00004071066,0.000021010523,0.00036200555,0.00018661794,0.000021038311,0.00009936624,0.0018043483,0.9946601,0.0023421715],"study_design_scores_gemma":[0.00006194401,0.0000242385,0.0014921875,0.00023405667,0.00005807271,0.0007154383,0.001217715,0.00007900253,0.00025446864,0.0041617956,0.99162394,0.00007713624],"about_ca_topic_score_codex":0.007368671,"about_ca_topic_score_gemma":0.008710257,"teacher_disagreement_score":0.9804407,"about_ca_system_score_codex":0.004686658,"about_ca_system_score_gemma":0.0055003907,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4237242270","doi":"10.1016/s0009-9236(01)70992-7","title":"Red wine decreases cyclosporine bioavailability","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Wine; Ciclosporin; Pharmacology; Bioavailability; CYP3A4; Pharmacokinetics; Crossover study; Chemistry; Grapefruit juice; Whole blood; Fluorescence polarization immunoassay; Medicine; Placebo; Chromatography; Cytochrome P450; Internal medicine; Food science; Biochemistry; Chemotherapy; Metabolism","score_opus":0.14501065618878375,"score_gpt":0.4814705665912841,"score_spread":0.33645991040250034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237242270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961169,0.002410922,0.00030400552,0.00013872416,0.0000666089,0.000020573994,0.00008265038,0.000062061816,0.00079767837],"genre_scores_gemma":[0.99573475,0.0015684656,0.00057918864,0.00019229561,0.00008071974,0.000017195194,0.00015212358,0.000015579013,0.0016596478],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998821,0.00003402592,0.000009818613,0.000022986274,0.000028893013,0.000022255384],"domain_scores_gemma":[0.9997414,0.00006922298,0.000082970815,0.000021402393,0.000031470852,0.000053549044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014639444,0.00028083092,0.00032696963,0.000113349,0.00012441064,0.00029279946,0.00011971164,0.00023882571,0.0028030346],"category_scores_gemma":[0.00036084262,0.00011089506,0.0002149564,0.000085040556,0.00010760455,0.00015098766,0.00014469506,0.0004322415,0.00029766234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018664833,0.0017765019,0.008091605,0.00046075325,0.0002384869,0.0002986205,0.00006510151,0.0002676993,0.88948363,0.00016905158,0.0012296307,0.07925414],"study_design_scores_gemma":[0.0032394086,0.0714414,0.17642766,0.0001582866,0.0007647706,0.0029204811,0.00016786632,0.0032543845,0.7163875,0.00041625838,0.024775544,0.000046451838],"about_ca_topic_score_codex":0.00033889187,"about_ca_topic_score_gemma":0.00042710063,"teacher_disagreement_score":0.0028030346,"about_ca_system_score_codex":0.0001571465,"about_ca_system_score_gemma":0.00014101964,"threshold_uncertainty_score":0.009377062},"labels":[],"label_agreement":null},{"id":"W4240364009","doi":"10.1038/clpt.2014.133","title":"Biotransformation","year":2014,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Clinical pharmacology; Clinical trial; Medicine; Drug development; Human immunodeficiency virus (HIV); Drug; Intensive care medicine; Pharmaceutical industry; Public health; Pharmacology; Virology; Internal medicine; Pathology","score_opus":0.13172511939189824,"score_gpt":0.5186376197035598,"score_spread":0.3869125003116616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240364009","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058270537,0.3115506,0.004123216,0.053665563,0.54099256,0.00011902873,0.0005111032,0.00052379386,0.087931454],"genre_scores_gemma":[0.009874929,0.40062466,0.002987075,0.061179772,0.19417624,0.0001494738,0.00082450453,0.0004654248,0.32971787],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772197,0.0003722439,0.00025907674,0.0003016297,0.0012069396,0.00013807995],"domain_scores_gemma":[0.9983481,0.0004911434,0.00022759389,0.000193437,0.00060527027,0.00013447467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020243851,0.0020664139,0.0013182127,0.0015243879,0.0007908906,0.0032916917,0.0018322791,0.0058756378,0.022529678],"category_scores_gemma":[0.004667889,0.0005734283,0.0011432654,0.0011844976,0.0020943736,0.0040958254,0.0021922323,0.007354364,0.026857426],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060526192,0.000037209742,0.00004764353,0.0013170587,0.00003605646,0.0004824389,0.00005836656,0.00018723543,0.0023163517,0.008898005,0.84693974,0.13961942],"study_design_scores_gemma":[0.0000047398853,0.00000947635,0.000024779722,0.000079771584,0.000004627239,0.00019065822,0.00000528347,0.000017214048,0.0005940773,0.00081962143,0.99824595,0.0000038294083],"about_ca_topic_score_codex":0.001137216,"about_ca_topic_score_gemma":0.0016295003,"teacher_disagreement_score":0.022529678,"about_ca_system_score_codex":0.002062988,"about_ca_system_score_gemma":0.0019553236,"threshold_uncertainty_score":0.0753693},"labels":[],"label_agreement":null},{"id":"W4244684940","doi":"10.1002/cpt.1194","title":"A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring <scp>SLE</scp>: Assessment by Drug Levels and Self‐Administered Questionnaires","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"National Institutes of Health; Johns Hopkins University","keywords":"Medicine; Drug; Hydroxychloroquine; Internal medicine; Systemic lupus erythematosus; Drug class; Prospective cohort study; Multivariate analysis; Drug holiday; Pharmacology; Immunology; Disease; Coronavirus disease 2019 (COVID-19)","score_opus":0.09093447510755344,"score_gpt":0.4739171374763177,"score_spread":0.38298266236876427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244684940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850816,0.0001492287,0.00009048667,0.000036335892,0.0000061450583,0.000054208263,0.0006278651,0.00000388231,0.00052364497],"genre_scores_gemma":[0.9982535,0.000090809684,0.00016358547,0.00011279902,0.000016907134,0.000060956154,0.0010274489,0.0000037490645,0.00027008983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987908,0.000419234,0.00018421096,0.00022819807,0.0002336631,0.0001440478],"domain_scores_gemma":[0.99586594,0.00075651583,0.0017833295,0.0003754439,0.0003855062,0.00083322125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001992232,0.00052635366,0.00068826356,0.0011205577,0.00075091055,0.0010273507,0.0004346206,0.00086515094,0.001959895],"category_scores_gemma":[0.0034584766,0.00060381583,0.0007685866,0.0016307825,0.00042217816,0.0008769876,0.00055981573,0.0013342262,0.0007553811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008482359,0.00034608765,0.9969893,0.000014787536,0.00011190224,0.000039991173,0.00019198326,0.000026943888,0.00014212311,0.000013718311,0.0001283777,0.0011466424],"study_design_scores_gemma":[0.0001454688,0.00089509005,0.9980788,0.000010959716,0.00006817218,0.0001489202,0.00017745768,0.00017489317,0.000056356123,0.000011022124,0.00022232912,0.000010495671],"about_ca_topic_score_codex":0.0059862374,"about_ca_topic_score_gemma":0.0053822114,"teacher_disagreement_score":0.0059862374,"about_ca_system_score_codex":0.0005292204,"about_ca_system_score_gemma":0.00036528902,"threshold_uncertainty_score":0.011902809},"labels":[],"label_agreement":null},{"id":"W4252666590","doi":"10.1016/s0009-9236(03)90389-4","title":"Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Purdue Pharma (Canada)","funders":"","keywords":"Acute chest syndrome; Medicine; Disease; Morphine; Intensive care medicine; Anesthesia; Internal medicine; Sickle cell anemia","score_opus":0.022918215778570835,"score_gpt":0.33414970316308495,"score_spread":0.3112314873845141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252666590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745995,0.0014600608,0.00017680808,0.00014606345,0.000015010124,0.0000070040746,0.00007761263,0.0000054126963,0.00065206725],"genre_scores_gemma":[0.99900275,0.00053117756,0.000103959115,0.00005147174,0.000062387044,0.000004301221,0.00006116018,0.0000016041007,0.00018113025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996928,0.0001457638,0.000026551434,0.00002564633,0.00007663097,0.000032657106],"domain_scores_gemma":[0.9969892,0.0010331923,0.001112308,0.00011430186,0.0001369138,0.0006140523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003730459,0.00022134633,0.00036614214,0.0003154769,0.00024677647,0.00046143166,0.00012282991,0.0006529002,0.001414315],"category_scores_gemma":[0.0034736043,0.00019224125,0.00025609188,0.00031667895,0.00025097662,0.00038567366,0.00033359317,0.00075954676,0.00015742125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003927782,0.00019315434,0.98282397,0.000047381072,0.00012831598,0.001434098,0.00009670533,0.00015527123,0.0026068578,0.00009112704,0.00021410006,0.00828126],"study_design_scores_gemma":[0.000034862293,0.001552093,0.995061,0.00001161266,0.000053872078,0.0021554516,0.000068889436,0.00050970557,0.00026138494,0.0000829851,0.00019974467,0.000008261984],"about_ca_topic_score_codex":0.0008018994,"about_ca_topic_score_gemma":0.0007965022,"teacher_disagreement_score":0.001414315,"about_ca_system_score_codex":0.00016696978,"about_ca_system_score_gemma":0.00025250792,"threshold_uncertainty_score":0.0047314167},"labels":[],"label_agreement":null},{"id":"W4280512618","doi":"10.1002/cpt.2652","title":"Rifampin Drug–Drug–Interaction Studies: Reflections on the Nitrosamine Impurities Issue","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Drug; Pharmacology; Pharmacokinetics; Drug interaction; Cytochrome P450; Chemistry; Medicine; Biochemistry; Enzyme","score_opus":0.7281972667024696,"score_gpt":0.6661751620883808,"score_spread":0.06202210461408886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280512618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049758335,0.9966718,0.00014632013,0.0018490046,0.00047141593,0.0000036749639,0.000016699505,0.000006109611,0.0007852127],"genre_scores_gemma":[0.0005022956,0.9963497,0.00031713725,0.0015146859,0.000615213,0.0000062342788,0.000026387039,0.0000034457207,0.000664965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999032,0.00033202977,0.0001383458,0.00009333382,0.0003673899,0.000036838548],"domain_scores_gemma":[0.9956527,0.0029143316,0.0002915338,0.000094229996,0.000960706,0.00008657608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028629098,0.0006270476,0.0015101474,0.0018456243,0.00020523043,0.0014631803,0.0009787425,0.0018640842,0.0045211506],"category_scores_gemma":[0.0034593246,0.00034504704,0.0011024914,0.001878876,0.0007972749,0.0025649227,0.0007063073,0.0037927998,0.0025016323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071620336,0.000060854094,0.00019699492,0.024488391,0.00021394406,0.00024029295,0.00011231477,0.00022014717,0.0018266842,0.008770343,0.07431984,0.8894785],"study_design_scores_gemma":[0.000015590178,0.000076947515,0.00044561358,0.005896491,0.00014900313,0.0008099052,0.0000596429,0.00005366134,0.00034053758,0.0029121847,0.98922414,0.000016103408],"about_ca_topic_score_codex":0.0011364591,"about_ca_topic_score_gemma":0.003239983,"teacher_disagreement_score":0.0045211506,"about_ca_system_score_codex":0.0007047021,"about_ca_system_score_gemma":0.002024024,"threshold_uncertainty_score":0.015140712},"labels":[],"label_agreement":null},{"id":"W4280526493","doi":"10.1002/cpt.2638","title":"Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Transporter; Toxicity; ATP-binding cassette transporter; Pharmacology; Solute carrier family; Biology; Medicine; Biochemistry; Internal medicine","score_opus":0.18589677694194875,"score_gpt":0.43870313585958853,"score_spread":0.2528063589176398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280526493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002728401,0.9880937,0.00027085835,0.004248979,0.0038755161,0.000011447004,0.00005881636,0.000015493808,0.0031523518],"genre_scores_gemma":[0.0013273513,0.9900941,0.00028289497,0.002560404,0.0016630625,0.000014874803,0.00011649458,0.0000071475597,0.0039335904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996855,0.00006317148,0.000036319117,0.000054737033,0.00010739572,0.000052859676],"domain_scores_gemma":[0.9995441,0.000115748815,0.000039064274,0.000010860831,0.00020037114,0.00008974391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016171648,0.0009698323,0.00088393525,0.002123715,0.00038601315,0.0019041463,0.0006608457,0.002046536,0.005766454],"category_scores_gemma":[0.000851349,0.00028725364,0.00081381743,0.0025122485,0.0004123307,0.0022666147,0.0016790496,0.0029493931,0.0030110017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022762125,0.00015404093,0.00022301482,0.015094119,0.00008630108,0.00053043023,0.0002497481,0.0004275478,0.0049538366,0.015510717,0.2584449,0.7040977],"study_design_scores_gemma":[0.000007700112,0.00006927221,0.00026476767,0.0023658369,0.000039082333,0.00040858137,0.00006389449,0.000043123073,0.00044961445,0.0010179025,0.99525756,0.000012575467],"about_ca_topic_score_codex":0.0010649058,"about_ca_topic_score_gemma":0.0021599282,"teacher_disagreement_score":0.005766454,"about_ca_system_score_codex":0.0010897154,"about_ca_system_score_gemma":0.0022844055,"threshold_uncertainty_score":0.019290686},"labels":[],"label_agreement":null},{"id":"W4280575162","doi":"10.1002/cpt.2644","title":"Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Transporter; Drug; Pharmacology; Multidrug resistance-associated protein 2; Drug development; Drug interaction; Medicine; Antifolate; Organic anion transporter 1; ATP-binding cassette transporter; Biology; Toxicity; Biochemistry; Internal medicine; Antimetabolite","score_opus":0.18934579634714893,"score_gpt":0.4877991353196528,"score_spread":0.29845333897250387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280575162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015679869,0.6936657,0.0065056644,0.19892865,0.077589534,0.00017293321,0.0012361115,0.0011511184,0.019182347],"genre_scores_gemma":[0.010697664,0.81670445,0.01275741,0.080536135,0.051760036,0.00031406307,0.0039569093,0.0003583472,0.02291496],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933868,0.0018168589,0.0011677376,0.00048103946,0.00251451,0.0006329664],"domain_scores_gemma":[0.9667499,0.00796631,0.0029562304,0.0010301538,0.01790992,0.0033873315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018474763,0.0013794742,0.0023980446,0.0049090893,0.00095483084,0.005049083,0.0030804998,0.006926354,0.008509621],"category_scores_gemma":[0.021655211,0.000685887,0.0017876143,0.0063384203,0.0013631482,0.007162341,0.0035257495,0.009398772,0.0054845572],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018240322,0.00008269651,0.00044780114,0.002284399,0.00006431732,0.00025355053,0.00008789182,0.00037183298,0.0008854557,0.0038408027,0.62395835,0.36754063],"study_design_scores_gemma":[0.000024309917,0.000078610225,0.0003339493,0.0012156803,0.00006360637,0.0003286202,0.00003860862,0.00018217544,0.0002754282,0.0007784662,0.9966583,0.0000222185],"about_ca_topic_score_codex":0.0027278154,"about_ca_topic_score_gemma":0.005035867,"teacher_disagreement_score":0.018474763,"about_ca_system_score_codex":0.0032046866,"about_ca_system_score_gemma":0.010018337,"threshold_uncertainty_score":0.09770501},"labels":[],"label_agreement":null},{"id":"W4283785081","doi":"10.1002/cpt.2700","title":"Sotrovimab Lowers the Risk of <scp>COVID</scp>‐19 Related Hospitalization or Death in a Large Population Cohort in the United Arab Emirates","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Deanship of Scientific Research, King Saud University","keywords":"Favipiravir; Medicine; Odds ratio; Hazard ratio; Internal medicine; Confidence interval; Retrospective cohort study; Population; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.0921600825197258,"score_gpt":0.44593573757270755,"score_spread":0.35377565505298175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283785081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996101,0.000091987786,0.000027730779,0.000029103045,0.000002901601,0.0000028877676,0.000047645375,0.0000019893025,0.00018560949],"genre_scores_gemma":[0.99955314,0.00012556335,0.000040167648,0.0000392118,0.000011035311,0.000004946567,0.00011543844,0.0000012271388,0.00010912681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972254,0.00011491424,0.000013744917,0.000048362777,0.0000428818,0.000057591496],"domain_scores_gemma":[0.9996087,0.00006927659,0.00017865552,0.000040680618,0.000037906062,0.00006488344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053295726,0.0003801887,0.0003011574,0.00035199823,0.00027190743,0.00049293425,0.00019991682,0.00034755483,0.0008412825],"category_scores_gemma":[0.0011689456,0.00033848858,0.0004639222,0.00030283537,0.00026948072,0.00022513904,0.00024490902,0.00046916926,0.00014550002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006224016,0.00012449462,0.9946008,0.000011314707,0.0001987958,0.00011335029,0.00008543075,0.00012414818,0.000954416,0.000029010462,0.00021415601,0.002921687],"study_design_scores_gemma":[0.000050011677,0.0004348981,0.9982407,0.0000048655806,0.00007228992,0.00024409001,0.00010550814,0.00041083145,0.0001254759,0.000015682399,0.00029173572,0.0000038066314],"about_ca_topic_score_codex":0.005751542,"about_ca_topic_score_gemma":0.006183058,"teacher_disagreement_score":0.005751542,"about_ca_system_score_codex":0.00023527193,"about_ca_system_score_gemma":0.00031127394,"threshold_uncertainty_score":0.011436164},"labels":[],"label_agreement":null},{"id":"W4285593302","doi":"10.1002/cpt.2712","title":"Population Pharmacokinetics of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: An Integrated Analysis","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Heart failure; Ejection fraction; Volume of distribution; Medicine; Pharmacokinetics; Population; Internal medicine; Renal function; Cardiology; Endocrinology","score_opus":0.03919895872102991,"score_gpt":0.38041107143812253,"score_spread":0.3412121127170926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285593302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97681886,0.0015713832,0.018337116,0.00010642533,0.000011938428,0.00030360866,0.0014065646,0.00017666626,0.0012673994],"genre_scores_gemma":[0.99406815,0.00031679237,0.0032103523,0.00007268499,0.000013064677,0.00013194578,0.0017193876,0.000030288084,0.00043737554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982382,0.0007867198,0.00009622931,0.00041558477,0.00031985258,0.00014328146],"domain_scores_gemma":[0.99689674,0.0016983297,0.0005492467,0.00034834287,0.00034687595,0.00016035931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054535638,0.00056139764,0.001911933,0.00056692463,0.00012255475,0.001112129,0.00090641197,0.000632749,0.0017251783],"category_scores_gemma":[0.0066266395,0.0005053643,0.0026149822,0.00072244665,0.00021998903,0.000710646,0.0007075891,0.0010939466,0.00029660764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04379797,0.0014494443,0.657795,0.00088073564,0.024822073,0.0009358566,0.00090734713,0.115496546,0.010579942,0.0017366598,0.0022067288,0.13939163],"study_design_scores_gemma":[0.0015213531,0.01105832,0.638618,0.000051912877,0.008073991,0.0007553719,0.00021498317,0.33292222,0.0017807627,0.0014468464,0.0034342927,0.00012197695],"about_ca_topic_score_codex":0.004502007,"about_ca_topic_score_gemma":0.0021797058,"teacher_disagreement_score":0.0054535638,"about_ca_system_score_codex":0.00086970377,"about_ca_system_score_gemma":0.0010615285,"threshold_uncertainty_score":0.028841496},"labels":[],"label_agreement":null},{"id":"W4288067911","doi":"10.1002/cpt.2721","title":"Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long‐Term Response to Atrasentan in Patients With Diabetic Kidney Disease","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Horizon 2020 Framework Programme; Innovative Medicines Initiative; European Commission; Steno Diabetes Center Copenhagen; European Federation of Pharmaceutical Industries and Associations","keywords":"Transporter; Diabetes mellitus; Organic anion transporter 1; Kidney disease; Kidney; Pharmacology; Medicine; Plasma concentration; Gene; Chemistry; Internal medicine; Endocrinology; Biochemistry","score_opus":0.022962206097100573,"score_gpt":0.3322508767920141,"score_spread":0.3092886706949135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288067911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994529,0.0002408395,0.00006744228,0.000023474868,0.0000063874227,0.000004208258,0.000108039094,0.000002193314,0.000094475334],"genre_scores_gemma":[0.9995814,0.000049102273,0.00006482824,0.00003532915,0.000011266424,0.000006692588,0.00014317082,0.0000017475751,0.000106463835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944144,0.00019727698,0.00006264623,0.00016999544,0.000056845303,0.00007172405],"domain_scores_gemma":[0.99871075,0.00042281573,0.00045622964,0.00014380417,0.00007359676,0.00019286612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091074954,0.0003349699,0.0006305712,0.0002715828,0.0002980215,0.00044654752,0.0003184082,0.0006843735,0.00089802704],"category_scores_gemma":[0.0016067673,0.00032554538,0.0007432887,0.00054507266,0.00022182464,0.00030235937,0.00023890224,0.0006825715,0.000116174735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004373681,0.00016034399,0.99032694,0.000018873177,0.0004071891,0.00025563635,0.00007287741,0.00016589249,0.0020845118,0.0000267281,0.00012416624,0.001983155],"study_design_scores_gemma":[0.00015944222,0.00057042175,0.9979231,0.0000054790207,0.00017496163,0.00029250944,0.000033747016,0.00051369454,0.00018008391,0.000038369144,0.00010019929,0.000008042594],"about_ca_topic_score_codex":0.0019160315,"about_ca_topic_score_gemma":0.0020010467,"teacher_disagreement_score":0.0019160315,"about_ca_system_score_codex":0.00019953879,"about_ca_system_score_gemma":0.0001400823,"threshold_uncertainty_score":0.004816532},"labels":[],"label_agreement":null},{"id":"W4294281525","doi":"10.1002/cpt.2737","title":"The Effect of Tobacco Use on the Expression of Placental Transporters in Alaska Native Women","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Birth, Development, and Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; University of Toronto; National Institute on Drug Abuse; Canada Research Chairs; National Cancer Institute; Centre for Addiction and Mental Health","keywords":"Placenta; Transporter; Fetus; Pregnancy; Medicine; Abcg2; Physiology; Nicotine; Genotype; Tobacco smoke; Biology; Andrology; Internal medicine; ATP-binding cassette transporter; Environmental health; Genetics; Gene","score_opus":0.07405333240630581,"score_gpt":0.4121692863026753,"score_spread":0.3381159538963695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294281525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989625,0.00044317928,0.000043377033,0.000025761683,0.0000024008946,0.000002028589,0.00008950278,0.0000025065885,0.00042866383],"genre_scores_gemma":[0.99932146,0.0002926641,0.00006272742,0.0000127051135,0.0000018583818,0.0000033491222,0.000050454546,0.0000012396551,0.00025355496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998864,0.000032473534,0.000007945173,0.000029884312,0.000027403074,0.000015881174],"domain_scores_gemma":[0.9998128,0.000059560272,0.00006918212,0.000013020845,0.000020862488,0.000024705878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016986624,0.0001236642,0.00011427735,0.0002949757,0.00021629168,0.00031640887,0.00007641532,0.00015646231,0.000925294],"category_scores_gemma":[0.0005853968,0.0001324109,0.00015976181,0.00029900027,0.00019951728,0.00014469436,0.00013425811,0.00018899288,0.00007633215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008146798,0.000054616412,0.9696899,0.000059793063,0.00008782241,0.0005052332,0.00062478177,0.00007754537,0.019124277,0.00007588937,0.00008872985,0.008796654],"study_design_scores_gemma":[0.0000017433086,0.00009647658,0.998162,0.000007253271,0.000032077765,0.00031447533,0.00029751816,0.00011237993,0.0007826854,0.00002765321,0.0001628989,0.0000029149105],"about_ca_topic_score_codex":0.011002986,"about_ca_topic_score_gemma":0.01229877,"teacher_disagreement_score":0.011002986,"about_ca_system_score_codex":0.00029475024,"about_ca_system_score_gemma":0.00015579803,"threshold_uncertainty_score":0.021877885},"labels":[],"label_agreement":null},{"id":"W4296028961","doi":"10.1002/cpt.2749","title":"Characterization of <scp><i>CYP2D6</i></scp> Pharmacogenetic Variation in <scp>Sub‐Saharan</scp> African Populations","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; University of the Witwatersrand, Johannesburg; South African Medical Research Council; National Research Foundation; Wellcome Trust; National Human Genome Research Institute; GlaxoSmithKline","keywords":"Genotyping; CYP2D6; Genetics; Allele; Biology; Context (archaeology); Pharmacogenetics; Haplotype; Population; Genotype; Gene; Computational biology; Medicine","score_opus":0.18229329636119448,"score_gpt":0.45458766997590283,"score_spread":0.2722943736147083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296028961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539125,0.0003655149,0.0020287153,0.00009147733,0.000006938179,0.000024637984,0.0015302363,0.000012847793,0.0005484188],"genre_scores_gemma":[0.99510694,0.00026693952,0.002866186,0.00009243915,0.000009398789,0.00003527487,0.0012927171,0.000017882572,0.00031224886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970394,0.000078743506,0.000025702077,0.00009874106,0.00005262284,0.00004010358],"domain_scores_gemma":[0.9996383,0.000108272456,0.00012479768,0.00004053922,0.000056125657,0.00003201691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051622407,0.00028586466,0.00029043763,0.0006991469,0.00041457592,0.00040826938,0.00020504033,0.00030791564,0.0017925714],"category_scores_gemma":[0.0013942119,0.0001121591,0.00038423878,0.0009125172,0.00023559901,0.00013376854,0.0002788893,0.00033673123,0.0003037514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095824327,0.00009547937,0.85175484,0.00019590085,0.0003755753,0.0017525282,0.001832213,0.0013641833,0.09311729,0.0008544611,0.001271207,0.046428],"study_design_scores_gemma":[0.00004636851,0.00021711946,0.9719635,0.00007843877,0.00018153782,0.0035483146,0.00091402687,0.0030038578,0.011031922,0.0006027457,0.008385155,0.000026885888],"about_ca_topic_score_codex":0.002311876,"about_ca_topic_score_gemma":0.0027872755,"teacher_disagreement_score":0.002311876,"about_ca_system_score_codex":0.00014200495,"about_ca_system_score_gemma":0.00017093128,"threshold_uncertainty_score":0.0059967637},"labels":[],"label_agreement":null},{"id":"W4296034623","doi":"10.1002/cpt.2748","title":"Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and <scp>Meta‐Analysis</scp> of Prospective, Controlled Clinical Trials","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"Meta-analysis; Pharmacogenomics; Clinical trial; Medicine; MEDLINE; Internal medicine; Pharmacology","score_opus":0.6450440072230488,"score_gpt":0.6158629572286234,"score_spread":0.02918104999442539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296034623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004887618,0.99155676,0.0013999041,0.00047629632,0.0002458483,0.00051498605,0.0005981115,0.000042935815,0.00027742586],"genre_scores_gemma":[0.30683723,0.6759624,0.008708542,0.002535954,0.00068221934,0.0031416824,0.001666195,0.00007214174,0.00039372488],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96527517,0.020904703,0.00786256,0.002424314,0.0030030597,0.000530153],"domain_scores_gemma":[0.9393559,0.048063584,0.007868696,0.0019777345,0.0024304776,0.00030356104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03812591,0.0025895946,0.015996456,0.0059377244,0.0006143888,0.004082924,0.0018139828,0.0022485927,0.0024860268],"category_scores_gemma":[0.07689544,0.0014048108,0.036248963,0.008024605,0.0010664429,0.0019723133,0.0013504288,0.0018511693,0.00025094405],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018085438,0.00002080348,0.0065381574,0.28074178,0.6964943,0.00008328562,0.000057748883,0.00053367135,0.00019978055,0.0002023687,0.00073746545,0.012582152],"study_design_scores_gemma":[0.00084750913,0.00019346688,0.0049465797,0.028743194,0.9628629,0.00007316674,0.0000307858,0.00035211944,0.00013241447,0.00035709378,0.0014373604,0.000023462988],"about_ca_topic_score_codex":0.005174003,"about_ca_topic_score_gemma":0.010290244,"teacher_disagreement_score":0.03812591,"about_ca_system_score_codex":0.0024024886,"about_ca_system_score_gemma":0.004134547,"threshold_uncertainty_score":0.20163155},"labels":[],"label_agreement":null},{"id":"W4306803289","doi":"10.1002/cpt.2768","title":"Impact of Drug Exposure on Resistance Selection Following Artemether‐Lumefantrine Treatment for Malaria in Children With and Without <scp>HIV</scp> in Uganda","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Malaria Research and Control","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; University of California, San Francisco; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; International Development Research Centre","keywords":"Artemether/lumefantrine; Nevirapine; Lumefantrine; Efavirenz; Lopinavir; Medicine; Malaria; Population; Lopinavir/ritonavir; Ritonavir; Pharmacology; Virology; Internal medicine; Immunology; Viral load; Plasmodium falciparum; Artemisinin; Human immunodeficiency virus (HIV); Antiretroviral therapy; Environmental health","score_opus":0.0429054703106308,"score_gpt":0.4118038061710506,"score_spread":0.3688983358604198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306803289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992887,0.00005492961,0.00047945676,0.000020678575,6.460942e-7,0.000006429799,0.000047073034,0.0000046478212,0.00009743087],"genre_scores_gemma":[0.999458,0.000036675265,0.00030460107,0.0000065271915,5.5166305e-7,0.000009111018,0.00006114798,0.0000018677102,0.00012141038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919325,0.00047471398,0.000028875644,0.00011497548,0.000046943293,0.00014135188],"domain_scores_gemma":[0.9972289,0.0020020888,0.00047313326,0.00009703403,0.00007570225,0.00012313203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017529082,0.00039594056,0.00073986687,0.00024264822,0.0002730911,0.0007180664,0.00043627014,0.00055164937,0.001123139],"category_scores_gemma":[0.005005342,0.00047312383,0.0008315856,0.00022074922,0.0004364286,0.0004441485,0.0006606458,0.0006549756,0.000102544014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023761247,0.00026308352,0.627123,0.000067909496,0.00058363733,0.0011762093,0.00054668804,0.3549295,0.0023686688,0.0007617792,0.0002515081,0.009551882],"study_design_scores_gemma":[0.00015769155,0.0022102513,0.23644939,0.000046500976,0.00035798937,0.0010242506,0.00058678794,0.75572187,0.0020318627,0.0007997346,0.0005547038,0.000058938123],"about_ca_topic_score_codex":0.01674428,"about_ca_topic_score_gemma":0.009474385,"teacher_disagreement_score":0.01674428,"about_ca_system_score_codex":0.0011830898,"about_ca_system_score_gemma":0.00085074484,"threshold_uncertainty_score":0.033293664},"labels":[],"label_agreement":null},{"id":"W4306803572","doi":"10.1002/cpt.2767","title":"Signal and Noise: Proton Pump Inhibitors and the Risk of Dementia?","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Ministry of Health; University of Manitoba","funders":"","keywords":"Dementia; Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Confidence interval; Cohort; Cohort study; Population; Disease; Environmental health","score_opus":0.04035446280081602,"score_gpt":0.3802120723772229,"score_spread":0.33985760957640687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306803572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.809193,0.109583,0.024329616,0.045158483,0.0029125472,0.00010457022,0.0014729233,0.000121810874,0.00712406],"genre_scores_gemma":[0.9824227,0.008559617,0.0022405586,0.0031327517,0.0023931416,0.000033790075,0.0003052488,0.000020608431,0.0008915935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99356645,0.0035248757,0.00051837106,0.0010608127,0.0009341737,0.00039529987],"domain_scores_gemma":[0.967262,0.021637537,0.0059746914,0.0024452922,0.001982707,0.0006976709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0135269435,0.000590972,0.0012951456,0.0013691109,0.00047255162,0.003453043,0.0010364674,0.0020180542,0.0018913093],"category_scores_gemma":[0.048298616,0.00039569417,0.002088474,0.0017215016,0.0018121705,0.0035720125,0.0012811102,0.0021319247,0.00027802537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00823699,0.00042134852,0.76060665,0.002938393,0.008361607,0.0015618671,0.0025265485,0.001693752,0.0014882773,0.010963916,0.0061287694,0.19507195],"study_design_scores_gemma":[0.0004574796,0.0033301888,0.8928055,0.0015247873,0.0114531005,0.0033670014,0.0032111057,0.010227545,0.001704421,0.04963379,0.021988742,0.00029632734],"about_ca_topic_score_codex":0.0026949341,"about_ca_topic_score_gemma":0.0032306537,"teacher_disagreement_score":0.0135269435,"about_ca_system_score_codex":0.0007108051,"about_ca_system_score_gemma":0.0011800835,"threshold_uncertainty_score":0.07153821},"labels":[],"label_agreement":null},{"id":"W4312114408","doi":"10.1002/cpt.2782","title":"Advancing Innovations in Biosimilars","year":2022,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Medicine; Pharmacology; Business; Internal medicine","score_opus":0.06304985624685244,"score_gpt":0.44777936023714354,"score_spread":0.3847295039902911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312114408","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006703114,0.31061575,0.06839559,0.43260345,0.03053375,0.00026264242,0.00042919343,0.0008199664,0.14963655],"genre_scores_gemma":[0.12472562,0.59377074,0.08955794,0.10209347,0.056852605,0.00026422768,0.0009573669,0.0007776378,0.031000381],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9838928,0.005295235,0.0011655007,0.0012410091,0.0076007075,0.0008047451],"domain_scores_gemma":[0.95309514,0.031418923,0.0034870643,0.0028731297,0.0068496023,0.0022761254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024781745,0.0008830951,0.0006282006,0.002649189,0.0012995896,0.00883307,0.0022647672,0.008868626,0.021005267],"category_scores_gemma":[0.051603515,0.0004693278,0.0011752197,0.00317999,0.0038111813,0.017287437,0.0056564608,0.007837239,0.0045984904],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046559933,0.00012411046,0.0007802685,0.0017633437,0.00003577167,0.000252985,0.00069814036,0.0030450942,0.00082147593,0.49515653,0.12509502,0.3721806],"study_design_scores_gemma":[0.000017912724,0.000055152817,0.00020268827,0.0019276027,0.000012424489,0.00021305964,0.00021960329,0.0016161045,0.0008037448,0.15561269,0.8392913,0.000027689659],"about_ca_topic_score_codex":0.0009959717,"about_ca_topic_score_gemma":0.0011082719,"teacher_disagreement_score":0.024781745,"about_ca_system_score_codex":0.004501729,"about_ca_system_score_gemma":0.009217636,"threshold_uncertainty_score":0.13106},"labels":[],"label_agreement":null},{"id":"W4313827968","doi":"10.1002/cpt.2842","title":"Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Dental and Craniofacial Research; Pfizer; Eli Lilly and Company","keywords":"WOMAC; Placebo; Osteoarthritis; Physical therapy; Medicine; Clinical trial; Placebo response; Randomized controlled trial; Internal medicine; Pathology","score_opus":0.1540398353393806,"score_gpt":0.4839731938438626,"score_spread":0.329933358504482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313827968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9296942,0.035592254,0.018739017,0.0031165332,0.0011756615,0.0060318965,0.0034515897,0.00029087663,0.0019080085],"genre_scores_gemma":[0.9779009,0.0036018847,0.008761253,0.0016476222,0.00039683565,0.003985511,0.0028032893,0.00008659251,0.000816117],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.930348,0.058870815,0.0038408814,0.0032869754,0.0026265127,0.0010269212],"domain_scores_gemma":[0.92499393,0.051112298,0.010241658,0.007959577,0.003995964,0.0016965483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08235811,0.00238806,0.005563856,0.00058637036,0.0006638264,0.0021981585,0.0013991972,0.0023695223,0.001695846],"category_scores_gemma":[0.087138616,0.000938112,0.01266483,0.0009504048,0.0016715802,0.002750867,0.001168611,0.0037942934,0.00042496054],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76460135,0.005020162,0.046813548,0.004452432,0.09077891,0.00013059053,0.00055016985,0.006328746,0.0029072056,0.00078303856,0.0026133866,0.07502042],"study_design_scores_gemma":[0.51756257,0.16305132,0.13823488,0.001547977,0.13202806,0.00045067002,0.00044920167,0.02820488,0.0033969486,0.006630137,0.008001619,0.00044177755],"about_ca_topic_score_codex":0.0007656789,"about_ca_topic_score_gemma":0.0019347122,"teacher_disagreement_score":0.08235811,"about_ca_system_score_codex":0.0010074899,"about_ca_system_score_gemma":0.0020278601,"threshold_uncertainty_score":0.43555653},"labels":[],"label_agreement":null},{"id":"W4317698015","doi":"10.1002/cpt.2854","title":"<scp><i>ABCB1</i></scp> Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the <scp>CAN‐BIND</scp>‐1 Study","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Douglas Mental Health University Institute; McGill University; Simon Fraser University; St. Joseph’s Healthcare Hamilton; Royal Ottawa Mental Health Centre; McMaster University; Queen's University; University of British Columbia; Centre for Addiction and Mental Health; University of Guelph; University of Calgary; University Health Network; University of Toronto","funders":"Janssen Canada; H. Lundbeck A/S; Pfizer Canada; Michael Smith Health Research BC; Mitacs; Eisai; Allergan; Canadian Network for Mood and Anxiety Treatments; Canadian Institutes of Health Research; Sunovion; Servier; Natural Sciences and Engineering Research Council of Canada; Fondation Brain Canada; Pfizer; Government of Ontario; Bristol-Myers Squibb","keywords":"Antidepressant; Single-nucleotide polymorphism; Meta-analysis; Major depressive disorder; Odds ratio; Medicine; Internal medicine; Tolerability; Oncology; Confidence interval; Genotyping; Pharmacogenetics; Pharmacology; Bioinformatics; Psychiatry; Genotype; Genetics; Biology; Gene; Adverse effect","score_opus":0.32817147146877756,"score_gpt":0.4800795561691877,"score_spread":0.15190808470041012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317698015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007260531,0.9896402,0.00044813688,0.000376184,0.00012649386,0.00019166146,0.0015645557,0.000023880684,0.00036831704],"genre_scores_gemma":[0.25586504,0.73455584,0.0026174611,0.0020002963,0.00037471257,0.001005945,0.0029587455,0.00005057828,0.0005713493],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99378777,0.0026595374,0.0018148703,0.0007695983,0.00069709594,0.0002712873],"domain_scores_gemma":[0.9880135,0.008623332,0.0017506944,0.00038419562,0.0010663179,0.0001619899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074120243,0.0018679936,0.011833204,0.00398325,0.0006853692,0.0024830266,0.0012815155,0.0017791011,0.003522486],"category_scores_gemma":[0.019753944,0.0010013516,0.025974054,0.008649193,0.0005287311,0.0010299707,0.0011473731,0.0015088236,0.00037203624],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020265172,0.00002757685,0.011906879,0.34847847,0.61880755,0.00025781785,0.000107357235,0.00063578953,0.00051930983,0.00018116698,0.0020996495,0.014951913],"study_design_scores_gemma":[0.00050912745,0.00009786332,0.0074401367,0.01731508,0.9718069,0.00012943817,0.000036760604,0.00018795196,0.00012016587,0.00018067751,0.0021545007,0.00002143675],"about_ca_topic_score_codex":0.012484484,"about_ca_topic_score_gemma":0.027672503,"teacher_disagreement_score":0.012484484,"about_ca_system_score_codex":0.00194563,"about_ca_system_score_gemma":0.0034725382,"threshold_uncertainty_score":0.039199054},"labels":[],"label_agreement":null},{"id":"W4327753841","doi":"10.1002/cpt.2894","title":"Thiopurine Methyltransferase Intermediate Metabolizer Status and Thiopurine‐Associated Toxicity During Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Children's Health Foundation","keywords":"Thiopurine methyltransferase; Maintenance therapy; Medicine; Lymphoblastic Leukemia; Oncology; Toxicity; Pharmacology; Internal medicine; Chemotherapy; Leukemia; Azathioprine","score_opus":0.04033367827705326,"score_gpt":0.37899921285048216,"score_spread":0.3386655345734289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327753841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996069,0.0001984466,0.000018676348,0.00001115187,0.0000010929151,0.0000025467007,0.00006393713,0.000001208672,0.00009612271],"genre_scores_gemma":[0.9997073,0.00011229723,0.00002469844,0.000008225464,0.0000028230738,0.0000024128476,0.00009198023,9.235019e-7,0.000049313076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996878,0.00007887421,0.0000374737,0.0000531826,0.000070689915,0.00007204717],"domain_scores_gemma":[0.9987908,0.00019339474,0.00071834505,0.00006608538,0.00006379823,0.0001676497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005044614,0.00019824808,0.00027784705,0.00039587548,0.00024681364,0.00052339764,0.00021926721,0.00022464737,0.0006759279],"category_scores_gemma":[0.0016452748,0.00018150514,0.00030728278,0.0007610745,0.00014626884,0.0003975478,0.0002934268,0.00046771442,0.00010418889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021422187,0.00002153574,0.99774194,0.0000052133887,0.000014894839,0.00011040519,0.000053896292,0.000020068424,0.00024098456,0.0000061429673,0.000024073408,0.0015467296],"study_design_scores_gemma":[0.000005818012,0.0002267647,0.9987288,0.0000042198403,0.00002353519,0.0006374295,0.00008774842,0.000065159606,0.00010248298,0.000008052881,0.00010841179,0.0000015418254],"about_ca_topic_score_codex":0.003120983,"about_ca_topic_score_gemma":0.003938298,"teacher_disagreement_score":0.003120983,"about_ca_system_score_codex":0.00030956249,"about_ca_system_score_gemma":0.00031422699,"threshold_uncertainty_score":0.0062056184},"labels":[],"label_agreement":null},{"id":"W4362735831","doi":"10.1002/cpt.2903","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i>, <i>CYP2C19</i>, <i>CYP2B6</i>, <i>SLC6A4</i>, and <i>HTR2A</i> Genotypes and Serotonin Reuptake Inhibitor Antidepressants","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":403,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institutes of Health; Patient-Centered Outcomes Research Institute","keywords":"CYP2C19; Pharmacogenetics; Serotonin reuptake inhibitor; Medicine; CYP2B6; CYP2D6; Guideline; Internal medicine; Genotype; Serotonin; CYP3A4; Biology; Genetics; Cytochrome P450","score_opus":0.260799143689104,"score_gpt":0.5708299925254577,"score_spread":0.31003084883635373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362735831","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007226702,0.046934087,0.1123848,0.3577135,0.016887588,0.0098652765,0.030929364,0.007087969,0.41097072],"genre_scores_gemma":[0.060442742,0.062185902,0.20617987,0.44570345,0.009284412,0.01713522,0.07320195,0.0024455194,0.123420954],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9750597,0.009213463,0.0054024896,0.001127296,0.007992034,0.0012049618],"domain_scores_gemma":[0.9531451,0.01487858,0.004371776,0.0019484845,0.02320146,0.0024545176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016612774,0.000892085,0.0016774526,0.002293568,0.0010746794,0.003255442,0.0041791094,0.008797057,0.017785354],"category_scores_gemma":[0.053329006,0.00078351196,0.0035591437,0.0024371848,0.0012160491,0.0018407431,0.0026217054,0.008102245,0.009264271],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014166097,0.00020785895,0.0016423321,0.0012544569,0.00008685019,0.0005092226,0.00028770283,0.00059199554,0.0007492058,0.008903202,0.8382323,0.14739312],"study_design_scores_gemma":[0.00034508988,0.0001358418,0.0039719283,0.0042301537,0.00020269323,0.000981889,0.00015573982,0.0007562956,0.00072048185,0.0057668276,0.98266995,0.0000630586],"about_ca_topic_score_codex":0.02220118,"about_ca_topic_score_gemma":0.03128536,"teacher_disagreement_score":0.02220118,"about_ca_system_score_codex":0.0032927918,"about_ca_system_score_gemma":0.019314576,"threshold_uncertainty_score":0.08785778},"labels":[],"label_agreement":null},{"id":"W4377565617","doi":"10.1002/cpt.2956","title":"Response‐Based Dosing for Ponatinib: Model‐Based Analyses of the Dose‐Ranging OPTIC Study","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Espace pour la vie","funders":"","keywords":"Ponatinib; Medicine; Neutropenia; Confidence interval; Internal medicine; Hazard ratio; Odds ratio; Dosing; Myeloid leukemia; Toxicity; Nilotinib; Imatinib","score_opus":0.30421762609624836,"score_gpt":0.533092272215992,"score_spread":0.22887464611974362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377565617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827868,0.0015298027,0.011140218,0.0006997861,0.000049503837,0.00025874216,0.0020452316,0.00017307595,0.0013167704],"genre_scores_gemma":[0.99430627,0.00026705154,0.002996513,0.00020388064,0.000028850041,0.00019187623,0.0012406522,0.000031475774,0.0007336432],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9956328,0.0036661073,0.0000812824,0.00027815803,0.00012929692,0.00021233558],"domain_scores_gemma":[0.9677642,0.028510787,0.0019836095,0.000826214,0.0004968151,0.0004184937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014064666,0.0012700526,0.002170991,0.00054678414,0.00020597933,0.0010602201,0.0018315277,0.0011203608,0.0025857498],"category_scores_gemma":[0.017118702,0.0005793422,0.0043982062,0.00047444348,0.0004728835,0.00062973343,0.00075322646,0.0021463332,0.0002221417],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02512693,0.0014689799,0.021966344,0.0004855342,0.0061742114,0.00019330492,0.000103385515,0.9271681,0.0013750794,0.0022943271,0.0020479676,0.01159589],"study_design_scores_gemma":[0.0026166434,0.0032852131,0.009138469,0.0000256491,0.0023472405,0.000067432695,0.000032921223,0.97935826,0.00067591364,0.001628468,0.0007708774,0.00005292287],"about_ca_topic_score_codex":0.009487048,"about_ca_topic_score_gemma":0.005071602,"teacher_disagreement_score":0.014064666,"about_ca_system_score_codex":0.0016799084,"about_ca_system_score_gemma":0.0017410193,"threshold_uncertainty_score":0.07438195},"labels":[],"label_agreement":null},{"id":"W4380871434","doi":"10.1002/cpt.2975","title":"Pharmacologic Heterogeneity and Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and <scp>DPP</scp>‐4 Inhibitors: Population‐Based Cohort Study","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; McGill University; American Diabetes Association","keywords":"Medicine; Concomitant; Hypoglycemia; Internal medicine; Gliclazide; Sitagliptin; Pharmacology; Population; Saxagliptin; Sulfonylurea; Alogliptin; Hazard ratio; Endocrinology; Insulin; Metformin; Confidence interval","score_opus":0.07703914487866334,"score_gpt":0.379905066417467,"score_spread":0.30286592153880365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380871434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784756,0.00034128933,0.00051779463,0.000055138327,0.000016938066,0.000027440594,0.0009851101,0.000012708765,0.00019611685],"genre_scores_gemma":[0.99882346,0.000097581105,0.00024516383,0.000037765487,0.000019213743,0.000022505124,0.0006278136,0.0000064050296,0.00012005979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965327,0.0012454323,0.00034280302,0.0011558617,0.00037681838,0.00034630214],"domain_scores_gemma":[0.9895131,0.002311229,0.003862901,0.0029025255,0.00066811044,0.00074213755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050179423,0.0006383148,0.0008392863,0.00091679615,0.00052669615,0.0016533927,0.0010677035,0.0012908531,0.001567723],"category_scores_gemma":[0.008906963,0.000980041,0.0033225701,0.0016930108,0.00043285012,0.0008160115,0.0009764243,0.0016975324,0.0002373649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013842613,0.00008791817,0.9945102,0.000017277014,0.002252657,0.000080030244,0.00006986983,0.0002683416,0.00021380064,0.000049748618,0.00016676396,0.000899206],"study_design_scores_gemma":[0.00015765936,0.00057261466,0.99358034,0.000012312886,0.0013516857,0.00031582147,0.00012708011,0.0032695362,0.00011689574,0.00013122601,0.00033051308,0.00003437102],"about_ca_topic_score_codex":0.009375343,"about_ca_topic_score_gemma":0.0062796907,"teacher_disagreement_score":0.009375343,"about_ca_system_score_codex":0.0005979756,"about_ca_system_score_gemma":0.0006868964,"threshold_uncertainty_score":0.026537716},"labels":[],"label_agreement":null},{"id":"W4385230989","doi":"10.1002/cpt.3009","title":"Design and Execution of Sustainable Decentralized Clinical Trials","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; Defense Threat Reduction Agency; Eidgenössische Technische Hochschule Zürich; European Commission; AstraZeneca; Eli Lilly and Company","keywords":"Sustainability; Process management; Health care; Clinical trial; Carbon footprint; Product (mathematics); Computer science; Business; Risk analysis (engineering); Knowledge management; Medicine; Political science","score_opus":0.9191579949922717,"score_gpt":0.6967284397073333,"score_spread":0.22242955528493835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385230989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064158184,0.478511,0.30635458,0.04271148,0.0056996057,0.12067469,0.0024235211,0.0007774502,0.03643176],"genre_scores_gemma":[0.098565765,0.2602367,0.47926605,0.015910292,0.0026302915,0.13865262,0.00129772,0.00022019233,0.0032203807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.75976354,0.20314367,0.01595031,0.005936046,0.0133922165,0.0018141809],"domain_scores_gemma":[0.72315013,0.22490072,0.023504732,0.012767296,0.013207223,0.0024699012],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20678318,0.0015310228,0.003952408,0.0032392961,0.00093742355,0.0076958467,0.0035710759,0.004348171,0.0072318665],"category_scores_gemma":[0.25551918,0.001255781,0.0036236236,0.0026104478,0.0030134635,0.005072408,0.0044292063,0.0048590405,0.0020523972],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013739667,0.0005572236,0.0013776327,0.09829909,0.0023427575,0.00020814879,0.0009619132,0.012617249,0.0006564657,0.1234203,0.015251498,0.7429338],"study_design_scores_gemma":[0.008017537,0.0037718832,0.0039261756,0.23168196,0.0043511055,0.0005167073,0.0014761796,0.011363152,0.0031733117,0.2488852,0.48259094,0.0002459206],"about_ca_topic_score_codex":0.0011214783,"about_ca_topic_score_gemma":0.0019095115,"teacher_disagreement_score":0.7932168,"about_ca_system_score_codex":0.0049810405,"about_ca_system_score_gemma":0.04372617,"threshold_uncertainty_score":0.97817755},"labels":[],"label_agreement":null},{"id":"W4385514873","doi":"10.1002/cpt.3006","title":"Model‐Informed Drug Development: Steps Toward Harmonized Guidance","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Harmonization; Drug development; Context (archaeology); Viewpoints; Consistency (knowledge bases); Guideline; Population; Medicine; Regulatory science; Risk analysis (engineering); Drug; Computer science; Pharmacology; Environmental health","score_opus":0.7476456105265453,"score_gpt":0.5707018036775844,"score_spread":0.17694380684896094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385514873","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001267808,0.030852163,0.45086467,0.47757116,0.0040089493,0.00307229,0.0006356154,0.001448117,0.030279292],"genre_scores_gemma":[0.020281767,0.025322577,0.8737738,0.07068198,0.0019033415,0.00410857,0.0010036678,0.00041744544,0.0025067674],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7574847,0.17133078,0.018947475,0.0068732225,0.040880855,0.004482998],"domain_scores_gemma":[0.6937231,0.21380913,0.013219093,0.023142554,0.046115633,0.009990507],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.26187313,0.0036360936,0.006219249,0.0075039933,0.0034488922,0.023713773,0.018064467,0.027919907,0.009106057],"category_scores_gemma":[0.27141044,0.0035050188,0.007323922,0.0050306376,0.01556939,0.018591031,0.023525633,0.04255449,0.0054276846],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018357637,0.00059652596,0.00055489055,0.005675805,0.00038571845,0.00048778846,0.0033523913,0.025812633,0.0007030333,0.5486266,0.17945805,0.23416308],"study_design_scores_gemma":[0.0002949395,0.00021612032,0.0003245099,0.014799675,0.00012696216,0.00019735337,0.0008721905,0.011456919,0.0006630066,0.5600245,0.41083622,0.00018762055],"about_ca_topic_score_codex":0.012090005,"about_ca_topic_score_gemma":0.010209888,"teacher_disagreement_score":0.26187313,"about_ca_system_score_codex":0.017938266,"about_ca_system_score_gemma":0.10199196,"threshold_uncertainty_score":0.91024184},"labels":[],"label_agreement":null},{"id":"W4386462042","doi":"10.1002/cpt.3044","title":"PharmVar Tutorial on <i>CYP2D6</i> Structural Variation Testing and Recommendations on Reporting","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); University of Calgary","funders":"National Human Genome Research Institute; National Institute on Drug Abuse; National Institutes of Health","keywords":"Variation (astronomy); CYP2D6; Medical physics; Medicine; Internal medicine; Physics","score_opus":0.6853737617081412,"score_gpt":0.635492340409372,"score_spread":0.04988142129876927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386462042","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060252484,0.7616306,0.015051656,0.047434915,0.020527188,0.00092647196,0.009691456,0.0027054483,0.1414297],"genre_scores_gemma":[0.0019403108,0.8018709,0.01602814,0.03655855,0.012053346,0.00097247906,0.009861016,0.0005475346,0.12016775],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985771,0.00037220496,0.00022262328,0.000103804276,0.0006348985,0.000089283116],"domain_scores_gemma":[0.9951597,0.0022050845,0.0006537145,0.00012593283,0.001567752,0.0002879315],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0032730913,0.000926046,0.0015238263,0.0034445517,0.00037266576,0.0021892784,0.001993699,0.0018595805,0.08446253],"category_scores_gemma":[0.008787943,0.00046342207,0.0014776861,0.0037209077,0.00042005331,0.0032654945,0.0015204201,0.003169876,0.06732206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039688002,0.000034772762,0.00005476767,0.0043606455,0.000019594387,0.00008558012,0.000037495483,0.00013790508,0.00059146597,0.0027010345,0.7088762,0.28306088],"study_design_scores_gemma":[0.0000074545796,0.000016670856,0.00011316436,0.0013625536,0.000009609581,0.00017337932,0.0000088038705,0.00002221256,0.00012111575,0.0005953584,0.99756324,0.0000064019046],"about_ca_topic_score_codex":0.0018891654,"about_ca_topic_score_gemma":0.0025902758,"teacher_disagreement_score":0.99672693,"about_ca_system_score_codex":0.0011765565,"about_ca_system_score_gemma":0.00227912,"threshold_uncertainty_score":0.28255528},"labels":[],"label_agreement":null},{"id":"W4387297227","doi":"10.1002/cpt.3068","title":"Nicotine Metabolite Ratio Decreases After Switching Off Efavirenz‐Based Therapy in People With <scp>HIV</scp> Who Smoke","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institute of Mental Health; Center for AIDS Research, University of Washington; Canada Research Chairs; University of Washington; Canadian Institutes of Health Research; Penn Mental Health AIDS Research Center; Cambia Health Foundation; National Institute on Alcohol Abuse and Alcoholism; University of Pennsylvania","keywords":"Efavirenz; CYP2A6; Cotinine; Regimen; Chemistry; Metabolite; Human immunodeficiency virus (HIV); Nicotine; Emtricitabine; Antiretroviral therapy; Pharmacology; Medicine; Internal medicine; Viral load; CYP3A4; Virology; Metabolism; Biochemistry","score_opus":0.08329523741160537,"score_gpt":0.43707824951528446,"score_spread":0.3537830121036791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387297227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922144,0.00014736385,0.000029409537,0.000026281306,0.000004537901,0.000006392805,0.00016066522,0.0000035211888,0.00040038567],"genre_scores_gemma":[0.9993339,0.000057841742,0.00004351118,0.00003832948,0.000005601807,0.000007083847,0.00017256469,0.0000014470083,0.0003396121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997583,0.00004983157,0.000024478593,0.000063973166,0.000048692174,0.000054660475],"domain_scores_gemma":[0.9993488,0.00012244438,0.0002952676,0.000039975446,0.00007178193,0.000121707904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036264176,0.00014961255,0.00033889787,0.000359157,0.00026367515,0.00053677504,0.00019036522,0.00047603075,0.0016080261],"category_scores_gemma":[0.0014826497,0.00020690306,0.00035006093,0.00037305322,0.00014902595,0.00035635146,0.00025670422,0.0006216594,0.0002968484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017572957,0.00028899914,0.985468,0.000023796385,0.00010306695,0.00012602174,0.00019159567,0.000033230954,0.002051505,0.000015334943,0.00014867111,0.009792453],"study_design_scores_gemma":[0.0000101885535,0.0002834753,0.99914587,0.000002951758,0.000024970663,0.00012327687,0.00007782928,0.000081279555,0.00015284179,0.000010756189,0.000084465726,0.000002206954],"about_ca_topic_score_codex":0.0040313345,"about_ca_topic_score_gemma":0.005050127,"teacher_disagreement_score":0.0040313345,"about_ca_system_score_codex":0.00026629807,"about_ca_system_score_gemma":0.00017639309,"threshold_uncertainty_score":0.008015752},"labels":[],"label_agreement":null},{"id":"W4387691682","doi":"10.1002/cpt.3078","title":"Treosulfan Exposure Predicts Thalassemia‐Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; The Wellcome Trust DBT India Alliance; Department of Biotechnology, Ministry of Science and Technology, India; Wellcome Trust","keywords":"Treosulfan; Medicine; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; ThioTEPA; Hazard ratio; Thalassemia; Oncology; Confidence interval; Busulfan; Chemotherapy","score_opus":0.04065219798733664,"score_gpt":0.3372681177469051,"score_spread":0.29661591975956847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387691682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997583,0.000081254024,0.00005248441,0.000011541397,8.734784e-7,0.0000012790405,0.000018865436,0.000001996478,0.000073456475],"genre_scores_gemma":[0.9998677,0.000026316493,0.000025908594,0.000007106189,0.0000020921564,9.5247015e-7,0.00003867175,5.391427e-7,0.00003068464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998783,0.00003789424,0.000012784447,0.000029149827,0.000020996675,0.000020945794],"domain_scores_gemma":[0.9995753,0.00012476102,0.00016342105,0.000028107326,0.000026951991,0.0000815131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031764715,0.00020215989,0.00023662533,0.00024405986,0.000121387835,0.00032502253,0.00011166363,0.00022271536,0.00057583954],"category_scores_gemma":[0.00089451554,0.00012214699,0.0002846821,0.00020616758,0.00013769376,0.0001610091,0.00014962438,0.0003722535,0.00013354907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045311768,0.00004010717,0.9949805,0.0000036851384,0.000038729,0.000064116386,0.000031426036,0.00020385826,0.0015009692,0.0000109236935,0.000042651984,0.0026298924],"study_design_scores_gemma":[0.000014852041,0.00038976604,0.996514,0.0000032930163,0.00005544055,0.0003874446,0.000052246636,0.002034566,0.000402899,0.000031113806,0.00011121326,0.000003182655],"about_ca_topic_score_codex":0.0008989353,"about_ca_topic_score_gemma":0.0008986703,"teacher_disagreement_score":0.0008989353,"about_ca_system_score_codex":0.00013782353,"about_ca_system_score_gemma":0.0001564441,"threshold_uncertainty_score":0.0019263625},"labels":[],"label_agreement":null},{"id":"W4389069801","doi":"10.1002/cpt.3112","title":"Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Waypoint Centre for Mental Health Care; British Columbia Centre on Substance Use; Université de Montréal; Public Health Ontario; University of British Columbia; Centre for Family Medicine; Centre Hospitalier de l’Université de Montréal; University of Toronto; Centre for Addiction and Mental Health","funders":"Health Canada; University of Toronto; Michael Smith Health Research BC; Department of Psychiatry, University of Toronto; Pfizer; Canadian Institutes of Health Research; GW Pharmaceuticals; Centre for Addiction and Mental Health Foundation; BrainsWay; Indivior; National Institutes of Health; Centre for Addiction and Mental Health","keywords":"Methadone; Buprenorphine; Medicine; Opioid use disorder; Opioid; (+)-Naloxone; Pharmacology; Pharmacogenetics; Randomized controlled trial; Internal medicine; Anesthesia; Genotype; Biology","score_opus":0.14027334896993393,"score_gpt":0.47521284732280694,"score_spread":0.334939498352873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389069801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523723,0.0017272227,0.000583577,0.00024794575,0.00009470354,0.00042429965,0.0004068655,0.000021454038,0.0012567587],"genre_scores_gemma":[0.99867934,0.00011278775,0.00034790242,0.00016392423,0.00001996522,0.0001623888,0.00020325877,0.000005092406,0.000305239],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99524045,0.0031335328,0.00034467707,0.00070956396,0.00034261652,0.00022919544],"domain_scores_gemma":[0.99713886,0.0013247689,0.0008570093,0.0002883699,0.00012834492,0.000262559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054957345,0.0003381359,0.0009061784,0.00022645616,0.00032886065,0.00084819074,0.00040148065,0.0011522181,0.0019095377],"category_scores_gemma":[0.0059064864,0.00031201466,0.0013876258,0.00030394839,0.00040759996,0.00035950507,0.00028176047,0.0010502227,0.00024144887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69579935,0.0030490358,0.23652025,0.0006010023,0.012051094,0.00056323496,0.0002386318,0.0010210269,0.016085804,0.00094554934,0.0019961484,0.031128844],"study_design_scores_gemma":[0.085705236,0.04439737,0.8449683,0.0002052649,0.008144344,0.000823793,0.00010297162,0.0072467797,0.0032192753,0.0019231065,0.0031807914,0.00008276677],"about_ca_topic_score_codex":0.0006161641,"about_ca_topic_score_gemma":0.0012402011,"teacher_disagreement_score":0.0054957345,"about_ca_system_score_codex":0.00033176693,"about_ca_system_score_gemma":0.00045781967,"threshold_uncertainty_score":0.029064596},"labels":[],"label_agreement":null},{"id":"W4389322814","doi":"10.1002/cpt.3124","title":"Characterization of <i>CYP2B6</i> and <i>CYP2A6</i> Pharmacogenetic Variation in <scp>Sub‐Saharan</scp> African Populations","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"National Institutes of Health; Medical Research Council; South African Medical Research Council; National Research Foundation; Wellcome Trust; National Human Genome Research Institute; GlaxoSmithKline; National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation","keywords":"1000 Genomes Project; Allele; Pharmacogenetics; Haplotype; CYP2A6; Genetics; Biology; Allele frequency; Genotype; Evolutionary biology; Gene; Single-nucleotide polymorphism","score_opus":0.21288528920082814,"score_gpt":0.4750250815627104,"score_spread":0.26213979236188223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389322814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930155,0.0006422539,0.00114664,0.00008772075,0.0000062403533,0.000015811322,0.004318275,0.000016897391,0.0007506719],"genre_scores_gemma":[0.9914452,0.0006418761,0.0019404944,0.00007938968,0.000017283763,0.000030806055,0.0054986468,0.000024703648,0.00032161624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997211,0.00007709795,0.000029360559,0.00009405734,0.00004301432,0.000035356203],"domain_scores_gemma":[0.9995782,0.00009644379,0.00018983045,0.000054068452,0.000044094424,0.000037356276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037582516,0.00020097102,0.00029309635,0.00082902814,0.00032388422,0.0004607133,0.00016821478,0.00023989285,0.0023843742],"category_scores_gemma":[0.0011780305,0.00010355675,0.00042513802,0.0019506643,0.00019846784,0.00019971121,0.0003538899,0.00028543247,0.00031282988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007817246,0.000040924377,0.92345977,0.00021474538,0.00047251786,0.000622065,0.0011817588,0.0007646318,0.029110856,0.00070681685,0.0018254794,0.04081873],"study_design_scores_gemma":[0.000024937926,0.00006629983,0.98979133,0.00004602601,0.00010619547,0.0009936685,0.0003558502,0.00068118976,0.001646481,0.0003586019,0.0059201317,0.00000928308],"about_ca_topic_score_codex":0.0023385421,"about_ca_topic_score_gemma":0.0027914203,"teacher_disagreement_score":0.0023843742,"about_ca_system_score_codex":0.00012962897,"about_ca_system_score_gemma":0.00013206061,"threshold_uncertainty_score":0.007976472},"labels":[],"label_agreement":null},{"id":"W4389508203","doi":"10.1002/cpt.3133","title":"Challenging the Norm: A Multidisciplinary Perspective on Intravenous to Subcutaneous Bridging Strategies for Biologics","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Dosing; Medicine; Bridging (networking); Comparability; Pharmacology; Patient safety; Intensive care medicine; Risk analysis (engineering); Computer science","score_opus":0.33356432890633997,"score_gpt":0.539773575557006,"score_spread":0.20620924665066603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389508203","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017978735,0.16326441,0.014363428,0.7944375,0.0123264035,0.00010217816,0.000031822638,0.00010527456,0.013571063],"genre_scores_gemma":[0.068204425,0.35503674,0.049112532,0.4777,0.03646502,0.0007921291,0.00012899435,0.00027212474,0.01228798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9756092,0.012501915,0.0020962122,0.0023434386,0.005543907,0.0019052892],"domain_scores_gemma":[0.95664287,0.023322217,0.002027815,0.0016611501,0.008120404,0.008225544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.058847092,0.0009754377,0.001979289,0.0017238295,0.004945425,0.018736582,0.0051721823,0.01602305,0.0059490157],"category_scores_gemma":[0.046432897,0.000533733,0.0012707671,0.0012776252,0.015714856,0.018334048,0.011977445,0.03117619,0.0022552535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019073173,0.00047667473,0.0010507612,0.0035064863,0.00008254467,0.0012213654,0.0075809765,0.001582559,0.0019412647,0.2805718,0.25636244,0.4454324],"study_design_scores_gemma":[0.00004102956,0.00034777218,0.0004374104,0.008487407,0.00003237649,0.0013384119,0.0069121313,0.00068099704,0.0005805865,0.15793654,0.82309675,0.000108575514],"about_ca_topic_score_codex":0.0022333008,"about_ca_topic_score_gemma":0.004392999,"teacher_disagreement_score":0.058847092,"about_ca_system_score_codex":0.007412898,"about_ca_system_score_gemma":0.02893805,"threshold_uncertainty_score":0.31121683},"labels":[],"label_agreement":null},{"id":"W4389628350","doi":"10.1002/cpt.3097","title":"Animal‐to‐Human Dose Translation of ANTHRASIL for Treatment of Inhalational Anthrax in Healthy Adults, Obese Adults, and Pediatric Subjects","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Bacillus and Francisella bacterial research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada); Centre for Drug Research and Development","funders":"","keywords":"Medicine; Pediatrics; Intensive care medicine","score_opus":0.10329842705157029,"score_gpt":0.45367051999075125,"score_spread":0.350372092939181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389628350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81154263,0.003296219,0.16403982,0.0010658469,0.0003419864,0.0021500331,0.006141146,0.00091101974,0.010511259],"genre_scores_gemma":[0.9662634,0.0016344242,0.02652119,0.0003056249,0.000023575198,0.00072889705,0.002333492,0.000056518482,0.0021328437],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997336,0.00013062306,0.000011062225,0.000045974033,0.00005473878,0.00002399804],"domain_scores_gemma":[0.99977845,0.00008194757,0.00004531781,0.000033376145,0.000039367424,0.000021627577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091285765,0.00035955766,0.0003228644,0.00015211916,0.00011215407,0.0003538997,0.0004121446,0.00046456206,0.0018052274],"category_scores_gemma":[0.0009448198,0.00020658138,0.00047176244,0.00016060584,0.00019039371,0.00016468248,0.00027267067,0.0005952666,0.000544921],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015497227,0.0065421253,0.02318342,0.001739881,0.00058221695,0.0015938518,0.00041968684,0.2169544,0.4036399,0.007073592,0.015295392,0.30747828],"study_design_scores_gemma":[0.0029341406,0.10164581,0.04674402,0.00035294003,0.0007843209,0.0033555117,0.00040916467,0.44775674,0.26459038,0.006017647,0.12522651,0.00018279493],"about_ca_topic_score_codex":0.0022268635,"about_ca_topic_score_gemma":0.0017396201,"teacher_disagreement_score":0.0022268635,"about_ca_system_score_codex":0.0006066574,"about_ca_system_score_gemma":0.0008258746,"threshold_uncertainty_score":0.0060390234},"labels":[],"label_agreement":null},{"id":"W4389681401","doi":"10.1002/cpt.3115","title":"Current Perspectives on Data Sharing and Open Science in Pharmacogenomics","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; Health Sciences Centre; CancerCare Manitoba; Research Manitoba; University of Manitoba","funders":"","keywords":"Genome-wide association study; Pharmacogenomics; Data science; Pooling; Data sharing; Genomics; Statistical power; Computer science; Data mining; Computational biology; Biology; Bioinformatics; Statistics; Genome; Medicine; Genetics; Artificial intelligence","score_opus":0.2853482510302646,"score_gpt":0.5334135100286765,"score_spread":0.24806525899841192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389681401","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013162227,0.22785735,0.043341093,0.7052571,0.009421258,0.00012354649,0.0010623678,0.00043812397,0.011182986],"genre_scores_gemma":[0.054723173,0.45872095,0.11585707,0.28480235,0.07613817,0.0015573812,0.0036514457,0.0009119374,0.0036375176],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.86055875,0.09797066,0.008523874,0.010554604,0.018429464,0.0039625564],"domain_scores_gemma":[0.29646757,0.6008592,0.011544633,0.039952178,0.035352107,0.015824197],"candidate_categories":["metaresearch","open_science"],"consensus_categories":[],"category_scores_codex":[0.2300868,0.0016449013,0.0039959736,0.0070377267,0.0048170323,0.023584543,0.012325949,0.02169078,0.028126776],"category_scores_gemma":[0.3034104,0.0015403171,0.0056282817,0.013861589,0.031804893,0.06130496,0.023257138,0.025006631,0.005458498],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048733837,0.00018182702,0.0032045706,0.0069450326,0.00039626283,0.00040048957,0.0018605377,0.0016355307,0.00041996452,0.53887844,0.1299259,0.3156642],"study_design_scores_gemma":[0.0001037559,0.0001203424,0.0011051137,0.008888595,0.000089685316,0.0005330561,0.0013813961,0.0014954704,0.00023990155,0.60482496,0.3810772,0.00014058362],"about_ca_topic_score_codex":0.004730766,"about_ca_topic_score_gemma":0.003521964,"teacher_disagreement_score":0.98767406,"about_ca_system_score_codex":0.009098049,"about_ca_system_score_gemma":0.028980233,"threshold_uncertainty_score":0.94944006},"labels":[],"label_agreement":null},{"id":"W4391322849","doi":"10.1002/cpt.3162","title":"<scp>CYP2D6</scp> Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis; National Center for Advancing Translational Sciences; National Institute of Mental Health; Campbell Family Mental Health Research Institute","keywords":"Ven; CYP2D6; Pharmacokinetics; Medicine; Pharmacology; NONMEM; Population; Pharmacogenetics; Active metabolite; Internal medicine; Chemistry; Cytochrome P450; Genotype","score_opus":0.05019779129283248,"score_gpt":0.3910578229988767,"score_spread":0.34086003170604423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391322849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98439837,0.00034144984,0.013807041,0.00019293331,0.0000133180865,0.00006446427,0.0005523591,0.00005543194,0.00057482114],"genre_scores_gemma":[0.99450666,0.00015650512,0.0037819238,0.000095396164,0.000008355489,0.00006468217,0.00062801054,0.0000141295495,0.00074425444],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99934727,0.00041369456,0.000028230868,0.0001343069,0.00003663701,0.000039819464],"domain_scores_gemma":[0.99793077,0.0015179636,0.00021483963,0.000122055804,0.00016025155,0.000054127235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024693804,0.00053653505,0.00077300624,0.0001536787,0.00017741327,0.0006687728,0.0004918161,0.0005481819,0.001199726],"category_scores_gemma":[0.0056286,0.000278276,0.0016602958,0.00019093129,0.0001562095,0.0003426895,0.00031975887,0.0007700132,0.00024118312],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008379846,0.0012925246,0.5157677,0.00034946823,0.0058880523,0.0010997895,0.0006876606,0.39996308,0.009909807,0.0020530536,0.002981759,0.051627263],"study_design_scores_gemma":[0.00060372095,0.0016428634,0.134328,0.000037023325,0.0017116042,0.00054549915,0.00013385342,0.8553241,0.0014852618,0.0014871723,0.002637493,0.00006341502],"about_ca_topic_score_codex":0.014276208,"about_ca_topic_score_gemma":0.008542727,"teacher_disagreement_score":0.014276208,"about_ca_system_score_codex":0.0005292123,"about_ca_system_score_gemma":0.00065712235,"threshold_uncertainty_score":0.028386235},"labels":[],"label_agreement":null},{"id":"W4391931994","doi":"10.1002/cpt.3210","title":"Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome‐Wide Investigation of Abnormal Dreams on Varenicline","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Varenicline; Smoking cessation; Medicine; Genome-wide association study; Odds ratio; Bupropion; Internal medicine; Nicotine replacement therapy; Allele; Nicotine; Placebo; Genotype; Genetics; Single-nucleotide polymorphism; Biology; Pathology","score_opus":0.07445360903375202,"score_gpt":0.39481104279617507,"score_spread":0.32035743376242304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391931994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837375,0.00034791575,0.00035051038,0.00009762605,0.000005865685,0.000009141277,0.00050720084,0.000009346541,0.00029866333],"genre_scores_gemma":[0.99908435,0.000107437125,0.0003224951,0.000031559866,0.0000062220674,0.000006213576,0.0002817986,0.000004055547,0.00015593163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996556,0.000113134585,0.000032170647,0.000114621114,0.00004817041,0.000036292924],"domain_scores_gemma":[0.99913615,0.0003118748,0.0003096252,0.00009646746,0.00006530497,0.000080547026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005773352,0.00032247495,0.00037375785,0.00041137607,0.00028696295,0.0005033457,0.00033132886,0.00046135992,0.0021039136],"category_scores_gemma":[0.0017344516,0.00026767238,0.00096210075,0.00070802245,0.00018686734,0.00021295171,0.00040114246,0.0005279437,0.00014332039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012979204,0.00008183781,0.9829028,0.00006542699,0.0013626043,0.0002726047,0.00014132229,0.00027720988,0.0063113226,0.00009071363,0.00027092575,0.006925398],"study_design_scores_gemma":[0.00003887757,0.00010971273,0.99803466,0.000007632877,0.00033944935,0.00024483123,0.00005223791,0.00071515766,0.00020595203,0.000059767586,0.00018615641,0.0000055078044],"about_ca_topic_score_codex":0.005786558,"about_ca_topic_score_gemma":0.00663407,"teacher_disagreement_score":0.005786558,"about_ca_system_score_codex":0.00015841809,"about_ca_system_score_gemma":0.00017778142,"threshold_uncertainty_score":0.011505783},"labels":[],"label_agreement":null},{"id":"W4392885091","doi":"10.1002/cpt.3235","title":"Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug–Drug Interactions","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Janssen Research and Development","keywords":"Golimumab; Medicine; Immunogenicity; Combination therapy; Pharmacokinetics; Pharmacology; Internal medicine; Immunology; Antibody; Adalimumab; Rheumatoid arthritis","score_opus":0.019850049621665703,"score_gpt":0.33769454991885833,"score_spread":0.31784450029719263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392885091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773119,0.01945868,0.0017648163,0.00033549627,0.00004410772,0.00013638829,0.00012329871,0.000048103797,0.0007772123],"genre_scores_gemma":[0.99590284,0.0021512823,0.0013396428,0.00013951884,0.000031673917,0.00007650866,0.00010750441,0.0000053256035,0.00024572876],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991627,0.00045254902,0.00006544773,0.00009654089,0.00016074436,0.00006204154],"domain_scores_gemma":[0.9994937,0.00018938894,0.00018148146,0.000030201858,0.000030047495,0.00007518922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013184933,0.00042861135,0.0018790523,0.00033159493,0.0002078603,0.00059414376,0.00023854354,0.0003686404,0.00089981715],"category_scores_gemma":[0.0012761907,0.00026617598,0.0014331663,0.00041185552,0.00022170346,0.00050209067,0.00031505342,0.0009612637,0.00020356046],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15625478,0.005796634,0.12728469,0.0032247163,0.009989624,0.0013384317,0.0005254935,0.015195881,0.08335472,0.00046140084,0.0017694506,0.59480417],"study_design_scores_gemma":[0.025213933,0.3773151,0.48175684,0.00053983944,0.011406595,0.0044781095,0.00046232087,0.047457233,0.02677998,0.0014881662,0.02291576,0.00018609414],"about_ca_topic_score_codex":0.00024835224,"about_ca_topic_score_gemma":0.00077301136,"teacher_disagreement_score":0.0018790523,"about_ca_system_score_codex":0.00043264282,"about_ca_system_score_gemma":0.00040737345,"threshold_uncertainty_score":0.0069729686},"labels":[],"label_agreement":null},{"id":"W4396623478","doi":"10.1002/cpt.3284","title":"Should You Run a Dedicated TQT Study? Sponsor and Regulatory Considerations on Substitution Pathways to Assess QT Liability","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Drug; Medicine; Substitution (logic); Pharmacology; Business; Actuarial science; Computer science","score_opus":0.36415714434018903,"score_gpt":0.5161278685460166,"score_spread":0.15197072420582752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396623478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031330387,0.9807382,0.0018670977,0.009249532,0.0012310594,0.00007465082,0.00010297806,0.00004175859,0.006381294],"genre_scores_gemma":[0.0031037182,0.9804906,0.0037317309,0.007857415,0.0012607126,0.00011656233,0.00013606764,0.000019114634,0.0032840578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99788034,0.00089022104,0.00036923593,0.0002122314,0.00056812214,0.000079821504],"domain_scores_gemma":[0.9936858,0.0047370684,0.0005719743,0.00013981643,0.00072605885,0.00013923972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072143422,0.00049951527,0.0012451545,0.0011608276,0.00031715454,0.0017402695,0.0013464977,0.0031517432,0.005868576],"category_scores_gemma":[0.008026727,0.0003356946,0.0012069822,0.0010371286,0.0010712729,0.0029034768,0.00072534365,0.0042956257,0.003534818],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014981798,0.000059181835,0.00021660561,0.013202486,0.000079761,0.00024006279,0.00015148643,0.0002789503,0.0009139,0.019048693,0.054949008,0.9107101],"study_design_scores_gemma":[0.000088678964,0.00017091232,0.0005664209,0.0115783885,0.000107174325,0.0016988068,0.000087082684,0.00014373496,0.00043765735,0.007933209,0.97715783,0.000030037021],"about_ca_topic_score_codex":0.0011425366,"about_ca_topic_score_gemma":0.0023643158,"teacher_disagreement_score":0.0072143422,"about_ca_system_score_codex":0.0007421195,"about_ca_system_score_gemma":0.0026501075,"threshold_uncertainty_score":0.03815353},"labels":[],"label_agreement":null},{"id":"W4399590993","doi":"10.1002/cpt.3338","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2B6</i> Genotype and Methadone Therapy","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institutes of Health; National Human Genome Research Institute; Universidad Autónoma de Madrid; National Institute of General Medical Sciences; Canada Research Chairs","keywords":"Methadone; CYP2B6; Pharmacogenetics; Pharmacology; Medicine; Opioid; Context (archaeology); Opioid use disorder; Pharmacokinetics; Anesthesia; Genotype; Internal medicine; Chemistry; Metabolism; CYP3A4; Receptor; Biology; Cytochrome P450","score_opus":0.5190700035271528,"score_gpt":0.6601642049216446,"score_spread":0.1410942013944918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399590993","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053005973,0.047487114,0.11308744,0.34864756,0.012148402,0.014843312,0.025711639,0.0070997137,0.42567423],"genre_scores_gemma":[0.042620823,0.07165114,0.3022635,0.330364,0.010806524,0.04018252,0.06509817,0.0028910975,0.13412231],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9737007,0.013226134,0.004976744,0.0010337323,0.0059143202,0.0011482924],"domain_scores_gemma":[0.94705087,0.020861708,0.0045979084,0.0028450675,0.022090912,0.0025535899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02176743,0.0010600651,0.0018065202,0.0024180824,0.0009658645,0.0030029307,0.0049403687,0.008590077,0.024184968],"category_scores_gemma":[0.055284772,0.0008469566,0.0034631768,0.0028589813,0.0010531388,0.0019847096,0.0025305853,0.008654694,0.01972553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020817868,0.0003256319,0.0018618095,0.0012983179,0.000072222414,0.000542314,0.0002745288,0.0005751778,0.00070606533,0.007889532,0.80121315,0.18503311],"study_design_scores_gemma":[0.0005035715,0.00019653024,0.005688714,0.0071152076,0.00014621165,0.0011264116,0.00018157,0.0008089396,0.00075669657,0.007208329,0.97620505,0.00006272456],"about_ca_topic_score_codex":0.011958816,"about_ca_topic_score_gemma":0.014453136,"teacher_disagreement_score":0.024184968,"about_ca_system_score_codex":0.0023164912,"about_ca_system_score_gemma":0.013191161,"threshold_uncertainty_score":0.1151185},"labels":[],"label_agreement":null},{"id":"W4400745688","doi":"10.1002/cpt.3370","title":"Integrated Population Exposure–Response of Dolutegravir in HIV‐1 Supports Bridging of Clinical Response Influenced by Relevant Intrinsic and Extrinsic Patient Characteristics","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Dolutegravir; Bridging (networking); Human immunodeficiency virus (HIV); Population; Medicine; Antiretroviral therapy; Virology; Environmental health; Viral load; Computer science","score_opus":0.041195131179588805,"score_gpt":0.3980079425941253,"score_spread":0.3568128114145365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400745688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98574126,0.00023020963,0.012099248,0.00011377655,0.0000064893147,0.000039810602,0.0004158736,0.00006543315,0.0012879246],"genre_scores_gemma":[0.9982849,0.000050454342,0.0010555795,0.000034943107,0.0000026531782,0.00002626594,0.00021252042,0.0000063476105,0.0003263101],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9995322,0.00025213644,0.000012103008,0.00010693379,0.000044216576,0.000052316245],"domain_scores_gemma":[0.99890053,0.0007678303,0.0001596966,0.000073204224,0.000060809572,0.00003782961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015234853,0.00041031407,0.00066779606,0.00021082355,0.00009958757,0.0005563006,0.00051725545,0.0005888624,0.0009772601],"category_scores_gemma":[0.002468301,0.0002685215,0.0009353318,0.00019668254,0.00017536661,0.00036900784,0.0003707929,0.00048794172,0.00012815047],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000966159,0.00021730422,0.026973275,0.00008493694,0.00039541538,0.00011965812,0.0000637609,0.9512098,0.010266017,0.0010344132,0.00021923466,0.008449997],"study_design_scores_gemma":[0.00005964048,0.0009780459,0.015033146,0.000008772934,0.00019236893,0.0000645282,0.000054768076,0.97825086,0.003417178,0.0014212574,0.0004984234,0.000020906149],"about_ca_topic_score_codex":0.0031931642,"about_ca_topic_score_gemma":0.002259615,"teacher_disagreement_score":0.0031931642,"about_ca_system_score_codex":0.00076942967,"about_ca_system_score_gemma":0.00061669707,"threshold_uncertainty_score":0.008056998},"labels":[],"label_agreement":null},{"id":"W4400930961","doi":"10.1002/cpt.3380","title":"Solanidine Metabolites as Diet‐Derived Biomarkers of <scp>CYP2D6</scp>‐Mediated Tamoxifen Metabolism in Breast Cancer Patients","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Tamoxifen; Internal medicine; Endocrinology; Metabolite; CYP2D6; Medicine; Chemistry; Breast cancer; Metabolism; Cancer; Cytochrome P450","score_opus":0.1032164564343435,"score_gpt":0.46476276253494675,"score_spread":0.36154630610060323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400930961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982889,0.0007356853,0.00009207768,0.000026465645,0.0000049019027,0.0000081779635,0.00045947256,0.000006277658,0.00037800192],"genre_scores_gemma":[0.9990404,0.00016144794,0.000120839606,0.000027834249,0.00000951217,0.000008164095,0.00043732708,0.0000026920093,0.00019174979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968207,0.00007980632,0.000042091404,0.00008425345,0.00007571397,0.000036123303],"domain_scores_gemma":[0.9993549,0.000118846874,0.00030944822,0.000052166335,0.000087604705,0.00007702614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036885132,0.00022792962,0.00041626705,0.0006919875,0.00026445283,0.0006024641,0.00020577438,0.00041634584,0.001056637],"category_scores_gemma":[0.0011011118,0.00021860984,0.000437403,0.001102881,0.00015138077,0.0002712495,0.0002672697,0.00045188077,0.00026433184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051960215,0.000030376601,0.996136,0.000011712608,0.00007502201,0.00009579269,0.00002745999,0.000040736515,0.001299359,0.000011074605,0.00006817979,0.0016845942],"study_design_scores_gemma":[0.000014229252,0.00017370524,0.9981944,0.0000034632658,0.0000635881,0.0005344419,0.000043309552,0.00028430836,0.00040577372,0.000018533045,0.00026120347,0.0000030629712],"about_ca_topic_score_codex":0.0012698312,"about_ca_topic_score_gemma":0.0013725399,"teacher_disagreement_score":0.0012698312,"about_ca_system_score_codex":0.00020462064,"about_ca_system_score_gemma":0.00013643334,"threshold_uncertainty_score":0.0035347939},"labels":[],"label_agreement":null},{"id":"W4400982324","doi":"10.1002/cpt.3387","title":"PharmVar GeneFocus: <i>CYP2A6</i>","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Human Genome Research Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institutes of Health","keywords":"CYP2A6; Allele; Genetics; Biology; Genetic variation; Gene; Phenotype; Genotype; Locus (genetics); Computational biology; Genotype-phenotype distinction; Bioinformatics","score_opus":0.5594046779091968,"score_gpt":0.6417700626406821,"score_spread":0.08236538473148536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400982324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089534756,0.8994175,0.0035420428,0.0060952306,0.005566308,0.00022117447,0.0052667083,0.0011872893,0.0778084],"genre_scores_gemma":[0.004413918,0.91199106,0.005516138,0.006124929,0.003401106,0.00020365197,0.010322938,0.00036220747,0.05766415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966276,0.00006072791,0.000045269975,0.000055613393,0.00012977222,0.00004579775],"domain_scores_gemma":[0.9993368,0.00020336716,0.00012153443,0.000037634964,0.00019264553,0.00010802035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062895333,0.00092196895,0.0011389414,0.003212165,0.00026933145,0.0016064552,0.0011557615,0.0011497183,0.03594747],"category_scores_gemma":[0.0011694507,0.00016659478,0.0006857622,0.004261412,0.00052099006,0.0014751757,0.0011070443,0.0019001622,0.040595368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108814376,0.00003710073,0.00019429644,0.008298022,0.000042746604,0.00019129692,0.000040009243,0.0001143424,0.0026847578,0.004666996,0.23805983,0.7455618],"study_design_scores_gemma":[0.0000067907827,0.00002042985,0.00031076596,0.0006441649,0.000014343521,0.00043104475,0.0000065702693,0.000017639484,0.00031134472,0.0005346861,0.9976967,0.0000055766304],"about_ca_topic_score_codex":0.0010637612,"about_ca_topic_score_gemma":0.001345274,"teacher_disagreement_score":0.03594747,"about_ca_system_score_codex":0.0005655934,"about_ca_system_score_gemma":0.0011889951,"threshold_uncertainty_score":0.120256245},"labels":[],"label_agreement":null},{"id":"W4400984543","doi":"10.1002/cpt.3360","title":"Racial and Ethnic Disparities in Antihypertensive Medication Prescribing Patterns and Effectiveness","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto","funders":"National Institutes of Health; University of South Dakota","keywords":"Medicine; Blood pressure; Antihypertensive drug; Ethnic group; Guideline; Internal medicine; Cohort; Demography; Gerontology; Pathology","score_opus":0.145234474189237,"score_gpt":0.45128188639284156,"score_spread":0.30604741220360454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400984543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807525,0.00023879387,0.00014830286,0.00010057937,0.0000042472366,0.000011848755,0.00036527935,0.000002221363,0.0010533407],"genre_scores_gemma":[0.99922705,0.00013264877,0.00018237032,0.00006699854,0.000011466876,0.000012933639,0.0002553682,0.0000019143602,0.0001092751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883384,0.00042427258,0.00014879712,0.00022752077,0.00021697454,0.00014859375],"domain_scores_gemma":[0.99782664,0.00057757884,0.001105089,0.00015088254,0.0002062668,0.00013360036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017473442,0.00012466252,0.00023051088,0.0008054167,0.0004198798,0.00046360455,0.000288917,0.00023220103,0.0012421049],"category_scores_gemma":[0.004312179,0.00012684912,0.0003269322,0.001018994,0.00022665145,0.00042301926,0.00044091046,0.00020911483,0.00012986393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039312843,0.000060657152,0.9965184,0.000012918126,0.00006788589,0.000024865885,0.00029002834,0.000034909757,0.00015862414,0.0001288662,0.000113422386,0.0025501475],"study_design_scores_gemma":[0.0000029231642,0.000027152919,0.99900466,0.000009761785,0.00002401432,0.00005685439,0.00033833776,0.00014279241,0.00008485972,0.00007730988,0.00022863601,0.0000026239184],"about_ca_topic_score_codex":0.0122187575,"about_ca_topic_score_gemma":0.019043153,"teacher_disagreement_score":0.0122187575,"about_ca_system_score_codex":0.00026574463,"about_ca_system_score_gemma":0.00040792176,"threshold_uncertainty_score":0.02429527},"labels":[],"label_agreement":null},{"id":"W4401522897","doi":"10.1002/cpt.3406","title":"Item Response Theory Quantifies the Relationship Between Improvements in Serum Phosphate and Patient‐Reported Outcomes in Adults With X‐Linked Hypophosphatemia","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hypophosphatemia; Biomarker; Population; Medicine; Internal medicine; Phosphate; Endocrinology; Chemistry; Biochemistry; Environmental health","score_opus":0.09063046115921253,"score_gpt":0.41930822129331213,"score_spread":0.3286777601340996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401522897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8830583,0.0037214549,0.098435625,0.0014256825,0.00013488613,0.0015573945,0.007256478,0.00028289514,0.004127264],"genre_scores_gemma":[0.9807438,0.0004660389,0.01351728,0.00032534546,0.00003170972,0.0018568677,0.002372989,0.000028135564,0.00065789564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96904826,0.024682704,0.0017657189,0.00187715,0.0021800422,0.00044603384],"domain_scores_gemma":[0.9402479,0.046251472,0.007410112,0.0029326528,0.0028238127,0.00033397696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032809783,0.0011594202,0.0012454932,0.0014371962,0.0003473142,0.0012139811,0.0009817919,0.0009889115,0.0027056513],"category_scores_gemma":[0.05439757,0.00039070705,0.004125167,0.0019962918,0.0008277979,0.0009043033,0.0011641856,0.0018601001,0.0005271389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013359463,0.000687416,0.89651906,0.001037609,0.005537626,0.00007979053,0.00083305396,0.023991352,0.00086285203,0.002373411,0.0020192193,0.064722575],"study_design_scores_gemma":[0.00024640936,0.004290965,0.9117219,0.0003915771,0.0015546159,0.00031557502,0.0006119898,0.067678235,0.0016911719,0.006349917,0.0050344025,0.000113227354],"about_ca_topic_score_codex":0.0018655956,"about_ca_topic_score_gemma":0.0023018979,"teacher_disagreement_score":0.032809783,"about_ca_system_score_codex":0.0011970036,"about_ca_system_score_gemma":0.0010004449,"threshold_uncertainty_score":0.17351675},"labels":[],"label_agreement":null},{"id":"W4401553233","doi":"10.1002/cpt.3405","title":"<scp>PharmVar GeneFocus</scp>: <i>CYP4F2</i>","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health; National Institute on Drug Abuse; National Institute of General Medical Sciences; Österreichische Forschungsförderungsgesellschaft; National Human Genome Research Institute; Universidad Autónoma de Madrid","keywords":"Chemistry","score_opus":0.44551167257493557,"score_gpt":0.5966109123631308,"score_spread":0.15109923978819523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401553233","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016974894,0.082499176,0.0062159393,0.01551459,0.0029064172,0.00083184923,0.54318297,0.014333821,0.3328178],"genre_scores_gemma":[0.0107406415,0.11672722,0.017512424,0.013701739,0.0024657096,0.0010528746,0.6418362,0.0060836505,0.18987957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996388,0.000050001072,0.000052311694,0.000052645915,0.00016342284,0.00004282034],"domain_scores_gemma":[0.9985098,0.0004733973,0.00021931803,0.00012398882,0.000489214,0.00018423327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007468011,0.0007142383,0.0012455389,0.0030858682,0.00027984948,0.0017702052,0.0016641795,0.0011738926,0.29865134],"category_scores_gemma":[0.0026177731,0.00025609112,0.0006032466,0.006230208,0.00028361852,0.0014470835,0.0013103037,0.0010281835,0.20429403],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007962659,0.000018127994,0.0001312887,0.004517868,0.000029342726,0.0001196848,0.000035082896,0.00008449017,0.0015627061,0.0021176971,0.8030403,0.18826391],"study_design_scores_gemma":[0.000014047111,0.0000065591566,0.00034013324,0.00035969264,0.0000098974315,0.000089909954,0.000006218263,0.00001953519,0.0003809039,0.00044131346,0.99832684,0.0000049813657],"about_ca_topic_score_codex":0.0033539028,"about_ca_topic_score_gemma":0.0044805272,"teacher_disagreement_score":0.29865134,"about_ca_system_score_codex":0.00078913657,"about_ca_system_score_gemma":0.0020208545,"threshold_uncertainty_score":0.9990882},"labels":[],"label_agreement":null},{"id":"W4401648132","doi":"10.1002/cpt.3407","title":"Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Modalities; Medicine; Intensive care medicine; Drug development; Clinical trial; Disease; Population; Orphan drug; Drug; Bioinformatics; Pharmacology; Pathology; Biology","score_opus":0.026236344515111473,"score_gpt":0.3615465485684599,"score_spread":0.33531020405334844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401648132","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011999456,0.32305422,0.11171924,0.5051302,0.006690186,0.00071707414,0.00045878737,0.0006647308,0.039566074],"genre_scores_gemma":[0.22425702,0.327744,0.2388394,0.17552869,0.015014946,0.0025694196,0.00052174623,0.0012622642,0.014262599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95655507,0.02210777,0.0044523957,0.0040573524,0.011338266,0.00148917],"domain_scores_gemma":[0.8831905,0.09110691,0.0066739353,0.0074371374,0.008142835,0.0034486698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1131457,0.001081824,0.0025753216,0.0012163694,0.001864328,0.012017854,0.0032127546,0.0075240824,0.008134621],"category_scores_gemma":[0.09482071,0.0009671269,0.001608464,0.0013009971,0.012588024,0.020021878,0.010188423,0.015486628,0.003119482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007524038,0.0004291571,0.0025014342,0.004723025,0.0001968339,0.00049868395,0.0017386301,0.0026952298,0.0045156693,0.2802281,0.049181644,0.65253913],"study_design_scores_gemma":[0.0003916001,0.002163014,0.002165182,0.0059697162,0.00016972447,0.0018567992,0.0017998192,0.0017825374,0.006220021,0.28874382,0.68850315,0.00023463983],"about_ca_topic_score_codex":0.0017717715,"about_ca_topic_score_gemma":0.0022188164,"teacher_disagreement_score":0.1131457,"about_ca_system_score_codex":0.0053684316,"about_ca_system_score_gemma":0.011565234,"threshold_uncertainty_score":0.5983788},"labels":[],"label_agreement":null},{"id":"W4402567628","doi":"10.1002/cpt.3404","title":"Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?","year":2024,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Medicine; Intensive care medicine; Pharmacology; Biology; Genotype; Genetics","score_opus":0.17465712181962192,"score_gpt":0.5086332172790551,"score_spread":0.3339760954594332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402567628","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003980702,0.07499126,0.010397812,0.8826244,0.005989274,0.00006271218,0.0009904149,0.0002796208,0.020683741],"genre_scores_gemma":[0.17239833,0.34636688,0.046027403,0.38025513,0.04187886,0.0003634019,0.0030408264,0.0005985596,0.009070642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99061525,0.0050101415,0.00073352025,0.0009578466,0.002237472,0.0004457115],"domain_scores_gemma":[0.9565521,0.023731558,0.0047889645,0.0028225104,0.007225327,0.0048796753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017125066,0.00064655166,0.0012777117,0.0023751413,0.0011903277,0.004857203,0.0015127308,0.003941129,0.015990281],"category_scores_gemma":[0.07632241,0.0003843758,0.00065524,0.0034827292,0.0042466833,0.009221544,0.0043770825,0.0067755347,0.0055460213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023447677,0.00017032586,0.022814108,0.0010184856,0.00014743343,0.00036566152,0.0005750006,0.00047588506,0.00047905568,0.045611586,0.2677467,0.6603613],"study_design_scores_gemma":[0.00009231307,0.00022280478,0.023729356,0.0076239356,0.00022254293,0.0017483053,0.0014263646,0.0012796377,0.0007273932,0.11174495,0.8510333,0.00014904166],"about_ca_topic_score_codex":0.005435448,"about_ca_topic_score_gemma":0.0046020015,"teacher_disagreement_score":0.017125066,"about_ca_system_score_codex":0.002362489,"about_ca_system_score_gemma":0.0067692255,"threshold_uncertainty_score":0.09056711},"labels":[],"label_agreement":null},{"id":"W4402929046","doi":"10.1002/cpt.3445","title":"A Novel Step‐Up Dosage Regimen for Enhancing the Benefit‐to‐Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; Roche","keywords":"Medicine; Regimen; Follicular lymphoma; Neutropenia; Dosing; Internal medicine; Adverse effect; Refractory (planetary science); Population; Pharmacokinetics; Oncology; Lymphoma; Gastroenterology; Pharmacology; Toxicity; Biology","score_opus":0.10287831559075052,"score_gpt":0.4523550682450669,"score_spread":0.3494767526543164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402929046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861247,0.0014446218,0.010040021,0.00016110764,0.000024897134,0.00027178894,0.00014204609,0.00018265484,0.0016082113],"genre_scores_gemma":[0.995555,0.00024004531,0.0036698643,0.000060161346,0.000011032021,0.00007578882,0.00007174768,0.000009420039,0.0003069058],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997782,0.00008057011,0.00001322463,0.00004316393,0.000056321405,0.000028437504],"domain_scores_gemma":[0.99984586,0.000059656097,0.000047234047,0.000015622938,0.000010606069,0.000020973699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037998526,0.00022973353,0.0004223941,0.00031155423,0.00006721795,0.00035501784,0.00037743026,0.0003034987,0.0013599007],"category_scores_gemma":[0.0009235757,0.00013116031,0.0003000388,0.00014929844,0.00012427986,0.00024448443,0.00021826266,0.0006524001,0.00018281456],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020088464,0.006514977,0.008266068,0.00035100445,0.000539894,0.0002575943,0.00018912106,0.047291093,0.28653252,0.0023949177,0.0023719885,0.6252023],"study_design_scores_gemma":[0.020706894,0.1826151,0.09551319,0.00019104403,0.0025429043,0.001913043,0.00017000415,0.4487567,0.21476433,0.0046826573,0.02788427,0.00025989124],"about_ca_topic_score_codex":0.0004358877,"about_ca_topic_score_gemma":0.00079068,"teacher_disagreement_score":0.0013599007,"about_ca_system_score_codex":0.0003504309,"about_ca_system_score_gemma":0.00026407564,"threshold_uncertainty_score":0.0045493245},"labels":[],"label_agreement":null},{"id":"W4403434151","doi":"10.1002/cpt.3466","title":"Longitudinal Analysis of Natural History Progression of Rare and Ultra‐Rare Cerebellar Ataxias Using Item Response Theory","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Vetenskapsrådet; Uppsala Multidisciplinary Center for Advanced Computational Science; Else Kröner-Fresenius-Stiftung","keywords":"Ataxia; Cohort; Natural history study; Medicine; Cerebellar ataxia; Cohort study; Pediatrics; Natural history; Internal medicine; Psychology; Psychiatry","score_opus":0.160688855391447,"score_gpt":0.4464478865971174,"score_spread":0.2857590312056704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403434151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79323566,0.0028149888,0.19616567,0.001226463,0.00014281657,0.0015562994,0.0029819116,0.0005287586,0.0013474853],"genre_scores_gemma":[0.9639288,0.00039993227,0.031049404,0.0003008945,0.000035507448,0.0018098648,0.0016459372,0.000043620086,0.00078594487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94372255,0.05054707,0.0013554324,0.0025385923,0.0012130528,0.00062328996],"domain_scores_gemma":[0.8838976,0.092034206,0.010807854,0.008978626,0.0032393523,0.0010423581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.101227716,0.0010258553,0.001360137,0.0015074795,0.00041181117,0.0015258938,0.0014164661,0.00144625,0.0035746829],"category_scores_gemma":[0.105526574,0.00051787583,0.0039546993,0.0016747796,0.0009897047,0.0013283108,0.0015208175,0.0022641239,0.00056412467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009915327,0.0023918897,0.67118883,0.001543469,0.01531103,0.0005427239,0.002350479,0.15932724,0.0025772036,0.011606728,0.0039950022,0.11925],"study_design_scores_gemma":[0.0013809933,0.01857363,0.2862276,0.00054045516,0.006483777,0.0005721231,0.000709325,0.6444546,0.0023594375,0.030254956,0.008161455,0.00028165104],"about_ca_topic_score_codex":0.0028551081,"about_ca_topic_score_gemma":0.0019917313,"teacher_disagreement_score":0.101227716,"about_ca_system_score_codex":0.0011785002,"about_ca_system_score_gemma":0.0019338719,"threshold_uncertainty_score":0.5353497},"labels":[],"label_agreement":null},{"id":"W4403658439","doi":"10.1002/cpt.3457","title":"Collaborative Real‐World Evidence Among Regulators: Lessons and Perspectives","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Timeline; Public relations; Transparency (behavior); Preparedness; Working group; Outreach; Business; Global health; Repurposing; Observational study; Pandemic; Public health; Political science; Coronavirus disease 2019 (COVID-19); Medicine; Engineering; Nursing; Infectious disease (medical specialty); Geography","score_opus":0.5045551526292459,"score_gpt":0.6237966433062814,"score_spread":0.11924149067703549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403658439","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001856013,0.041616634,0.011505161,0.93021786,0.004120092,0.00017923542,0.00013409449,0.000077096716,0.010293818],"genre_scores_gemma":[0.2525361,0.08407547,0.07674308,0.5609504,0.018058894,0.0019408603,0.000458758,0.00036263934,0.0048738346],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.6195799,0.30702296,0.012763172,0.01664862,0.03142175,0.012563559],"domain_scores_gemma":[0.25916305,0.6262455,0.017246954,0.021839311,0.050018508,0.025486708],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.43407288,0.0018732846,0.0035534021,0.0075567015,0.009824729,0.05051281,0.011536499,0.03571226,0.009727006],"category_scores_gemma":[0.4466087,0.0019945863,0.0034072823,0.0066501345,0.028563384,0.055409826,0.032386065,0.03643242,0.001853969],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027342048,0.0006853227,0.0071769473,0.0063938005,0.0009211662,0.0025168792,0.020939318,0.0037023595,0.00036380294,0.52519447,0.20468847,0.22714405],"study_design_scores_gemma":[0.00029196372,0.0002866401,0.0015104888,0.012604188,0.00020225259,0.0008309332,0.02571674,0.0016872396,0.000436931,0.6332969,0.32292464,0.00021113397],"about_ca_topic_score_codex":0.007358097,"about_ca_topic_score_gemma":0.010791168,"teacher_disagreement_score":0.56592715,"about_ca_system_score_codex":0.020065026,"about_ca_system_score_gemma":0.09012982,"threshold_uncertainty_score":0.6978889},"labels":[],"label_agreement":null},{"id":"W4404387167","doi":"10.1002/cpt.3484","title":"Hyponatremia Associated with the Use of Common Antidepressants in the <i>All of Us</i> Research Program","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Electrolyte and hormonal disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Human Genome Research Institute; Centers for Disease Control and Prevention; National Institutes of Health","keywords":"Venlafaxine; Sertraline; Escitalopram; Duloxetine; Hyponatremia; Citalopram; Bupropion; Medicine; Mirtazapine; Internal medicine; Reuptake inhibitor; Fluoxetine; Serotonin reuptake inhibitor; Antidepressant; Serotonin","score_opus":0.3985958998572817,"score_gpt":0.540353734815298,"score_spread":0.1417578349580163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404387167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978975,0.00033813046,0.00012714863,0.00008963709,0.0000080651225,0.00003357124,0.00093889073,0.000010595117,0.00055653014],"genre_scores_gemma":[0.9986493,0.00025010874,0.00012894375,0.000080160724,0.000015108234,0.00001845438,0.00075497857,0.000002098536,0.00010082339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993505,0.00017791287,0.00009537013,0.00016738969,0.00011656166,0.00009222686],"domain_scores_gemma":[0.9969921,0.00018680037,0.002225378,0.00021900433,0.00018107402,0.0001956171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081890175,0.00021761724,0.00030363357,0.0004897094,0.00048477767,0.00068167667,0.00033278886,0.00021646044,0.0007303993],"category_scores_gemma":[0.002458481,0.00030356902,0.0006862584,0.0010151129,0.00018485276,0.00035744056,0.000565609,0.00051710586,0.00008519014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011237424,0.00002574337,0.9981857,0.000014220582,0.000076282144,0.00003645649,0.000031186606,0.000010651862,0.00013074235,0.000011508438,0.00013251002,0.0012326457],"study_design_scores_gemma":[0.000008849187,0.0001116626,0.9991805,0.000008732222,0.0000675179,0.00026965368,0.00005227335,0.00007403923,0.00006898254,0.0000120662335,0.00014368424,0.0000020210307],"about_ca_topic_score_codex":0.018279439,"about_ca_topic_score_gemma":0.02167727,"teacher_disagreement_score":0.018279439,"about_ca_system_score_codex":0.00047306967,"about_ca_system_score_gemma":0.000871369,"threshold_uncertainty_score":0.036346078},"labels":[],"label_agreement":null},{"id":"W4405025489","doi":"10.1002/cpt.3498","title":"Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Medicine; Population; Enzyme replacement therapy; Pharmacodynamics; Disease; Clinical trial; Biomarker; Cohort; Glycogen storage disease; Internal medicine; Pharmacology; Pharmacokinetics; Biology; Genetics","score_opus":0.40785404046999735,"score_gpt":0.5612350576010974,"score_spread":0.15338101713110003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405025489","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31378007,0.0013371122,0.66960365,0.0015845153,0.00021392602,0.0009276973,0.004404281,0.0010346972,0.007114039],"genre_scores_gemma":[0.899504,0.00059380726,0.094963744,0.00046589543,0.00005886148,0.0006505119,0.0019898876,0.000117634016,0.0016556365],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979371,0.0015118273,0.00007705121,0.00020026814,0.00021418941,0.000059638427],"domain_scores_gemma":[0.9936173,0.0051158955,0.00041114824,0.0004059569,0.00028670652,0.0001629786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007743301,0.00058750465,0.0011827203,0.00077595684,0.00021973203,0.0012066971,0.0010143018,0.0006946321,0.0053416346],"category_scores_gemma":[0.013420563,0.00039920871,0.0014252885,0.0004127983,0.00047568307,0.0006888785,0.0010111849,0.00088582264,0.000411552],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015938351,0.00026600395,0.017625287,0.0005674599,0.0010225668,0.00042578555,0.00011442958,0.887342,0.0036731726,0.024491085,0.0021694768,0.06070885],"study_design_scores_gemma":[0.00019256205,0.0007488984,0.002691523,0.00003855004,0.00025801436,0.00013176489,0.000034831042,0.97131693,0.001426629,0.020245815,0.0028865736,0.00002785806],"about_ca_topic_score_codex":0.002739786,"about_ca_topic_score_gemma":0.002714699,"teacher_disagreement_score":0.007743301,"about_ca_system_score_codex":0.0010514425,"about_ca_system_score_gemma":0.0017413094,"threshold_uncertainty_score":0.040950954},"labels":[],"label_agreement":null},{"id":"W4405248118","doi":"10.1002/cpt.3512","title":"Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Chimeric antigen receptor; Clinical trial; Internal medicine; Oncology; Immunotherapy","score_opus":0.2873189533852471,"score_gpt":0.4787642868699958,"score_spread":0.19144533348474868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405248118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148095,0.001057697,0.0044743917,0.00011187584,0.000004479679,0.00010241622,0.0010008268,0.00004043941,0.0017269755],"genre_scores_gemma":[0.99717784,0.00033019326,0.0012263682,0.000022742262,0.0000048821507,0.00004988083,0.00086370244,0.000014042751,0.00031039826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99498343,0.0019881092,0.0006084534,0.0010266238,0.00094213407,0.0004511752],"domain_scores_gemma":[0.9457866,0.027399385,0.020840816,0.0019958252,0.002519287,0.0014580367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010884011,0.00039334845,0.00039141718,0.0022489813,0.00033209386,0.0017184477,0.00045185882,0.00053469517,0.0030263239],"category_scores_gemma":[0.029740108,0.0003324312,0.0010430212,0.0014418646,0.00067743956,0.0012955916,0.001272776,0.00085927965,0.00076641364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073650625,0.00006113913,0.97248566,0.00005923372,0.00017069456,0.00015338292,0.00015820896,0.005872156,0.000990485,0.0005126415,0.00020501153,0.018594906],"study_design_scores_gemma":[0.00006301029,0.0013564876,0.96311706,0.00006133444,0.00030822796,0.001636984,0.0004927278,0.02373595,0.003541562,0.0015642542,0.0040744008,0.000048000475],"about_ca_topic_score_codex":0.0014904779,"about_ca_topic_score_gemma":0.0012307762,"teacher_disagreement_score":0.010884011,"about_ca_system_score_codex":0.0007688338,"about_ca_system_score_gemma":0.0008874485,"threshold_uncertainty_score":0.05756086},"labels":[],"label_agreement":null},{"id":"W4405476348","doi":"10.1002/cpt.3534","title":"Prevalence Estimates of Cytochrome <scp>P450</scp> Phenoconversion in Youth Receiving Pharmacotherapy for Mental Health Conditions","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"CYP2C19; Pharmacogenetics; Medicine; Pharmacotherapy; CYP2D6; CYP2B6; Pharmacology; CYP3A4; Internal medicine; Cytochrome P450; Genotype; Biology; Genetics; Gene","score_opus":0.21507940728317868,"score_gpt":0.5323083967818297,"score_spread":0.3172289894986511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405476348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981229,0.00034468566,0.00035784632,0.000035811343,0.0000042867987,0.00001782919,0.00082730316,0.000010816148,0.0002785632],"genre_scores_gemma":[0.99877185,0.00022094611,0.00027465945,0.00002360249,0.0000058325736,0.000014115187,0.0005917481,0.0000025170323,0.00009463325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906105,0.00029028684,0.00012800112,0.00021299745,0.00018728247,0.000120356526],"domain_scores_gemma":[0.9966203,0.00058224937,0.001972735,0.00018843859,0.00040241505,0.00023378097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014389402,0.00022761125,0.00027845858,0.0012620391,0.0002791247,0.0004348151,0.0002788898,0.00030163839,0.0010148436],"category_scores_gemma":[0.003275703,0.00026168136,0.000528463,0.0010235036,0.00023286173,0.00032715485,0.0004083996,0.0005014751,0.00021809334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012506674,0.000005504356,0.9988776,0.000004546864,0.000012882259,0.000010681162,0.00003811602,0.000014760459,0.000045167817,0.000007788978,0.000037309626,0.0009331442],"study_design_scores_gemma":[9.4457175e-7,0.000026632128,0.9996393,0.0000053057806,0.00000939129,0.00008526491,0.00006075811,0.00007354866,0.000037019643,0.000006365389,0.000054541753,9.466432e-7],"about_ca_topic_score_codex":0.01802287,"about_ca_topic_score_gemma":0.016507292,"teacher_disagreement_score":0.01802287,"about_ca_system_score_codex":0.00038427117,"about_ca_system_score_gemma":0.00022151247,"threshold_uncertainty_score":0.03583592},"labels":[],"label_agreement":null},{"id":"W4407686581","doi":"10.1002/cpt.3551","title":"<scp>ASCPT</scp> News","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, Indiana University; University at Buffalo; Bristol-Myers Squibb; Universiti Sains Malaysia; University of Toronto; Seoul National University; Genentech; Seoul National University Hospital; SK Life Science; Istanbul Üniversitesi-Cerrahpasa; Vertex Pharmaceuticals; University of Minnesota; Brown University; Pfizer","keywords":"Chemistry","score_opus":0.13730371267469865,"score_gpt":0.369158236514969,"score_spread":0.23185452384027033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407686581","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041862167,0.0010517515,0.00069538085,0.019257981,0.015388121,0.00043159205,0.009541157,0.0034784863,0.9497369],"genre_scores_gemma":[0.0019945835,0.0007890694,0.000432222,0.011118068,0.0053268643,0.00020949713,0.0031000478,0.00064540276,0.9763842],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993162,0.00004362101,0.000024769362,0.000054449305,0.00046465622,0.00009630806],"domain_scores_gemma":[0.9962224,0.00075226056,0.00020019973,0.00029556383,0.0015480974,0.0009813989],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00085163256,0.0009976417,0.00086923904,0.0011451255,0.001999749,0.0056006038,0.0014874331,0.004880301,0.725851],"category_scores_gemma":[0.005629179,0.0005163579,0.0007133282,0.0016022293,0.00069572555,0.0020425392,0.0014846609,0.00461277,0.51683825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001718502,0.000014432936,0.000016715041,0.000027854168,5.266676e-7,0.000029201638,0.0000025630245,0.000011605333,0.000059823604,0.00019986858,0.9906393,0.008980809],"study_design_scores_gemma":[0.000022146298,0.000024079593,0.0003991903,0.000057330544,0.0000012944932,0.000044943423,0.000018129436,0.000077246215,0.00018122738,0.00035112703,0.9988153,0.000008006069],"about_ca_topic_score_codex":0.007479416,"about_ca_topic_score_gemma":0.018077236,"teacher_disagreement_score":0.274149,"about_ca_system_score_codex":0.0019029079,"about_ca_system_score_gemma":0.0025810208,"threshold_uncertainty_score":0.39104027},"labels":[],"label_agreement":null},{"id":"W4408287379","doi":"10.1002/cpt.3628","title":"Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Authorization; Medicine; Confidence interval; Family medicine; Regulatory science; Oncology; Exploratory analysis; Internal medicine; Marketing authorization; Bioinformatics; Pathology; Computer science","score_opus":0.700022351571417,"score_gpt":0.6620894597513208,"score_spread":0.03793289182009618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408287379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98007727,0.00023800854,0.010466032,0.0037320647,0.000031754298,0.00095254177,0.0009965763,0.00003556279,0.0034700986],"genre_scores_gemma":[0.9849474,0.00026697252,0.011380837,0.0008132629,0.000010094923,0.0011649204,0.000512229,0.000035111338,0.00086914736],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9414529,0.043292373,0.0031137278,0.0026588042,0.0069286753,0.0025536278],"domain_scores_gemma":[0.8024053,0.166394,0.01028438,0.002945916,0.015295503,0.00267493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07452239,0.0004361855,0.0006759862,0.0038679943,0.0038341954,0.0053410083,0.0020035135,0.0017369384,0.0021753034],"category_scores_gemma":[0.1485478,0.0006802269,0.00076146296,0.0039381445,0.0066733677,0.0071132137,0.005885639,0.0029789389,0.0002675935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087226945,0.00010843297,0.050742093,0.00043643513,0.000034169054,0.00027138938,0.918486,0.0004506611,0.000852597,0.0051914006,0.0014357454,0.021903843],"study_design_scores_gemma":[0.000017825203,0.00008031978,0.019427393,0.00032400253,0.000015364689,0.00014189628,0.96639633,0.0018225082,0.0005357285,0.00208174,0.009094761,0.00006215742],"about_ca_topic_score_codex":0.016011078,"about_ca_topic_score_gemma":0.016454402,"teacher_disagreement_score":0.07452239,"about_ca_system_score_codex":0.014722546,"about_ca_system_score_gemma":0.011204288,"threshold_uncertainty_score":0.39411676},"labels":[],"label_agreement":null},{"id":"W4409566964","doi":"10.1002/cpt.3658","title":"Oncology Dose Optimization: Tailored Approaches to Different Molecular Classes","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Clinical trial; Drug; Drug development; Clinical pharmacology; Immunotherapy; Pharmacology; Oncology; Cancer; Medical physics; Computational biology; Bioinformatics; Internal medicine; Biology","score_opus":0.4881619744201073,"score_gpt":0.5448352007766311,"score_spread":0.056673226356523776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409566964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029365597,0.9137127,0.06595058,0.0034346206,0.00036733315,0.0001818587,0.00012933745,0.00017457001,0.013112434],"genre_scores_gemma":[0.052909154,0.8876687,0.052400503,0.0021181824,0.0006279125,0.00030823442,0.00023397434,0.00011544415,0.0036179144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923086,0.0002844478,0.00006980659,0.00012082681,0.0002483564,0.000045731882],"domain_scores_gemma":[0.998923,0.00075134146,0.00013078727,0.00004834448,0.00011962246,0.000026907035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023690555,0.0008952761,0.0013000161,0.0015634521,0.00018871682,0.0014321792,0.0014851437,0.0009776154,0.0032396289],"category_scores_gemma":[0.0029428771,0.00036336988,0.0010798532,0.0009928094,0.0007609258,0.0014647794,0.0010108564,0.0026471727,0.0010249872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013276872,0.00013381834,0.0003807864,0.007401817,0.00017583313,0.00011859176,0.000073385025,0.020297281,0.0041858894,0.04145774,0.006978299,0.91866386],"study_design_scores_gemma":[0.00015981185,0.00088239706,0.0021032,0.007834438,0.0004773135,0.0025789733,0.00015176581,0.018263454,0.010343136,0.06715346,0.88993174,0.000120236065],"about_ca_topic_score_codex":0.0006715936,"about_ca_topic_score_gemma":0.00085107604,"teacher_disagreement_score":0.0032396289,"about_ca_system_score_codex":0.0011790359,"about_ca_system_score_gemma":0.0014708282,"threshold_uncertainty_score":0.012528956},"labels":[],"label_agreement":null},{"id":"W4409661637","doi":"10.1002/cpt.3673","title":"The Drug Titration Paradox Updated and Reinterpreted: With Perfect Titration, Dose and Effect Will Be Uncorrelated","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Titration; Uncorrelated; Correlation coefficient; Population; Drug; Statistics; Correlation; Metric (unit); Medicine; Mathematics; Pharmacology; Chemistry; Operations management; Economics","score_opus":0.020176439710911733,"score_gpt":0.38002330853783933,"score_spread":0.3598468688269276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409661637","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04738317,0.013301031,0.803008,0.06638242,0.010398311,0.0002903783,0.0010365164,0.00083357305,0.057366554],"genre_scores_gemma":[0.7311435,0.008033409,0.21812053,0.020561652,0.0035744172,0.00036653795,0.0002976598,0.0003307891,0.01757143],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9940989,0.002176682,0.00060299016,0.0011695548,0.0017672571,0.00018464304],"domain_scores_gemma":[0.9812476,0.010988701,0.0017300146,0.0025240362,0.0030686434,0.00044091733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008306562,0.00085831026,0.0014176794,0.0011553834,0.001000431,0.005238862,0.0021338277,0.0028565924,0.0039468273],"category_scores_gemma":[0.029846903,0.00048393692,0.001328803,0.0016355001,0.008892906,0.008509122,0.0029853513,0.007734202,0.0010608116],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032606107,0.00009654971,0.0026892473,0.00049091876,0.00012897865,0.0005926435,0.0010687073,0.012441371,0.003186782,0.8965741,0.011219927,0.071184844],"study_design_scores_gemma":[0.00011800219,0.00031026735,0.0024023768,0.00024295818,0.00013224898,0.0014333181,0.0002819523,0.047921814,0.0032688845,0.8726234,0.07109225,0.00017244178],"about_ca_topic_score_codex":0.0028744093,"about_ca_topic_score_gemma":0.0015811214,"teacher_disagreement_score":0.008306562,"about_ca_system_score_codex":0.0037465289,"about_ca_system_score_gemma":0.0044567497,"threshold_uncertainty_score":0.043929815},"labels":[],"label_agreement":null},{"id":"W4409852902","doi":"10.1002/cpt.3697","title":"Estimating the Frequency of False‐Negative Pharmacogenetic Test Results by Self‐Reported Ancestry","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"Alberta Innovates; Alberta Children's Hospital Foundation; American College Health Foundation; Children's Hospital Foundation","keywords":"Pharmacogenetics; Statistics; Test (biology); Medicine; Genetics; Biology; Mathematics; Genotype; Gene","score_opus":0.2090136641616907,"score_gpt":0.5244458290443401,"score_spread":0.3154321648826494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409852902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95383185,0.0031150526,0.036650248,0.00040366017,0.0001336719,0.00048731707,0.00095199374,0.00014361294,0.0042825313],"genre_scores_gemma":[0.9876396,0.0003526963,0.010073057,0.00038084935,0.000054381722,0.00023672904,0.00055902486,0.000029274832,0.0006743214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9433099,0.03732987,0.0050180666,0.00599889,0.007212845,0.0011304376],"domain_scores_gemma":[0.8978041,0.066251494,0.020875877,0.010531184,0.004063472,0.0004739722],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043447766,0.00072755694,0.00089069427,0.0018606563,0.00054108223,0.0011064579,0.001176998,0.0013848282,0.0009162762],"category_scores_gemma":[0.099623404,0.0005655246,0.0014266553,0.0012995253,0.0013913275,0.0010454396,0.0012684707,0.0011194556,0.00033866207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025068488,0.000036477755,0.990542,0.00004523157,0.00040649448,0.00012642017,0.00028147115,0.00033105115,0.0004367538,0.000268287,0.00027434167,0.007000801],"study_design_scores_gemma":[0.000050694955,0.00047541552,0.9798007,0.00011119824,0.0005860189,0.002487251,0.00030066675,0.010316854,0.0030225303,0.0011180647,0.0016972467,0.000033377735],"about_ca_topic_score_codex":0.003681327,"about_ca_topic_score_gemma":0.0033721593,"teacher_disagreement_score":0.9565522,"about_ca_system_score_codex":0.00042439788,"about_ca_system_score_gemma":0.00030995882,"threshold_uncertainty_score":0.2297765},"labels":[],"label_agreement":null},{"id":"W4409956483","doi":"10.1002/cpt.3693","title":"Impaired Drug Metabolism Caused by Compound Heterozygous Loss‐of‐Function Variants in <i>CYP3A4</i>: A Case Report","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Institute for Clinical Evaluative Sciences; Public Health Ontario; University of Toronto; Hospital for Sick Children","funders":"Hospital for Sick Children; University of Toronto","keywords":"CYP3A4; Pharmacogenetics; Medicine; Drug; Pharmacology; Population; Drug metabolism; Internal medicine; Metabolism; Biology; Genetics; Genotype; Gene","score_opus":0.11761001336131921,"score_gpt":0.47329417444472477,"score_spread":0.35568416108340556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409956483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613393,0.0064166393,0.010167883,0.0068191555,0.0005264206,0.00025934802,0.0005100037,0.0005837146,0.013377468],"genre_scores_gemma":[0.9921874,0.0016522463,0.0027507623,0.0012636773,0.0008096479,0.000023484754,0.00010996828,0.000064204454,0.0011385195],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99888915,0.00015402182,0.00011506179,0.00033917977,0.0001805459,0.00032216683],"domain_scores_gemma":[0.9973859,0.000896567,0.00068621564,0.00018166039,0.0001140894,0.0007355275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005373975,0.0029493694,0.0015270129,0.0029396329,0.0020754356,0.002092882,0.0013167472,0.0058960887,0.0022550058],"category_scores_gemma":[0.0028964502,0.0016512264,0.0015116257,0.0014638166,0.0027632602,0.0018290379,0.002050924,0.004873421,0.0011078971],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001534396,0.00001557381,0.0025861482,0.000012056403,0.0000062591894,0.9959216,0.00007323357,0.00004100203,0.00039194696,0.000117893826,0.00021943865,0.0005993941],"study_design_scores_gemma":[0.000002832466,0.000016397787,0.0006771274,0.000004300344,0.0000061912783,0.99878556,0.000021460744,0.00007263816,0.00020713104,0.00004523349,0.00015704529,0.0000040101277],"about_ca_topic_score_codex":0.002901375,"about_ca_topic_score_gemma":0.0022760353,"teacher_disagreement_score":0.0058960887,"about_ca_system_score_codex":0.0014098181,"about_ca_system_score_gemma":0.00079990976,"threshold_uncertainty_score":0.0102289915},"labels":[],"label_agreement":null},{"id":"W4409980303","doi":"10.1002/cpt.3616","title":"Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Lymphoblastic lymphoma; Lymphoblastic Leukemia; Dosing; Asparaginase; Medicine; Lymphoma; Acute lymphocytic leukemia; Oncology; Pediatrics; Internal medicine; Leukemia; Immunology","score_opus":0.08085524973616941,"score_gpt":0.43625565781602776,"score_spread":0.35540040807985834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409980303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6230692,0.0014355279,0.3489947,0.0025564695,0.00013822707,0.00028432385,0.0032008635,0.0012871057,0.019033603],"genre_scores_gemma":[0.9635879,0.00081041415,0.031819116,0.00015804652,0.000033660734,0.0001958156,0.001064536,0.00007872955,0.0022517398],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99971277,0.00015263172,0.00001620809,0.000038585527,0.000046780882,0.00003298605],"domain_scores_gemma":[0.9989213,0.0007783156,0.00011077999,0.00003408376,0.000114892464,0.000040664272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057726447,0.0005792864,0.0006177,0.00033329465,0.00027155664,0.00082765036,0.00069360144,0.00077067834,0.0017138867],"category_scores_gemma":[0.00252956,0.00042652938,0.0007781917,0.00037173808,0.00020417044,0.00050506357,0.0004565378,0.0008301752,0.0002416264],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004164971,0.000022700515,0.0025606658,0.00001424075,0.000022884971,0.000050324114,0.00001737938,0.9940003,0.00021884161,0.0008267432,0.00023530214,0.0019890699],"study_design_scores_gemma":[0.000013705506,0.000019955414,0.0003069566,0.0000037478596,0.000011032794,0.000012787334,0.000009099482,0.9984849,0.00013216033,0.0005117395,0.00049074634,0.0000032312885],"about_ca_topic_score_codex":0.03117092,"about_ca_topic_score_gemma":0.015553027,"teacher_disagreement_score":0.03117092,"about_ca_system_score_codex":0.0009916939,"about_ca_system_score_gemma":0.0018234651,"threshold_uncertainty_score":0.061978936},"labels":[],"label_agreement":null},{"id":"W4409984050","doi":"10.1002/cpt.3702","title":"Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community‐Dwelling Older Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Institute on Aging; National Health and Medical Research Council; Monash University; National Cancer Institute; National Institutes of Health; Australian Government; Commonwealth Scientific and Industrial Research Organisation; Medical Research Council","keywords":"Polypharmacy; Pharmacogenetics; Medicine; Genotype; Pharmacogenomics; Internal medicine; Pharmacology; Genetics; Biology; Gene","score_opus":0.15653193806827218,"score_gpt":0.4792447535376588,"score_spread":0.32271281546938657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409984050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993111,0.0002073549,0.000032659897,0.000029207124,0.0000022313923,0.0000056773715,0.00022572647,0.0000014102449,0.00018469119],"genre_scores_gemma":[0.9995295,0.00012309202,0.000055953347,0.000033710974,0.000007158668,0.0000058958763,0.00017749373,7.583573e-7,0.00006653362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992387,0.00020527597,0.00014782893,0.00014299106,0.00018688611,0.00007825085],"domain_scores_gemma":[0.9977336,0.00029434173,0.0014551748,0.0001570802,0.00016455728,0.00019511435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009761964,0.00020165798,0.00034670634,0.0007771216,0.0003011789,0.0004999621,0.00023274052,0.0005226068,0.00074747147],"category_scores_gemma":[0.0028358314,0.00026618663,0.00034818792,0.0010167602,0.00021205269,0.00050803035,0.00042285057,0.00040886996,0.000121476194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005704342,0.00002222431,0.9988385,0.0000065996796,0.00003186526,0.000018797924,0.000044089622,0.000011260606,0.000092566515,0.0000060058164,0.00003961874,0.0008314382],"study_design_scores_gemma":[0.0000038215994,0.000047512764,0.9996973,0.0000036553208,0.000012398193,0.00007319082,0.000049114944,0.000050891085,0.000016832604,0.000009468096,0.000034251414,0.0000016500697],"about_ca_topic_score_codex":0.0055578966,"about_ca_topic_score_gemma":0.008689547,"teacher_disagreement_score":0.0055578966,"about_ca_system_score_codex":0.0001722193,"about_ca_system_score_gemma":0.000171574,"threshold_uncertainty_score":0.011051059},"labels":[],"label_agreement":null},{"id":"W4410136343","doi":"10.1002/cpt.3694","title":"Populations Addressed in Vaccines Approved via the European Medicines Agency","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Marketing authorization; European union; Authorization; Family medicine; Agency (philosophy); Breastfeeding; Clinical trial; Randomized controlled trial; Inclusion (mineral); Environmental health; Pediatrics; Business; Internal medicine; Bioinformatics","score_opus":0.14306822477042724,"score_gpt":0.4754522399186983,"score_spread":0.33238401514827104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410136343","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27432126,0.48277175,0.03268828,0.026076248,0.0027482642,0.01750416,0.04392363,0.00032428408,0.1196421],"genre_scores_gemma":[0.86410725,0.061199266,0.02561514,0.020394007,0.0017120821,0.010358344,0.012524504,0.00012664877,0.003962756],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8851809,0.066676036,0.027416943,0.0054917587,0.01329871,0.0019356642],"domain_scores_gemma":[0.79218465,0.1149164,0.06778976,0.010450556,0.013121177,0.0015374592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.080574565,0.0005494606,0.0016978759,0.0042637056,0.00087882415,0.003728637,0.001043811,0.0020616376,0.010961366],"category_scores_gemma":[0.1587057,0.00048007525,0.0034242903,0.0054544304,0.0013811147,0.004029155,0.0024504086,0.002231699,0.0010778614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017278794,0.0006312494,0.15419273,0.034647513,0.010778928,0.0005463279,0.001629086,0.0011556175,0.0029630973,0.022297502,0.030358868,0.7235203],"study_design_scores_gemma":[0.008717386,0.009057165,0.3390403,0.037497446,0.018964102,0.0027912732,0.0018026602,0.0010658109,0.0070982305,0.025260245,0.5484555,0.00024984294],"about_ca_topic_score_codex":0.0014079048,"about_ca_topic_score_gemma":0.0021017033,"teacher_disagreement_score":0.080574565,"about_ca_system_score_codex":0.0018652829,"about_ca_system_score_gemma":0.005303545,"threshold_uncertainty_score":0.4261241},"labels":[],"label_agreement":null},{"id":"W4410483842","doi":"10.1002/cpt.3619","title":"Deciphering the Relative Contribution of <scp>CYP3A4</scp> Versus P‐Glycoprotein for the Shared Substrate Cyclosporine—Commentary on Lown <i>et al</i>.","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"P-glycoprotein; CYP3A4; Bioavailability; Pharmacokinetics; Glycoprotein; Substrate (aquarium); Pharmacology; Chemistry; Function (biology); Medicine; Internal medicine; Endocrinology; Biology; Biochemistry; Cell biology; Metabolism","score_opus":0.06248814900051441,"score_gpt":0.41263315606313505,"score_spread":0.35014500706262064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410483842","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018307447,0.030348862,0.00019959269,0.8587128,0.10969927,0.000011644986,0.000119923556,0.000042374653,0.00068249274],"genre_scores_gemma":[0.0020913903,0.017332818,0.00027398622,0.7904954,0.18774025,0.000026674497,0.000064016014,0.00003066154,0.001944886],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964978,0.000792947,0.00053142966,0.0005987391,0.0013078849,0.00027121737],"domain_scores_gemma":[0.97813386,0.011844282,0.0008976972,0.000454099,0.0070855943,0.001584495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067450507,0.0013596144,0.0022460707,0.0010688152,0.002028971,0.0027983056,0.0058172066,0.02657685,0.00349977],"category_scores_gemma":[0.021345852,0.0006390093,0.0016358225,0.0010621636,0.004740894,0.0063546463,0.0015699345,0.047121402,0.004668073],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006640226,0.000011856017,0.000095662945,0.00021489663,0.000018403018,0.00020562134,0.000042769774,0.000034623106,0.00014480286,0.0009937094,0.98839414,0.009777074],"study_design_scores_gemma":[0.000099118144,0.00009897155,0.00074914587,0.0008963866,0.000065708,0.0011255367,0.00023740093,0.00020834996,0.00043835823,0.006996439,0.98900807,0.00007654751],"about_ca_topic_score_codex":0.010060515,"about_ca_topic_score_gemma":0.015266984,"teacher_disagreement_score":0.02657685,"about_ca_system_score_codex":0.0047180154,"about_ca_system_score_gemma":0.0042162705,"threshold_uncertainty_score":0.03567171},"labels":[],"label_agreement":null},{"id":"W4413115464","doi":"10.1002/cpt.70021","title":"Rules of Thumb for Estimating Drug Levels in Breast Milk: How Well Do They Work?","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Rule of thumb; Work (physics); Breast milk; Drug; Medicine; Statistics; Computer science; Pharmacology; Mathematics; Biology; Engineering","score_opus":0.10350450613318889,"score_gpt":0.4536804243410876,"score_spread":0.3501759182078987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413115464","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09557708,0.10922375,0.7449737,0.018686762,0.0018230943,0.002656901,0.006657158,0.004897678,0.015503878],"genre_scores_gemma":[0.31395766,0.013988141,0.6616556,0.004621233,0.0005909753,0.0012899779,0.0027533981,0.00034552693,0.0007974343],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.94018364,0.035189737,0.007667892,0.0046065412,0.011680782,0.00067137886],"domain_scores_gemma":[0.83324176,0.1317752,0.014183971,0.0061212815,0.013271591,0.0014061858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.065314345,0.0032433497,0.0058878358,0.0051647313,0.0011529376,0.008299868,0.0052565346,0.003168606,0.0012935215],"category_scores_gemma":[0.24223931,0.0013122864,0.002771183,0.0047220765,0.0016955289,0.004148199,0.0022576046,0.0034358583,0.0018518982],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017068521,0.00057816977,0.13886474,0.0056903646,0.003734079,0.00072015525,0.0008544457,0.0394333,0.0015638515,0.007963155,0.034218673,0.7646723],"study_design_scores_gemma":[0.001457644,0.002988136,0.10524247,0.024181426,0.005396013,0.0049215155,0.0033950862,0.5551063,0.013938553,0.15500143,0.1268633,0.0015081358],"about_ca_topic_score_codex":0.008128376,"about_ca_topic_score_gemma":0.0106592225,"teacher_disagreement_score":0.065314345,"about_ca_system_score_codex":0.0015627228,"about_ca_system_score_gemma":0.004328932,"threshold_uncertainty_score":0.3454194},"labels":[],"label_agreement":null},{"id":"W4413140803","doi":"10.1002/cpt.70018","title":"Safety and Efficacy of the NMDA‐2b‐Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Allergan; Bausch Health; H. Lundbeck A/S; National Natural Science Foundation of China; Janssen Pharmaceuticals; Gilead Sciences; Yale University; Usona Institute; Eisai; Purdue University; Novo Nordisk; Teva Pharmaceutical Industries; Biogen; Canadian Institutes of Health Research; Sunovion; Sanofi; Pfizer","keywords":"Allosteric modulator; Allosteric regulation; NMDA receptor; Randomized controlled trial; Major depressive disorder; Pharmacology; Medicine; Psychology; Psychiatry; Internal medicine; Receptor; Cognition","score_opus":0.038910241321284435,"score_gpt":0.4279431943816881,"score_spread":0.38903295306040364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413140803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827806,0.0052640424,0.001034674,0.00064738916,0.0003978166,0.0052964576,0.0015657461,0.00023657839,0.0027767294],"genre_scores_gemma":[0.9764998,0.005466603,0.002526494,0.0011953722,0.0003083023,0.007730474,0.0015333404,0.00004463507,0.004694976],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996619,0.00016907585,0.00003388189,0.00005509107,0.000025542755,0.000054528326],"domain_scores_gemma":[0.99959856,0.000081919934,0.00010116108,0.000030742423,0.000032282125,0.0001553512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011912351,0.0013980271,0.0023898168,0.00039850624,0.00035117485,0.00094070134,0.0008660759,0.0015526888,0.0063611926],"category_scores_gemma":[0.0011373211,0.0006872905,0.0008392336,0.0003822635,0.0006886957,0.0008585725,0.0002935127,0.002048013,0.0013031401],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95098627,0.0078179035,0.0004531431,0.0010192425,0.0005031066,0.000057573325,0.00006465598,0.00034594274,0.010103601,0.00018936332,0.0011808319,0.027278403],"study_design_scores_gemma":[0.92548406,0.07109076,0.0011431477,0.000042791427,0.0002555121,0.00004814433,0.000022352284,0.00037895347,0.0006056624,0.00011912598,0.000794127,0.000015313513],"about_ca_topic_score_codex":0.0006860233,"about_ca_topic_score_gemma":0.0021081916,"teacher_disagreement_score":0.0063611926,"about_ca_system_score_codex":0.00048793992,"about_ca_system_score_gemma":0.0008463895,"threshold_uncertainty_score":0.021280289},"labels":[],"label_agreement":null},{"id":"W4414024538","doi":"10.1002/cpt.70059","title":"<scp>GenoStaR</scp> : An R Package for Genotype to Star Allele Conversion for Major Cytochrome <scp>P450</scp> Family of Genes","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Myriad Genetics; Assurex Health","keywords":"Pharmacogenomics; Genotyping; Genotype; CYP2D6; Genetics; Allele; CYP2C19; Pharmacogenetics; Biology; CYP2C9; Haplotype; Computational biology; Gene","score_opus":0.1804791213810116,"score_gpt":0.4970048930810093,"score_spread":0.31652577169999774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414024538","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013163854,0.0017538273,0.25908738,0.001236919,0.00052933884,0.00084659766,0.28569692,0.43186268,0.005822525],"genre_scores_gemma":[0.11529045,0.0022668988,0.39833286,0.003209379,0.0003870082,0.008436576,0.23123823,0.22964616,0.011192379],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757284,0.0010324011,0.00021798529,0.0005773455,0.00041082333,0.00018856312],"domain_scores_gemma":[0.98980623,0.0072894446,0.0010383709,0.00088030595,0.0007183029,0.00026733967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004289126,0.0032178373,0.0023572429,0.0017356442,0.00046280157,0.0019953183,0.0024301163,0.0009659629,0.058164563],"category_scores_gemma":[0.020038856,0.001402135,0.0029630233,0.001657856,0.0008770261,0.0015032156,0.0026613798,0.0029142033,0.030766133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016093545,0.00013333361,0.02095114,0.0046458608,0.0028705308,0.001070152,0.0005716929,0.015012684,0.005694926,0.010434049,0.8463829,0.09062337],"study_design_scores_gemma":[0.0021970544,0.0005984316,0.033017155,0.0011514245,0.0014612345,0.0019825576,0.00024044527,0.13610488,0.016976586,0.047847357,0.7578787,0.000544164],"about_ca_topic_score_codex":0.004448371,"about_ca_topic_score_gemma":0.0049677175,"teacher_disagreement_score":0.058164563,"about_ca_system_score_codex":0.0006891737,"about_ca_system_score_gemma":0.0026226393,"threshold_uncertainty_score":0.19457984},"labels":[],"label_agreement":null},{"id":"W4414618336","doi":"10.1002/cpt.70066","title":"Pharmacomicrobiomics","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Advanced Research","funders":"","keywords":"Microbiome; Drug; Leverage (statistics); Gut microbiome; Drug development; Standardization; Drug response; Affect (linguistics)","score_opus":0.1323773628249725,"score_gpt":0.5281699447942727,"score_spread":0.39579258196930023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414618336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009940206,0.42540115,0.29305235,0.18255223,0.0135894595,0.0011269734,0.008992927,0.0026088927,0.06273577],"genre_scores_gemma":[0.26552373,0.34627306,0.21021633,0.12812126,0.019344838,0.0044524665,0.0061977115,0.0016006859,0.01826996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97123826,0.018619884,0.0028054607,0.0021157651,0.0047579575,0.00046267506],"domain_scores_gemma":[0.92928404,0.052375928,0.005221876,0.005706107,0.006452758,0.0009592604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030301448,0.0011865377,0.0027035847,0.002621678,0.00073803036,0.0054448424,0.0022180977,0.0028532166,0.01175368],"category_scores_gemma":[0.075684704,0.000582712,0.0021928374,0.003339639,0.0060223346,0.004867145,0.003597916,0.005882284,0.0020443236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005771505,0.000115979055,0.006604432,0.013952025,0.0015547653,0.00093457854,0.0008400999,0.004494958,0.0012490471,0.3936389,0.09958393,0.47645405],"study_design_scores_gemma":[0.00011821884,0.00029176884,0.003782217,0.0066945557,0.0005925044,0.0018736055,0.00045648025,0.003868165,0.001452856,0.31919342,0.6615635,0.00011277766],"about_ca_topic_score_codex":0.0017936289,"about_ca_topic_score_gemma":0.0016113458,"teacher_disagreement_score":0.030301448,"about_ca_system_score_codex":0.0025513067,"about_ca_system_score_gemma":0.0069532157,"threshold_uncertainty_score":0.16025132},"labels":[],"label_agreement":null},{"id":"W4414982739","doi":"10.1002/cpt.70082","title":"Application of Physiologically Based Pharmacokinetic Modeling to Inform Dose Selection of Mezigdomide in a Phase I Drug–Drug Interaction Study","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Fungal Plant Pathogen Control","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; CYP3A; Pharmacokinetic interaction; Drug interaction; Dosing; Clinical pharmacology; P-glycoprotein; Clinical trial","score_opus":0.06323606875511817,"score_gpt":0.412159567254321,"score_spread":0.34892349849920284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414982739","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.387097,0.0035406896,0.5935469,0.0012232971,0.00010067131,0.0010306372,0.0018220034,0.0016239795,0.010014761],"genre_scores_gemma":[0.9269942,0.0012754967,0.06806294,0.0003954373,0.000026636264,0.00071092416,0.00069534866,0.00012390813,0.00171516],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995534,0.00024147573,0.000021693264,0.00007032125,0.00008349875,0.000029575998],"domain_scores_gemma":[0.9990132,0.0006936717,0.00013252543,0.000041061743,0.00008643741,0.00003301015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017464345,0.00081944035,0.0011337817,0.00037169288,0.00021080124,0.0015474688,0.0007489738,0.0010459747,0.001186723],"category_scores_gemma":[0.0031199178,0.0006805641,0.0010623478,0.0003057693,0.00022912057,0.00048286558,0.00048398832,0.0012827801,0.00042049625],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010497734,0.00038340545,0.005237394,0.00028864035,0.00026097678,0.0003532535,0.000109847824,0.9337926,0.020231541,0.0018826795,0.001287005,0.035123058],"study_design_scores_gemma":[0.00010982081,0.00072944607,0.0010721816,0.000017482238,0.0001442018,0.000112895075,0.000020215968,0.9891857,0.004947442,0.00110598,0.0025241387,0.000030593896],"about_ca_topic_score_codex":0.003321348,"about_ca_topic_score_gemma":0.0023993398,"teacher_disagreement_score":0.003321348,"about_ca_system_score_codex":0.00080820604,"about_ca_system_score_gemma":0.0016107383,"threshold_uncertainty_score":0.009236097},"labels":[],"label_agreement":null},{"id":"W4415617558","doi":"10.1002/cpt.70095","title":"Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SNC-Lavalin (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Pharmacovigilance; Pharmacogenomics; Adverse effect; Patient safety; Pharmacogenetics; Population; Health care; Drug reaction","score_opus":0.2948564498869957,"score_gpt":0.5553377293727445,"score_spread":0.2604812794857488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415617558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020908515,0.98829865,0.0031028914,0.006030026,0.0003035297,0.000022177086,0.00005429277,0.00007167576,0.0019076203],"genre_scores_gemma":[0.0025645383,0.9903556,0.0038790775,0.002221814,0.00048276494,0.000023354907,0.000076417295,0.000010172496,0.0003861777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975858,0.0010454791,0.00022910739,0.00018550144,0.0008667831,0.00008730354],"domain_scores_gemma":[0.9924286,0.0053022327,0.00069778366,0.0002234242,0.0011240728,0.00022389046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066609257,0.000993707,0.0020521355,0.0037839368,0.00023160137,0.002789023,0.0016684391,0.0022262523,0.0023557488],"category_scores_gemma":[0.008013646,0.0003261695,0.0018088322,0.0032191665,0.0009796452,0.0024186082,0.001636723,0.0044284933,0.0013066486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040061557,0.000059469094,0.0004305397,0.01585985,0.00046615527,0.00014528727,0.0001285003,0.0007773305,0.00055159297,0.014251672,0.022402551,0.9448869],"study_design_scores_gemma":[0.000049953916,0.00012201085,0.0021217056,0.022752574,0.0007392796,0.0011452055,0.00020231877,0.0009209034,0.0006371308,0.027675213,0.9435701,0.00006348072],"about_ca_topic_score_codex":0.0021927424,"about_ca_topic_score_gemma":0.0023528086,"teacher_disagreement_score":0.0066609257,"about_ca_system_score_codex":0.001825207,"about_ca_system_score_gemma":0.003978083,"threshold_uncertainty_score":0.035226762},"labels":[],"label_agreement":null},{"id":"W4415949485","doi":"10.1002/cpt.70120","title":"Evolving Standards: Good Clinical Practice Insights from US <scp>FDA</scp> , <scp>MHRA UK</scp> , and Health Canada","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Safeguarding; Clinical trial; Harmonization; Good clinical practice; Flexibility (engineering); Guideline; Quality (philosophy); Regulatory affairs; Best practice; Clinical Practice","score_opus":0.43095583600692045,"score_gpt":0.6335834548259027,"score_spread":0.20262761881898228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415949485","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020965189,0.02804121,0.007297972,0.9276709,0.0020071915,0.00028111044,0.00017446057,0.00013122689,0.03229932],"genre_scores_gemma":[0.1614389,0.10717895,0.11555865,0.590591,0.005014857,0.0010704899,0.00092328904,0.00086308393,0.017360792],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.6908121,0.12888849,0.018897569,0.014074781,0.13178827,0.015538787],"domain_scores_gemma":[0.43275315,0.22341672,0.016333863,0.019082338,0.2457154,0.06269854],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.26005793,0.0011229139,0.0020694397,0.0076931934,0.01753195,0.036570866,0.008618228,0.01907774,0.0049731866],"category_scores_gemma":[0.36073875,0.0014700777,0.0020006655,0.012875723,0.040503103,0.015481312,0.018802235,0.0346764,0.0016094415],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000108944485,0.00023831226,0.005863737,0.0023963011,0.00011864626,0.00071864726,0.038123183,0.0013610291,0.00060033175,0.2301136,0.3922679,0.32808936],"study_design_scores_gemma":[0.00009148129,0.00013532661,0.0064480235,0.009799611,0.00009573242,0.0005325845,0.020260477,0.0007600817,0.00056213146,0.09376535,0.8672459,0.00030328362],"about_ca_topic_score_codex":0.65377694,"about_ca_topic_score_gemma":0.7942265,"teacher_disagreement_score":0.828117,"about_ca_system_score_codex":0.17188297,"about_ca_system_score_gemma":0.5183105,"threshold_uncertainty_score":0.9604984},"labels":[],"label_agreement":null},{"id":"W4416850271","doi":"10.1002/cpt.70153","title":"An Update to the Clinical Pharmacogenetics Implementation Consortium ( <scp>CPIC</scp> ) <i>SLCO1B1</i> Allele Functionality Table Leveraging Evidence from Participants of Predominantly Sub‐Saharan African Ancestry","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Allele; Table (database); 1000 Genomes Project; Perspective (graphical); MEDLINE; Precision medicine","score_opus":0.3652053681126602,"score_gpt":0.5602017774771113,"score_spread":0.19499640936445112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416850271","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021339463,0.03328944,0.07941298,0.45296052,0.037109207,0.0059749084,0.12124678,0.014022617,0.23464409],"genre_scores_gemma":[0.07985601,0.039723538,0.28649443,0.300675,0.022591682,0.00837049,0.17379665,0.0050938604,0.08339829],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9706993,0.00943024,0.007839306,0.0012563649,0.009587746,0.0011869081],"domain_scores_gemma":[0.7896733,0.088872135,0.016226036,0.0092640985,0.08395915,0.012005293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035012465,0.0006450265,0.0014149493,0.0053477203,0.0013082891,0.005649436,0.0025809864,0.004059164,0.018337185],"category_scores_gemma":[0.12502286,0.00076451636,0.0017123944,0.005948387,0.0011191282,0.0032559263,0.0028420044,0.0061900117,0.007944588],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024375432,0.00016030621,0.00657721,0.0010864683,0.000102768616,0.00029920624,0.00026796563,0.00039745128,0.00055974675,0.0067473995,0.80605966,0.17749804],"study_design_scores_gemma":[0.00022163003,0.00015230014,0.011675881,0.0023787525,0.0002057575,0.00044698824,0.00018447342,0.00043068387,0.0008529924,0.004320618,0.9790419,0.000088009234],"about_ca_topic_score_codex":0.01602604,"about_ca_topic_score_gemma":0.024971772,"teacher_disagreement_score":0.035012465,"about_ca_system_score_codex":0.0030162297,"about_ca_system_score_gemma":0.025140643,"threshold_uncertainty_score":0.18516582},"labels":[],"label_agreement":null},{"id":"W4416910333","doi":"10.1002/cpt.70135","title":"Pathway‐Informed Machine Learning Identifies Genetic Predictors of High‐Dose Methotrexate‐Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; BC Children's Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Health Canada; Centers for Disease Control and Prevention; Genome British Columbia; BC Children’s Hospital Foundation; BC Children's Hospital; Michael Smith Health Research BC; Illumina; Provincial Health Services Authority; Thermo Fisher Scientific; Canadian Institutes of Health Research; Genome Canada","keywords":"Mucositis; Single-nucleotide polymorphism; Lymphoblastic Leukemia; Methotrexate; Genetic variation; Area under the curve; Acute lymphocytic leukemia; Risk assessment","score_opus":0.04262106986820542,"score_gpt":0.39241830252540616,"score_spread":0.34979723265720075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416910333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394375,0.0004792357,0.0043694978,0.0001692473,0.0000032926393,0.000016831926,0.00064356736,0.00006877286,0.00030580044],"genre_scores_gemma":[0.9966338,0.00017497972,0.0024142698,0.000020166131,0.0000028625016,0.00000860168,0.00062011974,0.000003497067,0.00012178678],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998154,0.00008123922,0.000011964663,0.000038798054,0.000028158245,0.000024528012],"domain_scores_gemma":[0.999527,0.00024210302,0.00010606697,0.000029983143,0.000059774753,0.000035036464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051793107,0.0002664728,0.00027026856,0.00057808537,0.00018435023,0.00044801892,0.00020019797,0.00023611308,0.0007477301],"category_scores_gemma":[0.0020503444,0.00011081515,0.00037772304,0.0005733835,0.00012841457,0.00016414383,0.0002909775,0.00038540133,0.00010775776],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080979173,0.00015958028,0.8590948,0.00007582323,0.000335158,0.00024113605,0.00008164792,0.064622425,0.0063956087,0.00028095758,0.0005725823,0.06733047],"study_design_scores_gemma":[0.00012350059,0.000270865,0.55109197,0.000042586053,0.0003721447,0.0006191249,0.0002128047,0.43927568,0.0040147137,0.0026032012,0.00134537,0.000028113911],"about_ca_topic_score_codex":0.01744483,"about_ca_topic_score_gemma":0.0248781,"teacher_disagreement_score":0.01744483,"about_ca_system_score_codex":0.0005661373,"about_ca_system_score_gemma":0.001117865,"threshold_uncertainty_score":0.034686565},"labels":[],"label_agreement":null},{"id":"W4417029509","doi":"10.1002/cpt.70160","title":"Navigating the Genetic Risk of Chemotherapy‐Induced Hearing Loss in the Stria Vascularis","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Research Institute in Oncology and Hematology; Children's Hospital of Winnipeg; Sunnybrook Hospital; CancerCare Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Toronto","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Ototoxicity; Hearing loss; Transcriptome; Genetic testing; Incidence (geometry); Inner ear; Risk assessment","score_opus":0.1281005476965739,"score_gpt":0.45693423455989707,"score_spread":0.32883368686332315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417029509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9402333,0.021437999,0.018868431,0.0077582556,0.00018274706,0.000078591635,0.0022197356,0.00024313896,0.008977811],"genre_scores_gemma":[0.9717003,0.011943753,0.011609157,0.0015809499,0.000121638586,0.00004516374,0.0009919251,0.00006953135,0.0019376411],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9996791,0.00009191872,0.000022328157,0.000101442456,0.000072795076,0.00003242744],"domain_scores_gemma":[0.9993443,0.00028687814,0.00018329654,0.000032209715,0.00008989882,0.000063278385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064126693,0.00036935788,0.00040342598,0.00092486216,0.00035753803,0.0010236274,0.0003755109,0.0006807074,0.0023417717],"category_scores_gemma":[0.0020621733,0.00017435853,0.00045319932,0.0006150936,0.0003702399,0.00049717014,0.0007204463,0.00092266966,0.00034771705],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015165274,0.0003740761,0.5308565,0.00067785126,0.0009902841,0.0050038584,0.0010481713,0.003104761,0.09890846,0.0064269723,0.0065552266,0.34453738],"study_design_scores_gemma":[0.00025474228,0.0018938314,0.79923886,0.001162591,0.0029494523,0.018826865,0.002214297,0.011733006,0.046080668,0.043213278,0.072198324,0.00023415197],"about_ca_topic_score_codex":0.0032957443,"about_ca_topic_score_gemma":0.0043030027,"teacher_disagreement_score":0.0032957443,"about_ca_system_score_codex":0.0003695114,"about_ca_system_score_gemma":0.0006960144,"threshold_uncertainty_score":0.007834017},"labels":[],"label_agreement":null},{"id":"W4417304124","doi":"10.1002/cpt.70154","title":"Prognostic Implication of <i>CYP2C19</i> Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Idorsia Pharmaceuticals; Chung-Ang University; Yuhan; Daewoong Pharmaceutical Company; Bayer HealthCare; Medicure; Sanofi; Amgen","keywords":"CYP2C19; Confidence interval; Risk stratification; Clinical endpoint; Genotype; Genotyping; Clopidogrel; Coronary stent","score_opus":0.04887897696284085,"score_gpt":0.4250951989225361,"score_spread":0.3762162219596953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417304124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878615,0.00025389108,0.000104429186,0.000086336884,0.000010294688,0.000005610501,0.0001354614,0.0000045015995,0.0006134329],"genre_scores_gemma":[0.999569,0.000051735235,0.00005281663,0.000032234348,0.000035847774,0.0000029401745,0.00017510302,0.000003043532,0.000077163524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995215,0.0001427301,0.000052947664,0.00010578213,0.00008161902,0.00009547527],"domain_scores_gemma":[0.99713886,0.0005975174,0.0014425124,0.00019409302,0.00016841975,0.0004585902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006444231,0.00030461446,0.00036469175,0.0005445007,0.00024490835,0.0006247164,0.00029232918,0.0007601318,0.0012620564],"category_scores_gemma":[0.0033629667,0.00014619564,0.0006118393,0.0006574109,0.00038313106,0.00030864924,0.00029562716,0.000678027,0.00030466556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006964893,0.000025493797,0.99652964,0.0000047948133,0.00005812361,0.00017032918,0.000019571453,0.0000697667,0.00055028807,0.000022628532,0.00010653542,0.0017463302],"study_design_scores_gemma":[0.000012616638,0.00012359598,0.99876165,0.0000034267316,0.000046340843,0.0004197989,0.000024959847,0.00034347572,0.00013192417,0.000043541,0.000082817845,0.000005829711],"about_ca_topic_score_codex":0.0010077932,"about_ca_topic_score_gemma":0.000992528,"teacher_disagreement_score":0.0012620564,"about_ca_system_score_codex":0.00016842085,"about_ca_system_score_gemma":0.00019618058,"threshold_uncertainty_score":0.0042220354},"labels":[],"label_agreement":null},{"id":"W7117119520","doi":"10.1002/cpt.70156","title":"Verekitug, a Novel Antibody Antagonist to the <scp>TSLP</scp> Receptor in Adults with Asthma: A 32‐Week Randomized Phase 1b Multiple Ascending‐Dose Trial","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Iron Ore Company (Canada)","funders":"Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Clinical endpoint; Dosing; Pharmacodynamics; Pharmacokinetics; Adverse effect; Biomarker; Thymic stromal lymphopoietin; Asthma","score_opus":0.050554718821735414,"score_gpt":0.432808475411597,"score_spread":0.3822537565898616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117119520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105996,0.0041540293,0.000525525,0.00042146057,0.00020928537,0.0020110977,0.00052516203,0.00011490915,0.0009787166],"genre_scores_gemma":[0.9878697,0.0033036906,0.001362701,0.0008632204,0.00028874664,0.0027014294,0.0009802361,0.000022550483,0.0026077505],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99965274,0.00014333105,0.000021848988,0.00007080119,0.000036235342,0.00007503077],"domain_scores_gemma":[0.99961394,0.000081065366,0.000091740556,0.000026291833,0.000027786662,0.00015920264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014059873,0.0016626646,0.0018219877,0.00028981027,0.00033951193,0.0008924999,0.00066555006,0.0015289598,0.002468449],"category_scores_gemma":[0.00073516817,0.0006546227,0.0011094132,0.00024277711,0.0007826862,0.0009127959,0.00032087683,0.0024274935,0.0006409422],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9345427,0.012797429,0.0012376952,0.0006049362,0.0005790799,0.00010889054,0.00012495964,0.0006292747,0.01592081,0.00016478918,0.0012943429,0.031994954],"study_design_scores_gemma":[0.85073966,0.14270772,0.0033379314,0.00002723453,0.00025116117,0.000073956326,0.000028477838,0.0006953517,0.001079947,0.00010026322,0.0009364009,0.00002183686],"about_ca_topic_score_codex":0.00075146096,"about_ca_topic_score_gemma":0.001468593,"teacher_disagreement_score":0.002468449,"about_ca_system_score_codex":0.00053460774,"about_ca_system_score_gemma":0.0007032171,"threshold_uncertainty_score":0.008257747},"labels":[],"label_agreement":null},{"id":"W7117768419","doi":"10.1002/cpt.70189","title":"Major Adverse Cardiac Events with Ondansetron: A Systematic Review","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nausea and vomiting management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; St. Joseph’s Healthcare Hamilton; Impact; Hamilton Medical Research Group; Ontario Clinical Oncology Group; University of Toronto","funders":"","keywords":"Ondansetron; Adverse effect; Torsades de pointes; Randomized controlled trial; Mace; Placebo; QT interval","score_opus":0.048872275969037746,"score_gpt":0.4353023206791349,"score_spread":0.3864300447100971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117768419","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086002273,0.99843353,0.00008248099,0.00013478703,0.000059733284,0.00014669358,0.00015271376,0.000006310683,0.00012388288],"genre_scores_gemma":[0.013259881,0.9853129,0.0003421122,0.00039588654,0.00010395836,0.0003101008,0.00016296328,0.000005033001,0.00010725856],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99664503,0.0010125198,0.0013618481,0.00027587614,0.0006066015,0.00009807826],"domain_scores_gemma":[0.98504514,0.010215878,0.0032298118,0.00020029634,0.0011580943,0.00015079763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052769543,0.0014559272,0.008138866,0.0050024292,0.0004414591,0.0018902898,0.0012151322,0.001456726,0.0042474177],"category_scores_gemma":[0.016253794,0.00087435567,0.0090889875,0.006050039,0.0005769012,0.0013574809,0.0010248491,0.000983806,0.000269711],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046900756,0.000019561783,0.0006065868,0.94383633,0.019046292,0.00007698577,0.00007188109,0.000109320594,0.00015789135,0.000102939,0.001428336,0.03407473],"study_design_scores_gemma":[0.0011331476,0.0005342711,0.007932532,0.6941974,0.27449307,0.00057341455,0.00017671348,0.00021535347,0.00038863678,0.00047943898,0.01981556,0.000060511033],"about_ca_topic_score_codex":0.0045501464,"about_ca_topic_score_gemma":0.013121957,"teacher_disagreement_score":0.008138866,"about_ca_system_score_codex":0.0022754744,"about_ca_system_score_gemma":0.0045917337,"threshold_uncertainty_score":0.02790749},"labels":[],"label_agreement":null}]}